Reference,Reference: DOI,Assay,Section,Antibodies,Control,Control: IC50 Cmp,Control: IC50 GeoMean,Control: IC50 Unit,Control: IC50 GSD,Variant,Variant: Pos,Variant: Mutations,# Results,Potency: IC50 Cmp,Potency: IC50 GeoMean,Potency: IC50 Unit,Potency: IC50 GSD,Fold Reduction: Cmp,Fold Reduction: Median,Fold Reduction: IQR25,Fold Reduction: IQR75,Correction
Rothenberger22,10.1038/s41587-022-01382-3,Pseudovirus (VSV),Extended Data Fig. 1,Bamlanivimab,Wild Type (B),=,13,ng/ml,1,Omicron/BA.1,(Various),(Various),2,>,1000,ng/ml,1,>,76.9,76.9,76.9,
Tada22,10.1016/j.ebiom.2022.103944,Pseudovirus (lentivirus),Figure 2e,Bamlanivimab,Wild Type (B.1),=,0.8,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493K + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,5000,ng/ml,1,>,1000,,,
Westendorf22,10.1016/j.celrep.2022.110812,Pseudovirus (VSV),Table 3D,Bamlanivimab,Wild Type (B.1),=,3.5,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,2,>,10000,ng/ml,1,>,1000,2762.3,2881.6,
Zhou21e,10.1126/science.abn8897,Pseudovirus (lentivirus),Figure 2C,Bamlanivimab,Wild Type (B.1),=,3.6,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Arora22f,10.1016/S1473-3099(22)00733-2,Pseudovirus (VSV),Figure B,Bamlanivimab,Wild Type (B.1),=,16,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,50000,ng/ml,1,>,1000,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Bamlanivimab,Wild Type (B.1),=,15,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,666.7,,,
Arora22b,10.1016/j.chom.2022.04.017,Pseudovirus (VSV),Supplementary Table 1,Bamlanivimab,Wild Type (B.1),=,23.2,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,431.6,,,
Arora22e,10.1016/S1473-3099(22)00422-4,Pseudovirus (VSV),Supplementary Figure B,Bamlanivimab,Wild Type (B.1),=,11.3,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,5000,ng/ml,1,>,442.5,,,
Cao22,10.1101/2022.02.07.479349,Pseudovirus (VSV),Table S2,Bamlanivimab,Wild Type (B.1),=,12.8,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,781.3,,,
Cao22d,10.1038/s41586-021-04385-3,Pseudovirus (VSV),Fig 4b,Bamlanivimab,Wild Type (B.1),=,13,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,769.2,,,
Cui22,10.1016/j.cell.2022.01.019,Pseudovirus (VSV),Figure 5C,Bamlanivimab,Wild Type (B.1),=,12.5,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,800,,,
Lusvarghi22,10.1126/scitranslmed.abn8543,Pseudovirus (lentivirus),Fig 4,Bamlanivimab,Wild Type (B.1),=,2.5,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Misasi22,10.1101/2022.07.29.502029,Pseudovirus (lentivirus),Figure 1A,Bamlanivimab,Wild Type (B.1),=,2.8,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10050,ng/ml,1,>,1000,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Table 1a,Bamlanivimab,Wild Type (B.1),=,4,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Zhou22b,10.1002/mco2.143,Pseudovirus,Figure 3A,Bamlanivimab,Wild Type (B.1),=,11,ng/ml,1,Omicron/BA.1,(Various),(Various),2,>,2000,ng/ml,1,>,181.8,181.8,181.8,
Tuekprakhon22,10.1016/j.cell.2022.06.005,Pseudovirus (lentivirus),Figure 3,Bamlanivimab,Wild Type (B),=,2,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Huo22b,10.1016/j.celrep.2022.111903,Pseudovirus (lentivirus),Supplementary Table 1B,Bamlanivimab,Wild Type (B),=,2,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Chen22e,10.1016/j.celrep.2022.111528,Pseudovirus (lentivirus),Figure 2B,Bamlanivimab,Wild Type (A),=,3,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Chen22,10.1101/2022.01.12.22269023,Pseudovirus (lentivirus),Fig 1h,Bamlanivimab,Wild Type (A),=,3,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Ai22,10.1016/j.chom.2022.05.001,Pseudovirus (VSV),Figure 3A,Bamlanivimab,Wild Type (B),=,3,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Gruell22b,10.1016/j.chom.2022.07.002,Pseudovirus (HIV),Figure 4B,Bamlanivimab,Wild Type (B),=,5,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Yuan22,10.1101/2022.03.13.484037,Pseudovirus (MLV),Figure 2A,Bamlanivimab,Wild Type (B),=,7,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,5000,ng/ml,1,>,714.3,,,
Iketani22,10.1038/s41586-022-04594-4,Pseudovirus (VSV),Figure 2b,Bamlanivimab,Wild Type (B.1),,,,,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,,,,,>,1000,,,
Aggarwal22,10.1038/s41564-022-01135-7,Virus isolate,Table 1,Bamlanivimab,Wild Type (A.2.2),=,32,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,312.5,,,
Touret22,10.1038/s41598-022-08559-5,Virus isolate,"Figure 1, Table 1",Bamlanivimab,Wild Type (B.1),=,13,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,1000,ng/ml,1,>,76.9,,,
Takashita22,10.1056/NEJMc2119407,Virus isolate,Table 1,Bamlanivimab,Wild Type (A),=,4.7,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,50000,ng/ml,1,>,1000,,,
VanBlargan22,10.1038/s41591-021-01678-y,Virus isolate,Figure 2g; Figure 3g,Bamlanivimab,Wild Type (B.1),=,11.8,ng/ml,1.2,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,2,>,10000,ng/ml,1,>,857.1,785.7,928.6,
Dejnirattisai22,10.1016/j.cell.2021.12.046,Virus isolate,"Figure 4C, Table S1",Bamlanivimab,Wild Type (B),=,6,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Ma22,10.1101/2022.02.25.482049,Virus isolate,Figure 2b,Bamlanivimab,Wild Type (A),=,80,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,100000,ng/ml,1,>,1000,,,
Cameroni21,10.1038/s41586-021-04386-2,Pseudovirus (VSV),"Figure 3b, 3c, Extended Data Table 2",Bamlanivimab,Wild Type (B.1),=,21.3,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,469.5,,,
Hoffmann22,10.1016/j.cell.2021.12.032,Pseudovirus (VSV),Figure 2C,Bamlanivimab,Wild Type (B.1),=,6,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Liu21l,10.1038/s41586-021-04388-0,Pseudovirus (VSV),Figure 2c,Bamlanivimab,Wild Type (B.1),=,0.7,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Sheward22,10.1016/S1473-3099(22)00129-3,Pseudovirus (HIV),Table 2,Bamlanivimab,Wild Type (B.1),=,7,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Wang22,10.1080/22221751.2022.2030200,Pseudovirus (VSV),Figure 2,Bamlanivimab,Wild Type (B.1),=,2.2,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Huang22,10.1016/j.immuni.2022.06.005,Pseudovirus (VSV),Figure 2,Bamlanivimab,Wild Type (B),=,10,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,100000,ng/ml,1,>,1000,,,
Gruell22,10.1038/s41591-021-01676-0,Pseudovirus (HIV),Fig 2,Bamlanivimab,Wild Type (B),=,3.1,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Boschi22,10.1093/cid/ciac143,Virus isolate,Figure 1A,Bamlanivimab,Wild Type (B.1.1),=,0.2,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + G339D + S371L + S373P + S375F + K417N + G446S + S477N + T478K + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + A701V + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,3500,ng/ml,1,>,1000,,,Censored at 3500
Rothenberger22,10.1038/s41587-022-01382-3,Pseudovirus (VSV),Extended Data Fig. 1,Etesevimab,Wild Type (B),=,6.4,ng/ml,1,Omicron/BA.1,(Various),(Various),2,>,1000,ng/ml,1,>,156.3,156.3,156.3,
Tada22,10.1016/j.ebiom.2022.103944,Pseudovirus (lentivirus),Figure 2e,Etesevimab,Wild Type (B.1),=,5.3,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493K + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,5000,ng/ml,1,>,943.4,,,
Westendorf22,10.1016/j.celrep.2022.110812,Pseudovirus (VSV),Table 3D,Etesevimab,Wild Type (B.1),=,29.5,ng/ml,1.1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,2,>,10000,ng/ml,1,>,339.9,331.2,348.5,
Zhou21e,10.1126/science.abn8897,Pseudovirus (lentivirus),Figure 2C,Etesevimab,Wild Type (B.1),=,50.5,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,198,,,
Arora22f,10.1016/S1473-3099(22)00733-2,Pseudovirus (VSV),Figure B,Etesevimab,Wild Type (B.1),=,53,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,50000,ng/ml,1,>,943.4,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Etesevimab,Wild Type (B.1),=,32,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,312.5,,,
Arora22b,10.1016/j.chom.2022.04.017,Pseudovirus (VSV),Supplementary Table 1,Etesevimab,Wild Type (B.1),=,20.6,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,486.1,,,
Arora22e,10.1016/S1473-3099(22)00422-4,Pseudovirus (VSV),Supplementary Figure B,Etesevimab,Wild Type (B.1),=,22.2,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,5000,ng/ml,1,>,225.2,,,
Cao22,10.1101/2022.02.07.479349,Pseudovirus (VSV),Table S2,Etesevimab,Wild Type (B.1),=,31.6,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,316.5,,,
Cao22d,10.1038/s41586-021-04385-3,Pseudovirus (VSV),Fig 4b,Etesevimab,Wild Type (B.1),=,32,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,312.5,,,
Cui22,10.1016/j.cell.2022.01.019,Pseudovirus (VSV),Figure 5C,Etesevimab,Wild Type (B.1),=,39.3,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,254.5,,,
Lusvarghi22,10.1126/scitranslmed.abn8543,Pseudovirus (lentivirus),Fig 4,Etesevimab,Wild Type (B.1),=,25,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,400,,,
Misasi22,10.1101/2022.07.29.502029,Pseudovirus (lentivirus),Figure 1A,Etesevimab,Wild Type (B.1),=,23.3,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10050,ng/ml,1,>,432.3,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Table 1a,Etesevimab,Wild Type (B.1),=,12,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,9253,ng/ml,1,=,771.1,,,
Zhou22b,10.1002/mco2.143,Pseudovirus,Figure 3A,Etesevimab,Wild Type (B.1),=,24,ng/ml,1,Omicron/BA.1,(Various),(Various),2,>,2000,ng/ml,1,>,83.3,83.3,83.3,
Tuekprakhon22,10.1016/j.cell.2022.06.005,Pseudovirus (lentivirus),Figure 3,Etesevimab,Wild Type (B),=,14,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,714.3,,,
Huo22b,10.1016/j.celrep.2022.111903,Pseudovirus (lentivirus),Supplementary Table 1B,Etesevimab,Wild Type (B),=,14,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,714.3,,,
Chen22e,10.1016/j.celrep.2022.111528,Pseudovirus (lentivirus),Figure 2B,Etesevimab,Wild Type (A),=,19,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,526.3,,,
Ai22,10.1016/j.chom.2022.05.001,Pseudovirus (VSV),Figure 3A,Etesevimab,Wild Type (B),=,7,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Gruell22b,10.1016/j.chom.2022.07.002,Pseudovirus (HIV),Figure 4B,Etesevimab,Wild Type (B),=,18,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,555.6,,,
Ju22,10.1038/s41422-022-00638-6,Pseudovirus (HIV),Figure S1F,Etesevimab,Wild Type (B),=,12,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,50000,ng/ml,1,>,1000,,,
Wang22c,10.1038/s41586-022-04466-x,Pseudovirus (VSV),Supplmentary Table 2,Etesevimab,Wild Type (B),=,19,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,526.3,,,
Yuan22,10.1101/2022.03.13.484037,Pseudovirus (MLV),Figure 2A,Etesevimab,Wild Type (B),=,9,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,5000,ng/ml,1,>,555.6,,,
Iketani22,10.1038/s41586-022-04594-4,Pseudovirus (VSV),Figure 2b,Etesevimab,Wild Type (B.1),,,,,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,,,,,>,428,,,
Bruel22,10.1038/s41591-022-01792-5,Virus isolate,Table 1,Etesevimab,Delta,=,3.8,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,9000,ng/ml,1,>,1000,,,
Planas21c,10.1038/s41586-021-04389-z,Virus isolate,Extended Data Fig 4,Etesevimab,Delta,=,15.4,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,9000,ng/ml,1,>,584.4,,,
Touret22,10.1038/s41598-022-08559-5,Virus isolate,"Figure 1, Table 1",Etesevimab,Wild Type (B.1),=,49,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,1000,ng/ml,1,>,20.4,,,
Takashita22,10.1056/NEJMc2119407,Virus isolate,Table 1,Etesevimab,Wild Type (A),=,18.2,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,50000,ng/ml,1,>,1000,,,
VanBlargan22,10.1038/s41591-021-01678-y,Virus isolate,Figure 2g; Figure 3g,Etesevimab,Wild Type (B.1),=,60,ng/ml,1.2,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,2,=,9148.2,ng/ml,1.1,=,153.2,146,160.3,
Dejnirattisai22,10.1016/j.cell.2021.12.046,Virus isolate,"Figure 4C, Table S1",Etesevimab,Wild Type (B),=,34,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,294.1,,,
Ma22,10.1101/2022.02.25.482049,Virus isolate,Figure 2b,Etesevimab,Wild Type (A),=,137,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,100000,ng/ml,1,>,729.9,,,
Cameroni21,10.1038/s41586-021-04386-2,Pseudovirus (VSV),"Figure 3b, 3c, Extended Data Table 2",Etesevimab,Wild Type (B.1),=,59.2,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,168.9,,,
Hoffmann22,10.1016/j.cell.2021.12.032,Pseudovirus (VSV),Figure 2C,Etesevimab,Wild Type (B.1),=,20,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,500,,,
Liu21l,10.1038/s41586-021-04388-0,Pseudovirus (VSV),Figure 2c,Etesevimab,Wild Type (B.1),=,8.6,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Sheward22,10.1016/S1473-3099(22)00129-3,Pseudovirus (HIV),Table 2,Etesevimab,Wild Type (B.1),=,40,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,250,,,
Wang22,10.1080/22221751.2022.2030200,Pseudovirus (VSV),Figure 2,Etesevimab,Wild Type (B.1),=,6.9,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Huang22,10.1016/j.immuni.2022.06.005,Pseudovirus (VSV),Figure 2,Etesevimab,Wild Type (B),=,20,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,100000,ng/ml,1,>,1000,,,
Gruell22,10.1038/s41591-021-01676-0,Pseudovirus (HIV),Fig 2,Etesevimab,Wild Type (B),=,19.4,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,515.5,,,
Boschi22,10.1093/cid/ciac143,Virus isolate,Figure 1A,Etesevimab,Wild Type (B.1.1),=,6,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + G339D + S371L + S373P + S375F + K417N + G446S + S477N + T478K + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + A701V + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,3500,ng/ml,1,=,600,,,Censored at 3500
Tada22,10.1016/j.ebiom.2022.103944,Pseudovirus (lentivirus),Figure 2e,Bamlanivimab + Etesevimab,Wild Type (B.1),=,5.1,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493K + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,5000,ng/ml,1,>,980.4,,,
Arora22f,10.1016/S1473-3099(22)00733-2,Pseudovirus (VSV),Figure B,Bamlanivimab + Etesevimab,Wild Type (B.1),=,18,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,50000,ng/ml,1,>,1000,,,
Arora22b,10.1016/j.chom.2022.04.017,Pseudovirus (VSV),Supplementary Table 1,Bamlanivimab + Etesevimab,Wild Type (B.1),=,13.5,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,743.5,,,
Arora22e,10.1016/S1473-3099(22)00422-4,Pseudovirus (VSV),Supplementary Figure B,Bamlanivimab + Etesevimab,Wild Type (B.1),=,16.9,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,5000,ng/ml,1,>,295.9,,,
Lusvarghi22,10.1126/scitranslmed.abn8543,Pseudovirus (lentivirus),Fig 4,Bamlanivimab + Etesevimab,Wild Type (B.1),=,3.9,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Misasi22,10.1101/2022.07.29.502029,Pseudovirus (lentivirus),Figure 1B,Bamlanivimab + Etesevimab,Wild Type (B.1),=,5.6,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10050,ng/ml,1,>,1000,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Table 1a,Bamlanivimab + Etesevimab,Wild Type (B.1),=,5,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Chen22e,10.1016/j.celrep.2022.111528,Pseudovirus (lentivirus),Figure 2C,Bamlanivimab + Etesevimab,Wild Type (A),=,1.5,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Park22,10.1126/science.adc9127,Pseudovirus (VSV),Fig 1A,Bamlanivimab + Etesevimab,Wild Type (B),=,17,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,588.2,,,
Yuan22,10.1101/2022.03.13.484037,Pseudovirus (MLV),Figure 2A,Bamlanivimab + Etesevimab,Wild Type (B),=,9,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,5000,ng/ml,1,>,555.6,,,
Planas21c,10.1038/s41586-021-04389-z,Virus isolate,Extended Data Fig 4,Bamlanivimab + Etesevimab,Delta,=,20.5,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,9000,ng/ml,1,>,439,,,
Takashita22,10.1056/NEJMc2119407,Virus isolate,Table 1,Bamlanivimab + Etesevimab,Wild Type (A),=,25.2,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,20000,ng/ml,1,>,793.7,,,Combination therapies in this study were specified at ng/ml of each component so needs to multiply by 2
VanBlargan22,10.1038/s41591-021-01678-y,Virus isolate,Figure 2g; Figure 3g,Bamlanivimab + Etesevimab,Wild Type (B.1),=,21.8,ng/ml,1.1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,2,>,10000,ng/ml,1,>,463.1,431.6,494.7,
Cameroni21,10.1038/s41586-021-04386-2,Pseudovirus (VSV),"Figure 3c, Extended Data Table 2",Bamlanivimab + Etesevimab,Wild Type (B.1),=,23,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,434.8,,,
Hoffmann22,10.1016/j.cell.2021.12.032,Pseudovirus (VSV),Figure 2C,Bamlanivimab + Etesevimab,Wild Type (B.1),=,5,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Liu21l,10.1038/s41586-021-04388-0,Pseudovirus (VSV),Figure 2c,Bamlanivimab + Etesevimab,Wild Type (B.1),=,2.4,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Boschi22,10.1093/cid/ciac143,Virus isolate,Figure 1A,Bamlanivimab + Etesevimab,Wild Type (B.1.1),=,0.5,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + G339D + S371L + S373P + S375F + K417N + G446S + S477N + T478K + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + A701V + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,3500,ng/ml,1,>,1000,,,Censored at 3500
Rothenberger22,10.1038/s41587-022-01382-3,Pseudovirus (VSV),Extended Data Fig. 1,Casirivimab,Wild Type (B),=,3.2,ng/ml,1,Omicron/BA.1,(Various),(Various),2,>,1000,ng/ml,1,>,312.5,312.5,312.5,
Tada22,10.1016/j.ebiom.2022.103944,Pseudovirus (lentivirus),Figure 2e,Casirivimab,Wild Type (B.1),=,2.1,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493K + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,5000,ng/ml,1,>,1000,,,
Westendorf22,10.1016/j.celrep.2022.110812,Pseudovirus (VSV),Table 3D,Casirivimab,Wild Type (B.1),=,6.4,ng/ml,1.2,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,2,>,10000,ng/ml,1,>,1000,1430.1,1758.8,
Zhou21e,10.1126/science.abn8897,Pseudovirus (lentivirus),Figure 2C,Casirivimab,Wild Type (B.1),=,6.1,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Arora22f,10.1016/S1473-3099(22)00733-2,Pseudovirus (VSV),Figure B,Casirivimab,Wild Type (B.1),=,21,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,1890,ng/ml,1,=,90,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Casirivimab,Wild Type (B.1),=,5.6,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Arora22b,10.1016/j.chom.2022.04.017,Pseudovirus (VSV),Supplementary Table 1,Casirivimab,Wild Type (B.1),=,19.1,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,2266,ng/ml,1,=,118.3,,,
Arora22e,10.1016/S1473-3099(22)00422-4,Pseudovirus (VSV),Supplementary Figure B,Casirivimab,Wild Type (B.1),=,12.1,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,1456,ng/ml,1,=,120.3,,,
Cao22,10.1101/2022.02.07.479349,Pseudovirus (VSV),Table S2,Casirivimab,Wild Type (B.1),=,5.3,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Cao22d,10.1038/s41586-021-04385-3,Pseudovirus (VSV),Fig 4b,Casirivimab,Wild Type (B.1),=,5,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Cui22,10.1016/j.cell.2022.01.019,Pseudovirus (VSV),Figure 5C,Casirivimab,Wild Type (B.1),=,6.1,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Misasi22,10.1101/2022.07.29.502029,Pseudovirus (lentivirus),Figure 1A,Casirivimab,Wild Type (B.1),=,5.3,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10050,ng/ml,1,>,1000,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Table 1a,Casirivimab,Wild Type (B.1),=,5,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Willett22,10.1101/2022.05.25.493397,Pseudovirus (lentivirus),Figure 1L,Casirivimab,Wild Type (B.1),=,3,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,25000,ng/ml,1,>,1000,,,
Yamasoba22,10.1016/j.cell.2022.04.035,Pseudovirus (HIV),Figure 2E,Casirivimab,Wild Type (B.1),=,8.7,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Zhou22b,10.1002/mco2.143,Pseudovirus,Figure 3A,Casirivimab,Wild Type (B.1),=,18,ng/ml,1,Omicron/BA.1,(Various),(Various),2,>,2000,ng/ml,1,>,111.1,111.1,111.1,
Tuekprakhon22,10.1016/j.cell.2022.06.005,Pseudovirus (lentivirus),Figure 3,Casirivimab,Wild Type (B),=,1,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Huo22b,10.1016/j.celrep.2022.111903,Pseudovirus (lentivirus),Supplementary Table 1B,Casirivimab,Wild Type (B),=,1,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Chen22e,10.1016/j.celrep.2022.111528,Pseudovirus (lentivirus),Figure 2B,Casirivimab,Wild Type (A),=,2,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Chen22,10.1101/2022.01.12.22269023,Pseudovirus (lentivirus),Fig 1h,Casirivimab,Wild Type (A),=,2,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Ai22,10.1016/j.chom.2022.05.001,Pseudovirus (VSV),Figure 3A,Casirivimab,Wild Type (B),=,2,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Du22,10.1126/sciimmunol.abp9312,Pseudovirus,Fig 1E,Casirivimab,Wild Type (B),=,3.2,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,1229,ng/ml,1,=,384.1,,,
Gruell22b,10.1016/j.chom.2022.07.002,Pseudovirus (HIV),Figure 4B,Casirivimab,Wild Type (B),=,5,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Ju22,10.1038/s41422-022-00638-6,Pseudovirus (HIV),Figure S1F,Casirivimab,Wild Type (B),=,2,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,50000,ng/ml,1,>,1000,,,
Yuan22,10.1101/2022.03.13.484037,Pseudovirus (MLV),Figure 2A,Casirivimab,Wild Type (B),=,6,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,5000,ng/ml,1,>,833.3,,,
Iketani22,10.1038/s41586-022-04594-4,Pseudovirus (VSV),Figure 2b,Casirivimab,Wild Type (B.1),,,,,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,,,,,>,1000,,,
Aggarwal22,10.1038/s41564-022-01135-7,Virus isolate,Table 1,Casirivimab,Wild Type (A.2.2),=,27,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,37,,,LOD is 10000
Planas22b,10.1101/2022.11.17.516888,Virus isolate,Figure 3b,Casirivimab,Wild Type (B.1),=,1.7,ng/ml,1,Omicron/BA.2,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,Variant was erroneously labelled BA.1 changed to BA.2
Bruel22,10.1038/s41591-022-01792-5,Virus isolate,Table 1,Casirivimab,Delta,=,0.6,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,9000,ng/ml,1,>,1000,,,
Planas21c,10.1038/s41586-021-04389-z,Virus isolate,Extended Data Fig 4,Casirivimab,Delta,=,3.1,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,9000,ng/ml,1,>,1000,,,
Touret22,10.1038/s41598-022-08559-5,Virus isolate,"Figure 1, Table 1",Casirivimab,Wild Type (B.1),=,8,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,1000,ng/ml,1,>,125,,,
Takashita22,10.1056/NEJMc2119407,Virus isolate,Table 1,Casirivimab,Wild Type (A),=,2.8,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,14110.7,ng/ml,1,>,1000,,,
Takashita22c,10.1056/NEJMc2207519,Virus isolate,Table 1,Casirivimab,Wild Type (A),=,6.1,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,50000,ng/ml,1,>,1000,,,
Meng22,10.1038/s41586-022-04474-x,Virus isolate,Figure 1a,Casirivimab,Delta,=,4.7,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Ohashi22,10.1101/2022.02.27.482147,Virus isolate,Table 1,Casirivimab,Wild Type (A),=,13.9,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,719.4,,,
VanBlargan22,10.1038/s41591-021-01678-y,Virus isolate,Figure 2g; Figure 3g,Casirivimab,Wild Type (B.1),=,12.4,ng/ml,1.1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,2,>,10000,ng/ml,1,>,811.7,763,860.4,
Dejnirattisai22,10.1016/j.cell.2021.12.046,Virus isolate,"Figure 4C, Table S1",Casirivimab,Wild Type (B),=,4,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Ma22,10.1101/2022.02.25.482049,Virus isolate,Figure 2b,Casirivimab,Wild Type (A),=,46,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,100000,ng/ml,1,>,1000,,,
Du22,10.1126/sciimmunol.abp9312,Virus isolate,Fig 1E,Casirivimab,Wild Type (B),=,3.4,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,1000,ng/ml,1,>,294.1,,,
Cameroni21,10.1038/s41586-021-04386-2,Pseudovirus (VSV),"Figure 3b, 3c, Extended Data Table 2",Casirivimab,Wild Type (B.1),=,8.9,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Hoffmann22,10.1016/j.cell.2021.12.032,Pseudovirus (VSV),Figure 2C,Casirivimab,Wild Type (B.1),=,4,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,963,ng/ml,1,=,240.8,,,
Liu21l,10.1038/s41586-021-04388-0,Pseudovirus (VSV),Figure 2c,Casirivimab,Wild Type (B.1),=,0.3,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Sheward22,10.1016/S1473-3099(22)00129-3,Pseudovirus (HIV),Table 2,Casirivimab,Wild Type (B.1),=,9,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Syed21,10.1101/2021.12.20.21268048,VLP,Table 2,Casirivimab,Wild Type (B.1),=,36,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,1000,ng/ml,1,>,27.8,,,
Wang22,10.1080/22221751.2022.2030200,Pseudovirus (VSV),Figure 2,Casirivimab,Wild Type (B.1),=,2,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Huang22,10.1016/j.immuni.2022.06.005,Pseudovirus (VSV),Figure 2,Casirivimab,Wild Type (B),=,11,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,100000,ng/ml,1,>,1000,,,
Gruell22,10.1038/s41591-021-01676-0,Pseudovirus (HIV),Fig 2,Casirivimab,Wild Type (B),=,1.9,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Boschi22,10.1093/cid/ciac143,Virus isolate,Figure 1B,Casirivimab,Wild Type (B.1.1),=,0.7,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + G339D + S371L + S373P + S375F + K417N + G446S + S477N + T478K + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + A701V + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,12000,ng/ml,1,>,1000,,,Censored at 12000
Rothenberger22,10.1038/s41587-022-01382-3,Pseudovirus (VSV),Extended Data Fig. 1,Imdevimab,Wild Type (B),=,3.3,ng/ml,1,Omicron/BA.1,(Various),(Various),2,>,1000,ng/ml,1,>,303,303,303,
Tada22,10.1016/j.ebiom.2022.103944,Pseudovirus (lentivirus),Figure 2e,Imdevimab,Wild Type (B.1),=,2,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493K + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,5000,ng/ml,1,>,1000,,,
Westendorf22,10.1016/j.celrep.2022.110812,Pseudovirus (VSV),Table 3D,Imdevimab,Wild Type (B.1),=,21,ng/ml,1.1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,2,>,10000,ng/ml,1,>,476.3,464.4,488.1,
Zhou21e,10.1126/science.abn8897,Pseudovirus (lentivirus),Figure 2C,Imdevimab,Wild Type (B.1),=,20,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,500,,,
Arora22f,10.1016/S1473-3099(22)00733-2,Pseudovirus (VSV),Figure B,Imdevimab,Wild Type (B.1),=,19,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,50000,ng/ml,1,>,1000,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Imdevimab,Wild Type (B.1),=,5.7,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Arora22b,10.1016/j.chom.2022.04.017,Pseudovirus (VSV),Supplementary Table 1,Imdevimab,Wild Type (B.1),=,23.7,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,421.4,,,
Arora22e,10.1016/S1473-3099(22)00422-4,Pseudovirus (VSV),Supplementary Figure B,Imdevimab,Wild Type (B.1),=,11.8,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,5000,ng/ml,1,>,423.7,,,
Cao22,10.1101/2022.02.07.479349,Pseudovirus (VSV),Table S2,Imdevimab,Wild Type (B.1),=,5.4,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Cao22d,10.1038/s41586-021-04385-3,Pseudovirus (VSV),Fig 4b,Imdevimab,Wild Type (B.1),=,5,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Cui22,10.1016/j.cell.2022.01.019,Pseudovirus (VSV),Figure 5C,Imdevimab,Wild Type (B.1),=,9.6,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Misasi22,10.1101/2022.07.29.502029,Pseudovirus (lentivirus),Figure 1A,Imdevimab,Wild Type (B.1),=,10.8,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10050,ng/ml,1,>,933.1,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Table 1a,Imdevimab,Wild Type (B.1),=,1,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,7586,ng/ml,1,>,1000,,,
Willett22,10.1101/2022.05.25.493397,Pseudovirus (lentivirus),Figure 1L,Imdevimab,Wild Type (B.1),=,2,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,25000,ng/ml,1,>,1000,,,
Yamasoba22,10.1016/j.cell.2022.04.035,Pseudovirus (HIV),Figure 2E,Imdevimab,Wild Type (B.1),=,6.6,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Zhou22b,10.1002/mco2.143,Pseudovirus,Figure 3A,Imdevimab,Wild Type (B.1),=,43,ng/ml,1,Omicron/BA.1,(Various),(Various),2,>,2000,ng/ml,1,>,46.5,46.5,46.5,
Tuekprakhon22,10.1016/j.cell.2022.06.005,Pseudovirus (lentivirus),Figure 3,Imdevimab,Wild Type (B),=,2,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Huo22b,10.1016/j.celrep.2022.111903,Pseudovirus (lentivirus),Supplementary Table 1B,Imdevimab,Wild Type (B),=,2,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Chen22e,10.1016/j.celrep.2022.111528,Pseudovirus (lentivirus),Figure 2B,Imdevimab,Wild Type (A),=,9,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Chen22,10.1101/2022.01.12.22269023,Pseudovirus (lentivirus),Fig 1h,Imdevimab,Wild Type (A),=,9,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Ai22,10.1016/j.chom.2022.05.001,Pseudovirus (VSV),Figure 3A,Imdevimab,Wild Type (B),=,3,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Du22,10.1126/sciimmunol.abp9312,Pseudovirus,Fig 1E,Imdevimab,Wild Type (B),=,4.7,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,6000,ng/ml,1,>,1000,,,
Gruell22b,10.1016/j.chom.2022.07.002,Pseudovirus (HIV),Figure 4B,Imdevimab,Wild Type (B),=,5,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Ju22,10.1038/s41422-022-00638-6,Pseudovirus (HIV),Figure S1F,Imdevimab,Wild Type (B),=,2,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,50000,ng/ml,1,>,1000,,,
Wang22b,10.1101/2022.01.30.478305,Pseudovirus (HIV),Figure 1B,Imdevimab,Wild Type (B),=,2.3,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Wang22c,10.1038/s41586-022-04466-x,Pseudovirus (VSV),Supplmentary Table 2,Imdevimab,Wild Type (B),=,13,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,769.2,,,
Yuan22,10.1101/2022.03.13.484037,Pseudovirus (MLV),Figure 2A,Imdevimab,Wild Type (B),=,25,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,5000,ng/ml,1,>,200,,,
Iketani22,10.1038/s41586-022-04594-4,Pseudovirus (VSV),Figure 2b,Imdevimab,Wild Type (B.1),,,,,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,,,,,>,1000,,,
Aggarwal22,10.1038/s41564-022-01135-7,Virus isolate,Table 1,Imdevimab,Wild Type (A.2.2),=,25,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,40,,,LOD is 10000
Planas22b,10.1101/2022.11.17.516888,Virus isolate,Figure 3b,Imdevimab,Wild Type (B.1),=,2.1,ng/ml,1,Omicron/BA.2,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,112,ng/ml,1,=,53.3,,,Variant was erroneously labelled BA.1 changed to BA.2
Bruel22,10.1038/s41591-022-01792-5,Virus isolate,Table 1,Imdevimab,Delta,=,1.2,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,9000,ng/ml,1,>,1000,,,
Planas21c,10.1038/s41586-021-04389-z,Virus isolate,Extended Data Fig 4,Imdevimab,Delta,=,6.5,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,9000,ng/ml,1,>,1000,,,
Touret22,10.1038/s41598-022-08559-5,Virus isolate,"Figure 1, Table 1",Imdevimab,Wild Type (B.1),=,9,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,1000,ng/ml,1,>,111.1,,,
Takashita22,10.1056/NEJMc2119407,Virus isolate,Table 1,Imdevimab,Wild Type (A),=,3,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,50000,ng/ml,1,>,1000,,,
Takashita22c,10.1056/NEJMc2207519,Virus isolate,Table 1,Imdevimab,Wild Type (A),=,7.4,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,50000,ng/ml,1,>,1000,,,
Meng22,10.1038/s41586-022-04474-x,Virus isolate,Figure 1a,Imdevimab,Delta,=,7,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Ohashi22,10.1101/2022.02.27.482147,Virus isolate,Table 1,Imdevimab,Wild Type (A),=,12.5,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,800,,,
VanBlargan22,10.1038/s41591-021-01678-y,Virus isolate,Figure 2g; Figure 3g,Imdevimab,Wild Type (B.1),=,36.1,ng/ml,1.2,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,2,>,10000,ng/ml,1,>,280.4,259.2,301.5,
Dejnirattisai22,10.1016/j.cell.2021.12.046,Virus isolate,"Figure 4C, Table S1",Imdevimab,Wild Type (B),=,32,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,312.5,,,
Ma22,10.1101/2022.02.25.482049,Virus isolate,Figure 2b,Imdevimab,Wild Type (A),=,46,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,100000,ng/ml,1,>,1000,,,
Cameroni21,10.1038/s41586-021-04386-2,Pseudovirus (VSV),"Figure 3b, 3c, Extended Data Table 2",Imdevimab,Wild Type (B.1),=,25.1,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,398.4,,,
Hoffmann22,10.1016/j.cell.2021.12.032,Pseudovirus (VSV),Figure 2C,Imdevimab,Wild Type (B.1),=,9,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Liu21l,10.1038/s41586-021-04388-0,Pseudovirus (VSV),Figure 2c,Imdevimab,Wild Type (B.1),=,0.6,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Sheward22,10.1016/S1473-3099(22)00129-3,Pseudovirus (HIV),Table 2,Imdevimab,Wild Type (B.1),=,8,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Syed21,10.1101/2021.12.20.21268048,VLP,Table 2,Imdevimab,Wild Type (B.1),=,34,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,1000,ng/ml,1,>,29.4,,,
Wang22,10.1080/22221751.2022.2030200,Pseudovirus (VSV),Figure 2,Imdevimab,Wild Type (B.1),=,2.8,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Huang22,10.1016/j.immuni.2022.06.005,Pseudovirus (VSV),Figure 2,Imdevimab,Wild Type (B),=,6,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,100000,ng/ml,1,>,1000,,,
Gruell22,10.1038/s41591-021-01676-0,Pseudovirus (HIV),Fig 2,Imdevimab,Wild Type (B),=,9.4,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Boschi22,10.1093/cid/ciac143,Virus isolate,Figure 1B,Imdevimab,Wild Type (B.1.1),=,8.9,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + G339D + S371L + S373P + S375F + K417N + G446S + S477N + T478K + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + A701V + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,12000,ng/ml,1,>,1000,,,Censored at 12000
Tada22,10.1016/j.ebiom.2022.103944,Pseudovirus (lentivirus),Figure 2e,Casirivimab + Imdevimab,Wild Type (B.1),=,0.8,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493K + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,5000,ng/ml,1,>,1000,,,
Arora22f,10.1016/S1473-3099(22)00733-2,Pseudovirus (VSV),Figure B,Casirivimab + Imdevimab,Wild Type (B.1),=,9,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,3642,ng/ml,1,=,404.7,,,
Arora22b,10.1016/j.chom.2022.04.017,Pseudovirus (VSV),Supplementary Table 1,Casirivimab + Imdevimab,Wild Type (B.1),=,7.6,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,2372,ng/ml,1,=,311.9,,,
Arora22e,10.1016/S1473-3099(22)00422-4,Pseudovirus (VSV),Supplementary Figure B,Casirivimab + Imdevimab,Wild Type (B.1),=,6.6,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,1469,ng/ml,1,=,222.6,,,
Lusvarghi22,10.1126/scitranslmed.abn8543,Pseudovirus (lentivirus),Fig 4,Casirivimab + Imdevimab,Wild Type (B.1),=,2.7,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Misasi22,10.1101/2022.07.29.502029,Pseudovirus (lentivirus),Figure 1B,Casirivimab + Imdevimab,Wild Type (B.1),=,3.4,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10050,ng/ml,1,>,1000,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Table 1a,Casirivimab + Imdevimab,Wild Type (B.1),=,1,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,2951,ng/ml,1,>,1000,,,
Yamasoba22,10.1016/j.cell.2022.04.035,Pseudovirus (HIV),Figure 2E,Casirivimab + Imdevimab,Wild Type (B.1),=,3.1,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Chen22e,10.1016/j.celrep.2022.111528,Pseudovirus (lentivirus),Figure 2C,Casirivimab + Imdevimab,Wild Type (A),=,0.9,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Park22,10.1126/science.adc9127,Pseudovirus (VSV),Fig 1A,Casirivimab + Imdevimab,Wild Type (B),=,5,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Yuan22,10.1101/2022.03.13.484037,Pseudovirus (MLV),Figure 2A,Casirivimab + Imdevimab,Wild Type (B),=,6,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,5000,ng/ml,1,>,833.3,,,
Planas22b,10.1101/2022.11.17.516888,Virus isolate,Figure 3b,Casirivimab + Imdevimab,Wild Type (B.1),=,1.6,ng/ml,1,Omicron/BA.2,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,1985,ng/ml,1,>,1000,,,Variant was erroneously labelled BA.1 changed to BA.2
Planas21c,10.1038/s41586-021-04389-z,Virus isolate,Extended Data Fig 4,Casirivimab + Imdevimab,Delta,=,7.6,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,9000,ng/ml,1,>,1000,,,
Wilhelm21b,10.1101/2021.12.07.21267432,Virus isolate,Figure 1,Casirivimab + Imdevimab,Wild Type (B),=,0.1,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,2000,ng/ml,1,>,1000,,,
Takashita22,10.1056/NEJMc2119407,Virus isolate,Table 1,Casirivimab + Imdevimab,Wild Type (A),=,7,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,20000,ng/ml,1,>,1000,,,Combination therapies in this study were specified at ng/ml of each component so needs to multiply by 2
Takashita22c,10.1056/NEJMc2207519,Virus isolate,Table 1,Casirivimab + Imdevimab,Wild Type (A),=,6.8,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,20000,ng/ml,1,>,1000,,,Combination therapies in this study were specified at ng/ml of each component so needs to multiply by 2
Meng22,10.1038/s41586-022-04474-x,Virus isolate,Figure 1a,Casirivimab + Imdevimab,Delta,=,4.8,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Fenwick22,10.1101/2022.03.18.484873,Virus isolate,Figure 2f,Casirivimab + Imdevimab,Delta,=,8,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,20000,ng/ml,1,>,1000,,,
VanBlargan22,10.1038/s41591-021-01678-y,Virus isolate,Figure 2g; Figure 3g,Casirivimab + Imdevimab,Wild Type (B.1),=,9.9,ng/ml,1.1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,2,>,10000,ng/ml,1,>,1000,959.6,1060.6,
Cameroni21,10.1038/s41586-021-04386-2,Pseudovirus (VSV),"Figure 3c, Extended Data Table 2",Casirivimab + Imdevimab,Wild Type (B.1),=,7.2,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Hoffmann22,10.1016/j.cell.2021.12.032,Pseudovirus (VSV),Figure 2C,Casirivimab + Imdevimab,Wild Type (B.1),=,4,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,797,ng/ml,1,=,199.3,,,
Liu21l,10.1038/s41586-021-04388-0,Pseudovirus (VSV),Figure 2c,Casirivimab + Imdevimab,Wild Type (B.1),=,1,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Ikemura21,10.1101/2021.12.13.21267761,Pseudovirus (lentivirus),Figure 2A,Casirivimab + Imdevimab,Wild Type (B),=,9,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,16623,ng/ml,1,>,1000,,,
Boschi22,10.1093/cid/ciac143,Virus isolate,Figure 1B,Casirivimab + Imdevimab,Wild Type (B.1.1),=,0.1,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + G339D + S371L + S373P + S375F + K417N + G446S + S477N + T478K + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + A701V + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,12000,ng/ml,1,>,1000,,,Censored at 12000
Hao22,10.1101/2022.08.12.22278720,Virus isolate,Figure 5A,Casirivimab + Imdevimab,Wild Type (A),=,87,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + Δ142-144 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,5017,ng/ml,1,=,57.7,,,
Rothenberger22,10.1038/s41587-022-01382-3,Pseudovirus (VSV),Extended Data Fig. 1,Cilgavimab,Wild Type (B),=,5.5,ng/ml,1,Omicron/BA.1,(Various),(Various),2,=,221.5,ng/ml,1.1,=,40.4,39,41.7,
Tada22,10.1016/j.ebiom.2022.103944,Pseudovirus (lentivirus),Figure 2e,Cilgavimab,Wild Type (B.1),=,18.2,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493K + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,5000,ng/ml,1,>,274.7,,,
Westendorf22,10.1016/j.celrep.2022.110812,Pseudovirus (VSV),Table 3D,Cilgavimab,Wild Type (B.1),=,4.2,ng/ml,1.1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,2,=,6184.6,ng/ml,1.1,>,1000,1375.3,1636.5,
Zhou21e,10.1126/science.abn8897,Pseudovirus (lentivirus),Figure 2C,Cilgavimab,Wild Type (B.1),=,3.7,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,5850,ng/ml,1,>,1000,,,
Arora22f,10.1016/S1473-3099(22)00733-2,Pseudovirus (VSV),Figure B,Cilgavimab,Wild Type (B.1),=,37,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,2658,ng/ml,1,=,71.8,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Cilgavimab,Wild Type (B.1),=,2.5,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,3010,ng/ml,1,>,1000,,,
Arora22b,10.1016/j.chom.2022.04.017,Pseudovirus (VSV),Supplementary Table 1,Cilgavimab,Wild Type (B.1),=,25.1,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,2693,ng/ml,1,=,107.4,,,
Arora22e,10.1016/S1473-3099(22)00422-4,Pseudovirus (VSV),Supplementary Figure B,Cilgavimab,Wild Type (B.1),=,21.7,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,2036,ng/ml,1,=,93.8,,,
Cao22,10.1101/2022.02.07.479349,Pseudovirus (VSV),Table S2,Cilgavimab,Wild Type (B.1),=,1.4,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Cao22d,10.1038/s41586-021-04385-3,Pseudovirus (VSV),Fig 4b,Cilgavimab,Wild Type (B.1),=,2,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,2178,ng/ml,1,>,1000,,,
Cui22,10.1016/j.cell.2022.01.019,Pseudovirus (VSV),Figure 5C,Cilgavimab,Wild Type (B.1),=,2.2,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,1656,ng/ml,1,=,752.7,,,
Duty22,10.1016/j.medj.2022.08.002,Pseudovirus (VSV),Table 3,Cilgavimab,Wild Type (B.1),=,35.3,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,9105,ng/ml,1,=,257.9,,,
Lusvarghi22,10.1126/scitranslmed.abn8543,Pseudovirus (lentivirus),Fig 4,Cilgavimab,Wild Type (B.1),=,3.7,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Misasi22,10.1101/2022.07.29.502029,Pseudovirus (lentivirus),Figure 1A,Cilgavimab,Wild Type (B.1),=,4.6,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,4154.2,ng/ml,1,=,899.2,,,
Schulz22,10.1002/eji.202249841,Pseudovirus (VSV),Table 1,Cilgavimab,Wild Type (B.1),=,14,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,882,ng/ml,1,=,63,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Table 1a,Cilgavimab,Wild Type (B.1),=,6,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,209,ng/ml,1,=,34.8,,,
Tuekprakhon22,10.1016/j.cell.2022.06.005,Pseudovirus (lentivirus),Figure 3,Cilgavimab,Wild Type (B),=,2,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,308,ng/ml,1,=,154,,,
Huo22b,10.1016/j.celrep.2022.111903,Pseudovirus (lentivirus),Supplementary Table 1B,Cilgavimab,Wild Type (B),=,2,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,308,ng/ml,1,=,154,,,
Chen22e,10.1016/j.celrep.2022.111528,Pseudovirus (lentivirus),Figure 2B,Cilgavimab,Wild Type (A),=,1,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,663,ng/ml,1,=,663,,,
Ai22,10.1016/j.chom.2022.05.001,Pseudovirus (VSV),Figure 3A,Cilgavimab,Wild Type (B),=,1,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Gruell22b,10.1016/j.chom.2022.07.002,Pseudovirus (HIV),Figure 4B,Cilgavimab,Wild Type (B),=,5,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,6848,ng/ml,1,>,1000,,,
Park22,10.1126/science.adc9127,Pseudovirus (VSV),Fig 1A,Cilgavimab,Wild Type (B),=,6,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,2821,ng/ml,1,=,470.2,,,
Yuan22,10.1101/2022.03.13.484037,Pseudovirus (MLV),Figure 2A,Cilgavimab,Wild Type (B),=,5,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,5000,ng/ml,1,>,1000,,,
FDA21c,https://www.fda.gov/media/154701/download,Pseudovirus,"Feb 2022, Page 17, Antiviral resistance paragraph 5",Cilgavimab,Wild Type (B),,,,,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,,,,,>,1000,,,
Iketani22,10.1038/s41586-022-04594-4,Pseudovirus (VSV),Figure 2b,Cilgavimab,Wild Type (B.1),,,,,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,,,,,=,84,,,
Aggarwal22,10.1038/s41564-022-01135-7,Virus isolate,Table 1,Cilgavimab,Wild Type (A.2.2),=,18,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,55.6,,,LOD is 10000
Aggarwal22b,10.1016/j.ebiom.2022.104270,Virus isolate,Figure 1,Cilgavimab,Wild Type (A.2.2),=,29,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,1910,ng/ml,1,=,65.9,,,
Planas22b,10.1101/2022.11.17.516888,Virus isolate,Figure 3b,Cilgavimab,Wild Type (B.1),=,2.9,ng/ml,1,Omicron/BA.2,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,6.1,ng/ml,1,=,2.1,,,Variant was erroneously labelled BA.1 changed to BA.2
Bruel22,10.1038/s41591-022-01792-5,Virus isolate,Table 1,Cilgavimab,Delta,=,8.5,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,1988,ng/ml,1,=,233.9,,,
Planas21c,10.1038/s41586-021-04389-z,Virus isolate,Extended Data Fig 4,Cilgavimab,Delta,=,50.3,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,1213,ng/ml,1,=,24.1,,,
Touret22,10.1038/s41598-022-08559-5,Virus isolate,"Figure 1, Table 1",Cilgavimab,Wild Type (B.1),=,93,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,1472,ng/ml,1,=,15.8,,,
Touret22b,10.1038/s41598-022-16964-z,Virus isolate,Table 1,Cilgavimab,Wild Type (B.1),=,19.2,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,1617,ng/ml,1,=,84.2,,,
Takashita22,10.1056/NEJMc2119407,Virus isolate,Table 1,Cilgavimab,Wild Type (A),=,7.7,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,443.9,ng/ml,1,=,57.6,,,
Takashita22c,10.1056/NEJMc2207519,Virus isolate,Table 1,Cilgavimab,Wild Type (A),=,7,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,2916.9,ng/ml,1,=,416.7,,,
Case22,10.1038/s41467-022-31615-7,Virus isolate,Figure 1n,Cilgavimab,Wild Type (B.1),=,29.5,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,6078.7,ng/ml,1,=,206.1,,,
VanBlargan22,10.1038/s41591-021-01678-y,Virus isolate,Figure 2g; Figure 3g,Cilgavimab,Wild Type (B.1),=,31.3,ng/ml,1.2,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,3,=,596.9,ng/ml,1.6,=,11.9,11.9,30.6,
Dejnirattisai22,10.1016/j.cell.2021.12.046,Virus isolate,"Figure 4C, Table S1",Cilgavimab,Wild Type (B),=,13,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,3488,ng/ml,1,=,268.3,,,
Duty22,10.1016/j.medj.2022.08.002,Virus isolate,Table 3,Cilgavimab,Wild Type (A),=,56.3,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,582.5,ng/ml,1,=,10.3,,,
Cameroni21,10.1038/s41586-021-04386-2,Pseudovirus (VSV),"Figure 3b, 3c, Extended Data Table 2",Cilgavimab,Wild Type (B.1),=,8.1,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,2772,ng/ml,1,=,342.2,,,
Liu21l,10.1038/s41586-021-04388-0,Pseudovirus (VSV),Figure 2c,Cilgavimab,Wild Type (B.1),=,2,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,763.8,ng/ml,1,=,381.9,,,
Wang22,10.1080/22221751.2022.2030200,Pseudovirus (VSV),Figure 2,Cilgavimab,Wild Type (B.1),=,2,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
AstraZenica21c,https://opendata.ncats.nih.gov/variant/datasets,Pseudovirus (FDA),Excel table,Cilgavimab,Wild Type (B),=,4.1,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,1600,ng/ml,1,>,388,,,
AstraZenica21c,https://opendata.ncats.nih.gov/variant/datasets,Pseudovirus (Monogram),Excel table,Cilgavimab,Wild Type (B),=,7.5,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,1000,ng/ml,1,>,133.3,,,
Boschi22,10.1093/cid/ciac143,Virus isolate,Figure 1C,Cilgavimab,Wild Type (B.1.1),=,0.3,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + G339D + S371L + S373P + S375F + K417N + G446S + S477N + T478K + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + A701V + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,1315.7,ng/ml,1,>,1000,,,
Rothenberger22,10.1038/s41587-022-01382-3,Pseudovirus (VSV),Extended Data Fig. 1,Tixagevimab,Wild Type (B),=,0.6,ng/ml,1,Omicron/BA.1,(Various),(Various),2,=,118.8,ng/ml,3.5,=,374.2,215.4,533,
Tada22,10.1016/j.ebiom.2022.103944,Pseudovirus (lentivirus),Figure 2e,Tixagevimab,Wild Type (B.1),=,41,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493K + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,5000,ng/ml,1,>,122,,,
Westendorf22,10.1016/j.celrep.2022.110812,Pseudovirus (VSV),Table 3D,Tixagevimab,Wild Type (B.1),=,1.5,ng/ml,1.3,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,2,=,154.1,ng/ml,1.7,=,144.4,94.3,194.4,
Zhou21e,10.1126/science.abn8897,Pseudovirus (lentivirus),Figure 2C,Tixagevimab,Wild Type (B.1),=,2,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,269,ng/ml,1,=,134.5,,,
Arora22f,10.1016/S1473-3099(22)00733-2,Pseudovirus (VSV),Figure B,Tixagevimab,Wild Type (B.1),=,7,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,173,ng/ml,1,=,24.7,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Tixagevimab,Wild Type (B.1),=,1.6,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,5420,ng/ml,1,>,1000,,,
Arora22b,10.1016/j.chom.2022.04.017,Pseudovirus (VSV),Supplementary Table 1,Tixagevimab,Wild Type (B.1),=,7.4,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,717.4,ng/ml,1,=,96.4,,,
Arora22e,10.1016/S1473-3099(22)00422-4,Pseudovirus (VSV),Supplementary Figure B,Tixagevimab,Wild Type (B.1),=,5.1,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,1253,ng/ml,1,=,245.7,,,
Cao22,10.1101/2022.02.07.479349,Pseudovirus (VSV),Table S2,Tixagevimab,Wild Type (B.1),=,1.3,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,6860,ng/ml,1,>,1000,,,
Cao22d,10.1038/s41586-021-04385-3,Pseudovirus (VSV),Fig 4b,Tixagevimab,Wild Type (B.1),=,1,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,6860,ng/ml,1,>,1000,,,
Cui22,10.1016/j.cell.2022.01.019,Pseudovirus (VSV),Figure 5C,Tixagevimab,Wild Type (B.1),=,2.2,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,6042,ng/ml,1,>,1000,,,
Duty22,10.1016/j.medj.2022.08.002,Pseudovirus (VSV),Table 3,Tixagevimab,Wild Type (B.1),=,6.7,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,638.6,ng/ml,1,=,95.3,,,
Lusvarghi22,10.1126/scitranslmed.abn8543,Pseudovirus (lentivirus),Fig 4,Tixagevimab,Wild Type (B.1),=,1.6,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,540.7,ng/ml,1,=,337.9,,,
Misasi22,10.1101/2022.07.29.502029,Pseudovirus (lentivirus),Figure 1A,Tixagevimab,Wild Type (B.1),=,1.5,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,258.3,ng/ml,1,=,175.7,,,
Schulz22,10.1002/eji.202249841,Pseudovirus (VSV),Table 1,Tixagevimab,Wild Type (B.1),=,5,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,115,ng/ml,1,=,23,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Table 1a,Tixagevimab,Wild Type (B.1),=,2,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,432,ng/ml,1,=,216,,,
Zhou22,10.3390/v14061334,Pseudovirus (lentivirus),Figure 2B,Tixagevimab,Wild Type (B.1),=,8.7,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,29498,ng/ml,1,>,1000,,,
Tuekprakhon22,10.1016/j.cell.2022.06.005,Pseudovirus (lentivirus),Figure 3,Tixagevimab,Wild Type (B),=,1,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,246,ng/ml,1,=,246,,,
Huo22b,10.1016/j.celrep.2022.111903,Pseudovirus (lentivirus),Supplementary Table 1B,Tixagevimab,Wild Type (B),=,1,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,246,ng/ml,1,=,246,,,
Chen22e,10.1016/j.celrep.2022.111528,Pseudovirus (lentivirus),Figure 2B,Tixagevimab,Wild Type (A),=,1,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,139,ng/ml,1,=,139,,,
Ai22,10.1016/j.chom.2022.05.001,Pseudovirus (VSV),Figure 3A,Tixagevimab,Wild Type (B),=,1,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Gruell22b,10.1016/j.chom.2022.07.002,Pseudovirus (HIV),Figure 4B,Tixagevimab,Wild Type (B),=,5,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Park22,10.1126/science.adc9127,Pseudovirus (VSV),Fig 1A,Tixagevimab,Wild Type (B),=,2,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,1913,ng/ml,1,=,956.5,,,
Wang22c,10.1038/s41586-022-04466-x,Pseudovirus (VSV),Supplmentary Table 2,Tixagevimab,Wild Type (B),=,5,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,4235,ng/ml,1,=,847,,,
Yuan22,10.1101/2022.03.13.484037,Pseudovirus (MLV),Figure 2A,Tixagevimab,Wild Type (B),=,1,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,5000,ng/ml,1,>,1000,,,
FDA21c,https://www.fda.gov/media/154701/download,Pseudovirus,"Feb 2022, Page 17, Antiviral resistance paragraph 5",Tixagevimab,Wild Type (B),,,,,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,,,,,>,1000,,,
Iketani22,10.1038/s41586-022-04594-4,Pseudovirus (VSV),Figure 2b,Tixagevimab,Wild Type (B.1),,,,,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,,,,,=,306,,,
Aggarwal22,10.1038/s41564-022-01135-7,Virus isolate,Table 1,Tixagevimab,Wild Type (A.2.2),=,47,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,3490,ng/ml,1,=,74.3,,,
Aggarwal22b,10.1016/j.ebiom.2022.104270,Virus isolate,Figure 1,Tixagevimab,Wild Type (A.2.2),=,9,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Planas22b,10.1101/2022.11.17.516888,Virus isolate,Figure 3b,Tixagevimab,Wild Type (B.1),=,1.3,ng/ml,1,Omicron/BA.2,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,Variant was erroneously labelled BA.1 changed to BA.2
Bruel22,10.1038/s41591-022-01792-5,Virus isolate,Table 1,Tixagevimab,Delta,=,3.2,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,9000,ng/ml,1,>,1000,,,
Planas21c,10.1038/s41586-021-04389-z,Virus isolate,Extended Data Fig 4,Tixagevimab,Delta,=,18.3,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,8305,ng/ml,1,=,453.8,,,
Touret22,10.1038/s41598-022-08559-5,Virus isolate,"Figure 1, Table 1",Tixagevimab,Wild Type (B.1),=,26,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,5000,ng/ml,1,>,192.3,,,
Touret22b,10.1038/s41598-022-16964-z,Virus isolate,Table 1,Tixagevimab,Wild Type (B.1),=,18.3,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,5000,ng/ml,1,>,273.2,,,
Takashita22,10.1056/NEJMc2119407,Virus isolate,Table 1,Tixagevimab,Wild Type (A),=,1.9,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,1299.9,ng/ml,1,=,677.1,,,
Takashita22c,10.1056/NEJMc2207519,Virus isolate,Table 1,Tixagevimab,Wild Type (A),=,6.1,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,1552.7,ng/ml,1,=,254.5,,,
Case22,10.1038/s41467-022-31615-7,Virus isolate,Figure 1n,Tixagevimab,Wild Type (B.1),=,5.4,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,635,ng/ml,1,=,117.6,,,
VanBlargan22,10.1038/s41591-021-01678-y,Virus isolate,Figure 2g; Figure 3g,Tixagevimab,Wild Type (B.1),=,5.8,ng/ml,1.3,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,3,=,348.8,ng/ml,2.2,=,92.3,54,122.3,
Dejnirattisai22,10.1016/j.cell.2021.12.046,Virus isolate,"Figure 4C, Table S1",Tixagevimab,Wild Type (B),=,5,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,1152,ng/ml,1,=,230.4,,,
Duty22,10.1016/j.medj.2022.08.002,Virus isolate,Table 3,Tixagevimab,Wild Type (A),=,8.7,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,197.2,ng/ml,1,=,22.6,,,
Cameroni21,10.1038/s41586-021-04386-2,Pseudovirus (VSV),"Figure 3b, 3c, Extended Data Table 2",Tixagevimab,Wild Type (B.1),=,4.3,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Liu21l,10.1038/s41586-021-04388-0,Pseudovirus (VSV),Figure 2c,Tixagevimab,Wild Type (B.1),=,0.2,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,201.5,ng/ml,1,>,1000,,,
Wang22,10.1080/22221751.2022.2030200,Pseudovirus (VSV),Figure 2,Tixagevimab,Wild Type (B.1),=,0.9,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
AstraZenica21c,https://opendata.ncats.nih.gov/variant/datasets,Pseudovirus (FDA),Excel table,Tixagevimab,Wild Type (B),=,1.6,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,1600,ng/ml,1,>,975,,,
AstraZenica21c,https://opendata.ncats.nih.gov/variant/datasets,Pseudovirus (Monogram),Excel table,Tixagevimab,Wild Type (B),=,1.3,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,799.8,ng/ml,1,=,615.2,,,
Boschi22,10.1093/cid/ciac143,Virus isolate,Figure 1C,Tixagevimab,Wild Type (B.1.1),=,0.1,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + G339D + S371L + S373P + S375F + K417N + G446S + S477N + T478K + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + A701V + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,Censored at 10000
Tada22,10.1016/j.ebiom.2022.103944,Pseudovirus (lentivirus),Figure 2e,Cilgavimab + Tixagevimab,Wild Type (B.1),=,13.6,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493K + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,1100,ng/ml,1,=,80.9,,,
Arora22f,10.1016/S1473-3099(22)00733-2,Pseudovirus (VSV),Figure B,Cilgavimab + Tixagevimab,Wild Type (B.1),=,7,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,97,ng/ml,1,=,13.9,,,
Arora22b,10.1016/j.chom.2022.04.017,Pseudovirus (VSV),Supplementary Table 1,Cilgavimab + Tixagevimab,Wild Type (B.1),=,5.9,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,170,ng/ml,1,=,29,,,
Arora22e,10.1016/S1473-3099(22)00422-4,Pseudovirus (VSV),Supplementary Figure B,Cilgavimab + Tixagevimab,Wild Type (B.1),=,7.6,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,269,ng/ml,1,=,35.4,,,
Duty22,10.1016/j.medj.2022.08.002,Pseudovirus (VSV),Table 3,Cilgavimab + Tixagevimab,Wild Type (B.1),=,4,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,73.8,ng/ml,1,=,18.5,,,
Lusvarghi22,10.1126/scitranslmed.abn8543,Pseudovirus (lentivirus),Fig 4,Cilgavimab + Tixagevimab,Wild Type (B.1),=,1.3,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,256.3,ng/ml,1,=,197.2,,,
Misasi22,10.1101/2022.07.29.502029,Pseudovirus (lentivirus),Figure 1B,Cilgavimab + Tixagevimab,Wild Type (B.1),=,2.2,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,50.9,ng/ml,1,=,23.1,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Table 1a,Cilgavimab + Tixagevimab,Wild Type (B.1),=,2,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,154,ng/ml,1,=,77,,,
Zhou22,10.3390/v14061334,Pseudovirus (lentivirus),Figure 2B,Cilgavimab + Tixagevimab,Wild Type (B.1),=,2.4,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,861.5,ng/ml,1,=,359,,,
Tuekprakhon22,10.1016/j.cell.2022.06.005,Pseudovirus (lentivirus),Figure 3,Cilgavimab + Tixagevimab,Wild Type (B),=,1,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,232,ng/ml,1,=,232,,,
Huo22b,10.1016/j.celrep.2022.111903,Pseudovirus (lentivirus),Supplementary Table 1B,Cilgavimab + Tixagevimab,Wild Type (B),=,1,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,232,ng/ml,1,=,232,,,
Chen22e,10.1016/j.celrep.2022.111528,Pseudovirus (lentivirus),Figure 2C,Cilgavimab + Tixagevimab,Wild Type (A),=,0.7,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,44,ng/ml,1,=,62.9,,,
EMA21e,https://www.ema.europa.eu/en/documents/product-information/evusheld-epar-product-information_en.pdf,Pseudovirus,Table 3,Cilgavimab + Tixagevimab,Wild Type (B),=,1.9,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,51,ng/ml,1,=,26.8,,,
Park22,10.1126/science.adc9127,Pseudovirus (VSV),Fig 1A,Cilgavimab + Tixagevimab,Wild Type (B),=,2,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,316,ng/ml,1,=,158,,,
Yuan22,10.1101/2022.03.13.484037,Pseudovirus (MLV),Figure 2A,Cilgavimab + Tixagevimab,Wild Type (B),=,5,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,1313,ng/ml,1,=,262.6,,,
FDA21c,https://www.fda.gov/media/154701/download,Pseudovirus,"Feb 2022, Table 6, Page 17, Antiviral resistance paragraph 7",Cilgavimab + Tixagevimab,Wild Type (B),,,,,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,,,,,=,157.5,,,
Aggarwal22b,10.1016/j.ebiom.2022.104270,Virus isolate,Figure 1,Cilgavimab + Tixagevimab,Wild Type (A.2.2),=,16,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,1026,ng/ml,1,=,64.1,,,
Planas22b,10.1101/2022.11.17.516888,Virus isolate,Figure 3b,Cilgavimab + Tixagevimab,Wild Type (B.1),=,1.3,ng/ml,1,Omicron/BA.2,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,24.7,ng/ml,1,=,19,,,Variant was erroneously labelled BA.1 changed to BA.2
Bruel22,10.1038/s41591-022-01792-5,Virus isolate,Table 1,Cilgavimab + Tixagevimab,Delta,=,2.6,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,715,ng/ml,1,=,275,,,
Planas21c,10.1038/s41586-021-04389-z,Virus isolate,Extended Data Fig 4,Cilgavimab + Tixagevimab,Delta,=,13.4,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,733,ng/ml,1,=,54.7,,,
Touret22,10.1038/s41598-022-08559-5,Virus isolate,"Figure 1, Table 1",Cilgavimab + Tixagevimab,Wild Type (B.1),=,35,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,1488,ng/ml,1,=,42.5,,,
Touret22b,10.1038/s41598-022-16964-z,Virus isolate,Table 1,Cilgavimab + Tixagevimab,Wild Type (B.1),=,20.2,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,594.6,ng/ml,1,=,29.4,,,
Takashita22,10.1056/NEJMc2119407,Virus isolate,Table 1,Cilgavimab + Tixagevimab,Wild Type (A),=,6.8,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,511.8,ng/ml,1,=,74.8,,,Combination therapies in this study were specified at ng/ml of each component so needs to multiply by 2
Takashita22c,10.1056/NEJMc2207519,Virus isolate,Table 1,Cilgavimab + Tixagevimab,Wild Type (A),=,12.6,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,702.2,ng/ml,1,=,55.7,,,Combination therapies in this study were specified at ng/ml of each component so needs to multiply by 2
Fenwick22,10.1101/2022.03.18.484873,Virus isolate,Figure 2f,Cilgavimab + Tixagevimab,Delta,=,17,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,435,ng/ml,1,=,25.6,,,
Case22,10.1038/s41467-022-31615-7,Virus isolate,Figure 1n,Cilgavimab + Tixagevimab,Wild Type (B.1),=,6.5,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,166.6,ng/ml,1,=,25.6,,,
VanBlargan22,10.1038/s41591-021-01678-y,Virus isolate,Figure 2g; Figure 3g,Cilgavimab + Tixagevimab,Wild Type (B.1),=,9.9,ng/ml,1.6,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,3,=,163.1,ng/ml,1.1,=,12.3,11.8,22.5,
Dejnirattisai22,10.1016/j.cell.2021.12.046,Virus isolate,"Figure 4C, Table S1",Cilgavimab + Tixagevimab,Wild Type (B),=,9,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,273,ng/ml,1,=,30.3,,,
EMA21e,https://www.ema.europa.eu/en/documents/product-information/evusheld-epar-product-information_en.pdf,Virus isolate,Table 3,Cilgavimab + Tixagevimab,Wild Type (B),=,8,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,147,ng/ml,1,=,18.4,,,
FDA21c,https://www.fda.gov/media/154701/download,Virus isolate,"Feb 2022, Table 6, Page 17, Antiviral resistance paragraph 7",Cilgavimab + Tixagevimab,Wild Type (B),,,,,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,,,,,=,21,,,
Cameroni21,10.1038/s41586-021-04386-2,Pseudovirus (VSV),"Figure 3c, Extended Data Table 2",Cilgavimab + Tixagevimab,Wild Type (B.1),=,3.8,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,418,ng/ml,1,=,110,,,
Liu21l,10.1038/s41586-021-04388-0,Pseudovirus (VSV),Figure 2c,Cilgavimab + Tixagevimab,Wild Type (B.1),=,0.5,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,50.4,ng/ml,1,=,100.8,,,
AstraZenica21c,https://opendata.ncats.nih.gov/variant/datasets,Pseudovirus (FDA),Excel table,Cilgavimab + Tixagevimab,Wild Type (B),=,1.5,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,276.7,ng/ml,1,=,183.2,,,
AstraZenica21c,https://opendata.ncats.nih.gov/variant/datasets,Pseudovirus (Monogram),Excel table,Cilgavimab + Tixagevimab,Wild Type (B),=,1.3,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,171.1,ng/ml,1,=,131.6,,,
Boschi22,10.1093/cid/ciac143,Virus isolate,Figure 1C,Cilgavimab + Tixagevimab,Wild Type (B.1.1),=,0.1,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + G339D + S371L + S373P + S375F + K417N + G446S + S477N + T478K + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + A701V + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,6.3,ng/ml,1,=,90.6,,,
Rothenberger22,10.1038/s41587-022-01382-3,Pseudovirus (VSV),Extended Data Fig. 1,Sotrovimab,Wild Type (B),=,23,ng/ml,1,Omicron/BA.1,(Various),(Various),2,=,79.1,ng/ml,1.1,=,3.5,3.3,3.6,
Tada22,10.1016/j.ebiom.2022.103944,Pseudovirus (lentivirus),Figure 2e,Sotrovimab,Wild Type (B.1),=,123.2,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493K + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,2334,ng/ml,1,=,18.9,,,
Westendorf22,10.1016/j.celrep.2022.110812,Pseudovirus (VSV),Table 3D,Sotrovimab,Wild Type (B.1),=,32.9,ng/ml,1.7,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,2,=,282.9,ng/ml,1,=,9.8,7.5,12.2,
Zhou21e,10.1126/science.abn8897,Pseudovirus (lentivirus),Figure 2C,Sotrovimab,Wild Type (B.1),=,36.1,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,281,ng/ml,1,=,7.8,,,
Arora22f,10.1016/S1473-3099(22)00733-2,Pseudovirus (VSV),Figure B,Sotrovimab,Wild Type (B.1),=,157,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,833,ng/ml,1,=,5.3,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Sotrovimab,Wild Type (B.1),=,74.1,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,361,ng/ml,1,=,4.9,,,
Arora22b,10.1016/j.chom.2022.04.017,Pseudovirus (VSV),Supplementary Table 1,Sotrovimab,Wild Type (B.1),=,198.3,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,749.1,ng/ml,1,=,3.8,,,
Arora22e,10.1016/S1473-3099(22)00422-4,Pseudovirus (VSV),Supplementary Figure B,Sotrovimab,Wild Type (B.1),=,77.5,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,501,ng/ml,1,=,6.5,,,
Cao22,10.1101/2022.02.07.479349,Pseudovirus (VSV),Table S2,Sotrovimab,Wild Type (B.1),=,78.3,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,356,ng/ml,1,=,4.5,,,
Cao22d,10.1038/s41586-021-04385-3,Pseudovirus (VSV),Fig 4b,Sotrovimab,Wild Type (B.1),=,58,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,181,ng/ml,1,=,3.1,,,
Gliga22,10.1093/cid/ciac802,Pseudovirus,Figure 3B,Sotrovimab,Wild Type (B.1),=,6,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,186,ng/ml,1,=,31,,,
Liu22,10.1126/scitranslmed.abn6859,Pseudovirus (VSV),Fig3C,Sotrovimab,Wild Type (B.1),=,12,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,49,ng/ml,1,=,4.1,,,
Misasi22,10.1101/2022.07.29.502029,Pseudovirus (lentivirus),Figure 1A,Sotrovimab,Wild Type (B.1),=,84.6,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,311.1,ng/ml,1,=,3.7,,,
Park22,10.1126/science.adc9127,Pseudovirus (VSV),Fig 1A,Sotrovimab,Wild Type,=,61.7,ng/ml,1.1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,2,=,156,ng/ml,1,=,2.5,2.4,2.7,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Table 1a,Sotrovimab,Wild Type (B.1),=,14,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,127,ng/ml,1,=,9.1,,,
Willett22,10.1101/2022.05.25.493397,Pseudovirus (lentivirus),Figure 1L,Sotrovimab,Wild Type (B.1),=,3,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,10,ng/ml,1,=,3.3,,,
Yamasoba22,10.1016/j.cell.2022.04.035,Pseudovirus (HIV),Figure 2E,Sotrovimab,Wild Type (B.1),=,12,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,57,ng/ml,1,=,4.8,,,
Zhou22,10.3390/v14061334,Pseudovirus (lentivirus),Figure 2B,Sotrovimab,Wild Type (B.1),=,140.3,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,1480,ng/ml,1,=,10.5,,,
Ragonnet-Cronin22,10.1101/2022.07.14.500063,Pseudovirus (lentivirus),Figure 1D,Sotrovimab,Wild Type (B),=,79,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,113,ng/ml,1,=,1.4,,,
Tuekprakhon22,10.1016/j.cell.2022.06.005,Pseudovirus (lentivirus),Figure 3,Sotrovimab,Wild Type (B),=,130,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,94,ng/ml,1,=,0.7,,,
Huo22b,10.1016/j.celrep.2022.111903,Pseudovirus (lentivirus),Supplementary Table 1B,Sotrovimab,Wild Type (B),=,79,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,113,ng/ml,1,=,1.4,,,
Chen22e,10.1016/j.celrep.2022.111528,Pseudovirus (lentivirus),Figure 2B,Sotrovimab,Wild Type (A),=,184,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,371,ng/ml,1,=,2,,,
Ai22,10.1016/j.chom.2022.05.001,Pseudovirus (VSV),Figure 3A,Sotrovimab,Wild Type (B),=,9,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,62,ng/ml,1,=,6.9,,,
Gruell22b,10.1016/j.chom.2022.07.002,Pseudovirus (HIV),Figure 4B,Sotrovimab,Wild Type (B),=,976,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,105,ng/ml,1,=,0.1,,,
Ju22,10.1038/s41422-022-00638-6,Pseudovirus (HIV),Figure S1F,Sotrovimab,Wild Type (B),=,93,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,158,ng/ml,1,=,1.7,,,
Pelzek22,10.1101/2022.02.06.479332,Pseudovirus (lentivirus),Extended Table 1,Sotrovimab,Wild Type (B),=,3819,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,453,ng/ml,1,=,0.1,,,
Wang22b,10.1101/2022.01.30.478305,Pseudovirus (HIV),Figure 1B,Sotrovimab,Wild Type (B),=,30.8,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,192,ng/ml,1,=,6.2,,,
Wang22c,10.1038/s41586-022-04466-x,Pseudovirus (VSV),Supplmentary Table 2,Sotrovimab,Wild Type (B),=,68,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,269,ng/ml,1,=,4,,,
Yuan22,10.1101/2022.03.13.484037,Pseudovirus (MLV),Figure 2A,Sotrovimab,Wild Type (B),=,72,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,925,ng/ml,1,=,12.8,,,
EMA21d,https://www.ema.europa.eu/en/documents/product-information/xevudy-epar-product-information_en.pdf,Pseudovirus,Table 2,Sotrovimab,Wild Type (B),,,,,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,,,,,=,1,,,
FDA21e,https://www.fda.gov/media/149534/download,Pseudovirus,SOT Page 23,Sotrovimab,Wild Type (B),,,,,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,,,,,=,1,,,
Iketani22,10.1038/s41586-022-04594-4,Pseudovirus (VSV),Figure 2b,Sotrovimab,Wild Type (B.1),,,,,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,,,,,=,6.9,,,
Aggarwal22,10.1038/s41564-022-01135-7,Virus isolate,Table 1,Sotrovimab,Wild Type (A.2.2),=,372,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,1059,ng/ml,1,=,2.8,,,
Aggarwal22b,10.1016/j.ebiom.2022.104270,Virus isolate,Figure 1,Sotrovimab,Wild Type (A.2.2),=,384,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,580,ng/ml,1,=,1.5,,,
Planas22b,10.1101/2022.11.17.516888,Virus isolate,Figure 3b,Sotrovimab,Wild Type (B.1),=,65,ng/ml,1,Omicron/BA.2,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,11519,ng/ml,1,>,177.2,,,Variant was erroneously labelled BA.1 changed to BA.2
Bruel22,10.1038/s41591-022-01792-5,Virus isolate,Table 1,Sotrovimab,Delta,=,280,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,1508,ng/ml,1,=,5.4,,,
Planas21c,10.1038/s41586-021-04389-z,Virus isolate,Extended Data Fig 4,Sotrovimab,Delta,=,325,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,917,ng/ml,1,=,2.8,,,
Touret22,10.1038/s41598-022-08559-5,Virus isolate,"Figure 1, Table 1",Sotrovimab,Wild Type (B.1),=,89,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,276,ng/ml,1,=,3.1,,,
Touret22b,10.1038/s41598-022-16964-z,Virus isolate,Table 1,Sotrovimab,Wild Type (B.1),=,46,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,315.6,ng/ml,1,=,6.9,,,
Takashita22,10.1056/NEJMc2119407,Virus isolate,Table 1,Sotrovimab,Wild Type (A),=,27.3,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,373.5,ng/ml,1,=,13.7,,,
Takashita22c,10.1056/NEJMc2207519,Virus isolate,Table 1,Sotrovimab,Wild Type (A),=,95.1,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,40727.1,ng/ml,1,=,428.3,,,
Ohashi22,10.1101/2022.02.27.482147,Virus isolate,Table 1,Sotrovimab,Wild Type (A),=,158.7,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,957.9,ng/ml,1,=,6,,,
Fenwick22,10.1101/2022.03.18.484873,Virus isolate,Figure 2f,Sotrovimab,Delta,=,147,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,990,ng/ml,1,=,6.7,,,
Cameroni21,10.1038/s41586-021-04386-2,Virus isolate,"Figure 3c, Extended Data Table 2",Sotrovimab,Wild Type (A),=,179,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,320,ng/ml,1,=,1.8,,,
Case22,10.1038/s41467-022-31615-7,Virus isolate,Figure 1n,Sotrovimab,Wild Type (B.1),=,185.2,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,452,ng/ml,1,=,2.4,,,
VanBlargan22,10.1038/s41591-021-01678-y,Virus isolate,Figure 2g; Figure 3g,Sotrovimab,Wild Type (B.1),=,485.7,ng/ml,2.4,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,2,=,1700.9,ng/ml,4.6,=,4.2,3,5.4,
Dejnirattisai22,10.1016/j.cell.2021.12.046,Virus isolate,"Figure 4C, Table S1",Sotrovimab,Wild Type (B),=,40,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,256,ng/ml,1,=,6.4,,,
Duty22,10.1016/j.medj.2022.08.002,Virus isolate,Table 3,Sotrovimab,Wild Type (A),=,166.7,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,393,ng/ml,1,=,2.4,,,
Ma22,10.1101/2022.02.25.482049,Virus isolate,Figure 2b,Sotrovimab,Wild Type (A),=,412,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,6409,ng/ml,1,=,15.6,,,
Cathcart21,10.1101/2021.03.09.434607,Virus isolate,Table 1,Sotrovimab,Wild Type (A),,,,,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,,,,,=,3.8,,,
FDA21e,https://www.fda.gov/media/149534/download,Virus isolate,SOT Page 23,Sotrovimab,Wild Type (B),,,,,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,,,,,=,1,,,
Cameroni21,10.1038/s41586-021-04386-2,Pseudovirus (VSV),"Figure 3b, 3c, Extended Data Table 2",Sotrovimab,Wild Type (B.1),=,90.6,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,260,ng/ml,1,=,2.9,,,
Hoffmann22,10.1016/j.cell.2021.12.032,Pseudovirus (VSV),Figure 2C,Sotrovimab,Wild Type (B.1),=,43,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,157,ng/ml,1,=,3.7,,,
Liu21l,10.1038/s41586-021-04388-0,Pseudovirus (VSV),Figure 2c,Sotrovimab,Wild Type (B.1),=,64.3,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,167.3,ng/ml,1,=,2.6,,,
Sheward22,10.1016/S1473-3099(22)00129-3,Pseudovirus (HIV),Table 2,Sotrovimab,Wild Type (B.1),=,100,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,200,ng/ml,1,=,2,,,
Wang22,10.1080/22221751.2022.2030200,Pseudovirus (VSV),Figure 2,Sotrovimab,Wild Type (B.1),=,8.4,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,58.5,ng/ml,1,=,7,,,
Ikemura21,10.1101/2021.12.13.21267761,Pseudovirus (lentivirus),Figure 2A,Sotrovimab,Wild Type (B),=,324,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,259,ng/ml,1,=,0.8,,,
Huang22,10.1016/j.immuni.2022.06.005,Pseudovirus (VSV),Figure 2,Sotrovimab,Wild Type (B),=,21,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,85,ng/ml,1,=,4,,,
Gruell22,10.1038/s41591-021-01676-0,Pseudovirus (HIV),Fig 2,Sotrovimab,Wild Type (B),=,1964.2,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,95,ng/ml,1,<,0.1,,,
Park22,10.1126/science.adc9127,Virus isolate,Fig S12A,Sotrovimab,Wild Type (B),=,49.8,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + Δ142-144 + Y145D + Δ211 + L212I + R214ins + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,169.2,ng/ml,1,=,3.4,,,
Westendorf22,10.1016/j.celrep.2022.110812,Pseudovirus (VSV),Table 3B; Table 3D,Bebtelovimab,Wild Type,=,2.9,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,4,=,2.5,ng/ml,1.5,=,0.7,0.7,0.9,
Zhou21e,10.1126/science.abn8897,Pseudovirus (lentivirus),Figure 2C,Bebtelovimab,Wild Type (B.1),=,3,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,5.1,ng/ml,1,=,1.7,,,
Arora22f,10.1016/S1473-3099(22)00733-2,Pseudovirus (VSV),Figure B,Bebtelovimab,Wild Type (B.1),=,5,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,7,ng/ml,1,=,1.4,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Bebtelovimab,Wild Type (B.1),=,0.8,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,0.6,ng/ml,1,=,0.8,,,
Arora22e,10.1016/S1473-3099(22)00422-4,Pseudovirus (VSV),Supplementary Figure B,Bebtelovimab,Wild Type (B.1),=,3.7,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,3.1,ng/ml,1,=,0.8,,,
Cao22,10.1101/2022.02.07.479349,Pseudovirus (VSV),Table S2,Bebtelovimab,Wild Type (B.1),=,1.5,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,0.6,ng/ml,1,=,0.4,,,
Cao22d,10.1038/s41586-021-04385-3,Pseudovirus (VSV),41586_2021_4385_MOESM1_ESM.xlsx,Bebtelovimab,Wild Type (B.1),=,1.5,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,0.6,ng/ml,1,=,0.4,,,
Duty22,10.1016/j.medj.2022.08.002,Pseudovirus (VSV),Table 3,Bebtelovimab,Wild Type (B.1),=,7.4,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,14.7,ng/ml,1,=,2,,,
Lusvarghi22,10.1126/scitranslmed.abn8543,Pseudovirus (lentivirus),Fig 4,Bebtelovimab,Wild Type (B.1),=,1.3,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,3.2,ng/ml,1,=,2.5,,,
Misasi22,10.1101/2022.07.29.502029,Pseudovirus (lentivirus),Figure 1A,Bebtelovimab,Wild Type (B.1),=,3.3,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,4.9,ng/ml,1,=,1.5,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Table 1a,Bebtelovimab,Wild Type (B.1),=,1,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,3,ng/ml,1,=,3,,,
Zhou22,10.3390/v14061334,Pseudovirus (lentivirus),Figure 2B,Bebtelovimab,Wild Type (B.1),=,9.5,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,26.2,ng/ml,1,=,2.8,,,
Huo22b,10.1016/j.celrep.2022.111903,Pseudovirus (lentivirus),Supplementary Table 1B,Bebtelovimab,Wild Type (B),=,1,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,2,ng/ml,1,=,2,,,
Ai22,10.1016/j.chom.2022.05.001,Pseudovirus (VSV),Figure 3A,Bebtelovimab,Wild Type (B),=,1.5,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,1.3,ng/ml,1,=,0.9,,,
Gruell22b,10.1016/j.chom.2022.07.002,Pseudovirus (HIV),Figure 4B,Bebtelovimab,Wild Type (B),=,5,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,5,ng/ml,1,=,1,,,
Park22,10.1126/science.adc9127,Pseudovirus (VSV),Fig 1A,Bebtelovimab,Wild Type (B),=,3,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,2,ng/ml,1,=,0.7,,,
FDA22,https://www.fda.gov/media/156152/download,Pseudovirus,"Mar 2022, Page 13, antiviral resistance, Table 2",Bebtelovimab,Wild Type (B),,,,,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,,,,,=,1,,,
Iketani22,10.1038/s41586-022-04594-4,Pseudovirus (VSV),Figure 2b,Bebtelovimab,Wild Type (B.1),,,,,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,,,,,=,0.7,,,
Planas22b,10.1101/2022.11.17.516888,Virus isolate,Figure 3b,Bebtelovimab,Wild Type (B.1),=,1.4,ng/ml,1,Omicron/BA.2,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,4.5,ng/ml,1,=,3.2,,,Variant was erroneously labelled BA.1 changed to BA.2
Takashita22c,10.1056/NEJMc2207519,Virus isolate,Table 1,Bebtelovimab,Wild Type (A),=,2.5,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,5.8,ng/ml,1,=,2.3,,,
Westendorf22,10.1016/j.celrep.2022.110812,Virus isolate,Table 3A,Bebtelovimab,Wild Type (A),=,11,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,16,ng/ml,1,=,1.5,,,
FDA22,https://www.fda.gov/media/156152/download,Virus isolate,"Mar 2022, Page 14, antiviral resistance, Table 3",Bebtelovimab,Wild Type (B),,,,,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,,,,,=,1,,,
Lusvarghi22,10.1126/scitranslmed.abn8543,Pseudovirus (lentivirus),Fig 4,Bamlanivimab + Bebtelovimab + Etesevimab,Wild Type (B.1),=,3.4,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,32.5,ng/ml,1,=,9.6,,,
Westendorf22,10.1016/j.celrep.2022.110812,Pseudovirus (VSV),Table 3D,Regdanvimab,Wild Type (B.1),=,1.5,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Zhou21e,10.1126/science.abn8897,Pseudovirus (lentivirus),Figure 2C,Regdanvimab,Wild Type (B.1),=,1.5,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Arora22f,10.1016/S1473-3099(22)00733-2,Pseudovirus (VSV),Figure B,Regdanvimab,Wild Type (B.1),=,7,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,50000,ng/ml,1,>,1000,,,
Arora22b,10.1016/j.chom.2022.04.017,Pseudovirus (VSV),Supplementary Table 1,Regdanvimab,Wild Type (B.1),=,4.9,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Arora22e,10.1016/S1473-3099(22)00422-4,Pseudovirus (VSV),Supplementary Figure B,Regdanvimab,Wild Type (B.1),=,2.9,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,5000,ng/ml,1,>,1000,,,
Misasi22,10.1101/2022.07.29.502029,Pseudovirus (lentivirus),Figure 1A,Regdanvimab,Wild Type (B.1),=,2.8,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10050,ng/ml,1,>,1000,,,
Ai22,10.1016/j.chom.2022.05.001,Pseudovirus (VSV),Figure 3A,Regdanvimab,Wild Type (B),=,1,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Gruell22b,10.1016/j.chom.2022.07.002,Pseudovirus (HIV),Figure 4B,Regdanvimab,Wild Type (B),=,5,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Park22,10.1126/science.adc9127,Pseudovirus (VSV),Fig 1A,Regdanvimab,Wild Type (B),=,1.5,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Bruel22,10.1038/s41591-022-01792-5,Virus isolate,Table 1,Regdanvimab,Delta,=,23,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,9000,ng/ml,1,>,391.3,,,
Planas21c,10.1038/s41586-021-04389-z,Virus isolate,Extended Data Fig 4,Regdanvimab,Delta,=,86.6,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,9000,ng/ml,1,>,103.9,,,
Touret22,10.1038/s41598-022-08559-5,Virus isolate,"Figure 1, Table 1",Regdanvimab,Wild Type (B.1),=,13,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,1000,ng/ml,1,>,76.9,,,
VanBlargan22,10.1038/s41591-021-01678-y,Virus isolate,Figure 2g; Figure 3g,Regdanvimab,Wild Type (B.1),=,2.4,ng/ml,1.2,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,2,>,10000,ng/ml,1,>,1000,3750,4583.3,
Cameroni21,10.1038/s41586-021-04386-2,Pseudovirus (VSV),"Figure 3b, 3c, Extended Data Table 2",Regdanvimab,Wild Type (B.1),=,4.3,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Wang22,10.1080/22221751.2022.2030200,Pseudovirus (VSV),Figure 2,Regdanvimab,Wild Type (B.1),=,0.8,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Rothenberger22,10.1038/s41587-022-01382-3,Pseudovirus (VSV),Extended Data Fig. 1,Amubarvimab,Wild Type (B),=,9.5,ng/ml,1,Omicron/BA.1,(Various),(Various),2,=,163.3,ng/ml,2.4,=,24.2,15.7,32.8,
Arora22f,10.1016/S1473-3099(22)00733-2,Pseudovirus (VSV),Figure B,Amubarvimab,Wild Type (B.1),=,53,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,5641,ng/ml,1,=,106.4,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Amubarvimab,Wild Type (B.1),=,53.2,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,7120,ng/ml,1,=,133.8,,,
Cao22,10.1101/2022.02.07.479349,Pseudovirus (VSV),Table S2,Amubarvimab,Wild Type (B.1),=,52.9,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,7260,ng/ml,1,=,137.2,,,
Cao22d,10.1038/s41586-021-04385-3,Pseudovirus (VSV),Fig 4b,Amubarvimab,Wild Type (B.1),=,53,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,7258,ng/ml,1,=,136.9,,,
Cui22,10.1016/j.cell.2022.01.019,Pseudovirus (VSV),Figure 5C,Amubarvimab,Wild Type (B.1),=,51.5,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,6239,ng/ml,1,=,121.1,,,
Lusvarghi22,10.1126/scitranslmed.abn8543,Pseudovirus (lentivirus),Fig 4,Amubarvimab,Wild Type (B.1),=,21.3,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,469.5,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Table 1a,Amubarvimab,Wild Type (B.1),=,18,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,2385,ng/ml,1,=,132.5,,,
Ai22,10.1016/j.chom.2022.05.001,Pseudovirus (VSV),Figure 3A,Amubarvimab,Wild Type (B),=,9,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,4048,ng/ml,1,=,449.8,,,
Gruell22b,10.1016/j.chom.2022.07.002,Pseudovirus (HIV),Figure 4B,Amubarvimab,Wild Type (B),=,8,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Iketani22,10.1038/s41586-022-04594-4,Pseudovirus (VSV),Figure 2b,Amubarvimab,Wild Type (B.1),,,,,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,,,,,=,298,,,
Brii21,https://opendata.ncats.nih.gov/variant/datasets?Brii,Pseudovirus (HIV),Table,Amubarvimab,Wild Type (B),,,,,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,,,,,=,103,,,
Liu21l,10.1038/s41586-021-04388-0,Pseudovirus (VSV),Figure 2c,Amubarvimab,Wild Type (B.1),=,6.9,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,1000,ng/ml,1,=,144.9,,,
Huang22,10.1016/j.immuni.2022.06.005,Pseudovirus (VSV),Figure 2,Amubarvimab,Wild Type (B),=,39,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,3810,ng/ml,1,=,97.7,,,
Rothenberger22,10.1038/s41587-022-01382-3,Pseudovirus (VSV),Extended Data Fig. 1,Romlusevimab,Wild Type (B),=,52,ng/ml,1,Omicron/BA.1,(Various),(Various),2,=,43.1,ng/ml,1.4,=,0.9,0.8,1,
Arora22f,10.1016/S1473-3099(22)00733-2,Pseudovirus (VSV),Figure B,Romlusevimab,Wild Type (B.1),=,852,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,866,ng/ml,1,=,1,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Romlusevimab,Wild Type (B.1),=,1240,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,1170,ng/ml,1,=,0.9,,,
Cao22,10.1101/2022.02.07.479349,Pseudovirus (VSV),Table S2,Romlusevimab,Wild Type (B.1),=,1240,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,1160,ng/ml,1,=,0.9,,,
Lusvarghi22,10.1126/scitranslmed.abn8543,Pseudovirus (lentivirus),Fig 4,Romlusevimab,Wild Type (B.1),=,203.8,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,232.1,ng/ml,1,=,1.1,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Table 1a,Romlusevimab,Wild Type (B.1),=,110,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,78,ng/ml,1,=,0.7,,,
Iketani22,10.1038/s41586-022-04594-4,Pseudovirus (VSV),Figure 2b,Romlusevimab,Wild Type (B.1),,,,,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,,,,,=,0.4,,,
Brii21,https://opendata.ncats.nih.gov/variant/datasets?Brii,Pseudovirus (HIV),Table,Romlusevimab,Wild Type (B),,,,,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,,,,,=,0.8,,,
Liu21l,10.1038/s41586-021-04388-0,Pseudovirus (VSV),Figure 2c,Romlusevimab,Wild Type (B.1),=,357.4,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,167.3,ng/ml,1,=,0.5,,,
Arora22f,10.1016/S1473-3099(22)00733-2,Pseudovirus (VSV),Figure B,Amubarvimab + Romlusevimab,Wild Type (B.1),=,64,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,657,ng/ml,1,=,10.3,,,
Lusvarghi22,10.1126/scitranslmed.abn8543,Pseudovirus (lentivirus),Fig 4,Amubarvimab + Romlusevimab,Wild Type (B.1),=,18.8,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,347.6,ng/ml,1,=,18.5,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Table 1a,Amubarvimab + Romlusevimab,Wild Type (B.1),=,22,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,260,ng/ml,1,=,11.8,,,
Brii21,https://opendata.ncats.nih.gov/variant/datasets?Brii,Pseudovirus (HIV),Table,Amubarvimab + Romlusevimab,Wild Type (B),,,,,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,,,,,=,9,,,
Liu21l,10.1038/s41586-021-04388-0,Pseudovirus (VSV),Figure 2c,Amubarvimab + Romlusevimab,Wild Type (B.1),=,18.4,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,235.7,ng/ml,1,=,12.8,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,DXP-604,Wild Type (B.1),=,11,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,285,ng/ml,1,=,25.9,,,
Cao22d,10.1038/s41586-021-04385-3,Pseudovirus (VSV),Fig 4b,DXP-604,Wild Type (B.1),=,10,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,287,ng/ml,1,=,28.7,,,
Wang22c,10.1038/s41586-022-04466-x,Pseudovirus (VSV),Supplmentary Table 2,DXP-604,Wild Type (B),=,17,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,154,ng/ml,1,=,9.1,,,
Huang22,10.1016/j.immuni.2022.06.005,Pseudovirus (VSV),Figure 2,DXP-604,Wild Type (B),=,27,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,170,ng/ml,1,=,6.3,,,
Nabel21,10.1126/science.abl6251,Pseudovirus (lentivirus),"Fig 2A, 2B",Bamlanivimab,Wild Type (B.1),=,22,ng/ml,1,SARS-CoV-1,(Various),(Various),2,>,100000,ng/ml,1,>,1000,4545.5,4545.5,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Bamlanivimab,Wild Type (B.1),=,15,ng/ml,1,SARS-CoV-1,3,V3I + V6L + L7F + P9T + V11T + S12ins + Q14D + C15L + V16D + N17R + L18C + R21F + T22D + Q23D + L24V + P25ins + A27N + N30ins + F32S + T33M + K41E + V42I + S46D + V47T + H49Y + S50L + F59Y + W64G + A67T + H69N + V70H + S71T + Δ72-78 + D80G + L84I + N87K + V90I + S94A + I100V + I101V + I105V + T108S + L110M + D111N + S112N + T114S + L117V + L118I + V120I + A123S + K129R + V130A + E132N + Q134E + F135L + N137D + D138N + L141F + G142A + Y144S + Y145K + H146P + Δ147 + N148M + N149G + Δ150-152 + M153T + E154Q + S155T + E156H + F157T + R158M + V159I + Y160F + S161D + S162N + N164F + V171I + Q173D + P174A + L176S + M177L + L179V + E180S + G181E + Q183S + N188H + I197K + Y200F + F201L + K202Y + I203V + S205K + K206G + H207Y + T208Q + N211D + L212V + Q218S + S221N + A222T + E224K + L226I + V227F + D228K + I231L + R237N + Q239R + T240A + L241I + A243T + L244A + Δ245-246 + S247F + Y248S + L249P + T250A + P251Q + G252D + D253I + Δ254-257 + T259G + A260T + G261S + Y266F + Q271K + R273T + L276M + N280D + A292S + L293Q + D294N + S297A + T299L + T302S + L303V + T307E + V308I + E309D + Q321V + T323S + E324G + S325D + I326V + R346K + A348P + N354E + R357K + A372T + S373F + P384A + T393S + I402V + R403K + E406D + K417V + T430M + I434L + S438T + N439R + L441I + S443A + K444T + V445S + G446T + L452K + L455Y + F456L + K458H + S459G + N460K + K462R + T470N + E471V + I472P + Y473F + Q474S + A475P + G476D + S477G + T478K + N481T + G482P + Δ483 + E484P + G485A + F486L + F490W + Q493N + S494D + Q498Y + P499T + N501T + V503I + H519N + K529L + N532D + V534I + K537Q + E554P + N556S + K558R + L560Q + I569V + A570S + T572F + A575S + Q580K + L582S + T588S + S591A + T604A + N606S + Q607E + E619D + P621S + V622T + T632A + V635I + S640N + R646Q + N657D + N658T + Q675H + Q677V + T678S + N679L + S680L + Δ681-684 + V687T + A688S + S689Q + Q690K + I693V + E702D + N703S + V705I + S711T + T719S + V722I + I726V + L727M + T732A + T739N + S750A + T768S + V772A + K776R + Q779R + I788M + P793T + I794L + D796Y + S810L + S813T + I834M + D839E + A845N + E868D + Q872A + S875A + L878V + A879S + I882A + S884A + L922Q + S929K + G932S + K933Q + D936E + S939T + S940T + A942S + S943T + S1055A + A1070S + K1073R + D1084E + H1088Y + S1097F + H1101S + V1104I + Y1110F + E1111S + V1133I + I1216V + M1233L + C1247A,1,>,10000,ng/ml,1,>,666.7,,,
Cao22,10.1101/2022.02.07.479349,Pseudovirus (VSV),Table S2,Bamlanivimab,Wild Type (B.1),=,12.8,ng/ml,1,SARS-CoV-1,3,V3I + V6L + L7F + P9T + V11T + S12ins + Q14D + C15L + V16D + N17R + L18C + R21F + T22D + Q23D + L24V + P25ins + A27N + N30ins + F32S + T33M + K41E + V42I + S46D + V47T + H49Y + S50L + F59Y + W64G + A67T + H69N + V70H + S71T + Δ72-78 + D80G + L84I + N87K + V90I + S94A + I100V + I101V + I105V + T108S + L110M + D111N + S112N + T114S + L117V + L118I + V120I + A123S + K129R + V130A + E132N + Q134E + F135L + N137D + D138N + L141F + G142A + Y144S + Y145K + H146P + Δ147 + N148M + N149G + Δ150-152 + M153T + E154Q + S155T + E156H + F157T + R158M + V159I + Y160F + S161D + S162N + N164F + V171I + Q173D + P174A + L176S + M177L + L179V + E180S + G181E + Q183S + N188H + I197K + Y200F + F201L + K202Y + I203V + S205K + K206G + H207Y + T208Q + N211D + L212V + Q218S + S221N + A222T + E224K + L226I + V227F + D228K + I231L + R237N + Q239R + T240A + L241I + A243T + L244A + Δ245-246 + S247F + Y248S + L249P + T250A + P251Q + G252D + D253I + Δ254-257 + T259G + A260T + G261S + Y266F + Q271K + R273T + L276M + N280D + A292S + L293Q + D294N + S297A + T299L + T302S + L303V + T307E + V308I + E309D + Q321V + T323S + E324G + S325D + I326V + R346K + A348P + N354E + R357K + A372T + S373F + P384A + T393S + I402V + R403K + E406D + K417V + T430M + I434L + S438T + N439R + L441I + S443A + K444T + V445S + G446T + L452K + L455Y + F456L + K458H + S459G + N460K + K462R + T470N + E471V + I472P + Y473F + Q474S + A475P + G476D + S477G + T478K + N481T + G482P + Δ483 + E484P + G485A + F486L + F490W + Q493N + S494D + Q498Y + P499T + N501T + V503I + H519N + K529L + N532D + V534I + K537Q + E554P + N556S + K558R + L560Q + I569V + A570S + T572F + A575S + Q580K + L582S + T588S + S591A + T604A + N606S + Q607E + E619D + P621S + V622T + T632A + V635I + S640N + R646Q + N657D + N658T + Q675H + Q677V + T678S + N679L + S680L + Δ681-684 + V687T + A688S + S689Q + Q690K + I693V + E702D + N703S + V705I + S711T + T719S + V722I + I726V + L727M + T732A + T739N + S750A + T768S + V772A + K776R + Q779R + I788M + P793T + I794L + D796Y + S810L + S813T + I834M + D839E + A845N + E868D + Q872A + S875A + L878V + A879S + I882A + S884A + L922Q + S929K + G932S + K933Q + D936E + S939T + S940T + A942S + S943T + S1055A + A1070S + K1073R + D1084E + H1088Y + S1097F + H1101S + V1104I + Y1110F + E1111S + V1133I + I1216V + M1233L + C1247A,1,>,10000,ng/ml,1,>,781.3,,,
Cao22c,10.1016/j.chom.2022.09.018,Pseudovirus (VSV),Figure 5b,Bamlanivimab,Wild Type (B.1),=,15,ng/ml,1,SARS-CoV-1,3,V3I + V6L + L7F + P9T + V11T + S12ins + Q14D + C15L + V16D + N17R + L18C + R21F + T22D + Q23D + L24V + P25ins + A27N + N30ins + F32S + T33M + K41E + V42I + S46D + V47T + H49Y + S50L + F59Y + W64G + A67T + H69N + V70H + S71T + Δ72-78 + D80G + L84I + N87K + V90I + S94A + I100V + I101V + I105V + T108S + L110M + D111N + S112N + T114S + L117V + L118I + V120I + A123S + K129R + V130A + E132N + Q134E + F135L + N137D + D138N + L141F + G142A + Y144S + Y145K + H146P + Δ147 + N148M + N149G + Δ150-152 + M153T + E154Q + S155T + E156H + F157T + R158M + V159I + Y160F + S161D + S162N + N164F + V171I + Q173D + P174A + L176S + M177L + L179V + E180S + G181E + Q183S + N188H + I197K + Y200F + F201L + K202Y + I203V + S205K + K206G + H207Y + T208Q + N211D + L212V + Q218S + S221N + A222T + E224K + L226I + V227F + D228K + I231L + R237N + Q239R + T240A + L241I + A243T + L244A + Δ245-246 + S247F + Y248S + L249P + T250A + P251Q + G252D + D253I + Δ254-257 + T259G + A260T + G261S + Y266F + Q271K + R273T + L276M + N280D + A292S + L293Q + D294N + S297A + T299L + T302S + L303V + T307E + V308I + E309D + Q321V + T323S + E324G + S325D + I326V + R346K + A348P + N354E + R357K + A372T + S373F + P384A + T393S + I402V + R403K + E406D + K417V + T430M + I434L + S438T + N439R + L441I + S443A + K444T + V445S + G446T + L452K + L455Y + F456L + K458H + S459G + N460K + K462R + T470N + E471V + I472P + Y473F + Q474S + A475P + G476D + S477G + T478K + N481T + G482P + Δ483 + E484P + G485A + F486L + F490W + Q493N + S494D + Q498Y + P499T + N501T + V503I + H519N + K529L + N532D + V534I + K537Q + E554P + N556S + K558R + L560Q + I569V + A570S + T572F + A575S + Q580K + L582S + T588S + S591A + T604A + N606S + Q607E + E619D + P621S + V622T + T632A + V635I + S640N + R646Q + N657D + N658T + Q675H + Q677V + T678S + N679L + S680L + Δ681-684 + V687T + A688S + S689Q + Q690K + I693V + E702D + N703S + V705I + S711T + T719S + V722I + I726V + L727M + T732A + T739N + S750A + T768S + V772A + K776R + Q779R + I788M + P793T + I794L + D796Y + S810L + S813T + I834M + D839E + A845N + E868D + Q872A + S875A + L878V + A879S + I882A + S884A + L922Q + S929K + G932S + K933Q + D936E + S939T + S940T + A942S + S943T + S1055A + A1070S + K1073R + D1084E + H1088Y + S1097F + H1101S + V1104I + Y1110F + E1111S + V1133I + I1216V + M1233L + C1247A,1,>,10000,ng/ml,1,>,666.7,,,
Cao22d,10.1038/s41586-021-04385-3,Pseudovirus (VSV),41586_2021_4385_MOESM1_ESM.xlsx,Bamlanivimab,Wild Type (B.1),=,13,ng/ml,1,SARS-CoV-1,3,V3I + V6L + L7F + P9T + V11T + S12ins + Q14D + C15L + V16D + N17R + L18C + R21F + T22D + Q23D + L24V + P25ins + A27N + N30ins + F32S + T33M + K41E + V42I + S46D + V47T + H49Y + S50L + F59Y + W64G + A67T + H69N + V70H + S71T + Δ72-78 + D80G + L84I + N87K + V90I + S94A + I100V + I101V + I105V + T108S + L110M + D111N + S112N + T114S + L117V + L118I + V120I + A123S + K129R + V130A + E132N + Q134E + F135L + N137D + D138N + L141F + G142A + Y144S + Y145K + H146P + Δ147 + N148M + N149G + Δ150-152 + M153T + E154Q + S155T + E156H + F157T + R158M + V159I + Y160F + S161D + S162N + N164F + V171I + Q173D + P174A + L176S + M177L + L179V + E180S + G181E + Q183S + N188H + I197K + Y200F + F201L + K202Y + I203V + S205K + K206G + H207Y + T208Q + N211D + L212V + Q218S + S221N + A222T + E224K + L226I + V227F + D228K + I231L + R237N + Q239R + T240A + L241I + A243T + L244A + Δ245-246 + S247F + Y248S + L249P + T250A + P251Q + G252D + D253I + Δ254-257 + T259G + A260T + G261S + Y266F + Q271K + R273T + L276M + N280D + A292S + L293Q + D294N + S297A + T299L + T302S + L303V + T307E + V308I + E309D + Q321V + T323S + E324G + S325D + I326V + R346K + A348P + N354E + R357K + A372T + S373F + P384A + T393S + I402V + R403K + E406D + K417V + T430M + I434L + S438T + N439R + L441I + S443A + K444T + V445S + G446T + L452K + L455Y + F456L + K458H + S459G + N460K + K462R + T470N + E471V + I472P + Y473F + Q474S + A475P + G476D + S477G + T478K + N481T + G482P + Δ483 + E484P + G485A + F486L + F490W + Q493N + S494D + Q498Y + P499T + N501T + V503I + H519N + K529L + N532D + V534I + K537Q + E554P + N556S + K558R + L560Q + I569V + A570S + T572F + A575S + Q580K + L582S + T588S + S591A + T604A + N606S + Q607E + E619D + P621S + V622T + T632A + V635I + S640N + R646Q + N657D + N658T + Q675H + Q677V + T678S + N679L + S680L + Δ681-684 + V687T + A688S + S689Q + Q690K + I693V + E702D + N703S + V705I + S711T + T719S + V722I + I726V + L727M + T732A + T739N + S750A + T768S + V772A + K776R + Q779R + I788M + P793T + I794L + D796Y + S810L + S813T + I834M + D839E + A845N + E868D + Q872A + S875A + L878V + A879S + I882A + S884A + L922Q + S929K + G932S + K933Q + D936E + S939T + S940T + A942S + S943T + S1055A + A1070S + K1073R + D1084E + H1088Y + S1097F + H1101S + V1104I + Y1110F + E1111S + V1133I + I1216V + M1233L + C1247A,1,>,10000,ng/ml,1,>,769.2,,,
Yuan22,10.1101/2022.03.13.484037,Pseudovirus (MLV),Figure 2A,Bamlanivimab,Wild Type (B),=,7,ng/ml,1,SARS-CoV-1,3,V3I + V6L + L7F + P9T + V11T + S12ins + Q14D + C15L + V16D + N17R + L18C + R21F + T22D + Q23D + L24V + P25ins + A27N + N30ins + F32S + T33M + K41E + V42I + S46D + V47T + H49Y + S50L + F59Y + W64G + A67T + H69N + V70H + S71T + Δ72-78 + D80G + L84I + N87K + V90I + S94A + I100V + I101V + I105V + T108S + L110M + D111N + S112N + T114S + L117V + L118I + V120I + A123S + K129R + V130A + E132N + Q134E + F135L + N137D + D138N + L141F + G142A + Y144S + Y145K + H146P + Δ147 + N148M + N149G + Δ150-152 + M153T + E154Q + S155T + E156H + F157T + R158M + V159I + Y160F + S161D + S162N + N164F + V171I + Q173D + P174A + L176S + M177L + L179V + E180S + G181E + Q183S + N188H + I197K + Y200F + F201L + K202Y + I203V + S205K + K206G + H207Y + T208Q + N211D + L212V + Q218S + S221N + A222T + E224K + L226I + V227F + D228K + I231L + R237N + Q239R + T240A + L241I + A243T + L244A + Δ245-246 + S247F + Y248S + L249P + T250A + P251Q + G252D + D253I + Δ254-257 + T259G + A260T + G261S + Y266F + Q271K + R273T + L276M + N280D + A292S + L293Q + D294N + S297A + T299L + T302S + L303V + T307E + V308I + E309D + Q321V + T323S + E324G + S325D + I326V + R346K + A348P + N354E + R357K + A372T + S373F + P384A + T393S + I402V + R403K + E406D + K417V + T430M + I434L + S438T + N439R + L441I + S443A + K444T + V445S + G446T + L452K + L455Y + F456L + K458H + S459G + N460K + K462R + T470N + E471V + I472P + Y473F + Q474S + A475P + G476D + S477G + T478K + N481T + G482P + Δ483 + E484P + G485A + F486L + F490W + Q493N + S494D + Q498Y + P499T + N501T + V503I + H519N + K529L + N532D + V534I + K537Q + E554P + N556S + K558R + L560Q + I569V + A570S + T572F + A575S + Q580K + L582S + T588S + S591A + T604A + N606S + Q607E + E619D + P621S + V622T + T632A + V635I + S640N + R646Q + N657D + N658T + Q675H + Q677V + T678S + N679L + S680L + Δ681-684 + V687T + A688S + S689Q + Q690K + I693V + E702D + N703S + V705I + S711T + T719S + V722I + I726V + L727M + T732A + T739N + S750A + T768S + V772A + K776R + Q779R + I788M + P793T + I794L + D796Y + S810L + S813T + I834M + D839E + A845N + E868D + Q872A + S875A + L878V + A879S + I882A + S884A + L922Q + S929K + G932S + K933Q + D936E + S939T + S940T + A942S + S943T + S1055A + A1070S + K1073R + D1084E + H1088Y + S1097F + H1101S + V1104I + Y1110F + E1111S + V1133I + I1216V + M1233L + C1247A,1,>,5000,ng/ml,1,>,714.3,,,
Nabel21,10.1126/science.abl6251,Pseudovirus (lentivirus),"Fig 2A, 2B",Etesevimab,Wild Type (B.1),=,27,ng/ml,1,SARS-CoV-1,(Various),(Various),2,>,100000,ng/ml,1,>,1000,3703.7,3703.7,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Etesevimab,Wild Type (B.1),=,32,ng/ml,1,SARS-CoV-1,3,V3I + V6L + L7F + P9T + V11T + S12ins + Q14D + C15L + V16D + N17R + L18C + R21F + T22D + Q23D + L24V + P25ins + A27N + N30ins + F32S + T33M + K41E + V42I + S46D + V47T + H49Y + S50L + F59Y + W64G + A67T + H69N + V70H + S71T + Δ72-78 + D80G + L84I + N87K + V90I + S94A + I100V + I101V + I105V + T108S + L110M + D111N + S112N + T114S + L117V + L118I + V120I + A123S + K129R + V130A + E132N + Q134E + F135L + N137D + D138N + L141F + G142A + Y144S + Y145K + H146P + Δ147 + N148M + N149G + Δ150-152 + M153T + E154Q + S155T + E156H + F157T + R158M + V159I + Y160F + S161D + S162N + N164F + V171I + Q173D + P174A + L176S + M177L + L179V + E180S + G181E + Q183S + N188H + I197K + Y200F + F201L + K202Y + I203V + S205K + K206G + H207Y + T208Q + N211D + L212V + Q218S + S221N + A222T + E224K + L226I + V227F + D228K + I231L + R237N + Q239R + T240A + L241I + A243T + L244A + Δ245-246 + S247F + Y248S + L249P + T250A + P251Q + G252D + D253I + Δ254-257 + T259G + A260T + G261S + Y266F + Q271K + R273T + L276M + N280D + A292S + L293Q + D294N + S297A + T299L + T302S + L303V + T307E + V308I + E309D + Q321V + T323S + E324G + S325D + I326V + R346K + A348P + N354E + R357K + A372T + S373F + P384A + T393S + I402V + R403K + E406D + K417V + T430M + I434L + S438T + N439R + L441I + S443A + K444T + V445S + G446T + L452K + L455Y + F456L + K458H + S459G + N460K + K462R + T470N + E471V + I472P + Y473F + Q474S + A475P + G476D + S477G + T478K + N481T + G482P + Δ483 + E484P + G485A + F486L + F490W + Q493N + S494D + Q498Y + P499T + N501T + V503I + H519N + K529L + N532D + V534I + K537Q + E554P + N556S + K558R + L560Q + I569V + A570S + T572F + A575S + Q580K + L582S + T588S + S591A + T604A + N606S + Q607E + E619D + P621S + V622T + T632A + V635I + S640N + R646Q + N657D + N658T + Q675H + Q677V + T678S + N679L + S680L + Δ681-684 + V687T + A688S + S689Q + Q690K + I693V + E702D + N703S + V705I + S711T + T719S + V722I + I726V + L727M + T732A + T739N + S750A + T768S + V772A + K776R + Q779R + I788M + P793T + I794L + D796Y + S810L + S813T + I834M + D839E + A845N + E868D + Q872A + S875A + L878V + A879S + I882A + S884A + L922Q + S929K + G932S + K933Q + D936E + S939T + S940T + A942S + S943T + S1055A + A1070S + K1073R + D1084E + H1088Y + S1097F + H1101S + V1104I + Y1110F + E1111S + V1133I + I1216V + M1233L + C1247A,1,>,10000,ng/ml,1,>,312.5,,,
Cao22,10.1101/2022.02.07.479349,Pseudovirus (VSV),Table S2,Etesevimab,Wild Type (B.1),=,31.6,ng/ml,1,SARS-CoV-1,3,V3I + V6L + L7F + P9T + V11T + S12ins + Q14D + C15L + V16D + N17R + L18C + R21F + T22D + Q23D + L24V + P25ins + A27N + N30ins + F32S + T33M + K41E + V42I + S46D + V47T + H49Y + S50L + F59Y + W64G + A67T + H69N + V70H + S71T + Δ72-78 + D80G + L84I + N87K + V90I + S94A + I100V + I101V + I105V + T108S + L110M + D111N + S112N + T114S + L117V + L118I + V120I + A123S + K129R + V130A + E132N + Q134E + F135L + N137D + D138N + L141F + G142A + Y144S + Y145K + H146P + Δ147 + N148M + N149G + Δ150-152 + M153T + E154Q + S155T + E156H + F157T + R158M + V159I + Y160F + S161D + S162N + N164F + V171I + Q173D + P174A + L176S + M177L + L179V + E180S + G181E + Q183S + N188H + I197K + Y200F + F201L + K202Y + I203V + S205K + K206G + H207Y + T208Q + N211D + L212V + Q218S + S221N + A222T + E224K + L226I + V227F + D228K + I231L + R237N + Q239R + T240A + L241I + A243T + L244A + Δ245-246 + S247F + Y248S + L249P + T250A + P251Q + G252D + D253I + Δ254-257 + T259G + A260T + G261S + Y266F + Q271K + R273T + L276M + N280D + A292S + L293Q + D294N + S297A + T299L + T302S + L303V + T307E + V308I + E309D + Q321V + T323S + E324G + S325D + I326V + R346K + A348P + N354E + R357K + A372T + S373F + P384A + T393S + I402V + R403K + E406D + K417V + T430M + I434L + S438T + N439R + L441I + S443A + K444T + V445S + G446T + L452K + L455Y + F456L + K458H + S459G + N460K + K462R + T470N + E471V + I472P + Y473F + Q474S + A475P + G476D + S477G + T478K + N481T + G482P + Δ483 + E484P + G485A + F486L + F490W + Q493N + S494D + Q498Y + P499T + N501T + V503I + H519N + K529L + N532D + V534I + K537Q + E554P + N556S + K558R + L560Q + I569V + A570S + T572F + A575S + Q580K + L582S + T588S + S591A + T604A + N606S + Q607E + E619D + P621S + V622T + T632A + V635I + S640N + R646Q + N657D + N658T + Q675H + Q677V + T678S + N679L + S680L + Δ681-684 + V687T + A688S + S689Q + Q690K + I693V + E702D + N703S + V705I + S711T + T719S + V722I + I726V + L727M + T732A + T739N + S750A + T768S + V772A + K776R + Q779R + I788M + P793T + I794L + D796Y + S810L + S813T + I834M + D839E + A845N + E868D + Q872A + S875A + L878V + A879S + I882A + S884A + L922Q + S929K + G932S + K933Q + D936E + S939T + S940T + A942S + S943T + S1055A + A1070S + K1073R + D1084E + H1088Y + S1097F + H1101S + V1104I + Y1110F + E1111S + V1133I + I1216V + M1233L + C1247A,1,>,10000,ng/ml,1,>,316.5,,,
Cao22c,10.1016/j.chom.2022.09.018,Pseudovirus (VSV),Figure 5b,Etesevimab,Wild Type (B.1),=,32,ng/ml,1,SARS-CoV-1,3,V3I + V6L + L7F + P9T + V11T + S12ins + Q14D + C15L + V16D + N17R + L18C + R21F + T22D + Q23D + L24V + P25ins + A27N + N30ins + F32S + T33M + K41E + V42I + S46D + V47T + H49Y + S50L + F59Y + W64G + A67T + H69N + V70H + S71T + Δ72-78 + D80G + L84I + N87K + V90I + S94A + I100V + I101V + I105V + T108S + L110M + D111N + S112N + T114S + L117V + L118I + V120I + A123S + K129R + V130A + E132N + Q134E + F135L + N137D + D138N + L141F + G142A + Y144S + Y145K + H146P + Δ147 + N148M + N149G + Δ150-152 + M153T + E154Q + S155T + E156H + F157T + R158M + V159I + Y160F + S161D + S162N + N164F + V171I + Q173D + P174A + L176S + M177L + L179V + E180S + G181E + Q183S + N188H + I197K + Y200F + F201L + K202Y + I203V + S205K + K206G + H207Y + T208Q + N211D + L212V + Q218S + S221N + A222T + E224K + L226I + V227F + D228K + I231L + R237N + Q239R + T240A + L241I + A243T + L244A + Δ245-246 + S247F + Y248S + L249P + T250A + P251Q + G252D + D253I + Δ254-257 + T259G + A260T + G261S + Y266F + Q271K + R273T + L276M + N280D + A292S + L293Q + D294N + S297A + T299L + T302S + L303V + T307E + V308I + E309D + Q321V + T323S + E324G + S325D + I326V + R346K + A348P + N354E + R357K + A372T + S373F + P384A + T393S + I402V + R403K + E406D + K417V + T430M + I434L + S438T + N439R + L441I + S443A + K444T + V445S + G446T + L452K + L455Y + F456L + K458H + S459G + N460K + K462R + T470N + E471V + I472P + Y473F + Q474S + A475P + G476D + S477G + T478K + N481T + G482P + Δ483 + E484P + G485A + F486L + F490W + Q493N + S494D + Q498Y + P499T + N501T + V503I + H519N + K529L + N532D + V534I + K537Q + E554P + N556S + K558R + L560Q + I569V + A570S + T572F + A575S + Q580K + L582S + T588S + S591A + T604A + N606S + Q607E + E619D + P621S + V622T + T632A + V635I + S640N + R646Q + N657D + N658T + Q675H + Q677V + T678S + N679L + S680L + Δ681-684 + V687T + A688S + S689Q + Q690K + I693V + E702D + N703S + V705I + S711T + T719S + V722I + I726V + L727M + T732A + T739N + S750A + T768S + V772A + K776R + Q779R + I788M + P793T + I794L + D796Y + S810L + S813T + I834M + D839E + A845N + E868D + Q872A + S875A + L878V + A879S + I882A + S884A + L922Q + S929K + G932S + K933Q + D936E + S939T + S940T + A942S + S943T + S1055A + A1070S + K1073R + D1084E + H1088Y + S1097F + H1101S + V1104I + Y1110F + E1111S + V1133I + I1216V + M1233L + C1247A,1,>,10000,ng/ml,1,>,312.5,,,
Cao22d,10.1038/s41586-021-04385-3,Pseudovirus (VSV),41586_2021_4385_MOESM1_ESM.xlsx,Etesevimab,Wild Type (B.1),=,32,ng/ml,1,SARS-CoV-1,3,V3I + V6L + L7F + P9T + V11T + S12ins + Q14D + C15L + V16D + N17R + L18C + R21F + T22D + Q23D + L24V + P25ins + A27N + N30ins + F32S + T33M + K41E + V42I + S46D + V47T + H49Y + S50L + F59Y + W64G + A67T + H69N + V70H + S71T + Δ72-78 + D80G + L84I + N87K + V90I + S94A + I100V + I101V + I105V + T108S + L110M + D111N + S112N + T114S + L117V + L118I + V120I + A123S + K129R + V130A + E132N + Q134E + F135L + N137D + D138N + L141F + G142A + Y144S + Y145K + H146P + Δ147 + N148M + N149G + Δ150-152 + M153T + E154Q + S155T + E156H + F157T + R158M + V159I + Y160F + S161D + S162N + N164F + V171I + Q173D + P174A + L176S + M177L + L179V + E180S + G181E + Q183S + N188H + I197K + Y200F + F201L + K202Y + I203V + S205K + K206G + H207Y + T208Q + N211D + L212V + Q218S + S221N + A222T + E224K + L226I + V227F + D228K + I231L + R237N + Q239R + T240A + L241I + A243T + L244A + Δ245-246 + S247F + Y248S + L249P + T250A + P251Q + G252D + D253I + Δ254-257 + T259G + A260T + G261S + Y266F + Q271K + R273T + L276M + N280D + A292S + L293Q + D294N + S297A + T299L + T302S + L303V + T307E + V308I + E309D + Q321V + T323S + E324G + S325D + I326V + R346K + A348P + N354E + R357K + A372T + S373F + P384A + T393S + I402V + R403K + E406D + K417V + T430M + I434L + S438T + N439R + L441I + S443A + K444T + V445S + G446T + L452K + L455Y + F456L + K458H + S459G + N460K + K462R + T470N + E471V + I472P + Y473F + Q474S + A475P + G476D + S477G + T478K + N481T + G482P + Δ483 + E484P + G485A + F486L + F490W + Q493N + S494D + Q498Y + P499T + N501T + V503I + H519N + K529L + N532D + V534I + K537Q + E554P + N556S + K558R + L560Q + I569V + A570S + T572F + A575S + Q580K + L582S + T588S + S591A + T604A + N606S + Q607E + E619D + P621S + V622T + T632A + V635I + S640N + R646Q + N657D + N658T + Q675H + Q677V + T678S + N679L + S680L + Δ681-684 + V687T + A688S + S689Q + Q690K + I693V + E702D + N703S + V705I + S711T + T719S + V722I + I726V + L727M + T732A + T739N + S750A + T768S + V772A + K776R + Q779R + I788M + P793T + I794L + D796Y + S810L + S813T + I834M + D839E + A845N + E868D + Q872A + S875A + L878V + A879S + I882A + S884A + L922Q + S929K + G932S + K933Q + D936E + S939T + S940T + A942S + S943T + S1055A + A1070S + K1073R + D1084E + H1088Y + S1097F + H1101S + V1104I + Y1110F + E1111S + V1133I + I1216V + M1233L + C1247A,1,>,10000,ng/ml,1,>,312.5,,,
Yuan22,10.1101/2022.03.13.484037,Pseudovirus (MLV),Figure 2A,Etesevimab,Wild Type (B),=,9,ng/ml,1,SARS-CoV-1,3,V3I + V6L + L7F + P9T + V11T + S12ins + Q14D + C15L + V16D + N17R + L18C + R21F + T22D + Q23D + L24V + P25ins + A27N + N30ins + F32S + T33M + K41E + V42I + S46D + V47T + H49Y + S50L + F59Y + W64G + A67T + H69N + V70H + S71T + Δ72-78 + D80G + L84I + N87K + V90I + S94A + I100V + I101V + I105V + T108S + L110M + D111N + S112N + T114S + L117V + L118I + V120I + A123S + K129R + V130A + E132N + Q134E + F135L + N137D + D138N + L141F + G142A + Y144S + Y145K + H146P + Δ147 + N148M + N149G + Δ150-152 + M153T + E154Q + S155T + E156H + F157T + R158M + V159I + Y160F + S161D + S162N + N164F + V171I + Q173D + P174A + L176S + M177L + L179V + E180S + G181E + Q183S + N188H + I197K + Y200F + F201L + K202Y + I203V + S205K + K206G + H207Y + T208Q + N211D + L212V + Q218S + S221N + A222T + E224K + L226I + V227F + D228K + I231L + R237N + Q239R + T240A + L241I + A243T + L244A + Δ245-246 + S247F + Y248S + L249P + T250A + P251Q + G252D + D253I + Δ254-257 + T259G + A260T + G261S + Y266F + Q271K + R273T + L276M + N280D + A292S + L293Q + D294N + S297A + T299L + T302S + L303V + T307E + V308I + E309D + Q321V + T323S + E324G + S325D + I326V + R346K + A348P + N354E + R357K + A372T + S373F + P384A + T393S + I402V + R403K + E406D + K417V + T430M + I434L + S438T + N439R + L441I + S443A + K444T + V445S + G446T + L452K + L455Y + F456L + K458H + S459G + N460K + K462R + T470N + E471V + I472P + Y473F + Q474S + A475P + G476D + S477G + T478K + N481T + G482P + Δ483 + E484P + G485A + F486L + F490W + Q493N + S494D + Q498Y + P499T + N501T + V503I + H519N + K529L + N532D + V534I + K537Q + E554P + N556S + K558R + L560Q + I569V + A570S + T572F + A575S + Q580K + L582S + T588S + S591A + T604A + N606S + Q607E + E619D + P621S + V622T + T632A + V635I + S640N + R646Q + N657D + N658T + Q675H + Q677V + T678S + N679L + S680L + Δ681-684 + V687T + A688S + S689Q + Q690K + I693V + E702D + N703S + V705I + S711T + T719S + V722I + I726V + L727M + T732A + T739N + S750A + T768S + V772A + K776R + Q779R + I788M + P793T + I794L + D796Y + S810L + S813T + I834M + D839E + A845N + E868D + Q872A + S875A + L878V + A879S + I882A + S884A + L922Q + S929K + G932S + K933Q + D936E + S939T + S940T + A942S + S943T + S1055A + A1070S + K1073R + D1084E + H1088Y + S1097F + H1101S + V1104I + Y1110F + E1111S + V1133I + I1216V + M1233L + C1247A,1,>,5000,ng/ml,1,>,555.6,,,
Cao22c,10.1016/j.chom.2022.09.018,Pseudovirus (VSV),Figure 5b,Bamlanivimab + Etesevimab,Wild Type (B.1),=,20,ng/ml,1,SARS-CoV-1,3,V3I + V6L + L7F + P9T + V11T + S12ins + Q14D + C15L + V16D + N17R + L18C + R21F + T22D + Q23D + L24V + P25ins + A27N + N30ins + F32S + T33M + K41E + V42I + S46D + V47T + H49Y + S50L + F59Y + W64G + A67T + H69N + V70H + S71T + Δ72-78 + D80G + L84I + N87K + V90I + S94A + I100V + I101V + I105V + T108S + L110M + D111N + S112N + T114S + L117V + L118I + V120I + A123S + K129R + V130A + E132N + Q134E + F135L + N137D + D138N + L141F + G142A + Y144S + Y145K + H146P + Δ147 + N148M + N149G + Δ150-152 + M153T + E154Q + S155T + E156H + F157T + R158M + V159I + Y160F + S161D + S162N + N164F + V171I + Q173D + P174A + L176S + M177L + L179V + E180S + G181E + Q183S + N188H + I197K + Y200F + F201L + K202Y + I203V + S205K + K206G + H207Y + T208Q + N211D + L212V + Q218S + S221N + A222T + E224K + L226I + V227F + D228K + I231L + R237N + Q239R + T240A + L241I + A243T + L244A + Δ245-246 + S247F + Y248S + L249P + T250A + P251Q + G252D + D253I + Δ254-257 + T259G + A260T + G261S + Y266F + Q271K + R273T + L276M + N280D + A292S + L293Q + D294N + S297A + T299L + T302S + L303V + T307E + V308I + E309D + Q321V + T323S + E324G + S325D + I326V + R346K + A348P + N354E + R357K + A372T + S373F + P384A + T393S + I402V + R403K + E406D + K417V + T430M + I434L + S438T + N439R + L441I + S443A + K444T + V445S + G446T + L452K + L455Y + F456L + K458H + S459G + N460K + K462R + T470N + E471V + I472P + Y473F + Q474S + A475P + G476D + S477G + T478K + N481T + G482P + Δ483 + E484P + G485A + F486L + F490W + Q493N + S494D + Q498Y + P499T + N501T + V503I + H519N + K529L + N532D + V534I + K537Q + E554P + N556S + K558R + L560Q + I569V + A570S + T572F + A575S + Q580K + L582S + T588S + S591A + T604A + N606S + Q607E + E619D + P621S + V622T + T632A + V635I + S640N + R646Q + N657D + N658T + Q675H + Q677V + T678S + N679L + S680L + Δ681-684 + V687T + A688S + S689Q + Q690K + I693V + E702D + N703S + V705I + S711T + T719S + V722I + I726V + L727M + T732A + T739N + S750A + T768S + V772A + K776R + Q779R + I788M + P793T + I794L + D796Y + S810L + S813T + I834M + D839E + A845N + E868D + Q872A + S875A + L878V + A879S + I882A + S884A + L922Q + S929K + G932S + K933Q + D936E + S939T + S940T + A942S + S943T + S1055A + A1070S + K1073R + D1084E + H1088Y + S1097F + H1101S + V1104I + Y1110F + E1111S + V1133I + I1216V + M1233L + C1247A,1,>,10000,ng/ml,1,>,500,,,
Yuan22,10.1101/2022.03.13.484037,Pseudovirus (MLV),Figure 2A,Bamlanivimab + Etesevimab,Wild Type (B),=,9,ng/ml,1,SARS-CoV-1,3,V3I + V6L + L7F + P9T + V11T + S12ins + Q14D + C15L + V16D + N17R + L18C + R21F + T22D + Q23D + L24V + P25ins + A27N + N30ins + F32S + T33M + K41E + V42I + S46D + V47T + H49Y + S50L + F59Y + W64G + A67T + H69N + V70H + S71T + Δ72-78 + D80G + L84I + N87K + V90I + S94A + I100V + I101V + I105V + T108S + L110M + D111N + S112N + T114S + L117V + L118I + V120I + A123S + K129R + V130A + E132N + Q134E + F135L + N137D + D138N + L141F + G142A + Y144S + Y145K + H146P + Δ147 + N148M + N149G + Δ150-152 + M153T + E154Q + S155T + E156H + F157T + R158M + V159I + Y160F + S161D + S162N + N164F + V171I + Q173D + P174A + L176S + M177L + L179V + E180S + G181E + Q183S + N188H + I197K + Y200F + F201L + K202Y + I203V + S205K + K206G + H207Y + T208Q + N211D + L212V + Q218S + S221N + A222T + E224K + L226I + V227F + D228K + I231L + R237N + Q239R + T240A + L241I + A243T + L244A + Δ245-246 + S247F + Y248S + L249P + T250A + P251Q + G252D + D253I + Δ254-257 + T259G + A260T + G261S + Y266F + Q271K + R273T + L276M + N280D + A292S + L293Q + D294N + S297A + T299L + T302S + L303V + T307E + V308I + E309D + Q321V + T323S + E324G + S325D + I326V + R346K + A348P + N354E + R357K + A372T + S373F + P384A + T393S + I402V + R403K + E406D + K417V + T430M + I434L + S438T + N439R + L441I + S443A + K444T + V445S + G446T + L452K + L455Y + F456L + K458H + S459G + N460K + K462R + T470N + E471V + I472P + Y473F + Q474S + A475P + G476D + S477G + T478K + N481T + G482P + Δ483 + E484P + G485A + F486L + F490W + Q493N + S494D + Q498Y + P499T + N501T + V503I + H519N + K529L + N532D + V534I + K537Q + E554P + N556S + K558R + L560Q + I569V + A570S + T572F + A575S + Q580K + L582S + T588S + S591A + T604A + N606S + Q607E + E619D + P621S + V622T + T632A + V635I + S640N + R646Q + N657D + N658T + Q675H + Q677V + T678S + N679L + S680L + Δ681-684 + V687T + A688S + S689Q + Q690K + I693V + E702D + N703S + V705I + S711T + T719S + V722I + I726V + L727M + T732A + T739N + S750A + T768S + V772A + K776R + Q779R + I788M + P793T + I794L + D796Y + S810L + S813T + I834M + D839E + A845N + E868D + Q872A + S875A + L878V + A879S + I882A + S884A + L922Q + S929K + G932S + K933Q + D936E + S939T + S940T + A942S + S943T + S1055A + A1070S + K1073R + D1084E + H1088Y + S1097F + H1101S + V1104I + Y1110F + E1111S + V1133I + I1216V + M1233L + C1247A,1,>,5000,ng/ml,1,>,555.6,,,
Nabel21,10.1126/science.abl6251,Pseudovirus (lentivirus),"Fig 2A, 2B",Casirivimab,Wild Type (B.1),=,25,ng/ml,1,SARS-CoV-1,(Various),(Various),2,>,100000,ng/ml,1,>,1000,4000,4000,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Casirivimab,Wild Type (B.1),=,5.6,ng/ml,1,SARS-CoV-1,3,V3I + V6L + L7F + P9T + V11T + S12ins + Q14D + C15L + V16D + N17R + L18C + R21F + T22D + Q23D + L24V + P25ins + A27N + N30ins + F32S + T33M + K41E + V42I + S46D + V47T + H49Y + S50L + F59Y + W64G + A67T + H69N + V70H + S71T + Δ72-78 + D80G + L84I + N87K + V90I + S94A + I100V + I101V + I105V + T108S + L110M + D111N + S112N + T114S + L117V + L118I + V120I + A123S + K129R + V130A + E132N + Q134E + F135L + N137D + D138N + L141F + G142A + Y144S + Y145K + H146P + Δ147 + N148M + N149G + Δ150-152 + M153T + E154Q + S155T + E156H + F157T + R158M + V159I + Y160F + S161D + S162N + N164F + V171I + Q173D + P174A + L176S + M177L + L179V + E180S + G181E + Q183S + N188H + I197K + Y200F + F201L + K202Y + I203V + S205K + K206G + H207Y + T208Q + N211D + L212V + Q218S + S221N + A222T + E224K + L226I + V227F + D228K + I231L + R237N + Q239R + T240A + L241I + A243T + L244A + Δ245-246 + S247F + Y248S + L249P + T250A + P251Q + G252D + D253I + Δ254-257 + T259G + A260T + G261S + Y266F + Q271K + R273T + L276M + N280D + A292S + L293Q + D294N + S297A + T299L + T302S + L303V + T307E + V308I + E309D + Q321V + T323S + E324G + S325D + I326V + R346K + A348P + N354E + R357K + A372T + S373F + P384A + T393S + I402V + R403K + E406D + K417V + T430M + I434L + S438T + N439R + L441I + S443A + K444T + V445S + G446T + L452K + L455Y + F456L + K458H + S459G + N460K + K462R + T470N + E471V + I472P + Y473F + Q474S + A475P + G476D + S477G + T478K + N481T + G482P + Δ483 + E484P + G485A + F486L + F490W + Q493N + S494D + Q498Y + P499T + N501T + V503I + H519N + K529L + N532D + V534I + K537Q + E554P + N556S + K558R + L560Q + I569V + A570S + T572F + A575S + Q580K + L582S + T588S + S591A + T604A + N606S + Q607E + E619D + P621S + V622T + T632A + V635I + S640N + R646Q + N657D + N658T + Q675H + Q677V + T678S + N679L + S680L + Δ681-684 + V687T + A688S + S689Q + Q690K + I693V + E702D + N703S + V705I + S711T + T719S + V722I + I726V + L727M + T732A + T739N + S750A + T768S + V772A + K776R + Q779R + I788M + P793T + I794L + D796Y + S810L + S813T + I834M + D839E + A845N + E868D + Q872A + S875A + L878V + A879S + I882A + S884A + L922Q + S929K + G932S + K933Q + D936E + S939T + S940T + A942S + S943T + S1055A + A1070S + K1073R + D1084E + H1088Y + S1097F + H1101S + V1104I + Y1110F + E1111S + V1133I + I1216V + M1233L + C1247A,1,>,10000,ng/ml,1,>,1000,,,
Cao22,10.1101/2022.02.07.479349,Pseudovirus (VSV),Table S2,Casirivimab,Wild Type (B.1),=,5.3,ng/ml,1,SARS-CoV-1,3,V3I + V6L + L7F + P9T + V11T + S12ins + Q14D + C15L + V16D + N17R + L18C + R21F + T22D + Q23D + L24V + P25ins + A27N + N30ins + F32S + T33M + K41E + V42I + S46D + V47T + H49Y + S50L + F59Y + W64G + A67T + H69N + V70H + S71T + Δ72-78 + D80G + L84I + N87K + V90I + S94A + I100V + I101V + I105V + T108S + L110M + D111N + S112N + T114S + L117V + L118I + V120I + A123S + K129R + V130A + E132N + Q134E + F135L + N137D + D138N + L141F + G142A + Y144S + Y145K + H146P + Δ147 + N148M + N149G + Δ150-152 + M153T + E154Q + S155T + E156H + F157T + R158M + V159I + Y160F + S161D + S162N + N164F + V171I + Q173D + P174A + L176S + M177L + L179V + E180S + G181E + Q183S + N188H + I197K + Y200F + F201L + K202Y + I203V + S205K + K206G + H207Y + T208Q + N211D + L212V + Q218S + S221N + A222T + E224K + L226I + V227F + D228K + I231L + R237N + Q239R + T240A + L241I + A243T + L244A + Δ245-246 + S247F + Y248S + L249P + T250A + P251Q + G252D + D253I + Δ254-257 + T259G + A260T + G261S + Y266F + Q271K + R273T + L276M + N280D + A292S + L293Q + D294N + S297A + T299L + T302S + L303V + T307E + V308I + E309D + Q321V + T323S + E324G + S325D + I326V + R346K + A348P + N354E + R357K + A372T + S373F + P384A + T393S + I402V + R403K + E406D + K417V + T430M + I434L + S438T + N439R + L441I + S443A + K444T + V445S + G446T + L452K + L455Y + F456L + K458H + S459G + N460K + K462R + T470N + E471V + I472P + Y473F + Q474S + A475P + G476D + S477G + T478K + N481T + G482P + Δ483 + E484P + G485A + F486L + F490W + Q493N + S494D + Q498Y + P499T + N501T + V503I + H519N + K529L + N532D + V534I + K537Q + E554P + N556S + K558R + L560Q + I569V + A570S + T572F + A575S + Q580K + L582S + T588S + S591A + T604A + N606S + Q607E + E619D + P621S + V622T + T632A + V635I + S640N + R646Q + N657D + N658T + Q675H + Q677V + T678S + N679L + S680L + Δ681-684 + V687T + A688S + S689Q + Q690K + I693V + E702D + N703S + V705I + S711T + T719S + V722I + I726V + L727M + T732A + T739N + S750A + T768S + V772A + K776R + Q779R + I788M + P793T + I794L + D796Y + S810L + S813T + I834M + D839E + A845N + E868D + Q872A + S875A + L878V + A879S + I882A + S884A + L922Q + S929K + G932S + K933Q + D936E + S939T + S940T + A942S + S943T + S1055A + A1070S + K1073R + D1084E + H1088Y + S1097F + H1101S + V1104I + Y1110F + E1111S + V1133I + I1216V + M1233L + C1247A,1,>,10000,ng/ml,1,>,1000,,,
Cao22c,10.1016/j.chom.2022.09.018,Pseudovirus (VSV),Figure 5b,Casirivimab,Wild Type (B.1),=,5.6,ng/ml,1,SARS-CoV-1,3,V3I + V6L + L7F + P9T + V11T + S12ins + Q14D + C15L + V16D + N17R + L18C + R21F + T22D + Q23D + L24V + P25ins + A27N + N30ins + F32S + T33M + K41E + V42I + S46D + V47T + H49Y + S50L + F59Y + W64G + A67T + H69N + V70H + S71T + Δ72-78 + D80G + L84I + N87K + V90I + S94A + I100V + I101V + I105V + T108S + L110M + D111N + S112N + T114S + L117V + L118I + V120I + A123S + K129R + V130A + E132N + Q134E + F135L + N137D + D138N + L141F + G142A + Y144S + Y145K + H146P + Δ147 + N148M + N149G + Δ150-152 + M153T + E154Q + S155T + E156H + F157T + R158M + V159I + Y160F + S161D + S162N + N164F + V171I + Q173D + P174A + L176S + M177L + L179V + E180S + G181E + Q183S + N188H + I197K + Y200F + F201L + K202Y + I203V + S205K + K206G + H207Y + T208Q + N211D + L212V + Q218S + S221N + A222T + E224K + L226I + V227F + D228K + I231L + R237N + Q239R + T240A + L241I + A243T + L244A + Δ245-246 + S247F + Y248S + L249P + T250A + P251Q + G252D + D253I + Δ254-257 + T259G + A260T + G261S + Y266F + Q271K + R273T + L276M + N280D + A292S + L293Q + D294N + S297A + T299L + T302S + L303V + T307E + V308I + E309D + Q321V + T323S + E324G + S325D + I326V + R346K + A348P + N354E + R357K + A372T + S373F + P384A + T393S + I402V + R403K + E406D + K417V + T430M + I434L + S438T + N439R + L441I + S443A + K444T + V445S + G446T + L452K + L455Y + F456L + K458H + S459G + N460K + K462R + T470N + E471V + I472P + Y473F + Q474S + A475P + G476D + S477G + T478K + N481T + G482P + Δ483 + E484P + G485A + F486L + F490W + Q493N + S494D + Q498Y + P499T + N501T + V503I + H519N + K529L + N532D + V534I + K537Q + E554P + N556S + K558R + L560Q + I569V + A570S + T572F + A575S + Q580K + L582S + T588S + S591A + T604A + N606S + Q607E + E619D + P621S + V622T + T632A + V635I + S640N + R646Q + N657D + N658T + Q675H + Q677V + T678S + N679L + S680L + Δ681-684 + V687T + A688S + S689Q + Q690K + I693V + E702D + N703S + V705I + S711T + T719S + V722I + I726V + L727M + T732A + T739N + S750A + T768S + V772A + K776R + Q779R + I788M + P793T + I794L + D796Y + S810L + S813T + I834M + D839E + A845N + E868D + Q872A + S875A + L878V + A879S + I882A + S884A + L922Q + S929K + G932S + K933Q + D936E + S939T + S940T + A942S + S943T + S1055A + A1070S + K1073R + D1084E + H1088Y + S1097F + H1101S + V1104I + Y1110F + E1111S + V1133I + I1216V + M1233L + C1247A,1,>,10000,ng/ml,1,>,1000,,,
Cao22d,10.1038/s41586-021-04385-3,Pseudovirus (VSV),41586_2021_4385_MOESM1_ESM.xlsx,Casirivimab,Wild Type (B.1),=,5,ng/ml,1,SARS-CoV-1,3,V3I + V6L + L7F + P9T + V11T + S12ins + Q14D + C15L + V16D + N17R + L18C + R21F + T22D + Q23D + L24V + P25ins + A27N + N30ins + F32S + T33M + K41E + V42I + S46D + V47T + H49Y + S50L + F59Y + W64G + A67T + H69N + V70H + S71T + Δ72-78 + D80G + L84I + N87K + V90I + S94A + I100V + I101V + I105V + T108S + L110M + D111N + S112N + T114S + L117V + L118I + V120I + A123S + K129R + V130A + E132N + Q134E + F135L + N137D + D138N + L141F + G142A + Y144S + Y145K + H146P + Δ147 + N148M + N149G + Δ150-152 + M153T + E154Q + S155T + E156H + F157T + R158M + V159I + Y160F + S161D + S162N + N164F + V171I + Q173D + P174A + L176S + M177L + L179V + E180S + G181E + Q183S + N188H + I197K + Y200F + F201L + K202Y + I203V + S205K + K206G + H207Y + T208Q + N211D + L212V + Q218S + S221N + A222T + E224K + L226I + V227F + D228K + I231L + R237N + Q239R + T240A + L241I + A243T + L244A + Δ245-246 + S247F + Y248S + L249P + T250A + P251Q + G252D + D253I + Δ254-257 + T259G + A260T + G261S + Y266F + Q271K + R273T + L276M + N280D + A292S + L293Q + D294N + S297A + T299L + T302S + L303V + T307E + V308I + E309D + Q321V + T323S + E324G + S325D + I326V + R346K + A348P + N354E + R357K + A372T + S373F + P384A + T393S + I402V + R403K + E406D + K417V + T430M + I434L + S438T + N439R + L441I + S443A + K444T + V445S + G446T + L452K + L455Y + F456L + K458H + S459G + N460K + K462R + T470N + E471V + I472P + Y473F + Q474S + A475P + G476D + S477G + T478K + N481T + G482P + Δ483 + E484P + G485A + F486L + F490W + Q493N + S494D + Q498Y + P499T + N501T + V503I + H519N + K529L + N532D + V534I + K537Q + E554P + N556S + K558R + L560Q + I569V + A570S + T572F + A575S + Q580K + L582S + T588S + S591A + T604A + N606S + Q607E + E619D + P621S + V622T + T632A + V635I + S640N + R646Q + N657D + N658T + Q675H + Q677V + T678S + N679L + S680L + Δ681-684 + V687T + A688S + S689Q + Q690K + I693V + E702D + N703S + V705I + S711T + T719S + V722I + I726V + L727M + T732A + T739N + S750A + T768S + V772A + K776R + Q779R + I788M + P793T + I794L + D796Y + S810L + S813T + I834M + D839E + A845N + E868D + Q872A + S875A + L878V + A879S + I882A + S884A + L922Q + S929K + G932S + K933Q + D936E + S939T + S940T + A942S + S943T + S1055A + A1070S + K1073R + D1084E + H1088Y + S1097F + H1101S + V1104I + Y1110F + E1111S + V1133I + I1216V + M1233L + C1247A,1,>,10000,ng/ml,1,>,1000,,,
Yuan22,10.1101/2022.03.13.484037,Pseudovirus (MLV),Figure 2A,Casirivimab,Wild Type (B),=,6,ng/ml,1,SARS-CoV-1,3,V3I + V6L + L7F + P9T + V11T + S12ins + Q14D + C15L + V16D + N17R + L18C + R21F + T22D + Q23D + L24V + P25ins + A27N + N30ins + F32S + T33M + K41E + V42I + S46D + V47T + H49Y + S50L + F59Y + W64G + A67T + H69N + V70H + S71T + Δ72-78 + D80G + L84I + N87K + V90I + S94A + I100V + I101V + I105V + T108S + L110M + D111N + S112N + T114S + L117V + L118I + V120I + A123S + K129R + V130A + E132N + Q134E + F135L + N137D + D138N + L141F + G142A + Y144S + Y145K + H146P + Δ147 + N148M + N149G + Δ150-152 + M153T + E154Q + S155T + E156H + F157T + R158M + V159I + Y160F + S161D + S162N + N164F + V171I + Q173D + P174A + L176S + M177L + L179V + E180S + G181E + Q183S + N188H + I197K + Y200F + F201L + K202Y + I203V + S205K + K206G + H207Y + T208Q + N211D + L212V + Q218S + S221N + A222T + E224K + L226I + V227F + D228K + I231L + R237N + Q239R + T240A + L241I + A243T + L244A + Δ245-246 + S247F + Y248S + L249P + T250A + P251Q + G252D + D253I + Δ254-257 + T259G + A260T + G261S + Y266F + Q271K + R273T + L276M + N280D + A292S + L293Q + D294N + S297A + T299L + T302S + L303V + T307E + V308I + E309D + Q321V + T323S + E324G + S325D + I326V + R346K + A348P + N354E + R357K + A372T + S373F + P384A + T393S + I402V + R403K + E406D + K417V + T430M + I434L + S438T + N439R + L441I + S443A + K444T + V445S + G446T + L452K + L455Y + F456L + K458H + S459G + N460K + K462R + T470N + E471V + I472P + Y473F + Q474S + A475P + G476D + S477G + T478K + N481T + G482P + Δ483 + E484P + G485A + F486L + F490W + Q493N + S494D + Q498Y + P499T + N501T + V503I + H519N + K529L + N532D + V534I + K537Q + E554P + N556S + K558R + L560Q + I569V + A570S + T572F + A575S + Q580K + L582S + T588S + S591A + T604A + N606S + Q607E + E619D + P621S + V622T + T632A + V635I + S640N + R646Q + N657D + N658T + Q675H + Q677V + T678S + N679L + S680L + Δ681-684 + V687T + A688S + S689Q + Q690K + I693V + E702D + N703S + V705I + S711T + T719S + V722I + I726V + L727M + T732A + T739N + S750A + T768S + V772A + K776R + Q779R + I788M + P793T + I794L + D796Y + S810L + S813T + I834M + D839E + A845N + E868D + Q872A + S875A + L878V + A879S + I882A + S884A + L922Q + S929K + G932S + K933Q + D936E + S939T + S940T + A942S + S943T + S1055A + A1070S + K1073R + D1084E + H1088Y + S1097F + H1101S + V1104I + Y1110F + E1111S + V1133I + I1216V + M1233L + C1247A,1,>,5000,ng/ml,1,>,833.3,,,
Nabel21,10.1126/science.abl6251,Pseudovirus (lentivirus),"Fig 2A, 2B",Imdevimab,Wild Type (B.1),=,32,ng/ml,1,SARS-CoV-1,(Various),(Various),2,>,100000,ng/ml,1,>,1000,3125,3125,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Imdevimab,Wild Type (B.1),=,5.7,ng/ml,1,SARS-CoV-1,3,V3I + V6L + L7F + P9T + V11T + S12ins + Q14D + C15L + V16D + N17R + L18C + R21F + T22D + Q23D + L24V + P25ins + A27N + N30ins + F32S + T33M + K41E + V42I + S46D + V47T + H49Y + S50L + F59Y + W64G + A67T + H69N + V70H + S71T + Δ72-78 + D80G + L84I + N87K + V90I + S94A + I100V + I101V + I105V + T108S + L110M + D111N + S112N + T114S + L117V + L118I + V120I + A123S + K129R + V130A + E132N + Q134E + F135L + N137D + D138N + L141F + G142A + Y144S + Y145K + H146P + Δ147 + N148M + N149G + Δ150-152 + M153T + E154Q + S155T + E156H + F157T + R158M + V159I + Y160F + S161D + S162N + N164F + V171I + Q173D + P174A + L176S + M177L + L179V + E180S + G181E + Q183S + N188H + I197K + Y200F + F201L + K202Y + I203V + S205K + K206G + H207Y + T208Q + N211D + L212V + Q218S + S221N + A222T + E224K + L226I + V227F + D228K + I231L + R237N + Q239R + T240A + L241I + A243T + L244A + Δ245-246 + S247F + Y248S + L249P + T250A + P251Q + G252D + D253I + Δ254-257 + T259G + A260T + G261S + Y266F + Q271K + R273T + L276M + N280D + A292S + L293Q + D294N + S297A + T299L + T302S + L303V + T307E + V308I + E309D + Q321V + T323S + E324G + S325D + I326V + R346K + A348P + N354E + R357K + A372T + S373F + P384A + T393S + I402V + R403K + E406D + K417V + T430M + I434L + S438T + N439R + L441I + S443A + K444T + V445S + G446T + L452K + L455Y + F456L + K458H + S459G + N460K + K462R + T470N + E471V + I472P + Y473F + Q474S + A475P + G476D + S477G + T478K + N481T + G482P + Δ483 + E484P + G485A + F486L + F490W + Q493N + S494D + Q498Y + P499T + N501T + V503I + H519N + K529L + N532D + V534I + K537Q + E554P + N556S + K558R + L560Q + I569V + A570S + T572F + A575S + Q580K + L582S + T588S + S591A + T604A + N606S + Q607E + E619D + P621S + V622T + T632A + V635I + S640N + R646Q + N657D + N658T + Q675H + Q677V + T678S + N679L + S680L + Δ681-684 + V687T + A688S + S689Q + Q690K + I693V + E702D + N703S + V705I + S711T + T719S + V722I + I726V + L727M + T732A + T739N + S750A + T768S + V772A + K776R + Q779R + I788M + P793T + I794L + D796Y + S810L + S813T + I834M + D839E + A845N + E868D + Q872A + S875A + L878V + A879S + I882A + S884A + L922Q + S929K + G932S + K933Q + D936E + S939T + S940T + A942S + S943T + S1055A + A1070S + K1073R + D1084E + H1088Y + S1097F + H1101S + V1104I + Y1110F + E1111S + V1133I + I1216V + M1233L + C1247A,1,>,10000,ng/ml,1,>,1000,,,
Cao22,10.1101/2022.02.07.479349,Pseudovirus (VSV),Table S2,Imdevimab,Wild Type (B.1),=,5.4,ng/ml,1,SARS-CoV-1,3,V3I + V6L + L7F + P9T + V11T + S12ins + Q14D + C15L + V16D + N17R + L18C + R21F + T22D + Q23D + L24V + P25ins + A27N + N30ins + F32S + T33M + K41E + V42I + S46D + V47T + H49Y + S50L + F59Y + W64G + A67T + H69N + V70H + S71T + Δ72-78 + D80G + L84I + N87K + V90I + S94A + I100V + I101V + I105V + T108S + L110M + D111N + S112N + T114S + L117V + L118I + V120I + A123S + K129R + V130A + E132N + Q134E + F135L + N137D + D138N + L141F + G142A + Y144S + Y145K + H146P + Δ147 + N148M + N149G + Δ150-152 + M153T + E154Q + S155T + E156H + F157T + R158M + V159I + Y160F + S161D + S162N + N164F + V171I + Q173D + P174A + L176S + M177L + L179V + E180S + G181E + Q183S + N188H + I197K + Y200F + F201L + K202Y + I203V + S205K + K206G + H207Y + T208Q + N211D + L212V + Q218S + S221N + A222T + E224K + L226I + V227F + D228K + I231L + R237N + Q239R + T240A + L241I + A243T + L244A + Δ245-246 + S247F + Y248S + L249P + T250A + P251Q + G252D + D253I + Δ254-257 + T259G + A260T + G261S + Y266F + Q271K + R273T + L276M + N280D + A292S + L293Q + D294N + S297A + T299L + T302S + L303V + T307E + V308I + E309D + Q321V + T323S + E324G + S325D + I326V + R346K + A348P + N354E + R357K + A372T + S373F + P384A + T393S + I402V + R403K + E406D + K417V + T430M + I434L + S438T + N439R + L441I + S443A + K444T + V445S + G446T + L452K + L455Y + F456L + K458H + S459G + N460K + K462R + T470N + E471V + I472P + Y473F + Q474S + A475P + G476D + S477G + T478K + N481T + G482P + Δ483 + E484P + G485A + F486L + F490W + Q493N + S494D + Q498Y + P499T + N501T + V503I + H519N + K529L + N532D + V534I + K537Q + E554P + N556S + K558R + L560Q + I569V + A570S + T572F + A575S + Q580K + L582S + T588S + S591A + T604A + N606S + Q607E + E619D + P621S + V622T + T632A + V635I + S640N + R646Q + N657D + N658T + Q675H + Q677V + T678S + N679L + S680L + Δ681-684 + V687T + A688S + S689Q + Q690K + I693V + E702D + N703S + V705I + S711T + T719S + V722I + I726V + L727M + T732A + T739N + S750A + T768S + V772A + K776R + Q779R + I788M + P793T + I794L + D796Y + S810L + S813T + I834M + D839E + A845N + E868D + Q872A + S875A + L878V + A879S + I882A + S884A + L922Q + S929K + G932S + K933Q + D936E + S939T + S940T + A942S + S943T + S1055A + A1070S + K1073R + D1084E + H1088Y + S1097F + H1101S + V1104I + Y1110F + E1111S + V1133I + I1216V + M1233L + C1247A,1,>,10000,ng/ml,1,>,1000,,,
Cao22c,10.1016/j.chom.2022.09.018,Pseudovirus (VSV),Figure 5b,Imdevimab,Wild Type (B.1),=,5.7,ng/ml,1,SARS-CoV-1,3,V3I + V6L + L7F + P9T + V11T + S12ins + Q14D + C15L + V16D + N17R + L18C + R21F + T22D + Q23D + L24V + P25ins + A27N + N30ins + F32S + T33M + K41E + V42I + S46D + V47T + H49Y + S50L + F59Y + W64G + A67T + H69N + V70H + S71T + Δ72-78 + D80G + L84I + N87K + V90I + S94A + I100V + I101V + I105V + T108S + L110M + D111N + S112N + T114S + L117V + L118I + V120I + A123S + K129R + V130A + E132N + Q134E + F135L + N137D + D138N + L141F + G142A + Y144S + Y145K + H146P + Δ147 + N148M + N149G + Δ150-152 + M153T + E154Q + S155T + E156H + F157T + R158M + V159I + Y160F + S161D + S162N + N164F + V171I + Q173D + P174A + L176S + M177L + L179V + E180S + G181E + Q183S + N188H + I197K + Y200F + F201L + K202Y + I203V + S205K + K206G + H207Y + T208Q + N211D + L212V + Q218S + S221N + A222T + E224K + L226I + V227F + D228K + I231L + R237N + Q239R + T240A + L241I + A243T + L244A + Δ245-246 + S247F + Y248S + L249P + T250A + P251Q + G252D + D253I + Δ254-257 + T259G + A260T + G261S + Y266F + Q271K + R273T + L276M + N280D + A292S + L293Q + D294N + S297A + T299L + T302S + L303V + T307E + V308I + E309D + Q321V + T323S + E324G + S325D + I326V + R346K + A348P + N354E + R357K + A372T + S373F + P384A + T393S + I402V + R403K + E406D + K417V + T430M + I434L + S438T + N439R + L441I + S443A + K444T + V445S + G446T + L452K + L455Y + F456L + K458H + S459G + N460K + K462R + T470N + E471V + I472P + Y473F + Q474S + A475P + G476D + S477G + T478K + N481T + G482P + Δ483 + E484P + G485A + F486L + F490W + Q493N + S494D + Q498Y + P499T + N501T + V503I + H519N + K529L + N532D + V534I + K537Q + E554P + N556S + K558R + L560Q + I569V + A570S + T572F + A575S + Q580K + L582S + T588S + S591A + T604A + N606S + Q607E + E619D + P621S + V622T + T632A + V635I + S640N + R646Q + N657D + N658T + Q675H + Q677V + T678S + N679L + S680L + Δ681-684 + V687T + A688S + S689Q + Q690K + I693V + E702D + N703S + V705I + S711T + T719S + V722I + I726V + L727M + T732A + T739N + S750A + T768S + V772A + K776R + Q779R + I788M + P793T + I794L + D796Y + S810L + S813T + I834M + D839E + A845N + E868D + Q872A + S875A + L878V + A879S + I882A + S884A + L922Q + S929K + G932S + K933Q + D936E + S939T + S940T + A942S + S943T + S1055A + A1070S + K1073R + D1084E + H1088Y + S1097F + H1101S + V1104I + Y1110F + E1111S + V1133I + I1216V + M1233L + C1247A,1,>,10000,ng/ml,1,>,1000,,,
Cao22d,10.1038/s41586-021-04385-3,Pseudovirus (VSV),41586_2021_4385_MOESM1_ESM.xlsx,Imdevimab,Wild Type (B.1),=,5,ng/ml,1,SARS-CoV-1,3,V3I + V6L + L7F + P9T + V11T + S12ins + Q14D + C15L + V16D + N17R + L18C + R21F + T22D + Q23D + L24V + P25ins + A27N + N30ins + F32S + T33M + K41E + V42I + S46D + V47T + H49Y + S50L + F59Y + W64G + A67T + H69N + V70H + S71T + Δ72-78 + D80G + L84I + N87K + V90I + S94A + I100V + I101V + I105V + T108S + L110M + D111N + S112N + T114S + L117V + L118I + V120I + A123S + K129R + V130A + E132N + Q134E + F135L + N137D + D138N + L141F + G142A + Y144S + Y145K + H146P + Δ147 + N148M + N149G + Δ150-152 + M153T + E154Q + S155T + E156H + F157T + R158M + V159I + Y160F + S161D + S162N + N164F + V171I + Q173D + P174A + L176S + M177L + L179V + E180S + G181E + Q183S + N188H + I197K + Y200F + F201L + K202Y + I203V + S205K + K206G + H207Y + T208Q + N211D + L212V + Q218S + S221N + A222T + E224K + L226I + V227F + D228K + I231L + R237N + Q239R + T240A + L241I + A243T + L244A + Δ245-246 + S247F + Y248S + L249P + T250A + P251Q + G252D + D253I + Δ254-257 + T259G + A260T + G261S + Y266F + Q271K + R273T + L276M + N280D + A292S + L293Q + D294N + S297A + T299L + T302S + L303V + T307E + V308I + E309D + Q321V + T323S + E324G + S325D + I326V + R346K + A348P + N354E + R357K + A372T + S373F + P384A + T393S + I402V + R403K + E406D + K417V + T430M + I434L + S438T + N439R + L441I + S443A + K444T + V445S + G446T + L452K + L455Y + F456L + K458H + S459G + N460K + K462R + T470N + E471V + I472P + Y473F + Q474S + A475P + G476D + S477G + T478K + N481T + G482P + Δ483 + E484P + G485A + F486L + F490W + Q493N + S494D + Q498Y + P499T + N501T + V503I + H519N + K529L + N532D + V534I + K537Q + E554P + N556S + K558R + L560Q + I569V + A570S + T572F + A575S + Q580K + L582S + T588S + S591A + T604A + N606S + Q607E + E619D + P621S + V622T + T632A + V635I + S640N + R646Q + N657D + N658T + Q675H + Q677V + T678S + N679L + S680L + Δ681-684 + V687T + A688S + S689Q + Q690K + I693V + E702D + N703S + V705I + S711T + T719S + V722I + I726V + L727M + T732A + T739N + S750A + T768S + V772A + K776R + Q779R + I788M + P793T + I794L + D796Y + S810L + S813T + I834M + D839E + A845N + E868D + Q872A + S875A + L878V + A879S + I882A + S884A + L922Q + S929K + G932S + K933Q + D936E + S939T + S940T + A942S + S943T + S1055A + A1070S + K1073R + D1084E + H1088Y + S1097F + H1101S + V1104I + Y1110F + E1111S + V1133I + I1216V + M1233L + C1247A,1,>,10000,ng/ml,1,>,1000,,,
Wang22b,10.1101/2022.01.30.478305,Pseudovirus (HIV),Figure 1B,Imdevimab,Wild Type (B),=,2.3,ng/ml,1,SARS-CoV-1,3,V3I + V6L + L7F + P9T + V11T + S12ins + Q14D + C15L + V16D + N17R + L18C + R21F + T22D + Q23D + L24V + P25ins + A27N + N30ins + F32S + T33M + K41E + V42I + S46D + V47T + H49Y + S50L + F59Y + W64G + A67T + H69N + V70H + S71T + Δ72-78 + D80G + L84I + N87K + V90I + S94A + I100V + I101V + I105V + T108S + L110M + D111N + S112N + T114S + L117V + L118I + V120I + A123S + K129R + V130A + E132N + Q134E + F135L + N137D + D138N + L141F + G142A + Y144S + Y145K + H146P + Δ147 + N148M + N149G + Δ150-152 + M153T + E154Q + S155T + E156H + F157T + R158M + V159I + Y160F + S161D + S162N + N164F + V171I + Q173D + P174A + L176S + M177L + L179V + E180S + G181E + Q183S + N188H + I197K + Y200F + F201L + K202Y + I203V + S205K + K206G + H207Y + T208Q + N211D + L212V + Q218S + S221N + A222T + E224K + L226I + V227F + D228K + I231L + R237N + Q239R + T240A + L241I + A243T + L244A + Δ245-246 + S247F + Y248S + L249P + T250A + P251Q + G252D + D253I + Δ254-257 + T259G + A260T + G261S + Y266F + Q271K + R273T + L276M + N280D + A292S + L293Q + D294N + S297A + T299L + T302S + L303V + T307E + V308I + E309D + Q321V + T323S + E324G + S325D + I326V + R346K + A348P + N354E + R357K + A372T + S373F + P384A + T393S + I402V + R403K + E406D + K417V + T430M + I434L + S438T + N439R + L441I + S443A + K444T + V445S + G446T + L452K + L455Y + F456L + K458H + S459G + N460K + K462R + T470N + E471V + I472P + Y473F + Q474S + A475P + G476D + S477G + T478K + N481T + G482P + Δ483 + E484P + G485A + F486L + F490W + Q493N + S494D + Q498Y + P499T + N501T + V503I + H519N + K529L + N532D + V534I + K537Q + E554P + N556S + K558R + L560Q + I569V + A570S + T572F + A575S + Q580K + L582S + T588S + S591A + T604A + N606S + Q607E + E619D + P621S + V622T + T632A + V635I + S640N + R646Q + N657D + N658T + Q675H + Q677V + T678S + N679L + S680L + Δ681-684 + V687T + A688S + S689Q + Q690K + I693V + E702D + N703S + V705I + S711T + T719S + V722I + I726V + L727M + T732A + T739N + S750A + T768S + V772A + K776R + Q779R + I788M + P793T + I794L + D796Y + S810L + S813T + I834M + D839E + A845N + E868D + Q872A + S875A + L878V + A879S + I882A + S884A + L922Q + S929K + G932S + K933Q + D936E + S939T + S940T + A942S + S943T + S1055A + A1070S + K1073R + D1084E + H1088Y + S1097F + H1101S + V1104I + Y1110F + E1111S + V1133I + I1216V + M1233L + C1247A,1,>,10000,ng/ml,1,>,1000,,,
Yuan22,10.1101/2022.03.13.484037,Pseudovirus (MLV),Figure 2A,Imdevimab,Wild Type (B),=,25,ng/ml,1,SARS-CoV-1,3,V3I + V6L + L7F + P9T + V11T + S12ins + Q14D + C15L + V16D + N17R + L18C + R21F + T22D + Q23D + L24V + P25ins + A27N + N30ins + F32S + T33M + K41E + V42I + S46D + V47T + H49Y + S50L + F59Y + W64G + A67T + H69N + V70H + S71T + Δ72-78 + D80G + L84I + N87K + V90I + S94A + I100V + I101V + I105V + T108S + L110M + D111N + S112N + T114S + L117V + L118I + V120I + A123S + K129R + V130A + E132N + Q134E + F135L + N137D + D138N + L141F + G142A + Y144S + Y145K + H146P + Δ147 + N148M + N149G + Δ150-152 + M153T + E154Q + S155T + E156H + F157T + R158M + V159I + Y160F + S161D + S162N + N164F + V171I + Q173D + P174A + L176S + M177L + L179V + E180S + G181E + Q183S + N188H + I197K + Y200F + F201L + K202Y + I203V + S205K + K206G + H207Y + T208Q + N211D + L212V + Q218S + S221N + A222T + E224K + L226I + V227F + D228K + I231L + R237N + Q239R + T240A + L241I + A243T + L244A + Δ245-246 + S247F + Y248S + L249P + T250A + P251Q + G252D + D253I + Δ254-257 + T259G + A260T + G261S + Y266F + Q271K + R273T + L276M + N280D + A292S + L293Q + D294N + S297A + T299L + T302S + L303V + T307E + V308I + E309D + Q321V + T323S + E324G + S325D + I326V + R346K + A348P + N354E + R357K + A372T + S373F + P384A + T393S + I402V + R403K + E406D + K417V + T430M + I434L + S438T + N439R + L441I + S443A + K444T + V445S + G446T + L452K + L455Y + F456L + K458H + S459G + N460K + K462R + T470N + E471V + I472P + Y473F + Q474S + A475P + G476D + S477G + T478K + N481T + G482P + Δ483 + E484P + G485A + F486L + F490W + Q493N + S494D + Q498Y + P499T + N501T + V503I + H519N + K529L + N532D + V534I + K537Q + E554P + N556S + K558R + L560Q + I569V + A570S + T572F + A575S + Q580K + L582S + T588S + S591A + T604A + N606S + Q607E + E619D + P621S + V622T + T632A + V635I + S640N + R646Q + N657D + N658T + Q675H + Q677V + T678S + N679L + S680L + Δ681-684 + V687T + A688S + S689Q + Q690K + I693V + E702D + N703S + V705I + S711T + T719S + V722I + I726V + L727M + T732A + T739N + S750A + T768S + V772A + K776R + Q779R + I788M + P793T + I794L + D796Y + S810L + S813T + I834M + D839E + A845N + E868D + Q872A + S875A + L878V + A879S + I882A + S884A + L922Q + S929K + G932S + K933Q + D936E + S939T + S940T + A942S + S943T + S1055A + A1070S + K1073R + D1084E + H1088Y + S1097F + H1101S + V1104I + Y1110F + E1111S + V1133I + I1216V + M1233L + C1247A,1,>,5000,ng/ml,1,>,200,,,
Cao22c,10.1016/j.chom.2022.09.018,Pseudovirus (VSV),Figure 5b,Casirivimab + Imdevimab,Wild Type (B.1),=,5,ng/ml,1,SARS-CoV-1,3,V3I + V6L + L7F + P9T + V11T + S12ins + Q14D + C15L + V16D + N17R + L18C + R21F + T22D + Q23D + L24V + P25ins + A27N + N30ins + F32S + T33M + K41E + V42I + S46D + V47T + H49Y + S50L + F59Y + W64G + A67T + H69N + V70H + S71T + Δ72-78 + D80G + L84I + N87K + V90I + S94A + I100V + I101V + I105V + T108S + L110M + D111N + S112N + T114S + L117V + L118I + V120I + A123S + K129R + V130A + E132N + Q134E + F135L + N137D + D138N + L141F + G142A + Y144S + Y145K + H146P + Δ147 + N148M + N149G + Δ150-152 + M153T + E154Q + S155T + E156H + F157T + R158M + V159I + Y160F + S161D + S162N + N164F + V171I + Q173D + P174A + L176S + M177L + L179V + E180S + G181E + Q183S + N188H + I197K + Y200F + F201L + K202Y + I203V + S205K + K206G + H207Y + T208Q + N211D + L212V + Q218S + S221N + A222T + E224K + L226I + V227F + D228K + I231L + R237N + Q239R + T240A + L241I + A243T + L244A + Δ245-246 + S247F + Y248S + L249P + T250A + P251Q + G252D + D253I + Δ254-257 + T259G + A260T + G261S + Y266F + Q271K + R273T + L276M + N280D + A292S + L293Q + D294N + S297A + T299L + T302S + L303V + T307E + V308I + E309D + Q321V + T323S + E324G + S325D + I326V + R346K + A348P + N354E + R357K + A372T + S373F + P384A + T393S + I402V + R403K + E406D + K417V + T430M + I434L + S438T + N439R + L441I + S443A + K444T + V445S + G446T + L452K + L455Y + F456L + K458H + S459G + N460K + K462R + T470N + E471V + I472P + Y473F + Q474S + A475P + G476D + S477G + T478K + N481T + G482P + Δ483 + E484P + G485A + F486L + F490W + Q493N + S494D + Q498Y + P499T + N501T + V503I + H519N + K529L + N532D + V534I + K537Q + E554P + N556S + K558R + L560Q + I569V + A570S + T572F + A575S + Q580K + L582S + T588S + S591A + T604A + N606S + Q607E + E619D + P621S + V622T + T632A + V635I + S640N + R646Q + N657D + N658T + Q675H + Q677V + T678S + N679L + S680L + Δ681-684 + V687T + A688S + S689Q + Q690K + I693V + E702D + N703S + V705I + S711T + T719S + V722I + I726V + L727M + T732A + T739N + S750A + T768S + V772A + K776R + Q779R + I788M + P793T + I794L + D796Y + S810L + S813T + I834M + D839E + A845N + E868D + Q872A + S875A + L878V + A879S + I882A + S884A + L922Q + S929K + G932S + K933Q + D936E + S939T + S940T + A942S + S943T + S1055A + A1070S + K1073R + D1084E + H1088Y + S1097F + H1101S + V1104I + Y1110F + E1111S + V1133I + I1216V + M1233L + C1247A,1,>,10000,ng/ml,1,>,1000,,,
Yuan22,10.1101/2022.03.13.484037,Pseudovirus (MLV),Figure 2A,Casirivimab + Imdevimab,Wild Type (B),=,6,ng/ml,1,SARS-CoV-1,3,V3I + V6L + L7F + P9T + V11T + S12ins + Q14D + C15L + V16D + N17R + L18C + R21F + T22D + Q23D + L24V + P25ins + A27N + N30ins + F32S + T33M + K41E + V42I + S46D + V47T + H49Y + S50L + F59Y + W64G + A67T + H69N + V70H + S71T + Δ72-78 + D80G + L84I + N87K + V90I + S94A + I100V + I101V + I105V + T108S + L110M + D111N + S112N + T114S + L117V + L118I + V120I + A123S + K129R + V130A + E132N + Q134E + F135L + N137D + D138N + L141F + G142A + Y144S + Y145K + H146P + Δ147 + N148M + N149G + Δ150-152 + M153T + E154Q + S155T + E156H + F157T + R158M + V159I + Y160F + S161D + S162N + N164F + V171I + Q173D + P174A + L176S + M177L + L179V + E180S + G181E + Q183S + N188H + I197K + Y200F + F201L + K202Y + I203V + S205K + K206G + H207Y + T208Q + N211D + L212V + Q218S + S221N + A222T + E224K + L226I + V227F + D228K + I231L + R237N + Q239R + T240A + L241I + A243T + L244A + Δ245-246 + S247F + Y248S + L249P + T250A + P251Q + G252D + D253I + Δ254-257 + T259G + A260T + G261S + Y266F + Q271K + R273T + L276M + N280D + A292S + L293Q + D294N + S297A + T299L + T302S + L303V + T307E + V308I + E309D + Q321V + T323S + E324G + S325D + I326V + R346K + A348P + N354E + R357K + A372T + S373F + P384A + T393S + I402V + R403K + E406D + K417V + T430M + I434L + S438T + N439R + L441I + S443A + K444T + V445S + G446T + L452K + L455Y + F456L + K458H + S459G + N460K + K462R + T470N + E471V + I472P + Y473F + Q474S + A475P + G476D + S477G + T478K + N481T + G482P + Δ483 + E484P + G485A + F486L + F490W + Q493N + S494D + Q498Y + P499T + N501T + V503I + H519N + K529L + N532D + V534I + K537Q + E554P + N556S + K558R + L560Q + I569V + A570S + T572F + A575S + Q580K + L582S + T588S + S591A + T604A + N606S + Q607E + E619D + P621S + V622T + T632A + V635I + S640N + R646Q + N657D + N658T + Q675H + Q677V + T678S + N679L + S680L + Δ681-684 + V687T + A688S + S689Q + Q690K + I693V + E702D + N703S + V705I + S711T + T719S + V722I + I726V + L727M + T732A + T739N + S750A + T768S + V772A + K776R + Q779R + I788M + P793T + I794L + D796Y + S810L + S813T + I834M + D839E + A845N + E868D + Q872A + S875A + L878V + A879S + I882A + S884A + L922Q + S929K + G932S + K933Q + D936E + S939T + S940T + A942S + S943T + S1055A + A1070S + K1073R + D1084E + H1088Y + S1097F + H1101S + V1104I + Y1110F + E1111S + V1133I + I1216V + M1233L + C1247A,1,>,5000,ng/ml,1,>,833.3,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Cilgavimab,Wild Type (B.1),=,2.5,ng/ml,1,SARS-CoV-1,3,V3I + V6L + L7F + P9T + V11T + S12ins + Q14D + C15L + V16D + N17R + L18C + R21F + T22D + Q23D + L24V + P25ins + A27N + N30ins + F32S + T33M + K41E + V42I + S46D + V47T + H49Y + S50L + F59Y + W64G + A67T + H69N + V70H + S71T + Δ72-78 + D80G + L84I + N87K + V90I + S94A + I100V + I101V + I105V + T108S + L110M + D111N + S112N + T114S + L117V + L118I + V120I + A123S + K129R + V130A + E132N + Q134E + F135L + N137D + D138N + L141F + G142A + Y144S + Y145K + H146P + Δ147 + N148M + N149G + Δ150-152 + M153T + E154Q + S155T + E156H + F157T + R158M + V159I + Y160F + S161D + S162N + N164F + V171I + Q173D + P174A + L176S + M177L + L179V + E180S + G181E + Q183S + N188H + I197K + Y200F + F201L + K202Y + I203V + S205K + K206G + H207Y + T208Q + N211D + L212V + Q218S + S221N + A222T + E224K + L226I + V227F + D228K + I231L + R237N + Q239R + T240A + L241I + A243T + L244A + Δ245-246 + S247F + Y248S + L249P + T250A + P251Q + G252D + D253I + Δ254-257 + T259G + A260T + G261S + Y266F + Q271K + R273T + L276M + N280D + A292S + L293Q + D294N + S297A + T299L + T302S + L303V + T307E + V308I + E309D + Q321V + T323S + E324G + S325D + I326V + R346K + A348P + N354E + R357K + A372T + S373F + P384A + T393S + I402V + R403K + E406D + K417V + T430M + I434L + S438T + N439R + L441I + S443A + K444T + V445S + G446T + L452K + L455Y + F456L + K458H + S459G + N460K + K462R + T470N + E471V + I472P + Y473F + Q474S + A475P + G476D + S477G + T478K + N481T + G482P + Δ483 + E484P + G485A + F486L + F490W + Q493N + S494D + Q498Y + P499T + N501T + V503I + H519N + K529L + N532D + V534I + K537Q + E554P + N556S + K558R + L560Q + I569V + A570S + T572F + A575S + Q580K + L582S + T588S + S591A + T604A + N606S + Q607E + E619D + P621S + V622T + T632A + V635I + S640N + R646Q + N657D + N658T + Q675H + Q677V + T678S + N679L + S680L + Δ681-684 + V687T + A688S + S689Q + Q690K + I693V + E702D + N703S + V705I + S711T + T719S + V722I + I726V + L727M + T732A + T739N + S750A + T768S + V772A + K776R + Q779R + I788M + P793T + I794L + D796Y + S810L + S813T + I834M + D839E + A845N + E868D + Q872A + S875A + L878V + A879S + I882A + S884A + L922Q + S929K + G932S + K933Q + D936E + S939T + S940T + A942S + S943T + S1055A + A1070S + K1073R + D1084E + H1088Y + S1097F + H1101S + V1104I + Y1110F + E1111S + V1133I + I1216V + M1233L + C1247A,1,>,10000,ng/ml,1,>,1000,,,
Cao22,10.1101/2022.02.07.479349,Pseudovirus (VSV),Table S2,Cilgavimab,Wild Type (B.1),=,1.4,ng/ml,1,SARS-CoV-1,3,V3I + V6L + L7F + P9T + V11T + S12ins + Q14D + C15L + V16D + N17R + L18C + R21F + T22D + Q23D + L24V + P25ins + A27N + N30ins + F32S + T33M + K41E + V42I + S46D + V47T + H49Y + S50L + F59Y + W64G + A67T + H69N + V70H + S71T + Δ72-78 + D80G + L84I + N87K + V90I + S94A + I100V + I101V + I105V + T108S + L110M + D111N + S112N + T114S + L117V + L118I + V120I + A123S + K129R + V130A + E132N + Q134E + F135L + N137D + D138N + L141F + G142A + Y144S + Y145K + H146P + Δ147 + N148M + N149G + Δ150-152 + M153T + E154Q + S155T + E156H + F157T + R158M + V159I + Y160F + S161D + S162N + N164F + V171I + Q173D + P174A + L176S + M177L + L179V + E180S + G181E + Q183S + N188H + I197K + Y200F + F201L + K202Y + I203V + S205K + K206G + H207Y + T208Q + N211D + L212V + Q218S + S221N + A222T + E224K + L226I + V227F + D228K + I231L + R237N + Q239R + T240A + L241I + A243T + L244A + Δ245-246 + S247F + Y248S + L249P + T250A + P251Q + G252D + D253I + Δ254-257 + T259G + A260T + G261S + Y266F + Q271K + R273T + L276M + N280D + A292S + L293Q + D294N + S297A + T299L + T302S + L303V + T307E + V308I + E309D + Q321V + T323S + E324G + S325D + I326V + R346K + A348P + N354E + R357K + A372T + S373F + P384A + T393S + I402V + R403K + E406D + K417V + T430M + I434L + S438T + N439R + L441I + S443A + K444T + V445S + G446T + L452K + L455Y + F456L + K458H + S459G + N460K + K462R + T470N + E471V + I472P + Y473F + Q474S + A475P + G476D + S477G + T478K + N481T + G482P + Δ483 + E484P + G485A + F486L + F490W + Q493N + S494D + Q498Y + P499T + N501T + V503I + H519N + K529L + N532D + V534I + K537Q + E554P + N556S + K558R + L560Q + I569V + A570S + T572F + A575S + Q580K + L582S + T588S + S591A + T604A + N606S + Q607E + E619D + P621S + V622T + T632A + V635I + S640N + R646Q + N657D + N658T + Q675H + Q677V + T678S + N679L + S680L + Δ681-684 + V687T + A688S + S689Q + Q690K + I693V + E702D + N703S + V705I + S711T + T719S + V722I + I726V + L727M + T732A + T739N + S750A + T768S + V772A + K776R + Q779R + I788M + P793T + I794L + D796Y + S810L + S813T + I834M + D839E + A845N + E868D + Q872A + S875A + L878V + A879S + I882A + S884A + L922Q + S929K + G932S + K933Q + D936E + S939T + S940T + A942S + S943T + S1055A + A1070S + K1073R + D1084E + H1088Y + S1097F + H1101S + V1104I + Y1110F + E1111S + V1133I + I1216V + M1233L + C1247A,1,>,10000,ng/ml,1,>,1000,,,
Cao22c,10.1016/j.chom.2022.09.018,Pseudovirus (VSV),Figure 5b,Cilgavimab,Wild Type (B.1),=,2.5,ng/ml,1,SARS-CoV-1,3,V3I + V6L + L7F + P9T + V11T + S12ins + Q14D + C15L + V16D + N17R + L18C + R21F + T22D + Q23D + L24V + P25ins + A27N + N30ins + F32S + T33M + K41E + V42I + S46D + V47T + H49Y + S50L + F59Y + W64G + A67T + H69N + V70H + S71T + Δ72-78 + D80G + L84I + N87K + V90I + S94A + I100V + I101V + I105V + T108S + L110M + D111N + S112N + T114S + L117V + L118I + V120I + A123S + K129R + V130A + E132N + Q134E + F135L + N137D + D138N + L141F + G142A + Y144S + Y145K + H146P + Δ147 + N148M + N149G + Δ150-152 + M153T + E154Q + S155T + E156H + F157T + R158M + V159I + Y160F + S161D + S162N + N164F + V171I + Q173D + P174A + L176S + M177L + L179V + E180S + G181E + Q183S + N188H + I197K + Y200F + F201L + K202Y + I203V + S205K + K206G + H207Y + T208Q + N211D + L212V + Q218S + S221N + A222T + E224K + L226I + V227F + D228K + I231L + R237N + Q239R + T240A + L241I + A243T + L244A + Δ245-246 + S247F + Y248S + L249P + T250A + P251Q + G252D + D253I + Δ254-257 + T259G + A260T + G261S + Y266F + Q271K + R273T + L276M + N280D + A292S + L293Q + D294N + S297A + T299L + T302S + L303V + T307E + V308I + E309D + Q321V + T323S + E324G + S325D + I326V + R346K + A348P + N354E + R357K + A372T + S373F + P384A + T393S + I402V + R403K + E406D + K417V + T430M + I434L + S438T + N439R + L441I + S443A + K444T + V445S + G446T + L452K + L455Y + F456L + K458H + S459G + N460K + K462R + T470N + E471V + I472P + Y473F + Q474S + A475P + G476D + S477G + T478K + N481T + G482P + Δ483 + E484P + G485A + F486L + F490W + Q493N + S494D + Q498Y + P499T + N501T + V503I + H519N + K529L + N532D + V534I + K537Q + E554P + N556S + K558R + L560Q + I569V + A570S + T572F + A575S + Q580K + L582S + T588S + S591A + T604A + N606S + Q607E + E619D + P621S + V622T + T632A + V635I + S640N + R646Q + N657D + N658T + Q675H + Q677V + T678S + N679L + S680L + Δ681-684 + V687T + A688S + S689Q + Q690K + I693V + E702D + N703S + V705I + S711T + T719S + V722I + I726V + L727M + T732A + T739N + S750A + T768S + V772A + K776R + Q779R + I788M + P793T + I794L + D796Y + S810L + S813T + I834M + D839E + A845N + E868D + Q872A + S875A + L878V + A879S + I882A + S884A + L922Q + S929K + G932S + K933Q + D936E + S939T + S940T + A942S + S943T + S1055A + A1070S + K1073R + D1084E + H1088Y + S1097F + H1101S + V1104I + Y1110F + E1111S + V1133I + I1216V + M1233L + C1247A,1,>,10000,ng/ml,1,>,1000,,,
Cao22d,10.1038/s41586-021-04385-3,Pseudovirus (VSV),41586_2021_4385_MOESM1_ESM.xlsx,Cilgavimab,Wild Type (B.1),=,2,ng/ml,1,SARS-CoV-1,3,V3I + V6L + L7F + P9T + V11T + S12ins + Q14D + C15L + V16D + N17R + L18C + R21F + T22D + Q23D + L24V + P25ins + A27N + N30ins + F32S + T33M + K41E + V42I + S46D + V47T + H49Y + S50L + F59Y + W64G + A67T + H69N + V70H + S71T + Δ72-78 + D80G + L84I + N87K + V90I + S94A + I100V + I101V + I105V + T108S + L110M + D111N + S112N + T114S + L117V + L118I + V120I + A123S + K129R + V130A + E132N + Q134E + F135L + N137D + D138N + L141F + G142A + Y144S + Y145K + H146P + Δ147 + N148M + N149G + Δ150-152 + M153T + E154Q + S155T + E156H + F157T + R158M + V159I + Y160F + S161D + S162N + N164F + V171I + Q173D + P174A + L176S + M177L + L179V + E180S + G181E + Q183S + N188H + I197K + Y200F + F201L + K202Y + I203V + S205K + K206G + H207Y + T208Q + N211D + L212V + Q218S + S221N + A222T + E224K + L226I + V227F + D228K + I231L + R237N + Q239R + T240A + L241I + A243T + L244A + Δ245-246 + S247F + Y248S + L249P + T250A + P251Q + G252D + D253I + Δ254-257 + T259G + A260T + G261S + Y266F + Q271K + R273T + L276M + N280D + A292S + L293Q + D294N + S297A + T299L + T302S + L303V + T307E + V308I + E309D + Q321V + T323S + E324G + S325D + I326V + R346K + A348P + N354E + R357K + A372T + S373F + P384A + T393S + I402V + R403K + E406D + K417V + T430M + I434L + S438T + N439R + L441I + S443A + K444T + V445S + G446T + L452K + L455Y + F456L + K458H + S459G + N460K + K462R + T470N + E471V + I472P + Y473F + Q474S + A475P + G476D + S477G + T478K + N481T + G482P + Δ483 + E484P + G485A + F486L + F490W + Q493N + S494D + Q498Y + P499T + N501T + V503I + H519N + K529L + N532D + V534I + K537Q + E554P + N556S + K558R + L560Q + I569V + A570S + T572F + A575S + Q580K + L582S + T588S + S591A + T604A + N606S + Q607E + E619D + P621S + V622T + T632A + V635I + S640N + R646Q + N657D + N658T + Q675H + Q677V + T678S + N679L + S680L + Δ681-684 + V687T + A688S + S689Q + Q690K + I693V + E702D + N703S + V705I + S711T + T719S + V722I + I726V + L727M + T732A + T739N + S750A + T768S + V772A + K776R + Q779R + I788M + P793T + I794L + D796Y + S810L + S813T + I834M + D839E + A845N + E868D + Q872A + S875A + L878V + A879S + I882A + S884A + L922Q + S929K + G932S + K933Q + D936E + S939T + S940T + A942S + S943T + S1055A + A1070S + K1073R + D1084E + H1088Y + S1097F + H1101S + V1104I + Y1110F + E1111S + V1133I + I1216V + M1233L + C1247A,1,>,10000,ng/ml,1,>,1000,,,
Yuan22,10.1101/2022.03.13.484037,Pseudovirus (MLV),Figure 2A,Cilgavimab,Wild Type (B),=,5,ng/ml,1,SARS-CoV-1,3,V3I + V6L + L7F + P9T + V11T + S12ins + Q14D + C15L + V16D + N17R + L18C + R21F + T22D + Q23D + L24V + P25ins + A27N + N30ins + F32S + T33M + K41E + V42I + S46D + V47T + H49Y + S50L + F59Y + W64G + A67T + H69N + V70H + S71T + Δ72-78 + D80G + L84I + N87K + V90I + S94A + I100V + I101V + I105V + T108S + L110M + D111N + S112N + T114S + L117V + L118I + V120I + A123S + K129R + V130A + E132N + Q134E + F135L + N137D + D138N + L141F + G142A + Y144S + Y145K + H146P + Δ147 + N148M + N149G + Δ150-152 + M153T + E154Q + S155T + E156H + F157T + R158M + V159I + Y160F + S161D + S162N + N164F + V171I + Q173D + P174A + L176S + M177L + L179V + E180S + G181E + Q183S + N188H + I197K + Y200F + F201L + K202Y + I203V + S205K + K206G + H207Y + T208Q + N211D + L212V + Q218S + S221N + A222T + E224K + L226I + V227F + D228K + I231L + R237N + Q239R + T240A + L241I + A243T + L244A + Δ245-246 + S247F + Y248S + L249P + T250A + P251Q + G252D + D253I + Δ254-257 + T259G + A260T + G261S + Y266F + Q271K + R273T + L276M + N280D + A292S + L293Q + D294N + S297A + T299L + T302S + L303V + T307E + V308I + E309D + Q321V + T323S + E324G + S325D + I326V + R346K + A348P + N354E + R357K + A372T + S373F + P384A + T393S + I402V + R403K + E406D + K417V + T430M + I434L + S438T + N439R + L441I + S443A + K444T + V445S + G446T + L452K + L455Y + F456L + K458H + S459G + N460K + K462R + T470N + E471V + I472P + Y473F + Q474S + A475P + G476D + S477G + T478K + N481T + G482P + Δ483 + E484P + G485A + F486L + F490W + Q493N + S494D + Q498Y + P499T + N501T + V503I + H519N + K529L + N532D + V534I + K537Q + E554P + N556S + K558R + L560Q + I569V + A570S + T572F + A575S + Q580K + L582S + T588S + S591A + T604A + N606S + Q607E + E619D + P621S + V622T + T632A + V635I + S640N + R646Q + N657D + N658T + Q675H + Q677V + T678S + N679L + S680L + Δ681-684 + V687T + A688S + S689Q + Q690K + I693V + E702D + N703S + V705I + S711T + T719S + V722I + I726V + L727M + T732A + T739N + S750A + T768S + V772A + K776R + Q779R + I788M + P793T + I794L + D796Y + S810L + S813T + I834M + D839E + A845N + E868D + Q872A + S875A + L878V + A879S + I882A + S884A + L922Q + S929K + G932S + K933Q + D936E + S939T + S940T + A942S + S943T + S1055A + A1070S + K1073R + D1084E + H1088Y + S1097F + H1101S + V1104I + Y1110F + E1111S + V1133I + I1216V + M1233L + C1247A,1,>,5000,ng/ml,1,>,1000,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Tixagevimab,Wild Type (B.1),=,1.6,ng/ml,1,SARS-CoV-1,3,V3I + V6L + L7F + P9T + V11T + S12ins + Q14D + C15L + V16D + N17R + L18C + R21F + T22D + Q23D + L24V + P25ins + A27N + N30ins + F32S + T33M + K41E + V42I + S46D + V47T + H49Y + S50L + F59Y + W64G + A67T + H69N + V70H + S71T + Δ72-78 + D80G + L84I + N87K + V90I + S94A + I100V + I101V + I105V + T108S + L110M + D111N + S112N + T114S + L117V + L118I + V120I + A123S + K129R + V130A + E132N + Q134E + F135L + N137D + D138N + L141F + G142A + Y144S + Y145K + H146P + Δ147 + N148M + N149G + Δ150-152 + M153T + E154Q + S155T + E156H + F157T + R158M + V159I + Y160F + S161D + S162N + N164F + V171I + Q173D + P174A + L176S + M177L + L179V + E180S + G181E + Q183S + N188H + I197K + Y200F + F201L + K202Y + I203V + S205K + K206G + H207Y + T208Q + N211D + L212V + Q218S + S221N + A222T + E224K + L226I + V227F + D228K + I231L + R237N + Q239R + T240A + L241I + A243T + L244A + Δ245-246 + S247F + Y248S + L249P + T250A + P251Q + G252D + D253I + Δ254-257 + T259G + A260T + G261S + Y266F + Q271K + R273T + L276M + N280D + A292S + L293Q + D294N + S297A + T299L + T302S + L303V + T307E + V308I + E309D + Q321V + T323S + E324G + S325D + I326V + R346K + A348P + N354E + R357K + A372T + S373F + P384A + T393S + I402V + R403K + E406D + K417V + T430M + I434L + S438T + N439R + L441I + S443A + K444T + V445S + G446T + L452K + L455Y + F456L + K458H + S459G + N460K + K462R + T470N + E471V + I472P + Y473F + Q474S + A475P + G476D + S477G + T478K + N481T + G482P + Δ483 + E484P + G485A + F486L + F490W + Q493N + S494D + Q498Y + P499T + N501T + V503I + H519N + K529L + N532D + V534I + K537Q + E554P + N556S + K558R + L560Q + I569V + A570S + T572F + A575S + Q580K + L582S + T588S + S591A + T604A + N606S + Q607E + E619D + P621S + V622T + T632A + V635I + S640N + R646Q + N657D + N658T + Q675H + Q677V + T678S + N679L + S680L + Δ681-684 + V687T + A688S + S689Q + Q690K + I693V + E702D + N703S + V705I + S711T + T719S + V722I + I726V + L727M + T732A + T739N + S750A + T768S + V772A + K776R + Q779R + I788M + P793T + I794L + D796Y + S810L + S813T + I834M + D839E + A845N + E868D + Q872A + S875A + L878V + A879S + I882A + S884A + L922Q + S929K + G932S + K933Q + D936E + S939T + S940T + A942S + S943T + S1055A + A1070S + K1073R + D1084E + H1088Y + S1097F + H1101S + V1104I + Y1110F + E1111S + V1133I + I1216V + M1233L + C1247A,1,>,10000,ng/ml,1,>,1000,,,
Cao22,10.1101/2022.02.07.479349,Pseudovirus (VSV),Table S2,Tixagevimab,Wild Type (B.1),=,1.3,ng/ml,1,SARS-CoV-1,3,V3I + V6L + L7F + P9T + V11T + S12ins + Q14D + C15L + V16D + N17R + L18C + R21F + T22D + Q23D + L24V + P25ins + A27N + N30ins + F32S + T33M + K41E + V42I + S46D + V47T + H49Y + S50L + F59Y + W64G + A67T + H69N + V70H + S71T + Δ72-78 + D80G + L84I + N87K + V90I + S94A + I100V + I101V + I105V + T108S + L110M + D111N + S112N + T114S + L117V + L118I + V120I + A123S + K129R + V130A + E132N + Q134E + F135L + N137D + D138N + L141F + G142A + Y144S + Y145K + H146P + Δ147 + N148M + N149G + Δ150-152 + M153T + E154Q + S155T + E156H + F157T + R158M + V159I + Y160F + S161D + S162N + N164F + V171I + Q173D + P174A + L176S + M177L + L179V + E180S + G181E + Q183S + N188H + I197K + Y200F + F201L + K202Y + I203V + S205K + K206G + H207Y + T208Q + N211D + L212V + Q218S + S221N + A222T + E224K + L226I + V227F + D228K + I231L + R237N + Q239R + T240A + L241I + A243T + L244A + Δ245-246 + S247F + Y248S + L249P + T250A + P251Q + G252D + D253I + Δ254-257 + T259G + A260T + G261S + Y266F + Q271K + R273T + L276M + N280D + A292S + L293Q + D294N + S297A + T299L + T302S + L303V + T307E + V308I + E309D + Q321V + T323S + E324G + S325D + I326V + R346K + A348P + N354E + R357K + A372T + S373F + P384A + T393S + I402V + R403K + E406D + K417V + T430M + I434L + S438T + N439R + L441I + S443A + K444T + V445S + G446T + L452K + L455Y + F456L + K458H + S459G + N460K + K462R + T470N + E471V + I472P + Y473F + Q474S + A475P + G476D + S477G + T478K + N481T + G482P + Δ483 + E484P + G485A + F486L + F490W + Q493N + S494D + Q498Y + P499T + N501T + V503I + H519N + K529L + N532D + V534I + K537Q + E554P + N556S + K558R + L560Q + I569V + A570S + T572F + A575S + Q580K + L582S + T588S + S591A + T604A + N606S + Q607E + E619D + P621S + V622T + T632A + V635I + S640N + R646Q + N657D + N658T + Q675H + Q677V + T678S + N679L + S680L + Δ681-684 + V687T + A688S + S689Q + Q690K + I693V + E702D + N703S + V705I + S711T + T719S + V722I + I726V + L727M + T732A + T739N + S750A + T768S + V772A + K776R + Q779R + I788M + P793T + I794L + D796Y + S810L + S813T + I834M + D839E + A845N + E868D + Q872A + S875A + L878V + A879S + I882A + S884A + L922Q + S929K + G932S + K933Q + D936E + S939T + S940T + A942S + S943T + S1055A + A1070S + K1073R + D1084E + H1088Y + S1097F + H1101S + V1104I + Y1110F + E1111S + V1133I + I1216V + M1233L + C1247A,1,>,10000,ng/ml,1,>,1000,,,
Cao22c,10.1016/j.chom.2022.09.018,Pseudovirus (VSV),Figure 5b,Tixagevimab,Wild Type (B.1),=,1.6,ng/ml,1,SARS-CoV-1,3,V3I + V6L + L7F + P9T + V11T + S12ins + Q14D + C15L + V16D + N17R + L18C + R21F + T22D + Q23D + L24V + P25ins + A27N + N30ins + F32S + T33M + K41E + V42I + S46D + V47T + H49Y + S50L + F59Y + W64G + A67T + H69N + V70H + S71T + Δ72-78 + D80G + L84I + N87K + V90I + S94A + I100V + I101V + I105V + T108S + L110M + D111N + S112N + T114S + L117V + L118I + V120I + A123S + K129R + V130A + E132N + Q134E + F135L + N137D + D138N + L141F + G142A + Y144S + Y145K + H146P + Δ147 + N148M + N149G + Δ150-152 + M153T + E154Q + S155T + E156H + F157T + R158M + V159I + Y160F + S161D + S162N + N164F + V171I + Q173D + P174A + L176S + M177L + L179V + E180S + G181E + Q183S + N188H + I197K + Y200F + F201L + K202Y + I203V + S205K + K206G + H207Y + T208Q + N211D + L212V + Q218S + S221N + A222T + E224K + L226I + V227F + D228K + I231L + R237N + Q239R + T240A + L241I + A243T + L244A + Δ245-246 + S247F + Y248S + L249P + T250A + P251Q + G252D + D253I + Δ254-257 + T259G + A260T + G261S + Y266F + Q271K + R273T + L276M + N280D + A292S + L293Q + D294N + S297A + T299L + T302S + L303V + T307E + V308I + E309D + Q321V + T323S + E324G + S325D + I326V + R346K + A348P + N354E + R357K + A372T + S373F + P384A + T393S + I402V + R403K + E406D + K417V + T430M + I434L + S438T + N439R + L441I + S443A + K444T + V445S + G446T + L452K + L455Y + F456L + K458H + S459G + N460K + K462R + T470N + E471V + I472P + Y473F + Q474S + A475P + G476D + S477G + T478K + N481T + G482P + Δ483 + E484P + G485A + F486L + F490W + Q493N + S494D + Q498Y + P499T + N501T + V503I + H519N + K529L + N532D + V534I + K537Q + E554P + N556S + K558R + L560Q + I569V + A570S + T572F + A575S + Q580K + L582S + T588S + S591A + T604A + N606S + Q607E + E619D + P621S + V622T + T632A + V635I + S640N + R646Q + N657D + N658T + Q675H + Q677V + T678S + N679L + S680L + Δ681-684 + V687T + A688S + S689Q + Q690K + I693V + E702D + N703S + V705I + S711T + T719S + V722I + I726V + L727M + T732A + T739N + S750A + T768S + V772A + K776R + Q779R + I788M + P793T + I794L + D796Y + S810L + S813T + I834M + D839E + A845N + E868D + Q872A + S875A + L878V + A879S + I882A + S884A + L922Q + S929K + G932S + K933Q + D936E + S939T + S940T + A942S + S943T + S1055A + A1070S + K1073R + D1084E + H1088Y + S1097F + H1101S + V1104I + Y1110F + E1111S + V1133I + I1216V + M1233L + C1247A,1,>,10000,ng/ml,1,>,1000,,,
Cao22d,10.1038/s41586-021-04385-3,Pseudovirus (VSV),41586_2021_4385_MOESM1_ESM.xlsx,Tixagevimab,Wild Type (B.1),=,1,ng/ml,1,SARS-CoV-1,3,V3I + V6L + L7F + P9T + V11T + S12ins + Q14D + C15L + V16D + N17R + L18C + R21F + T22D + Q23D + L24V + P25ins + A27N + N30ins + F32S + T33M + K41E + V42I + S46D + V47T + H49Y + S50L + F59Y + W64G + A67T + H69N + V70H + S71T + Δ72-78 + D80G + L84I + N87K + V90I + S94A + I100V + I101V + I105V + T108S + L110M + D111N + S112N + T114S + L117V + L118I + V120I + A123S + K129R + V130A + E132N + Q134E + F135L + N137D + D138N + L141F + G142A + Y144S + Y145K + H146P + Δ147 + N148M + N149G + Δ150-152 + M153T + E154Q + S155T + E156H + F157T + R158M + V159I + Y160F + S161D + S162N + N164F + V171I + Q173D + P174A + L176S + M177L + L179V + E180S + G181E + Q183S + N188H + I197K + Y200F + F201L + K202Y + I203V + S205K + K206G + H207Y + T208Q + N211D + L212V + Q218S + S221N + A222T + E224K + L226I + V227F + D228K + I231L + R237N + Q239R + T240A + L241I + A243T + L244A + Δ245-246 + S247F + Y248S + L249P + T250A + P251Q + G252D + D253I + Δ254-257 + T259G + A260T + G261S + Y266F + Q271K + R273T + L276M + N280D + A292S + L293Q + D294N + S297A + T299L + T302S + L303V + T307E + V308I + E309D + Q321V + T323S + E324G + S325D + I326V + R346K + A348P + N354E + R357K + A372T + S373F + P384A + T393S + I402V + R403K + E406D + K417V + T430M + I434L + S438T + N439R + L441I + S443A + K444T + V445S + G446T + L452K + L455Y + F456L + K458H + S459G + N460K + K462R + T470N + E471V + I472P + Y473F + Q474S + A475P + G476D + S477G + T478K + N481T + G482P + Δ483 + E484P + G485A + F486L + F490W + Q493N + S494D + Q498Y + P499T + N501T + V503I + H519N + K529L + N532D + V534I + K537Q + E554P + N556S + K558R + L560Q + I569V + A570S + T572F + A575S + Q580K + L582S + T588S + S591A + T604A + N606S + Q607E + E619D + P621S + V622T + T632A + V635I + S640N + R646Q + N657D + N658T + Q675H + Q677V + T678S + N679L + S680L + Δ681-684 + V687T + A688S + S689Q + Q690K + I693V + E702D + N703S + V705I + S711T + T719S + V722I + I726V + L727M + T732A + T739N + S750A + T768S + V772A + K776R + Q779R + I788M + P793T + I794L + D796Y + S810L + S813T + I834M + D839E + A845N + E868D + Q872A + S875A + L878V + A879S + I882A + S884A + L922Q + S929K + G932S + K933Q + D936E + S939T + S940T + A942S + S943T + S1055A + A1070S + K1073R + D1084E + H1088Y + S1097F + H1101S + V1104I + Y1110F + E1111S + V1133I + I1216V + M1233L + C1247A,1,>,10000,ng/ml,1,>,1000,,,
Yuan22,10.1101/2022.03.13.484037,Pseudovirus (MLV),Figure 2A,Tixagevimab,Wild Type (B),=,1,ng/ml,1,SARS-CoV-1,3,V3I + V6L + L7F + P9T + V11T + S12ins + Q14D + C15L + V16D + N17R + L18C + R21F + T22D + Q23D + L24V + P25ins + A27N + N30ins + F32S + T33M + K41E + V42I + S46D + V47T + H49Y + S50L + F59Y + W64G + A67T + H69N + V70H + S71T + Δ72-78 + D80G + L84I + N87K + V90I + S94A + I100V + I101V + I105V + T108S + L110M + D111N + S112N + T114S + L117V + L118I + V120I + A123S + K129R + V130A + E132N + Q134E + F135L + N137D + D138N + L141F + G142A + Y144S + Y145K + H146P + Δ147 + N148M + N149G + Δ150-152 + M153T + E154Q + S155T + E156H + F157T + R158M + V159I + Y160F + S161D + S162N + N164F + V171I + Q173D + P174A + L176S + M177L + L179V + E180S + G181E + Q183S + N188H + I197K + Y200F + F201L + K202Y + I203V + S205K + K206G + H207Y + T208Q + N211D + L212V + Q218S + S221N + A222T + E224K + L226I + V227F + D228K + I231L + R237N + Q239R + T240A + L241I + A243T + L244A + Δ245-246 + S247F + Y248S + L249P + T250A + P251Q + G252D + D253I + Δ254-257 + T259G + A260T + G261S + Y266F + Q271K + R273T + L276M + N280D + A292S + L293Q + D294N + S297A + T299L + T302S + L303V + T307E + V308I + E309D + Q321V + T323S + E324G + S325D + I326V + R346K + A348P + N354E + R357K + A372T + S373F + P384A + T393S + I402V + R403K + E406D + K417V + T430M + I434L + S438T + N439R + L441I + S443A + K444T + V445S + G446T + L452K + L455Y + F456L + K458H + S459G + N460K + K462R + T470N + E471V + I472P + Y473F + Q474S + A475P + G476D + S477G + T478K + N481T + G482P + Δ483 + E484P + G485A + F486L + F490W + Q493N + S494D + Q498Y + P499T + N501T + V503I + H519N + K529L + N532D + V534I + K537Q + E554P + N556S + K558R + L560Q + I569V + A570S + T572F + A575S + Q580K + L582S + T588S + S591A + T604A + N606S + Q607E + E619D + P621S + V622T + T632A + V635I + S640N + R646Q + N657D + N658T + Q675H + Q677V + T678S + N679L + S680L + Δ681-684 + V687T + A688S + S689Q + Q690K + I693V + E702D + N703S + V705I + S711T + T719S + V722I + I726V + L727M + T732A + T739N + S750A + T768S + V772A + K776R + Q779R + I788M + P793T + I794L + D796Y + S810L + S813T + I834M + D839E + A845N + E868D + Q872A + S875A + L878V + A879S + I882A + S884A + L922Q + S929K + G932S + K933Q + D936E + S939T + S940T + A942S + S943T + S1055A + A1070S + K1073R + D1084E + H1088Y + S1097F + H1101S + V1104I + Y1110F + E1111S + V1133I + I1216V + M1233L + C1247A,1,>,5000,ng/ml,1,>,1000,,,
Cao22c,10.1016/j.chom.2022.09.018,Pseudovirus (VSV),Figure 5b,Cilgavimab + Tixagevimab,Wild Type (B.1),=,2.1,ng/ml,1,SARS-CoV-1,3,V3I + V6L + L7F + P9T + V11T + S12ins + Q14D + C15L + V16D + N17R + L18C + R21F + T22D + Q23D + L24V + P25ins + A27N + N30ins + F32S + T33M + K41E + V42I + S46D + V47T + H49Y + S50L + F59Y + W64G + A67T + H69N + V70H + S71T + Δ72-78 + D80G + L84I + N87K + V90I + S94A + I100V + I101V + I105V + T108S + L110M + D111N + S112N + T114S + L117V + L118I + V120I + A123S + K129R + V130A + E132N + Q134E + F135L + N137D + D138N + L141F + G142A + Y144S + Y145K + H146P + Δ147 + N148M + N149G + Δ150-152 + M153T + E154Q + S155T + E156H + F157T + R158M + V159I + Y160F + S161D + S162N + N164F + V171I + Q173D + P174A + L176S + M177L + L179V + E180S + G181E + Q183S + N188H + I197K + Y200F + F201L + K202Y + I203V + S205K + K206G + H207Y + T208Q + N211D + L212V + Q218S + S221N + A222T + E224K + L226I + V227F + D228K + I231L + R237N + Q239R + T240A + L241I + A243T + L244A + Δ245-246 + S247F + Y248S + L249P + T250A + P251Q + G252D + D253I + Δ254-257 + T259G + A260T + G261S + Y266F + Q271K + R273T + L276M + N280D + A292S + L293Q + D294N + S297A + T299L + T302S + L303V + T307E + V308I + E309D + Q321V + T323S + E324G + S325D + I326V + R346K + A348P + N354E + R357K + A372T + S373F + P384A + T393S + I402V + R403K + E406D + K417V + T430M + I434L + S438T + N439R + L441I + S443A + K444T + V445S + G446T + L452K + L455Y + F456L + K458H + S459G + N460K + K462R + T470N + E471V + I472P + Y473F + Q474S + A475P + G476D + S477G + T478K + N481T + G482P + Δ483 + E484P + G485A + F486L + F490W + Q493N + S494D + Q498Y + P499T + N501T + V503I + H519N + K529L + N532D + V534I + K537Q + E554P + N556S + K558R + L560Q + I569V + A570S + T572F + A575S + Q580K + L582S + T588S + S591A + T604A + N606S + Q607E + E619D + P621S + V622T + T632A + V635I + S640N + R646Q + N657D + N658T + Q675H + Q677V + T678S + N679L + S680L + Δ681-684 + V687T + A688S + S689Q + Q690K + I693V + E702D + N703S + V705I + S711T + T719S + V722I + I726V + L727M + T732A + T739N + S750A + T768S + V772A + K776R + Q779R + I788M + P793T + I794L + D796Y + S810L + S813T + I834M + D839E + A845N + E868D + Q872A + S875A + L878V + A879S + I882A + S884A + L922Q + S929K + G932S + K933Q + D936E + S939T + S940T + A942S + S943T + S1055A + A1070S + K1073R + D1084E + H1088Y + S1097F + H1101S + V1104I + Y1110F + E1111S + V1133I + I1216V + M1233L + C1247A,1,>,10000,ng/ml,1,>,1000,,,
Yuan22,10.1101/2022.03.13.484037,Pseudovirus (MLV),Figure 2A,Cilgavimab + Tixagevimab,Wild Type (B),=,5,ng/ml,1,SARS-CoV-1,3,V3I + V6L + L7F + P9T + V11T + S12ins + Q14D + C15L + V16D + N17R + L18C + R21F + T22D + Q23D + L24V + P25ins + A27N + N30ins + F32S + T33M + K41E + V42I + S46D + V47T + H49Y + S50L + F59Y + W64G + A67T + H69N + V70H + S71T + Δ72-78 + D80G + L84I + N87K + V90I + S94A + I100V + I101V + I105V + T108S + L110M + D111N + S112N + T114S + L117V + L118I + V120I + A123S + K129R + V130A + E132N + Q134E + F135L + N137D + D138N + L141F + G142A + Y144S + Y145K + H146P + Δ147 + N148M + N149G + Δ150-152 + M153T + E154Q + S155T + E156H + F157T + R158M + V159I + Y160F + S161D + S162N + N164F + V171I + Q173D + P174A + L176S + M177L + L179V + E180S + G181E + Q183S + N188H + I197K + Y200F + F201L + K202Y + I203V + S205K + K206G + H207Y + T208Q + N211D + L212V + Q218S + S221N + A222T + E224K + L226I + V227F + D228K + I231L + R237N + Q239R + T240A + L241I + A243T + L244A + Δ245-246 + S247F + Y248S + L249P + T250A + P251Q + G252D + D253I + Δ254-257 + T259G + A260T + G261S + Y266F + Q271K + R273T + L276M + N280D + A292S + L293Q + D294N + S297A + T299L + T302S + L303V + T307E + V308I + E309D + Q321V + T323S + E324G + S325D + I326V + R346K + A348P + N354E + R357K + A372T + S373F + P384A + T393S + I402V + R403K + E406D + K417V + T430M + I434L + S438T + N439R + L441I + S443A + K444T + V445S + G446T + L452K + L455Y + F456L + K458H + S459G + N460K + K462R + T470N + E471V + I472P + Y473F + Q474S + A475P + G476D + S477G + T478K + N481T + G482P + Δ483 + E484P + G485A + F486L + F490W + Q493N + S494D + Q498Y + P499T + N501T + V503I + H519N + K529L + N532D + V534I + K537Q + E554P + N556S + K558R + L560Q + I569V + A570S + T572F + A575S + Q580K + L582S + T588S + S591A + T604A + N606S + Q607E + E619D + P621S + V622T + T632A + V635I + S640N + R646Q + N657D + N658T + Q675H + Q677V + T678S + N679L + S680L + Δ681-684 + V687T + A688S + S689Q + Q690K + I693V + E702D + N703S + V705I + S711T + T719S + V722I + I726V + L727M + T732A + T739N + S750A + T768S + V772A + K776R + Q779R + I788M + P793T + I794L + D796Y + S810L + S813T + I834M + D839E + A845N + E868D + Q872A + S875A + L878V + A879S + I882A + S884A + L922Q + S929K + G932S + K933Q + D936E + S939T + S940T + A942S + S943T + S1055A + A1070S + K1073R + D1084E + H1088Y + S1097F + H1101S + V1104I + Y1110F + E1111S + V1133I + I1216V + M1233L + C1247A,1,>,5000,ng/ml,1,>,1000,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Sotrovimab,Wild Type (B.1),=,74.1,ng/ml,1,SARS-CoV-1,3,V3I + V6L + L7F + P9T + V11T + S12ins + Q14D + C15L + V16D + N17R + L18C + R21F + T22D + Q23D + L24V + P25ins + A27N + N30ins + F32S + T33M + K41E + V42I + S46D + V47T + H49Y + S50L + F59Y + W64G + A67T + H69N + V70H + S71T + Δ72-78 + D80G + L84I + N87K + V90I + S94A + I100V + I101V + I105V + T108S + L110M + D111N + S112N + T114S + L117V + L118I + V120I + A123S + K129R + V130A + E132N + Q134E + F135L + N137D + D138N + L141F + G142A + Y144S + Y145K + H146P + Δ147 + N148M + N149G + Δ150-152 + M153T + E154Q + S155T + E156H + F157T + R158M + V159I + Y160F + S161D + S162N + N164F + V171I + Q173D + P174A + L176S + M177L + L179V + E180S + G181E + Q183S + N188H + I197K + Y200F + F201L + K202Y + I203V + S205K + K206G + H207Y + T208Q + N211D + L212V + Q218S + S221N + A222T + E224K + L226I + V227F + D228K + I231L + R237N + Q239R + T240A + L241I + A243T + L244A + Δ245-246 + S247F + Y248S + L249P + T250A + P251Q + G252D + D253I + Δ254-257 + T259G + A260T + G261S + Y266F + Q271K + R273T + L276M + N280D + A292S + L293Q + D294N + S297A + T299L + T302S + L303V + T307E + V308I + E309D + Q321V + T323S + E324G + S325D + I326V + R346K + A348P + N354E + R357K + A372T + S373F + P384A + T393S + I402V + R403K + E406D + K417V + T430M + I434L + S438T + N439R + L441I + S443A + K444T + V445S + G446T + L452K + L455Y + F456L + K458H + S459G + N460K + K462R + T470N + E471V + I472P + Y473F + Q474S + A475P + G476D + S477G + T478K + N481T + G482P + Δ483 + E484P + G485A + F486L + F490W + Q493N + S494D + Q498Y + P499T + N501T + V503I + H519N + K529L + N532D + V534I + K537Q + E554P + N556S + K558R + L560Q + I569V + A570S + T572F + A575S + Q580K + L582S + T588S + S591A + T604A + N606S + Q607E + E619D + P621S + V622T + T632A + V635I + S640N + R646Q + N657D + N658T + Q675H + Q677V + T678S + N679L + S680L + Δ681-684 + V687T + A688S + S689Q + Q690K + I693V + E702D + N703S + V705I + S711T + T719S + V722I + I726V + L727M + T732A + T739N + S750A + T768S + V772A + K776R + Q779R + I788M + P793T + I794L + D796Y + S810L + S813T + I834M + D839E + A845N + E868D + Q872A + S875A + L878V + A879S + I882A + S884A + L922Q + S929K + G932S + K933Q + D936E + S939T + S940T + A942S + S943T + S1055A + A1070S + K1073R + D1084E + H1088Y + S1097F + H1101S + V1104I + Y1110F + E1111S + V1133I + I1216V + M1233L + C1247A,1,=,31.3,ng/ml,1,=,0.4,,,
Cao22,10.1101/2022.02.07.479349,Pseudovirus (VSV),Table S2,Sotrovimab,Wild Type (B.1),=,78.3,ng/ml,1,SARS-CoV-1,3,V3I + V6L + L7F + P9T + V11T + S12ins + Q14D + C15L + V16D + N17R + L18C + R21F + T22D + Q23D + L24V + P25ins + A27N + N30ins + F32S + T33M + K41E + V42I + S46D + V47T + H49Y + S50L + F59Y + W64G + A67T + H69N + V70H + S71T + Δ72-78 + D80G + L84I + N87K + V90I + S94A + I100V + I101V + I105V + T108S + L110M + D111N + S112N + T114S + L117V + L118I + V120I + A123S + K129R + V130A + E132N + Q134E + F135L + N137D + D138N + L141F + G142A + Y144S + Y145K + H146P + Δ147 + N148M + N149G + Δ150-152 + M153T + E154Q + S155T + E156H + F157T + R158M + V159I + Y160F + S161D + S162N + N164F + V171I + Q173D + P174A + L176S + M177L + L179V + E180S + G181E + Q183S + N188H + I197K + Y200F + F201L + K202Y + I203V + S205K + K206G + H207Y + T208Q + N211D + L212V + Q218S + S221N + A222T + E224K + L226I + V227F + D228K + I231L + R237N + Q239R + T240A + L241I + A243T + L244A + Δ245-246 + S247F + Y248S + L249P + T250A + P251Q + G252D + D253I + Δ254-257 + T259G + A260T + G261S + Y266F + Q271K + R273T + L276M + N280D + A292S + L293Q + D294N + S297A + T299L + T302S + L303V + T307E + V308I + E309D + Q321V + T323S + E324G + S325D + I326V + R346K + A348P + N354E + R357K + A372T + S373F + P384A + T393S + I402V + R403K + E406D + K417V + T430M + I434L + S438T + N439R + L441I + S443A + K444T + V445S + G446T + L452K + L455Y + F456L + K458H + S459G + N460K + K462R + T470N + E471V + I472P + Y473F + Q474S + A475P + G476D + S477G + T478K + N481T + G482P + Δ483 + E484P + G485A + F486L + F490W + Q493N + S494D + Q498Y + P499T + N501T + V503I + H519N + K529L + N532D + V534I + K537Q + E554P + N556S + K558R + L560Q + I569V + A570S + T572F + A575S + Q580K + L582S + T588S + S591A + T604A + N606S + Q607E + E619D + P621S + V622T + T632A + V635I + S640N + R646Q + N657D + N658T + Q675H + Q677V + T678S + N679L + S680L + Δ681-684 + V687T + A688S + S689Q + Q690K + I693V + E702D + N703S + V705I + S711T + T719S + V722I + I726V + L727M + T732A + T739N + S750A + T768S + V772A + K776R + Q779R + I788M + P793T + I794L + D796Y + S810L + S813T + I834M + D839E + A845N + E868D + Q872A + S875A + L878V + A879S + I882A + S884A + L922Q + S929K + G932S + K933Q + D936E + S939T + S940T + A942S + S943T + S1055A + A1070S + K1073R + D1084E + H1088Y + S1097F + H1101S + V1104I + Y1110F + E1111S + V1133I + I1216V + M1233L + C1247A,1,=,31.3,ng/ml,1,=,0.4,,,
Cao22c,10.1016/j.chom.2022.09.018,Pseudovirus (VSV),Figure 5b,Sotrovimab,Wild Type (B.1),=,74,ng/ml,1,SARS-CoV-1,3,V3I + V6L + L7F + P9T + V11T + S12ins + Q14D + C15L + V16D + N17R + L18C + R21F + T22D + Q23D + L24V + P25ins + A27N + N30ins + F32S + T33M + K41E + V42I + S46D + V47T + H49Y + S50L + F59Y + W64G + A67T + H69N + V70H + S71T + Δ72-78 + D80G + L84I + N87K + V90I + S94A + I100V + I101V + I105V + T108S + L110M + D111N + S112N + T114S + L117V + L118I + V120I + A123S + K129R + V130A + E132N + Q134E + F135L + N137D + D138N + L141F + G142A + Y144S + Y145K + H146P + Δ147 + N148M + N149G + Δ150-152 + M153T + E154Q + S155T + E156H + F157T + R158M + V159I + Y160F + S161D + S162N + N164F + V171I + Q173D + P174A + L176S + M177L + L179V + E180S + G181E + Q183S + N188H + I197K + Y200F + F201L + K202Y + I203V + S205K + K206G + H207Y + T208Q + N211D + L212V + Q218S + S221N + A222T + E224K + L226I + V227F + D228K + I231L + R237N + Q239R + T240A + L241I + A243T + L244A + Δ245-246 + S247F + Y248S + L249P + T250A + P251Q + G252D + D253I + Δ254-257 + T259G + A260T + G261S + Y266F + Q271K + R273T + L276M + N280D + A292S + L293Q + D294N + S297A + T299L + T302S + L303V + T307E + V308I + E309D + Q321V + T323S + E324G + S325D + I326V + R346K + A348P + N354E + R357K + A372T + S373F + P384A + T393S + I402V + R403K + E406D + K417V + T430M + I434L + S438T + N439R + L441I + S443A + K444T + V445S + G446T + L452K + L455Y + F456L + K458H + S459G + N460K + K462R + T470N + E471V + I472P + Y473F + Q474S + A475P + G476D + S477G + T478K + N481T + G482P + Δ483 + E484P + G485A + F486L + F490W + Q493N + S494D + Q498Y + P499T + N501T + V503I + H519N + K529L + N532D + V534I + K537Q + E554P + N556S + K558R + L560Q + I569V + A570S + T572F + A575S + Q580K + L582S + T588S + S591A + T604A + N606S + Q607E + E619D + P621S + V622T + T632A + V635I + S640N + R646Q + N657D + N658T + Q675H + Q677V + T678S + N679L + S680L + Δ681-684 + V687T + A688S + S689Q + Q690K + I693V + E702D + N703S + V705I + S711T + T719S + V722I + I726V + L727M + T732A + T739N + S750A + T768S + V772A + K776R + Q779R + I788M + P793T + I794L + D796Y + S810L + S813T + I834M + D839E + A845N + E868D + Q872A + S875A + L878V + A879S + I882A + S884A + L922Q + S929K + G932S + K933Q + D936E + S939T + S940T + A942S + S943T + S1055A + A1070S + K1073R + D1084E + H1088Y + S1097F + H1101S + V1104I + Y1110F + E1111S + V1133I + I1216V + M1233L + C1247A,1,=,31,ng/ml,1,=,0.4,,,
Cao22d,10.1038/s41586-021-04385-3,Pseudovirus (VSV),41586_2021_4385_MOESM1_ESM.xlsx,Sotrovimab,Wild Type (B.1),=,58,ng/ml,1,SARS-CoV-1,3,V3I + V6L + L7F + P9T + V11T + S12ins + Q14D + C15L + V16D + N17R + L18C + R21F + T22D + Q23D + L24V + P25ins + A27N + N30ins + F32S + T33M + K41E + V42I + S46D + V47T + H49Y + S50L + F59Y + W64G + A67T + H69N + V70H + S71T + Δ72-78 + D80G + L84I + N87K + V90I + S94A + I100V + I101V + I105V + T108S + L110M + D111N + S112N + T114S + L117V + L118I + V120I + A123S + K129R + V130A + E132N + Q134E + F135L + N137D + D138N + L141F + G142A + Y144S + Y145K + H146P + Δ147 + N148M + N149G + Δ150-152 + M153T + E154Q + S155T + E156H + F157T + R158M + V159I + Y160F + S161D + S162N + N164F + V171I + Q173D + P174A + L176S + M177L + L179V + E180S + G181E + Q183S + N188H + I197K + Y200F + F201L + K202Y + I203V + S205K + K206G + H207Y + T208Q + N211D + L212V + Q218S + S221N + A222T + E224K + L226I + V227F + D228K + I231L + R237N + Q239R + T240A + L241I + A243T + L244A + Δ245-246 + S247F + Y248S + L249P + T250A + P251Q + G252D + D253I + Δ254-257 + T259G + A260T + G261S + Y266F + Q271K + R273T + L276M + N280D + A292S + L293Q + D294N + S297A + T299L + T302S + L303V + T307E + V308I + E309D + Q321V + T323S + E324G + S325D + I326V + R346K + A348P + N354E + R357K + A372T + S373F + P384A + T393S + I402V + R403K + E406D + K417V + T430M + I434L + S438T + N439R + L441I + S443A + K444T + V445S + G446T + L452K + L455Y + F456L + K458H + S459G + N460K + K462R + T470N + E471V + I472P + Y473F + Q474S + A475P + G476D + S477G + T478K + N481T + G482P + Δ483 + E484P + G485A + F486L + F490W + Q493N + S494D + Q498Y + P499T + N501T + V503I + H519N + K529L + N532D + V534I + K537Q + E554P + N556S + K558R + L560Q + I569V + A570S + T572F + A575S + Q580K + L582S + T588S + S591A + T604A + N606S + Q607E + E619D + P621S + V622T + T632A + V635I + S640N + R646Q + N657D + N658T + Q675H + Q677V + T678S + N679L + S680L + Δ681-684 + V687T + A688S + S689Q + Q690K + I693V + E702D + N703S + V705I + S711T + T719S + V722I + I726V + L727M + T732A + T739N + S750A + T768S + V772A + K776R + Q779R + I788M + P793T + I794L + D796Y + S810L + S813T + I834M + D839E + A845N + E868D + Q872A + S875A + L878V + A879S + I882A + S884A + L922Q + S929K + G932S + K933Q + D936E + S939T + S940T + A942S + S943T + S1055A + A1070S + K1073R + D1084E + H1088Y + S1097F + H1101S + V1104I + Y1110F + E1111S + V1133I + I1216V + M1233L + C1247A,1,=,35,ng/ml,1,=,0.6,,,
Liu22,10.1126/scitranslmed.abn6859,Pseudovirus (VSV),Fig2C,Sotrovimab,Wild Type (B.1),=,11,ng/ml,1,SARS-CoV-1,3,V3I + V6L + L7F + P9T + V11T + S12ins + Q14D + C15L + V16D + N17R + L18C + R21F + T22D + Q23D + L24V + P25ins + A27N + N30ins + F32S + T33M + K41E + V42I + S46D + V47T + H49Y + S50L + F59Y + W64G + A67T + H69N + V70H + S71T + Δ72-78 + D80G + L84I + N87K + V90I + S94A + I100V + I101V + I105V + T108S + L110M + D111N + S112N + T114S + L117V + L118I + V120I + A123S + K129R + V130A + E132N + Q134E + F135L + N137D + D138N + L141F + G142A + Y144S + Y145K + H146P + Δ147 + N148M + N149G + Δ150-152 + M153T + E154Q + S155T + E156H + F157T + R158M + V159I + Y160F + S161D + S162N + N164F + V171I + Q173D + P174A + L176S + M177L + L179V + E180S + G181E + Q183S + N188H + I197K + Y200F + F201L + K202Y + I203V + S205K + K206G + H207Y + T208Q + N211D + L212V + Q218S + S221N + A222T + E224K + L226I + V227F + D228K + I231L + R237N + Q239R + T240A + L241I + A243T + L244A + Δ245-246 + S247F + Y248S + L249P + T250A + P251Q + G252D + D253I + Δ254-257 + T259G + A260T + G261S + Y266F + Q271K + R273T + L276M + N280D + A292S + L293Q + D294N + S297A + T299L + T302S + L303V + T307E + V308I + E309D + Q321V + T323S + E324G + S325D + I326V + R346K + A348P + N354E + R357K + A372T + S373F + P384A + T393S + I402V + R403K + E406D + K417V + T430M + I434L + S438T + N439R + L441I + S443A + K444T + V445S + G446T + L452K + L455Y + F456L + K458H + S459G + N460K + K462R + T470N + E471V + I472P + Y473F + Q474S + A475P + G476D + S477G + T478K + N481T + G482P + Δ483 + E484P + G485A + F486L + F490W + Q493N + S494D + Q498Y + P499T + N501T + V503I + H519N + K529L + N532D + V534I + K537Q + E554P + N556S + K558R + L560Q + I569V + A570S + T572F + A575S + Q580K + L582S + T588S + S591A + T604A + N606S + Q607E + E619D + P621S + V622T + T632A + V635I + S640N + R646Q + N657D + N658T + Q675H + Q677V + T678S + N679L + S680L + Δ681-684 + V687T + A688S + S689Q + Q690K + I693V + E702D + N703S + V705I + S711T + T719S + V722I + I726V + L727M + T732A + T739N + S750A + T768S + V772A + K776R + Q779R + I788M + P793T + I794L + D796Y + S810L + S813T + I834M + D839E + A845N + E868D + Q872A + S875A + L878V + A879S + I882A + S884A + L922Q + S929K + G932S + K933Q + D936E + S939T + S940T + A942S + S943T + S1055A + A1070S + K1073R + D1084E + H1088Y + S1097F + H1101S + V1104I + Y1110F + E1111S + V1133I + I1216V + M1233L + C1247A,1,=,28,ng/ml,1,=,2.5,,,
Pelzek22,10.1101/2022.02.06.479332,Pseudovirus (lentivirus),Extended Table 1,Sotrovimab,Wild Type (B),=,3819,ng/ml,1,SARS-CoV-1,3,V3I + V6L + L7F + P9T + V11T + S12ins + Q14D + C15L + V16D + N17R + L18C + R21F + T22D + Q23D + L24V + P25ins + A27N + N30ins + F32S + T33M + K41E + V42I + S46D + V47T + H49Y + S50L + F59Y + W64G + A67T + H69N + V70H + S71T + Δ72-78 + D80G + L84I + N87K + V90I + S94A + I100V + I101V + I105V + T108S + L110M + D111N + S112N + T114S + L117V + L118I + V120I + A123S + K129R + V130A + E132N + Q134E + F135L + N137D + D138N + L141F + G142A + Y144S + Y145K + H146P + Δ147 + N148M + N149G + Δ150-152 + M153T + E154Q + S155T + E156H + F157T + R158M + V159I + Y160F + S161D + S162N + N164F + V171I + Q173D + P174A + L176S + M177L + L179V + E180S + G181E + Q183S + N188H + I197K + Y200F + F201L + K202Y + I203V + S205K + K206G + H207Y + T208Q + N211D + L212V + Q218S + S221N + A222T + E224K + L226I + V227F + D228K + I231L + R237N + Q239R + T240A + L241I + A243T + L244A + Δ245-246 + S247F + Y248S + L249P + T250A + P251Q + G252D + D253I + Δ254-257 + T259G + A260T + G261S + Y266F + Q271K + R273T + L276M + N280D + A292S + L293Q + D294N + S297A + T299L + T302S + L303V + T307E + V308I + E309D + Q321V + T323S + E324G + S325D + I326V + R346K + A348P + N354E + R357K + A372T + S373F + P384A + T393S + I402V + R403K + E406D + K417V + T430M + I434L + S438T + N439R + L441I + S443A + K444T + V445S + G446T + L452K + L455Y + F456L + K458H + S459G + N460K + K462R + T470N + E471V + I472P + Y473F + Q474S + A475P + G476D + S477G + T478K + N481T + G482P + Δ483 + E484P + G485A + F486L + F490W + Q493N + S494D + Q498Y + P499T + N501T + V503I + H519N + K529L + N532D + V534I + K537Q + E554P + N556S + K558R + L560Q + I569V + A570S + T572F + A575S + Q580K + L582S + T588S + S591A + T604A + N606S + Q607E + E619D + P621S + V622T + T632A + V635I + S640N + R646Q + N657D + N658T + Q675H + Q677V + T678S + N679L + S680L + Δ681-684 + V687T + A688S + S689Q + Q690K + I693V + E702D + N703S + V705I + S711T + T719S + V722I + I726V + L727M + T732A + T739N + S750A + T768S + V772A + K776R + Q779R + I788M + P793T + I794L + D796Y + S810L + S813T + I834M + D839E + A845N + E868D + Q872A + S875A + L878V + A879S + I882A + S884A + L922Q + S929K + G932S + K933Q + D936E + S939T + S940T + A942S + S943T + S1055A + A1070S + K1073R + D1084E + H1088Y + S1097F + H1101S + V1104I + Y1110F + E1111S + V1133I + I1216V + M1233L + C1247A,1,=,64,ng/ml,1,<,0.1,,,
Wang22b,10.1101/2022.01.30.478305,Pseudovirus (HIV),Figure 1B,Sotrovimab,Wild Type (B),=,30.8,ng/ml,1,SARS-CoV-1,3,V3I + V6L + L7F + P9T + V11T + S12ins + Q14D + C15L + V16D + N17R + L18C + R21F + T22D + Q23D + L24V + P25ins + A27N + N30ins + F32S + T33M + K41E + V42I + S46D + V47T + H49Y + S50L + F59Y + W64G + A67T + H69N + V70H + S71T + Δ72-78 + D80G + L84I + N87K + V90I + S94A + I100V + I101V + I105V + T108S + L110M + D111N + S112N + T114S + L117V + L118I + V120I + A123S + K129R + V130A + E132N + Q134E + F135L + N137D + D138N + L141F + G142A + Y144S + Y145K + H146P + Δ147 + N148M + N149G + Δ150-152 + M153T + E154Q + S155T + E156H + F157T + R158M + V159I + Y160F + S161D + S162N + N164F + V171I + Q173D + P174A + L176S + M177L + L179V + E180S + G181E + Q183S + N188H + I197K + Y200F + F201L + K202Y + I203V + S205K + K206G + H207Y + T208Q + N211D + L212V + Q218S + S221N + A222T + E224K + L226I + V227F + D228K + I231L + R237N + Q239R + T240A + L241I + A243T + L244A + Δ245-246 + S247F + Y248S + L249P + T250A + P251Q + G252D + D253I + Δ254-257 + T259G + A260T + G261S + Y266F + Q271K + R273T + L276M + N280D + A292S + L293Q + D294N + S297A + T299L + T302S + L303V + T307E + V308I + E309D + Q321V + T323S + E324G + S325D + I326V + R346K + A348P + N354E + R357K + A372T + S373F + P384A + T393S + I402V + R403K + E406D + K417V + T430M + I434L + S438T + N439R + L441I + S443A + K444T + V445S + G446T + L452K + L455Y + F456L + K458H + S459G + N460K + K462R + T470N + E471V + I472P + Y473F + Q474S + A475P + G476D + S477G + T478K + N481T + G482P + Δ483 + E484P + G485A + F486L + F490W + Q493N + S494D + Q498Y + P499T + N501T + V503I + H519N + K529L + N532D + V534I + K537Q + E554P + N556S + K558R + L560Q + I569V + A570S + T572F + A575S + Q580K + L582S + T588S + S591A + T604A + N606S + Q607E + E619D + P621S + V622T + T632A + V635I + S640N + R646Q + N657D + N658T + Q675H + Q677V + T678S + N679L + S680L + Δ681-684 + V687T + A688S + S689Q + Q690K + I693V + E702D + N703S + V705I + S711T + T719S + V722I + I726V + L727M + T732A + T739N + S750A + T768S + V772A + K776R + Q779R + I788M + P793T + I794L + D796Y + S810L + S813T + I834M + D839E + A845N + E868D + Q872A + S875A + L878V + A879S + I882A + S884A + L922Q + S929K + G932S + K933Q + D936E + S939T + S940T + A942S + S943T + S1055A + A1070S + K1073R + D1084E + H1088Y + S1097F + H1101S + V1104I + Y1110F + E1111S + V1133I + I1216V + M1233L + C1247A,1,=,24.1,ng/ml,1,=,0.8,,,
Yuan22,10.1101/2022.03.13.484037,Pseudovirus (MLV),Figure 2A,Sotrovimab,Wild Type (B),=,72,ng/ml,1,SARS-CoV-1,3,V3I + V6L + L7F + P9T + V11T + S12ins + Q14D + C15L + V16D + N17R + L18C + R21F + T22D + Q23D + L24V + P25ins + A27N + N30ins + F32S + T33M + K41E + V42I + S46D + V47T + H49Y + S50L + F59Y + W64G + A67T + H69N + V70H + S71T + Δ72-78 + D80G + L84I + N87K + V90I + S94A + I100V + I101V + I105V + T108S + L110M + D111N + S112N + T114S + L117V + L118I + V120I + A123S + K129R + V130A + E132N + Q134E + F135L + N137D + D138N + L141F + G142A + Y144S + Y145K + H146P + Δ147 + N148M + N149G + Δ150-152 + M153T + E154Q + S155T + E156H + F157T + R158M + V159I + Y160F + S161D + S162N + N164F + V171I + Q173D + P174A + L176S + M177L + L179V + E180S + G181E + Q183S + N188H + I197K + Y200F + F201L + K202Y + I203V + S205K + K206G + H207Y + T208Q + N211D + L212V + Q218S + S221N + A222T + E224K + L226I + V227F + D228K + I231L + R237N + Q239R + T240A + L241I + A243T + L244A + Δ245-246 + S247F + Y248S + L249P + T250A + P251Q + G252D + D253I + Δ254-257 + T259G + A260T + G261S + Y266F + Q271K + R273T + L276M + N280D + A292S + L293Q + D294N + S297A + T299L + T302S + L303V + T307E + V308I + E309D + Q321V + T323S + E324G + S325D + I326V + R346K + A348P + N354E + R357K + A372T + S373F + P384A + T393S + I402V + R403K + E406D + K417V + T430M + I434L + S438T + N439R + L441I + S443A + K444T + V445S + G446T + L452K + L455Y + F456L + K458H + S459G + N460K + K462R + T470N + E471V + I472P + Y473F + Q474S + A475P + G476D + S477G + T478K + N481T + G482P + Δ483 + E484P + G485A + F486L + F490W + Q493N + S494D + Q498Y + P499T + N501T + V503I + H519N + K529L + N532D + V534I + K537Q + E554P + N556S + K558R + L560Q + I569V + A570S + T572F + A575S + Q580K + L582S + T588S + S591A + T604A + N606S + Q607E + E619D + P621S + V622T + T632A + V635I + S640N + R646Q + N657D + N658T + Q675H + Q677V + T678S + N679L + S680L + Δ681-684 + V687T + A688S + S689Q + Q690K + I693V + E702D + N703S + V705I + S711T + T719S + V722I + I726V + L727M + T732A + T739N + S750A + T768S + V772A + K776R + Q779R + I788M + P793T + I794L + D796Y + S810L + S813T + I834M + D839E + A845N + E868D + Q872A + S875A + L878V + A879S + I882A + S884A + L922Q + S929K + G932S + K933Q + D936E + S939T + S940T + A942S + S943T + S1055A + A1070S + K1073R + D1084E + H1088Y + S1097F + H1101S + V1104I + Y1110F + E1111S + V1133I + I1216V + M1233L + C1247A,1,=,31,ng/ml,1,=,0.4,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Bebtelovimab,Wild Type (B.1),=,0.8,ng/ml,1,SARS-CoV-1,3,V3I + V6L + L7F + P9T + V11T + S12ins + Q14D + C15L + V16D + N17R + L18C + R21F + T22D + Q23D + L24V + P25ins + A27N + N30ins + F32S + T33M + K41E + V42I + S46D + V47T + H49Y + S50L + F59Y + W64G + A67T + H69N + V70H + S71T + Δ72-78 + D80G + L84I + N87K + V90I + S94A + I100V + I101V + I105V + T108S + L110M + D111N + S112N + T114S + L117V + L118I + V120I + A123S + K129R + V130A + E132N + Q134E + F135L + N137D + D138N + L141F + G142A + Y144S + Y145K + H146P + Δ147 + N148M + N149G + Δ150-152 + M153T + E154Q + S155T + E156H + F157T + R158M + V159I + Y160F + S161D + S162N + N164F + V171I + Q173D + P174A + L176S + M177L + L179V + E180S + G181E + Q183S + N188H + I197K + Y200F + F201L + K202Y + I203V + S205K + K206G + H207Y + T208Q + N211D + L212V + Q218S + S221N + A222T + E224K + L226I + V227F + D228K + I231L + R237N + Q239R + T240A + L241I + A243T + L244A + Δ245-246 + S247F + Y248S + L249P + T250A + P251Q + G252D + D253I + Δ254-257 + T259G + A260T + G261S + Y266F + Q271K + R273T + L276M + N280D + A292S + L293Q + D294N + S297A + T299L + T302S + L303V + T307E + V308I + E309D + Q321V + T323S + E324G + S325D + I326V + R346K + A348P + N354E + R357K + A372T + S373F + P384A + T393S + I402V + R403K + E406D + K417V + T430M + I434L + S438T + N439R + L441I + S443A + K444T + V445S + G446T + L452K + L455Y + F456L + K458H + S459G + N460K + K462R + T470N + E471V + I472P + Y473F + Q474S + A475P + G476D + S477G + T478K + N481T + G482P + Δ483 + E484P + G485A + F486L + F490W + Q493N + S494D + Q498Y + P499T + N501T + V503I + H519N + K529L + N532D + V534I + K537Q + E554P + N556S + K558R + L560Q + I569V + A570S + T572F + A575S + Q580K + L582S + T588S + S591A + T604A + N606S + Q607E + E619D + P621S + V622T + T632A + V635I + S640N + R646Q + N657D + N658T + Q675H + Q677V + T678S + N679L + S680L + Δ681-684 + V687T + A688S + S689Q + Q690K + I693V + E702D + N703S + V705I + S711T + T719S + V722I + I726V + L727M + T732A + T739N + S750A + T768S + V772A + K776R + Q779R + I788M + P793T + I794L + D796Y + S810L + S813T + I834M + D839E + A845N + E868D + Q872A + S875A + L878V + A879S + I882A + S884A + L922Q + S929K + G932S + K933Q + D936E + S939T + S940T + A942S + S943T + S1055A + A1070S + K1073R + D1084E + H1088Y + S1097F + H1101S + V1104I + Y1110F + E1111S + V1133I + I1216V + M1233L + C1247A,1,>,10000,ng/ml,1,>,1000,,,
Cao22,10.1101/2022.02.07.479349,Pseudovirus (VSV),Table S2,Bebtelovimab,Wild Type (B.1),=,1.5,ng/ml,1,SARS-CoV-1,3,V3I + V6L + L7F + P9T + V11T + S12ins + Q14D + C15L + V16D + N17R + L18C + R21F + T22D + Q23D + L24V + P25ins + A27N + N30ins + F32S + T33M + K41E + V42I + S46D + V47T + H49Y + S50L + F59Y + W64G + A67T + H69N + V70H + S71T + Δ72-78 + D80G + L84I + N87K + V90I + S94A + I100V + I101V + I105V + T108S + L110M + D111N + S112N + T114S + L117V + L118I + V120I + A123S + K129R + V130A + E132N + Q134E + F135L + N137D + D138N + L141F + G142A + Y144S + Y145K + H146P + Δ147 + N148M + N149G + Δ150-152 + M153T + E154Q + S155T + E156H + F157T + R158M + V159I + Y160F + S161D + S162N + N164F + V171I + Q173D + P174A + L176S + M177L + L179V + E180S + G181E + Q183S + N188H + I197K + Y200F + F201L + K202Y + I203V + S205K + K206G + H207Y + T208Q + N211D + L212V + Q218S + S221N + A222T + E224K + L226I + V227F + D228K + I231L + R237N + Q239R + T240A + L241I + A243T + L244A + Δ245-246 + S247F + Y248S + L249P + T250A + P251Q + G252D + D253I + Δ254-257 + T259G + A260T + G261S + Y266F + Q271K + R273T + L276M + N280D + A292S + L293Q + D294N + S297A + T299L + T302S + L303V + T307E + V308I + E309D + Q321V + T323S + E324G + S325D + I326V + R346K + A348P + N354E + R357K + A372T + S373F + P384A + T393S + I402V + R403K + E406D + K417V + T430M + I434L + S438T + N439R + L441I + S443A + K444T + V445S + G446T + L452K + L455Y + F456L + K458H + S459G + N460K + K462R + T470N + E471V + I472P + Y473F + Q474S + A475P + G476D + S477G + T478K + N481T + G482P + Δ483 + E484P + G485A + F486L + F490W + Q493N + S494D + Q498Y + P499T + N501T + V503I + H519N + K529L + N532D + V534I + K537Q + E554P + N556S + K558R + L560Q + I569V + A570S + T572F + A575S + Q580K + L582S + T588S + S591A + T604A + N606S + Q607E + E619D + P621S + V622T + T632A + V635I + S640N + R646Q + N657D + N658T + Q675H + Q677V + T678S + N679L + S680L + Δ681-684 + V687T + A688S + S689Q + Q690K + I693V + E702D + N703S + V705I + S711T + T719S + V722I + I726V + L727M + T732A + T739N + S750A + T768S + V772A + K776R + Q779R + I788M + P793T + I794L + D796Y + S810L + S813T + I834M + D839E + A845N + E868D + Q872A + S875A + L878V + A879S + I882A + S884A + L922Q + S929K + G932S + K933Q + D936E + S939T + S940T + A942S + S943T + S1055A + A1070S + K1073R + D1084E + H1088Y + S1097F + H1101S + V1104I + Y1110F + E1111S + V1133I + I1216V + M1233L + C1247A,1,>,10000,ng/ml,1,>,1000,,,
Cao22c,10.1016/j.chom.2022.09.018,Pseudovirus (VSV),Figure 5b,Bebtelovimab,Wild Type (B.1),=,0.7,ng/ml,1,SARS-CoV-1,3,V3I + V6L + L7F + P9T + V11T + S12ins + Q14D + C15L + V16D + N17R + L18C + R21F + T22D + Q23D + L24V + P25ins + A27N + N30ins + F32S + T33M + K41E + V42I + S46D + V47T + H49Y + S50L + F59Y + W64G + A67T + H69N + V70H + S71T + Δ72-78 + D80G + L84I + N87K + V90I + S94A + I100V + I101V + I105V + T108S + L110M + D111N + S112N + T114S + L117V + L118I + V120I + A123S + K129R + V130A + E132N + Q134E + F135L + N137D + D138N + L141F + G142A + Y144S + Y145K + H146P + Δ147 + N148M + N149G + Δ150-152 + M153T + E154Q + S155T + E156H + F157T + R158M + V159I + Y160F + S161D + S162N + N164F + V171I + Q173D + P174A + L176S + M177L + L179V + E180S + G181E + Q183S + N188H + I197K + Y200F + F201L + K202Y + I203V + S205K + K206G + H207Y + T208Q + N211D + L212V + Q218S + S221N + A222T + E224K + L226I + V227F + D228K + I231L + R237N + Q239R + T240A + L241I + A243T + L244A + Δ245-246 + S247F + Y248S + L249P + T250A + P251Q + G252D + D253I + Δ254-257 + T259G + A260T + G261S + Y266F + Q271K + R273T + L276M + N280D + A292S + L293Q + D294N + S297A + T299L + T302S + L303V + T307E + V308I + E309D + Q321V + T323S + E324G + S325D + I326V + R346K + A348P + N354E + R357K + A372T + S373F + P384A + T393S + I402V + R403K + E406D + K417V + T430M + I434L + S438T + N439R + L441I + S443A + K444T + V445S + G446T + L452K + L455Y + F456L + K458H + S459G + N460K + K462R + T470N + E471V + I472P + Y473F + Q474S + A475P + G476D + S477G + T478K + N481T + G482P + Δ483 + E484P + G485A + F486L + F490W + Q493N + S494D + Q498Y + P499T + N501T + V503I + H519N + K529L + N532D + V534I + K537Q + E554P + N556S + K558R + L560Q + I569V + A570S + T572F + A575S + Q580K + L582S + T588S + S591A + T604A + N606S + Q607E + E619D + P621S + V622T + T632A + V635I + S640N + R646Q + N657D + N658T + Q675H + Q677V + T678S + N679L + S680L + Δ681-684 + V687T + A688S + S689Q + Q690K + I693V + E702D + N703S + V705I + S711T + T719S + V722I + I726V + L727M + T732A + T739N + S750A + T768S + V772A + K776R + Q779R + I788M + P793T + I794L + D796Y + S810L + S813T + I834M + D839E + A845N + E868D + Q872A + S875A + L878V + A879S + I882A + S884A + L922Q + S929K + G932S + K933Q + D936E + S939T + S940T + A942S + S943T + S1055A + A1070S + K1073R + D1084E + H1088Y + S1097F + H1101S + V1104I + Y1110F + E1111S + V1133I + I1216V + M1233L + C1247A,1,>,10000,ng/ml,1,>,1000,,,
Cao22d,10.1038/s41586-021-04385-3,Pseudovirus (VSV),41586_2021_4385_MOESM1_ESM.xlsx,Bebtelovimab,Wild Type (B.1),=,1.5,ng/ml,1,SARS-CoV-1,3,V3I + V6L + L7F + P9T + V11T + S12ins + Q14D + C15L + V16D + N17R + L18C + R21F + T22D + Q23D + L24V + P25ins + A27N + N30ins + F32S + T33M + K41E + V42I + S46D + V47T + H49Y + S50L + F59Y + W64G + A67T + H69N + V70H + S71T + Δ72-78 + D80G + L84I + N87K + V90I + S94A + I100V + I101V + I105V + T108S + L110M + D111N + S112N + T114S + L117V + L118I + V120I + A123S + K129R + V130A + E132N + Q134E + F135L + N137D + D138N + L141F + G142A + Y144S + Y145K + H146P + Δ147 + N148M + N149G + Δ150-152 + M153T + E154Q + S155T + E156H + F157T + R158M + V159I + Y160F + S161D + S162N + N164F + V171I + Q173D + P174A + L176S + M177L + L179V + E180S + G181E + Q183S + N188H + I197K + Y200F + F201L + K202Y + I203V + S205K + K206G + H207Y + T208Q + N211D + L212V + Q218S + S221N + A222T + E224K + L226I + V227F + D228K + I231L + R237N + Q239R + T240A + L241I + A243T + L244A + Δ245-246 + S247F + Y248S + L249P + T250A + P251Q + G252D + D253I + Δ254-257 + T259G + A260T + G261S + Y266F + Q271K + R273T + L276M + N280D + A292S + L293Q + D294N + S297A + T299L + T302S + L303V + T307E + V308I + E309D + Q321V + T323S + E324G + S325D + I326V + R346K + A348P + N354E + R357K + A372T + S373F + P384A + T393S + I402V + R403K + E406D + K417V + T430M + I434L + S438T + N439R + L441I + S443A + K444T + V445S + G446T + L452K + L455Y + F456L + K458H + S459G + N460K + K462R + T470N + E471V + I472P + Y473F + Q474S + A475P + G476D + S477G + T478K + N481T + G482P + Δ483 + E484P + G485A + F486L + F490W + Q493N + S494D + Q498Y + P499T + N501T + V503I + H519N + K529L + N532D + V534I + K537Q + E554P + N556S + K558R + L560Q + I569V + A570S + T572F + A575S + Q580K + L582S + T588S + S591A + T604A + N606S + Q607E + E619D + P621S + V622T + T632A + V635I + S640N + R646Q + N657D + N658T + Q675H + Q677V + T678S + N679L + S680L + Δ681-684 + V687T + A688S + S689Q + Q690K + I693V + E702D + N703S + V705I + S711T + T719S + V722I + I726V + L727M + T732A + T739N + S750A + T768S + V772A + K776R + Q779R + I788M + P793T + I794L + D796Y + S810L + S813T + I834M + D839E + A845N + E868D + Q872A + S875A + L878V + A879S + I882A + S884A + L922Q + S929K + G932S + K933Q + D936E + S939T + S940T + A942S + S943T + S1055A + A1070S + K1073R + D1084E + H1088Y + S1097F + H1101S + V1104I + Y1110F + E1111S + V1133I + I1216V + M1233L + C1247A,1,>,10000,ng/ml,1,>,1000,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Amubarvimab,Wild Type (B.1),=,53.2,ng/ml,1,SARS-CoV-1,3,V3I + V6L + L7F + P9T + V11T + S12ins + Q14D + C15L + V16D + N17R + L18C + R21F + T22D + Q23D + L24V + P25ins + A27N + N30ins + F32S + T33M + K41E + V42I + S46D + V47T + H49Y + S50L + F59Y + W64G + A67T + H69N + V70H + S71T + Δ72-78 + D80G + L84I + N87K + V90I + S94A + I100V + I101V + I105V + T108S + L110M + D111N + S112N + T114S + L117V + L118I + V120I + A123S + K129R + V130A + E132N + Q134E + F135L + N137D + D138N + L141F + G142A + Y144S + Y145K + H146P + Δ147 + N148M + N149G + Δ150-152 + M153T + E154Q + S155T + E156H + F157T + R158M + V159I + Y160F + S161D + S162N + N164F + V171I + Q173D + P174A + L176S + M177L + L179V + E180S + G181E + Q183S + N188H + I197K + Y200F + F201L + K202Y + I203V + S205K + K206G + H207Y + T208Q + N211D + L212V + Q218S + S221N + A222T + E224K + L226I + V227F + D228K + I231L + R237N + Q239R + T240A + L241I + A243T + L244A + Δ245-246 + S247F + Y248S + L249P + T250A + P251Q + G252D + D253I + Δ254-257 + T259G + A260T + G261S + Y266F + Q271K + R273T + L276M + N280D + A292S + L293Q + D294N + S297A + T299L + T302S + L303V + T307E + V308I + E309D + Q321V + T323S + E324G + S325D + I326V + R346K + A348P + N354E + R357K + A372T + S373F + P384A + T393S + I402V + R403K + E406D + K417V + T430M + I434L + S438T + N439R + L441I + S443A + K444T + V445S + G446T + L452K + L455Y + F456L + K458H + S459G + N460K + K462R + T470N + E471V + I472P + Y473F + Q474S + A475P + G476D + S477G + T478K + N481T + G482P + Δ483 + E484P + G485A + F486L + F490W + Q493N + S494D + Q498Y + P499T + N501T + V503I + H519N + K529L + N532D + V534I + K537Q + E554P + N556S + K558R + L560Q + I569V + A570S + T572F + A575S + Q580K + L582S + T588S + S591A + T604A + N606S + Q607E + E619D + P621S + V622T + T632A + V635I + S640N + R646Q + N657D + N658T + Q675H + Q677V + T678S + N679L + S680L + Δ681-684 + V687T + A688S + S689Q + Q690K + I693V + E702D + N703S + V705I + S711T + T719S + V722I + I726V + L727M + T732A + T739N + S750A + T768S + V772A + K776R + Q779R + I788M + P793T + I794L + D796Y + S810L + S813T + I834M + D839E + A845N + E868D + Q872A + S875A + L878V + A879S + I882A + S884A + L922Q + S929K + G932S + K933Q + D936E + S939T + S940T + A942S + S943T + S1055A + A1070S + K1073R + D1084E + H1088Y + S1097F + H1101S + V1104I + Y1110F + E1111S + V1133I + I1216V + M1233L + C1247A,1,>,10000,ng/ml,1,>,188,,,
Cao22,10.1101/2022.02.07.479349,Pseudovirus (VSV),Table S2,Amubarvimab,Wild Type (B.1),=,52.9,ng/ml,1,SARS-CoV-1,3,V3I + V6L + L7F + P9T + V11T + S12ins + Q14D + C15L + V16D + N17R + L18C + R21F + T22D + Q23D + L24V + P25ins + A27N + N30ins + F32S + T33M + K41E + V42I + S46D + V47T + H49Y + S50L + F59Y + W64G + A67T + H69N + V70H + S71T + Δ72-78 + D80G + L84I + N87K + V90I + S94A + I100V + I101V + I105V + T108S + L110M + D111N + S112N + T114S + L117V + L118I + V120I + A123S + K129R + V130A + E132N + Q134E + F135L + N137D + D138N + L141F + G142A + Y144S + Y145K + H146P + Δ147 + N148M + N149G + Δ150-152 + M153T + E154Q + S155T + E156H + F157T + R158M + V159I + Y160F + S161D + S162N + N164F + V171I + Q173D + P174A + L176S + M177L + L179V + E180S + G181E + Q183S + N188H + I197K + Y200F + F201L + K202Y + I203V + S205K + K206G + H207Y + T208Q + N211D + L212V + Q218S + S221N + A222T + E224K + L226I + V227F + D228K + I231L + R237N + Q239R + T240A + L241I + A243T + L244A + Δ245-246 + S247F + Y248S + L249P + T250A + P251Q + G252D + D253I + Δ254-257 + T259G + A260T + G261S + Y266F + Q271K + R273T + L276M + N280D + A292S + L293Q + D294N + S297A + T299L + T302S + L303V + T307E + V308I + E309D + Q321V + T323S + E324G + S325D + I326V + R346K + A348P + N354E + R357K + A372T + S373F + P384A + T393S + I402V + R403K + E406D + K417V + T430M + I434L + S438T + N439R + L441I + S443A + K444T + V445S + G446T + L452K + L455Y + F456L + K458H + S459G + N460K + K462R + T470N + E471V + I472P + Y473F + Q474S + A475P + G476D + S477G + T478K + N481T + G482P + Δ483 + E484P + G485A + F486L + F490W + Q493N + S494D + Q498Y + P499T + N501T + V503I + H519N + K529L + N532D + V534I + K537Q + E554P + N556S + K558R + L560Q + I569V + A570S + T572F + A575S + Q580K + L582S + T588S + S591A + T604A + N606S + Q607E + E619D + P621S + V622T + T632A + V635I + S640N + R646Q + N657D + N658T + Q675H + Q677V + T678S + N679L + S680L + Δ681-684 + V687T + A688S + S689Q + Q690K + I693V + E702D + N703S + V705I + S711T + T719S + V722I + I726V + L727M + T732A + T739N + S750A + T768S + V772A + K776R + Q779R + I788M + P793T + I794L + D796Y + S810L + S813T + I834M + D839E + A845N + E868D + Q872A + S875A + L878V + A879S + I882A + S884A + L922Q + S929K + G932S + K933Q + D936E + S939T + S940T + A942S + S943T + S1055A + A1070S + K1073R + D1084E + H1088Y + S1097F + H1101S + V1104I + Y1110F + E1111S + V1133I + I1216V + M1233L + C1247A,1,>,10000,ng/ml,1,>,189,,,
Cao22c,10.1016/j.chom.2022.09.018,Pseudovirus (VSV),Figure 5b,Amubarvimab,Wild Type (B.1),=,53,ng/ml,1,SARS-CoV-1,3,V3I + V6L + L7F + P9T + V11T + S12ins + Q14D + C15L + V16D + N17R + L18C + R21F + T22D + Q23D + L24V + P25ins + A27N + N30ins + F32S + T33M + K41E + V42I + S46D + V47T + H49Y + S50L + F59Y + W64G + A67T + H69N + V70H + S71T + Δ72-78 + D80G + L84I + N87K + V90I + S94A + I100V + I101V + I105V + T108S + L110M + D111N + S112N + T114S + L117V + L118I + V120I + A123S + K129R + V130A + E132N + Q134E + F135L + N137D + D138N + L141F + G142A + Y144S + Y145K + H146P + Δ147 + N148M + N149G + Δ150-152 + M153T + E154Q + S155T + E156H + F157T + R158M + V159I + Y160F + S161D + S162N + N164F + V171I + Q173D + P174A + L176S + M177L + L179V + E180S + G181E + Q183S + N188H + I197K + Y200F + F201L + K202Y + I203V + S205K + K206G + H207Y + T208Q + N211D + L212V + Q218S + S221N + A222T + E224K + L226I + V227F + D228K + I231L + R237N + Q239R + T240A + L241I + A243T + L244A + Δ245-246 + S247F + Y248S + L249P + T250A + P251Q + G252D + D253I + Δ254-257 + T259G + A260T + G261S + Y266F + Q271K + R273T + L276M + N280D + A292S + L293Q + D294N + S297A + T299L + T302S + L303V + T307E + V308I + E309D + Q321V + T323S + E324G + S325D + I326V + R346K + A348P + N354E + R357K + A372T + S373F + P384A + T393S + I402V + R403K + E406D + K417V + T430M + I434L + S438T + N439R + L441I + S443A + K444T + V445S + G446T + L452K + L455Y + F456L + K458H + S459G + N460K + K462R + T470N + E471V + I472P + Y473F + Q474S + A475P + G476D + S477G + T478K + N481T + G482P + Δ483 + E484P + G485A + F486L + F490W + Q493N + S494D + Q498Y + P499T + N501T + V503I + H519N + K529L + N532D + V534I + K537Q + E554P + N556S + K558R + L560Q + I569V + A570S + T572F + A575S + Q580K + L582S + T588S + S591A + T604A + N606S + Q607E + E619D + P621S + V622T + T632A + V635I + S640N + R646Q + N657D + N658T + Q675H + Q677V + T678S + N679L + S680L + Δ681-684 + V687T + A688S + S689Q + Q690K + I693V + E702D + N703S + V705I + S711T + T719S + V722I + I726V + L727M + T732A + T739N + S750A + T768S + V772A + K776R + Q779R + I788M + P793T + I794L + D796Y + S810L + S813T + I834M + D839E + A845N + E868D + Q872A + S875A + L878V + A879S + I882A + S884A + L922Q + S929K + G932S + K933Q + D936E + S939T + S940T + A942S + S943T + S1055A + A1070S + K1073R + D1084E + H1088Y + S1097F + H1101S + V1104I + Y1110F + E1111S + V1133I + I1216V + M1233L + C1247A,1,>,10000,ng/ml,1,>,188.7,,,
Cao22d,10.1038/s41586-021-04385-3,Pseudovirus (VSV),41586_2021_4385_MOESM1_ESM.xlsx,Amubarvimab,Wild Type (B.1),=,53,ng/ml,1,SARS-CoV-1,3,V3I + V6L + L7F + P9T + V11T + S12ins + Q14D + C15L + V16D + N17R + L18C + R21F + T22D + Q23D + L24V + P25ins + A27N + N30ins + F32S + T33M + K41E + V42I + S46D + V47T + H49Y + S50L + F59Y + W64G + A67T + H69N + V70H + S71T + Δ72-78 + D80G + L84I + N87K + V90I + S94A + I100V + I101V + I105V + T108S + L110M + D111N + S112N + T114S + L117V + L118I + V120I + A123S + K129R + V130A + E132N + Q134E + F135L + N137D + D138N + L141F + G142A + Y144S + Y145K + H146P + Δ147 + N148M + N149G + Δ150-152 + M153T + E154Q + S155T + E156H + F157T + R158M + V159I + Y160F + S161D + S162N + N164F + V171I + Q173D + P174A + L176S + M177L + L179V + E180S + G181E + Q183S + N188H + I197K + Y200F + F201L + K202Y + I203V + S205K + K206G + H207Y + T208Q + N211D + L212V + Q218S + S221N + A222T + E224K + L226I + V227F + D228K + I231L + R237N + Q239R + T240A + L241I + A243T + L244A + Δ245-246 + S247F + Y248S + L249P + T250A + P251Q + G252D + D253I + Δ254-257 + T259G + A260T + G261S + Y266F + Q271K + R273T + L276M + N280D + A292S + L293Q + D294N + S297A + T299L + T302S + L303V + T307E + V308I + E309D + Q321V + T323S + E324G + S325D + I326V + R346K + A348P + N354E + R357K + A372T + S373F + P384A + T393S + I402V + R403K + E406D + K417V + T430M + I434L + S438T + N439R + L441I + S443A + K444T + V445S + G446T + L452K + L455Y + F456L + K458H + S459G + N460K + K462R + T470N + E471V + I472P + Y473F + Q474S + A475P + G476D + S477G + T478K + N481T + G482P + Δ483 + E484P + G485A + F486L + F490W + Q493N + S494D + Q498Y + P499T + N501T + V503I + H519N + K529L + N532D + V534I + K537Q + E554P + N556S + K558R + L560Q + I569V + A570S + T572F + A575S + Q580K + L582S + T588S + S591A + T604A + N606S + Q607E + E619D + P621S + V622T + T632A + V635I + S640N + R646Q + N657D + N658T + Q675H + Q677V + T678S + N679L + S680L + Δ681-684 + V687T + A688S + S689Q + Q690K + I693V + E702D + N703S + V705I + S711T + T719S + V722I + I726V + L727M + T732A + T739N + S750A + T768S + V772A + K776R + Q779R + I788M + P793T + I794L + D796Y + S810L + S813T + I834M + D839E + A845N + E868D + Q872A + S875A + L878V + A879S + I882A + S884A + L922Q + S929K + G932S + K933Q + D936E + S939T + S940T + A942S + S943T + S1055A + A1070S + K1073R + D1084E + H1088Y + S1097F + H1101S + V1104I + Y1110F + E1111S + V1133I + I1216V + M1233L + C1247A,1,>,10000,ng/ml,1,>,188.7,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Romlusevimab,Wild Type (B.1),=,1240,ng/ml,1,SARS-CoV-1,3,V3I + V6L + L7F + P9T + V11T + S12ins + Q14D + C15L + V16D + N17R + L18C + R21F + T22D + Q23D + L24V + P25ins + A27N + N30ins + F32S + T33M + K41E + V42I + S46D + V47T + H49Y + S50L + F59Y + W64G + A67T + H69N + V70H + S71T + Δ72-78 + D80G + L84I + N87K + V90I + S94A + I100V + I101V + I105V + T108S + L110M + D111N + S112N + T114S + L117V + L118I + V120I + A123S + K129R + V130A + E132N + Q134E + F135L + N137D + D138N + L141F + G142A + Y144S + Y145K + H146P + Δ147 + N148M + N149G + Δ150-152 + M153T + E154Q + S155T + E156H + F157T + R158M + V159I + Y160F + S161D + S162N + N164F + V171I + Q173D + P174A + L176S + M177L + L179V + E180S + G181E + Q183S + N188H + I197K + Y200F + F201L + K202Y + I203V + S205K + K206G + H207Y + T208Q + N211D + L212V + Q218S + S221N + A222T + E224K + L226I + V227F + D228K + I231L + R237N + Q239R + T240A + L241I + A243T + L244A + Δ245-246 + S247F + Y248S + L249P + T250A + P251Q + G252D + D253I + Δ254-257 + T259G + A260T + G261S + Y266F + Q271K + R273T + L276M + N280D + A292S + L293Q + D294N + S297A + T299L + T302S + L303V + T307E + V308I + E309D + Q321V + T323S + E324G + S325D + I326V + R346K + A348P + N354E + R357K + A372T + S373F + P384A + T393S + I402V + R403K + E406D + K417V + T430M + I434L + S438T + N439R + L441I + S443A + K444T + V445S + G446T + L452K + L455Y + F456L + K458H + S459G + N460K + K462R + T470N + E471V + I472P + Y473F + Q474S + A475P + G476D + S477G + T478K + N481T + G482P + Δ483 + E484P + G485A + F486L + F490W + Q493N + S494D + Q498Y + P499T + N501T + V503I + H519N + K529L + N532D + V534I + K537Q + E554P + N556S + K558R + L560Q + I569V + A570S + T572F + A575S + Q580K + L582S + T588S + S591A + T604A + N606S + Q607E + E619D + P621S + V622T + T632A + V635I + S640N + R646Q + N657D + N658T + Q675H + Q677V + T678S + N679L + S680L + Δ681-684 + V687T + A688S + S689Q + Q690K + I693V + E702D + N703S + V705I + S711T + T719S + V722I + I726V + L727M + T732A + T739N + S750A + T768S + V772A + K776R + Q779R + I788M + P793T + I794L + D796Y + S810L + S813T + I834M + D839E + A845N + E868D + Q872A + S875A + L878V + A879S + I882A + S884A + L922Q + S929K + G932S + K933Q + D936E + S939T + S940T + A942S + S943T + S1055A + A1070S + K1073R + D1084E + H1088Y + S1097F + H1101S + V1104I + Y1110F + E1111S + V1133I + I1216V + M1233L + C1247A,1,>,10000,ng/ml,1,>,8.1,,,
Cao22,10.1101/2022.02.07.479349,Pseudovirus (VSV),Table S2,Romlusevimab,Wild Type (B.1),=,1240,ng/ml,1,SARS-CoV-1,3,V3I + V6L + L7F + P9T + V11T + S12ins + Q14D + C15L + V16D + N17R + L18C + R21F + T22D + Q23D + L24V + P25ins + A27N + N30ins + F32S + T33M + K41E + V42I + S46D + V47T + H49Y + S50L + F59Y + W64G + A67T + H69N + V70H + S71T + Δ72-78 + D80G + L84I + N87K + V90I + S94A + I100V + I101V + I105V + T108S + L110M + D111N + S112N + T114S + L117V + L118I + V120I + A123S + K129R + V130A + E132N + Q134E + F135L + N137D + D138N + L141F + G142A + Y144S + Y145K + H146P + Δ147 + N148M + N149G + Δ150-152 + M153T + E154Q + S155T + E156H + F157T + R158M + V159I + Y160F + S161D + S162N + N164F + V171I + Q173D + P174A + L176S + M177L + L179V + E180S + G181E + Q183S + N188H + I197K + Y200F + F201L + K202Y + I203V + S205K + K206G + H207Y + T208Q + N211D + L212V + Q218S + S221N + A222T + E224K + L226I + V227F + D228K + I231L + R237N + Q239R + T240A + L241I + A243T + L244A + Δ245-246 + S247F + Y248S + L249P + T250A + P251Q + G252D + D253I + Δ254-257 + T259G + A260T + G261S + Y266F + Q271K + R273T + L276M + N280D + A292S + L293Q + D294N + S297A + T299L + T302S + L303V + T307E + V308I + E309D + Q321V + T323S + E324G + S325D + I326V + R346K + A348P + N354E + R357K + A372T + S373F + P384A + T393S + I402V + R403K + E406D + K417V + T430M + I434L + S438T + N439R + L441I + S443A + K444T + V445S + G446T + L452K + L455Y + F456L + K458H + S459G + N460K + K462R + T470N + E471V + I472P + Y473F + Q474S + A475P + G476D + S477G + T478K + N481T + G482P + Δ483 + E484P + G485A + F486L + F490W + Q493N + S494D + Q498Y + P499T + N501T + V503I + H519N + K529L + N532D + V534I + K537Q + E554P + N556S + K558R + L560Q + I569V + A570S + T572F + A575S + Q580K + L582S + T588S + S591A + T604A + N606S + Q607E + E619D + P621S + V622T + T632A + V635I + S640N + R646Q + N657D + N658T + Q675H + Q677V + T678S + N679L + S680L + Δ681-684 + V687T + A688S + S689Q + Q690K + I693V + E702D + N703S + V705I + S711T + T719S + V722I + I726V + L727M + T732A + T739N + S750A + T768S + V772A + K776R + Q779R + I788M + P793T + I794L + D796Y + S810L + S813T + I834M + D839E + A845N + E868D + Q872A + S875A + L878V + A879S + I882A + S884A + L922Q + S929K + G932S + K933Q + D936E + S939T + S940T + A942S + S943T + S1055A + A1070S + K1073R + D1084E + H1088Y + S1097F + H1101S + V1104I + Y1110F + E1111S + V1133I + I1216V + M1233L + C1247A,1,>,10000,ng/ml,1,>,8.1,,,
Cao22c,10.1016/j.chom.2022.09.018,Pseudovirus (VSV),Figure 5b,Romlusevimab,Wild Type (B.1),=,1239,ng/ml,1,SARS-CoV-1,3,V3I + V6L + L7F + P9T + V11T + S12ins + Q14D + C15L + V16D + N17R + L18C + R21F + T22D + Q23D + L24V + P25ins + A27N + N30ins + F32S + T33M + K41E + V42I + S46D + V47T + H49Y + S50L + F59Y + W64G + A67T + H69N + V70H + S71T + Δ72-78 + D80G + L84I + N87K + V90I + S94A + I100V + I101V + I105V + T108S + L110M + D111N + S112N + T114S + L117V + L118I + V120I + A123S + K129R + V130A + E132N + Q134E + F135L + N137D + D138N + L141F + G142A + Y144S + Y145K + H146P + Δ147 + N148M + N149G + Δ150-152 + M153T + E154Q + S155T + E156H + F157T + R158M + V159I + Y160F + S161D + S162N + N164F + V171I + Q173D + P174A + L176S + M177L + L179V + E180S + G181E + Q183S + N188H + I197K + Y200F + F201L + K202Y + I203V + S205K + K206G + H207Y + T208Q + N211D + L212V + Q218S + S221N + A222T + E224K + L226I + V227F + D228K + I231L + R237N + Q239R + T240A + L241I + A243T + L244A + Δ245-246 + S247F + Y248S + L249P + T250A + P251Q + G252D + D253I + Δ254-257 + T259G + A260T + G261S + Y266F + Q271K + R273T + L276M + N280D + A292S + L293Q + D294N + S297A + T299L + T302S + L303V + T307E + V308I + E309D + Q321V + T323S + E324G + S325D + I326V + R346K + A348P + N354E + R357K + A372T + S373F + P384A + T393S + I402V + R403K + E406D + K417V + T430M + I434L + S438T + N439R + L441I + S443A + K444T + V445S + G446T + L452K + L455Y + F456L + K458H + S459G + N460K + K462R + T470N + E471V + I472P + Y473F + Q474S + A475P + G476D + S477G + T478K + N481T + G482P + Δ483 + E484P + G485A + F486L + F490W + Q493N + S494D + Q498Y + P499T + N501T + V503I + H519N + K529L + N532D + V534I + K537Q + E554P + N556S + K558R + L560Q + I569V + A570S + T572F + A575S + Q580K + L582S + T588S + S591A + T604A + N606S + Q607E + E619D + P621S + V622T + T632A + V635I + S640N + R646Q + N657D + N658T + Q675H + Q677V + T678S + N679L + S680L + Δ681-684 + V687T + A688S + S689Q + Q690K + I693V + E702D + N703S + V705I + S711T + T719S + V722I + I726V + L727M + T732A + T739N + S750A + T768S + V772A + K776R + Q779R + I788M + P793T + I794L + D796Y + S810L + S813T + I834M + D839E + A845N + E868D + Q872A + S875A + L878V + A879S + I882A + S884A + L922Q + S929K + G932S + K933Q + D936E + S939T + S940T + A942S + S943T + S1055A + A1070S + K1073R + D1084E + H1088Y + S1097F + H1101S + V1104I + Y1110F + E1111S + V1133I + I1216V + M1233L + C1247A,1,>,10000,ng/ml,1,>,8.1,,,
Cao22c,10.1016/j.chom.2022.09.018,Pseudovirus (VSV),Figure 5b,Amubarvimab + Romlusevimab,Wild Type (B.1),=,81,ng/ml,1,SARS-CoV-1,3,V3I + V6L + L7F + P9T + V11T + S12ins + Q14D + C15L + V16D + N17R + L18C + R21F + T22D + Q23D + L24V + P25ins + A27N + N30ins + F32S + T33M + K41E + V42I + S46D + V47T + H49Y + S50L + F59Y + W64G + A67T + H69N + V70H + S71T + Δ72-78 + D80G + L84I + N87K + V90I + S94A + I100V + I101V + I105V + T108S + L110M + D111N + S112N + T114S + L117V + L118I + V120I + A123S + K129R + V130A + E132N + Q134E + F135L + N137D + D138N + L141F + G142A + Y144S + Y145K + H146P + Δ147 + N148M + N149G + Δ150-152 + M153T + E154Q + S155T + E156H + F157T + R158M + V159I + Y160F + S161D + S162N + N164F + V171I + Q173D + P174A + L176S + M177L + L179V + E180S + G181E + Q183S + N188H + I197K + Y200F + F201L + K202Y + I203V + S205K + K206G + H207Y + T208Q + N211D + L212V + Q218S + S221N + A222T + E224K + L226I + V227F + D228K + I231L + R237N + Q239R + T240A + L241I + A243T + L244A + Δ245-246 + S247F + Y248S + L249P + T250A + P251Q + G252D + D253I + Δ254-257 + T259G + A260T + G261S + Y266F + Q271K + R273T + L276M + N280D + A292S + L293Q + D294N + S297A + T299L + T302S + L303V + T307E + V308I + E309D + Q321V + T323S + E324G + S325D + I326V + R346K + A348P + N354E + R357K + A372T + S373F + P384A + T393S + I402V + R403K + E406D + K417V + T430M + I434L + S438T + N439R + L441I + S443A + K444T + V445S + G446T + L452K + L455Y + F456L + K458H + S459G + N460K + K462R + T470N + E471V + I472P + Y473F + Q474S + A475P + G476D + S477G + T478K + N481T + G482P + Δ483 + E484P + G485A + F486L + F490W + Q493N + S494D + Q498Y + P499T + N501T + V503I + H519N + K529L + N532D + V534I + K537Q + E554P + N556S + K558R + L560Q + I569V + A570S + T572F + A575S + Q580K + L582S + T588S + S591A + T604A + N606S + Q607E + E619D + P621S + V622T + T632A + V635I + S640N + R646Q + N657D + N658T + Q675H + Q677V + T678S + N679L + S680L + Δ681-684 + V687T + A688S + S689Q + Q690K + I693V + E702D + N703S + V705I + S711T + T719S + V722I + I726V + L727M + T732A + T739N + S750A + T768S + V772A + K776R + Q779R + I788M + P793T + I794L + D796Y + S810L + S813T + I834M + D839E + A845N + E868D + Q872A + S875A + L878V + A879S + I882A + S884A + L922Q + S929K + G932S + K933Q + D936E + S939T + S940T + A942S + S943T + S1055A + A1070S + K1073R + D1084E + H1088Y + S1097F + H1101S + V1104I + Y1110F + E1111S + V1133I + I1216V + M1233L + C1247A,1,>,10000,ng/ml,1,>,123.5,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,DXP-604,Wild Type (B.1),=,11,ng/ml,1,SARS-CoV-1,3,V3I + V6L + L7F + P9T + V11T + S12ins + Q14D + C15L + V16D + N17R + L18C + R21F + T22D + Q23D + L24V + P25ins + A27N + N30ins + F32S + T33M + K41E + V42I + S46D + V47T + H49Y + S50L + F59Y + W64G + A67T + H69N + V70H + S71T + Δ72-78 + D80G + L84I + N87K + V90I + S94A + I100V + I101V + I105V + T108S + L110M + D111N + S112N + T114S + L117V + L118I + V120I + A123S + K129R + V130A + E132N + Q134E + F135L + N137D + D138N + L141F + G142A + Y144S + Y145K + H146P + Δ147 + N148M + N149G + Δ150-152 + M153T + E154Q + S155T + E156H + F157T + R158M + V159I + Y160F + S161D + S162N + N164F + V171I + Q173D + P174A + L176S + M177L + L179V + E180S + G181E + Q183S + N188H + I197K + Y200F + F201L + K202Y + I203V + S205K + K206G + H207Y + T208Q + N211D + L212V + Q218S + S221N + A222T + E224K + L226I + V227F + D228K + I231L + R237N + Q239R + T240A + L241I + A243T + L244A + Δ245-246 + S247F + Y248S + L249P + T250A + P251Q + G252D + D253I + Δ254-257 + T259G + A260T + G261S + Y266F + Q271K + R273T + L276M + N280D + A292S + L293Q + D294N + S297A + T299L + T302S + L303V + T307E + V308I + E309D + Q321V + T323S + E324G + S325D + I326V + R346K + A348P + N354E + R357K + A372T + S373F + P384A + T393S + I402V + R403K + E406D + K417V + T430M + I434L + S438T + N439R + L441I + S443A + K444T + V445S + G446T + L452K + L455Y + F456L + K458H + S459G + N460K + K462R + T470N + E471V + I472P + Y473F + Q474S + A475P + G476D + S477G + T478K + N481T + G482P + Δ483 + E484P + G485A + F486L + F490W + Q493N + S494D + Q498Y + P499T + N501T + V503I + H519N + K529L + N532D + V534I + K537Q + E554P + N556S + K558R + L560Q + I569V + A570S + T572F + A575S + Q580K + L582S + T588S + S591A + T604A + N606S + Q607E + E619D + P621S + V622T + T632A + V635I + S640N + R646Q + N657D + N658T + Q675H + Q677V + T678S + N679L + S680L + Δ681-684 + V687T + A688S + S689Q + Q690K + I693V + E702D + N703S + V705I + S711T + T719S + V722I + I726V + L727M + T732A + T739N + S750A + T768S + V772A + K776R + Q779R + I788M + P793T + I794L + D796Y + S810L + S813T + I834M + D839E + A845N + E868D + Q872A + S875A + L878V + A879S + I882A + S884A + L922Q + S929K + G932S + K933Q + D936E + S939T + S940T + A942S + S943T + S1055A + A1070S + K1073R + D1084E + H1088Y + S1097F + H1101S + V1104I + Y1110F + E1111S + V1133I + I1216V + M1233L + C1247A,1,>,10000,ng/ml,1,>,909.1,,,
Cao22c,10.1016/j.chom.2022.09.018,Pseudovirus (VSV),Figure 5b,DXP-604,Wild Type (B.1),=,11,ng/ml,1,SARS-CoV-1,3,V3I + V6L + L7F + P9T + V11T + S12ins + Q14D + C15L + V16D + N17R + L18C + R21F + T22D + Q23D + L24V + P25ins + A27N + N30ins + F32S + T33M + K41E + V42I + S46D + V47T + H49Y + S50L + F59Y + W64G + A67T + H69N + V70H + S71T + Δ72-78 + D80G + L84I + N87K + V90I + S94A + I100V + I101V + I105V + T108S + L110M + D111N + S112N + T114S + L117V + L118I + V120I + A123S + K129R + V130A + E132N + Q134E + F135L + N137D + D138N + L141F + G142A + Y144S + Y145K + H146P + Δ147 + N148M + N149G + Δ150-152 + M153T + E154Q + S155T + E156H + F157T + R158M + V159I + Y160F + S161D + S162N + N164F + V171I + Q173D + P174A + L176S + M177L + L179V + E180S + G181E + Q183S + N188H + I197K + Y200F + F201L + K202Y + I203V + S205K + K206G + H207Y + T208Q + N211D + L212V + Q218S + S221N + A222T + E224K + L226I + V227F + D228K + I231L + R237N + Q239R + T240A + L241I + A243T + L244A + Δ245-246 + S247F + Y248S + L249P + T250A + P251Q + G252D + D253I + Δ254-257 + T259G + A260T + G261S + Y266F + Q271K + R273T + L276M + N280D + A292S + L293Q + D294N + S297A + T299L + T302S + L303V + T307E + V308I + E309D + Q321V + T323S + E324G + S325D + I326V + R346K + A348P + N354E + R357K + A372T + S373F + P384A + T393S + I402V + R403K + E406D + K417V + T430M + I434L + S438T + N439R + L441I + S443A + K444T + V445S + G446T + L452K + L455Y + F456L + K458H + S459G + N460K + K462R + T470N + E471V + I472P + Y473F + Q474S + A475P + G476D + S477G + T478K + N481T + G482P + Δ483 + E484P + G485A + F486L + F490W + Q493N + S494D + Q498Y + P499T + N501T + V503I + H519N + K529L + N532D + V534I + K537Q + E554P + N556S + K558R + L560Q + I569V + A570S + T572F + A575S + Q580K + L582S + T588S + S591A + T604A + N606S + Q607E + E619D + P621S + V622T + T632A + V635I + S640N + R646Q + N657D + N658T + Q675H + Q677V + T678S + N679L + S680L + Δ681-684 + V687T + A688S + S689Q + Q690K + I693V + E702D + N703S + V705I + S711T + T719S + V722I + I726V + L727M + T732A + T739N + S750A + T768S + V772A + K776R + Q779R + I788M + P793T + I794L + D796Y + S810L + S813T + I834M + D839E + A845N + E868D + Q872A + S875A + L878V + A879S + I882A + S884A + L922Q + S929K + G932S + K933Q + D936E + S939T + S940T + A942S + S943T + S1055A + A1070S + K1073R + D1084E + H1088Y + S1097F + H1101S + V1104I + Y1110F + E1111S + V1133I + I1216V + M1233L + C1247A,1,>,10000,ng/ml,1,>,909.1,,,
Cao22d,10.1038/s41586-021-04385-3,Pseudovirus (VSV),41586_2021_4385_MOESM1_ESM.xlsx,DXP-604,Wild Type (B.1),=,10,ng/ml,1,SARS-CoV-1,3,V3I + V6L + L7F + P9T + V11T + S12ins + Q14D + C15L + V16D + N17R + L18C + R21F + T22D + Q23D + L24V + P25ins + A27N + N30ins + F32S + T33M + K41E + V42I + S46D + V47T + H49Y + S50L + F59Y + W64G + A67T + H69N + V70H + S71T + Δ72-78 + D80G + L84I + N87K + V90I + S94A + I100V + I101V + I105V + T108S + L110M + D111N + S112N + T114S + L117V + L118I + V120I + A123S + K129R + V130A + E132N + Q134E + F135L + N137D + D138N + L141F + G142A + Y144S + Y145K + H146P + Δ147 + N148M + N149G + Δ150-152 + M153T + E154Q + S155T + E156H + F157T + R158M + V159I + Y160F + S161D + S162N + N164F + V171I + Q173D + P174A + L176S + M177L + L179V + E180S + G181E + Q183S + N188H + I197K + Y200F + F201L + K202Y + I203V + S205K + K206G + H207Y + T208Q + N211D + L212V + Q218S + S221N + A222T + E224K + L226I + V227F + D228K + I231L + R237N + Q239R + T240A + L241I + A243T + L244A + Δ245-246 + S247F + Y248S + L249P + T250A + P251Q + G252D + D253I + Δ254-257 + T259G + A260T + G261S + Y266F + Q271K + R273T + L276M + N280D + A292S + L293Q + D294N + S297A + T299L + T302S + L303V + T307E + V308I + E309D + Q321V + T323S + E324G + S325D + I326V + R346K + A348P + N354E + R357K + A372T + S373F + P384A + T393S + I402V + R403K + E406D + K417V + T430M + I434L + S438T + N439R + L441I + S443A + K444T + V445S + G446T + L452K + L455Y + F456L + K458H + S459G + N460K + K462R + T470N + E471V + I472P + Y473F + Q474S + A475P + G476D + S477G + T478K + N481T + G482P + Δ483 + E484P + G485A + F486L + F490W + Q493N + S494D + Q498Y + P499T + N501T + V503I + H519N + K529L + N532D + V534I + K537Q + E554P + N556S + K558R + L560Q + I569V + A570S + T572F + A575S + Q580K + L582S + T588S + S591A + T604A + N606S + Q607E + E619D + P621S + V622T + T632A + V635I + S640N + R646Q + N657D + N658T + Q675H + Q677V + T678S + N679L + S680L + Δ681-684 + V687T + A688S + S689Q + Q690K + I693V + E702D + N703S + V705I + S711T + T719S + V722I + I726V + L727M + T732A + T739N + S750A + T768S + V772A + K776R + Q779R + I788M + P793T + I794L + D796Y + S810L + S813T + I834M + D839E + A845N + E868D + Q872A + S875A + L878V + A879S + I882A + S884A + L922Q + S929K + G932S + K933Q + D936E + S939T + S940T + A942S + S943T + S1055A + A1070S + K1073R + D1084E + H1088Y + S1097F + H1101S + V1104I + Y1110F + E1111S + V1133I + I1216V + M1233L + C1247A,1,>,10000,ng/ml,1,>,1000,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Bamlanivimab,Wild Type (B.1),=,15,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,666.7,,,
Cao22,10.1101/2022.02.07.479349,Pseudovirus (VSV),Table S2,Bamlanivimab,Wild Type (B.1),=,12.8,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,781.3,,,
Cui22,10.1016/j.cell.2022.01.019,Pseudovirus (VSV),Figure 5C,Bamlanivimab,Wild Type (B.1),=,12.5,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,800,,,
Liu21l,10.1038/s41586-021-04388-0,Pseudovirus (VSV),Figure 2d,Bamlanivimab,Wild Type (B.1),=,0.7,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Misasi22,10.1101/2022.07.29.502029,Pseudovirus (lentivirus),Figure 1A,Bamlanivimab,Wild Type (B.1),=,2.8,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10050,ng/ml,1,>,1000,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Table 1a,Bamlanivimab,Wild Type (B.1),=,4,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Tuekprakhon22,10.1016/j.cell.2022.06.005,Pseudovirus (lentivirus),Figure 3,Bamlanivimab,Wild Type (B),=,2,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Huo22b,10.1016/j.celrep.2022.111903,Pseudovirus (lentivirus),Supplementary Table 1B,Bamlanivimab,Wild Type (B),=,2,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Ai22,10.1016/j.chom.2022.05.001,Pseudovirus (VSV),Figure 3A,Bamlanivimab,Wild Type (B),=,3,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Gruell22b,10.1016/j.chom.2022.07.002,Pseudovirus (HIV),Figure 4B,Bamlanivimab,Wild Type (B),=,5,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Huang22,10.1016/j.immuni.2022.06.005,Pseudovirus (VSV),Figure 2,Bamlanivimab,Wild Type (B),=,10,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,100000,ng/ml,1,>,1000,,,
Iketani22,10.1038/s41586-022-04594-4,Pseudovirus (VSV),Figure 2b,Bamlanivimab,Wild Type (B.1),,,,,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,,,,,>,1000,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Etesevimab,Wild Type (B.1),=,32,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,312.5,,,
Cao22,10.1101/2022.02.07.479349,Pseudovirus (VSV),Table S2,Etesevimab,Wild Type (B.1),=,31.6,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,316.5,,,
Cui22,10.1016/j.cell.2022.01.019,Pseudovirus (VSV),Figure 5C,Etesevimab,Wild Type (B.1),=,39.3,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,254.5,,,
Liu21l,10.1038/s41586-021-04388-0,Pseudovirus (VSV),Figure 2d,Etesevimab,Wild Type (B.1),=,8.6,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Misasi22,10.1101/2022.07.29.502029,Pseudovirus (lentivirus),Figure 1A,Etesevimab,Wild Type (B.1),=,23.3,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10050,ng/ml,1,>,432.3,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Table 1a,Etesevimab,Wild Type (B.1),=,12,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,833.3,,,
Tuekprakhon22,10.1016/j.cell.2022.06.005,Pseudovirus (lentivirus),Figure 3,Etesevimab,Wild Type (B),=,14,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,714.3,,,
Huo22b,10.1016/j.celrep.2022.111903,Pseudovirus (lentivirus),Supplementary Table 1B,Etesevimab,Wild Type (B),=,14,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,714.3,,,
Ai22,10.1016/j.chom.2022.05.001,Pseudovirus (VSV),Figure 3A,Etesevimab,Wild Type (B),=,7,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Gruell22b,10.1016/j.chom.2022.07.002,Pseudovirus (HIV),Figure 4B,Etesevimab,Wild Type (B),=,18,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,555.6,,,
Huang22,10.1016/j.immuni.2022.06.005,Pseudovirus (VSV),Figure 2,Etesevimab,Wild Type (B),=,20,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,100000,ng/ml,1,>,1000,,,
Iketani22,10.1038/s41586-022-04594-4,Pseudovirus (VSV),Figure 2b,Etesevimab,Wild Type (B.1),,,,,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,,,,,>,428,,,
Misasi22,10.1101/2022.07.29.502029,Pseudovirus (lentivirus),Figure 1B,Bamlanivimab + Etesevimab,Wild Type (B.1),=,5.6,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10050,ng/ml,1,>,1000,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Table 1a,Bamlanivimab + Etesevimab,Wild Type (B.1),=,5,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Casirivimab,Wild Type (B.1),=,5.6,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,8910,ng/ml,1,>,1000,,,
Cao22,10.1101/2022.02.07.479349,Pseudovirus (VSV),Table S2,Casirivimab,Wild Type (B.1),=,5.3,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Cui22,10.1016/j.cell.2022.01.019,Pseudovirus (VSV),Figure 5C,Casirivimab,Wild Type (B.1),=,6.1,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Liu21l,10.1038/s41586-021-04388-0,Pseudovirus (VSV),Figure 2d,Casirivimab,Wild Type (B.1),=,0.3,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Misasi22,10.1101/2022.07.29.502029,Pseudovirus (lentivirus),Figure 1A,Casirivimab,Wild Type (B.1),=,5.3,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10050,ng/ml,1,>,1000,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Table 1a,Casirivimab,Wild Type (B.1),=,5,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Tuekprakhon22,10.1016/j.cell.2022.06.005,Pseudovirus (lentivirus),Figure 3,Casirivimab,Wild Type (B),=,1,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Huo22b,10.1016/j.celrep.2022.111903,Pseudovirus (lentivirus),Supplementary Table 1B,Casirivimab,Wild Type (B),=,1,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Ai22,10.1016/j.chom.2022.05.001,Pseudovirus (VSV),Figure 3A,Casirivimab,Wild Type (B),=,2,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Gruell22b,10.1016/j.chom.2022.07.002,Pseudovirus (HIV),Figure 4B,Casirivimab,Wild Type (B),=,5,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Huang22,10.1016/j.immuni.2022.06.005,Pseudovirus (VSV),Figure 2,Casirivimab,Wild Type (B),=,11,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,100000,ng/ml,1,>,1000,,,
Iketani22,10.1038/s41586-022-04594-4,Pseudovirus (VSV),Figure 2b,Casirivimab,Wild Type (B.1),,,,,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,,,,,=,415,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Imdevimab,Wild Type (B.1),=,5.7,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Cao22,10.1101/2022.02.07.479349,Pseudovirus (VSV),Table S2,Imdevimab,Wild Type (B.1),=,5.4,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Cui22,10.1016/j.cell.2022.01.019,Pseudovirus (VSV),Figure 5C,Imdevimab,Wild Type (B.1),=,9.6,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Liu21l,10.1038/s41586-021-04388-0,Pseudovirus (VSV),Figure 2d,Imdevimab,Wild Type (B.1),=,0.6,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Misasi22,10.1101/2022.07.29.502029,Pseudovirus (lentivirus),Figure 1A,Imdevimab,Wild Type (B.1),=,10.8,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10050,ng/ml,1,>,933.1,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Table 1a,Imdevimab,Wild Type (B.1),=,1,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Tuekprakhon22,10.1016/j.cell.2022.06.005,Pseudovirus (lentivirus),Figure 3,Imdevimab,Wild Type (B),=,2,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Huo22b,10.1016/j.celrep.2022.111903,Pseudovirus (lentivirus),Supplementary Table 1B,Imdevimab,Wild Type (B),=,2,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Ai22,10.1016/j.chom.2022.05.001,Pseudovirus (VSV),Figure 3A,Imdevimab,Wild Type (B),=,3,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Gruell22b,10.1016/j.chom.2022.07.002,Pseudovirus (HIV),Figure 4B,Imdevimab,Wild Type (B),=,5,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Huang22,10.1016/j.immuni.2022.06.005,Pseudovirus (VSV),Figure 2,Imdevimab,Wild Type (B),=,6,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,100000,ng/ml,1,>,1000,,,
Iketani22,10.1038/s41586-022-04594-4,Pseudovirus (VSV),Figure 2b,Imdevimab,Wild Type (B.1),,,,,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,,,,,>,1000,,,
Misasi22,10.1101/2022.07.29.502029,Pseudovirus (lentivirus),Figure 1B,Casirivimab + Imdevimab,Wild Type (B.1),=,3.4,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10050,ng/ml,1,>,1000,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Table 1a,Casirivimab + Imdevimab,Wild Type (B.1),=,1,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Cilgavimab,Wild Type (B.1),=,2.5,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Cao22,10.1101/2022.02.07.479349,Pseudovirus (VSV),Table S2,Cilgavimab,Wild Type (B.1),=,1.4,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Cui22,10.1016/j.cell.2022.01.019,Pseudovirus (VSV),Figure 5C,Cilgavimab,Wild Type (B.1),=,2.2,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Duty22,10.1016/j.medj.2022.08.002,Pseudovirus (VSV),Table 3,Cilgavimab,Wild Type (B.1),=,35.3,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,283.3,,,
Liu21l,10.1038/s41586-021-04388-0,Pseudovirus (VSV),Figure 2d,Cilgavimab,Wild Type (B.1),=,2,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Misasi22,10.1101/2022.07.29.502029,Pseudovirus (lentivirus),Figure 1A,Cilgavimab,Wild Type (B.1),=,4.6,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10050,ng/ml,1,>,1000,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Table 1a,Cilgavimab,Wild Type (B.1),=,6,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Tuekprakhon22,10.1016/j.cell.2022.06.005,Pseudovirus (lentivirus),Figure 3,Cilgavimab,Wild Type (B),=,2,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Huo22b,10.1016/j.celrep.2022.111903,Pseudovirus (lentivirus),Supplementary Table 1B,Cilgavimab,Wild Type (B),=,2,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Ai22,10.1016/j.chom.2022.05.001,Pseudovirus (VSV),Figure 3A,Cilgavimab,Wild Type (B),=,1,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Gruell22b,10.1016/j.chom.2022.07.002,Pseudovirus (HIV),Figure 4B,Cilgavimab,Wild Type (B),=,5,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
FDA21c,https://www.fda.gov/media/154701/download,Pseudovirus,"Feb 2022, Page 17, Antiviral resistance paragraph 5",Cilgavimab,Wild Type (B),,,,,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,,,,,>,500,,,
Iketani22,10.1038/s41586-022-04594-4,Pseudovirus (VSV),Figure 2b,Cilgavimab,Wild Type (B.1),,,,,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,,,,,=,687,,,
Case22,10.1038/s41467-022-31615-7,Virus isolate,Figure 1n,Cilgavimab,Wild Type (B.1),=,29.5,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,50000,ng/ml,1,>,1000,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Tixagevimab,Wild Type (B.1),=,1.6,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,4760,ng/ml,1,>,1000,,,
Cao22,10.1101/2022.02.07.479349,Pseudovirus (VSV),Table S2,Tixagevimab,Wild Type (B.1),=,1.3,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,4760,ng/ml,1,>,1000,,,
Cui22,10.1016/j.cell.2022.01.019,Pseudovirus (VSV),Figure 5C,Tixagevimab,Wild Type (B.1),=,2.2,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,6448,ng/ml,1,>,1000,,,
Duty22,10.1016/j.medj.2022.08.002,Pseudovirus (VSV),Table 3,Tixagevimab,Wild Type (B.1),=,6.7,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,469.6,ng/ml,1,=,70.1,,,
Liu21l,10.1038/s41586-021-04388-0,Pseudovirus (VSV),Figure 2d,Tixagevimab,Wild Type (B.1),=,0.2,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,252.7,ng/ml,1,>,1000,,,
Misasi22,10.1101/2022.07.29.502029,Pseudovirus (lentivirus),Figure 1A,Tixagevimab,Wild Type (B.1),=,1.5,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,156.8,ng/ml,1,=,106.6,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Table 1a,Tixagevimab,Wild Type (B.1),=,2,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,385,ng/ml,1,=,192.5,,,
Tuekprakhon22,10.1016/j.cell.2022.06.005,Pseudovirus (lentivirus),Figure 3,Tixagevimab,Wild Type (B),=,1,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,100,ng/ml,1,=,100,,,
Huo22b,10.1016/j.celrep.2022.111903,Pseudovirus (lentivirus),Supplementary Table 1B,Tixagevimab,Wild Type (B),=,1,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,1000,ng/ml,1,=,1000,,,
Ai22,10.1016/j.chom.2022.05.001,Pseudovirus (VSV),Figure 3A,Tixagevimab,Wild Type (B),=,1,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Gruell22b,10.1016/j.chom.2022.07.002,Pseudovirus (HIV),Figure 4B,Tixagevimab,Wild Type (B),=,5,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
FDA21c,https://www.fda.gov/media/154701/download,Pseudovirus,"Feb 2022, Page 17, Antiviral resistance paragraph 5",Tixagevimab,Wild Type (B),,,,,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,,,,,=,460,,,
Iketani22,10.1038/s41586-022-04594-4,Pseudovirus (VSV),Figure 2b,Tixagevimab,Wild Type (B.1),,,,,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,,,,,=,187,,,
Case22,10.1038/s41467-022-31615-7,Virus isolate,Figure 1n,Tixagevimab,Wild Type (B.1),=,5.4,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,686.2,ng/ml,1,=,127.1,,,
Duty22,10.1016/j.medj.2022.08.002,Pseudovirus (VSV),Table 3,Cilgavimab + Tixagevimab,Wild Type (B.1),=,4,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,89.4,ng/ml,1,=,22.4,,,
Misasi22,10.1101/2022.07.29.502029,Pseudovirus (lentivirus),Figure 1B,Cilgavimab + Tixagevimab,Wild Type (B.1),=,2.2,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,63.9,ng/ml,1,=,29,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Table 1a,Cilgavimab + Tixagevimab,Wild Type (B.1),=,2,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,708,ng/ml,1,=,354,,,
Tuekprakhon22,10.1016/j.cell.2022.06.005,Pseudovirus (lentivirus),Figure 3,Cilgavimab + Tixagevimab,Wild Type (B),=,1,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,806,ng/ml,1,=,806,,,
Huo22b,10.1016/j.celrep.2022.111903,Pseudovirus (lentivirus),Supplementary Table 1B,Cilgavimab + Tixagevimab,Wild Type (B),=,1,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,806,ng/ml,1,=,806,,,
EMA21e,https://www.ema.europa.eu/en/documents/product-information/evusheld-epar-product-information_en.pdf,Pseudovirus,Table 3,Cilgavimab + Tixagevimab,Wild Type (B),=,1.9,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,66,ng/ml,1,=,34.7,,,
FDA21c,https://www.fda.gov/media/154701/download,Pseudovirus,"Feb 2022, Table 6, Page 17, Antiviral resistance paragraph 7",Cilgavimab + Tixagevimab,Wild Type (B),,,,,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,,,,,=,424,,,
Case22,10.1038/s41467-022-31615-7,Virus isolate,Figure 1n,Cilgavimab + Tixagevimab,Wild Type (B.1),=,6.5,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,1146.8,ng/ml,1,=,176.4,,,
EMA21e,https://www.ema.europa.eu/en/documents/product-information/evusheld-epar-product-information_en.pdf,Virus isolate,Table 3,Cilgavimab + Tixagevimab,Wild Type (B),=,8,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,1147,ng/ml,1,=,143.4,,,
FDA21c,https://www.fda.gov/media/154701/download,Virus isolate,"Feb 2022, Table 6, Page 17, Antiviral resistance paragraph 7",Cilgavimab + Tixagevimab,Wild Type (B),,,,,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,,,,,=,176,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Sotrovimab,Wild Type (B.1),=,74.1,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,314,ng/ml,1,=,4.2,,,
Cameroni21,10.1038/s41586-021-04386-2,Pseudovirus (VSV),"Figure 3c, Extended Data Table 2",Sotrovimab,Wild Type (B.1),=,90.6,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,209,ng/ml,1,=,2.3,,,
Cao22,10.1101/2022.02.07.479349,Pseudovirus (VSV),Table S2,Sotrovimab,Wild Type (B.1),=,78.3,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,314,ng/ml,1,=,4,,,
Liu21l,10.1038/s41586-021-04388-0,Pseudovirus (VSV),Figure 2d,Sotrovimab,Wild Type (B.1),=,64.3,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,172.4,ng/ml,1,=,2.7,,,
Misasi22,10.1101/2022.07.29.502029,Pseudovirus (lentivirus),Figure 1A,Sotrovimab,Wild Type (B.1),=,84.6,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,208.5,ng/ml,1,=,2.5,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Table 1a,Sotrovimab,Wild Type (B.1),=,14,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,200,ng/ml,1,=,14.3,,,
Tuekprakhon22,10.1016/j.cell.2022.06.005,Pseudovirus (lentivirus),Figure 3,Sotrovimab,Wild Type (B),=,130,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,138,ng/ml,1,=,1.1,,,
Huo22b,10.1016/j.celrep.2022.111903,Pseudovirus (lentivirus),Supplementary Table 1B,Sotrovimab,Wild Type (B),=,79,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,142,ng/ml,1,=,1.8,,,
Ai22,10.1016/j.chom.2022.05.001,Pseudovirus (VSV),Figure 3A,Sotrovimab,Wild Type (B),=,9,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,24,ng/ml,1,=,2.7,,,
Gruell22b,10.1016/j.chom.2022.07.002,Pseudovirus (HIV),Figure 4B,Sotrovimab,Wild Type (B),=,976,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,127,ng/ml,1,=,0.1,,,
Huang22,10.1016/j.immuni.2022.06.005,Pseudovirus (VSV),Figure 2,Sotrovimab,Wild Type (B),=,21,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,86,ng/ml,1,=,4.1,,,
EMA21d,https://www.ema.europa.eu/en/documents/product-information/xevudy-epar-product-information_en.pdf,Pseudovirus,Table 2,Sotrovimab,Wild Type (B),,,,,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,,,,,=,1,,,
FDA21e,https://www.fda.gov/media/149534/download,Pseudovirus,SOT Page 23,Sotrovimab,Wild Type (B),,,,,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,,,,,=,1,,,
Iketani22,10.1038/s41586-022-04594-4,Pseudovirus (VSV),Figure 2b,Sotrovimab,Wild Type (B.1),,,,,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,,,,,=,4.5,,,
Case22,10.1038/s41467-022-31615-7,Virus isolate,Figure 1n,Sotrovimab,Wild Type (B.1),=,185.2,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,717.4,ng/ml,1,=,3.9,,,
Cathcart21,10.1101/2021.03.09.434607,Virus isolate,Table 1,Sotrovimab,Wild Type (A),,,,,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,,,,,=,4.3,,,
FDA21e,https://www.fda.gov/media/149534/download,Virus isolate,SOT Page 23,Sotrovimab,Wild Type (B),,,,,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,,,,,=,1,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Bebtelovimab,Wild Type (B.1),=,0.8,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,1.8,ng/ml,1,=,2.4,,,
Cao22,10.1101/2022.02.07.479349,Pseudovirus (VSV),Table S2,Bebtelovimab,Wild Type (B.1),=,1.5,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,1.8,ng/ml,1,=,1.2,,,
Duty22,10.1016/j.medj.2022.08.002,Pseudovirus (VSV),Table 3,Bebtelovimab,Wild Type (B.1),=,7.4,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,11.1,ng/ml,1,=,1.5,,,
Misasi22,10.1101/2022.07.29.502029,Pseudovirus (lentivirus),Figure 1A,Bebtelovimab,Wild Type (B.1),=,3.3,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,2.7,ng/ml,1,=,0.8,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Table 1a,Bebtelovimab,Wild Type (B.1),=,1,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,2,ng/ml,1,=,2,,,
Huo22b,10.1016/j.celrep.2022.111903,Pseudovirus (lentivirus),Supplementary Table 1B,Bebtelovimab,Wild Type (B),=,1,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,1,ng/ml,1,=,1,,,
Ai22,10.1016/j.chom.2022.05.001,Pseudovirus (VSV),Figure 3A,Bebtelovimab,Wild Type (B),=,1.5,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,0.7,ng/ml,1,=,0.5,,,
Gruell22b,10.1016/j.chom.2022.07.002,Pseudovirus (HIV),Figure 4B,Bebtelovimab,Wild Type (B),=,5,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,5,ng/ml,1,=,1,,,
FDA22,https://www.fda.gov/media/156152/download,Pseudovirus,"Mar 2022, Page 13, antiviral resistance, Table 2",Bebtelovimab,Wild Type (B),,,,,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,,,,,=,1,,,
Iketani22,10.1038/s41586-022-04594-4,Pseudovirus (VSV),Figure 2b,Bebtelovimab,Wild Type (B.1),,,,,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,,,,,=,0.7,,,
FDA22,https://www.fda.gov/media/156152/download,Virus isolate,"Mar 2022, Page 14, antiviral resistance, Table 3",Bebtelovimab,Wild Type (B),,,,,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,,,,,=,1,,,
Misasi22,10.1101/2022.07.29.502029,Pseudovirus (lentivirus),Figure 1A,Regdanvimab,Wild Type (B.1),=,2.8,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10050,ng/ml,1,>,1000,,,
Ai22,10.1016/j.chom.2022.05.001,Pseudovirus (VSV),Figure 3A,Regdanvimab,Wild Type (B),=,1,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Gruell22b,10.1016/j.chom.2022.07.002,Pseudovirus (HIV),Figure 4B,Regdanvimab,Wild Type (B),=,5,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Amubarvimab,Wild Type (B.1),=,53.2,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,6320,ng/ml,1,=,118.8,,,
Cao22,10.1101/2022.02.07.479349,Pseudovirus (VSV),Table S2,Amubarvimab,Wild Type (B.1),=,52.9,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,8320,ng/ml,1,=,157.3,,,
Cui22,10.1016/j.cell.2022.01.019,Pseudovirus (VSV),Figure 5C,Amubarvimab,Wild Type (B.1),=,51.5,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,9619,ng/ml,1,=,186.8,,,
Liu21l,10.1038/s41586-021-04388-0,Pseudovirus (VSV),Figure 2d,Amubarvimab,Wild Type (B.1),=,6.9,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,2034.7,ng/ml,1,=,294.9,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Table 1a,Amubarvimab,Wild Type (B.1),=,18,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,1792,ng/ml,1,=,99.6,,,
Ai22,10.1016/j.chom.2022.05.001,Pseudovirus (VSV),Figure 3A,Amubarvimab,Wild Type (B),=,9,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,3593,ng/ml,1,=,399.2,,,
Gruell22b,10.1016/j.chom.2022.07.002,Pseudovirus (HIV),Figure 4B,Amubarvimab,Wild Type (B),=,8,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,1000,,,
Huang22,10.1016/j.immuni.2022.06.005,Pseudovirus (VSV),Figure 2,Amubarvimab,Wild Type (B),=,39,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,2620,ng/ml,1,=,67.2,,,
Iketani22,10.1038/s41586-022-04594-4,Pseudovirus (VSV),Figure 2b,Amubarvimab,Wild Type (B.1),,,,,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,,,,,=,135,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Romlusevimab,Wild Type (B.1),=,1240,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,8.1,,,
Cao22,10.1101/2022.02.07.479349,Pseudovirus (VSV),Table S2,Romlusevimab,Wild Type (B.1),=,1240,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,8.1,,,
Liu21l,10.1038/s41586-021-04388-0,Pseudovirus (VSV),Figure 2d,Romlusevimab,Wild Type (B.1),=,357.4,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,28,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Table 1a,Romlusevimab,Wild Type (B.1),=,110,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,90.9,,,
Iketani22,10.1038/s41586-022-04594-4,Pseudovirus (VSV),Figure 2b,Romlusevimab,Wild Type (B.1),,,,,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,,,,,>,22,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Table 1a,Amubarvimab + Romlusevimab,Wild Type (B.1),=,22,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,4394,ng/ml,1,=,199.7,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,DXP-604,Wild Type (B.1),=,11,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,198,ng/ml,1,=,18,,,
Huang22,10.1016/j.immuni.2022.06.005,Pseudovirus (VSV),Figure 2,DXP-604,Wild Type (B),=,27,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,49,ng/ml,1,=,1.8,,,
Arora22f,10.1016/S1473-3099(22)00733-2,Pseudovirus (VSV),Figure B,Bamlanivimab,Wild Type (B.1),=,16,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,50000,ng/ml,1,>,1000,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Bamlanivimab,Wild Type (B.1),=,15,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,666.7,,,
Gruell22c,10.1016/S1473-3099(22)00580-1,Pseudovirus,Figure B,Bamlanivimab,Wild Type (B.1),=,5,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Saito22,10.1016/j.chom.2022.10.003,Pseudovirus (lentivirus),Table 1,Bamlanivimab,Wild Type (B.1),=,6.7,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,4725,ng/ml,1,>,705.2,,,
Arora22e,10.1016/S1473-3099(22)00422-4,Pseudovirus (VSV),Supplementary Figure B,Bamlanivimab,Wild Type (B.1),=,11.3,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,5000,ng/ml,1,>,442.5,,,
Cao22c,10.1016/j.chom.2022.09.018,Pseudovirus (VSV),Figure 5b,Bamlanivimab,Wild Type (B.1),=,15,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,666.7,,,
Misasi22,10.1101/2022.07.29.502029,Pseudovirus (lentivirus),Figure 1A,Bamlanivimab,Wild Type (B.1),=,2.8,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10050,ng/ml,1,>,1000,,,
Sheward22b,10.1101/2022.07.19.500716,Pseudovirus (lentivirus),Table S1,Bamlanivimab,Wild Type (B.1),=,7,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,1000,ng/ml,1,>,142.9,,,Some LOD values of 10000 were reported. Corrected to 1000
Sheward22c,10.1101/2022.09.16.508299,Pseudovirus,Figure 1B,Bamlanivimab,Wild Type (B.1),=,9,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,1000,ng/ml,1,>,111.1,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Table 1a,Bamlanivimab,Wild Type (B.1),=,4,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Bamlanivimab,Wild Type (B.1),=,6,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Yamasoba22b,10.1016/S1473-3099(22)00365-6,Pseudovirus (HIV),Table,Bamlanivimab,Wild Type (B.1),=,12.8,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,3700,ng/ml,1,>,289.1,,,
Yamasoba22c,10.1101/2022.07.14.500041,Pseudovirus,Table 1,Bamlanivimab,Wild Type (B.1),=,6.7,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,4725,ng/ml,1,>,705.2,,,
Tuekprakhon22,10.1016/j.cell.2022.06.005,Pseudovirus (lentivirus),Figure 3,Bamlanivimab,Wild Type (B),=,2,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Huo22b,10.1016/j.celrep.2022.111903,Pseudovirus (lentivirus),Supplementary Table 1B,Bamlanivimab,Wild Type (B),=,2,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Chen22e,10.1016/j.celrep.2022.111528,Pseudovirus (lentivirus),Figure 2B,Bamlanivimab,Wild Type (A),=,3,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Gruell22b,10.1016/j.chom.2022.07.002,Pseudovirus (HIV),Figure 4B,Bamlanivimab,Wild Type (B),=,5,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Arora22f,10.1016/S1473-3099(22)00733-2,Pseudovirus (VSV),Figure B,Etesevimab,Wild Type (B.1),=,53,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,50000,ng/ml,1,>,943.4,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Etesevimab,Wild Type (B.1),=,32,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,312.5,,,
Gruell22c,10.1016/S1473-3099(22)00580-1,Pseudovirus,Figure B,Etesevimab,Wild Type (B.1),=,30,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,333.3,,,
Saito22,10.1016/j.chom.2022.10.003,Pseudovirus (lentivirus),Table 1,Etesevimab,Wild Type (B.1),=,12,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,4600,ng/ml,1,>,383.3,,,
Arora22e,10.1016/S1473-3099(22)00422-4,Pseudovirus (VSV),Supplementary Figure B,Etesevimab,Wild Type (B.1),=,22.2,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,5000,ng/ml,1,>,225.2,,,
Cao22c,10.1016/j.chom.2022.09.018,Pseudovirus (VSV),Figure 5b,Etesevimab,Wild Type (B.1),=,32,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,312.5,,,
Misasi22,10.1101/2022.07.29.502029,Pseudovirus (lentivirus),Figure 1A,Etesevimab,Wild Type (B.1),=,23.3,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10050,ng/ml,1,>,432.3,,,
Sheward22b,10.1101/2022.07.19.500716,Pseudovirus (lentivirus),Table S1,Etesevimab,Wild Type (B.1),=,34,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,1000,ng/ml,1,>,29.4,,,Some LOD values of 10000 were reported. Corrected to 1000
Sheward22c,10.1101/2022.09.16.508299,Pseudovirus,Figure 1B,Etesevimab,Wild Type (B.1),=,29,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,1000,ng/ml,1,>,34.5,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Table 1a,Etesevimab,Wild Type (B.1),=,12,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,833.3,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Etesevimab,Wild Type (B.1),=,9,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Yamasoba22b,10.1016/S1473-3099(22)00365-6,Pseudovirus (HIV),Table,Etesevimab,Wild Type (B.1),=,12,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,6050,ng/ml,1,>,504.2,,,
Yamasoba22c,10.1101/2022.07.14.500041,Pseudovirus,Table 1,Etesevimab,Wild Type (B.1),=,12,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,4600,ng/ml,1,>,383.3,,,
Tuekprakhon22,10.1016/j.cell.2022.06.005,Pseudovirus (lentivirus),Figure 3,Etesevimab,Wild Type (B),=,14,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,714.3,,,
Huo22b,10.1016/j.celrep.2022.111903,Pseudovirus (lentivirus),Supplementary Table 1B,Etesevimab,Wild Type (B),=,14,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,714.3,,,
Chen22e,10.1016/j.celrep.2022.111528,Pseudovirus (lentivirus),Figure 2B,Etesevimab,Wild Type (A),=,19,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,526.3,,,
Gruell22b,10.1016/j.chom.2022.07.002,Pseudovirus (HIV),Figure 4B,Etesevimab,Wild Type (B),=,18,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,555.6,,,
Arora22f,10.1016/S1473-3099(22)00733-2,Pseudovirus (VSV),Figure B,Bamlanivimab + Etesevimab,Wild Type (B.1),=,18,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,50000,ng/ml,1,>,1000,,,
Saito22,10.1016/j.chom.2022.10.003,Pseudovirus (lentivirus),Table 1,Bamlanivimab + Etesevimab,Wild Type (B.1),=,8.3,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,4600,ng/ml,1,>,554.2,,,
Arora22e,10.1016/S1473-3099(22)00422-4,Pseudovirus (VSV),Supplementary Figure B,Bamlanivimab + Etesevimab,Wild Type (B.1),=,16.9,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,5000,ng/ml,1,>,295.9,,,
Cao22c,10.1016/j.chom.2022.09.018,Pseudovirus (VSV),Figure 5b,Bamlanivimab + Etesevimab,Wild Type (B.1),=,20,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,500,,,
Misasi22,10.1101/2022.07.29.502029,Pseudovirus (lentivirus),Figure 1B,Bamlanivimab + Etesevimab,Wild Type (B.1),=,5.6,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10050,ng/ml,1,>,1000,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Table 1a,Bamlanivimab + Etesevimab,Wild Type (B.1),=,5,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Bamlanivimab + Etesevimab,Wild Type (B.1),=,6,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Yamasoba22b,10.1016/S1473-3099(22)00365-6,Pseudovirus (HIV),Table,Bamlanivimab + Etesevimab,Wild Type (B.1),=,6.7,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,3700,ng/ml,1,>,552.2,,,
Yamasoba22c,10.1101/2022.07.14.500041,Pseudovirus,Table 1,Bamlanivimab + Etesevimab,Wild Type (B.1),=,8.3,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,4600,ng/ml,1,>,554.2,,,
Chen22e,10.1016/j.celrep.2022.111528,Pseudovirus (lentivirus),Figure 2C,Bamlanivimab + Etesevimab,Wild Type (A),=,1.5,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Park22,10.1126/science.adc9127,Pseudovirus (VSV),Fig 1A,Bamlanivimab + Etesevimab,Wild Type (B),=,17,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,588.2,,,
Arora22f,10.1016/S1473-3099(22)00733-2,Pseudovirus (VSV),Figure B,Casirivimab,Wild Type (B.1),=,21,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,50000,ng/ml,1,>,1000,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Casirivimab,Wild Type (B.1),=,5.6,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Gruell22c,10.1016/S1473-3099(22)00580-1,Pseudovirus,Figure B,Casirivimab,Wild Type (B.1),=,5,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Saito22,10.1016/j.chom.2022.10.003,Pseudovirus (lentivirus),Table 1,Casirivimab,Wild Type (B.1),=,3.4,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,5042,ng/ml,1,>,1000,,,
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Casirivimab,Omicron/BA.2,>,10000,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Arora22e,10.1016/S1473-3099(22)00422-4,Pseudovirus (VSV),Supplementary Figure B,Casirivimab,Wild Type (B.1),=,12.1,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,5000,ng/ml,1,>,413.2,,,
Cao22c,10.1016/j.chom.2022.09.018,Pseudovirus (VSV),Figure 5b,Casirivimab,Wild Type (B.1),=,5.6,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Misasi22,10.1101/2022.07.29.502029,Pseudovirus (lentivirus),Figure 1A,Casirivimab,Wild Type (B.1),=,5.3,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10050,ng/ml,1,>,1000,,,
Sheward22b,10.1101/2022.07.19.500716,Pseudovirus (lentivirus),Table S1,Casirivimab,Wild Type (B.1),=,11,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,1000,ng/ml,1,>,90.9,,,Some LOD values of 10000 were reported. Corrected to 1000
Sheward22c,10.1101/2022.09.16.508299,Pseudovirus,Figure 1B,Casirivimab,Wild Type (B.1),=,14,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,1000,ng/ml,1,>,71.4,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Table 1a,Casirivimab,Wild Type (B.1),=,5,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Casirivimab,Wild Type (B.1),=,3,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Willett22,10.1101/2022.05.25.493397,Pseudovirus (lentivirus),Figure 1L,Casirivimab,Wild Type (B.1),=,3,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,25000,ng/ml,1,>,1000,,,
Yamasoba22b,10.1016/S1473-3099(22)00365-6,Pseudovirus (HIV),Table,Casirivimab,Wild Type (B.1),=,9.9,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,50417,ng/ml,1,>,1000,,,
Yamasoba22c,10.1101/2022.07.14.500041,Pseudovirus,Table 1,Casirivimab,Wild Type (B.1),=,3.4,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,5042,ng/ml,1,>,1000,,,
Tuekprakhon22,10.1016/j.cell.2022.06.005,Pseudovirus (lentivirus),Figure 3,Casirivimab,Wild Type (B),=,1,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Huo22b,10.1016/j.celrep.2022.111903,Pseudovirus (lentivirus),Supplementary Table 1B,Casirivimab,Wild Type (B),=,1,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Chen22e,10.1016/j.celrep.2022.111528,Pseudovirus (lentivirus),Figure 2B,Casirivimab,Wild Type (A),=,2,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Gruell22b,10.1016/j.chom.2022.07.002,Pseudovirus (HIV),Figure 4B,Casirivimab,Wild Type (B),=,5,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Touret22c,10.1101/2022.12.22.521201,Virus isolate,Table 1,Casirivimab,Delta,=,14.7,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,5000,ng/ml,1,>,340.1,,,
Planas22b,10.1101/2022.11.17.516888,Virus isolate,Figure 3b,Casirivimab,Wild Type (B.1),=,1.7,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Takashita22c,10.1056/NEJMc2207519,Virus isolate,Table 1,Casirivimab,Wild Type (A),=,6.1,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,50000,ng/ml,1,>,1000,,,
Takashita22d,10.1056/NEJMc2209952,Virus isolate,Table 1,Casirivimab,Wild Type (A),=,2.4,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,50000,ng/ml,1,>,1000,,,
Arora22f,10.1016/S1473-3099(22)00733-2,Pseudovirus (VSV),Figure B,Imdevimab,Wild Type (B.1),=,19,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,994,ng/ml,1,=,52.3,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Imdevimab,Wild Type (B.1),=,5.7,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,520,ng/ml,1,=,90.8,,,
Gruell22c,10.1016/S1473-3099(22)00580-1,Pseudovirus,Figure B,Imdevimab,Wild Type (B.1),=,5,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,2438,ng/ml,1,=,487.6,,,
Saito22,10.1016/j.chom.2022.10.003,Pseudovirus (lentivirus),Table 1,Imdevimab,Wild Type (B.1),=,8,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,5000,ng/ml,1,>,625,,,
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Imdevimab,Omicron/BA.2,=,590,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,520,ng/ml,1,=,0.9,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Arora22e,10.1016/S1473-3099(22)00422-4,Pseudovirus (VSV),Supplementary Figure B,Imdevimab,Wild Type (B.1),=,11.8,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,844,ng/ml,1,=,71.5,,,
Cao22c,10.1016/j.chom.2022.09.018,Pseudovirus (VSV),Figure 5b,Imdevimab,Wild Type (B.1),=,5.7,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,520,ng/ml,1,=,91.2,,,
Misasi22,10.1101/2022.07.29.502029,Pseudovirus (lentivirus),Figure 1A,Imdevimab,Wild Type (B.1),=,10.8,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,5888.4,ng/ml,1,=,546.7,,,
Sheward22b,10.1101/2022.07.19.500716,Pseudovirus (lentivirus),Table S1,Imdevimab,Wild Type (B.1),=,7,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,1000,ng/ml,1,>,142.9,,,Some LOD values of 10000 were reported. Corrected to 1000
Sheward22c,10.1101/2022.09.16.508299,Pseudovirus,Figure 1B,Imdevimab,Wild Type (B.1),=,10,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,1000,ng/ml,1,>,100,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Table 1a,Imdevimab,Wild Type (B.1),=,1,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,2682,ng/ml,1,>,1000,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Imdevimab,Wild Type (B.1),=,3,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1230,ng/ml,1,=,410,,,
Willett22,10.1101/2022.05.25.493397,Pseudovirus (lentivirus),Figure 1L,Imdevimab,Wild Type (B.1),=,2,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1487,ng/ml,1,=,743.5,,,
Yamasoba22b,10.1016/S1473-3099(22)00365-6,Pseudovirus (HIV),Table,Imdevimab,Wild Type (B.1),=,79,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,50000,ng/ml,1,>,632.9,,,
Yamasoba22c,10.1101/2022.07.14.500041,Pseudovirus,Table 1,Imdevimab,Wild Type (B.1),=,8,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,5000,ng/ml,1,>,625,,,
Tuekprakhon22,10.1016/j.cell.2022.06.005,Pseudovirus (lentivirus),Figure 3,Imdevimab,Wild Type (B),=,2,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Huo22b,10.1016/j.celrep.2022.111903,Pseudovirus (lentivirus),Supplementary Table 1B,Imdevimab,Wild Type (B),=,2,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Chen22e,10.1016/j.celrep.2022.111528,Pseudovirus (lentivirus),Figure 2B,Imdevimab,Wild Type (A),=,9,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,358,ng/ml,1,=,39.8,,,
Gruell22b,10.1016/j.chom.2022.07.002,Pseudovirus (HIV),Figure 4B,Imdevimab,Wild Type (B),=,5,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,3392,ng/ml,1,=,678.4,,,
Touret22c,10.1101/2022.12.22.521201,Virus isolate,Table 1,Imdevimab,Delta,=,20.1,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,254.4,ng/ml,1,=,12.7,,,
Planas22b,10.1101/2022.11.17.516888,Virus isolate,Figure 3b,Imdevimab,Wild Type (B.1),=,2.1,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,208,ng/ml,1,=,99,,,
Takashita22c,10.1056/NEJMc2207519,Virus isolate,Table 1,Imdevimab,Wild Type (A),=,7.4,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,583.4,ng/ml,1,=,78.8,,,
Takashita22d,10.1056/NEJMc2209952,Virus isolate,Table 1,Imdevimab,Wild Type (A),=,4.4,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,174.4,ng/ml,1,=,40,,,
Arora22f,10.1016/S1473-3099(22)00733-2,Pseudovirus (VSV),Figure B,Casirivimab + Imdevimab,Wild Type (B.1),=,9,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,2611,ng/ml,1,=,290.1,,,
Saito22,10.1016/j.chom.2022.10.003,Pseudovirus (lentivirus),Table 1,Casirivimab + Imdevimab,Wild Type (B.1),=,3.9,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,5000,ng/ml,1,>,1000,,,
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Casirivimab + Imdevimab,Omicron/BA.2,=,821,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,709,ng/ml,1,=,0.9,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Arora22e,10.1016/S1473-3099(22)00422-4,Pseudovirus (VSV),Supplementary Figure B,Casirivimab + Imdevimab,Wild Type (B.1),=,6.6,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,966,ng/ml,1,=,146.4,,,
Cao22c,10.1016/j.chom.2022.09.018,Pseudovirus (VSV),Figure 5b,Casirivimab + Imdevimab,Wild Type (B.1),=,5,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,709,ng/ml,1,=,141.8,,,
Misasi22,10.1101/2022.07.29.502029,Pseudovirus (lentivirus),Figure 1B,Casirivimab + Imdevimab,Wild Type (B.1),=,3.4,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1469.3,ng/ml,1,=,431.5,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Table 1a,Casirivimab + Imdevimab,Wild Type (B.1),=,1,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1998,ng/ml,1,>,1000,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Casirivimab + Imdevimab,Wild Type (B.1),=,3,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,2779,ng/ml,1,=,926.3,,,
Yamasoba22b,10.1016/S1473-3099(22)00365-6,Pseudovirus (HIV),Table,Casirivimab + Imdevimab,Wild Type (B.1),=,6.2,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,2400,ng/ml,1,>,387.1,,,
Yamasoba22c,10.1101/2022.07.14.500041,Pseudovirus,Table 1,Casirivimab + Imdevimab,Wild Type (B.1),=,3.9,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,5000,ng/ml,1,>,1000,,,
Chen22e,10.1016/j.celrep.2022.111528,Pseudovirus (lentivirus),Figure 2C,Casirivimab + Imdevimab,Wild Type (A),=,0.9,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,334,ng/ml,1,=,371.1,,,
Park22,10.1126/science.adc9127,Pseudovirus (VSV),Fig 1A,Casirivimab + Imdevimab,Wild Type (B),=,5,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Planas22b,10.1101/2022.11.17.516888,Virus isolate,Figure 3b,Casirivimab + Imdevimab,Wild Type (B.1),=,1.6,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,700,ng/ml,1,=,437.5,,,
Takashita22c,10.1056/NEJMc2207519,Virus isolate,Table 1,Casirivimab + Imdevimab,Wild Type (A),=,6.8,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,2186.2,ng/ml,1,=,321.5,,,Combination therapies in this study were specified at ng/ml of each component so needs to multiply by 2
Takashita22d,10.1056/NEJMc2209952,Virus isolate,Table 1,Casirivimab + Imdevimab,Wild Type (A),=,4.4,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,385.8,ng/ml,1,=,86.5,,,Combination therapies in this study were specified at ng/ml of each component so needs to multiply by 2
Turelli22b,10.1101/2022.07.28.501852,Virus isolate,Table 2,Casirivimab + Imdevimab,Omicron/BA.4,=,2000,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,2800,ng/ml,1,=,1.4,,,
Touret22b,10.1038/s41598-022-16964-z,Virus isolate,Table 1,Cilgavimab,Wild Type (B.1),=,19.2,ng/ml,1,Omicron/BA.5,5,L5F + T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,23.5,ng/ml,1,=,1.2,,,
Arora22f,10.1016/S1473-3099(22)00733-2,Pseudovirus (VSV),Figure B,Cilgavimab,Wild Type (B.1),=,37,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,88,ng/ml,1,=,2.4,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Cilgavimab,Wild Type (B.1),=,2.5,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,23.4,ng/ml,1,=,9.4,,,
Gruell22c,10.1016/S1473-3099(22)00580-1,Pseudovirus,Figure B,Cilgavimab,Wild Type (B.1),=,5,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,94,ng/ml,1,=,18.8,,,
Saito22,10.1016/j.chom.2022.10.003,Pseudovirus (lentivirus),Table 1,Cilgavimab,Wild Type (B.1),=,14,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,305,ng/ml,1,=,21.8,,,
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Cilgavimab,Omicron/BA.2,=,6.3,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,23,ng/ml,1,=,3.7,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Arora22e,10.1016/S1473-3099(22)00422-4,Pseudovirus (VSV),Supplementary Figure B,Cilgavimab,Wild Type (B.1),=,21.7,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,83.4,ng/ml,1,=,3.8,,,
Cao22c,10.1016/j.chom.2022.09.018,Pseudovirus (VSV),Figure 5b,Cilgavimab,Wild Type (B.1),=,2.5,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,23,ng/ml,1,=,9.2,,,
Misasi22,10.1101/2022.07.29.502029,Pseudovirus (lentivirus),Figure 1A,Cilgavimab,Wild Type (B.1),=,4.6,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,47.4,ng/ml,1,=,10.3,,,
Sheward22b,10.1101/2022.07.19.500716,Pseudovirus (lentivirus),Table S1,Cilgavimab,Wild Type (B.1),=,6,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,86,ng/ml,1,=,14.3,,,Some LOD values of 10000 were reported. Corrected to 1000
Sheward22c,10.1101/2022.09.16.508299,Pseudovirus,Figure 1B,Cilgavimab,Wild Type (B.1),=,12,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,71,ng/ml,1,=,5.9,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Table 1a,Cilgavimab,Wild Type (B.1),=,6,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,22,ng/ml,1,=,3.7,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Cilgavimab,Wild Type (B.1),=,10,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,25,ng/ml,1,=,2.5,,,
Wang22j,10.1016/S1473-3099(22)00694-6,Pseudovirus (VSV),Figure S3,Cilgavimab,Wild Type (B.1),=,8,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,61,ng/ml,1,=,7.6,,,
Wang22l,10.1101/2022.11.23.517532,Pseudovirus,Figure S2,Cilgavimab,Wild Type (B.1),=,7,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,21,ng/ml,1,=,3,,,
Yamasoba22b,10.1016/S1473-3099(22)00365-6,Pseudovirus (HIV),Table,Cilgavimab,Wild Type (B.1),=,21,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,443,ng/ml,1,=,21.1,,,
Yamasoba22c,10.1101/2022.07.14.500041,Pseudovirus,Table 1,Cilgavimab,Wild Type (B.1),=,14,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,305,ng/ml,1,=,21.8,,,
Tuekprakhon22,10.1016/j.cell.2022.06.005,Pseudovirus (lentivirus),Figure 3,Cilgavimab,Wild Type (B),=,2,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,15,ng/ml,1,=,7.5,,,
Huo22b,10.1016/j.celrep.2022.111903,Pseudovirus (lentivirus),Supplementary Table 1B,Cilgavimab,Wild Type (B),=,2,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,15,ng/ml,1,=,7.5,,,
Chen22e,10.1016/j.celrep.2022.111528,Pseudovirus (lentivirus),Figure 2B,Cilgavimab,Wild Type (A),=,1,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,40,ng/ml,1,=,40,,,
Gruell22b,10.1016/j.chom.2022.07.002,Pseudovirus (HIV),Figure 4B,Cilgavimab,Wild Type (B),=,5,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,85,ng/ml,1,=,17,,,
Park22,10.1126/science.adc9127,Pseudovirus (VSV),Fig 1A,Cilgavimab,Wild Type (B),=,6,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,62,ng/ml,1,=,10.3,,,
Aggarwal22b,10.1016/j.ebiom.2022.104270,Virus isolate,Figure 1,Cilgavimab,Wild Type (A.2.2),=,29,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,144,ng/ml,1,=,5,,,
Touret22c,10.1101/2022.12.22.521201,Virus isolate,Table 1,Cilgavimab,Delta,=,21.7,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,147.4,ng/ml,1,=,6.8,,,
Planas22b,10.1101/2022.11.17.516888,Virus isolate,Figure 3b,Cilgavimab,Wild Type (B.1),=,2.9,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,11,ng/ml,1,=,3.8,,,
Takashita22c,10.1056/NEJMc2207519,Virus isolate,Table 1,Cilgavimab,Wild Type (A),=,7,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,56.8,ng/ml,1,=,8.1,,,
Takashita22d,10.1056/NEJMc2209952,Virus isolate,Table 1,Cilgavimab,Wild Type (A),=,5.4,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,54,ng/ml,1,=,10.1,,,
Turelli22b,10.1101/2022.07.28.501852,Virus isolate,Table 2,Cilgavimab,Omicron/BA.4,=,121,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,143,ng/ml,1,=,1.2,,,
Touret22b,10.1038/s41598-022-16964-z,Virus isolate,Table 1,Tixagevimab,Wild Type (B.1),=,18.3,ng/ml,1,Omicron/BA.5,5,L5F + T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,5000,ng/ml,1,>,273.2,,,
Arora22f,10.1016/S1473-3099(22)00733-2,Pseudovirus (VSV),Figure B,Tixagevimab,Wild Type (B.1),=,7,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,10090,ng/ml,1,>,1000,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Tixagevimab,Wild Type (B.1),=,1.6,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Gruell22c,10.1016/S1473-3099(22)00580-1,Pseudovirus,Figure B,Tixagevimab,Wild Type (B.1),=,5,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Saito22,10.1016/j.chom.2022.10.003,Pseudovirus (lentivirus),Table 1,Tixagevimab,Wild Type (B.1),=,1.5,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,4375,ng/ml,1,>,1000,,,
Arora22e,10.1016/S1473-3099(22)00422-4,Pseudovirus (VSV),Supplementary Figure B,Tixagevimab,Wild Type (B.1),=,5.1,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,5000,ng/ml,1,>,980.4,,,
Cao22c,10.1016/j.chom.2022.09.018,Pseudovirus (VSV),Figure 5b,Tixagevimab,Wild Type (B.1),=,1.6,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Misasi22,10.1101/2022.07.29.502029,Pseudovirus (lentivirus),Figure 1A,Tixagevimab,Wild Type (B.1),=,1.5,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10050,ng/ml,1,>,1000,,,
Sheward22b,10.1101/2022.07.19.500716,Pseudovirus (lentivirus),Table S1,Tixagevimab,Wild Type (B.1),=,4,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,1000,ng/ml,1,>,1000,,,Some LOD values of 10000 were reported. Corrected to 1000
Sheward22c,10.1101/2022.09.16.508299,Pseudovirus,Figure 1B,Tixagevimab,Wild Type (B.1),=,4,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,1000,ng/ml,1,>,250,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Table 1a,Tixagevimab,Wild Type (B.1),=,2,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Tixagevimab,Wild Type (B.1),=,3,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Wang22j,10.1016/S1473-3099(22)00694-6,Pseudovirus (VSV),Figure S3,Tixagevimab,Wild Type (B.1),=,3,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Wang22l,10.1101/2022.11.23.517532,Pseudovirus,Figure S2,Tixagevimab,Wild Type (B.1),=,2,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Yamasoba22b,10.1016/S1473-3099(22)00365-6,Pseudovirus (HIV),Table,Tixagevimab,Wild Type (B.1),=,6.7,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,2750,ng/ml,1,>,410.4,,,
Yamasoba22c,10.1101/2022.07.14.500041,Pseudovirus,Table 1,Tixagevimab,Wild Type (B.1),=,1.5,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,4375,ng/ml,1,>,1000,,,
Tuekprakhon22,10.1016/j.cell.2022.06.005,Pseudovirus (lentivirus),Figure 3,Tixagevimab,Wild Type (B),=,1,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Huo22b,10.1016/j.celrep.2022.111903,Pseudovirus (lentivirus),Supplementary Table 1B,Tixagevimab,Wild Type (B),=,1,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Chen22e,10.1016/j.celrep.2022.111528,Pseudovirus (lentivirus),Figure 2B,Tixagevimab,Wild Type (A),=,1,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Gruell22b,10.1016/j.chom.2022.07.002,Pseudovirus (HIV),Figure 4B,Tixagevimab,Wild Type (B),=,5,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Park22,10.1126/science.adc9127,Pseudovirus (VSV),Fig 1A,Tixagevimab,Wild Type (B),=,2,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Aggarwal22b,10.1016/j.ebiom.2022.104270,Virus isolate,Figure 1,Tixagevimab,Wild Type (A.2.2),=,9,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Touret22c,10.1101/2022.12.22.521201,Virus isolate,Table 1,Tixagevimab,Delta,=,12.4,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,5000,ng/ml,1,>,403.2,,,
Planas22b,10.1101/2022.11.17.516888,Virus isolate,Figure 3b,Tixagevimab,Wild Type (B.1),=,1.3,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Takashita22c,10.1056/NEJMc2207519,Virus isolate,Table 1,Tixagevimab,Wild Type (A),=,6.1,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,50000,ng/ml,1,>,1000,,,
Takashita22d,10.1056/NEJMc2209952,Virus isolate,Table 1,Tixagevimab,Wild Type (A),=,1.9,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,50000,ng/ml,1,>,1000,,,
Touret22b,10.1038/s41598-022-16964-z,Virus isolate,Table 1,Cilgavimab + Tixagevimab,Wild Type (B.1),=,20.2,ng/ml,1,Omicron/BA.5,5,L5F + T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,56.6,ng/ml,1,=,2.8,,,
Arora22f,10.1016/S1473-3099(22)00733-2,Pseudovirus (VSV),Figure B,Cilgavimab + Tixagevimab,Wild Type (B.1),=,7,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,155,ng/ml,1,=,22.1,,,
Saito22,10.1016/j.chom.2022.10.003,Pseudovirus (lentivirus),Table 1,Cilgavimab + Tixagevimab,Wild Type (B.1),=,4.7,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,586,ng/ml,1,=,124.7,,,
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Cilgavimab + Tixagevimab,Omicron/BA.2,=,8.2,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,40,ng/ml,1,=,4.9,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Arora22e,10.1016/S1473-3099(22)00422-4,Pseudovirus (VSV),Supplementary Figure B,Cilgavimab + Tixagevimab,Wild Type (B.1),=,7.6,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,117,ng/ml,1,=,15.4,,,
Cao22c,10.1016/j.chom.2022.09.018,Pseudovirus (VSV),Figure 5b,Cilgavimab + Tixagevimab,Wild Type (B.1),=,2.1,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,40,ng/ml,1,=,19,,,
Misasi22,10.1101/2022.07.29.502029,Pseudovirus (lentivirus),Figure 1B,Cilgavimab + Tixagevimab,Wild Type (B.1),=,2.2,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,47.1,ng/ml,1,=,21.4,,,
Sheward22c,10.1101/2022.09.16.508299,Pseudovirus,Figure 1B,Cilgavimab + Tixagevimab,Wild Type (B.1),=,6,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,120,ng/ml,1,=,20,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Table 1a,Cilgavimab + Tixagevimab,Wild Type (B.1),=,2,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,49,ng/ml,1,=,24.5,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Cilgavimab + Tixagevimab,Wild Type (B.1),=,2,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,68,ng/ml,1,=,34,,,
Wang22j,10.1016/S1473-3099(22)00694-6,Pseudovirus (VSV),Figure S3,Cilgavimab + Tixagevimab,Wild Type (B.1),=,3,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,74,ng/ml,1,=,24.7,,,
Wang22l,10.1101/2022.11.23.517532,Pseudovirus,Figure S2,Cilgavimab + Tixagevimab,Wild Type (B.1),=,3,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,35,ng/ml,1,=,11.7,,,
Yamasoba22b,10.1016/S1473-3099(22)00365-6,Pseudovirus (HIV),Table,Cilgavimab + Tixagevimab,Wild Type (B.1),=,4.1,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,609,ng/ml,1,=,148.5,,,
Yamasoba22c,10.1101/2022.07.14.500041,Pseudovirus,Table 1,Cilgavimab + Tixagevimab,Wild Type (B.1),=,4.7,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,586,ng/ml,1,=,124.7,,,
Tuekprakhon22,10.1016/j.cell.2022.06.005,Pseudovirus (lentivirus),Figure 3,Cilgavimab + Tixagevimab,Wild Type (B),=,1,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,65,ng/ml,1,=,65,,,
Huo22b,10.1016/j.celrep.2022.111903,Pseudovirus (lentivirus),Supplementary Table 1B,Cilgavimab + Tixagevimab,Wild Type (B),=,1,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,65,ng/ml,1,=,65,,,
Chen22e,10.1016/j.celrep.2022.111528,Pseudovirus (lentivirus),Figure 2C,Cilgavimab + Tixagevimab,Wild Type (A),=,0.7,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,35,ng/ml,1,=,50,,,
Park22,10.1126/science.adc9127,Pseudovirus (VSV),Fig 1A,Cilgavimab + Tixagevimab,Wild Type (B),=,2,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,122,ng/ml,1,=,61,,,
Aggarwal22b,10.1016/j.ebiom.2022.104270,Virus isolate,Figure 1,Cilgavimab + Tixagevimab,Wild Type (A.2.2),=,16,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,224,ng/ml,1,=,14,,,
Touret22c,10.1101/2022.12.22.521201,Virus isolate,Table 1,Cilgavimab + Tixagevimab,Delta,=,12.5,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,265.4,ng/ml,1,=,21.2,,,
Planas22b,10.1101/2022.11.17.516888,Virus isolate,Figure 3b,Cilgavimab + Tixagevimab,Wild Type (B.1),=,1.3,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,22.6,ng/ml,1,=,17.4,,,
Takashita22c,10.1056/NEJMc2207519,Virus isolate,Table 1,Cilgavimab + Tixagevimab,Wild Type (A),=,12.6,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,385,ng/ml,1,=,30.6,,,Combination therapies in this study were specified at ng/ml of each component so needs to multiply by 2
Takashita22d,10.1056/NEJMc2209952,Virus isolate,Table 1,Cilgavimab + Tixagevimab,Wild Type (A),=,13,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,247.4,ng/ml,1,=,19.1,,,Combination therapies in this study were specified at ng/ml of each component so needs to multiply by 2
Turelli22b,10.1101/2022.07.28.501852,Virus isolate,Table 2,Cilgavimab + Tixagevimab,Omicron/BA.4,=,249,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,281,ng/ml,1,=,1.1,,,
Touret22b,10.1038/s41598-022-16964-z,Virus isolate,Table 1,Sotrovimab,Wild Type (B.1),=,46,ng/ml,1,Omicron/BA.5,5,L5F + T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,858.2,ng/ml,1,=,18.7,,,
Park22,10.1126/science.adc9127,Virus isolate,Fig S12A,Sotrovimab,Wild Type (B),=,49.8,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + T76I + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1001.2,ng/ml,1,=,20.1,,,
Arora22f,10.1016/S1473-3099(22)00733-2,Pseudovirus (VSV),Figure B,Sotrovimab,Wild Type (B.1),=,157,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,5554,ng/ml,1,=,35.4,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Sotrovimab,Wild Type (B.1),=,74.1,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,792,ng/ml,1,=,10.7,,,
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Sotrovimab,Omicron/BA.2,=,852,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1055,ng/ml,1,>,1.2,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Gruell22c,10.1016/S1473-3099(22)00580-1,Pseudovirus,Figure B,Sotrovimab,Wild Type (B.1),=,28,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,4309,ng/ml,1,=,153.9,,,
Saito22,10.1016/j.chom.2022.10.003,Pseudovirus (lentivirus),Table 1,Sotrovimab,Wild Type (B.1),=,47,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1149,ng/ml,1,=,24.4,,,
Arora22e,10.1016/S1473-3099(22)00422-4,Pseudovirus (VSV),Supplementary Figure B,Sotrovimab,Wild Type (B.1),=,77.5,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,3840,ng/ml,1,=,49.5,,,
Cao22c,10.1016/j.chom.2022.09.018,Pseudovirus (VSV),Figure 5b,Sotrovimab,Wild Type (B.1),=,74,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,792,ng/ml,1,=,10.7,,,
Misasi22,10.1101/2022.07.29.502029,Pseudovirus (lentivirus),Figure 1A,Sotrovimab,Wild Type (B.1),=,84.6,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1534.8,ng/ml,1,=,18.1,,,
Park22,10.1126/science.adc9127,Pseudovirus (VSV),Fig 1A,Sotrovimab,Wild Type,=,61.7,ng/ml,1.1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,2,=,1603,ng/ml,1,=,26.1,24.7,27.6,
Sheward22b,10.1101/2022.07.19.500716,Pseudovirus (lentivirus),Table S1,Sotrovimab,Wild Type (B.1),=,78,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,1000,ng/ml,1,>,12.8,,,Some LOD values of 10000 were reported. Corrected to 1000
Sheward22c,10.1101/2022.09.16.508299,Pseudovirus,Figure 1B,Sotrovimab,Wild Type (B.1),=,119,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,559,ng/ml,1,=,4.7,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Table 1a,Sotrovimab,Wild Type (B.1),=,14,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1120,ng/ml,1,=,80,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Sotrovimab,Wild Type (B.1),=,25,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,669,ng/ml,1,=,26.8,,,
Wang22j,10.1016/S1473-3099(22)00694-6,Pseudovirus (VSV),Figure S3,Sotrovimab,Wild Type (B.1),=,66,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,2534,ng/ml,1,=,38.4,,,
Wang22l,10.1101/2022.11.23.517532,Pseudovirus,Figure S2,Sotrovimab,Wild Type (B.1),=,23,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,514,ng/ml,1,=,22.3,,,
Willett22,10.1101/2022.05.25.493397,Pseudovirus (lentivirus),Figure 1L,Sotrovimab,Wild Type (B.1),=,3,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,142,ng/ml,1,=,47.3,,,
Yamasoba22b,10.1016/S1473-3099(22)00365-6,Pseudovirus (HIV),Table,Sotrovimab,Wild Type (B.1),=,94,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1261,ng/ml,1,=,13.4,,,
Yamasoba22c,10.1101/2022.07.14.500041,Pseudovirus,Table 1,Sotrovimab,Wild Type (B.1),=,47,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1149,ng/ml,1,=,24.4,,,
Tuekprakhon22,10.1016/j.cell.2022.06.005,Pseudovirus (lentivirus),Figure 3,Sotrovimab,Wild Type (B),=,130,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1041,ng/ml,1,=,8,,,
Huo22b,10.1016/j.celrep.2022.111903,Pseudovirus (lentivirus),Supplementary Table 1B,Sotrovimab,Wild Type (B),=,79,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,689,ng/ml,1,=,8.7,,,
Chen22e,10.1016/j.celrep.2022.111528,Pseudovirus (lentivirus),Figure 2B,Sotrovimab,Wild Type (A),=,184,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1732,ng/ml,1,=,9.4,,,
Gruell22b,10.1016/j.chom.2022.07.002,Pseudovirus (HIV),Figure 4B,Sotrovimab,Wild Type (B),=,976,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,3671,ng/ml,1,=,3.8,,,
EMA21d,https://www.ema.europa.eu/en/documents/product-information/xevudy-epar-product-information_en.pdf,Pseudovirus,Table 2,Sotrovimab,Wild Type (B),,,,,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,,,,,=,21.3,,,
Aggarwal22b,10.1016/j.ebiom.2022.104270,Virus isolate,Figure 1,Sotrovimab,Wild Type (A.2.2),=,384,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,6429,ng/ml,1,=,16.7,,,
Touret22c,10.1101/2022.12.22.521201,Virus isolate,Table 1,Sotrovimab,Delta,=,98.6,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,596.5,ng/ml,1,=,6,,,
Planas22b,10.1101/2022.11.17.516888,Virus isolate,Figure 3b,Sotrovimab,Wild Type (B.1),=,65,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1088,ng/ml,1,=,16.7,,,
Takashita22c,10.1056/NEJMc2207519,Virus isolate,Table 1,Sotrovimab,Wild Type (A),=,95.1,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,50000,ng/ml,1,>,525.8,,,
Takashita22d,10.1056/NEJMc2209952,Virus isolate,Table 1,Sotrovimab,Wild Type (A),=,32.8,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,6240.4,ng/ml,1,=,190.3,,,
Arora22f,10.1016/S1473-3099(22)00733-2,Pseudovirus (VSV),Figure B,Bebtelovimab,Wild Type (B.1),=,5,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,6,ng/ml,1,=,1.2,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Bebtelovimab,Wild Type (B.1),=,0.8,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,0.9,ng/ml,1,=,1.1,,,
Gruell22c,10.1016/S1473-3099(22)00580-1,Pseudovirus,Figure B,Bebtelovimab,Wild Type (B.1),=,1,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1,ng/ml,1,=,1,,,
Saito22,10.1016/j.chom.2022.10.003,Pseudovirus (lentivirus),Table 1,Bebtelovimab,Wild Type (B.1),=,2.4,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1.3,ng/ml,1,=,0.5,,,
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Bebtelovimab,Omicron/BA.2,=,0.9,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,0.8,ng/ml,1,=,0.9,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Arora22e,10.1016/S1473-3099(22)00422-4,Pseudovirus (VSV),Supplementary Figure B,Bebtelovimab,Wild Type (B.1),=,3.7,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,4.1,ng/ml,1,=,1.1,,,
Cao22c,10.1016/j.chom.2022.09.018,Pseudovirus (VSV),Figure 5b,Bebtelovimab,Wild Type (B.1),=,0.7,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,0.9,ng/ml,1,=,1.3,,,
Misasi22,10.1101/2022.07.29.502029,Pseudovirus (lentivirus),Figure 1A,Bebtelovimab,Wild Type (B.1),=,3.3,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1.1,ng/ml,1,=,0.3,,,
Sheward22b,10.1101/2022.07.19.500716,Pseudovirus (lentivirus),Table S1,Bebtelovimab,Wild Type (B.1),=,2,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,2,ng/ml,1,=,1,,,Some LOD values of 10000 were reported. Corrected to 1000
Sheward22c,10.1101/2022.09.16.508299,Pseudovirus,Figure 1B,Bebtelovimab,Wild Type (B.1),=,4,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1,ng/ml,1,=,0.3,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Table 1a,Bebtelovimab,Wild Type (B.1),=,1,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,2,ng/ml,1,=,2,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Bebtelovimab,Wild Type (B.1),=,2,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,2,ng/ml,1,=,1,,,
Wang22j,10.1016/S1473-3099(22)00694-6,Pseudovirus (VSV),Figure S3,Bebtelovimab,Wild Type (B.1),=,1.5,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1.2,ng/ml,1,=,0.8,,,
Wang22l,10.1101/2022.11.23.517532,Pseudovirus,Figure S2,Bebtelovimab,Wild Type (B.1),=,2,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1,ng/ml,1,=,0.5,,,
Yamasoba22b,10.1016/S1473-3099(22)00365-6,Pseudovirus (HIV),Table,Bebtelovimab,Wild Type (B.1),=,8.1,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,6.3,ng/ml,1,=,0.8,,,
Yamasoba22c,10.1101/2022.07.14.500041,Pseudovirus,Table 1,Bebtelovimab,Wild Type (B.1),=,2.4,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1.3,ng/ml,1,=,0.5,,,
Huo22b,10.1016/j.celrep.2022.111903,Pseudovirus (lentivirus),Supplementary Table 1B,Bebtelovimab,Wild Type (B),=,1,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,2,ng/ml,1,=,2,,,
Gruell22b,10.1016/j.chom.2022.07.002,Pseudovirus (HIV),Figure 4B,Bebtelovimab,Wild Type (B),=,5,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,5,ng/ml,1,=,1,,,
Park22,10.1126/science.adc9127,Pseudovirus (VSV),Fig 1A,Bebtelovimab,Wild Type (B),=,3,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,2,ng/ml,1,=,0.7,,,
Touret22c,10.1101/2022.12.22.521201,Virus isolate,Table 1,Bebtelovimab,Delta,=,0.4,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,6.8,ng/ml,1,=,17,,,
Planas22b,10.1101/2022.11.17.516888,Virus isolate,Figure 3b,Bebtelovimab,Wild Type (B.1),=,1.4,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,2,ng/ml,1,=,1.4,,,
Takashita22c,10.1056/NEJMc2207519,Virus isolate,Table 1,Bebtelovimab,Wild Type (A),=,2.5,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,3.3,ng/ml,1,=,1.3,,,
Takashita22d,10.1056/NEJMc2209952,Virus isolate,Table 1,Bebtelovimab,Wild Type (A),=,1.4,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,2.4,ng/ml,1,=,1.7,,,
Turelli22b,10.1101/2022.07.28.501852,Virus isolate,Table 2,Bebtelovimab,Omicron/BA.4,=,12,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,15,ng/ml,1,=,1.3,,,
Arora22f,10.1016/S1473-3099(22)00733-2,Pseudovirus (VSV),Figure B,Regdanvimab,Wild Type (B.1),=,7,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,50000,ng/ml,1,>,1000,,,
Gruell22c,10.1016/S1473-3099(22)00580-1,Pseudovirus,Figure B,Regdanvimab,Wild Type (B.1),=,5,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Saito22,10.1016/j.chom.2022.10.003,Pseudovirus (lentivirus),Table 1,Regdanvimab,Wild Type (B.1),=,1,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,4025,ng/ml,1,>,1000,,,
Arora22e,10.1016/S1473-3099(22)00422-4,Pseudovirus (VSV),Supplementary Figure B,Regdanvimab,Wild Type (B.1),=,2.9,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,5000,ng/ml,1,>,1000,,,
Misasi22,10.1101/2022.07.29.502029,Pseudovirus (lentivirus),Figure 1A,Regdanvimab,Wild Type (B.1),=,2.8,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10050,ng/ml,1,>,1000,,,
Yamasoba22c,10.1101/2022.07.14.500041,Pseudovirus,Table 1,Regdanvimab,Wild Type (B.1),=,1,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,4025,ng/ml,1,>,1000,,,
Gruell22b,10.1016/j.chom.2022.07.002,Pseudovirus (HIV),Figure 4B,Regdanvimab,Wild Type (B),=,5,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Park22,10.1126/science.adc9127,Pseudovirus (VSV),Fig 1A,Regdanvimab,Wild Type (B),=,1.5,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Arora22f,10.1016/S1473-3099(22)00733-2,Pseudovirus (VSV),Figure B,Amubarvimab,Wild Type (B.1),=,53,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1234,ng/ml,1,=,23.3,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Amubarvimab,Wild Type (B.1),=,53.2,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,7120,ng/ml,1,=,133.8,,,
Gruell22c,10.1016/S1473-3099(22)00580-1,Pseudovirus,Figure B,Amubarvimab,Wild Type (B.1),=,9,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1160,ng/ml,1,=,128.9,,,
Cao22c,10.1016/j.chom.2022.09.018,Pseudovirus (VSV),Figure 5b,Amubarvimab,Wild Type (B.1),=,53,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,7124,ng/ml,1,=,134.4,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Table 1a,Amubarvimab,Wild Type (B.1),=,18,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,978,ng/ml,1,=,54.3,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Amubarvimab,Wild Type (B.1),=,15,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1181,ng/ml,1,=,78.7,,,
Wang22j,10.1016/S1473-3099(22)00694-6,Pseudovirus (VSV),Figure S3,Amubarvimab,Wild Type (B.1),=,24,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,730,ng/ml,1,=,30.4,,,
Gruell22b,10.1016/j.chom.2022.07.002,Pseudovirus (HIV),Figure 4B,Amubarvimab,Wild Type (B),=,8,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,820,ng/ml,1,=,102.5,,,
Arora22f,10.1016/S1473-3099(22)00733-2,Pseudovirus (VSV),Figure B,Romlusevimab,Wild Type (B.1),=,852,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,8279,ng/ml,1,=,9.7,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Romlusevimab,Wild Type (B.1),=,1240,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,8.1,,,
Cao22c,10.1016/j.chom.2022.09.018,Pseudovirus (VSV),Figure 5b,Romlusevimab,Wild Type (B.1),=,1239,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,8.1,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Table 1a,Romlusevimab,Wild Type (B.1),=,110,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,90.9,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Romlusevimab,Wild Type (B.1),=,166,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,60.2,,,
Wang22j,10.1016/S1473-3099(22)00694-6,Pseudovirus (VSV),Figure S3,Romlusevimab,Wild Type (B.1),=,436,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,22.9,,,
Arora22f,10.1016/S1473-3099(22)00733-2,Pseudovirus (VSV),Figure B,Amubarvimab + Romlusevimab,Wild Type (B.1),=,64,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1819,ng/ml,1,=,28.4,,,
Cao22c,10.1016/j.chom.2022.09.018,Pseudovirus (VSV),Figure 5b,Amubarvimab + Romlusevimab,Wild Type (B.1),=,81,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,123.5,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Table 1a,Amubarvimab + Romlusevimab,Wild Type (B.1),=,22,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,2445,ng/ml,1,=,111.1,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Amubarvimab + Romlusevimab,Wild Type (B.1),=,32,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1625,ng/ml,1,=,50.8,,,
Wang22j,10.1016/S1473-3099(22)00694-6,Pseudovirus (VSV),Figure S3,Amubarvimab + Romlusevimab,Wild Type (B.1),=,34,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,2177,ng/ml,1,=,64,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,DXP-604,Wild Type (B.1),=,11,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,6260,ng/ml,1,=,569.1,,,
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,DXP-604,Omicron/BA.2,=,219,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,6264,ng/ml,1,>,28.6,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22c,10.1016/j.chom.2022.09.018,Pseudovirus (VSV),Figure 5b,DXP-604,Wild Type (B.1),=,11,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,6264,ng/ml,1,=,569.5,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Bamlanivimab,Wild Type (B.1),=,15,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,666.7,,,
Gruell22c,10.1016/S1473-3099(22)00580-1,Pseudovirus,Figure B,Bamlanivimab,Wild Type (B.1),=,5,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Arora22e,10.1016/S1473-3099(22)00422-4,Pseudovirus (VSV),Supplementary Figure B,Bamlanivimab,Wild Type (B.1),=,11.3,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,>,5000,ng/ml,1,>,442.5,,,
Cao22c,10.1016/j.chom.2022.09.018,Pseudovirus (VSV),Figure 5b,Bamlanivimab,Wild Type (B.1),=,15,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,666.7,,,
Misasi22,10.1101/2022.07.29.502029,Pseudovirus (lentivirus),Figure 1A,Bamlanivimab,Wild Type (B.1),=,2.8,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,>,10050,ng/ml,1,>,1000,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Table 1a,Bamlanivimab,Wild Type (B.1),=,4,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Bamlanivimab,Wild Type (B.1),=,6,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Yamasoba22b,10.1016/S1473-3099(22)00365-6,Pseudovirus (HIV),Table,Bamlanivimab,Wild Type (B.1),=,12.8,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,>,3700,ng/ml,1,>,289.1,,,
Chen22e,10.1016/j.celrep.2022.111528,Pseudovirus (lentivirus),Figure 2B,Bamlanivimab,Wild Type (A),=,3,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Gruell22b,10.1016/j.chom.2022.07.002,Pseudovirus (HIV),Figure 4B,Bamlanivimab,Wild Type (B),=,5,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Etesevimab,Wild Type (B.1),=,32,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,312.5,,,
Gruell22c,10.1016/S1473-3099(22)00580-1,Pseudovirus,Figure B,Etesevimab,Wild Type (B.1),=,30,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,333.3,,,
Arora22e,10.1016/S1473-3099(22)00422-4,Pseudovirus (VSV),Supplementary Figure B,Etesevimab,Wild Type (B.1),=,22.2,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,>,5000,ng/ml,1,>,225.2,,,
Cao22c,10.1016/j.chom.2022.09.018,Pseudovirus (VSV),Figure 5b,Etesevimab,Wild Type (B.1),=,32,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,312.5,,,
Misasi22,10.1101/2022.07.29.502029,Pseudovirus (lentivirus),Figure 1A,Etesevimab,Wild Type (B.1),=,23.3,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,>,10050,ng/ml,1,>,432.3,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Table 1a,Etesevimab,Wild Type (B.1),=,12,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,833.3,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Etesevimab,Wild Type (B.1),=,9,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Yamasoba22b,10.1016/S1473-3099(22)00365-6,Pseudovirus (HIV),Table,Etesevimab,Wild Type (B.1),=,12,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,>,6050,ng/ml,1,>,504.2,,,
Chen22e,10.1016/j.celrep.2022.111528,Pseudovirus (lentivirus),Figure 2B,Etesevimab,Wild Type (A),=,19,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,526.3,,,
Gruell22b,10.1016/j.chom.2022.07.002,Pseudovirus (HIV),Figure 4B,Etesevimab,Wild Type (B),=,18,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,555.6,,,
Arora22e,10.1016/S1473-3099(22)00422-4,Pseudovirus (VSV),Supplementary Figure B,Bamlanivimab + Etesevimab,Wild Type (B.1),=,16.9,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,>,5000,ng/ml,1,>,295.9,,,
Cao22c,10.1016/j.chom.2022.09.018,Pseudovirus (VSV),Figure 5b,Bamlanivimab + Etesevimab,Wild Type (B.1),=,20,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,500,,,
Misasi22,10.1101/2022.07.29.502029,Pseudovirus (lentivirus),Figure 1B,Bamlanivimab + Etesevimab,Wild Type (B.1),=,5.6,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,>,10050,ng/ml,1,>,1000,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Table 1a,Bamlanivimab + Etesevimab,Wild Type (B.1),=,5,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Bamlanivimab + Etesevimab,Wild Type (B.1),=,6,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Yamasoba22b,10.1016/S1473-3099(22)00365-6,Pseudovirus (HIV),Table,Bamlanivimab + Etesevimab,Wild Type (B.1),=,6.7,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,>,3700,ng/ml,1,>,552.2,,,
Chen22e,10.1016/j.celrep.2022.111528,Pseudovirus (lentivirus),Figure 2C,Bamlanivimab + Etesevimab,Wild Type (A),=,1.5,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Park22,10.1126/science.adc9127,Pseudovirus (VSV),Fig 1A,Bamlanivimab + Etesevimab,Wild Type (B),=,17,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,588.2,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Casirivimab,Wild Type (B.1),=,5.6,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Gruell22c,10.1016/S1473-3099(22)00580-1,Pseudovirus,Figure B,Casirivimab,Wild Type (B.1),=,5,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Arora22e,10.1016/S1473-3099(22)00422-4,Pseudovirus (VSV),Supplementary Figure B,Casirivimab,Wild Type (B.1),=,12.1,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,=,480,ng/ml,1,=,39.7,,,
Cao22c,10.1016/j.chom.2022.09.018,Pseudovirus (VSV),Figure 5b,Casirivimab,Wild Type (B.1),=,5.6,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Misasi22,10.1101/2022.07.29.502029,Pseudovirus (lentivirus),Figure 1A,Casirivimab,Wild Type (B.1),=,5.3,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,>,10050,ng/ml,1,>,1000,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Table 1a,Casirivimab,Wild Type (B.1),=,5,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Casirivimab,Wild Type (B.1),=,3,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Yamasoba22b,10.1016/S1473-3099(22)00365-6,Pseudovirus (HIV),Table,Casirivimab,Wild Type (B.1),=,9.9,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,>,50417,ng/ml,1,>,1000,,,
Chen22e,10.1016/j.celrep.2022.111528,Pseudovirus (lentivirus),Figure 2B,Casirivimab,Wild Type (A),=,2,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Gruell22b,10.1016/j.chom.2022.07.002,Pseudovirus (HIV),Figure 4B,Casirivimab,Wild Type (B),=,5,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Takashita22c,10.1056/NEJMc2207519,Virus isolate,Table 1,Casirivimab,Wild Type (A),=,6.1,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,>,50000,ng/ml,1,>,1000,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Imdevimab,Wild Type (B.1),=,5.7,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,=,499,ng/ml,1,=,87.1,,,
Gruell22c,10.1016/S1473-3099(22)00580-1,Pseudovirus,Figure B,Imdevimab,Wild Type (B.1),=,5,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,=,4484,ng/ml,1,=,896.8,,,
Arora22e,10.1016/S1473-3099(22)00422-4,Pseudovirus (VSV),Supplementary Figure B,Imdevimab,Wild Type (B.1),=,11.8,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,=,345,ng/ml,1,=,29.2,,,
Cao22c,10.1016/j.chom.2022.09.018,Pseudovirus (VSV),Figure 5b,Imdevimab,Wild Type (B.1),=,5.7,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,=,499,ng/ml,1,=,87.5,,,
Misasi22,10.1101/2022.07.29.502029,Pseudovirus (lentivirus),Figure 1A,Imdevimab,Wild Type (B.1),=,10.8,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,=,562.1,ng/ml,1,=,52.2,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Table 1a,Imdevimab,Wild Type (B.1),=,1,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,=,2125,ng/ml,1,>,1000,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Imdevimab,Wild Type (B.1),=,3,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,=,4002,ng/ml,1,>,1000,,,
Yamasoba22b,10.1016/S1473-3099(22)00365-6,Pseudovirus (HIV),Table,Imdevimab,Wild Type (B.1),=,79,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,>,50000,ng/ml,1,>,632.9,,,
Chen22e,10.1016/j.celrep.2022.111528,Pseudovirus (lentivirus),Figure 2B,Imdevimab,Wild Type (A),=,9,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,=,544,ng/ml,1,=,60.4,,,
Gruell22b,10.1016/j.chom.2022.07.002,Pseudovirus (HIV),Figure 4B,Imdevimab,Wild Type (B),=,5,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,=,4624,ng/ml,1,=,924.8,,,
Takashita22c,10.1056/NEJMc2207519,Virus isolate,Table 1,Imdevimab,Wild Type (A),=,7.4,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,=,238.1,ng/ml,1,=,32.2,,,
Arora22e,10.1016/S1473-3099(22)00422-4,Pseudovirus (VSV),Supplementary Figure B,Casirivimab + Imdevimab,Wild Type (B.1),=,6.6,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,=,293,ng/ml,1,=,44.4,,,
Cao22c,10.1016/j.chom.2022.09.018,Pseudovirus (VSV),Figure 5b,Casirivimab + Imdevimab,Wild Type (B.1),=,5,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,=,714,ng/ml,1,=,142.8,,,
Misasi22,10.1101/2022.07.29.502029,Pseudovirus (lentivirus),Figure 1B,Casirivimab + Imdevimab,Wild Type (B.1),=,3.4,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,=,365.1,ng/ml,1,=,107.2,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Table 1a,Casirivimab + Imdevimab,Wild Type (B.1),=,1,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,=,2400,ng/ml,1,>,1000,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Casirivimab + Imdevimab,Wild Type (B.1),=,3,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,=,2343,ng/ml,1,=,781,,,
Yamasoba22b,10.1016/S1473-3099(22)00365-6,Pseudovirus (HIV),Table,Casirivimab + Imdevimab,Wild Type (B.1),=,6.2,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,>,2400,ng/ml,1,>,387.1,,,
Chen22e,10.1016/j.celrep.2022.111528,Pseudovirus (lentivirus),Figure 2C,Casirivimab + Imdevimab,Wild Type (A),=,0.9,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,=,225,ng/ml,1,=,250,,,
Park22,10.1126/science.adc9127,Pseudovirus (VSV),Fig 1A,Casirivimab + Imdevimab,Wild Type (B),=,5,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,=,3366,ng/ml,1,=,673.2,,,
Takashita22c,10.1056/NEJMc2207519,Virus isolate,Table 1,Casirivimab + Imdevimab,Wild Type (A),=,6.8,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,=,905.4,ng/ml,1,=,133.1,,,Combination therapies in this study were specified at ng/ml of each component so needs to multiply by 2
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Cilgavimab,Wild Type (B.1),=,2.5,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,=,11,ng/ml,1,=,4.4,,,
Gruell22c,10.1016/S1473-3099(22)00580-1,Pseudovirus,Figure B,Cilgavimab,Wild Type (B.1),=,5,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,=,17,ng/ml,1,=,3.4,,,
Arora22e,10.1016/S1473-3099(22)00422-4,Pseudovirus (VSV),Supplementary Figure B,Cilgavimab,Wild Type (B.1),=,21.7,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,=,47.7,ng/ml,1,=,2.2,,,
Cao22c,10.1016/j.chom.2022.09.018,Pseudovirus (VSV),Figure 5b,Cilgavimab,Wild Type (B.1),=,2.5,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,=,11,ng/ml,1,=,4.4,,,
Misasi22,10.1101/2022.07.29.502029,Pseudovirus (lentivirus),Figure 1A,Cilgavimab,Wild Type (B.1),=,4.6,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,=,6.9,ng/ml,1,=,1.5,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Table 1a,Cilgavimab,Wild Type (B.1),=,6,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,=,18,ng/ml,1,=,3,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Cilgavimab,Wild Type (B.1),=,10,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,=,12,ng/ml,1,=,1.2,,,
Yamasoba22b,10.1016/S1473-3099(22)00365-6,Pseudovirus (HIV),Table,Cilgavimab,Wild Type (B.1),=,21,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,=,75,ng/ml,1,=,3.6,,,
Chen22e,10.1016/j.celrep.2022.111528,Pseudovirus (lentivirus),Figure 2B,Cilgavimab,Wild Type (A),=,1,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,=,8,ng/ml,1,=,8,,,
Gruell22b,10.1016/j.chom.2022.07.002,Pseudovirus (HIV),Figure 4B,Cilgavimab,Wild Type (B),=,5,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,=,14,ng/ml,1,=,2.8,,,
Park22,10.1126/science.adc9127,Pseudovirus (VSV),Fig 1A,Cilgavimab,Wild Type (B),=,6,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,=,15,ng/ml,1,=,2.5,,,
Takashita22c,10.1056/NEJMc2207519,Virus isolate,Table 1,Cilgavimab,Wild Type (A),=,7,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,=,21,ng/ml,1,=,3,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Tixagevimab,Wild Type (B.1),=,1.6,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,=,5520,ng/ml,1,>,1000,,,
Gruell22c,10.1016/S1473-3099(22)00580-1,Pseudovirus,Figure B,Tixagevimab,Wild Type (B.1),=,5,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,=,8612,ng/ml,1,>,1000,,,
Arora22e,10.1016/S1473-3099(22)00422-4,Pseudovirus (VSV),Supplementary Figure B,Tixagevimab,Wild Type (B.1),=,5.1,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,=,1322,ng/ml,1,=,259.2,,,
Cao22c,10.1016/j.chom.2022.09.018,Pseudovirus (VSV),Figure 5b,Tixagevimab,Wild Type (B.1),=,1.6,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,=,5521,ng/ml,1,>,1000,,,
Misasi22,10.1101/2022.07.29.502029,Pseudovirus (lentivirus),Figure 1A,Tixagevimab,Wild Type (B.1),=,1.5,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,=,520.6,ng/ml,1,=,354.2,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Table 1a,Tixagevimab,Wild Type (B.1),=,2,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,=,361,ng/ml,1,=,180.5,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Tixagevimab,Wild Type (B.1),=,3,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,=,334,ng/ml,1,=,111.3,,,
Yamasoba22b,10.1016/S1473-3099(22)00365-6,Pseudovirus (HIV),Table,Tixagevimab,Wild Type (B.1),=,6.7,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,>,2750,ng/ml,1,>,410.4,,,
Chen22e,10.1016/j.celrep.2022.111528,Pseudovirus (lentivirus),Figure 2B,Tixagevimab,Wild Type (A),=,1,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,=,55,ng/ml,1,=,55,,,
Gruell22b,10.1016/j.chom.2022.07.002,Pseudovirus (HIV),Figure 4B,Tixagevimab,Wild Type (B),=,5,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,=,3438,ng/ml,1,=,687.6,,,
Park22,10.1126/science.adc9127,Pseudovirus (VSV),Fig 1A,Tixagevimab,Wild Type (B),=,2,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,=,4465,ng/ml,1,>,1000,,,
Takashita22c,10.1056/NEJMc2207519,Virus isolate,Table 1,Tixagevimab,Wild Type (A),=,6.1,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,=,335.2,ng/ml,1,=,55,,,
Arora22e,10.1016/S1473-3099(22)00422-4,Pseudovirus (VSV),Supplementary Figure B,Cilgavimab + Tixagevimab,Wild Type (B.1),=,7.6,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,=,71.9,ng/ml,1,=,9.5,,,
Cao22c,10.1016/j.chom.2022.09.018,Pseudovirus (VSV),Figure 5b,Cilgavimab + Tixagevimab,Wild Type (B.1),=,2.1,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,=,18,ng/ml,1,=,8.6,,,
Misasi22,10.1101/2022.07.29.502029,Pseudovirus (lentivirus),Figure 1B,Cilgavimab + Tixagevimab,Wild Type (B.1),=,2.2,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,=,6.4,ng/ml,1,=,2.9,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Table 1a,Cilgavimab + Tixagevimab,Wild Type (B.1),=,2,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,=,26,ng/ml,1,=,13,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Cilgavimab + Tixagevimab,Wild Type (B.1),=,2,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,=,31,ng/ml,1,=,15.5,,,
Yamasoba22b,10.1016/S1473-3099(22)00365-6,Pseudovirus (HIV),Table,Cilgavimab + Tixagevimab,Wild Type (B.1),=,4.1,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,=,135,ng/ml,1,=,32.9,,,
Chen22e,10.1016/j.celrep.2022.111528,Pseudovirus (lentivirus),Figure 2C,Cilgavimab + Tixagevimab,Wild Type (A),=,0.7,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,=,5,ng/ml,1,=,7.1,,,
Park22,10.1126/science.adc9127,Pseudovirus (VSV),Fig 1A,Cilgavimab + Tixagevimab,Wild Type (B),=,2,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,=,27,ng/ml,1,=,13.5,,,
Takashita22c,10.1056/NEJMc2207519,Virus isolate,Table 1,Cilgavimab + Tixagevimab,Wild Type (A),=,12.6,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,=,76.2,ng/ml,1,=,6,,,Combination therapies in this study were specified at ng/ml of each component so needs to multiply by 2
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Sotrovimab,Wild Type (B.1),=,74.1,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,=,989,ng/ml,1,=,13.3,,,
Gruell22c,10.1016/S1473-3099(22)00580-1,Pseudovirus,Figure B,Sotrovimab,Wild Type (B.1),=,28,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,=,4671,ng/ml,1,=,166.8,,,
Arora22e,10.1016/S1473-3099(22)00422-4,Pseudovirus (VSV),Supplementary Figure B,Sotrovimab,Wild Type (B.1),=,77.5,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,=,3032,ng/ml,1,=,39.1,,,
Cao22c,10.1016/j.chom.2022.09.018,Pseudovirus (VSV),Figure 5b,Sotrovimab,Wild Type (B.1),=,74,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,=,989,ng/ml,1,=,13.4,,,
Misasi22,10.1101/2022.07.29.502029,Pseudovirus (lentivirus),Figure 1A,Sotrovimab,Wild Type (B.1),=,84.6,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,=,3653.9,ng/ml,1,=,43.2,,,
Park22,10.1126/science.adc9127,Pseudovirus (VSV),Fig 1A,Sotrovimab,Wild Type,=,61.7,ng/ml,1.1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,2,=,1126,ng/ml,1,=,18.4,17.3,19.4,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Table 1a,Sotrovimab,Wild Type (B.1),=,14,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,=,1035,ng/ml,1,=,73.9,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Sotrovimab,Wild Type (B.1),=,25,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,=,484,ng/ml,1,=,19.4,,,
Yamasoba22b,10.1016/S1473-3099(22)00365-6,Pseudovirus (HIV),Table,Sotrovimab,Wild Type (B.1),=,94,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,=,629,ng/ml,1,=,6.7,,,
Chen22e,10.1016/j.celrep.2022.111528,Pseudovirus (lentivirus),Figure 2B,Sotrovimab,Wild Type (A),=,184,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,=,1774,ng/ml,1,=,9.6,,,
Gruell22b,10.1016/j.chom.2022.07.002,Pseudovirus (HIV),Figure 4B,Sotrovimab,Wild Type (B),=,976,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,=,3949,ng/ml,1,=,4,,,
EMA21d,https://www.ema.europa.eu/en/documents/product-information/xevudy-epar-product-information_en.pdf,Pseudovirus,Table 2,Sotrovimab,Wild Type (B),,,,,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,,,,,=,16.6,,,
Takashita22c,10.1056/NEJMc2207519,Virus isolate,Table 1,Sotrovimab,Wild Type (A),=,95.1,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,>,50000,ng/ml,1,>,525.8,,,
Park22,10.1126/science.adc9127,Virus isolate,Fig S12A,Sotrovimab,Wild Type (B),=,49.8,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,=,1896.7,ng/ml,1,=,38.1,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Bebtelovimab,Wild Type (B.1),=,0.8,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,=,0.8,ng/ml,1,=,1,,,
Gruell22c,10.1016/S1473-3099(22)00580-1,Pseudovirus,Figure B,Bebtelovimab,Wild Type (B.1),=,1,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,=,1,ng/ml,1,=,1,,,
Arora22e,10.1016/S1473-3099(22)00422-4,Pseudovirus (VSV),Supplementary Figure B,Bebtelovimab,Wild Type (B.1),=,3.7,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,=,3.1,ng/ml,1,=,0.8,,,
Cao22c,10.1016/j.chom.2022.09.018,Pseudovirus (VSV),Figure 5b,Bebtelovimab,Wild Type (B.1),=,0.7,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,=,0.8,ng/ml,1,=,1.1,,,
Misasi22,10.1101/2022.07.29.502029,Pseudovirus (lentivirus),Figure 1A,Bebtelovimab,Wild Type (B.1),=,3.3,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,=,1.5,ng/ml,1,=,0.5,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Table 1a,Bebtelovimab,Wild Type (B.1),=,1,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,=,2,ng/ml,1,=,2,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Bebtelovimab,Wild Type (B.1),=,2,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,=,2,ng/ml,1,=,1,,,
Yamasoba22b,10.1016/S1473-3099(22)00365-6,Pseudovirus (HIV),Table,Bebtelovimab,Wild Type (B.1),=,8.1,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,=,5.5,ng/ml,1,=,0.7,,,
Gruell22b,10.1016/j.chom.2022.07.002,Pseudovirus (HIV),Figure 4B,Bebtelovimab,Wild Type (B),=,5,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,=,5,ng/ml,1,=,1,,,
Park22,10.1126/science.adc9127,Pseudovirus (VSV),Fig 1A,Bebtelovimab,Wild Type (B),=,3,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,=,1,ng/ml,1,=,0.3,,,
Takashita22c,10.1056/NEJMc2207519,Virus isolate,Table 1,Bebtelovimab,Wild Type (A),=,2.5,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,=,4,ng/ml,1,=,1.6,,,
Gruell22c,10.1016/S1473-3099(22)00580-1,Pseudovirus,Figure B,Regdanvimab,Wild Type (B.1),=,5,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Arora22e,10.1016/S1473-3099(22)00422-4,Pseudovirus (VSV),Supplementary Figure B,Regdanvimab,Wild Type (B.1),=,2.9,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,>,5000,ng/ml,1,>,1000,,,
Misasi22,10.1101/2022.07.29.502029,Pseudovirus (lentivirus),Figure 1A,Regdanvimab,Wild Type (B.1),=,2.8,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,>,10050,ng/ml,1,>,1000,,,
Gruell22b,10.1016/j.chom.2022.07.002,Pseudovirus (HIV),Figure 4B,Regdanvimab,Wild Type (B),=,5,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Park22,10.1126/science.adc9127,Pseudovirus (VSV),Fig 1A,Regdanvimab,Wild Type (B),=,1.5,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Amubarvimab,Wild Type (B.1),=,53.2,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,=,7620,ng/ml,1,=,143.2,,,
Gruell22c,10.1016/S1473-3099(22)00580-1,Pseudovirus,Figure B,Amubarvimab,Wild Type (B.1),=,9,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,=,3610,ng/ml,1,=,401.1,,,
Cao22c,10.1016/j.chom.2022.09.018,Pseudovirus (VSV),Figure 5b,Amubarvimab,Wild Type (B.1),=,53,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,=,7620,ng/ml,1,=,143.8,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Table 1a,Amubarvimab,Wild Type (B.1),=,18,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,=,1171,ng/ml,1,=,65.1,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Amubarvimab,Wild Type (B.1),=,15,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,=,1066,ng/ml,1,=,71.1,,,
Gruell22b,10.1016/j.chom.2022.07.002,Pseudovirus (HIV),Figure 4B,Amubarvimab,Wild Type (B),=,8,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,=,5398,ng/ml,1,=,674.8,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Romlusevimab,Wild Type (B.1),=,1240,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,8.1,,,
Cao22c,10.1016/j.chom.2022.09.018,Pseudovirus (VSV),Figure 5b,Romlusevimab,Wild Type (B.1),=,1239,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,8.1,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Table 1a,Romlusevimab,Wild Type (B.1),=,110,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,90.9,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Romlusevimab,Wild Type (B.1),=,166,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,60.2,,,
Cao22c,10.1016/j.chom.2022.09.018,Pseudovirus (VSV),Figure 5b,Amubarvimab + Romlusevimab,Wild Type (B.1),=,81,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,123.5,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Table 1a,Amubarvimab + Romlusevimab,Wild Type (B.1),=,22,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,=,1936,ng/ml,1,=,88,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Amubarvimab + Romlusevimab,Wild Type (B.1),=,32,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,=,2155,ng/ml,1,=,67.3,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,DXP-604,Wild Type (B.1),=,11,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,=,201,ng/ml,1,=,18.3,,,
Cao22c,10.1016/j.chom.2022.09.018,Pseudovirus (VSV),Figure 5b,DXP-604,Wild Type (B.1),=,11,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,=,201,ng/ml,1,=,18.3,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Bamlanivimab,Wild Type (B.1),=,15,ng/ml,1,Omicron/BA.3,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + G339D + S371F + S373P + S375F + D405N + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,666.7,,,
Arora22b,10.1016/j.chom.2022.04.017,Pseudovirus (VSV),Supplementary Table 1,Bamlanivimab,Wild Type (B.1),=,23.2,ng/ml,1,Omicron/BA.3,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + G339D + S371F + S373P + S375F + D405N + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,431.6,,,
Tuekprakhon22,10.1016/j.cell.2022.06.005,Pseudovirus (lentivirus),Figure 3,Bamlanivimab,Wild Type (B),=,2,ng/ml,1,Omicron/BA.3,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + G339D + S371F + S373P + S375F + D405N + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Huo22b,10.1016/j.celrep.2022.111903,Pseudovirus (lentivirus),Supplementary Table 1B,Bamlanivimab,Wild Type (B),=,2,ng/ml,1,Omicron/BA.3,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + G339D + S371F + S373P + S375F + D405N + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Ai22,10.1016/j.chom.2022.05.001,Pseudovirus (VSV),Figure 3A,Bamlanivimab,Wild Type (B),=,3,ng/ml,1,Omicron/BA.3,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + G339D + S371F + S373P + S375F + D405N + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Huang22,10.1016/j.immuni.2022.06.005,Pseudovirus (VSV),Figure 2,Bamlanivimab,Wild Type (B),=,10,ng/ml,1,Omicron/BA.3,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + G339D + S371F + S373P + S375F + D405N + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,100000,ng/ml,1,>,1000,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Etesevimab,Wild Type (B.1),=,32,ng/ml,1,Omicron/BA.3,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + G339D + S371F + S373P + S375F + D405N + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,312.5,,,
Arora22b,10.1016/j.chom.2022.04.017,Pseudovirus (VSV),Supplementary Table 1,Etesevimab,Wild Type (B.1),=,20.6,ng/ml,1,Omicron/BA.3,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + G339D + S371F + S373P + S375F + D405N + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,486.1,,,
Tuekprakhon22,10.1016/j.cell.2022.06.005,Pseudovirus (lentivirus),Figure 3,Etesevimab,Wild Type (B),=,14,ng/ml,1,Omicron/BA.3,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + G339D + S371F + S373P + S375F + D405N + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,714.3,,,
Huo22b,10.1016/j.celrep.2022.111903,Pseudovirus (lentivirus),Supplementary Table 1B,Etesevimab,Wild Type (B),=,14,ng/ml,1,Omicron/BA.3,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + G339D + S371F + S373P + S375F + D405N + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,714.3,,,
Ai22,10.1016/j.chom.2022.05.001,Pseudovirus (VSV),Figure 3A,Etesevimab,Wild Type (B),=,7,ng/ml,1,Omicron/BA.3,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + G339D + S371F + S373P + S375F + D405N + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Huang22,10.1016/j.immuni.2022.06.005,Pseudovirus (VSV),Figure 2,Etesevimab,Wild Type (B),=,20,ng/ml,1,Omicron/BA.3,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + G339D + S371F + S373P + S375F + D405N + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,100000,ng/ml,1,>,1000,,,
Arora22b,10.1016/j.chom.2022.04.017,Pseudovirus (VSV),Supplementary Table 1,Bamlanivimab + Etesevimab,Wild Type (B.1),=,13.5,ng/ml,1,Omicron/BA.3,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + G339D + S371F + S373P + S375F + D405N + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,743.5,,,
Park22,10.1126/science.adc9127,Pseudovirus (VSV),Fig 1A,Bamlanivimab + Etesevimab,Wild Type (B),=,17,ng/ml,1,Omicron/BA.3,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + G339D + S371F + S373P + S375F + D405N + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,588.2,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Casirivimab,Wild Type (B.1),=,5.6,ng/ml,1,Omicron/BA.3,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + G339D + S371F + S373P + S375F + D405N + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Arora22b,10.1016/j.chom.2022.04.017,Pseudovirus (VSV),Supplementary Table 1,Casirivimab,Wild Type (B.1),=,19.1,ng/ml,1,Omicron/BA.3,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + G339D + S371F + S373P + S375F + D405N + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,3475,ng/ml,1,=,181.5,,,
Tuekprakhon22,10.1016/j.cell.2022.06.005,Pseudovirus (lentivirus),Figure 3,Casirivimab,Wild Type (B),=,1,ng/ml,1,Omicron/BA.3,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + G339D + S371F + S373P + S375F + D405N + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Huo22b,10.1016/j.celrep.2022.111903,Pseudovirus (lentivirus),Supplementary Table 1B,Casirivimab,Wild Type (B),=,1,ng/ml,1,Omicron/BA.3,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + G339D + S371F + S373P + S375F + D405N + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Ai22,10.1016/j.chom.2022.05.001,Pseudovirus (VSV),Figure 3A,Casirivimab,Wild Type (B),=,2,ng/ml,1,Omicron/BA.3,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + G339D + S371F + S373P + S375F + D405N + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Huang22,10.1016/j.immuni.2022.06.005,Pseudovirus (VSV),Figure 2,Casirivimab,Wild Type (B),=,11,ng/ml,1,Omicron/BA.3,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + G339D + S371F + S373P + S375F + D405N + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,100000,ng/ml,1,>,1000,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Imdevimab,Wild Type (B.1),=,5.7,ng/ml,1,Omicron/BA.3,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + G339D + S371F + S373P + S375F + D405N + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Arora22b,10.1016/j.chom.2022.04.017,Pseudovirus (VSV),Supplementary Table 1,Imdevimab,Wild Type (B.1),=,23.7,ng/ml,1,Omicron/BA.3,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + G339D + S371F + S373P + S375F + D405N + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,421.4,,,
Tuekprakhon22,10.1016/j.cell.2022.06.005,Pseudovirus (lentivirus),Figure 3,Imdevimab,Wild Type (B),=,2,ng/ml,1,Omicron/BA.3,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + G339D + S371F + S373P + S375F + D405N + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Huo22b,10.1016/j.celrep.2022.111903,Pseudovirus (lentivirus),Supplementary Table 1B,Imdevimab,Wild Type (B),=,2,ng/ml,1,Omicron/BA.3,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + G339D + S371F + S373P + S375F + D405N + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Ai22,10.1016/j.chom.2022.05.001,Pseudovirus (VSV),Figure 3A,Imdevimab,Wild Type (B),=,3,ng/ml,1,Omicron/BA.3,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + G339D + S371F + S373P + S375F + D405N + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Huang22,10.1016/j.immuni.2022.06.005,Pseudovirus (VSV),Figure 2,Imdevimab,Wild Type (B),=,6,ng/ml,1,Omicron/BA.3,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + G339D + S371F + S373P + S375F + D405N + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,100000,ng/ml,1,>,1000,,,
Arora22b,10.1016/j.chom.2022.04.017,Pseudovirus (VSV),Supplementary Table 1,Casirivimab + Imdevimab,Wild Type (B.1),=,7.6,ng/ml,1,Omicron/BA.3,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + G339D + S371F + S373P + S375F + D405N + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,5092,ng/ml,1,=,669.6,,,
Park22,10.1126/science.adc9127,Pseudovirus (VSV),Fig 1A,Casirivimab + Imdevimab,Wild Type (B),=,5,ng/ml,1,Omicron/BA.3,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + G339D + S371F + S373P + S375F + D405N + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Cilgavimab,Wild Type (B.1),=,2.5,ng/ml,1,Omicron/BA.3,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + G339D + S371F + S373P + S375F + D405N + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,11.2,ng/ml,1,=,4.5,,,
Arora22b,10.1016/j.chom.2022.04.017,Pseudovirus (VSV),Supplementary Table 1,Cilgavimab,Wild Type (B.1),=,25.1,ng/ml,1,Omicron/BA.3,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + G339D + S371F + S373P + S375F + D405N + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,89.5,ng/ml,1,=,3.6,,,
Tuekprakhon22,10.1016/j.cell.2022.06.005,Pseudovirus (lentivirus),Figure 3,Cilgavimab,Wild Type (B),=,2,ng/ml,1,Omicron/BA.3,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + G339D + S371F + S373P + S375F + D405N + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,19,ng/ml,1,=,9.5,,,
Huo22b,10.1016/j.celrep.2022.111903,Pseudovirus (lentivirus),Supplementary Table 1B,Cilgavimab,Wild Type (B),=,2,ng/ml,1,Omicron/BA.3,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + G339D + S371F + S373P + S375F + D405N + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,19,ng/ml,1,=,9.5,,,
Ai22,10.1016/j.chom.2022.05.001,Pseudovirus (VSV),Figure 3A,Cilgavimab,Wild Type (B),=,1,ng/ml,1,Omicron/BA.3,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + G339D + S371F + S373P + S375F + D405N + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,13,ng/ml,1,=,13,,,
Park22,10.1126/science.adc9127,Pseudovirus (VSV),Fig 1A,Cilgavimab,Wild Type (B),=,6,ng/ml,1,Omicron/BA.3,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + G339D + S371F + S373P + S375F + D405N + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,37,ng/ml,1,=,6.2,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Tixagevimab,Wild Type (B.1),=,1.6,ng/ml,1,Omicron/BA.3,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + G339D + S371F + S373P + S375F + D405N + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,5610,ng/ml,1,>,1000,,,
Arora22b,10.1016/j.chom.2022.04.017,Pseudovirus (VSV),Supplementary Table 1,Tixagevimab,Wild Type (B.1),=,7.4,ng/ml,1,Omicron/BA.3,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + G339D + S371F + S373P + S375F + D405N + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1809,ng/ml,1,=,243.1,,,
Tuekprakhon22,10.1016/j.cell.2022.06.005,Pseudovirus (lentivirus),Figure 3,Tixagevimab,Wild Type (B),=,1,ng/ml,1,Omicron/BA.3,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + G339D + S371F + S373P + S375F + D405N + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Huo22b,10.1016/j.celrep.2022.111903,Pseudovirus (lentivirus),Supplementary Table 1B,Tixagevimab,Wild Type (B),=,1,ng/ml,1,Omicron/BA.3,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + G339D + S371F + S373P + S375F + D405N + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Ai22,10.1016/j.chom.2022.05.001,Pseudovirus (VSV),Figure 3A,Tixagevimab,Wild Type (B),=,1,ng/ml,1,Omicron/BA.3,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + G339D + S371F + S373P + S375F + D405N + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Park22,10.1126/science.adc9127,Pseudovirus (VSV),Fig 1A,Tixagevimab,Wild Type (B),=,2,ng/ml,1,Omicron/BA.3,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + G339D + S371F + S373P + S375F + D405N + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Arora22b,10.1016/j.chom.2022.04.017,Pseudovirus (VSV),Supplementary Table 1,Cilgavimab + Tixagevimab,Wild Type (B.1),=,5.9,ng/ml,1,Omicron/BA.3,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + G339D + S371F + S373P + S375F + D405N + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,94.8,ng/ml,1,=,16.2,,,
Tuekprakhon22,10.1016/j.cell.2022.06.005,Pseudovirus (lentivirus),Figure 3,Cilgavimab + Tixagevimab,Wild Type (B),=,1,ng/ml,1,Omicron/BA.3,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + G339D + S371F + S373P + S375F + D405N + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,65,ng/ml,1,=,65,,,
Huo22b,10.1016/j.celrep.2022.111903,Pseudovirus (lentivirus),Supplementary Table 1B,Cilgavimab + Tixagevimab,Wild Type (B),=,1,ng/ml,1,Omicron/BA.3,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + G339D + S371F + S373P + S375F + D405N + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,65,ng/ml,1,=,65,,,
Park22,10.1126/science.adc9127,Pseudovirus (VSV),Fig 1A,Cilgavimab + Tixagevimab,Wild Type (B),=,2,ng/ml,1,Omicron/BA.3,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + G339D + S371F + S373P + S375F + D405N + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,86,ng/ml,1,=,43,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Sotrovimab,Wild Type (B.1),=,74.1,ng/ml,1,Omicron/BA.3,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + G339D + S371F + S373P + S375F + D405N + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,972,ng/ml,1,=,13.1,,,
Arora22b,10.1016/j.chom.2022.04.017,Pseudovirus (VSV),Supplementary Table 1,Sotrovimab,Wild Type (B.1),=,198.3,ng/ml,1,Omicron/BA.3,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + G339D + S371F + S373P + S375F + D405N + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1316,ng/ml,1,=,6.6,,,
Tuekprakhon22,10.1016/j.cell.2022.06.005,Pseudovirus (lentivirus),Figure 3,Sotrovimab,Wild Type (B),=,130,ng/ml,1,Omicron/BA.3,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + G339D + S371F + S373P + S375F + D405N + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,228,ng/ml,1,=,1.8,,,
Huo22b,10.1016/j.celrep.2022.111903,Pseudovirus (lentivirus),Supplementary Table 1B,Sotrovimab,Wild Type (B),=,79,ng/ml,1,Omicron/BA.3,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + G339D + S371F + S373P + S375F + D405N + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,311,ng/ml,1,=,3.9,,,
Ai22,10.1016/j.chom.2022.05.001,Pseudovirus (VSV),Figure 3A,Sotrovimab,Wild Type (B),=,9,ng/ml,1,Omicron/BA.3,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + G339D + S371F + S373P + S375F + D405N + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,222,ng/ml,1,=,24.7,,,
Park22,10.1126/science.adc9127,Pseudovirus (VSV),Fig 1A,Sotrovimab,Wild Type (B),=,69,ng/ml,1,Omicron/BA.3,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + G339D + S371F + S373P + S375F + D405N + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,434,ng/ml,1,=,6.3,,,
Huang22,10.1016/j.immuni.2022.06.005,Pseudovirus (VSV),Figure 2,Sotrovimab,Wild Type (B),=,21,ng/ml,1,Omicron/BA.3,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + G339D + S371F + S373P + S375F + D405N + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,15,ng/ml,1,=,0.7,,,
Cathcart21,10.1101/2021.03.09.434607,Pseudovirus (VSV),Table 2,Sotrovimab,Wild Type (B),,,,,Omicron/BA.3,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + G339D + S371F + S373P + S375F + D405N + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,,,,,=,7.3,,,
EMA21d,https://www.ema.europa.eu/en/documents/product-information/xevudy-epar-product-information_en.pdf,Pseudovirus,Table 2,Sotrovimab,Wild Type (B),,,,,Omicron/BA.3,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + G339D + S371F + S373P + S375F + D405N + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,,,,,=,7.3,,,
FDA21e,https://www.fda.gov/media/149534/download,Pseudovirus,SOT Page 23,Sotrovimab,Wild Type (B),,,,,Omicron/BA.3,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + G339D + S371F + S373P + S375F + D405N + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,,,,,=,7.3,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Bebtelovimab,Wild Type (B.1),=,0.8,ng/ml,1,Omicron/BA.3,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + G339D + S371F + S373P + S375F + D405N + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1.1,ng/ml,1,=,1.5,,,
Huo22b,10.1016/j.celrep.2022.111903,Pseudovirus (lentivirus),Supplementary Table 1B,Bebtelovimab,Wild Type (B),=,1,ng/ml,1,Omicron/BA.3,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + G339D + S371F + S373P + S375F + D405N + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,2,ng/ml,1,=,2,,,
Ai22,10.1016/j.chom.2022.05.001,Pseudovirus (VSV),Figure 3A,Bebtelovimab,Wild Type (B),=,1.5,ng/ml,1,Omicron/BA.3,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + G339D + S371F + S373P + S375F + D405N + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,170,ng/ml,1,=,113.3,,,
Park22,10.1126/science.adc9127,Pseudovirus (VSV),Fig 1A,Bebtelovimab,Wild Type (B),=,3,ng/ml,1,Omicron/BA.3,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + G339D + S371F + S373P + S375F + D405N + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,3,ng/ml,1,=,1,,,
Arora22b,10.1016/j.chom.2022.04.017,Pseudovirus (VSV),Supplementary Table 1,Regdanvimab,Wild Type (B.1),=,4.9,ng/ml,1,Omicron/BA.3,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + G339D + S371F + S373P + S375F + D405N + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Ai22,10.1016/j.chom.2022.05.001,Pseudovirus (VSV),Figure 3A,Regdanvimab,Wild Type (B),=,1,ng/ml,1,Omicron/BA.3,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + G339D + S371F + S373P + S375F + D405N + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Park22,10.1126/science.adc9127,Pseudovirus (VSV),Fig 1A,Regdanvimab,Wild Type (B),=,1.5,ng/ml,1,Omicron/BA.3,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + G339D + S371F + S373P + S375F + D405N + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Amubarvimab,Wild Type (B.1),=,53.2,ng/ml,1,Omicron/BA.3,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + G339D + S371F + S373P + S375F + D405N + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,7830,ng/ml,1,=,147.2,,,
Ai22,10.1016/j.chom.2022.05.001,Pseudovirus (VSV),Figure 3A,Amubarvimab,Wild Type (B),=,9,ng/ml,1,Omicron/BA.3,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + G339D + S371F + S373P + S375F + D405N + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,2944,ng/ml,1,=,327.1,,,
Huang22,10.1016/j.immuni.2022.06.005,Pseudovirus (VSV),Figure 2,Amubarvimab,Wild Type (B),=,39,ng/ml,1,Omicron/BA.3,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + G339D + S371F + S373P + S375F + D405N + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,2570,ng/ml,1,=,65.9,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Romlusevimab,Wild Type (B.1),=,1240,ng/ml,1,Omicron/BA.3,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + G339D + S371F + S373P + S375F + D405N + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1690,ng/ml,1,=,1.4,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,DXP-604,Wild Type (B.1),=,11,ng/ml,1,Omicron/BA.3,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + G339D + S371F + S373P + S375F + D405N + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,259,ng/ml,1,=,23.5,,,
Huang22,10.1016/j.immuni.2022.06.005,Pseudovirus (VSV),Figure 2,DXP-604,Wild Type (B),=,27,ng/ml,1,Omicron/BA.3,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + G339D + S371F + S373P + S375F + D405N + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,13,ng/ml,1,=,0.5,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Bamlanivimab,Wild Type (B.1),=,15,ng/ml,1,Omicron/BA.2/G446S,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,666.7,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Bamlanivimab,Wild Type (B.1),=,6,ng/ml,1,Omicron/BA.2/G446S,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Huang22,10.1016/j.immuni.2022.06.005,Pseudovirus (VSV),Figure 2,Bamlanivimab,Wild Type (B),=,10,ng/ml,1,Omicron/BA.2/G446S,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,100000,ng/ml,1,>,1000,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Etesevimab,Wild Type (B.1),=,32,ng/ml,1,Omicron/BA.2/G446S,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,312.5,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Etesevimab,Wild Type (B.1),=,9,ng/ml,1,Omicron/BA.2/G446S,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Huang22,10.1016/j.immuni.2022.06.005,Pseudovirus (VSV),Figure 2,Etesevimab,Wild Type (B),=,20,ng/ml,1,Omicron/BA.2/G446S,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,100000,ng/ml,1,>,1000,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Bamlanivimab + Etesevimab,Wild Type (B.1),=,6,ng/ml,1,Omicron/BA.2/G446S,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Casirivimab,Wild Type (B.1),=,5.6,ng/ml,1,Omicron/BA.2/G446S,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Casirivimab,Wild Type (B.1),=,3,ng/ml,1,Omicron/BA.2/G446S,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Huang22,10.1016/j.immuni.2022.06.005,Pseudovirus (VSV),Figure 2,Casirivimab,Wild Type (B),=,11,ng/ml,1,Omicron/BA.2/G446S,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,100000,ng/ml,1,>,1000,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Imdevimab,Wild Type (B.1),=,5.7,ng/ml,1,Omicron/BA.2/G446S,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,590,ng/ml,1,=,103,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Imdevimab,Wild Type (B.1),=,3,ng/ml,1,Omicron/BA.2/G446S,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Huang22,10.1016/j.immuni.2022.06.005,Pseudovirus (VSV),Figure 2,Imdevimab,Wild Type (B),=,6,ng/ml,1,Omicron/BA.2/G446S,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,100000,ng/ml,1,>,1000,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Casirivimab + Imdevimab,Wild Type (B.1),=,3,ng/ml,1,Omicron/BA.2/G446S,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Cilgavimab,Wild Type (B.1),=,2.5,ng/ml,1,Omicron/BA.2/G446S,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,6.3,ng/ml,1,=,2.5,,,
Saito22,10.1016/j.chom.2022.10.003,Pseudovirus (lentivirus),Table S3,Cilgavimab,Wild Type (B.1),=,14,ng/ml,1,Omicron/BA.2/G446S,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,210.2,ng/ml,1,=,15,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Cilgavimab,Wild Type (B.1),=,10,ng/ml,1,Omicron/BA.2/G446S,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,16,ng/ml,1,=,1.6,,,
Wang22l,10.1101/2022.11.23.517532,Pseudovirus,Figure S2,Cilgavimab,Wild Type (B.1),=,7,ng/ml,1,Omicron/BA.2/G446S,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,17,ng/ml,1,=,2.4,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Tixagevimab,Wild Type (B.1),=,1.6,ng/ml,1,Omicron/BA.2/G446S,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,4310,ng/ml,1,>,1000,,,
Saito22,10.1016/j.chom.2022.10.003,Pseudovirus (lentivirus),Table S3,Tixagevimab,Wild Type (B.1),=,1.5,ng/ml,1,Omicron/BA.2/G446S,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,4375,ng/ml,1,>,1000,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Tixagevimab,Wild Type (B.1),=,3,ng/ml,1,Omicron/BA.2/G446S,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1140,ng/ml,1,=,380,,,
Wang22l,10.1101/2022.11.23.517532,Pseudovirus,Figure S2,Tixagevimab,Wild Type (B.1),=,2,ng/ml,1,Omicron/BA.2/G446S,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,2614,ng/ml,1,>,1000,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Cilgavimab + Tixagevimab,Wild Type (B.1),=,2,ng/ml,1,Omicron/BA.2/G446S,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,27,ng/ml,1,=,13.5,,,
Wang22l,10.1101/2022.11.23.517532,Pseudovirus,Figure S2,Cilgavimab + Tixagevimab,Wild Type (B.1),=,3,ng/ml,1,Omicron/BA.2/G446S,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,29,ng/ml,1,=,9.7,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Sotrovimab,Wild Type (B.1),=,74.1,ng/ml,1,Omicron/BA.2/G446S,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,918,ng/ml,1,=,12.4,,,
Saito22,10.1016/j.chom.2022.10.003,Pseudovirus (lentivirus),Table S3,Sotrovimab,Wild Type (B.1),=,47,ng/ml,1,Omicron/BA.2/G446S,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,894,ng/ml,1,=,19,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Sotrovimab,Wild Type (B.1),=,25,ng/ml,1,Omicron/BA.2/G446S,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,450,ng/ml,1,=,18,,,
Wang22l,10.1101/2022.11.23.517532,Pseudovirus,Figure S2,Sotrovimab,Wild Type (B.1),=,23,ng/ml,1,Omicron/BA.2/G446S,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,686,ng/ml,1,=,29.8,,,
Huang22,10.1016/j.immuni.2022.06.005,Pseudovirus (VSV),Figure 2,Sotrovimab,Wild Type (B),=,21,ng/ml,1,Omicron/BA.2/G446S,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,270,ng/ml,1,=,12.9,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Bebtelovimab,Wild Type (B.1),=,0.8,ng/ml,1,Omicron/BA.2/G446S,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,0.9,ng/ml,1,=,1.2,,,
Saito22,10.1016/j.chom.2022.10.003,Pseudovirus (lentivirus),Table S3,Bebtelovimab,Wild Type (B.1),=,2.4,ng/ml,1,Omicron/BA.2/G446S,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,25.6,ng/ml,1,=,10.7,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Bebtelovimab,Wild Type (B.1),=,2,ng/ml,1,Omicron/BA.2/G446S,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,2,ng/ml,1,=,1,,,
Wang22l,10.1101/2022.11.23.517532,Pseudovirus,Figure S2,Bebtelovimab,Wild Type (B.1),=,2,ng/ml,1,Omicron/BA.2/G446S,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,2,ng/ml,1,=,1,,,
Saito22,10.1016/j.chom.2022.10.003,Pseudovirus (lentivirus),Table S3,Regdanvimab,Wild Type (B.1),=,1,ng/ml,1,Omicron/BA.2/G446S,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,6175,ng/ml,1,>,1000,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Amubarvimab,Wild Type (B.1),=,53.2,ng/ml,1,Omicron/BA.2/G446S,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,8530,ng/ml,1,=,160.3,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Amubarvimab,Wild Type (B.1),=,15,ng/ml,1,Omicron/BA.2/G446S,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1408,ng/ml,1,=,93.9,,,
Huang22,10.1016/j.immuni.2022.06.005,Pseudovirus (VSV),Figure 2,Amubarvimab,Wild Type (B),=,39,ng/ml,1,Omicron/BA.2/G446S,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1040,ng/ml,1,=,26.7,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Romlusevimab,Wild Type (B.1),=,1240,ng/ml,1,Omicron/BA.2/G446S,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,8990,ng/ml,1,=,7.3,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Romlusevimab,Wild Type (B.1),=,166,ng/ml,1,Omicron/BA.2/G446S,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1778,ng/ml,1,=,10.7,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Amubarvimab + Romlusevimab,Wild Type (B.1),=,32,ng/ml,1,Omicron/BA.2/G446S,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,780,ng/ml,1,=,24.4,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,DXP-604,Wild Type (B.1),=,11,ng/ml,1,Omicron/BA.2/G446S,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,219,ng/ml,1,=,19.9,,,
Huang22,10.1016/j.immuni.2022.06.005,Pseudovirus (VSV),Figure 2,DXP-604,Wild Type (B),=,27,ng/ml,1,Omicron/BA.2/G446S,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,66,ng/ml,1,=,2.4,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Bamlanivimab,Wild Type (B.1),=,15,ng/ml,1,Omicron/BA.2.13,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452M + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,666.7,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b,Bamlanivimab,Wild Type (B.1),=,4,ng/ml,1,Omicron/BA.2.13,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452M + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Etesevimab,Wild Type (B.1),=,32,ng/ml,1,Omicron/BA.2.13,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452M + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,312.5,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b,Etesevimab,Wild Type (B.1),=,12,ng/ml,1,Omicron/BA.2.13,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452M + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,833.3,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b,Bamlanivimab + Etesevimab,Wild Type (B.1),=,5,ng/ml,1,Omicron/BA.2.13,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452M + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Casirivimab,Wild Type (B.1),=,5.6,ng/ml,1,Omicron/BA.2.13,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452M + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,9220,ng/ml,1,>,1000,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b,Casirivimab,Wild Type (B.1),=,5,ng/ml,1,Omicron/BA.2.13,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452M + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Imdevimab,Wild Type (B.1),=,5.7,ng/ml,1,Omicron/BA.2.13,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452M + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,417,ng/ml,1,=,72.8,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b,Imdevimab,Wild Type (B.1),=,1,ng/ml,1,Omicron/BA.2.13,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452M + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1081,ng/ml,1,>,1000,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b,Casirivimab + Imdevimab,Wild Type (B.1),=,1,ng/ml,1,Omicron/BA.2.13,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452M + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1276,ng/ml,1,>,1000,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Cilgavimab,Wild Type (B.1),=,2.5,ng/ml,1,Omicron/BA.2.13,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452M + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,6.6,ng/ml,1,=,2.7,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b,Cilgavimab,Wild Type (B.1),=,6,ng/ml,1,Omicron/BA.2.13,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452M + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,15,ng/ml,1,=,2.5,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Tixagevimab,Wild Type (B.1),=,1.6,ng/ml,1,Omicron/BA.2.13,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452M + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,3590,ng/ml,1,>,1000,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b,Tixagevimab,Wild Type (B.1),=,2,ng/ml,1,Omicron/BA.2.13,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452M + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,970,ng/ml,1,=,485,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b,Cilgavimab + Tixagevimab,Wild Type (B.1),=,2,ng/ml,1,Omicron/BA.2.13,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452M + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,15,ng/ml,1,=,7.5,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Sotrovimab,Wild Type (B.1),=,74.1,ng/ml,1,Omicron/BA.2.13,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452M + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,700,ng/ml,1,=,9.4,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b,Sotrovimab,Wild Type (B.1),=,14,ng/ml,1,Omicron/BA.2.13,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452M + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,557,ng/ml,1,=,39.8,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Bebtelovimab,Wild Type (B.1),=,0.8,ng/ml,1,Omicron/BA.2.13,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452M + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1,ng/ml,1,=,1.3,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b,Bebtelovimab,Wild Type (B.1),=,1,ng/ml,1,Omicron/BA.2.13,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452M + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,2,ng/ml,1,=,2,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Amubarvimab,Wild Type (B.1),=,53.2,ng/ml,1,Omicron/BA.2.13,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452M + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,6900,ng/ml,1,=,129.7,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b,Amubarvimab,Wild Type (B.1),=,18,ng/ml,1,Omicron/BA.2.13,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452M + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,907,ng/ml,1,=,50.4,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Romlusevimab,Wild Type (B.1),=,1240,ng/ml,1,Omicron/BA.2.13,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452M + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,8.1,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b,Romlusevimab,Wild Type (B.1),=,110,ng/ml,1,Omicron/BA.2.13,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452M + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,90.9,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b,Amubarvimab + Romlusevimab,Wild Type (B.1),=,22,ng/ml,1,Omicron/BA.2.13,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452M + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1163,ng/ml,1,=,52.9,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,DXP-604,Wild Type (B.1),=,11,ng/ml,1,Omicron/BA.2.13,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452M + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,148,ng/ml,1,=,13.5,,,
Boschi22,10.1093/cid/ciac143,Virus isolate,Figure 1A,Bamlanivimab,Wild Type (B.1.1),=,0.2,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ241-244 + K417N + E484K + N501Y + A701V,1,>,3500,ng/ml,1,>,1000,,,Censored at 3500
Takashita22,10.1056/NEJMc2119407,Virus isolate,Table 1,Bamlanivimab,Wild Type (A),=,4.7,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ241-244 + K417N + E484K + N501Y + A701V,1,=,9554.9,ng/ml,1,>,1000,,,
Chen22,10.1101/2022.01.12.22269023,Virus isolate,Fig 1i,Bamlanivimab,Wild Type (A),=,89,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ241-244 + K417N + E484K + N501Y + A701V,1,>,10000,ng/ml,1,>,112.4,,,
Chen22e,10.1016/j.celrep.2022.111528,Virus isolate,Figure 5A,Bamlanivimab,Wild Type (A),=,89,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ241-244 + K417N + E484K + N501Y + A701V,1,>,10000,ng/ml,1,>,112.4,,,
Kaleta22,10.1038/s41467-022-28766-y,Virus isolate,Table 2,Bamlanivimab,Wild Type (B.1),=,110,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,>,10000,ng/ml,1,>,90.9,,,
Planas21b,10.1038/s41586-021-03777-9,Virus isolate,"Fig.1, Extended Data Fig.5, 2021.05.26.445838 Figure 3a",Bamlanivimab,Wild Type (B.1),=,0.2,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,>,10000,ng/ml,1,>,1000,,,
Makdasi21,10.1016/j.celrep.2021.109679,Virus isolate,Table S1,Bamlanivimab,Wild Type (B.1),=,10,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,>,100000,ng/ml,1,>,1000,,,
Dejnirattisai22,10.1016/j.cell.2021.12.046,Virus isolate,"Figure 4C, Table S1",Bamlanivimab,Wild Type (B),=,6,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,>,10000,ng/ml,1,>,1000,,,
Zhou21b,10.1016/j.cell.2021.02.037,Virus isolate,Dejnirattisai21 Table S2,Bamlanivimab,Wild Type (B),=,6,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,>,10000,ng/ml,1,>,1000,,,
Wang21b,10.1038/s41586-021-03398-2,Virus isolate,"Fig. 2c, 2e",Bamlanivimab,Wild Type (A),,,,,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,,,,,>,1000,,,
Arora22c,10.1016/j.celrep.2022.110754,Pseudovirus (VSV),Supplementary Figure 1D,Bamlanivimab,Wild Type (B.1),=,11.7,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,>,2000,ng/ml,1,>,170.9,,,
Cao22d,10.1038/s41586-021-04385-3,Pseudovirus (VSV),Fig 4b,Bamlanivimab,Wild Type (B.1),=,13,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,>,10000,ng/ml,1,>,769.2,,,
Hoffmann21,10.1016/j.cell.2021.03.036,Pseudovirus (VSV),Figure 6,Bamlanivimab,Wild Type (B.1),=,4.8,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,>,16000,ng/ml,1,>,1000,,,
Hoffmann21c,10.1016/j.celrep.2021.109415,Pseudovirus (VSV),Figure 4,Bamlanivimab,Wild Type (B.1),=,4.5,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,>,10000,ng/ml,1,>,1000,,,
Tada22,10.1016/j.ebiom.2022.103944,Pseudovirus (lentivirus),Figure 2e,Bamlanivimab,Wild Type (B.1),=,0.8,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,=,2363,ng/ml,1,>,1000,,,
Zhou21e,10.1126/science.abn8897,Pseudovirus (lentivirus),Figure 2C,Bamlanivimab,Wild Type (B.1),=,3.6,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,>,10000,ng/ml,1,>,1000,,,
Chen22e,10.1016/j.celrep.2022.111528,Pseudovirus (lentivirus),Figure 2B,Bamlanivimab,Wild Type (A),=,3,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,>,10000,ng/ml,1,>,1000,,,
Chen22,10.1101/2022.01.12.22269023,Pseudovirus (lentivirus),Fig 1h,Bamlanivimab,Wild Type (A),=,3,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,>,10000,ng/ml,1,>,1000,,,
Yuan22,10.1101/2022.03.13.484037,Pseudovirus (MLV),Figure 2A,Bamlanivimab,Wild Type (B),=,7,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,>,5000,ng/ml,1,>,714.3,,,
FDA21,https://www.fda.gov/drugs/drug-safety-and-availability/fda-authorizes-revisions-fact-sheets-address-sars-cov-2-variants-monoclonal-antibody-products-under,Pseudovirus (VSV),BAM Table 3,Bamlanivimab,Wild Type (B),,,,,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,,,,,>,1000,,,
Wang21b,10.1038/s41586-021-03398-2,Pseudovirus (VSV),Figure 2a,Bamlanivimab,Wild Type (B.1),,,,,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,,,,,>,1000,,,
Wang21e,10.1126/science.abh1766,Pseudovirus (lentivirus),Fig 2C,Bamlanivimab,Wild Type (A),=,7.1,ng/ml,1,Beta,(Various),(Various),2,>,10000,ng/ml,1,>,1000,1408.5,1408.5,
Yao21,10.1101/2021.01.27.428353,Pseudovirus (MLV),Figure 5,Bamlanivimab,Wild Type (B),=,6.8,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,>,4000,ng/ml,1,>,588.2,,,
Misasi22,10.1101/2022.07.29.502029,Pseudovirus (lentivirus),Figure 1A,Bamlanivimab,Wild Type (B.1),=,2.8,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ241-244 + K417N + E484K + N501Y + A701V,1,>,10050,ng/ml,1,>,1000,,,
Vanhove21,10.3389/fimmu.2021.761250,Virus isolate,Figure 3B,Bamlanivimab,Wild Type (B.1),=,106,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ241-244 + K417N + E484K + N501Y + A701V,1,>,50000,ng/ml,1,>,471.7,,,
Chen21e,10.1038/s41586-021-03720-y,SARS-CoV-2 recombinant,Figure 1c,Bamlanivimab,Wild Type (B.1),=,5,ng/ml,1,Beta,80,D80A + T95I + D215G + Δ242-244 + K417N + E484K + N501Y + A701V,1,>,10000,ng/ml,1,>,1000,,,
Nabel21,10.1126/science.abl6251,Pseudovirus (lentivirus),"Fig 2A, 2B",Bamlanivimab,Wild Type (B.1),=,22,ng/ml,1,Beta,80,D80A + D215G + Δ241-244 + K417N + E484K + N501Y + A701V,1,>,100000,ng/ml,1,>,1000,,,
Gruell22,10.1038/s41591-021-01676-0,Pseudovirus (HIV),Fig 2,Bamlanivimab,Wild Type (B),=,3.1,ng/ml,1,Beta,80,D80A + D215G + Δ242-244 + K417N + E484K + N501Y + A570D + A701V,1,>,10000,ng/ml,1,>,1000,,,
Boschi22,10.1093/cid/ciac143,Virus isolate,Figure 1A,Etesevimab,Wild Type (B.1.1),=,6,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ241-244 + K417N + E484K + N501Y + A701V,1,>,3500,ng/ml,1,=,600,,,Censored at 3500
Takashita22,10.1056/NEJMc2119407,Virus isolate,Table 1,Etesevimab,Wild Type (A),=,18.2,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ241-244 + K417N + E484K + N501Y + A701V,1,>,50000,ng/ml,1,>,1000,,,
Planas21b,10.1038/s41586-021-03777-9,Virus isolate,"Fig.1, Extended Data Fig.5, 2021.05.26.445838 Figure 3a",Etesevimab,Wild Type (B.1),=,1.2,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,>,10000,ng/ml,1,>,1000,,,
Dejnirattisai22,10.1016/j.cell.2021.12.046,Virus isolate,"Figure 4C, Table S1",Etesevimab,Wild Type (B),=,34,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,>,10000,ng/ml,1,>,294.1,,,
Zhou21b,10.1016/j.cell.2021.02.037,Virus isolate,Dejnirattisai21 Table S2,Etesevimab,Wild Type (B),=,34,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,>,10000,ng/ml,1,>,294.1,,,
Wang21b,10.1038/s41586-021-03398-2,Virus isolate,Extended Data Fig 5,Etesevimab,Wild Type (A),,,,,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,,,,,>,1000,,,
Arora22c,10.1016/j.celrep.2022.110754,Pseudovirus (VSV),Supplementary Figure 1D,Etesevimab,Wild Type (B.1),=,29.4,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,>,2000,ng/ml,1,>,68,,,
Cao22d,10.1038/s41586-021-04385-3,Pseudovirus (VSV),Fig 4b,Etesevimab,Wild Type (B.1),=,32,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,>,10000,ng/ml,1,>,312.5,,,
Hoffmann21c,10.1016/j.celrep.2021.109415,Pseudovirus (VSV),Figure 4,Etesevimab,Wild Type (B.1),=,14.3,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,>,10000,ng/ml,1,>,701.7,,,
Tada22,10.1016/j.ebiom.2022.103944,Pseudovirus (lentivirus),Figure 2e,Etesevimab,Wild Type (B.1),=,5.3,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,>,5000,ng/ml,1,>,943.4,,,
Zhou21e,10.1126/science.abn8897,Pseudovirus (lentivirus),Figure 2C,Etesevimab,Wild Type (B.1),=,50.5,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,>,10000,ng/ml,1,>,198,,,
Chen22e,10.1016/j.celrep.2022.111528,Pseudovirus (lentivirus),Figure 2B,Etesevimab,Wild Type (A),=,19,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,>,10000,ng/ml,1,>,526.3,,,
Wang22c,10.1038/s41586-022-04466-x,Pseudovirus (VSV),Supplmentary Table 2,Etesevimab,Wild Type (B),=,19,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,>,10000,ng/ml,1,>,526.3,,,
Yuan22,10.1101/2022.03.13.484037,Pseudovirus (MLV),Figure 2A,Etesevimab,Wild Type (B),=,9,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,>,5000,ng/ml,1,>,555.6,,,
Wang21b,10.1038/s41586-021-03398-2,Pseudovirus (VSV),Extended Data Fig 5,Etesevimab,Wild Type (B.1),,,,,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,,,,,>,1000,,,
Wang21e,10.1126/science.abh1766,Pseudovirus (lentivirus),Fig 2C,Etesevimab,Wild Type (A),=,26.2,ng/ml,1,Beta,(Various),(Various),2,>,10000,ng/ml,1,>,381.7,381.7,381.7,
Yao21,10.1101/2021.01.27.428353,Pseudovirus (MLV),Figure 5,Etesevimab,Wild Type (B),=,80.5,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,>,4000,ng/ml,1,>,49.7,,,
Wang21f,10.1016/j.immuni.2021.06.003,Pseudovirus (HIV),"Figure 1C, Figure S1",Etesevimab,Wild Type (B.1),=,20.4,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + S305T + K417N + E484K + N501Y + A701V,1,>,1000,ng/ml,1,>,49,,,
Misasi22,10.1101/2022.07.29.502029,Pseudovirus (lentivirus),Figure 1A,Etesevimab,Wild Type (B.1),=,23.3,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ241-244 + K417N + E484K + N501Y + A701V,1,>,10050,ng/ml,1,>,432.3,,,
Chen21e,10.1038/s41586-021-03720-y,SARS-CoV-2 recombinant,Extended Data Fig 13,Etesevimab,Wild Type (B.1),=,52,ng/ml,1,Beta,80,D80A + T95I + D215G + Δ242-244 + K417N + E484K + N501Y + A701V,1,>,10000,ng/ml,1,>,192.3,,,
Nabel21,10.1126/science.abl6251,Pseudovirus (lentivirus),"Fig 2A, 2B",Etesevimab,Wild Type (B.1),=,27,ng/ml,1,Beta,80,D80A + D215G + Δ241-244 + K417N + E484K + N501Y + A701V,1,>,100000,ng/ml,1,>,1000,,,
Gruell22,10.1038/s41591-021-01676-0,Pseudovirus (HIV),Fig 2,Etesevimab,Wild Type (B),=,19.4,ng/ml,1,Beta,80,D80A + D215G + Δ242-244 + K417N + E484K + N501Y + A570D + A701V,1,>,10000,ng/ml,1,>,515.5,,,
Ju22,10.1038/s41422-022-00638-6,Pseudovirus (HIV),Figure S1F,Etesevimab,Wild Type (B),=,12,ng/ml,1,Beta,80,D80A + D215G + Δ241-244 + K417N + E484K + N501Y + A701V,1,>,50000,ng/ml,1,>,1000,,,
Zhang21c,10.1038/s42003-021-02728-4,Pseudovirus (VSV),Supplementary Figure 3,Etesevimab,Wild Type (B.1),,,,,Beta,80,D80A + D215G + K417N + E484K + N501Y + A701V,1,,,,,=,70.2,,,
Boschi22,10.1093/cid/ciac143,Virus isolate,Figure 1A,Bamlanivimab + Etesevimab,Wild Type (B.1.1),=,0.5,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ241-244 + K417N + E484K + N501Y + A701V,1,>,3500,ng/ml,1,>,1000,,,Censored at 3500
Takashita22,10.1056/NEJMc2119407,Virus isolate,Table 1,Bamlanivimab + Etesevimab,Wild Type (A),=,25.2,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ241-244 + K417N + E484K + N501Y + A701V,1,>,20000,ng/ml,1,>,793.7,,,Combination therapies in this study were specified at ng/ml of each component so needs to multiply by 2
FDA21,https://www.fda.gov/drugs/drug-safety-and-availability/fda-authorizes-revisions-fact-sheets-address-sars-cov-2-variants-monoclonal-antibody-products-under,Virus isolate,BAM+ETE Table 4 page 27,Bamlanivimab + Etesevimab,Wild Type (B),,,,,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,,,,,>,325,,,
Wang21b,10.1038/s41586-021-03398-2,Virus isolate,Fig. 2e,Bamlanivimab + Etesevimab,Wild Type (A),,,,,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,,,,,>,1000,,,
Arora22c,10.1016/j.celrep.2022.110754,Pseudovirus (VSV),Supplementary Figure 1D,Bamlanivimab + Etesevimab,Wild Type (B.1),=,11.2,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,>,2000,ng/ml,1,>,178.6,,,
Hoffmann21c,10.1016/j.celrep.2021.109415,Pseudovirus (VSV),Figure 4,Bamlanivimab + Etesevimab,Wild Type (B.1),=,6.4,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,>,10000,ng/ml,1,>,1000,,,
Tada22,10.1016/j.ebiom.2022.103944,Pseudovirus (lentivirus),Figure 2e,Bamlanivimab + Etesevimab,Wild Type (B.1),=,5.1,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,>,5000,ng/ml,1,>,980.4,,,
Yuan22,10.1101/2022.03.13.484037,Pseudovirus (MLV),Figure 2A,Bamlanivimab + Etesevimab,Wild Type (B),=,9,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,>,5000,ng/ml,1,>,555.6,,,
FDA21,https://www.fda.gov/drugs/drug-safety-and-availability/fda-authorizes-revisions-fact-sheets-address-sars-cov-2-variants-monoclonal-antibody-products-under,Pseudovirus (VSV),BAM+ETE Table 3 page 27,Bamlanivimab + Etesevimab,Wild Type (B),,,,,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,,,,,=,431,,,
Wang21b,10.1038/s41586-021-03398-2,Pseudovirus (VSV),Fig. 2e,Bamlanivimab + Etesevimab,Wild Type (B.1),,,,,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,,,,,>,1000,,,
Misasi22,10.1101/2022.07.29.502029,Pseudovirus (lentivirus),Figure 1B,Bamlanivimab + Etesevimab,Wild Type (B.1),=,5.6,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ241-244 + K417N + E484K + N501Y + A701V,1,>,10050,ng/ml,1,>,1000,,,
Chen21e,10.1038/s41586-021-03720-y,SARS-CoV-2 recombinant,Extended Data Fig 13,Bamlanivimab + Etesevimab,Wild Type (B.1),=,9,ng/ml,1,Beta,80,D80A + T95I + D215G + Δ242-244 + K417N + E484K + N501Y + A701V,1,>,10000,ng/ml,1,>,1000,,,
Boschi22,10.1093/cid/ciac143,Virus isolate,Figure 1B,Casirivimab,Wild Type (B.1.1),=,0.7,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ241-244 + K417N + E484K + N501Y + A701V,1,>,12000,ng/ml,1,>,1000,,,Censored at 12000
Takashita22,10.1056/NEJMc2119407,Virus isolate,Table 1,Casirivimab,Wild Type (A),=,2.8,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ241-244 + K417N + E484K + N501Y + A701V,1,=,757.1,ng/ml,1,=,271.4,,,
Kaleta22,10.1038/s41467-022-28766-y,Virus isolate,Table 2,Casirivimab,Wild Type (B.1),=,90,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,=,4700,ng/ml,1,=,52.2,,,
Planas21b,10.1038/s41586-021-03777-9,Virus isolate,"Fig.1, Extended Data Fig.5, 2021.05.26.445838 Figure 3a",Casirivimab,Wild Type (B.1),=,0.1,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,=,398.3,ng/ml,1,>,1000,,,
Dejnirattisai22,10.1016/j.cell.2021.12.046,Virus isolate,"Figure 4C, Table S1",Casirivimab,Wild Type (B),=,4,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,=,3284,ng/ml,1,=,821,,,
Zhou21b,10.1016/j.cell.2021.02.037,Virus isolate,Dejnirattisai21 Table S2,Casirivimab,Wild Type (B),=,4,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,=,3284,ng/ml,1,=,821,,,
Du22,10.1126/sciimmunol.abp9312,Virus isolate,Fig 1E,Casirivimab,Wild Type (B),=,3.4,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,=,26.4,ng/ml,1,=,7.8,,,
FDA21,https://www.fda.gov/drugs/drug-safety-and-availability/fda-authorizes-revisions-fact-sheets-address-sars-cov-2-variants-monoclonal-antibody-products-under,Virus isolate,CAS+IMD Table 10 page 42,Casirivimab,Wild Type (B),,,,,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,,,,,=,5,,,
Wang21b,10.1038/s41586-021-03398-2,Virus isolate,Figure 2a,Casirivimab,Wild Type (A),,,,,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,,,,,>,1000,,,
Arora22c,10.1016/j.celrep.2022.110754,Pseudovirus (VSV),Supplementary Figure 1D,Casirivimab,Wild Type (B.1),=,9.7,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,=,220.6,ng/ml,1,=,22.7,,,
Cao22d,10.1038/s41586-021-04385-3,Pseudovirus (VSV),Fig 4b,Casirivimab,Wild Type (B.1),=,5,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,=,98,ng/ml,1,=,19.6,,,
Hoffmann21,10.1016/j.cell.2021.03.036,Pseudovirus (VSV),Figure 6,Casirivimab,Wild Type (B.1),=,1,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,=,45.7,ng/ml,1,>,47.9,,,Mistakenly censored
Hoffmann21c,10.1016/j.celrep.2021.109415,Pseudovirus (VSV),Figure 4,Casirivimab,Wild Type (B.1),=,2.9,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,=,11.9,ng/ml,1,=,4.1,,,
Miyakawa21b,10.1101/2021.09.23.21264014,Pseudovirus,Figure 1C,Casirivimab,Wild Type (B.1),=,89,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,=,1096,ng/ml,1,=,12.3,,,
Tada21,10.1128/mBio.00696-21,Pseudovirus (HIV),Table 3,Casirivimab,Wild Type (B.1),=,7.4,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,=,567.6,ng/ml,1,=,76.3,,,
Tada21c,10.1016/j.isci.2021.103341,Pseudovirus (HIV),Table 1,Casirivimab,Wild Type (B.1),=,3.2,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,=,424.6,ng/ml,1,=,132.7,,,
Tada21d,10.1101/2021.07.02.450959,Pseudovirus (HIV),Figure 2A table,Casirivimab,Wild Type (B.1),=,3.3,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,=,420.4,ng/ml,1,=,127.4,,,
Tada21e,10.3389/fimmu.2022.797589,Pseudovirus (HIV),Figure 2,Casirivimab,Wild Type (B.1),=,3.3,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,=,420.4,ng/ml,1,=,127.4,,,
Tada22,10.1016/j.ebiom.2022.103944,Pseudovirus (lentivirus),Figure 2e,Casirivimab,Wild Type (B.1),=,2.1,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,=,76.2,ng/ml,1,=,36.3,,,
Zhou21e,10.1126/science.abn8897,Pseudovirus (lentivirus),Figure 2C,Casirivimab,Wild Type (B.1),=,6.1,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,>,10000,ng/ml,1,>,1000,,,
Chen22e,10.1016/j.celrep.2022.111528,Pseudovirus (lentivirus),Figure 2B,Casirivimab,Wild Type (A),=,2,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,>,10000,ng/ml,1,>,1000,,,
Chen22,10.1101/2022.01.12.22269023,Pseudovirus (lentivirus),Fig 1h,Casirivimab,Wild Type (A),=,2,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,>,10000,ng/ml,1,>,1000,,,
Du22,10.1126/sciimmunol.abp9312,Pseudovirus,Fig 1E,Casirivimab,Wild Type (B),=,3.2,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,=,66.9,ng/ml,1,=,20.9,,,
Pelzek22,10.1101/2022.02.06.479332,Pseudovirus (lentivirus),Extended Table 1,Casirivimab,Wild Type (B),=,24,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,=,1733,ng/ml,1,=,72.2,,,
Yuan22,10.1101/2022.03.13.484037,Pseudovirus (MLV),Figure 2A,Casirivimab,Wild Type (B),=,6,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,=,295,ng/ml,1,=,49.2,,,
Wang21b,10.1038/s41586-021-03398-2,Pseudovirus (VSV),Figure 2a,Casirivimab,Wild Type (B.1),,,,,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,,,,,=,58.8,,,
Wang21e,10.1126/science.abh1766,Pseudovirus (lentivirus),Fig 2C,Casirivimab,Wild Type (A),=,7.7,ng/ml,1,Beta,(Various),(Various),2,>,10000,ng/ml,1,>,1000,1298.7,1298.7,
Fenwick21,10.1016/j.celrep.2021.109814,SARS-CoV-2 recombinant,Figure 3B,Casirivimab,Wild Type (B),=,48,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,=,3354,ng/ml,1,=,69.9,,,
Yao21,10.1101/2021.01.27.428353,Pseudovirus (MLV),Figure 5,Casirivimab,Wild Type (B),=,6.8,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,=,2142.8,ng/ml,1,=,315.1,,,
Wang21f,10.1016/j.immuni.2021.06.003,Pseudovirus (HIV),"Figure 1C, Figure S1",Casirivimab,Wild Type (B.1),=,3.3,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + S305T + K417N + E484K + N501Y + A701V,1,=,43.5,ng/ml,1,=,13.2,,,
Misasi22,10.1101/2022.07.29.502029,Pseudovirus (lentivirus),Figure 1A,Casirivimab,Wild Type (B.1),=,5.3,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ241-244 + K417N + E484K + N501Y + A701V,1,=,175.3,ng/ml,1,=,33.3,,,
Chen21e,10.1038/s41586-021-03720-y,SARS-CoV-2 recombinant,Figure 1c,Casirivimab,Wild Type (B.1),=,7,ng/ml,1,Beta,80,D80A + T95I + D215G + Δ242-244 + K417N + E484K + N501Y + A701V,1,=,9462,ng/ml,1,>,1000,,,
Moriyama21,10.1016/j.immuni.2021.06.015,Virus isolate,Figure 3I,Casirivimab,Wild Type (A),=,941,ng/ml,1,Beta,80,D80A + D215G + Δ241-244 + K417N + E484K + N501Y + A701V,1,>,100000,ng/ml,1,>,106.3,,,
Nabel21,10.1126/science.abl6251,Pseudovirus (lentivirus),"Fig 2A, 2B",Casirivimab,Wild Type (B.1),=,25,ng/ml,1,Beta,80,D80A + D215G + Δ241-244 + K417N + E484K + N501Y + A701V,1,=,883,ng/ml,1,=,35.3,,,
Gruell22,10.1038/s41591-021-01676-0,Pseudovirus (HIV),Fig 2,Casirivimab,Wild Type (B),=,1.9,ng/ml,1,Beta,80,D80A + D215G + Δ242-244 + K417N + E484K + N501Y + A570D + A701V,1,=,1830.3,ng/ml,1,=,963.3,,,
Ju22,10.1038/s41422-022-00638-6,Pseudovirus (HIV),Figure S1F,Casirivimab,Wild Type (B),=,2,ng/ml,1,Beta,80,D80A + D215G + Δ241-244 + K417N + E484K + N501Y + A701V,1,=,1492,ng/ml,1,=,746,,,
Copin21,10.1016/j.cell.2021.06.002,Pseudovirus (VSV),Figure 1A,Casirivimab,Wild Type (B.1),=,8.4,ng/ml,1,Beta,80,D80Y + D215Y + Δ242-244 + K417N + E484K + N501Y + A701V,1,=,493.9,ng/ml,1,=,58.8,,,
Boschi22,10.1093/cid/ciac143,Virus isolate,Figure 1B,Imdevimab,Wild Type (B.1.1),=,8.9,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ241-244 + K417N + E484K + N501Y + A701V,1,=,3.8,ng/ml,1,=,0.4,,,
Takashita22,10.1056/NEJMc2119407,Virus isolate,Table 1,Imdevimab,Wild Type (A),=,3,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ241-244 + K417N + E484K + N501Y + A701V,1,=,2.2,ng/ml,1,=,0.7,,,
Kaleta22,10.1038/s41467-022-28766-y,Virus isolate,Table 2,Imdevimab,Wild Type (B.1),=,20,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,=,10,ng/ml,1,=,0.5,,,
Planas21b,10.1038/s41586-021-03777-9,Virus isolate,"Fig.1, Extended Data Fig.5, 2021.05.26.445838 Figure 3a",Imdevimab,Wild Type (B.1),=,0.1,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,=,0.1,ng/ml,1,=,1,,,
Dejnirattisai22,10.1016/j.cell.2021.12.046,Virus isolate,"Figure 4C, Table S1",Imdevimab,Wild Type (B),=,32,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,=,7,ng/ml,1,=,0.2,,,
Zhou21b,10.1016/j.cell.2021.02.037,Virus isolate,Dejnirattisai21 Table S2,Imdevimab,Wild Type (B),=,32,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,=,7,ng/ml,1,=,0.2,,,
Wang21b,10.1038/s41586-021-03398-2,Virus isolate,Figure 2a,Imdevimab,Wild Type (A),,,,,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,,,,,=,3.5,,,
Arora22c,10.1016/j.celrep.2022.110754,Pseudovirus (VSV),Supplementary Figure 1D,Imdevimab,Wild Type (B.1),=,10.5,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,=,5.8,ng/ml,1,=,0.6,,,
Cao22d,10.1038/s41586-021-04385-3,Pseudovirus (VSV),Fig 4b,Imdevimab,Wild Type (B.1),=,5,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,=,2,ng/ml,1,=,0.4,,,
Hoffmann21,10.1016/j.cell.2021.03.036,Pseudovirus (VSV),Figure 6,Imdevimab,Wild Type (B.1),=,0.9,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,=,0.9,ng/ml,1,=,1,,,
Hoffmann21c,10.1016/j.celrep.2021.109415,Pseudovirus (VSV),Figure 4,Imdevimab,Wild Type (B.1),=,0.9,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,=,0.9,ng/ml,1,=,1,,,
Miyakawa21b,10.1101/2021.09.23.21264014,Pseudovirus,Figure 1C,Imdevimab,Wild Type (B.1),=,65,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,=,56,ng/ml,1,=,0.9,,,
Tada21,10.1128/mBio.00696-21,Pseudovirus (HIV),Table 3,Imdevimab,Wild Type (B.1),=,19.4,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,=,43.7,ng/ml,1,=,2.3,,,
Tada21c,10.1016/j.isci.2021.103341,Pseudovirus (HIV),Table 1,Imdevimab,Wild Type (B.1),=,50.3,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,=,73.5,ng/ml,1,=,1.5,,,
Tada21d,10.1101/2021.07.02.450959,Pseudovirus (HIV),Figure 2A table,Imdevimab,Wild Type (B.1),=,9.3,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,=,16.4,ng/ml,1,=,1.8,,,
Tada21e,10.3389/fimmu.2022.797589,Pseudovirus (HIV),Figure 2,Imdevimab,Wild Type (B.1),=,9.3,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,=,16.4,ng/ml,1,=,1.8,,,
Tada22,10.1016/j.ebiom.2022.103944,Pseudovirus (lentivirus),Figure 2e,Imdevimab,Wild Type (B.1),=,2,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,=,3.9,ng/ml,1,=,2,,,
Zhou21e,10.1126/science.abn8897,Pseudovirus (lentivirus),Figure 2C,Imdevimab,Wild Type (B.1),=,20,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,=,24.4,ng/ml,1,=,1.2,,,
Chen22e,10.1016/j.celrep.2022.111528,Pseudovirus (lentivirus),Figure 2B,Imdevimab,Wild Type (A),=,9,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,=,2,ng/ml,1,=,0.2,,,
Chen22,10.1101/2022.01.12.22269023,Pseudovirus (lentivirus),Fig 1h,Imdevimab,Wild Type (A),=,9,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,=,2,ng/ml,1,=,0.2,,,
Du22,10.1126/sciimmunol.abp9312,Pseudovirus,Fig 1E,Imdevimab,Wild Type (B),=,4.7,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,=,2.3,ng/ml,1,=,0.5,,,
Pelzek22,10.1101/2022.02.06.479332,Pseudovirus (lentivirus),Extended Table 1,Imdevimab,Wild Type (B),=,23,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,=,10,ng/ml,1,=,0.4,,,
Wang22c,10.1038/s41586-022-04466-x,Pseudovirus (VSV),Supplmentary Table 2,Imdevimab,Wild Type (B),=,13,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,=,7,ng/ml,1,=,0.5,,,
Yuan22,10.1101/2022.03.13.484037,Pseudovirus (MLV),Figure 2A,Imdevimab,Wild Type (B),=,25,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,=,13,ng/ml,1,=,0.5,,,
Wang21b,10.1038/s41586-021-03398-2,Pseudovirus (VSV),Figure 2a,Imdevimab,Wild Type (B.1),,,,,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,,,,,=,0.6,,,
Wang21e,10.1126/science.abh1766,Pseudovirus (lentivirus),Fig 2C,Imdevimab,Wild Type (A),=,71,ng/ml,1,Beta,(Various),(Various),2,=,18.7,ng/ml,1.3,=,0.3,0.2,0.3,
Fenwick21,10.1016/j.celrep.2021.109814,SARS-CoV-2 recombinant,Figure 3B,Imdevimab,Wild Type (B),=,28,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,=,12,ng/ml,1,=,0.4,,,
Yao21,10.1101/2021.01.27.428353,Pseudovirus (MLV),Figure 5,Imdevimab,Wild Type (B),=,6.8,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,=,5,ng/ml,1,=,0.7,,,
Wang21f,10.1016/j.immuni.2021.06.003,Pseudovirus (HIV),"Figure 1C, Figure S1",Imdevimab,Wild Type (B.1),=,4.4,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + S305T + K417N + E484K + N501Y + A701V,1,=,2.2,ng/ml,1,=,0.5,,,
Misasi22,10.1101/2022.07.29.502029,Pseudovirus (lentivirus),Figure 1A,Imdevimab,Wild Type (B.1),=,10.8,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ241-244 + K417N + E484K + N501Y + A701V,1,=,22.1,ng/ml,1,=,2,,,
Chen21e,10.1038/s41586-021-03720-y,SARS-CoV-2 recombinant,Figure 1c,Imdevimab,Wild Type (B.1),=,12,ng/ml,1,Beta,80,D80A + T95I + D215G + Δ242-244 + K417N + E484K + N501Y + A701V,1,=,4,ng/ml,1,=,0.3,,,
Moriyama21,10.1016/j.immuni.2021.06.015,Virus isolate,Figure 3K,Imdevimab,Wild Type (A),=,2581,ng/ml,1,Beta,80,D80A + D215G + Δ241-244 + K417N + E484K + N501Y + A701V,1,=,352,ng/ml,1,=,0.1,,,
Nabel21,10.1126/science.abl6251,Pseudovirus (lentivirus),"Fig 2A, 2B",Imdevimab,Wild Type (B.1),=,32,ng/ml,1,Beta,80,D80A + D215G + Δ241-244 + K417N + E484K + N501Y + A701V,1,=,50,ng/ml,1,=,1.6,,,
Wang22b,10.1101/2022.01.30.478305,Pseudovirus (HIV),Figure 1B,Imdevimab,Wild Type (B),=,2.3,ng/ml,1,Beta,80,D80A + D215G + Δ241-244 + K417N + E484K + N501Y + A701V,1,=,5.7,ng/ml,1,=,2.5,,,
Gruell22,10.1038/s41591-021-01676-0,Pseudovirus (HIV),Fig 2,Imdevimab,Wild Type (B),=,9.4,ng/ml,1,Beta,80,D80A + D215G + Δ242-244 + K417N + E484K + N501Y + A570D + A701V,1,=,1.1,ng/ml,1,=,0.1,,,
Ju22,10.1038/s41422-022-00638-6,Pseudovirus (HIV),Figure S1F,Imdevimab,Wild Type (B),=,2,ng/ml,1,Beta,80,D80A + D215G + Δ241-244 + K417N + E484K + N501Y + A701V,1,=,2,ng/ml,1,=,1,,,
Copin21,10.1016/j.cell.2021.06.002,Pseudovirus (VSV),Figure 1A,Imdevimab,Wild Type (B.1),=,6.9,ng/ml,1,Beta,80,D80Y + D215Y + Δ242-244 + K417N + E484K + N501Y + A701V,1,=,1.2,ng/ml,1,=,0.2,,,
Boschi22,10.1093/cid/ciac143,Virus isolate,Figure 1B,Casirivimab + Imdevimab,Wild Type (B.1.1),=,0.1,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ241-244 + K417N + E484K + N501Y + A701V,1,=,0.8,ng/ml,1,=,5.1,,,
Takashita22,10.1056/NEJMc2119407,Virus isolate,Table 1,Casirivimab + Imdevimab,Wild Type (A),=,7,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ241-244 + K417N + E484K + N501Y + A701V,1,=,10.4,ng/ml,1,=,1.5,,,Combination therapies in this study were specified at ng/ml of each component so needs to multiply by 2
Kaleta22,10.1038/s41467-022-28766-y,Virus isolate,Table 2,Casirivimab + Imdevimab,Wild Type (B.1),=,30,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,=,50,ng/ml,1,=,1.7,,,
FDA21,https://www.fda.gov/drugs/drug-safety-and-availability/fda-authorizes-revisions-fact-sheets-address-sars-cov-2-variants-monoclonal-antibody-products-under,Virus isolate,CAS+IMD Table 10 page 42,Casirivimab + Imdevimab,Wild Type (B),,,,,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,,,,,=,1,,,
Wang21b,10.1038/s41586-021-03398-2,Virus isolate,Fig. 2e,Casirivimab + Imdevimab,Wild Type (A),,,,,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,,,,,=,8.1,,,
Arora22c,10.1016/j.celrep.2022.110754,Pseudovirus (VSV),Supplementary Figure 1D,Casirivimab + Imdevimab,Wild Type (B.1),=,11.1,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,=,17.8,ng/ml,1,=,1.6,,,
Hoffmann21,10.1016/j.cell.2021.03.036,Pseudovirus (VSV),Figure 6,Casirivimab + Imdevimab,Wild Type (B.1),=,1,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,=,1,ng/ml,1,=,1,,,
Hoffmann21c,10.1016/j.celrep.2021.109415,Pseudovirus (VSV),Figure 4,Casirivimab + Imdevimab,Wild Type (B.1),=,2.2,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,=,2.2,ng/ml,1,=,1,,,
Tada21,10.1128/mBio.00696-21,Pseudovirus (HIV),Table 3,Casirivimab + Imdevimab,Wild Type (B.1),=,1.7,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,=,15.5,ng/ml,1,=,9.1,,,
Tada21c,10.1016/j.isci.2021.103341,Pseudovirus (HIV),Table 1,Casirivimab + Imdevimab,Wild Type (B.1),=,8.1,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,=,14.6,ng/ml,1,=,1.8,,,
Tada21d,10.1101/2021.07.02.450959,Pseudovirus (HIV),Figure 2A table,Casirivimab + Imdevimab,Wild Type (B.1),=,4.4,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,=,33.1,ng/ml,1,=,7.5,,,
Tada21e,10.3389/fimmu.2022.797589,Pseudovirus (HIV),Figure 2,Casirivimab + Imdevimab,Wild Type (B.1),=,4.4,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,=,33.1,ng/ml,1,=,7.5,,,
Tada22,10.1016/j.ebiom.2022.103944,Pseudovirus (lentivirus),Figure 2e,Casirivimab + Imdevimab,Wild Type (B.1),=,0.8,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,=,1.1,ng/ml,1,=,1.4,,,
Yuan22,10.1101/2022.03.13.484037,Pseudovirus (MLV),Figure 2A,Casirivimab + Imdevimab,Wild Type (B),=,6,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,=,20,ng/ml,1,=,3.3,,,
Wang21b,10.1038/s41586-021-03398-2,Pseudovirus (VSV),Fig. 2e,Casirivimab + Imdevimab,Wild Type (B.1),,,,,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,,,,,=,1.3,,,
Misasi22,10.1101/2022.07.29.502029,Pseudovirus (lentivirus),Figure 1B,Casirivimab + Imdevimab,Wild Type (B.1),=,3.4,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ241-244 + K417N + E484K + N501Y + A701V,1,=,19.3,ng/ml,1,=,5.7,,,
Chen21e,10.1038/s41586-021-03720-y,SARS-CoV-2 recombinant,Figure 1c,Casirivimab + Imdevimab,Wild Type (B.1),=,5,ng/ml,1,Beta,80,D80A + T95I + D215G + Δ242-244 + K417N + E484K + N501Y + A701V,1,=,8,ng/ml,1,=,1.6,,,
Copin21,10.1016/j.cell.2021.06.002,Pseudovirus (VSV),Figure 1A,Casirivimab + Imdevimab,Wild Type (B.1),=,5.7,ng/ml,1,Beta,80,D80Y + D215Y + Δ242-244 + K417N + E484K + N501Y + A701V,1,=,4.1,ng/ml,1,=,0.7,,,
FDA21,https://www.fda.gov/drugs/drug-safety-and-availability/fda-authorizes-revisions-fact-sheets-address-sars-cov-2-variants-monoclonal-antibody-products-under,Pseudovirus,CAS+IMD Table 9 page 42,Casirivimab + Imdevimab,Wild Type (B),,,,,Beta,80,D80Y + D215Y + Δ242-244 + K417N + E484K + N501Y + A701V,1,,,,,=,1,,,
Aggarwal22b,10.1016/j.ebiom.2022.104270,Virus isolate,Figure 1,Cilgavimab,Wild Type (A.2.2),=,29,ng/ml,1,Beta,18,L18F + A67V + D80A + D215G + Δ241-243 + K417N + E484K + N501Y + A701V,1,=,21,ng/ml,1,=,0.7,,,
Takashita22,10.1056/NEJMc2119407,Virus isolate,Table 1,Cilgavimab,Wild Type (A),=,7.7,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ241-244 + K417N + E484K + N501Y + A701V,1,=,10,ng/ml,1,=,1.3,,,
Dejnirattisai22,10.1016/j.cell.2021.12.046,Virus isolate,"Figure 4C, Table S1",Cilgavimab,Wild Type (B),=,13,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,=,14,ng/ml,1,=,1.1,,,
Zhou21b,10.1016/j.cell.2021.02.037,Virus isolate,Dejnirattisai21 Table S2,Cilgavimab,Wild Type (B),=,13,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,=,14,ng/ml,1,=,1.1,,,
Wang21b,10.1038/s41586-021-03398-2,Virus isolate,Extended Data Fig 5,Cilgavimab,Wild Type (A),,,,,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,,,,,=,0.3,,,
Cao22d,10.1038/s41586-021-04385-3,Pseudovirus (VSV),Fig 4b,Cilgavimab,Wild Type (B.1),=,2,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,=,3,ng/ml,1,=,1.5,,,
Tada22,10.1016/j.ebiom.2022.103944,Pseudovirus (lentivirus),Figure 2e,Cilgavimab,Wild Type (B.1),=,18.2,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,=,59,ng/ml,1,=,3.2,,,
Zhou21e,10.1126/science.abn8897,Pseudovirus (lentivirus),Figure 2C,Cilgavimab,Wild Type (B.1),=,3.7,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,=,5.4,ng/ml,1,=,1.5,,,
Chen22e,10.1016/j.celrep.2022.111528,Pseudovirus (lentivirus),Figure 2B,Cilgavimab,Wild Type (A),=,1,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,=,4,ng/ml,1,=,4,,,
Yuan22,10.1101/2022.03.13.484037,Pseudovirus (MLV),Figure 2A,Cilgavimab,Wild Type (B),=,5,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,=,6,ng/ml,1,=,1.2,,,
Chen21,10.1038/s41591-021-01294-w,SARS-CoV-2 recombinant,"Fig 1h, Source Data fig 1h",Cilgavimab,Wild Type (B.1),,,,,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,,,,,=,0.3,,,
Wang21b,10.1038/s41586-021-03398-2,Pseudovirus (VSV),Extended Data Fig 5,Cilgavimab,Wild Type (B.1),,,,,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,,,,,=,1,,,
Dong21,10.1038/s41564-021-00972-2,SARS-CoV-2 recombinant,Figure 4i,Cilgavimab,Wild Type (B.1),=,28,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,=,22,ng/ml,1,=,0.8,,,
Misasi22,10.1101/2022.07.29.502029,Pseudovirus (lentivirus),Figure 1A,Cilgavimab,Wild Type (B.1),=,4.6,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ241-244 + K417N + E484K + N501Y + A701V,1,=,5,ng/ml,1,=,1.1,,,
Chen21e,10.1038/s41586-021-03720-y,SARS-CoV-2 recombinant,Figure 1c,Cilgavimab,Wild Type (B.1),=,26,ng/ml,1,Beta,80,D80A + T95I + D215G + Δ242-244 + K417N + E484K + N501Y + A701V,1,=,19,ng/ml,1,=,0.7,,,
House22,10.1371/journal.pone.0267796,Pseudovirus,Fig 1A,Cilgavimab,Wild Type (B.1),,,,,Beta,80,D80A + D215G + Δ241-244 + K417N + E484K + N501Y + A701V,1,,,,,=,1.4,,,
Aggarwal22b,10.1016/j.ebiom.2022.104270,Virus isolate,Figure 1,Tixagevimab,Wild Type (A.2.2),=,9,ng/ml,1,Beta,18,L18F + A67V + D80A + D215G + Δ241-243 + K417N + E484K + N501Y + A701V,1,=,58,ng/ml,1,=,6.4,,,
Takashita22,10.1056/NEJMc2119407,Virus isolate,Table 1,Tixagevimab,Wild Type (A),=,1.9,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ241-244 + K417N + E484K + N501Y + A701V,1,=,19,ng/ml,1,=,9.9,,,
Dejnirattisai22,10.1016/j.cell.2021.12.046,Virus isolate,"Figure 4C, Table S1",Tixagevimab,Wild Type (B),=,5,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,=,46,ng/ml,1,=,9.2,,,
Zhou21b,10.1016/j.cell.2021.02.037,Virus isolate,Dejnirattisai21 Table S2,Tixagevimab,Wild Type (B),=,5,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,=,46,ng/ml,1,=,9.2,,,
Wang21b,10.1038/s41586-021-03398-2,Virus isolate,Extended Data Fig 5,Tixagevimab,Wild Type (A),,,,,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,,,,,=,6.3,,,
Cao22d,10.1038/s41586-021-04385-3,Pseudovirus (VSV),Fig 4b,Tixagevimab,Wild Type (B.1),=,1,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,=,14,ng/ml,1,=,14,,,
Tada22,10.1016/j.ebiom.2022.103944,Pseudovirus (lentivirus),Figure 2e,Tixagevimab,Wild Type (B.1),=,41,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,=,24.5,ng/ml,1,=,0.6,,,
Zhou21e,10.1126/science.abn8897,Pseudovirus (lentivirus),Figure 2C,Tixagevimab,Wild Type (B.1),=,2,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,=,3.5,ng/ml,1,=,1.8,,,
Chen22e,10.1016/j.celrep.2022.111528,Pseudovirus (lentivirus),Figure 2B,Tixagevimab,Wild Type (A),=,1,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,=,4,ng/ml,1,=,4,,,
Wang22c,10.1038/s41586-022-04466-x,Pseudovirus (VSV),Supplmentary Table 2,Tixagevimab,Wild Type (B),=,5,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,=,20,ng/ml,1,=,4,,,
Yuan22,10.1101/2022.03.13.484037,Pseudovirus (MLV),Figure 2A,Tixagevimab,Wild Type (B),=,1,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,=,4,ng/ml,1,=,4,,,
Chen21,10.1038/s41591-021-01294-w,SARS-CoV-2 recombinant,"Fig 1h, Source Data fig 1h",Tixagevimab,Wild Type (B.1),,,,,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,,,,,=,1.7,,,
FDA21c,https://www.fda.gov/media/154701/download,Pseudovirus,"Feb 2022, Page 17, Antiviral resistance paragraph 4",Tixagevimab,Wild Type (B),,,,,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,,,,,=,9.3,,,
Wang21b,10.1038/s41586-021-03398-2,Pseudovirus (VSV),Extended Data Fig 5,Tixagevimab,Wild Type (B.1),,,,,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,,,,,=,3.5,,,
Dong21,10.1038/s41564-021-00972-2,SARS-CoV-2 recombinant,Figure 4i,Tixagevimab,Wild Type (B.1),=,4,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,=,25,ng/ml,1,=,6.3,,,
Misasi22,10.1101/2022.07.29.502029,Pseudovirus (lentivirus),Figure 1A,Tixagevimab,Wild Type (B.1),=,1.5,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ241-244 + K417N + E484K + N501Y + A701V,1,=,8.1,ng/ml,1,=,5.5,,,
Chen21e,10.1038/s41586-021-03720-y,SARS-CoV-2 recombinant,Figure 1c,Tixagevimab,Wild Type (B.1),=,4,ng/ml,1,Beta,80,D80A + T95I + D215G + Δ242-244 + K417N + E484K + N501Y + A701V,1,=,23,ng/ml,1,=,5.8,,,
Aggarwal22b,10.1016/j.ebiom.2022.104270,Virus isolate,Figure 1,Cilgavimab + Tixagevimab,Wild Type (A.2.2),=,16,ng/ml,1,Beta,18,L18F + A67V + D80A + D215G + Δ241-243 + K417N + E484K + N501Y + A701V,1,=,20,ng/ml,1,=,1.3,,,
Takashita22,10.1056/NEJMc2119407,Virus isolate,Table 1,Cilgavimab + Tixagevimab,Wild Type (A),=,6.8,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ241-244 + K417N + E484K + N501Y + A701V,1,=,20.6,ng/ml,1,=,3,,,Combination therapies in this study were specified at ng/ml of each component so needs to multiply by 2
Dejnirattisai22,10.1016/j.cell.2021.12.046,Virus isolate,"Figure 4C, Table S1",Cilgavimab + Tixagevimab,Wild Type (B),=,9,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,=,12,ng/ml,1,=,1.3,,,
Zhou21b,10.1016/j.cell.2021.02.037,Virus isolate,Dejnirattisai21 Table S2,Cilgavimab + Tixagevimab,Wild Type (B),=,9,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,=,12,ng/ml,1,=,1.3,,,
EMA21e,https://www.ema.europa.eu/en/documents/product-information/evusheld-epar-product-information_en.pdf,Virus isolate,Table 3,Cilgavimab + Tixagevimab,Wild Type (B),=,8,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,=,6.5,ng/ml,1,=,0.8,,,
FDA21c,https://www.fda.gov/media/154701/download,Virus isolate,"Feb 2022, Table 6",Cilgavimab + Tixagevimab,Wild Type (B),,,,,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,,,,,=,1,,,
Wang21b,10.1038/s41586-021-03398-2,Virus isolate,Fig. 2e,Cilgavimab + Tixagevimab,Wild Type (A),,,,,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,,,,,=,12,,,
Tada22,10.1016/j.ebiom.2022.103944,Pseudovirus (lentivirus),Figure 2e,Cilgavimab + Tixagevimab,Wild Type (B.1),=,13.6,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,=,27.8,ng/ml,1,=,2,,,
EMA21e,https://www.ema.europa.eu/en/documents/product-information/evusheld-epar-product-information_en.pdf,Pseudovirus,Table 3,Cilgavimab + Tixagevimab,Wild Type (B),=,1.9,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,=,5.6,ng/ml,1,=,2.9,,,
Yuan22,10.1101/2022.03.13.484037,Pseudovirus (MLV),Figure 2A,Cilgavimab + Tixagevimab,Wild Type (B),=,5,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,=,7,ng/ml,1,=,1.4,,,
Chen21,10.1038/s41591-021-01294-w,SARS-CoV-2 recombinant,"Fig 1h, Source Data fig 1h",Cilgavimab + Tixagevimab,Wild Type (B.1),,,,,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,,,,,=,0.8,,,
FDA21c,https://www.fda.gov/media/154701/download,Pseudovirus,"Feb 2022, Table 6, Page 17, Antiviral resistance paragraph 6",Cilgavimab + Tixagevimab,Wild Type (B),,,,,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,,,,,=,2.4,,,
Wang21b,10.1038/s41586-021-03398-2,Pseudovirus (VSV),Fig. 2e,Cilgavimab + Tixagevimab,Wild Type (B.1),,,,,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,,,,,=,1.3,,,
Dong21,10.1038/s41564-021-00972-2,SARS-CoV-2 recombinant,Figure 4i,Cilgavimab + Tixagevimab,Wild Type (B.1),=,4,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,=,15,ng/ml,1,=,3.8,,,
Misasi22,10.1101/2022.07.29.502029,Pseudovirus (lentivirus),Figure 1B,Cilgavimab + Tixagevimab,Wild Type (B.1),=,2.2,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ241-244 + K417N + E484K + N501Y + A701V,1,=,4.3,ng/ml,1,=,2,,,
Chen21e,10.1038/s41586-021-03720-y,SARS-CoV-2 recombinant,Figure 1c,Cilgavimab + Tixagevimab,Wild Type (B.1),=,4,ng/ml,1,Beta,80,D80A + T95I + D215G + Δ242-244 + K417N + E484K + N501Y + A701V,1,=,11,ng/ml,1,=,2.8,,,
Aggarwal22b,10.1016/j.ebiom.2022.104270,Virus isolate,Figure 1,Sotrovimab,Wild Type (A.2.2),=,384,ng/ml,1,Beta,18,L18F + A67V + D80A + D215G + Δ241-243 + K417N + E484K + N501Y + A701V,1,=,269,ng/ml,1,=,0.7,,,
Takashita22,10.1056/NEJMc2119407,Virus isolate,Table 1,Sotrovimab,Wild Type (A),=,27.3,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ241-244 + K417N + E484K + N501Y + A701V,1,=,101,ng/ml,1,=,3.7,,,
Dejnirattisai22,10.1016/j.cell.2021.12.046,Virus isolate,"Figure 4C, Table S1",Sotrovimab,Wild Type (B),=,40,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,=,82,ng/ml,1,=,2.1,,,
Zhou21b,10.1016/j.cell.2021.02.037,Virus isolate,Dejnirattisai21 Table S2,Sotrovimab,Wild Type (B),=,40,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,=,82,ng/ml,1,=,2.1,,,
Cathcart21,10.1101/2021.03.09.434607,Virus isolate,Table 1,Sotrovimab,Wild Type (A),,,,,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,,,,,=,1.2,,,
EMA21d,https://www.ema.europa.eu/en/documents/product-information/xevudy-epar-product-information_en.pdf,Virus isolate,Table 2,Sotrovimab,Wild Type (B),,,,,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,,,,,=,1,,,
FDA21e,https://www.fda.gov/media/149534/download,Virus isolate,"SOT Page 22, Table 1",Sotrovimab,Wild Type (B),,,,,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,,,,,=,1.2,,,
Wang21b,10.1038/s41586-021-03398-2,Virus isolate,"Fig. 2c, 2e",Sotrovimab,Wild Type (A),,,,,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,,,,,=,2.2,,,
Cao22d,10.1038/s41586-021-04385-3,Pseudovirus (VSV),Fig 4b,Sotrovimab,Wild Type (B.1),=,58,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,=,50,ng/ml,1,=,0.9,,,
Liu22,10.1126/scitranslmed.abn6859,Pseudovirus (VSV),Fig2A,Sotrovimab,Wild Type (B.1),=,11,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,=,26,ng/ml,1,=,2.4,,,
Tada22,10.1016/j.ebiom.2022.103944,Pseudovirus (lentivirus),Figure 2e,Sotrovimab,Wild Type (B.1),=,123.2,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,=,605.6,ng/ml,1,=,4.9,,,
Zhou21e,10.1126/science.abn8897,Pseudovirus (lentivirus),Figure 2C,Sotrovimab,Wild Type (B.1),=,36.1,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,=,27.7,ng/ml,1,=,0.8,,,
Chen22e,10.1016/j.celrep.2022.111528,Pseudovirus (lentivirus),Figure 2B,Sotrovimab,Wild Type (A),=,184,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,=,65,ng/ml,1,=,0.4,,,
Pelzek22,10.1101/2022.02.06.479332,Pseudovirus (lentivirus),Extended Table 1,Sotrovimab,Wild Type (B),=,3819,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,=,192,ng/ml,1,=,0.1,,,
Wang22c,10.1038/s41586-022-04466-x,Pseudovirus (VSV),Supplmentary Table 2,Sotrovimab,Wild Type (B),=,68,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,=,62,ng/ml,1,=,0.9,,,
Yuan22,10.1101/2022.03.13.484037,Pseudovirus (MLV),Figure 2A,Sotrovimab,Wild Type (B),=,72,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,=,233,ng/ml,1,=,3.2,,,
Chen21,10.1038/s41591-021-01294-w,SARS-CoV-2 recombinant,"Fig 1h, Source Data fig 1h",Sotrovimab,Wild Type (B.1),,,,,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,,,,,=,1,,,
Chen21,10.1038/s41591-021-01294-w,Pseudovirus (VSV),Extended Data Fig. 3b,Sotrovimab,Wild Type (B.1),,,,,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,,,,,=,1,,,
EMA21d,https://www.ema.europa.eu/en/documents/product-information/xevudy-epar-product-information_en.pdf,Pseudovirus,Table 2,Sotrovimab,Wild Type (B),,,,,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,,,,,=,1,,,
Wang21b,10.1038/s41586-021-03398-2,Pseudovirus (VSV),Figure 2a,Sotrovimab,Wild Type (B.1),,,,,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,,,,,=,0.8,,,
Fenwick21,10.1016/j.celrep.2021.109814,SARS-CoV-2 recombinant,Figure 3B,Sotrovimab,Wild Type (B),=,147,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,=,365,ng/ml,1,=,2.5,,,
Wang21f,10.1016/j.immuni.2021.06.003,Pseudovirus (HIV),"Figure 1C, Figure S1",Sotrovimab,Wild Type (B.1),=,4.1,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + S305T + K417N + E484K + N501Y + A701V,1,=,2,ng/ml,1,=,0.5,,,
Misasi22,10.1101/2022.07.29.502029,Pseudovirus (lentivirus),Figure 1A,Sotrovimab,Wild Type (B.1),=,84.6,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ241-244 + K417N + E484K + N501Y + A701V,1,=,53.4,ng/ml,1,=,0.6,,,
Cathcart21,10.1101/2021.03.09.434607,Pseudovirus (VSV),Table 2,Sotrovimab,Wild Type (B),,,,,Beta,18,L18F + D80A + D215G + R246I + K417N + E484K + N501Y + A701V,1,,,,,=,0.6,,,
FDA21e,https://www.fda.gov/media/149534/download,Pseudovirus,"SOT Page 22, Table 1",Sotrovimab,Wild Type (B),,,,,Beta,18,L18F + D80A + D215G + R246I + K417N + E484K + N501Y + A701V,1,,,,,=,0.6,,,
Chen21e,10.1038/s41586-021-03720-y,SARS-CoV-2 recombinant,Figure 1c,Sotrovimab,Wild Type (B.1),=,156,ng/ml,1,Beta,80,D80A + T95I + D215G + Δ242-244 + K417N + E484K + N501Y + A701V,1,=,98,ng/ml,1,=,0.6,,,
Wang22b,10.1101/2022.01.30.478305,Pseudovirus (HIV),Figure 1B,Sotrovimab,Wild Type (B),=,30.8,ng/ml,1,Beta,80,D80A + D215G + Δ241-244 + K417N + E484K + N501Y + A701V,1,=,41.1,ng/ml,1,=,1.3,,,
Gruell22,10.1038/s41591-021-01676-0,Pseudovirus (HIV),Fig 2,Sotrovimab,Wild Type (B),=,1964.2,ng/ml,1,Beta,80,D80A + D215G + Δ242-244 + K417N + E484K + N501Y + A570D + A701V,1,=,33.5,ng/ml,1,<,0.1,,,
Liu22,10.1126/scitranslmed.abn6859,Virus isolate,Fig2B,Sotrovimab,Wild Type (A),=,39,ng/ml,1,Beta,80,D80A + D215G + Δ241-244 + K417N + E484K + N501Y + A701V,1,=,27,ng/ml,1,=,0.7,,,
Ju22,10.1038/s41422-022-00638-6,Pseudovirus (HIV),Figure S1F,Sotrovimab,Wild Type (B),=,93,ng/ml,1,Beta,80,D80A + D215G + Δ241-244 + K417N + E484K + N501Y + A701V,1,=,42,ng/ml,1,=,0.5,,,
Westendorf22,10.1016/j.celrep.2022.110812,Virus isolate,Table 3A,Bebtelovimab,Wild Type (A),=,11,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ241-244 + K417N + E484K + N501Y + A701V,1,=,7,ng/ml,1,=,0.6,,,
FDA22,https://www.fda.gov/media/156152/download,Virus isolate,"Mar 2022, Page 14, antiviral resistance, Table 3",Bebtelovimab,Wild Type (B),,,,,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,,,,,=,1,,,
Cao22d,10.1038/s41586-021-04385-3,Pseudovirus (VSV),41586_2021_4385_MOESM1_ESM.xlsx,Bebtelovimab,Wild Type (B.1),=,1.5,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,=,2.1,ng/ml,1,=,1.4,,,
Zhou21e,10.1126/science.abn8897,Pseudovirus (lentivirus),Figure 2C,Bebtelovimab,Wild Type (B.1),=,3,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,=,4.1,ng/ml,1,=,1.4,,,
Westendorf22,10.1016/j.celrep.2022.110812,Pseudovirus (VSV),Table 3B,Bebtelovimab,Wild Type (A),=,3,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,=,2,ng/ml,1,=,0.7,,,
Westendorf22,10.1016/j.celrep.2022.110812,Pseudovirus (lentivirus),Table 3B,Bebtelovimab,Wild Type (A),=,5,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,=,3,ng/ml,1,=,0.6,,,
FDA22,https://www.fda.gov/media/156152/download,Pseudovirus,"Mar 2022, Page 13, antiviral resistance, Table 2",Bebtelovimab,Wild Type (B),,,,,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,,,,,=,1,,,
Misasi22,10.1101/2022.07.29.502029,Pseudovirus (lentivirus),Figure 1A,Bebtelovimab,Wild Type (B.1),=,3.3,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ241-244 + K417N + E484K + N501Y + A701V,1,=,7.7,ng/ml,1,=,2.4,,,
Ryu21,10.1016/j.bbrc.2021.06.016,Virus isolate,Supplementary Table 4,Regdanvimab,Wild Type (B.1),=,2,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,=,39.5,ng/ml,1,=,19.8,,,
EMA21c,https://www.ema.europa.eu/en/documents/product-information/regkirona-epar-product-information_en.pdf,Virus isolate,Table 3,Regdanvimab,Wild Type (B),,,,,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,,,,,=,310.1,,,
Ryu21,10.1016/j.bbrc.2021.06.016,Pseudovirus (HIV),Supplementary Table 3,Regdanvimab,Wild Type (B.1),=,10,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,=,330,ng/ml,1,=,33,,,
Zhou21e,10.1126/science.abn8897,Pseudovirus (lentivirus),Figure 2C,Regdanvimab,Wild Type (B.1),=,1.5,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,=,65.8,ng/ml,1,=,43.9,,,
EMA21c,https://www.ema.europa.eu/en/documents/product-information/regkirona-epar-product-information_en.pdf,Pseudovirus,Table 3,Regdanvimab,Wild Type (B),,,,,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,,,,,=,184.3,,,
Misasi22,10.1101/2022.07.29.502029,Pseudovirus (lentivirus),Figure 1A,Regdanvimab,Wild Type (B.1),=,2.8,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ241-244 + K417N + E484K + N501Y + A701V,1,=,97.1,ng/ml,1,=,34.4,,,
Wang21b,10.1038/s41586-021-03398-2,Virus isolate,Extended Data Fig 5,Amubarvimab,Wild Type (A),,,,,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,,,,,=,0.5,,,
Cao22d,10.1038/s41586-021-04385-3,Pseudovirus (VSV),Fig 4b,Amubarvimab,Wild Type (B.1),=,53,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,=,30,ng/ml,1,=,0.6,,,
Wang21b,10.1038/s41586-021-03398-2,Pseudovirus (VSV),Extended Data Fig 5,Amubarvimab,Wild Type (B.1),,,,,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,,,,,=,0.6,,,
Wang21f,10.1016/j.immuni.2021.06.003,Pseudovirus (HIV),"Figure 1C, Figure S1",Amubarvimab,Wild Type (B.1),=,14.1,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + S305T + K417N + E484K + N501Y + A701V,1,=,6.4,ng/ml,1,=,0.5,,,
Li21c,10.1016/j.cell.2021.02.042,Pseudovirus (VSV),Figure S2,Amubarvimab,Wild Type (B.1),,,,,Beta,(Various),(Various),2,,,,,=,1,1,1,
Wang21b,10.1038/s41586-021-03398-2,Virus isolate,Extended Data Fig 5,Romlusevimab,Wild Type (A),,,,,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,,,,,=,14.6,,,
Wang21b,10.1038/s41586-021-03398-2,Pseudovirus (VSV),Extended Data Fig 5,Romlusevimab,Wild Type (B.1),,,,,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,,,,,=,3.4,,,
Wang21f,10.1016/j.immuni.2021.06.003,Pseudovirus (HIV),"Figure 1C, Figure S1",Romlusevimab,Wild Type (B.1),=,18.6,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + S305T + K417N + E484K + N501Y + A701V,1,=,111.5,ng/ml,1,=,6,,,
Margolis21,https://idweek.org/Margolis,Virus isolate,Table 2,Amubarvimab + Romlusevimab,Wild Type (B),,,,,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,,,,,=,2.5,,,
Wang21b,10.1038/s41586-021-03398-2,Virus isolate,Fig. 2e,Amubarvimab + Romlusevimab,Wild Type (A),,,,,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,,,,,=,1.1,,,
Margolis21,https://idweek.org/Margolis,Pseudovirus,Table 2,Amubarvimab + Romlusevimab,Wild Type (B.1),,,,,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,,,,,=,2.5,,,
Wang21b,10.1038/s41586-021-03398-2,Pseudovirus (VSV),Fig. 2e,Amubarvimab + Romlusevimab,Wild Type (B.1),,,,,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,,,,,=,0.8,,,
Cao22d,10.1038/s41586-021-04385-3,Pseudovirus (VSV),Fig 4b,DXP-604,Wild Type (B.1),=,10,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,=,65,ng/ml,1,=,6.5,,,
Wang22c,10.1038/s41586-022-04466-x,Pseudovirus (VSV),Supplmentary Table 2,DXP-604,Wild Type (B),=,17,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,=,171,ng/ml,1,=,10.1,,,
Chen21,10.1038/s41591-021-01294-w,SARS-CoV-2 recombinant,"Fig 1h, Source Data fig 1h",S2E12 + Sotrovimab,Wild Type (B.1),,,,,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,,,,,=,0.6,,,
Chen21e,10.1038/s41586-021-03720-y,SARS-CoV-2 recombinant,Figure 1c,S2E12 + Sotrovimab,Wild Type (B.1),=,7,ng/ml,1,Beta,80,D80A + T95I + D215G + Δ242-244 + K417N + E484K + N501Y + A701V,1,=,15,ng/ml,1,=,2.1,,,
Cobb22,10.1016/j.medj.2022.01.004,Virus isolate,Table 1,COV2-2381 + Cilgavimab,Wild Type (A),=,28,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,=,19,ng/ml,1,=,0.7,,,
House22,10.1371/journal.pone.0267796,Pseudovirus,Fig 1A,COV2-2381 + Cilgavimab,Wild Type (B.1),,,,,Beta,80,D80A + D215G + Δ241-244 + K417N + E484K + N501Y + A701V,1,,,,,=,0.8,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b; Extended Data Table 1a,Bamlanivimab,Wild Type (B.1),=,4,ng/ml,1,Omicron/BA.2,(Various),(Various),2,>,10000,ng/ml,1,>,1000,2500,2500,
Yamasoba22b,10.1016/S1473-3099(22)00365-6,Pseudovirus (HIV),Table,Bamlanivimab,Wild Type (B.1),=,12.8,ng/ml,1,Omicron/BA.2,(Various),(Various),2,>,3700,ng/ml,1,>,289.1,289.1,289.1,
Gruell22c,10.1016/S1473-3099(22)00580-1,Pseudovirus,Figure B,Bamlanivimab,Wild Type (B.1),=,5,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Saito22,10.1016/j.chom.2022.10.003,Pseudovirus (lentivirus),Table 1,Bamlanivimab,Wild Type (B.1),=,6.7,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,4725,ng/ml,1,>,705.2,,,
Arora22b,10.1016/j.chom.2022.04.017,Pseudovirus (VSV),Supplementary Table 1,Bamlanivimab,Wild Type (B.1),=,23.2,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,431.6,,,
Arora22e,10.1016/S1473-3099(22)00422-4,Pseudovirus (VSV),Supplementary Figure B,Bamlanivimab,Wild Type (B.1),=,11.3,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,5000,ng/ml,1,>,442.5,,,
Cao22,10.1101/2022.02.07.479349,Pseudovirus (VSV),Table S2,Bamlanivimab,Wild Type (B.1),=,12.8,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,781.3,,,
Cao22c,10.1016/j.chom.2022.09.018,Pseudovirus (VSV),Figure 5b,Bamlanivimab,Wild Type (B.1),=,15,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,666.7,,,
Iketani22,10.1038/s41586-022-04594-4,Pseudovirus (VSV),Figure 2a,Bamlanivimab,Wild Type (B.1),=,7.2,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Misasi22,10.1101/2022.07.29.502029,Pseudovirus (lentivirus),Figure 1A,Bamlanivimab,Wild Type (B.1),=,2.8,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10050,ng/ml,1,>,1000,,,
Sheward22b,10.1101/2022.07.19.500716,Pseudovirus (lentivirus),Table S1,Bamlanivimab,Wild Type (B.1),=,7,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,1000,ng/ml,1,>,142.9,,,Some LOD values of 10000 were reported. Corrected to 1000
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Bamlanivimab,Wild Type (B.1),=,6,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Yamasoba22c,10.1101/2022.07.14.500041,Pseudovirus,Table 1,Bamlanivimab,Wild Type (B.1),=,6.7,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,4725,ng/ml,1,>,705.2,,,
Tuekprakhon22,10.1016/j.cell.2022.06.005,Pseudovirus (lentivirus),Figure 3,Bamlanivimab,Wild Type (B),=,2,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Huo22b,10.1016/j.celrep.2022.111903,Pseudovirus (lentivirus),Supplementary Table 1B,Bamlanivimab,Wild Type (B),=,2,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Chen22e,10.1016/j.celrep.2022.111528,Pseudovirus (lentivirus),Figure 2B,Bamlanivimab,Wild Type (A),=,3,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Ai22,10.1016/j.chom.2022.05.001,Pseudovirus (VSV),Figure 3A,Bamlanivimab,Wild Type (B),=,3,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Gruell22b,10.1016/j.chom.2022.07.002,Pseudovirus (HIV),Figure 4B,Bamlanivimab,Wild Type (B),=,5,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Huang22,10.1016/j.immuni.2022.06.005,Pseudovirus (VSV),Figure 2,Bamlanivimab,Wild Type (B),=,10,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,100000,ng/ml,1,>,1000,,,
Takashita22b,10.1056/NEJMc2201933,Virus isolate,Table 1,Bamlanivimab,Wild Type (A),=,4.7,ng/ml,1,Omicron/BA.2,19,T19I + Δ24-26 + A27S + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,50000,ng/ml,1,>,1000,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b; Extended Data Table 1a,Etesevimab,Wild Type (B.1),=,12,ng/ml,1,Omicron/BA.2,(Various),(Various),2,>,10000,ng/ml,1,>,833.3,833.3,833.3,
Yamasoba22b,10.1016/S1473-3099(22)00365-6,Pseudovirus (HIV),Table,Etesevimab,Wild Type (B.1),=,12,ng/ml,1,Omicron/BA.2,(Various),(Various),2,>,6050,ng/ml,1,>,504.2,504.2,504.2,
Gruell22c,10.1016/S1473-3099(22)00580-1,Pseudovirus,Figure B,Etesevimab,Wild Type (B.1),=,30,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,333.3,,,
Saito22,10.1016/j.chom.2022.10.003,Pseudovirus (lentivirus),Table 1,Etesevimab,Wild Type (B.1),=,12,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,4600,ng/ml,1,>,383.3,,,
Arora22b,10.1016/j.chom.2022.04.017,Pseudovirus (VSV),Supplementary Table 1,Etesevimab,Wild Type (B.1),=,20.6,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,486.1,,,
Arora22e,10.1016/S1473-3099(22)00422-4,Pseudovirus (VSV),Supplementary Figure B,Etesevimab,Wild Type (B.1),=,22.2,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,5000,ng/ml,1,>,225.2,,,
Cao22,10.1101/2022.02.07.479349,Pseudovirus (VSV),Table S2,Etesevimab,Wild Type (B.1),=,31.6,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,316.5,,,
Cao22c,10.1016/j.chom.2022.09.018,Pseudovirus (VSV),Figure 5b,Etesevimab,Wild Type (B.1),=,32,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,312.5,,,
Iketani22,10.1038/s41586-022-04594-4,Pseudovirus (VSV),Figure 2a,Etesevimab,Wild Type (B.1),=,22.5,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,444.4,,,
Misasi22,10.1101/2022.07.29.502029,Pseudovirus (lentivirus),Figure 1A,Etesevimab,Wild Type (B.1),=,23.3,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10050,ng/ml,1,>,432.3,,,
Sheward22b,10.1101/2022.07.19.500716,Pseudovirus (lentivirus),Table S1,Etesevimab,Wild Type (B.1),=,34,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,1000,ng/ml,1,>,29.4,,,Some LOD values of 10000 were reported. Corrected to 1000
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Etesevimab,Wild Type (B.1),=,9,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Yamasoba22c,10.1101/2022.07.14.500041,Pseudovirus,Table 1,Etesevimab,Wild Type (B.1),=,12,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,4600,ng/ml,1,>,383.3,,,
Tuekprakhon22,10.1016/j.cell.2022.06.005,Pseudovirus (lentivirus),Figure 3,Etesevimab,Wild Type (B),=,14,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,714.3,,,
Huo22b,10.1016/j.celrep.2022.111903,Pseudovirus (lentivirus),Supplementary Table 1B,Etesevimab,Wild Type (B),=,14,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,714.3,,,
Chen22e,10.1016/j.celrep.2022.111528,Pseudovirus (lentivirus),Figure 2B,Etesevimab,Wild Type (A),=,19,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,526.3,,,
Ai22,10.1016/j.chom.2022.05.001,Pseudovirus (VSV),Figure 3A,Etesevimab,Wild Type (B),=,7,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Gruell22b,10.1016/j.chom.2022.07.002,Pseudovirus (HIV),Figure 4B,Etesevimab,Wild Type (B),=,18,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,555.6,,,
Huang22,10.1016/j.immuni.2022.06.005,Pseudovirus (VSV),Figure 2,Etesevimab,Wild Type (B),=,20,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,100000,ng/ml,1,>,1000,,,
Bruel22,10.1038/s41591-022-01792-5,Virus isolate,Table 1,Etesevimab,Delta,=,3.8,ng/ml,1,Omicron/BA.2,19,T19I + Δ24-26 + A27S + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + R682W + N764K + D796Y + Q954H + N969K,1,>,9000,ng/ml,1,>,1000,,,
Takashita22b,10.1056/NEJMc2201933,Virus isolate,Table 1,Etesevimab,Wild Type (A),=,18.2,ng/ml,1,Omicron/BA.2,19,T19I + Δ24-26 + A27S + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,50000,ng/ml,1,>,1000,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b; Extended Data Table 1a,Bamlanivimab + Etesevimab,Wild Type (B.1),=,5,ng/ml,1,Omicron/BA.2,(Various),(Various),2,>,10000,ng/ml,1,>,1000,2000,2000,
Yamasoba22b,10.1016/S1473-3099(22)00365-6,Pseudovirus (HIV),Table,Bamlanivimab + Etesevimab,Wild Type (B.1),=,6.7,ng/ml,1,Omicron/BA.2,(Various),(Various),2,>,3700,ng/ml,1,>,552.2,552.2,552.2,
Saito22,10.1016/j.chom.2022.10.003,Pseudovirus (lentivirus),Table 1,Bamlanivimab + Etesevimab,Wild Type (B.1),=,8.3,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,4600,ng/ml,1,>,554.2,,,
Arora22b,10.1016/j.chom.2022.04.017,Pseudovirus (VSV),Supplementary Table 1,Bamlanivimab + Etesevimab,Wild Type (B.1),=,13.5,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,743.5,,,
Arora22e,10.1016/S1473-3099(22)00422-4,Pseudovirus (VSV),Supplementary Figure B,Bamlanivimab + Etesevimab,Wild Type (B.1),=,16.9,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,5000,ng/ml,1,>,295.9,,,
Cao22c,10.1016/j.chom.2022.09.018,Pseudovirus (VSV),Figure 5b,Bamlanivimab + Etesevimab,Wild Type (B.1),=,20,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,500,,,
Iketani22,10.1038/s41586-022-04594-4,Pseudovirus (VSV),Figure 2a,Bamlanivimab + Etesevimab,Wild Type (B.1),=,10,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Misasi22,10.1101/2022.07.29.502029,Pseudovirus (lentivirus),Figure 1B,Bamlanivimab + Etesevimab,Wild Type (B.1),=,5.6,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10050,ng/ml,1,>,1000,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Bamlanivimab + Etesevimab,Wild Type (B.1),=,6,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Yamasoba22c,10.1101/2022.07.14.500041,Pseudovirus,Table 1,Bamlanivimab + Etesevimab,Wild Type (B.1),=,8.3,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,4600,ng/ml,1,>,554.2,,,
Chen22e,10.1016/j.celrep.2022.111528,Pseudovirus (lentivirus),Figure 2C,Bamlanivimab + Etesevimab,Wild Type (A),=,1.5,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Park22,10.1126/science.adc9127,Pseudovirus (VSV),Fig 1A,Bamlanivimab + Etesevimab,Wild Type (B),=,17,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,588.2,,,
Takashita22b,10.1056/NEJMc2201933,Virus isolate,Table 1,Bamlanivimab + Etesevimab,Wild Type (A),=,25.2,ng/ml,1,Omicron/BA.2,19,T19I + Δ24-26 + A27S + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,20000,ng/ml,1,>,793.7,,,Combination therapies in this study were specified at ng/ml of each component so needs to multiply by 2
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b; Extended Data Table 1a,Casirivimab,Wild Type (B.1),=,5,ng/ml,1,Omicron/BA.2,(Various),(Various),2,>,10000,ng/ml,1,>,1000,2000,2000,
Yamasoba22b,10.1016/S1473-3099(22)00365-6,Pseudovirus (HIV),Table,Casirivimab,Wild Type (B.1),=,9.9,ng/ml,1,Omicron/BA.2,(Various),(Various),2,>,50417,ng/ml,1,>,1000,5092.6,5092.6,
Gruell22c,10.1016/S1473-3099(22)00580-1,Pseudovirus,Figure B,Casirivimab,Wild Type (B.1),=,5,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Saito22,10.1016/j.chom.2022.10.003,Pseudovirus (lentivirus),Table 1,Casirivimab,Wild Type (B.1),=,3.4,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,5042,ng/ml,1,>,1000,,,
Arora22b,10.1016/j.chom.2022.04.017,Pseudovirus (VSV),Supplementary Table 1,Casirivimab,Wild Type (B.1),=,19.1,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1998,ng/ml,1,=,104.3,,,
Arora22e,10.1016/S1473-3099(22)00422-4,Pseudovirus (VSV),Supplementary Figure B,Casirivimab,Wild Type (B.1),=,12.1,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,938,ng/ml,1,=,77.5,,,
Cao22,10.1101/2022.02.07.479349,Pseudovirus (VSV),Table S2,Casirivimab,Wild Type (B.1),=,5.3,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Cao22c,10.1016/j.chom.2022.09.018,Pseudovirus (VSV),Figure 5b,Casirivimab,Wild Type (B.1),=,5.6,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Iketani22,10.1038/s41586-022-04594-4,Pseudovirus (VSV),Figure 2a,Casirivimab,Wild Type (B.1),=,4.8,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Misasi22,10.1101/2022.07.29.502029,Pseudovirus (lentivirus),Figure 1A,Casirivimab,Wild Type (B.1),=,5.3,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10050,ng/ml,1,>,1000,,,
Sheward22b,10.1101/2022.07.19.500716,Pseudovirus (lentivirus),Table S1,Casirivimab,Wild Type (B.1),=,11,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,1000,ng/ml,1,>,90.9,,,Some LOD values of 10000 were reported. Corrected to 1000
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Casirivimab,Wild Type (B.1),=,3,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Willett22,10.1101/2022.05.25.493397,Pseudovirus (lentivirus),Figure 1L,Casirivimab,Wild Type (B.1),=,3,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,21878,ng/ml,1,>,1000,,,
Yamasoba22,10.1016/j.cell.2022.04.035,Pseudovirus (HIV),Figure 2E,Casirivimab,Wild Type (B.1),=,8.7,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Yamasoba22c,10.1101/2022.07.14.500041,Pseudovirus,Table 1,Casirivimab,Wild Type (B.1),=,3.4,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,5042,ng/ml,1,>,1000,,,
Tuekprakhon22,10.1016/j.cell.2022.06.005,Pseudovirus (lentivirus),Figure 3,Casirivimab,Wild Type (B),=,1,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Huo22b,10.1016/j.celrep.2022.111903,Pseudovirus (lentivirus),Supplementary Table 1B,Casirivimab,Wild Type (B),=,1,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Chen22e,10.1016/j.celrep.2022.111528,Pseudovirus (lentivirus),Figure 2B,Casirivimab,Wild Type (A),=,2,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Ai22,10.1016/j.chom.2022.05.001,Pseudovirus (VSV),Figure 3A,Casirivimab,Wild Type (B),=,2,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Gruell22b,10.1016/j.chom.2022.07.002,Pseudovirus (HIV),Figure 4B,Casirivimab,Wild Type (B),=,5,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Huang22,10.1016/j.immuni.2022.06.005,Pseudovirus (VSV),Figure 2,Casirivimab,Wild Type (B),=,11,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,100000,ng/ml,1,>,1000,,,
Ohashi22,10.1101/2022.02.27.482147,Virus isolate,Table 1,Casirivimab,Wild Type (A),=,13.9,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,719.4,,,
Du22,10.1126/sciimmunol.abp9312,Virus isolate,Fig 1E,Casirivimab,Wild Type (B),=,3.4,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,1000,ng/ml,1,>,294.1,,,
Touret22c,10.1101/2022.12.22.521201,Virus isolate,Table 1,Casirivimab,Delta,=,14.7,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,5000,ng/ml,1,>,340.1,,,
Bruel22,10.1038/s41591-022-01792-5,Virus isolate,Table 1,Casirivimab,Delta,=,0.6,ng/ml,1,Omicron/BA.2,19,T19I + Δ24-26 + A27S + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + R682W + N764K + D796Y + Q954H + N969K,1,>,9000,ng/ml,1,>,1000,,,
Takashita22b,10.1056/NEJMc2201933,Virus isolate,Table 1,Casirivimab,Wild Type (A),=,2.8,ng/ml,1,Omicron/BA.2,19,T19I + Δ24-26 + A27S + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1666.2,ng/ml,1,=,597.2,,,
Takashita22c,10.1056/NEJMc2207519,Virus isolate,Table 1,Casirivimab,Wild Type (A),=,6.1,ng/ml,1,Omicron/BA.2,(Various),(Various),2,>,50000,ng/ml,1,>,1000,8196.7,8196.7,
Takashita22d,10.1056/NEJMc2209952,Virus isolate,Table 1,Casirivimab,Wild Type (A),=,2.4,ng/ml,1,Omicron/BA.2,19,T19I + Δ24-26 + A27S + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,50000,ng/ml,1,>,1000,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b; Extended Data Table 1a,Imdevimab,Wild Type (B.1),=,1,ng/ml,1,Omicron/BA.2,(Various),(Various),2,=,387.9,ng/ml,1.3,=,401.5,349.8,453.3,
Yamasoba22b,10.1016/S1473-3099(22)00365-6,Pseudovirus (HIV),Table,Imdevimab,Wild Type (B.1),=,79,ng/ml,1,Omicron/BA.2,(Various),(Various),2,>,50000,ng/ml,1,>,632.9,632.9,632.9,
Gruell22c,10.1016/S1473-3099(22)00580-1,Pseudovirus,Figure B,Imdevimab,Wild Type (B.1),=,5,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,2001,ng/ml,1,=,400.2,,,
Saito22,10.1016/j.chom.2022.10.003,Pseudovirus (lentivirus),Table 1,Imdevimab,Wild Type (B.1),=,8,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,5000,ng/ml,1,>,625,,,
Arora22b,10.1016/j.chom.2022.04.017,Pseudovirus (VSV),Supplementary Table 1,Imdevimab,Wild Type (B.1),=,23.7,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1166,ng/ml,1,=,49.1,,,
Arora22e,10.1016/S1473-3099(22)00422-4,Pseudovirus (VSV),Supplementary Figure B,Imdevimab,Wild Type (B.1),=,11.8,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,415,ng/ml,1,=,35.2,,,
Cao22,10.1101/2022.02.07.479349,Pseudovirus (VSV),Table S2,Imdevimab,Wild Type (B.1),=,5.4,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,549,ng/ml,1,=,101.9,,,
Cao22c,10.1016/j.chom.2022.09.018,Pseudovirus (VSV),Figure 5b,Imdevimab,Wild Type (B.1),=,5.7,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,590,ng/ml,1,=,103.5,,,
Iketani22,10.1038/s41586-022-04594-4,Pseudovirus (VSV),Figure 2a,Imdevimab,Wild Type (B.1),=,6.5,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1425.9,ng/ml,1,=,219.4,,,
Misasi22,10.1101/2022.07.29.502029,Pseudovirus (lentivirus),Figure 1A,Imdevimab,Wild Type (B.1),=,10.8,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,604.7,ng/ml,1,=,56.1,,,
Sheward22b,10.1101/2022.07.19.500716,Pseudovirus (lentivirus),Table S1,Imdevimab,Wild Type (B.1),=,7,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,1000,ng/ml,1,>,142.9,,,Some LOD values of 10000 were reported. Corrected to 1000
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Imdevimab,Wild Type (B.1),=,3,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1066,ng/ml,1,=,355.3,,,
Willett22,10.1101/2022.05.25.493397,Pseudovirus (lentivirus),Figure 1L,Imdevimab,Wild Type (B.1),=,2,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1021,ng/ml,1,=,510.5,,,
Yamasoba22,10.1016/j.cell.2022.04.035,Pseudovirus (HIV),Figure 2E,Imdevimab,Wild Type (B.1),=,6.6,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Yamasoba22c,10.1101/2022.07.14.500041,Pseudovirus,Table 1,Imdevimab,Wild Type (B.1),=,8,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,5000,ng/ml,1,>,625,,,
Tuekprakhon22,10.1016/j.cell.2022.06.005,Pseudovirus (lentivirus),Figure 3,Imdevimab,Wild Type (B),=,2,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,616,ng/ml,1,=,308,,,
Huo22b,10.1016/j.celrep.2022.111903,Pseudovirus (lentivirus),Supplementary Table 1B,Imdevimab,Wild Type (B),=,2,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,616,ng/ml,1,=,308,,,
Chen22e,10.1016/j.celrep.2022.111528,Pseudovirus (lentivirus),Figure 2B,Imdevimab,Wild Type (A),=,9,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,669,ng/ml,1,=,74.3,,,
Ai22,10.1016/j.chom.2022.05.001,Pseudovirus (VSV),Figure 3A,Imdevimab,Wild Type (B),=,3,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,353,ng/ml,1,=,117.7,,,
Gruell22b,10.1016/j.chom.2022.07.002,Pseudovirus (HIV),Figure 4B,Imdevimab,Wild Type (B),=,5,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,4173,ng/ml,1,=,834.6,,,
Huang22,10.1016/j.immuni.2022.06.005,Pseudovirus (VSV),Figure 2,Imdevimab,Wild Type (B),=,6,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,450,ng/ml,1,=,75,,,
Ohashi22,10.1101/2022.02.27.482147,Virus isolate,Table 1,Imdevimab,Wild Type (A),=,12.5,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1252.5,ng/ml,1,=,100.2,,,
Touret22c,10.1101/2022.12.22.521201,Virus isolate,Table 1,Imdevimab,Delta,=,20.1,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,345.9,ng/ml,1,=,17.2,,,
Bruel22,10.1038/s41591-022-01792-5,Virus isolate,Table 1,Imdevimab,Delta,=,1.2,ng/ml,1,Omicron/BA.2,19,T19I + Δ24-26 + A27S + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + R682W + N764K + D796Y + Q954H + N969K,1,=,693,ng/ml,1,=,577.5,,,
Takashita22b,10.1056/NEJMc2201933,Virus isolate,Table 1,Imdevimab,Wild Type (A),=,3,ng/ml,1,Omicron/BA.2,19,T19I + Δ24-26 + A27S + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,68.7,ng/ml,1,=,22.5,,,
Takashita22c,10.1056/NEJMc2207519,Virus isolate,Table 1,Imdevimab,Wild Type (A),=,7.4,ng/ml,1,Omicron/BA.2,(Various),(Various),2,=,4055.9,ng/ml,12.3,>,1000,1722.6,5078.7,
Takashita22d,10.1056/NEJMc2209952,Virus isolate,Table 1,Imdevimab,Wild Type (A),=,4.4,ng/ml,1,Omicron/BA.2,19,T19I + Δ24-26 + A27S + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,958.3,ng/ml,1,=,219.8,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b; Extended Data Table 1a,Casirivimab + Imdevimab,Wild Type (B.1),=,1,ng/ml,1,Omicron/BA.2,(Various),(Various),2,=,2024.6,ng/ml,1.1,>,1000,1956,2104,
Yamasoba22b,10.1016/S1473-3099(22)00365-6,Pseudovirus (HIV),Table,Casirivimab + Imdevimab,Wild Type (B.1),=,6.2,ng/ml,1,Omicron/BA.2,(Various),(Various),2,>,2400,ng/ml,1,>,387.1,387.1,387.1,
Saito22,10.1016/j.chom.2022.10.003,Pseudovirus (lentivirus),Table 1,Casirivimab + Imdevimab,Wild Type (B.1),=,3.9,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,5000,ng/ml,1,>,1000,,,
Arora22b,10.1016/j.chom.2022.04.017,Pseudovirus (VSV),Supplementary Table 1,Casirivimab + Imdevimab,Wild Type (B.1),=,7.6,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,485.9,ng/ml,1,=,63.9,,,
Arora22e,10.1016/S1473-3099(22)00422-4,Pseudovirus (VSV),Supplementary Figure B,Casirivimab + Imdevimab,Wild Type (B.1),=,6.6,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,267,ng/ml,1,=,40.5,,,
Cao22c,10.1016/j.chom.2022.09.018,Pseudovirus (VSV),Figure 5b,Casirivimab + Imdevimab,Wild Type (B.1),=,5,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,821,ng/ml,1,=,164.2,,,
Iketani22,10.1038/s41586-022-04594-4,Pseudovirus (VSV),Figure 2a,Casirivimab + Imdevimab,Wild Type (B.1),=,6.7,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,2303.2,ng/ml,1,=,343.8,,,
Misasi22,10.1101/2022.07.29.502029,Pseudovirus (lentivirus),Figure 1B,Casirivimab + Imdevimab,Wild Type (B.1),=,3.4,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,383.3,ng/ml,1,=,112.6,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Casirivimab + Imdevimab,Wild Type (B.1),=,3,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,2701,ng/ml,1,=,900.3,,,
Yamasoba22,10.1016/j.cell.2022.04.035,Pseudovirus (HIV),Figure 2E,Casirivimab + Imdevimab,Wild Type (B.1),=,3.1,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Yamasoba22c,10.1101/2022.07.14.500041,Pseudovirus,Table 1,Casirivimab + Imdevimab,Wild Type (B.1),=,3.9,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,5000,ng/ml,1,>,1000,,,
Chen22e,10.1016/j.celrep.2022.111528,Pseudovirus (lentivirus),Figure 2C,Casirivimab + Imdevimab,Wild Type (A),=,0.9,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,232,ng/ml,1,=,257.8,,,
Park22,10.1126/science.adc9127,Pseudovirus (VSV),Fig 1A,Casirivimab + Imdevimab,Wild Type (B),=,5,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,3366,ng/ml,1,=,673.2,,,
Fenwick22,10.1101/2022.03.18.484873,Virus isolate,Figure 2f,Casirivimab + Imdevimab,Delta,=,8,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,980,ng/ml,1,=,122.5,,,
Takashita22b,10.1056/NEJMc2201933,Virus isolate,Table 1,Casirivimab + Imdevimab,Wild Type (A),=,7,ng/ml,1,Omicron/BA.2,19,T19I + Δ24-26 + A27S + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,445.2,ng/ml,1,=,63.1,,,Combination therapies in this study were specified at ng/ml of each component so needs to multiply by 2
Takashita22c,10.1056/NEJMc2207519,Virus isolate,Table 1,Casirivimab + Imdevimab,Wild Type (A),=,6.8,ng/ml,1,Omicron/BA.2,(Various),(Various),2,=,5779.6,ng/ml,3.5,>,1000,919.5,2267.3,Combination therapies in this study were specified at ng/ml of each component so needs to multiply by 2
Takashita22d,10.1056/NEJMc2209952,Virus isolate,Table 1,Casirivimab + Imdevimab,Wild Type (A),=,4.4,ng/ml,1,Omicron/BA.2,19,T19I + Δ24-26 + A27S + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1936,ng/ml,1,=,434.1,,,Combination therapies in this study were specified at ng/ml of each component so needs to multiply by 2
Hao22,10.1101/2022.08.12.22278720,Virus isolate,Figure 5A,Casirivimab + Imdevimab,Wild Type (A),=,87,ng/ml,1,Omicron/BA.2,67,A67V + T95I + Y144L + Y145D + L212I + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,4446,ng/ml,1,=,51.1,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b; Extended Data Table 1a,Cilgavimab,Wild Type (B.1),=,6,ng/ml,1,Omicron/BA.2,(Various),(Various),2,=,7.7,ng/ml,1.5,=,1.4,1.1,1.7,
Yamasoba22b,10.1016/S1473-3099(22)00365-6,Pseudovirus (HIV),Table,Cilgavimab,Wild Type (B.1),=,21,ng/ml,1,Omicron/BA.2,(Various),(Various),2,=,19,ng/ml,1,=,0.9,0.9,0.9,
Gruell22c,10.1016/S1473-3099(22)00580-1,Pseudovirus,Figure B,Cilgavimab,Wild Type (B.1),=,5,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,8,ng/ml,1,=,1.6,,,
Saito22,10.1016/j.chom.2022.10.003,Pseudovirus (lentivirus),Table 1,Cilgavimab,Wild Type (B.1),=,14,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,21,ng/ml,1,=,1.5,,,
Arora22b,10.1016/j.chom.2022.04.017,Pseudovirus (VSV),Supplementary Table 1,Cilgavimab,Wild Type (B.1),=,25.1,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,52,ng/ml,1,=,2.1,,,
Arora22e,10.1016/S1473-3099(22)00422-4,Pseudovirus (VSV),Supplementary Figure B,Cilgavimab,Wild Type (B.1),=,21.7,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,48.9,ng/ml,1,=,2.3,,,
Cao22,10.1101/2022.02.07.479349,Pseudovirus (VSV),Table S2,Cilgavimab,Wild Type (B.1),=,1.4,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,5.6,ng/ml,1,=,3.9,,,
Cao22c,10.1016/j.chom.2022.09.018,Pseudovirus (VSV),Figure 5b,Cilgavimab,Wild Type (B.1),=,2.5,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,6.3,ng/ml,1,=,2.5,,,
Iketani22,10.1038/s41586-022-04594-4,Pseudovirus (VSV),Figure 2a,Cilgavimab,Wild Type (B.1),=,16.5,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,28.1,ng/ml,1,=,1.7,,,
Misasi22,10.1101/2022.07.29.502029,Pseudovirus (lentivirus),Figure 1A,Cilgavimab,Wild Type (B.1),=,4.6,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,5.5,ng/ml,1,=,1.2,,,
Sheward22b,10.1101/2022.07.19.500716,Pseudovirus (lentivirus),Table S1,Cilgavimab,Wild Type (B.1),=,6,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,15,ng/ml,1,=,2.5,,,Some LOD values of 10000 were reported. Corrected to 1000
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Cilgavimab,Wild Type (B.1),=,10,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,14,ng/ml,1,=,1.4,,,
Wang22j,10.1016/S1473-3099(22)00694-6,Pseudovirus (VSV),Figure S3,Cilgavimab,Wild Type (B.1),=,8,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,14,ng/ml,1,=,1.8,,,
Wang22l,10.1101/2022.11.23.517532,Pseudovirus,Figure S2,Cilgavimab,Wild Type (B.1),=,7,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,9,ng/ml,1,=,1.3,,,
Yamasoba22c,10.1101/2022.07.14.500041,Pseudovirus,Table 1,Cilgavimab,Wild Type (B.1),=,14,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,21,ng/ml,1,=,1.5,,,
Zhou22,10.3390/v14061334,Pseudovirus (lentivirus),Figure 2B,Cilgavimab,Wild Type (B.1),=,6.9,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,12192,ng/ml,1,>,1000,,,
Tuekprakhon22,10.1016/j.cell.2022.06.005,Pseudovirus (lentivirus),Figure 3,Cilgavimab,Wild Type (B),=,2,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,8,ng/ml,1,=,4,,,
Huo22b,10.1016/j.celrep.2022.111903,Pseudovirus (lentivirus),Supplementary Table 1B,Cilgavimab,Wild Type (B),=,2,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,8,ng/ml,1,=,4,,,
Chen22e,10.1016/j.celrep.2022.111528,Pseudovirus (lentivirus),Figure 2B,Cilgavimab,Wild Type (A),=,1,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,5,ng/ml,1,=,5,,,
Ai22,10.1016/j.chom.2022.05.001,Pseudovirus (VSV),Figure 3A,Cilgavimab,Wild Type (B),=,1,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,4,ng/ml,1,=,4,,,
Gruell22b,10.1016/j.chom.2022.07.002,Pseudovirus (HIV),Figure 4B,Cilgavimab,Wild Type (B),=,5,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,8,ng/ml,1,=,1.6,,,
Park22,10.1126/science.adc9127,Pseudovirus (VSV),Fig 1A,Cilgavimab,Wild Type (B),=,6,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,13,ng/ml,1,=,2.2,,,
FDA21c,https://www.fda.gov/media/154701/download,Pseudovirus,"Feb 2022, Page 17, Antiviral resistance paragraph 5",Cilgavimab,Wild Type (B),,,,,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,,,,,=,1.9,,,
Aggarwal22b,10.1016/j.ebiom.2022.104270,Virus isolate,Figure 1,Cilgavimab,Wild Type (A.2.2),=,29,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,62,ng/ml,1,=,2.1,,,
Touret22b,10.1038/s41598-022-16964-z,Virus isolate,Table 1,Cilgavimab,Wild Type (B.1),=,19.2,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,49.8,ng/ml,1,=,2.6,,,
Touret22c,10.1101/2022.12.22.521201,Virus isolate,Table 1,Cilgavimab,Delta,=,21.7,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,184,ng/ml,1,=,8.5,,,
Bruel22,10.1038/s41591-022-01792-5,Virus isolate,Table 1,Cilgavimab,Delta,=,8.5,ng/ml,1,Omicron/BA.2,19,T19I + Δ24-26 + A27S + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + R682W + N764K + D796Y + Q954H + N969K,1,=,9.3,ng/ml,1,=,1.1,,,
Takashita22b,10.1056/NEJMc2201933,Virus isolate,Table 1,Cilgavimab,Wild Type (A),=,7.7,ng/ml,1,Omicron/BA.2,19,T19I + Δ24-26 + A27S + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,4.4,ng/ml,1,=,0.6,,,
Takashita22c,10.1056/NEJMc2207519,Virus isolate,Table 1,Cilgavimab,Wild Type (A),=,7,ng/ml,1,Omicron/BA.2,(Various),(Various),2,=,919.2,ng/ml,54.4,>,1000,1787.5,5357.8,
Takashita22d,10.1056/NEJMc2209952,Virus isolate,Table 1,Cilgavimab,Wild Type (A),=,5.4,ng/ml,1,Omicron/BA.2,19,T19I + Δ24-26 + A27S + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,21.6,ng/ml,1,=,4,,,
Case22,10.1038/s41467-022-31615-7,Virus isolate,Figure 1n,Cilgavimab,Wild Type (B.1),=,29.5,ng/ml,1,Omicron/BA.2,19,T19I + Δ24-26 + A27S + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,32,ng/ml,1,=,1.1,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b; Extended Data Table 1a,Tixagevimab,Wild Type (B.1),=,2,ng/ml,1,Omicron/BA.2,(Various),(Various),2,=,766.7,ng/ml,1.1,=,384.8,368.4,401.1,
Yamasoba22b,10.1016/S1473-3099(22)00365-6,Pseudovirus (HIV),Table,Tixagevimab,Wild Type (B.1),=,6.7,ng/ml,1,Omicron/BA.2,(Various),(Various),2,>,2750,ng/ml,1,>,410.4,410.4,410.4,
Gruell22c,10.1016/S1473-3099(22)00580-1,Pseudovirus,Figure B,Tixagevimab,Wild Type (B.1),=,5,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Saito22,10.1016/j.chom.2022.10.003,Pseudovirus (lentivirus),Table 1,Tixagevimab,Wild Type (B.1),=,1.5,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,3815,ng/ml,1,>,1000,,,
Arora22b,10.1016/j.chom.2022.04.017,Pseudovirus (VSV),Supplementary Table 1,Tixagevimab,Wild Type (B.1),=,7.4,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,987,ng/ml,1,=,132.7,,,
Arora22e,10.1016/S1473-3099(22)00422-4,Pseudovirus (VSV),Supplementary Figure B,Tixagevimab,Wild Type (B.1),=,5.1,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1460,ng/ml,1,=,286.3,,,
Cao22,10.1101/2022.02.07.479349,Pseudovirus (VSV),Table S2,Tixagevimab,Wild Type (B.1),=,1.3,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,3420,ng/ml,1,>,1000,,,
Cao22c,10.1016/j.chom.2022.09.018,Pseudovirus (VSV),Figure 5b,Tixagevimab,Wild Type (B.1),=,1.6,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,4312,ng/ml,1,>,1000,,,
Iketani22,10.1038/s41586-022-04594-4,Pseudovirus (VSV),Figure 2a,Tixagevimab,Wild Type (B.1),=,5.1,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,3437.5,ng/ml,1,=,674,,,
Misasi22,10.1101/2022.07.29.502029,Pseudovirus (lentivirus),Figure 1A,Tixagevimab,Wild Type (B.1),=,1.5,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1211.6,ng/ml,1,=,824.2,,,
Sheward22b,10.1101/2022.07.19.500716,Pseudovirus (lentivirus),Table S1,Tixagevimab,Wild Type (B.1),=,4,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,1000,ng/ml,1,>,1000,,,Some LOD values of 10000 were reported. Corrected to 1000
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Tixagevimab,Wild Type (B.1),=,3,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1825,ng/ml,1,=,608.3,,,
Wang22j,10.1016/S1473-3099(22)00694-6,Pseudovirus (VSV),Figure S3,Tixagevimab,Wild Type (B.1),=,3,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,958,ng/ml,1,=,319.3,,,
Wang22l,10.1101/2022.11.23.517532,Pseudovirus,Figure S2,Tixagevimab,Wild Type (B.1),=,2,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1924,ng/ml,1,=,962,,,
Yamasoba22c,10.1101/2022.07.14.500041,Pseudovirus,Table 1,Tixagevimab,Wild Type (B.1),=,1.5,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,3815,ng/ml,1,>,1000,,,
Tuekprakhon22,10.1016/j.cell.2022.06.005,Pseudovirus (lentivirus),Figure 3,Tixagevimab,Wild Type (B),=,1,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1333,ng/ml,1,>,1000,,,
Huo22b,10.1016/j.celrep.2022.111903,Pseudovirus (lentivirus),Supplementary Table 1B,Tixagevimab,Wild Type (B),=,1,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1333,ng/ml,1,>,1000,,,
Chen22e,10.1016/j.celrep.2022.111528,Pseudovirus (lentivirus),Figure 2B,Tixagevimab,Wild Type (A),=,1,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,309,ng/ml,1,=,309,,,
Ai22,10.1016/j.chom.2022.05.001,Pseudovirus (VSV),Figure 3A,Tixagevimab,Wild Type (B),=,1,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Gruell22b,10.1016/j.chom.2022.07.002,Pseudovirus (HIV),Figure 4B,Tixagevimab,Wild Type (B),=,5,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Park22,10.1126/science.adc9127,Pseudovirus (VSV),Fig 1A,Tixagevimab,Wild Type (B),=,2,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,5717,ng/ml,1,>,1000,,,
FDA21c,https://www.fda.gov/media/154701/download,Pseudovirus,"Feb 2022, Page 17, Antiviral resistance paragraph 5",Tixagevimab,Wild Type (B),,,,,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,,,,,>,1000,,,
Aggarwal22b,10.1016/j.ebiom.2022.104270,Virus isolate,Figure 1,Tixagevimab,Wild Type (A.2.2),=,9,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Touret22b,10.1038/s41598-022-16964-z,Virus isolate,Table 1,Tixagevimab,Wild Type (B.1),=,18.3,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,5000,ng/ml,1,>,273.2,,,
Touret22c,10.1101/2022.12.22.521201,Virus isolate,Table 1,Tixagevimab,Delta,=,12.4,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,5000,ng/ml,1,>,403.2,,,
Bruel22,10.1038/s41591-022-01792-5,Virus isolate,Table 1,Tixagevimab,Delta,=,3.2,ng/ml,1,Omicron/BA.2,19,T19I + Δ24-26 + A27S + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + R682W + N764K + D796Y + Q954H + N969K,1,>,9000,ng/ml,1,>,1000,,,
Takashita22b,10.1056/NEJMc2201933,Virus isolate,Table 1,Tixagevimab,Wild Type (A),=,1.9,ng/ml,1,Omicron/BA.2,19,T19I + Δ24-26 + A27S + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,395.8,ng/ml,1,=,206.1,,,
Takashita22c,10.1056/NEJMc2207519,Virus isolate,Table 1,Tixagevimab,Wild Type (A),=,6.1,ng/ml,1,Omicron/BA.2,(Various),(Various),2,=,1289.8,ng/ml,2.1,=,275.4,187.2,363.6,
Takashita22d,10.1056/NEJMc2209952,Virus isolate,Table 1,Tixagevimab,Wild Type (A),=,1.9,ng/ml,1,Omicron/BA.2,19,T19I + Δ24-26 + A27S + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,4374.2,ng/ml,1,>,1000,,,
Case22,10.1038/s41467-022-31615-7,Virus isolate,Figure 1n,Tixagevimab,Wild Type (B.1),=,5.4,ng/ml,1,Omicron/BA.2,19,T19I + Δ24-26 + A27S + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,364.7,ng/ml,1,=,67.5,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b; Extended Data Table 1a,Cilgavimab + Tixagevimab,Wild Type (B.1),=,2,ng/ml,1,Omicron/BA.2,(Various),(Various),2,=,17.7,ng/ml,1.2,=,9,8.3,9.8,
Yamasoba22b,10.1016/S1473-3099(22)00365-6,Pseudovirus (HIV),Table,Cilgavimab + Tixagevimab,Wild Type (B.1),=,4.1,ng/ml,1,Omicron/BA.2,(Various),(Various),2,=,33.5,ng/ml,1,=,8.2,8.1,8.2,
Saito22,10.1016/j.chom.2022.10.003,Pseudovirus (lentivirus),Table 1,Cilgavimab + Tixagevimab,Wild Type (B.1),=,4.7,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,42,ng/ml,1,=,8.9,,,
Arora22b,10.1016/j.chom.2022.04.017,Pseudovirus (VSV),Supplementary Table 1,Cilgavimab + Tixagevimab,Wild Type (B.1),=,5.9,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,56.4,ng/ml,1,=,9.6,,,
Arora22e,10.1016/S1473-3099(22)00422-4,Pseudovirus (VSV),Supplementary Figure B,Cilgavimab + Tixagevimab,Wild Type (B.1),=,7.6,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,70.9,ng/ml,1,=,9.3,,,
Cao22c,10.1016/j.chom.2022.09.018,Pseudovirus (VSV),Figure 5b,Cilgavimab + Tixagevimab,Wild Type (B.1),=,2.1,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,8.2,ng/ml,1,=,3.9,,,
Iketani22,10.1038/s41586-022-04594-4,Pseudovirus (VSV),Figure 2a,Cilgavimab + Tixagevimab,Wild Type (B.1),=,5.3,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,44.4,ng/ml,1,=,8.4,,,
Misasi22,10.1101/2022.07.29.502029,Pseudovirus (lentivirus),Figure 1B,Cilgavimab + Tixagevimab,Wild Type (B.1),=,2.2,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,7.3,ng/ml,1,=,3.3,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Cilgavimab + Tixagevimab,Wild Type (B.1),=,2,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,22,ng/ml,1,=,11,,,
Wang22j,10.1016/S1473-3099(22)00694-6,Pseudovirus (VSV),Figure S3,Cilgavimab + Tixagevimab,Wild Type (B.1),=,3,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,29,ng/ml,1,=,9.7,,,
Wang22l,10.1101/2022.11.23.517532,Pseudovirus,Figure S2,Cilgavimab + Tixagevimab,Wild Type (B.1),=,3,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,19,ng/ml,1,=,6.3,,,
Yamasoba22c,10.1101/2022.07.14.500041,Pseudovirus,Table 1,Cilgavimab + Tixagevimab,Wild Type (B.1),=,4.7,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,42,ng/ml,1,=,8.9,,,
Zhou22,10.3390/v14061334,Pseudovirus (lentivirus),Figure 2B,Cilgavimab + Tixagevimab,Wild Type (B.1),=,2.4,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,4608,ng/ml,1,>,1000,,,
Tuekprakhon22,10.1016/j.cell.2022.06.005,Pseudovirus (lentivirus),Figure 3,Cilgavimab + Tixagevimab,Wild Type (B),=,1,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,8,ng/ml,1,=,8,,,
Huo22b,10.1016/j.celrep.2022.111903,Pseudovirus (lentivirus),Supplementary Table 1B,Cilgavimab + Tixagevimab,Wild Type (B),=,1,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,8,ng/ml,1,=,8,,,
Chen22e,10.1016/j.celrep.2022.111528,Pseudovirus (lentivirus),Figure 2C,Cilgavimab + Tixagevimab,Wild Type (A),=,0.7,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,6,ng/ml,1,=,8.6,,,
EMA21e,https://www.ema.europa.eu/en/documents/product-information/evusheld-epar-product-information_en.pdf,Pseudovirus,Table 3,Cilgavimab + Tixagevimab,Wild Type (B),=,1.9,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,9.8,ng/ml,1,=,5.2,,,
Park22,10.1126/science.adc9127,Pseudovirus (VSV),Fig 1A,Cilgavimab + Tixagevimab,Wild Type (B),=,2,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,22,ng/ml,1,=,11,,,
FDA21c,https://www.fda.gov/media/154701/download,Pseudovirus,"Feb 2022, Table 6, Page 17, Antiviral resistance paragraph 7",Cilgavimab + Tixagevimab,Wild Type (B),,,,,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,,,,,=,3.2,,,
Aggarwal22b,10.1016/j.ebiom.2022.104270,Virus isolate,Figure 1,Cilgavimab + Tixagevimab,Wild Type (A.2.2),=,16,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,113,ng/ml,1,=,7.1,,,
Fenwick22,10.1101/2022.03.18.484873,Virus isolate,Figure 2f,Cilgavimab + Tixagevimab,Delta,=,17,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,25,ng/ml,1,=,1.5,,,
EMA21e,https://www.ema.europa.eu/en/documents/product-information/evusheld-epar-product-information_en.pdf,Virus isolate,Table 3,Cilgavimab + Tixagevimab,Wild Type (B),=,8,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,35,ng/ml,1,=,4.4,,,
FDA21c,https://www.fda.gov/media/154701/download,Virus isolate,"Feb 2022, Table 6, Page 17, Antiviral resistance paragraph 7",Cilgavimab + Tixagevimab,Wild Type (B),,,,,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,,,,,=,5.4,,,
Touret22b,10.1038/s41598-022-16964-z,Virus isolate,Table 1,Cilgavimab + Tixagevimab,Wild Type (B.1),=,20.2,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,37.4,ng/ml,1,=,1.9,,,
Touret22c,10.1101/2022.12.22.521201,Virus isolate,Table 1,Cilgavimab + Tixagevimab,Delta,=,12.5,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,114.9,ng/ml,1,=,9.2,,,
Bruel22,10.1038/s41591-022-01792-5,Virus isolate,Table 1,Cilgavimab + Tixagevimab,Delta,=,2.6,ng/ml,1,Omicron/BA.2,19,T19I + Δ24-26 + A27S + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + R682W + N764K + D796Y + Q954H + N969K,1,=,23,ng/ml,1,=,8.8,,,
Takashita22b,10.1056/NEJMc2201933,Virus isolate,Table 1,Cilgavimab + Tixagevimab,Wild Type (A),=,6.8,ng/ml,1,Omicron/BA.2,19,T19I + Δ24-26 + A27S + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,29,ng/ml,1,=,4.2,,,Combination therapies in this study were specified at ng/ml of each component so needs to multiply by 2
Takashita22c,10.1056/NEJMc2207519,Virus isolate,Table 1,Cilgavimab + Tixagevimab,Wild Type (A),=,12.6,ng/ml,1,Omicron/BA.2,(Various),(Various),2,=,423.6,ng/ml,6.1,=,105.7,55.6,155.7,Combination therapies in this study were specified at ng/ml of each component so needs to multiply by 2
Takashita22d,10.1056/NEJMc2209952,Virus isolate,Table 1,Cilgavimab + Tixagevimab,Wild Type (A),=,13,ng/ml,1,Omicron/BA.2,19,T19I + Δ24-26 + A27S + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,86.4,ng/ml,1,=,6.7,,,Combination therapies in this study were specified at ng/ml of each component so needs to multiply by 2
Case22,10.1038/s41467-022-31615-7,Virus isolate,Figure 1n,Cilgavimab + Tixagevimab,Wild Type (B.1),=,6.5,ng/ml,1,Omicron/BA.2,19,T19I + Δ24-26 + A27S + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,35.4,ng/ml,1,=,5.4,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b; Extended Data Table 1a,Sotrovimab,Wild Type (B.1),=,14,ng/ml,1,Omicron/BA.2,(Various),(Various),2,=,691.3,ng/ml,1.5,=,53.1,43.3,63,
Yamasoba22b,10.1016/S1473-3099(22)00365-6,Pseudovirus (HIV),Table,Sotrovimab,Wild Type (B.1),=,94,ng/ml,1,Omicron/BA.2,(Various),(Various),2,=,1301.9,ng/ml,1.7,=,15.8,12,19.5,
Gruell22c,10.1016/S1473-3099(22)00580-1,Pseudovirus,Figure B,Sotrovimab,Wild Type (B.1),=,28,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,2118,ng/ml,1,=,75.6,,,
Saito22,10.1016/j.chom.2022.10.003,Pseudovirus (lentivirus),Table 1,Sotrovimab,Wild Type (B.1),=,47,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1213,ng/ml,1,=,25.8,,,
Arora22b,10.1016/j.chom.2022.04.017,Pseudovirus (VSV),Supplementary Table 1,Sotrovimab,Wild Type (B.1),=,198.3,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,7032,ng/ml,1,=,35.5,,,
Arora22e,10.1016/S1473-3099(22)00422-4,Pseudovirus (VSV),Supplementary Figure B,Sotrovimab,Wild Type (B.1),=,77.5,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,3060,ng/ml,1,=,39.5,,,
Cao22,10.1101/2022.02.07.479349,Pseudovirus (VSV),Table S2,Sotrovimab,Wild Type (B.1),=,78.3,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,944,ng/ml,1,=,12.1,,,
Cao22c,10.1016/j.chom.2022.09.018,Pseudovirus (VSV),Figure 5b,Sotrovimab,Wild Type (B.1),=,74,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,918,ng/ml,1,=,12.4,,,
Gliga22,10.1093/cid/ciac802,Pseudovirus,Figure 3B,Sotrovimab,Wild Type (B.1),=,6,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,2707,ng/ml,1,=,451.2,,,
Iketani22,10.1038/s41586-022-04594-4,Pseudovirus (VSV),Figure 2a,Sotrovimab,Wild Type (B.1),=,43.4,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1142.8,ng/ml,1,=,26.3,,,
Misasi22,10.1101/2022.07.29.502029,Pseudovirus (lentivirus),Figure 1A,Sotrovimab,Wild Type (B.1),=,84.6,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,2236.1,ng/ml,1,=,26.4,,,
Park22,10.1126/science.adc9127,Pseudovirus (VSV),Fig 1A,Sotrovimab,Wild Type,=,61.7,ng/ml,1.1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,2,=,1013,ng/ml,1,=,16.5,15.6,17.5,
Sheward22b,10.1101/2022.07.19.500716,Pseudovirus (lentivirus),Table S1,Sotrovimab,Wild Type (B.1),=,78,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,1000,ng/ml,1,>,12.8,,,Some LOD values of 10000 were reported. Corrected to 1000
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Sotrovimab,Wild Type (B.1),=,25,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,558,ng/ml,1,=,22.3,,,
Wang22j,10.1016/S1473-3099(22)00694-6,Pseudovirus (VSV),Figure S3,Sotrovimab,Wild Type (B.1),=,66,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1320,ng/ml,1,=,20,,,
Wang22l,10.1101/2022.11.23.517532,Pseudovirus,Figure S2,Sotrovimab,Wild Type (B.1),=,23,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,833,ng/ml,1,=,36.2,,,
Willett22,10.1101/2022.05.25.493397,Pseudovirus (lentivirus),Figure 1L,Sotrovimab,Wild Type (B.1),=,3,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,400,ng/ml,1,=,133.3,,,
Yamasoba22,10.1016/j.cell.2022.04.035,Pseudovirus (HIV),Figure 2E,Sotrovimab,Wild Type (B.1),=,12,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,420,ng/ml,1,=,35,,,
Yamasoba22c,10.1101/2022.07.14.500041,Pseudovirus,Table 1,Sotrovimab,Wild Type (B.1),=,47,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1213,ng/ml,1,=,25.8,,,
Zhou22,10.3390/v14061334,Pseudovirus (lentivirus),Figure 2B,Sotrovimab,Wild Type (B.1),=,140.3,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,47755,ng/ml,1,=,340.4,,,
Tuekprakhon22,10.1016/j.cell.2022.06.005,Pseudovirus (lentivirus),Figure 3,Sotrovimab,Wild Type (B),=,130,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,638,ng/ml,1,=,4.9,,,
Huo22b,10.1016/j.celrep.2022.111903,Pseudovirus (lentivirus),Supplementary Table 1B,Sotrovimab,Wild Type (B),=,79,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,638,ng/ml,1,=,8.1,,,
Chen22e,10.1016/j.celrep.2022.111528,Pseudovirus (lentivirus),Figure 2B,Sotrovimab,Wild Type (A),=,184,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1454,ng/ml,1,=,7.9,,,
Ai22,10.1016/j.chom.2022.05.001,Pseudovirus (VSV),Figure 3A,Sotrovimab,Wild Type (B),=,9,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,160,ng/ml,1,=,17.8,,,
Gruell22b,10.1016/j.chom.2022.07.002,Pseudovirus (HIV),Figure 4B,Sotrovimab,Wild Type (B),=,976,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1488,ng/ml,1,=,1.5,,,
Huang22,10.1016/j.immuni.2022.06.005,Pseudovirus (VSV),Figure 2,Sotrovimab,Wild Type (B),=,21,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,190,ng/ml,1,=,9,,,
Cathcart21,10.1101/2021.03.09.434607,Pseudovirus (VSV),Table 2,Sotrovimab,Wild Type (B),,,,,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,,,,,=,16,,,
EMA21d,https://www.ema.europa.eu/en/documents/product-information/xevudy-epar-product-information_en.pdf,Pseudovirus,Table 2,Sotrovimab,Wild Type (B),,,,,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,,,,,=,16,,,
FDA21e,https://www.fda.gov/media/149534/download,Pseudovirus,SOT Page 23,Sotrovimab,Wild Type (B),,,,,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,,,,,=,16,,,
Aggarwal22b,10.1016/j.ebiom.2022.104270,Virus isolate,Figure 1,Sotrovimab,Wild Type (A.2.2),=,384,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,17590,ng/ml,1,>,45.8,,,
Ohashi22,10.1101/2022.02.27.482147,Virus isolate,Table 1,Sotrovimab,Wild Type (A),=,158.7,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1357.9,ng/ml,1,=,8.6,,,
Fenwick22,10.1101/2022.03.18.484873,Virus isolate,Figure 2f,Sotrovimab,Delta,=,147,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,2200,ng/ml,1,=,15,,,
Cathcart21,10.1101/2021.03.09.434607,Virus isolate,Table 1,Sotrovimab,Wild Type (A),,,,,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,,,,,=,15.7,,,
EMA21d,https://www.ema.europa.eu/en/documents/product-information/xevudy-epar-product-information_en.pdf,Virus isolate,Table 2,Sotrovimab,Wild Type (B),,,,,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,,,,,=,35.1,,,
FDA21e,https://www.fda.gov/media/149534/download,Virus isolate,SOT Page 23,Sotrovimab,Wild Type (B),,,,,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,,,,,=,25.3,,,
Park22,10.1126/science.adc9127,Virus isolate,Fig S12A,Sotrovimab,Wild Type (B),=,49.8,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N556K + N556N + K557E + K557K + K557Q + K557stop + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,885.5,ng/ml,1,=,17.8,,,
Touret22b,10.1038/s41598-022-16964-z,Virus isolate,Table 1,Sotrovimab,Wild Type (B.1),=,46,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,441,ng/ml,1,=,9.6,,,
Touret22c,10.1101/2022.12.22.521201,Virus isolate,Table 1,Sotrovimab,Delta,=,98.6,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,578.9,ng/ml,1,=,5.9,,,
Bruel22,10.1038/s41591-022-01792-5,Virus isolate,Table 1,Sotrovimab,Delta,=,280,ng/ml,1,Omicron/BA.2,19,T19I + Δ24-26 + A27S + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + R682W + N764K + D796Y + Q954H + N969K,1,>,9000,ng/ml,1,>,32.1,,,
Takashita22b,10.1056/NEJMc2201933,Virus isolate,Table 1,Sotrovimab,Wild Type (A),=,27.3,ng/ml,1,Omicron/BA.2,19,T19I + Δ24-26 + A27S + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1359,ng/ml,1,=,49.7,,,
Takashita22c,10.1056/NEJMc2207519,Virus isolate,Table 1,Sotrovimab,Wild Type (A),=,95.1,ng/ml,1,Omicron/BA.2,(Various),(Various),2,=,13728.1,ng/ml,3.6,=,282.7,161.1,404.3,
Takashita22d,10.1056/NEJMc2209952,Virus isolate,Table 1,Sotrovimab,Wild Type (A),=,32.8,ng/ml,1,Omicron/BA.2,19,T19I + Δ24-26 + A27S + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,50000,ng/ml,1,>,1000,,,
Case22,10.1038/s41467-022-31615-7,Virus isolate,Figure 1n,Sotrovimab,Wild Type (B.1),=,185.2,ng/ml,1,Omicron/BA.2,19,T19I + Δ24-26 + A27S + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,5885,ng/ml,1,=,31.8,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b; Extended Data Table 1a,Bebtelovimab,Wild Type (B.1),=,1,ng/ml,1,Omicron/BA.2,(Various),(Various),2,=,2,ng/ml,1,=,2,2,2,
Yamasoba22b,10.1016/S1473-3099(22)00365-6,Pseudovirus (HIV),Table,Bebtelovimab,Wild Type (B.1),=,8.1,ng/ml,1,Omicron/BA.2,(Various),(Various),2,=,2.9,ng/ml,1.3,=,0.4,0.3,0.5,
Gruell22c,10.1016/S1473-3099(22)00580-1,Pseudovirus,Figure B,Bebtelovimab,Wild Type (B.1),=,1,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1,ng/ml,1,=,1,,,
Saito22,10.1016/j.chom.2022.10.003,Pseudovirus (lentivirus),Table 1,Bebtelovimab,Wild Type (B.1),=,2.4,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1.7,ng/ml,1,=,0.7,,,
Arora22e,10.1016/S1473-3099(22)00422-4,Pseudovirus (VSV),Supplementary Figure B,Bebtelovimab,Wild Type (B.1),=,3.7,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,3.9,ng/ml,1,=,1.1,,,
Cao22,10.1101/2022.02.07.479349,Pseudovirus (VSV),Table S2,Bebtelovimab,Wild Type (B.1),=,1.5,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,0.8,ng/ml,1,=,0.5,,,
Cao22c,10.1016/j.chom.2022.09.018,Pseudovirus (VSV),Figure 5b,Bebtelovimab,Wild Type (B.1),=,0.7,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,0.9,ng/ml,1,=,1.3,,,
Iketani22,10.1038/s41586-022-04594-4,Pseudovirus (VSV),Figure 2a,Bebtelovimab,Wild Type (B.1),=,5.3,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,5.3,ng/ml,1,=,1,,,
Misasi22,10.1101/2022.07.29.502029,Pseudovirus (lentivirus),Figure 1A,Bebtelovimab,Wild Type (B.1),=,3.3,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1.3,ng/ml,1,=,0.4,,,
Sheward22b,10.1101/2022.07.19.500716,Pseudovirus (lentivirus),Table S1,Bebtelovimab,Wild Type (B.1),=,2,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,3,ng/ml,1,=,1.5,,,Some LOD values of 10000 were reported. Corrected to 1000
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Bebtelovimab,Wild Type (B.1),=,2,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,2,ng/ml,1,=,1,,,
Wang22j,10.1016/S1473-3099(22)00694-6,Pseudovirus (VSV),Figure S3,Bebtelovimab,Wild Type (B.1),=,1.5,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1.1,ng/ml,1,=,0.7,,,
Wang22l,10.1101/2022.11.23.517532,Pseudovirus,Figure S2,Bebtelovimab,Wild Type (B.1),=,2,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1,ng/ml,1,=,0.5,,,
Yamasoba22c,10.1101/2022.07.14.500041,Pseudovirus,Table 1,Bebtelovimab,Wild Type (B.1),=,2.4,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1.7,ng/ml,1,=,0.7,,,
Zhou22,10.3390/v14061334,Pseudovirus (lentivirus),Figure 2B,Bebtelovimab,Wild Type (B.1),=,9.5,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,11.5,ng/ml,1,=,1.2,,,
Huo22b,10.1016/j.celrep.2022.111903,Pseudovirus (lentivirus),Supplementary Table 1B,Bebtelovimab,Wild Type (B),=,1,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1,ng/ml,1,=,1,,,
Westendorf22,10.1016/j.celrep.2022.110812,Pseudovirus (VSV),Table 3B,Bebtelovimab,Wild Type (A),=,3,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,4,ng/ml,1,=,1.3,,,
Ai22,10.1016/j.chom.2022.05.001,Pseudovirus (VSV),Figure 3A,Bebtelovimab,Wild Type (B),=,1.5,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,0.7,ng/ml,1,=,0.5,,,
Gruell22b,10.1016/j.chom.2022.07.002,Pseudovirus (HIV),Figure 4B,Bebtelovimab,Wild Type (B),=,5,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,5,ng/ml,1,=,1,,,
Park22,10.1126/science.adc9127,Pseudovirus (VSV),Fig 1A,Bebtelovimab,Wild Type (B),=,3,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,2,ng/ml,1,=,0.7,,,
FDA22,https://www.fda.gov/media/156152/download,Pseudovirus,"Mar 2022, Page 13, antiviral resistance, Table 2",Bebtelovimab,Wild Type (B),,,,,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,,,,,=,1,,,
Touret22c,10.1101/2022.12.22.521201,Virus isolate,Table 1,Bebtelovimab,Delta,=,0.4,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,2.6,ng/ml,1,=,6.5,,,
Takashita22c,10.1056/NEJMc2207519,Virus isolate,Table 1,Bebtelovimab,Wild Type (A),=,2.5,ng/ml,1,Omicron/BA.2,(Various),(Various),2,=,3.6,ng/ml,1.1,=,1.5,1.4,1.5,
Takashita22d,10.1056/NEJMc2209952,Virus isolate,Table 1,Bebtelovimab,Wild Type (A),=,1.4,ng/ml,1,Omicron/BA.2,19,T19I + Δ24-26 + A27S + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,6.1,ng/ml,1,=,4.4,,,
Gruell22c,10.1016/S1473-3099(22)00580-1,Pseudovirus,Figure B,Regdanvimab,Wild Type (B.1),=,5,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Saito22,10.1016/j.chom.2022.10.003,Pseudovirus (lentivirus),Table 1,Regdanvimab,Wild Type (B.1),=,1,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,4025,ng/ml,1,>,1000,,,
Arora22b,10.1016/j.chom.2022.04.017,Pseudovirus (VSV),Supplementary Table 1,Regdanvimab,Wild Type (B.1),=,4.9,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Arora22e,10.1016/S1473-3099(22)00422-4,Pseudovirus (VSV),Supplementary Figure B,Regdanvimab,Wild Type (B.1),=,2.9,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,5000,ng/ml,1,>,1000,,,
Misasi22,10.1101/2022.07.29.502029,Pseudovirus (lentivirus),Figure 1A,Regdanvimab,Wild Type (B.1),=,2.8,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10050,ng/ml,1,>,1000,,,
Yamasoba22c,10.1101/2022.07.14.500041,Pseudovirus,Table 1,Regdanvimab,Wild Type (B.1),=,1,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,4025,ng/ml,1,>,1000,,,
Ai22,10.1016/j.chom.2022.05.001,Pseudovirus (VSV),Figure 3A,Regdanvimab,Wild Type (B),=,1,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Gruell22b,10.1016/j.chom.2022.07.002,Pseudovirus (HIV),Figure 4B,Regdanvimab,Wild Type (B),=,5,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Park22,10.1126/science.adc9127,Pseudovirus (VSV),Fig 1A,Regdanvimab,Wild Type (B),=,1.5,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Bruel22,10.1038/s41591-022-01792-5,Virus isolate,Table 1,Regdanvimab,Delta,=,23,ng/ml,1,Omicron/BA.2,19,T19I + Δ24-26 + A27S + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + R682W + N764K + D796Y + Q954H + N969K,1,>,9000,ng/ml,1,>,391.3,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b; Extended Data Table 1a,Amubarvimab,Wild Type (B.1),=,18,ng/ml,1,Omicron/BA.2,(Various),(Various),2,=,1915.5,ng/ml,1.4,=,113.1,94,132.3,
Gruell22c,10.1016/S1473-3099(22)00580-1,Pseudovirus,Figure B,Amubarvimab,Wild Type (B.1),=,9,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Cao22,10.1101/2022.02.07.479349,Pseudovirus (VSV),Table S2,Amubarvimab,Wild Type (B.1),=,52.9,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,4120,ng/ml,1,=,77.9,,,
Cao22c,10.1016/j.chom.2022.09.018,Pseudovirus (VSV),Figure 5b,Amubarvimab,Wild Type (B.1),=,53,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,8530,ng/ml,1,=,160.9,,,
Iketani22,10.1038/s41586-022-04594-4,Pseudovirus (VSV),Figure 2a,Amubarvimab,Wild Type (B.1),=,18.8,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,531.9,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Amubarvimab,Wild Type (B.1),=,15,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,2555,ng/ml,1,=,170.3,,,
Wang22j,10.1016/S1473-3099(22)00694-6,Pseudovirus (VSV),Figure S3,Amubarvimab,Wild Type (B.1),=,24,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1576,ng/ml,1,=,65.7,,,
Ai22,10.1016/j.chom.2022.05.001,Pseudovirus (VSV),Figure 3A,Amubarvimab,Wild Type (B),=,9,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1340,ng/ml,1,=,148.9,,,
Gruell22b,10.1016/j.chom.2022.07.002,Pseudovirus (HIV),Figure 4B,Amubarvimab,Wild Type (B),=,8,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Huang22,10.1016/j.immuni.2022.06.005,Pseudovirus (VSV),Figure 2,Amubarvimab,Wild Type (B),=,39,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,530,ng/ml,1,=,13.6,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b; Extended Data Table 1a,Romlusevimab,Wild Type (B.1),=,110,ng/ml,1,Omicron/BA.2,(Various),(Various),2,=,555.1,ng/ml,1.4,=,5.3,4.5,6.2,
Cao22,10.1101/2022.02.07.479349,Pseudovirus (VSV),Table S2,Romlusevimab,Wild Type (B.1),=,1240,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,8.1,,,
Cao22c,10.1016/j.chom.2022.09.018,Pseudovirus (VSV),Figure 5b,Romlusevimab,Wild Type (B.1),=,1239,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,8990,ng/ml,1,=,7.3,,,
Iketani22,10.1038/s41586-022-04594-4,Pseudovirus (VSV),Figure 2a,Romlusevimab,Wild Type (B.1),=,464.2,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,4509,ng/ml,1,=,9.7,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Romlusevimab,Wild Type (B.1),=,166,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1931,ng/ml,1,=,11.6,,,
Wang22j,10.1016/S1473-3099(22)00694-6,Pseudovirus (VSV),Figure S3,Romlusevimab,Wild Type (B.1),=,436,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,2597,ng/ml,1,=,6,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b; Extended Data Table 1a,Amubarvimab + Romlusevimab,Wild Type (B.1),=,22,ng/ml,1,Omicron/BA.2,(Various),(Various),2,=,1586.6,ng/ml,1.2,=,73.3,66.7,80,
Cao22c,10.1016/j.chom.2022.09.018,Pseudovirus (VSV),Figure 5b,Amubarvimab + Romlusevimab,Wild Type (B.1),=,81,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,8610,ng/ml,1,=,106.3,,,
Iketani22,10.1038/s41586-022-04594-4,Pseudovirus (VSV),Figure 2a,Amubarvimab + Romlusevimab,Wild Type (B.1),=,46.4,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,5304.4,ng/ml,1,=,114.3,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Amubarvimab + Romlusevimab,Wild Type (B.1),=,32,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1164,ng/ml,1,=,36.4,,,
Wang22j,10.1016/S1473-3099(22)00694-6,Pseudovirus (VSV),Figure S3,Amubarvimab + Romlusevimab,Wild Type (B.1),=,34,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,3992,ng/ml,1,=,117.4,,,
Cao22c,10.1016/j.chom.2022.09.018,Pseudovirus (VSV),Figure 5b,DXP-604,Wild Type (B.1),=,11,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,219,ng/ml,1,=,19.9,,,
Huang22,10.1016/j.immuni.2022.06.005,Pseudovirus (VSV),Figure 2,DXP-604,Wild Type (B),=,27,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,100,ng/ml,1,=,3.7,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Bamlanivimab,Wild Type (B.1),=,15,ng/ml,1,pCoV-GD,6,V6ins + L7H + L8F + P9A + S12N + T20G + T22A + Q23A + L24I + P25Q + A27S + Y28F + F32S + T33Q + K41T + V42I + S46N + V47T + S50L + T51S + D53G + L54Y + F59Y + T63S + F65Y + H66Y + I68L + Δ69-70 + S71T + G72K + N74ins + G75A + T76E + F79V + P85D + N87K + V90I + S94A + I101V + S112N + K113T + T114S + V127I + E132N + N137Y + F140Y + G142S + V143G + Δ147 + S151T + M153S + E154T + S155R + R158A + A163Y + N164A + Q173K + P174S + L176M + M177L + L179I + E180A + Q183V + G184A + F186I + N188H + L189I + R190K + K195R + I197V + H207Y + I210V + L212V + V213N + R214S + D215N + Q218I + D228E + L229I + I231A + R237K + Q239R + A243T + L244I + S247G + Y248D + L249P + T250M + Δ252-254 + A260V + G261F + A262S + Q271A + L276M + K278N + T299A + F306L + R346T + A372T + I402V + K417R + Q498H + H519N + K529Q + N556S + R634S + Δ681-684 + A688S + S691A + S708A + T747I + A1070S + A1078T + D1084E + N1125S + V1228I,1,=,6.8,ng/ml,1,=,0.5,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Etesevimab,Wild Type (B.1),=,32,ng/ml,1,pCoV-GD,6,V6ins + L7H + L8F + P9A + S12N + T20G + T22A + Q23A + L24I + P25Q + A27S + Y28F + F32S + T33Q + K41T + V42I + S46N + V47T + S50L + T51S + D53G + L54Y + F59Y + T63S + F65Y + H66Y + I68L + Δ69-70 + S71T + G72K + N74ins + G75A + T76E + F79V + P85D + N87K + V90I + S94A + I101V + S112N + K113T + T114S + V127I + E132N + N137Y + F140Y + G142S + V143G + Δ147 + S151T + M153S + E154T + S155R + R158A + A163Y + N164A + Q173K + P174S + L176M + M177L + L179I + E180A + Q183V + G184A + F186I + N188H + L189I + R190K + K195R + I197V + H207Y + I210V + L212V + V213N + R214S + D215N + Q218I + D228E + L229I + I231A + R237K + Q239R + A243T + L244I + S247G + Y248D + L249P + T250M + Δ252-254 + A260V + G261F + A262S + Q271A + L276M + K278N + T299A + F306L + R346T + A372T + I402V + K417R + Q498H + H519N + K529Q + N556S + R634S + Δ681-684 + A688S + S691A + S708A + T747I + A1070S + A1078T + D1084E + N1125S + V1228I,1,=,1120,ng/ml,1,=,35,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Casirivimab,Wild Type (B.1),=,5.6,ng/ml,1,pCoV-GD,6,V6ins + L7H + L8F + P9A + S12N + T20G + T22A + Q23A + L24I + P25Q + A27S + Y28F + F32S + T33Q + K41T + V42I + S46N + V47T + S50L + T51S + D53G + L54Y + F59Y + T63S + F65Y + H66Y + I68L + Δ69-70 + S71T + G72K + N74ins + G75A + T76E + F79V + P85D + N87K + V90I + S94A + I101V + S112N + K113T + T114S + V127I + E132N + N137Y + F140Y + G142S + V143G + Δ147 + S151T + M153S + E154T + S155R + R158A + A163Y + N164A + Q173K + P174S + L176M + M177L + L179I + E180A + Q183V + G184A + F186I + N188H + L189I + R190K + K195R + I197V + H207Y + I210V + L212V + V213N + R214S + D215N + Q218I + D228E + L229I + I231A + R237K + Q239R + A243T + L244I + S247G + Y248D + L249P + T250M + Δ252-254 + A260V + G261F + A262S + Q271A + L276M + K278N + T299A + F306L + R346T + A372T + I402V + K417R + Q498H + H519N + K529Q + N556S + R634S + Δ681-684 + A688S + S691A + S708A + T747I + A1070S + A1078T + D1084E + N1125S + V1228I,1,=,157,ng/ml,1,=,27.8,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Imdevimab,Wild Type (B.1),=,5.7,ng/ml,1,pCoV-GD,6,V6ins + L7H + L8F + P9A + S12N + T20G + T22A + Q23A + L24I + P25Q + A27S + Y28F + F32S + T33Q + K41T + V42I + S46N + V47T + S50L + T51S + D53G + L54Y + F59Y + T63S + F65Y + H66Y + I68L + Δ69-70 + S71T + G72K + N74ins + G75A + T76E + F79V + P85D + N87K + V90I + S94A + I101V + S112N + K113T + T114S + V127I + E132N + N137Y + F140Y + G142S + V143G + Δ147 + S151T + M153S + E154T + S155R + R158A + A163Y + N164A + Q173K + P174S + L176M + M177L + L179I + E180A + Q183V + G184A + F186I + N188H + L189I + R190K + K195R + I197V + H207Y + I210V + L212V + V213N + R214S + D215N + Q218I + D228E + L229I + I231A + R237K + Q239R + A243T + L244I + S247G + Y248D + L249P + T250M + Δ252-254 + A260V + G261F + A262S + Q271A + L276M + K278N + T299A + F306L + R346T + A372T + I402V + K417R + Q498H + H519N + K529Q + N556S + R634S + Δ681-684 + A688S + S691A + S708A + T747I + A1070S + A1078T + D1084E + N1125S + V1228I,1,=,83.7,ng/ml,1,=,14.6,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Cilgavimab,Wild Type (B.1),=,2.5,ng/ml,1,pCoV-GD,6,V6ins + L7H + L8F + P9A + S12N + T20G + T22A + Q23A + L24I + P25Q + A27S + Y28F + F32S + T33Q + K41T + V42I + S46N + V47T + S50L + T51S + D53G + L54Y + F59Y + T63S + F65Y + H66Y + I68L + Δ69-70 + S71T + G72K + N74ins + G75A + T76E + F79V + P85D + N87K + V90I + S94A + I101V + S112N + K113T + T114S + V127I + E132N + N137Y + F140Y + G142S + V143G + Δ147 + S151T + M153S + E154T + S155R + R158A + A163Y + N164A + Q173K + P174S + L176M + M177L + L179I + E180A + Q183V + G184A + F186I + N188H + L189I + R190K + K195R + I197V + H207Y + I210V + L212V + V213N + R214S + D215N + Q218I + D228E + L229I + I231A + R237K + Q239R + A243T + L244I + S247G + Y248D + L249P + T250M + Δ252-254 + A260V + G261F + A262S + Q271A + L276M + K278N + T299A + F306L + R346T + A372T + I402V + K417R + Q498H + H519N + K529Q + N556S + R634S + Δ681-684 + A688S + S691A + S708A + T747I + A1070S + A1078T + D1084E + N1125S + V1228I,1,>,10000,ng/ml,1,>,1000,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Tixagevimab,Wild Type (B.1),=,1.6,ng/ml,1,pCoV-GD,6,V6ins + L7H + L8F + P9A + S12N + T20G + T22A + Q23A + L24I + P25Q + A27S + Y28F + F32S + T33Q + K41T + V42I + S46N + V47T + S50L + T51S + D53G + L54Y + F59Y + T63S + F65Y + H66Y + I68L + Δ69-70 + S71T + G72K + N74ins + G75A + T76E + F79V + P85D + N87K + V90I + S94A + I101V + S112N + K113T + T114S + V127I + E132N + N137Y + F140Y + G142S + V143G + Δ147 + S151T + M153S + E154T + S155R + R158A + A163Y + N164A + Q173K + P174S + L176M + M177L + L179I + E180A + Q183V + G184A + F186I + N188H + L189I + R190K + K195R + I197V + H207Y + I210V + L212V + V213N + R214S + D215N + Q218I + D228E + L229I + I231A + R237K + Q239R + A243T + L244I + S247G + Y248D + L249P + T250M + Δ252-254 + A260V + G261F + A262S + Q271A + L276M + K278N + T299A + F306L + R346T + A372T + I402V + K417R + Q498H + H519N + K529Q + N556S + R634S + Δ681-684 + A688S + S691A + S708A + T747I + A1070S + A1078T + D1084E + N1125S + V1228I,1,=,17.4,ng/ml,1,=,11.1,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Sotrovimab,Wild Type (B.1),=,74.1,ng/ml,1,pCoV-GD,6,V6ins + L7H + L8F + P9A + S12N + T20G + T22A + Q23A + L24I + P25Q + A27S + Y28F + F32S + T33Q + K41T + V42I + S46N + V47T + S50L + T51S + D53G + L54Y + F59Y + T63S + F65Y + H66Y + I68L + Δ69-70 + S71T + G72K + N74ins + G75A + T76E + F79V + P85D + N87K + V90I + S94A + I101V + S112N + K113T + T114S + V127I + E132N + N137Y + F140Y + G142S + V143G + Δ147 + S151T + M153S + E154T + S155R + R158A + A163Y + N164A + Q173K + P174S + L176M + M177L + L179I + E180A + Q183V + G184A + F186I + N188H + L189I + R190K + K195R + I197V + H207Y + I210V + L212V + V213N + R214S + D215N + Q218I + D228E + L229I + I231A + R237K + Q239R + A243T + L244I + S247G + Y248D + L249P + T250M + Δ252-254 + A260V + G261F + A262S + Q271A + L276M + K278N + T299A + F306L + R346T + A372T + I402V + K417R + Q498H + H519N + K529Q + N556S + R634S + Δ681-684 + A688S + S691A + S708A + T747I + A1070S + A1078T + D1084E + N1125S + V1228I,1,>,10000,ng/ml,1,>,135,,,
Liu22,10.1126/scitranslmed.abn6859,Pseudovirus (VSV),Fig2C,Sotrovimab,Wild Type (B.1),=,11,ng/ml,1,pCoV-GD,79,F79V + P85D + N87K + V90I + S94A + I101V + S112N + K113T + T114S + V127I + E132N + N137Y + F140Y + G142S + V143G + Δ147 + S151T + M153S + E154T + S155R + R158A + A163Y + N164A + Q173K + P174S + L176M + M177L + L179I + E180A + Q183S + N185L + K187D + N188T + K195R + I197V + H207Y + I210V + L212V + V213N + R214S + D215N + Q218I + D228E + L229I + I231A + R237K + Q239R + A243T + L244I + S247G + Y248D + L249P + T250M + Δ252-254 + S255N + S256N + A260V + G261F + A262S + Q271A + L276M + K278N + T299A + F306L + R346T + A372T + I402V + K417R + Q498H + H519N + K529Q + N556S + R634S + Δ681-684 + A688S + S691A + S708A + T747I + A1070S + A1078T + D1084E + N1125S + V1228I,1,=,140,ng/ml,1,=,12.7,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Bebtelovimab,Wild Type (B.1),=,0.8,ng/ml,1,pCoV-GD,6,V6ins + L7H + L8F + P9A + S12N + T20G + T22A + Q23A + L24I + P25Q + A27S + Y28F + F32S + T33Q + K41T + V42I + S46N + V47T + S50L + T51S + D53G + L54Y + F59Y + T63S + F65Y + H66Y + I68L + Δ69-70 + S71T + G72K + N74ins + G75A + T76E + F79V + P85D + N87K + V90I + S94A + I101V + S112N + K113T + T114S + V127I + E132N + N137Y + F140Y + G142S + V143G + Δ147 + S151T + M153S + E154T + S155R + R158A + A163Y + N164A + Q173K + P174S + L176M + M177L + L179I + E180A + Q183V + G184A + F186I + N188H + L189I + R190K + K195R + I197V + H207Y + I210V + L212V + V213N + R214S + D215N + Q218I + D228E + L229I + I231A + R237K + Q239R + A243T + L244I + S247G + Y248D + L249P + T250M + Δ252-254 + A260V + G261F + A262S + Q271A + L276M + K278N + T299A + F306L + R346T + A372T + I402V + K417R + Q498H + H519N + K529Q + N556S + R634S + Δ681-684 + A688S + S691A + S708A + T747I + A1070S + A1078T + D1084E + N1125S + V1228I,1,=,8.6,ng/ml,1,=,11.5,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Amubarvimab,Wild Type (B.1),=,53.2,ng/ml,1,pCoV-GD,6,V6ins + L7H + L8F + P9A + S12N + T20G + T22A + Q23A + L24I + P25Q + A27S + Y28F + F32S + T33Q + K41T + V42I + S46N + V47T + S50L + T51S + D53G + L54Y + F59Y + T63S + F65Y + H66Y + I68L + Δ69-70 + S71T + G72K + N74ins + G75A + T76E + F79V + P85D + N87K + V90I + S94A + I101V + S112N + K113T + T114S + V127I + E132N + N137Y + F140Y + G142S + V143G + Δ147 + S151T + M153S + E154T + S155R + R158A + A163Y + N164A + Q173K + P174S + L176M + M177L + L179I + E180A + Q183V + G184A + F186I + N188H + L189I + R190K + K195R + I197V + H207Y + I210V + L212V + V213N + R214S + D215N + Q218I + D228E + L229I + I231A + R237K + Q239R + A243T + L244I + S247G + Y248D + L249P + T250M + Δ252-254 + A260V + G261F + A262S + Q271A + L276M + K278N + T299A + F306L + R346T + A372T + I402V + K417R + Q498H + H519N + K529Q + N556S + R634S + Δ681-684 + A688S + S691A + S708A + T747I + A1070S + A1078T + D1084E + N1125S + V1228I,1,=,12.6,ng/ml,1,=,0.2,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Romlusevimab,Wild Type (B.1),=,1240,ng/ml,1,pCoV-GD,6,V6ins + L7H + L8F + P9A + S12N + T20G + T22A + Q23A + L24I + P25Q + A27S + Y28F + F32S + T33Q + K41T + V42I + S46N + V47T + S50L + T51S + D53G + L54Y + F59Y + T63S + F65Y + H66Y + I68L + Δ69-70 + S71T + G72K + N74ins + G75A + T76E + F79V + P85D + N87K + V90I + S94A + I101V + S112N + K113T + T114S + V127I + E132N + N137Y + F140Y + G142S + V143G + Δ147 + S151T + M153S + E154T + S155R + R158A + A163Y + N164A + Q173K + P174S + L176M + M177L + L179I + E180A + Q183V + G184A + F186I + N188H + L189I + R190K + K195R + I197V + H207Y + I210V + L212V + V213N + R214S + D215N + Q218I + D228E + L229I + I231A + R237K + Q239R + A243T + L244I + S247G + Y248D + L249P + T250M + Δ252-254 + A260V + G261F + A262S + Q271A + L276M + K278N + T299A + F306L + R346T + A372T + I402V + K417R + Q498H + H519N + K529Q + N556S + R634S + Δ681-684 + A688S + S691A + S708A + T747I + A1070S + A1078T + D1084E + N1125S + V1228I,1,>,10000,ng/ml,1,>,8.1,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,DXP-604,Wild Type (B.1),=,11,ng/ml,1,pCoV-GD,6,V6ins + L7H + L8F + P9A + S12N + T20G + T22A + Q23A + L24I + P25Q + A27S + Y28F + F32S + T33Q + K41T + V42I + S46N + V47T + S50L + T51S + D53G + L54Y + F59Y + T63S + F65Y + H66Y + I68L + Δ69-70 + S71T + G72K + N74ins + G75A + T76E + F79V + P85D + N87K + V90I + S94A + I101V + S112N + K113T + T114S + V127I + E132N + N137Y + F140Y + G142S + V143G + Δ147 + S151T + M153S + E154T + S155R + R158A + A163Y + N164A + Q173K + P174S + L176M + M177L + L179I + E180A + Q183V + G184A + F186I + N188H + L189I + R190K + K195R + I197V + H207Y + I210V + L212V + V213N + R214S + D215N + Q218I + D228E + L229I + I231A + R237K + Q239R + A243T + L244I + S247G + Y248D + L249P + T250M + Δ252-254 + A260V + G261F + A262S + Q271A + L276M + K278N + T299A + F306L + R346T + A372T + I402V + K417R + Q498H + H519N + K529Q + N556S + R634S + Δ681-684 + A688S + S691A + S708A + T747I + A1070S + A1078T + D1084E + N1125S + V1228I,1,=,7.4,ng/ml,1,=,0.7,,,
Kaleta22,10.1038/s41467-022-28766-y,Virus isolate,Table 2,Bamlanivimab,Wild Type (B.1),=,110,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,60,ng/ml,1,=,0.5,,,
Planas21b,10.1038/s41586-021-03777-9,Virus isolate,"Fig.1, Extended Data Fig.5, 2021.05.26.445838 Figure 3a",Bamlanivimab,Wild Type (B.1),=,0.2,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,0.2,ng/ml,1,=,1,,,
Makdasi21,10.1016/j.celrep.2021.109679,Virus isolate,Table S1,Bamlanivimab,Wild Type (B.1),=,10,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,10,ng/ml,1,=,1,,,
Dejnirattisai22,10.1016/j.cell.2021.12.046,Virus isolate,"Figure 4C, Table S1",Bamlanivimab,Wild Type (B),=,6,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,9,ng/ml,1,=,1.5,,,
Supasa21,10.1016/j.cell.2021.02.033,Virus isolate,Dejnirattisai21 Table S2,Bamlanivimab,Wild Type (B),=,6,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,9,ng/ml,1,=,1.5,,,
Wang21b,10.1038/s41586-021-03398-2,Virus isolate,"Fig. 2c, 2e",Bamlanivimab,Wild Type (A),,,,,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,,,,,=,2.8,,,
Chen21e,10.1038/s41586-021-03720-y,SARS-CoV-2 recombinant,Figure 1c,Bamlanivimab,Wild Type (B.1),=,5,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,4,ng/ml,1,=,0.8,,,
Takashita22,10.1056/NEJMc2119407,Virus isolate,Table 1,Bamlanivimab,Wild Type (A),=,4.7,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,2.7,ng/ml,1,=,0.6,,,
Cao22d,10.1038/s41586-021-04385-3,Pseudovirus (VSV),Fig 4b,Bamlanivimab,Wild Type (B.1),=,13,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,8,ng/ml,1,=,0.6,,,
Hoffmann21,10.1016/j.cell.2021.03.036,Pseudovirus (VSV),Figure 6,Bamlanivimab,Wild Type (B.1),=,4.8,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,2.4,ng/ml,1,=,0.5,,,
Tada22,10.1016/j.ebiom.2022.103944,Pseudovirus (lentivirus),Figure 2e,Bamlanivimab,Wild Type (B.1),=,0.8,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,0.8,ng/ml,1,=,1,,,
Zhou21e,10.1126/science.abn8897,Pseudovirus (lentivirus),Figure 2C,Bamlanivimab,Wild Type (B.1),=,3.6,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,7.7,ng/ml,1,=,2.1,,,
Chen22e,10.1016/j.celrep.2022.111528,Pseudovirus (lentivirus),Figure 2B,Bamlanivimab,Wild Type (A),=,3,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,4,ng/ml,1,=,1.3,,,
Chen22,10.1101/2022.01.12.22269023,Pseudovirus (lentivirus),Fig 1h,Bamlanivimab,Wild Type (A),=,3,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,4,ng/ml,1,=,1.3,,,
Yuan22,10.1101/2022.03.13.484037,Pseudovirus (MLV),Figure 2A,Bamlanivimab,Wild Type (B),=,7,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,5,ng/ml,1,=,0.7,,,
FDA21,https://www.fda.gov/drugs/drug-safety-and-availability/fda-authorizes-revisions-fact-sheets-address-sars-cov-2-variants-monoclonal-antibody-products-under,Pseudovirus (VSV),BAM Table 3,Bamlanivimab,Wild Type (B),,,,,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,,,,,=,1,,,
Wang21b,10.1038/s41586-021-03398-2,Pseudovirus (VSV),Figure 2a,Bamlanivimab,Wild Type (B.1),,,,,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,,,,,=,0.6,,,
Boschi22,10.1093/cid/ciac143,Virus isolate,Figure 1A,Bamlanivimab,Wild Type (B.1.1),=,0.2,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,5.6,ng/ml,1,=,24.4,,,
Vanhove21,10.3389/fimmu.2021.761250,Virus isolate,Figure 3B,Bamlanivimab,Wild Type (B.1),=,106,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,139,ng/ml,1,=,1.3,,,
Nabel21,10.1126/science.abl6251,Pseudovirus (lentivirus),"Fig 2A, 2B",Bamlanivimab,Wild Type (B.1),=,22,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,30,ng/ml,1,=,1.4,,,
Wang21e,10.1126/science.abh1766,Pseudovirus (lentivirus),Fig 2C,Bamlanivimab,Wild Type (A),=,7.1,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,4.1,ng/ml,1,=,0.6,,,
Gruell22,10.1038/s41591-021-01676-0,Pseudovirus (HIV),Fig 2,Bamlanivimab,Wild Type (B),=,3.1,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,4.3,ng/ml,1,=,1.4,,,
Yao21,10.1101/2021.01.27.428353,Pseudovirus (MLV),Figure 5,Bamlanivimab,Wild Type (B),=,6.8,ng/ml,1,Alpha,69,Δ69-70 + Δ144 + N501Y + A570D + T716I + S982A + D1118H,1,=,5,ng/ml,1,=,0.7,,,
Planas21b,10.1038/s41586-021-03777-9,Virus isolate,"Fig.1, Extended Data Fig.5, 2021.05.26.445838 Figure 3a",Etesevimab,Wild Type (B.1),=,1.2,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,39.3,ng/ml,1,=,34.1,,,
Dejnirattisai22,10.1016/j.cell.2021.12.046,Virus isolate,"Figure 4C, Table S1",Etesevimab,Wild Type (B),=,34,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,3225,ng/ml,1,=,94.9,,,
Supasa21,10.1016/j.cell.2021.02.033,Virus isolate,Dejnirattisai21 Table S2,Etesevimab,Wild Type (B),=,34,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,3225,ng/ml,1,=,94.9,,,
Wang21b,10.1038/s41586-021-03398-2,Virus isolate,Extended Data Fig 5,Etesevimab,Wild Type (A),,,,,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,,,,,=,0.7,,,
Chen21e,10.1038/s41586-021-03720-y,SARS-CoV-2 recombinant,Extended Data Fig 13,Etesevimab,Wild Type (B.1),=,52,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,169,ng/ml,1,=,3.3,,,
Takashita22,10.1056/NEJMc2119407,Virus isolate,Table 1,Etesevimab,Wild Type (A),=,18.2,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,150.4,ng/ml,1,=,8.3,,,
Cao22d,10.1038/s41586-021-04385-3,Pseudovirus (VSV),Fig 4b,Etesevimab,Wild Type (B.1),=,32,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,1707,ng/ml,1,=,53.3,,,
Tada22,10.1016/j.ebiom.2022.103944,Pseudovirus (lentivirus),Figure 2e,Etesevimab,Wild Type (B.1),=,5.3,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,9.4,ng/ml,1,=,1.8,,,
Zhou21e,10.1126/science.abn8897,Pseudovirus (lentivirus),Figure 2C,Etesevimab,Wild Type (B.1),=,50.5,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,22.7,ng/ml,1,=,0.4,,,
Chen22e,10.1016/j.celrep.2022.111528,Pseudovirus (lentivirus),Figure 2B,Etesevimab,Wild Type (A),=,19,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,371,ng/ml,1,=,19.5,,,
Wang22c,10.1038/s41586-022-04466-x,Pseudovirus (VSV),Supplmentary Table 2,Etesevimab,Wild Type (B),=,19,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,88,ng/ml,1,=,4.6,,,
Yuan22,10.1101/2022.03.13.484037,Pseudovirus (MLV),Figure 2A,Etesevimab,Wild Type (B),=,9,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,133,ng/ml,1,=,14.8,,,
Wang21b,10.1038/s41586-021-03398-2,Pseudovirus (VSV),Extended Data Fig 5,Etesevimab,Wild Type (B.1),,,,,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,,,,,=,3.6,,,
Wang21f,10.1016/j.immuni.2021.06.003,Pseudovirus (HIV),"Figure 1C, Figure S1",Etesevimab,Wild Type (B.1),=,20.4,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,99.9,ng/ml,1,=,4.9,,,
Boschi22,10.1093/cid/ciac143,Virus isolate,Figure 1A,Etesevimab,Wild Type (B.1.1),=,6,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,68.1,ng/ml,1,=,11.4,,,
Nabel21,10.1126/science.abl6251,Pseudovirus (lentivirus),"Fig 2A, 2B",Etesevimab,Wild Type (B.1),=,27,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,411,ng/ml,1,=,15.2,,,
Wang21e,10.1126/science.abh1766,Pseudovirus (lentivirus),Fig 2C,Etesevimab,Wild Type (A),=,26.2,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,40.1,ng/ml,1,=,1.5,,,
Gruell22,10.1038/s41591-021-01676-0,Pseudovirus (HIV),Fig 2,Etesevimab,Wild Type (B),=,19.4,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,913.9,ng/ml,1,=,47.1,,,
Zhang21c,10.1038/s42003-021-02728-4,Pseudovirus (VSV),Supplementary Figure 3,Etesevimab,Wild Type (B.1),,,,,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,,,,,=,49.2,,,
Yao21,10.1101/2021.01.27.428353,Pseudovirus (MLV),Figure 5,Etesevimab,Wild Type (B),=,80.5,ng/ml,1,Alpha,69,Δ69-70 + Δ144 + N501Y + A570D + T716I + S982A + D1118H,1,=,1296.2,ng/ml,1,=,16.1,,,
FDA21,https://www.fda.gov/drugs/drug-safety-and-availability/fda-authorizes-revisions-fact-sheets-address-sars-cov-2-variants-monoclonal-antibody-products-under,Virus isolate,BAM+ETE Table 4 page 27,Bamlanivimab + Etesevimab,Wild Type (B),,,,,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,,,,,=,1,,,
Wang21b,10.1038/s41586-021-03398-2,Virus isolate,Fig. 2e,Bamlanivimab + Etesevimab,Wild Type (A),,,,,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,,,,,=,1.3,,,
Chen21e,10.1038/s41586-021-03720-y,SARS-CoV-2 recombinant,Extended Data Fig 13,Bamlanivimab + Etesevimab,Wild Type (B.1),=,9,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,11,ng/ml,1,=,1.2,,,
Takashita22,10.1056/NEJMc2119407,Virus isolate,Table 1,Bamlanivimab + Etesevimab,Wild Type (A),=,25.2,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,30.6,ng/ml,1,=,1.2,,,Combination therapies in this study were specified at ng/ml of each component so needs to multiply by 2
Tada22,10.1016/j.ebiom.2022.103944,Pseudovirus (lentivirus),Figure 2e,Bamlanivimab + Etesevimab,Wild Type (B.1),=,5.1,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,9.9,ng/ml,1,=,1.9,,,
Yuan22,10.1101/2022.03.13.484037,Pseudovirus (MLV),Figure 2A,Bamlanivimab + Etesevimab,Wild Type (B),=,9,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,17,ng/ml,1,=,1.9,,,
FDA21,https://www.fda.gov/drugs/drug-safety-and-availability/fda-authorizes-revisions-fact-sheets-address-sars-cov-2-variants-monoclonal-antibody-products-under,Pseudovirus (VSV),BAM+ETE Table 3 page 27,Bamlanivimab + Etesevimab,Wild Type (B),,,,,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,,,,,=,1,,,
Wang21b,10.1038/s41586-021-03398-2,Pseudovirus (VSV),Fig. 2e,Bamlanivimab + Etesevimab,Wild Type (B.1),,,,,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,,,,,=,1.7,,,
Boschi22,10.1093/cid/ciac143,Virus isolate,Figure 1A,Bamlanivimab + Etesevimab,Wild Type (B.1.1),=,0.5,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,2.6,ng/ml,1,=,4.9,,,
Kaleta22,10.1038/s41467-022-28766-y,Virus isolate,Table 2,Casirivimab,Wild Type (B.1),=,90,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,20,ng/ml,1,=,0.2,,,
Planas21b,10.1038/s41586-021-03777-9,Virus isolate,"Fig.1, Extended Data Fig.5, 2021.05.26.445838 Figure 3a",Casirivimab,Wild Type (B.1),=,0.1,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,0.1,ng/ml,1,=,1,,,
Dejnirattisai22,10.1016/j.cell.2021.12.046,Virus isolate,"Figure 4C, Table S1",Casirivimab,Wild Type (B),=,4,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,14,ng/ml,1,=,3.5,,,
Supasa21,10.1016/j.cell.2021.02.033,Virus isolate,Dejnirattisai21 Table S2,Casirivimab,Wild Type (B),=,4,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,14,ng/ml,1,=,3.5,,,
Du22,10.1126/sciimmunol.abp9312,Virus isolate,Fig 1E,Casirivimab,Wild Type (B),=,3.4,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,0.7,ng/ml,1,=,0.2,,,
Wang21b,10.1038/s41586-021-03398-2,Virus isolate,Figure 2a,Casirivimab,Wild Type (A),,,,,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,,,,,=,1,,,
Chen21e,10.1038/s41586-021-03720-y,SARS-CoV-2 recombinant,Figure 1c,Casirivimab,Wild Type (B.1),=,7,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,8,ng/ml,1,=,1.1,,,
Takashita22,10.1056/NEJMc2119407,Virus isolate,Table 1,Casirivimab,Wild Type (A),=,2.8,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,2.7,ng/ml,1,=,1,,,
Cao22d,10.1038/s41586-021-04385-3,Pseudovirus (VSV),Fig 4b,Casirivimab,Wild Type (B.1),=,5,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,7,ng/ml,1,=,1.4,,,
EMA21,https://www.ema.europa.eu/en/documents/referral/regn-cov2-antibody-combination-casirivimab/imdevimab-covid19-article-53-procedure-assessment-report_en.pdf,Pseudovirus (VSV),page 25. Table 8.,Casirivimab,Wild Type (B.1),=,6.5,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,22.8,ng/ml,1,=,3.5,,,
Hoffmann21,10.1016/j.cell.2021.03.036,Pseudovirus (VSV),Figure 6,Casirivimab,Wild Type (B.1),=,1,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,1.9,ng/ml,1,=,2,,,
Miyakawa21b,10.1101/2021.09.23.21264014,Pseudovirus,Figure 1C,Casirivimab,Wild Type (B.1),=,89,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,77,ng/ml,1,=,0.9,,,
Tada21,10.1128/mBio.00696-21,Pseudovirus (HIV),Table 3,Casirivimab,Wild Type (B.1),=,7.4,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,7.4,ng/ml,1,=,1,,,
Tada22,10.1016/j.ebiom.2022.103944,Pseudovirus (lentivirus),Figure 2e,Casirivimab,Wild Type (B.1),=,2.1,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,1.5,ng/ml,1,=,0.7,,,
Zhou21e,10.1126/science.abn8897,Pseudovirus (lentivirus),Figure 2C,Casirivimab,Wild Type (B.1),=,6.1,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,9.7,ng/ml,1,=,1.6,,,
Chen22e,10.1016/j.celrep.2022.111528,Pseudovirus (lentivirus),Figure 2B,Casirivimab,Wild Type (A),=,2,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,3,ng/ml,1,=,1.5,,,
Chen22,10.1101/2022.01.12.22269023,Pseudovirus (lentivirus),Fig 1h,Casirivimab,Wild Type (A),=,2,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,3,ng/ml,1,=,1.5,,,
Du22,10.1126/sciimmunol.abp9312,Pseudovirus,Fig 1E,Casirivimab,Wild Type (B),=,3.2,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,2.8,ng/ml,1,=,0.9,,,
Pelzek22,10.1101/2022.02.06.479332,Pseudovirus (lentivirus),Extended Table 1,Casirivimab,Wild Type (B),=,24,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,26,ng/ml,1,=,1.1,,,
Yuan22,10.1101/2022.03.13.484037,Pseudovirus (MLV),Figure 2A,Casirivimab,Wild Type (B),=,6,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,5,ng/ml,1,=,0.8,,,
Wang21b,10.1038/s41586-021-03398-2,Pseudovirus (VSV),Figure 2a,Casirivimab,Wild Type (B.1),,,,,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,,,,,=,0.4,,,
Wang21f,10.1016/j.immuni.2021.06.003,Pseudovirus (HIV),"Figure 1C, Figure S1",Casirivimab,Wild Type (B.1),=,3.3,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,2.1,ng/ml,1,=,0.6,,,
Boschi22,10.1093/cid/ciac143,Virus isolate,Figure 1B,Casirivimab,Wild Type (B.1.1),=,0.7,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,1.8,ng/ml,1,=,2.4,,,
Moriyama21,10.1016/j.immuni.2021.06.015,Virus isolate,Figure 3A,Casirivimab,Wild Type (A),=,941,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,941,ng/ml,1,=,1,,,
Ohashi22,10.1101/2022.02.27.482147,Virus isolate,Table 1,Casirivimab,Wild Type (A),=,13.9,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,13.6,ng/ml,1,=,1,,,
Nabel21,10.1126/science.abl6251,Pseudovirus (lentivirus),"Fig 2A, 2B",Casirivimab,Wild Type (B.1),=,25,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,22,ng/ml,1,=,0.9,,,
Wang21e,10.1126/science.abh1766,Pseudovirus (lentivirus),Fig 2C,Casirivimab,Wild Type (A),=,7.7,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,6.9,ng/ml,1,=,0.9,,,
Fenwick21,10.1016/j.celrep.2021.109814,SARS-CoV-2 recombinant,Figure 3B,Casirivimab,Wild Type (B),=,48,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,8,ng/ml,1,=,0.2,,,
Gruell22,10.1038/s41591-021-01676-0,Pseudovirus (HIV),Fig 2,Casirivimab,Wild Type (B),=,1.9,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,0.6,ng/ml,1,=,0.3,,,
Yao21,10.1101/2021.01.27.428353,Pseudovirus (MLV),Figure 5,Casirivimab,Wild Type (B),=,6.8,ng/ml,1,Alpha,69,Δ69-70 + Δ144 + N501Y + A570D + T716I + S982A + D1118H,1,=,5,ng/ml,1,=,0.7,,,
Copin21,10.1016/j.cell.2021.06.002,Pseudovirus (VSV),Figure 1A,Casirivimab,Wild Type (B.1),=,8.4,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,9.2,ng/ml,1,=,1.1,,,
FDA21,https://www.fda.gov/drugs/drug-safety-and-availability/fda-authorizes-revisions-fact-sheets-address-sars-cov-2-variants-monoclonal-antibody-products-under,Pseudovirus (VSV),CAS+IMD Table 9 page 42,Casirivimab,Wild Type (B),,,,,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,,,,,=,1,,,
Kaleta22,10.1038/s41467-022-28766-y,Virus isolate,Table 2,Imdevimab,Wild Type (B.1),=,20,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,10,ng/ml,1,=,0.5,,,
Planas21b,10.1038/s41586-021-03777-9,Virus isolate,"Fig.1, Extended Data Fig.5, 2021.05.26.445838 Figure 3a",Imdevimab,Wild Type (B.1),=,0.1,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,0.1,ng/ml,1,=,1,,,
Dejnirattisai22,10.1016/j.cell.2021.12.046,Virus isolate,"Figure 4C, Table S1",Imdevimab,Wild Type (B),=,32,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,28,ng/ml,1,=,0.9,,,
Supasa21,10.1016/j.cell.2021.02.033,Virus isolate,Dejnirattisai21 Table S2,Imdevimab,Wild Type (B),=,32,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,28,ng/ml,1,=,0.9,,,
Wang21b,10.1038/s41586-021-03398-2,Virus isolate,Figure 2a,Imdevimab,Wild Type (A),,,,,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,,,,,=,1,,,
Chen21e,10.1038/s41586-021-03720-y,SARS-CoV-2 recombinant,Figure 1c,Imdevimab,Wild Type (B.1),=,12,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,7,ng/ml,1,=,0.6,,,
Takashita22,10.1056/NEJMc2119407,Virus isolate,Table 1,Imdevimab,Wild Type (A),=,3,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,1.9,ng/ml,1,=,0.6,,,
Cao22d,10.1038/s41586-021-04385-3,Pseudovirus (VSV),Fig 4b,Imdevimab,Wild Type (B.1),=,5,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,3,ng/ml,1,=,0.6,,,
EMA21,https://www.ema.europa.eu/en/documents/referral/regn-cov2-antibody-combination-casirivimab/imdevimab-covid19-article-53-procedure-assessment-report_en.pdf,Pseudovirus (VSV),page 25. Table 8.,Imdevimab,Wild Type (B.1),=,6.9,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,12,ng/ml,1,=,1.7,,,
Hoffmann21,10.1016/j.cell.2021.03.036,Pseudovirus (VSV),Figure 6,Imdevimab,Wild Type (B.1),=,0.9,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,0.9,ng/ml,1,=,1,,,
Miyakawa21b,10.1101/2021.09.23.21264014,Pseudovirus,Figure 1C,Imdevimab,Wild Type (B.1),=,65,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,20,ng/ml,1,=,0.3,,,
Tada21,10.1128/mBio.00696-21,Pseudovirus (HIV),Table 3,Imdevimab,Wild Type (B.1),=,19.4,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,19.4,ng/ml,1,=,1,,,
Tada22,10.1016/j.ebiom.2022.103944,Pseudovirus (lentivirus),Figure 2e,Imdevimab,Wild Type (B.1),=,2,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,1.5,ng/ml,1,=,0.8,,,
Zhou21e,10.1126/science.abn8897,Pseudovirus (lentivirus),Figure 2C,Imdevimab,Wild Type (B.1),=,20,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,13.5,ng/ml,1,=,0.7,,,
Chen22e,10.1016/j.celrep.2022.111528,Pseudovirus (lentivirus),Figure 2B,Imdevimab,Wild Type (A),=,9,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,1,ng/ml,1,=,0.1,,,
Chen22,10.1101/2022.01.12.22269023,Pseudovirus (lentivirus),Fig 1h,Imdevimab,Wild Type (A),=,9,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,1,ng/ml,1,=,0.1,,,
Du22,10.1126/sciimmunol.abp9312,Pseudovirus,Fig 1E,Imdevimab,Wild Type (B),=,4.7,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,4,ng/ml,1,=,0.9,,,
Pelzek22,10.1101/2022.02.06.479332,Pseudovirus (lentivirus),Extended Table 1,Imdevimab,Wild Type (B),=,23,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,3,ng/ml,1,=,0.1,,,
Wang22c,10.1038/s41586-022-04466-x,Pseudovirus (VSV),Supplmentary Table 2,Imdevimab,Wild Type (B),=,13,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,6,ng/ml,1,=,0.5,,,
Yuan22,10.1101/2022.03.13.484037,Pseudovirus (MLV),Figure 2A,Imdevimab,Wild Type (B),=,25,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,5,ng/ml,1,=,0.2,,,
Wang21b,10.1038/s41586-021-03398-2,Pseudovirus (VSV),Figure 2a,Imdevimab,Wild Type (B.1),,,,,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,,,,,=,0.5,,,
Wang21f,10.1016/j.immuni.2021.06.003,Pseudovirus (HIV),"Figure 1C, Figure S1",Imdevimab,Wild Type (B.1),=,4.4,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,1.8,ng/ml,1,=,0.4,,,
Boschi22,10.1093/cid/ciac143,Virus isolate,Figure 1B,Imdevimab,Wild Type (B.1.1),=,8.9,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,19,ng/ml,1,=,2.1,,,
Moriyama21,10.1016/j.immuni.2021.06.015,Virus isolate,Figure 3C,Imdevimab,Wild Type (A),=,2581,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,590,ng/ml,1,=,0.2,,,
Ohashi22,10.1101/2022.02.27.482147,Virus isolate,Table 1,Imdevimab,Wild Type (A),=,12.5,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,22.7,ng/ml,1,=,1.8,,,
Nabel21,10.1126/science.abl6251,Pseudovirus (lentivirus),"Fig 2A, 2B",Imdevimab,Wild Type (B.1),=,32,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,28,ng/ml,1,=,0.9,,,
Wang21e,10.1126/science.abh1766,Pseudovirus (lentivirus),Fig 2C,Imdevimab,Wild Type (A),=,71,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,16.8,ng/ml,1,=,0.2,,,
Fenwick21,10.1016/j.celrep.2021.109814,SARS-CoV-2 recombinant,Figure 3B,Imdevimab,Wild Type (B),=,28,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,4,ng/ml,1,=,0.1,,,
Gruell22,10.1038/s41591-021-01676-0,Pseudovirus (HIV),Fig 2,Imdevimab,Wild Type (B),=,9.4,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,0.6,ng/ml,1,=,0.1,,,
Wang22b,10.1101/2022.01.30.478305,Pseudovirus (HIV),Figure 1B,Imdevimab,Wild Type (B),=,2.3,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,1.7,ng/ml,1,=,0.7,,,
Yao21,10.1101/2021.01.27.428353,Pseudovirus (MLV),Figure 5,Imdevimab,Wild Type (B),=,6.8,ng/ml,1,Alpha,69,Δ69-70 + Δ144 + N501Y + A570D + T716I + S982A + D1118H,1,=,5,ng/ml,1,=,0.7,,,
Copin21,10.1016/j.cell.2021.06.002,Pseudovirus (VSV),Figure 1A,Imdevimab,Wild Type (B.1),=,6.9,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,2.9,ng/ml,1,=,0.4,,,
FDA21,https://www.fda.gov/drugs/drug-safety-and-availability/fda-authorizes-revisions-fact-sheets-address-sars-cov-2-variants-monoclonal-antibody-products-under,Pseudovirus (VSV),CAS+IMD Table 9 page 42,Imdevimab,Wild Type (B),,,,,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,,,,,=,1,,,
Kaleta22,10.1038/s41467-022-28766-y,Virus isolate,Table 2,Casirivimab + Imdevimab,Wild Type (B.1),=,30,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,20,ng/ml,1,=,0.7,,,
FDA21,https://www.fda.gov/drugs/drug-safety-and-availability/fda-authorizes-revisions-fact-sheets-address-sars-cov-2-variants-monoclonal-antibody-products-under,Virus isolate,CAS+IMD Table 10 page 42,Casirivimab + Imdevimab,Wild Type (B),,,,,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,,,,,=,1,,,
Wang21b,10.1038/s41586-021-03398-2,Virus isolate,Fig. 2e,Casirivimab + Imdevimab,Wild Type (A),,,,,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,,,,,=,1,,,
Chen21e,10.1038/s41586-021-03720-y,SARS-CoV-2 recombinant,Figure 1c,Casirivimab + Imdevimab,Wild Type (B.1),=,5,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,3,ng/ml,1,=,0.6,,,
Takashita22,10.1056/NEJMc2119407,Virus isolate,Table 1,Casirivimab + Imdevimab,Wild Type (A),=,7,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,3.2,ng/ml,1,=,0.4,,,Combination therapies in this study were specified at ng/ml of each component so needs to multiply by 2
EMA21,https://www.ema.europa.eu/en/documents/referral/regn-cov2-antibody-combination-casirivimab/imdevimab-covid19-article-53-procedure-assessment-report_en.pdf,Pseudovirus (VSV),page 25. Table 8.,Casirivimab + Imdevimab,Wild Type (B.1),=,4.9,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,21,ng/ml,1,=,4.3,,,
Hoffmann21,10.1016/j.cell.2021.03.036,Pseudovirus (VSV),Figure 6,Casirivimab + Imdevimab,Wild Type (B.1),=,1,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,1,ng/ml,1,=,1,,,
Tada21,10.1128/mBio.00696-21,Pseudovirus (HIV),Table 3,Casirivimab + Imdevimab,Wild Type (B.1),=,1.7,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,1.7,ng/ml,1,=,1,,,
Tada22,10.1016/j.ebiom.2022.103944,Pseudovirus (lentivirus),Figure 2e,Casirivimab + Imdevimab,Wild Type (B.1),=,0.8,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,0.6,ng/ml,1,=,0.8,,,
Yuan22,10.1101/2022.03.13.484037,Pseudovirus (MLV),Figure 2A,Casirivimab + Imdevimab,Wild Type (B),=,6,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,2,ng/ml,1,=,0.3,,,
Wang21b,10.1038/s41586-021-03398-2,Pseudovirus (VSV),Fig. 2e,Casirivimab + Imdevimab,Wild Type (B.1),,,,,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,,,,,=,0.6,,,
Boschi22,10.1093/cid/ciac143,Virus isolate,Figure 1B,Casirivimab + Imdevimab,Wild Type (B.1.1),=,0.1,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,0.1,ng/ml,1,=,1,,,
Copin21,10.1016/j.cell.2021.06.002,Pseudovirus (VSV),Figure 1A,Casirivimab + Imdevimab,Wild Type (B.1),=,5.7,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,4.4,ng/ml,1,=,0.8,,,
FDA21,https://www.fda.gov/drugs/drug-safety-and-availability/fda-authorizes-revisions-fact-sheets-address-sars-cov-2-variants-monoclonal-antibody-products-under,Pseudovirus (VSV),CAS+IMD Table 9 page 42,Casirivimab + Imdevimab,Wild Type (B),,,,,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,,,,,=,1,,,
Chen21d,10.1016/j.celrep.2021.109604,Virus isolate,Figure 2K,Cilgavimab,Wild Type (B.1),=,3,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,9,ng/ml,1,=,3,,,
Dejnirattisai22,10.1016/j.cell.2021.12.046,Virus isolate,"Figure 4C, Table S1",Cilgavimab,Wild Type (B),=,13,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,12,ng/ml,1,=,0.9,,,
Supasa21,10.1016/j.cell.2021.02.033,Virus isolate,Dejnirattisai21 Table S2,Cilgavimab,Wild Type (B),=,13,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,12,ng/ml,1,=,0.9,,,
Chen21,10.1038/s41591-021-01294-w,SARS-CoV-2 recombinant,"Fig 1h, Source Data fig 1h",Cilgavimab,Wild Type (B.1),,,,,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,,,,,=,0.5,,,
Wang21b,10.1038/s41586-021-03398-2,Virus isolate,Extended Data Fig 5,Cilgavimab,Wild Type (A),,,,,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,,,,,=,0.3,,,
Chen21e,10.1038/s41586-021-03720-y,SARS-CoV-2 recombinant,Figure 1c,Cilgavimab,Wild Type (B.1),=,26,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,10,ng/ml,1,=,0.4,,,
Dong21,10.1038/s41564-021-00972-2,SARS-CoV-2 recombinant,Figure 4i,Cilgavimab,Wild Type (B.1),=,28,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,10,ng/ml,1,=,0.4,,,
Takashita22,10.1056/NEJMc2119407,Virus isolate,Table 1,Cilgavimab,Wild Type (A),=,7.7,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,3.6,ng/ml,1,=,0.5,,,
Cao22d,10.1038/s41586-021-04385-3,Pseudovirus (VSV),Fig 4b,Cilgavimab,Wild Type (B.1),=,2,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,1,ng/ml,1,=,0.5,,,
Tada22,10.1016/j.ebiom.2022.103944,Pseudovirus (lentivirus),Figure 2e,Cilgavimab,Wild Type (B.1),=,18.2,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,18.4,ng/ml,1,=,1,,,
Zhou21e,10.1126/science.abn8897,Pseudovirus (lentivirus),Figure 2C,Cilgavimab,Wild Type (B.1),=,3.7,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,6.3,ng/ml,1,=,1.7,,,
Chen22e,10.1016/j.celrep.2022.111528,Pseudovirus (lentivirus),Figure 2B,Cilgavimab,Wild Type (A),=,1,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,1,ng/ml,1,=,1,,,
Yuan22,10.1101/2022.03.13.484037,Pseudovirus (MLV),Figure 2A,Cilgavimab,Wild Type (B),=,5,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,3,ng/ml,1,=,0.6,,,
House22,10.1371/journal.pone.0267796,Pseudovirus,Fig 1A,Cilgavimab,Wild Type (B.1),,,,,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,,,,,=,0.5,,,
Wang21b,10.1038/s41586-021-03398-2,Pseudovirus (VSV),Extended Data Fig 5,Cilgavimab,Wild Type (B.1),,,,,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,,,,,=,1.1,,,
Dejnirattisai22,10.1016/j.cell.2021.12.046,Virus isolate,"Figure 4C, Table S1",Tixagevimab,Wild Type (B),=,5,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,11,ng/ml,1,=,2.2,,,
Supasa21,10.1016/j.cell.2021.02.033,Virus isolate,Dejnirattisai21 Table S2,Tixagevimab,Wild Type (B),=,5,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,11,ng/ml,1,=,2.2,,,
Chen21,10.1038/s41591-021-01294-w,SARS-CoV-2 recombinant,"Fig 1h, Source Data fig 1h",Tixagevimab,Wild Type (B.1),,,,,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,,,,,=,1.7,,,
Wang21b,10.1038/s41586-021-03398-2,Virus isolate,Extended Data Fig 5,Tixagevimab,Wild Type (A),,,,,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,,,,,=,0.3,,,
Chen21e,10.1038/s41586-021-03720-y,SARS-CoV-2 recombinant,Figure 1c,Tixagevimab,Wild Type (B.1),=,4,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,5,ng/ml,1,=,1.3,,,
Dong21,10.1038/s41564-021-00972-2,SARS-CoV-2 recombinant,Figure 4i,Tixagevimab,Wild Type (B.1),=,4,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,6,ng/ml,1,=,1.5,,,
Takashita22,10.1056/NEJMc2119407,Virus isolate,Table 1,Tixagevimab,Wild Type (A),=,1.9,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,1.3,ng/ml,1,=,0.7,,,
Cao22d,10.1038/s41586-021-04385-3,Pseudovirus (VSV),Fig 4b,Tixagevimab,Wild Type (B.1),=,1,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,2,ng/ml,1,=,2,,,
Tada22,10.1016/j.ebiom.2022.103944,Pseudovirus (lentivirus),Figure 2e,Tixagevimab,Wild Type (B.1),=,41,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,27.3,ng/ml,1,=,0.7,,,
Zhou21e,10.1126/science.abn8897,Pseudovirus (lentivirus),Figure 2C,Tixagevimab,Wild Type (B.1),=,2,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,2.7,ng/ml,1,=,1.4,,,
Chen22e,10.1016/j.celrep.2022.111528,Pseudovirus (lentivirus),Figure 2B,Tixagevimab,Wild Type (A),=,1,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,1,ng/ml,1,=,1,,,
Wang22c,10.1038/s41586-022-04466-x,Pseudovirus (VSV),Supplmentary Table 2,Tixagevimab,Wild Type (B),=,5,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,16,ng/ml,1,=,3.2,,,
Yuan22,10.1101/2022.03.13.484037,Pseudovirus (MLV),Figure 2A,Tixagevimab,Wild Type (B),=,1,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,2,ng/ml,1,=,2,,,
Wang21b,10.1038/s41586-021-03398-2,Pseudovirus (VSV),Extended Data Fig 5,Tixagevimab,Wild Type (B.1),,,,,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,,,,,=,1.5,,,
Dejnirattisai22,10.1016/j.cell.2021.12.046,Virus isolate,"Figure 4C, Table S1",Cilgavimab + Tixagevimab,Wild Type (B),=,9,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,7,ng/ml,1,=,0.8,,,
Supasa21,10.1016/j.cell.2021.02.033,Virus isolate,Dejnirattisai21 Table S2,Cilgavimab + Tixagevimab,Wild Type (B),=,9,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,7,ng/ml,1,=,0.8,,,
EMA21e,https://www.ema.europa.eu/en/documents/product-information/evusheld-epar-product-information_en.pdf,Virus isolate,Table 3,Cilgavimab + Tixagevimab,Wild Type (B),=,8,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,4,ng/ml,1,=,0.5,,,
Chen21,10.1038/s41591-021-01294-w,SARS-CoV-2 recombinant,"Fig 1h, Source Data fig 1h",Cilgavimab + Tixagevimab,Wild Type (B.1),,,,,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,,,,,=,0.5,,,
FDA21c,https://www.fda.gov/media/154701/download,Virus isolate,"Feb 2022, Table 6",Cilgavimab + Tixagevimab,Wild Type (B),,,,,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,,,,,=,1,,,
Wang21b,10.1038/s41586-021-03398-2,Virus isolate,Fig. 2e,Cilgavimab + Tixagevimab,Wild Type (A),,,,,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,,,,,=,1,,,
Chen21e,10.1038/s41586-021-03720-y,SARS-CoV-2 recombinant,Figure 1c,Cilgavimab + Tixagevimab,Wild Type (B.1),=,4,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,4,ng/ml,1,=,1,,,
Dong21,10.1038/s41564-021-00972-2,SARS-CoV-2 recombinant,Figure 4i,Cilgavimab + Tixagevimab,Wild Type (B.1),=,4,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,4,ng/ml,1,=,1,,,
Takashita22,10.1056/NEJMc2119407,Virus isolate,Table 1,Cilgavimab + Tixagevimab,Wild Type (A),=,6.8,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,3.8,ng/ml,1,=,0.6,,,Combination therapies in this study were specified at ng/ml of each component so needs to multiply by 2
Tada22,10.1016/j.ebiom.2022.103944,Pseudovirus (lentivirus),Figure 2e,Cilgavimab + Tixagevimab,Wild Type (B.1),=,13.6,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,20.8,ng/ml,1,=,1.5,,,
EMA21e,https://www.ema.europa.eu/en/documents/product-information/evusheld-epar-product-information_en.pdf,Pseudovirus,Table 3,Cilgavimab + Tixagevimab,Wild Type (B),=,1.9,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,0.7,ng/ml,1,=,0.4,,,
Yuan22,10.1101/2022.03.13.484037,Pseudovirus (MLV),Figure 2A,Cilgavimab + Tixagevimab,Wild Type (B),=,5,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,2,ng/ml,1,=,0.4,,,
FDA21c,https://www.fda.gov/media/154701/download,Pseudovirus,"Feb 2022, Table 6, Page 17, Antiviral resistance paragraph 6",Cilgavimab + Tixagevimab,Wild Type (B),,,,,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,,,,,=,2.9,,,
Wang21b,10.1038/s41586-021-03398-2,Pseudovirus (VSV),Fig. 2e,Cilgavimab + Tixagevimab,Wild Type (B.1),,,,,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,,,,,=,0.8,,,
Dejnirattisai22,10.1016/j.cell.2021.12.046,Virus isolate,"Figure 4C, Table S1",Sotrovimab,Wild Type (B),=,40,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,78,ng/ml,1,=,2,,,
Supasa21,10.1016/j.cell.2021.02.033,Virus isolate,Dejnirattisai21 Table S2,Sotrovimab,Wild Type (B),=,40,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,78,ng/ml,1,=,2,,,
Cathcart21,10.1101/2021.03.09.434607,Virus isolate,Table 1,Sotrovimab,Wild Type (A),,,,,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,,,,,=,3,,,
Chen21,10.1038/s41591-021-01294-w,SARS-CoV-2 recombinant,"Fig 1h, Source Data fig 1h",Sotrovimab,Wild Type (B.1),,,,,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,,,,,=,12.5,,,
Chen21,10.1038/s41591-021-01294-w,Pseudovirus (VSV),Extended Data Fig. 3b,Sotrovimab,Wild Type (B.1),,,,,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,,,,,=,4,,,
EMA21d,https://www.ema.europa.eu/en/documents/product-information/xevudy-epar-product-information_en.pdf,Virus isolate,Table 2,Sotrovimab,Wild Type (B),,,,,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,,,,,=,1,,,
FDA21e,https://www.fda.gov/media/149534/download,Virus isolate,"SOT Page 22, Table 1",Sotrovimab,Wild Type (B),,,,,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,,,,,=,3,,,
Wang21b,10.1038/s41586-021-03398-2,Virus isolate,"Fig. 2c, 2e",Sotrovimab,Wild Type (A),,,,,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,,,,,=,4,,,
Chen21e,10.1038/s41586-021-03720-y,SARS-CoV-2 recombinant,Figure 1c,Sotrovimab,Wild Type (B.1),=,156,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,209,ng/ml,1,=,1.3,,,
Takashita22,10.1056/NEJMc2119407,Virus isolate,Table 1,Sotrovimab,Wild Type (A),=,27.3,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,44.9,ng/ml,1,=,1.6,,,
Cao22d,10.1038/s41586-021-04385-3,Pseudovirus (VSV),Fig 4b,Sotrovimab,Wild Type (B.1),=,58,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,80,ng/ml,1,=,1.4,,,
Liu22,10.1126/scitranslmed.abn6859,Pseudovirus (VSV),Fig2A,Sotrovimab,Wild Type (B.1),=,11,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,62,ng/ml,1,=,5.6,,,
Shen21,10.1016/j.chom.2021.03.002,Pseudovirus (lentivirus),Table 1,Sotrovimab,Wild Type (B.1),=,48,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,9200,ng/ml,1,=,191.7,,,
Tada22,10.1016/j.ebiom.2022.103944,Pseudovirus (lentivirus),Figure 2e,Sotrovimab,Wild Type (B.1),=,123.2,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,172.5,ng/ml,1,=,1.4,,,
Zhou21e,10.1126/science.abn8897,Pseudovirus (lentivirus),Figure 2C,Sotrovimab,Wild Type (B.1),=,36.1,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,30.6,ng/ml,1,=,0.8,,,
Chen22e,10.1016/j.celrep.2022.111528,Pseudovirus (lentivirus),Figure 2B,Sotrovimab,Wild Type (A),=,184,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,254,ng/ml,1,=,1.4,,,
Pelzek22,10.1101/2022.02.06.479332,Pseudovirus (lentivirus),Extended Table 1,Sotrovimab,Wild Type (B),=,3819,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,693,ng/ml,1,=,0.2,,,
Wang22c,10.1038/s41586-022-04466-x,Pseudovirus (VSV),Supplmentary Table 2,Sotrovimab,Wild Type (B),=,68,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,81,ng/ml,1,=,1.2,,,
Yuan22,10.1101/2022.03.13.484037,Pseudovirus (MLV),Figure 2A,Sotrovimab,Wild Type (B),=,72,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,76,ng/ml,1,=,1.1,,,
EMA21d,https://www.ema.europa.eu/en/documents/product-information/xevudy-epar-product-information_en.pdf,Pseudovirus,Table 2,Sotrovimab,Wild Type (B),,,,,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,,,,,=,1,,,
Wang21b,10.1038/s41586-021-03398-2,Pseudovirus (VSV),Figure 2a,Sotrovimab,Wild Type (B.1),,,,,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,,,,,=,3.1,,,
Wang21f,10.1016/j.immuni.2021.06.003,Pseudovirus (HIV),"Figure 1C, Figure S1",Sotrovimab,Wild Type (B.1),=,4.1,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,2,ng/ml,1,=,0.5,,,
Ohashi22,10.1101/2022.02.27.482147,Virus isolate,Table 1,Sotrovimab,Wild Type (A),=,158.7,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,55.2,ng/ml,1,=,0.3,,,
Liu22,10.1126/scitranslmed.abn6859,Virus isolate,Fig2B,Sotrovimab,Wild Type (A),=,39,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,17,ng/ml,1,=,0.4,,,
Fenwick21,10.1016/j.celrep.2021.109814,SARS-CoV-2 recombinant,Figure 3B,Sotrovimab,Wild Type (B),=,147,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,299,ng/ml,1,=,2,,,
Gruell22,10.1038/s41591-021-01676-0,Pseudovirus (HIV),Fig 2,Sotrovimab,Wild Type (B),=,1964.2,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,115.4,ng/ml,1,=,0.1,,,
Wang22b,10.1101/2022.01.30.478305,Pseudovirus (HIV),Figure 1B,Sotrovimab,Wild Type (B),=,30.8,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,86.6,ng/ml,1,=,2.8,,,
Cathcart21,10.1101/2021.03.09.434607,Pseudovirus (VSV),Table 2,Sotrovimab,Wild Type (B),,,,,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,,,,,=,2.3,,,
FDA21e,https://www.fda.gov/media/149534/download,Pseudovirus,"SOT Page 22, Table 1",Sotrovimab,Wild Type (B),,,,,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,,,,,=,2.3,,,
FDA22,https://www.fda.gov/media/156152/download,Virus isolate,"Mar 2022, Page 14, antiviral resistance, Table 3",Bebtelovimab,Wild Type (B),,,,,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,,,,,=,1,,,
Zhou21e,10.1126/science.abn8897,Pseudovirus (lentivirus),Figure 2C,Bebtelovimab,Wild Type (B.1),=,3,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,30.6,ng/ml,1,=,10.2,,,
Westendorf22,10.1016/j.celrep.2022.110812,Pseudovirus (VSV),Table 3B,Bebtelovimab,Wild Type (A),=,3,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,1,ng/ml,1,=,0.3,,,
Westendorf22,10.1016/j.celrep.2022.110812,Pseudovirus (lentivirus),Table 3B,Bebtelovimab,Wild Type (A),=,5,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,4,ng/ml,1,=,0.8,,,
FDA22,https://www.fda.gov/media/156152/download,Pseudovirus,"Mar 2022, Page 13, antiviral resistance, Table 2",Bebtelovimab,Wild Type (B),,,,,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,,,,,=,1,,,
Westendorf22,10.1016/j.celrep.2022.110812,Virus isolate,Table 3A,Bebtelovimab,Wild Type (A),=,11,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,4,ng/ml,1,=,0.4,,,
Ryu21,10.1016/j.bbrc.2021.06.016,Virus isolate,Supplementary Table 4,Regdanvimab,Wild Type (B.1),=,2,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,2.8,ng/ml,1,=,1.4,,,
EMA21c,https://www.ema.europa.eu/en/documents/product-information/regkirona-epar-product-information_en.pdf,Virus isolate,Table 3,Regdanvimab,Wild Type (B),,,,,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,,,,,=,1,,,
Zhou21e,10.1126/science.abn8897,Pseudovirus (lentivirus),Figure 2C,Regdanvimab,Wild Type (B.1),=,1.5,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,5.5,ng/ml,1,=,3.7,,,
EMA21c,https://www.ema.europa.eu/en/documents/product-information/regkirona-epar-product-information_en.pdf,Pseudovirus,Table 3,Regdanvimab,Wild Type (B),,,,,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,,,,,=,1,,,
Wang21b,10.1038/s41586-021-03398-2,Virus isolate,Extended Data Fig 5,Amubarvimab,Wild Type (A),,,,,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,,,,,=,0.1,,,
Cao22d,10.1038/s41586-021-04385-3,Pseudovirus (VSV),Fig 4b,Amubarvimab,Wild Type (B.1),=,53,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,31,ng/ml,1,=,0.6,,,
Wang21b,10.1038/s41586-021-03398-2,Pseudovirus (VSV),Extended Data Fig 5,Amubarvimab,Wild Type (B.1),,,,,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,,,,,=,0.5,,,
Wang21f,10.1016/j.immuni.2021.06.003,Pseudovirus (HIV),"Figure 1C, Figure S1",Amubarvimab,Wild Type (B.1),=,14.1,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,10.1,ng/ml,1,=,0.7,,,
Wang21b,10.1038/s41586-021-03398-2,Virus isolate,Extended Data Fig 5,Romlusevimab,Wild Type (A),,,,,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,,,,,=,0.2,,,
Wang21b,10.1038/s41586-021-03398-2,Pseudovirus (VSV),Extended Data Fig 5,Romlusevimab,Wild Type (B.1),,,,,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,,,,,=,0.2,,,
Wang21f,10.1016/j.immuni.2021.06.003,Pseudovirus (HIV),"Figure 1C, Figure S1",Romlusevimab,Wild Type (B.1),=,18.6,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,14.3,ng/ml,1,=,0.8,,,
Margolis21,https://idweek.org/Margolis,Virus isolate,Table 2,Amubarvimab + Romlusevimab,Wild Type (B),,,,,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,,,,,=,2.5,,,
Wang21b,10.1038/s41586-021-03398-2,Virus isolate,Fig. 2e,Amubarvimab + Romlusevimab,Wild Type (A),,,,,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,,,,,=,0.2,,,
Margolis21,https://idweek.org/Margolis,Pseudovirus,Table 2,Amubarvimab + Romlusevimab,Wild Type (B.1),,,,,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,,,,,=,2.5,,,
Wang21b,10.1038/s41586-021-03398-2,Pseudovirus (VSV),Fig. 2e,Amubarvimab + Romlusevimab,Wild Type (B.1),,,,,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,,,,,=,0.5,,,
Cao22d,10.1038/s41586-021-04385-3,Pseudovirus (VSV),Fig 4b,DXP-604,Wild Type (B.1),=,10,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,7,ng/ml,1,=,0.7,,,
Wang22c,10.1038/s41586-022-04466-x,Pseudovirus (VSV),Supplmentary Table 2,DXP-604,Wild Type (B),=,17,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,13,ng/ml,1,=,0.8,,,
Chen21,10.1038/s41591-021-01294-w,SARS-CoV-2 recombinant,"Fig 1h, Source Data fig 1h",S2E12 + Sotrovimab,Wild Type (B.1),,,,,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,,,,,=,0.7,,,
Chen21e,10.1038/s41586-021-03720-y,SARS-CoV-2 recombinant,Figure 1c,S2E12 + Sotrovimab,Wild Type (B.1),=,7,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,8,ng/ml,1,=,1.1,,,
Cobb22,10.1016/j.medj.2022.01.004,Virus isolate,Table 1,COV2-2381 + Cilgavimab,Wild Type (A),=,28,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,20,ng/ml,1,=,0.7,,,
House22,10.1371/journal.pone.0267796,Pseudovirus,Fig 1A,COV2-2381 + Cilgavimab,Wild Type (B.1),,,,,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,,,,,=,0.9,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Bamlanivimab,Wild Type (B.1),=,15,ng/ml,1,bCoV-RaTG13,32,F32S + S50L + T76I + Q218P + E324D + R346T + A372T + R403T + N439K + N440H + L441I + S443A + V445E + Y449F + S459A + T478K + V483Q + E484T + F486L + F490Y + Q493Y + S494R + Q498Y + N501D + Y505H + H519N + T604A + Δ681-684 + N1125S + V1228I,1,>,10000,ng/ml,1,>,666.7,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Etesevimab,Wild Type (B.1),=,32,ng/ml,1,bCoV-RaTG13,32,F32S + S50L + T76I + Q218P + E324D + R346T + A372T + R403T + N439K + N440H + L441I + S443A + V445E + Y449F + S459A + T478K + V483Q + E484T + F486L + F490Y + Q493Y + S494R + Q498Y + N501D + Y505H + H519N + T604A + Δ681-684 + N1125S + V1228I,1,>,10000,ng/ml,1,>,312.5,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Casirivimab,Wild Type (B.1),=,5.6,ng/ml,1,bCoV-RaTG13,32,F32S + S50L + T76I + Q218P + E324D + R346T + A372T + R403T + N439K + N440H + L441I + S443A + V445E + Y449F + S459A + T478K + V483Q + E484T + F486L + F490Y + Q493Y + S494R + Q498Y + N501D + Y505H + H519N + T604A + Δ681-684 + N1125S + V1228I,1,>,10000,ng/ml,1,>,1000,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Imdevimab,Wild Type (B.1),=,5.7,ng/ml,1,bCoV-RaTG13,32,F32S + S50L + T76I + Q218P + E324D + R346T + A372T + R403T + N439K + N440H + L441I + S443A + V445E + Y449F + S459A + T478K + V483Q + E484T + F486L + F490Y + Q493Y + S494R + Q498Y + N501D + Y505H + H519N + T604A + Δ681-684 + N1125S + V1228I,1,>,10000,ng/ml,1,>,1000,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Cilgavimab,Wild Type (B.1),=,2.5,ng/ml,1,bCoV-RaTG13,32,F32S + S50L + T76I + Q218P + E324D + R346T + A372T + R403T + N439K + N440H + L441I + S443A + V445E + Y449F + S459A + T478K + V483Q + E484T + F486L + F490Y + Q493Y + S494R + Q498Y + N501D + Y505H + H519N + T604A + Δ681-684 + N1125S + V1228I,1,>,10000,ng/ml,1,>,1000,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Tixagevimab,Wild Type (B.1),=,1.6,ng/ml,1,bCoV-RaTG13,32,F32S + S50L + T76I + Q218P + E324D + R346T + A372T + R403T + N439K + N440H + L441I + S443A + V445E + Y449F + S459A + T478K + V483Q + E484T + F486L + F490Y + Q493Y + S494R + Q498Y + N501D + Y505H + H519N + T604A + Δ681-684 + N1125S + V1228I,1,>,10000,ng/ml,1,>,1000,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Sotrovimab,Wild Type (B.1),=,74.1,ng/ml,1,bCoV-RaTG13,32,F32S + S50L + T76I + Q218P + E324D + R346T + A372T + R403T + N439K + N440H + L441I + S443A + V445E + Y449F + S459A + T478K + V483Q + E484T + F486L + F490Y + Q493Y + S494R + Q498Y + N501D + Y505H + H519N + T604A + Δ681-684 + N1125S + V1228I,1,>,10000,ng/ml,1,>,135,,,
Liu22,10.1126/scitranslmed.abn6859,Pseudovirus (VSV),Fig2C,Sotrovimab,Wild Type (B.1),=,11,ng/ml,1,bCoV-RaTG13,32,F32S + S50L + T76I + Q218P + E324D + R346T + A372T + R403T + N439K + N440H + L441I + S443A + V445E + Y449F + S459A + T478K + V483Q + E484T + F486L + F490Y + Q493Y + S494R + Q498Y + N501D + Y505H + H519N + T604A + Δ681-684 + N1125S + V1228I,1,>,10000,ng/ml,1,>,909.1,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Bebtelovimab,Wild Type (B.1),=,0.8,ng/ml,1,bCoV-RaTG13,32,F32S + S50L + T76I + Q218P + E324D + R346T + A372T + R403T + N439K + N440H + L441I + S443A + V445E + Y449F + S459A + T478K + V483Q + E484T + F486L + F490Y + Q493Y + S494R + Q498Y + N501D + Y505H + H519N + T604A + Δ681-684 + N1125S + V1228I,1,>,10000,ng/ml,1,>,1000,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Amubarvimab,Wild Type (B.1),=,53.2,ng/ml,1,bCoV-RaTG13,32,F32S + S50L + T76I + Q218P + E324D + R346T + A372T + R403T + N439K + N440H + L441I + S443A + V445E + Y449F + S459A + T478K + V483Q + E484T + F486L + F490Y + Q493Y + S494R + Q498Y + N501D + Y505H + H519N + T604A + Δ681-684 + N1125S + V1228I,1,=,15.6,ng/ml,1,=,0.3,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Romlusevimab,Wild Type (B.1),=,1240,ng/ml,1,bCoV-RaTG13,32,F32S + S50L + T76I + Q218P + E324D + R346T + A372T + R403T + N439K + N440H + L441I + S443A + V445E + Y449F + S459A + T478K + V483Q + E484T + F486L + F490Y + Q493Y + S494R + Q498Y + N501D + Y505H + H519N + T604A + Δ681-684 + N1125S + V1228I,1,>,10000,ng/ml,1,>,8.1,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,DXP-604,Wild Type (B.1),=,11,ng/ml,1,bCoV-RaTG13,32,F32S + S50L + T76I + Q218P + E324D + R346T + A372T + R403T + N439K + N440H + L441I + S443A + V445E + Y449F + S459A + T478K + V483Q + E484T + F486L + F490Y + Q493Y + S494R + Q498Y + N501D + Y505H + H519N + T604A + Δ681-684 + N1125S + V1228I,1,=,1.1,ng/ml,1,=,0.1,,,
Boschi22,10.1093/cid/ciac143,Virus isolate,Figure 1A,Bamlanivimab,Wild Type (B.1.1),=,0.2,ng/ml,1,Delta,(Various),(Various),2,>,3500,ng/ml,1,>,1000,15625.4,15625.4,Censored at 3500
Takashita22,10.1056/NEJMc2119407,Virus isolate,Table 1,Bamlanivimab,Wild Type (A),=,4.7,ng/ml,1,Delta,19,T19R + T95I + G142D + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,641.7,ng/ml,1,=,136.8,,,
Misasi22,10.1101/2022.07.29.502029,Pseudovirus (lentivirus),Figure 1A,Bamlanivimab,Wild Type (B.1),=,2.8,ng/ml,1,Delta,19,T19R + G142D + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,>,10050,ng/ml,1,>,1000,,,
Huang22,10.1016/j.immuni.2022.06.005,Pseudovirus (VSV),Figure 2,Bamlanivimab,Wild Type (B),=,10,ng/ml,1,Delta,19,T19R + G142D + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,2890,ng/ml,1,=,289,,,
Wang21e,10.1126/science.abh1766,Pseudovirus (lentivirus),Fig 2C,Bamlanivimab,Wild Type (A),=,7.1,ng/ml,1,Delta,19,T19R + G142D + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,>,10000,ng/ml,1,>,1000,,,
Arora21,10.1016/j.celrep.2021.109825,Pseudovirus (VSV),Figure 1F,Bamlanivimab,Wild Type (B),=,17.2,ng/ml,1,Delta,19,T19R + G142D + Δ156-157 + R158G + L452R + T478K + P681R + D950N,1,>,10000,ng/ml,1,>,581.4,,,
Arora21b,10.1038/s41423-021-00772-y,Pseudovirus (VSV),Figure 1D,Bamlanivimab,Wild Type (B),=,14.1,ng/ml,1,Delta,19,T19R + G142D + Δ156-157 + R158G + L452R + T478K + P681R + D950N,1,>,10000,ng/ml,1,>,709.2,,,
Gruell22,10.1038/s41591-021-01676-0,Pseudovirus (HIV),Fig 2,Bamlanivimab,Wild Type (B),=,3.1,ng/ml,1,Delta,19,T19R + G142D + Δ156-157 + R158G + L452R + T478K + P681R + D950N,1,>,10000,ng/ml,1,>,1000,,,
Mlcochova21,10.1038/s41586-021-03944-y,Pseudovirus (VSV),Extended Data Table 2,Bamlanivimab,Wild Type (B),=,7.8,ng/ml,1,Delta,19,T19R + G142D + Δ156-157 + R158G + L452R + T478K + P681R + D950N,1,>,10000,ng/ml,1,>,1000,,,
Yao21,10.1101/2021.01.27.428353,Pseudovirus (MLV),Figure 5,Bamlanivimab,Wild Type (B),=,6.8,ng/ml,1,Delta,19,T19R + G142D + Δ156-157 + R158G + L452R + T478K + D950N,1,>,4000,ng/ml,1,>,588.2,,,
Kaleta22,10.1038/s41467-022-28766-y,Virus isolate,Table 2,Bamlanivimab,Wild Type (B.1),=,110,ng/ml,1,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,>,10000,ng/ml,1,>,90.9,,,
Dejnirattisai22,10.1016/j.cell.2021.12.046,Virus isolate,"Figure 4C, Table S1",Bamlanivimab,Wild Type (B),=,6,ng/ml,1,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,8311,ng/ml,1,>,1000,,,
Liu21f,10.1016/j.cell.2021.06.020,Virus isolate,Table S1,Bamlanivimab,Wild Type (B),=,6,ng/ml,1,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,8311,ng/ml,1,>,1000,,,
FDA21,https://www.fda.gov/drugs/drug-safety-and-availability/fda-authorizes-revisions-fact-sheets-address-sars-cov-2-variants-monoclonal-antibody-products-under,Virus isolate,BAM+ETE page 27,Bamlanivimab,Wild Type (B),,,,,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,,,,,>,1000,,,
Cao22d,10.1038/s41586-021-04385-3,Pseudovirus (VSV),Fig 4b,Bamlanivimab,Wild Type (B.1),=,13,ng/ml,1,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,>,10000,ng/ml,1,>,769.2,,,
Tada22,10.1016/j.ebiom.2022.103944,Pseudovirus (lentivirus),Figure 2e,Bamlanivimab,Wild Type (B.1),=,0.8,ng/ml,1,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,472.6,ng/ml,1,=,590.8,,,
Zhou21e,10.1126/science.abn8897,Pseudovirus (lentivirus),Figure 2C,Bamlanivimab,Wild Type (B.1),=,3.6,ng/ml,1,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,>,10000,ng/ml,1,>,1000,,,
Zhou22,10.3390/v14061334,Pseudovirus (lentivirus),Figure 2B,Bamlanivimab,Wild Type (B.1),=,4.7,ng/ml,1,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,996,ng/ml,1,=,211.9,,,
Chen22e,10.1016/j.celrep.2022.111528,Pseudovirus (lentivirus),Figure 2B,Bamlanivimab,Wild Type (A),=,3,ng/ml,1,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,3000,ng/ml,1,=,1000,,,
Chen22,10.1101/2022.01.12.22269023,Pseudovirus (lentivirus),Fig 1h,Bamlanivimab,Wild Type (A),=,3,ng/ml,1,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,3000,ng/ml,1,=,1000,,,
Yuan22,10.1101/2022.03.13.484037,Pseudovirus (MLV),Figure 2A,Bamlanivimab,Wild Type (B),=,7,ng/ml,1,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,>,5000,ng/ml,1,>,714.3,,,
FDA21,https://www.fda.gov/drugs/drug-safety-and-availability/fda-authorizes-revisions-fact-sheets-address-sars-cov-2-variants-monoclonal-antibody-products-under,Pseudovirus (VSV),BAM+ETE page 27,Bamlanivimab,Wild Type (B),,,,,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,,,,,>,1000,,,
Planas21b,10.1038/s41586-021-03777-9,Virus isolate,"Fig.1, Extended Data Fig.5, 2021.05.26.445838 Figure 3a",Bamlanivimab,Wild Type (B.1),=,0.2,ng/ml,1,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,>,10000,ng/ml,1,>,1000,,,
Boschi22,10.1093/cid/ciac143,Virus isolate,Figure 1A,Etesevimab,Wild Type (B.1.1),=,6,ng/ml,1,Delta,(Various),(Various),2,=,0.2,ng/ml,1.4,<,0.1,0,0,
Takashita22,10.1056/NEJMc2119407,Virus isolate,Table 1,Etesevimab,Wild Type (A),=,18.2,ng/ml,1,Delta,19,T19R + T95I + G142D + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,15.4,ng/ml,1,=,0.8,,,
Misasi22,10.1101/2022.07.29.502029,Pseudovirus (lentivirus),Figure 1A,Etesevimab,Wild Type (B.1),=,23.3,ng/ml,1,Delta,19,T19R + G142D + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,10.2,ng/ml,1,=,0.4,,,
Huang22,10.1016/j.immuni.2022.06.005,Pseudovirus (VSV),Figure 2,Etesevimab,Wild Type (B),=,20,ng/ml,1,Delta,19,T19R + G142D + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,8,ng/ml,1,=,0.4,,,
Wang21e,10.1126/science.abh1766,Pseudovirus (lentivirus),Fig 2C,Etesevimab,Wild Type (A),=,26.2,ng/ml,1,Delta,19,T19R + G142D + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,13.9,ng/ml,1,=,0.5,,,
Arora21,10.1016/j.celrep.2021.109825,Pseudovirus (VSV),Figure 1F,Etesevimab,Wild Type (B),=,16.6,ng/ml,1,Delta,19,T19R + G142D + Δ156-157 + R158G + L452R + T478K + P681R + D950N,1,=,10.8,ng/ml,1,=,0.6,,,
Arora21b,10.1038/s41423-021-00772-y,Pseudovirus (VSV),Figure 1D,Etesevimab,Wild Type (B),=,105.9,ng/ml,1,Delta,19,T19R + G142D + Δ156-157 + R158G + L452R + T478K + P681R + D950N,1,=,18,ng/ml,1,=,0.2,,,
Gruell22,10.1038/s41591-021-01676-0,Pseudovirus (HIV),Fig 2,Etesevimab,Wild Type (B),=,19.4,ng/ml,1,Delta,19,T19R + G142D + Δ156-157 + R158G + L452R + T478K + P681R + D950N,1,=,1.9,ng/ml,1,=,0.1,,,
Mlcochova21,10.1038/s41586-021-03944-y,Pseudovirus (VSV),Extended Data Table 2,Etesevimab,Wild Type (B),=,28.7,ng/ml,1,Delta,19,T19R + G142D + Δ156-157 + R158G + L452R + T478K + P681R + D950N,1,=,10.3,ng/ml,1,=,0.4,,,
Yao21,10.1101/2021.01.27.428353,Pseudovirus (MLV),Figure 5,Etesevimab,Wild Type (B),=,80.5,ng/ml,1,Delta,19,T19R + G142D + Δ156-157 + R158G + L452R + T478K + D950N,1,=,10.2,ng/ml,1,=,0.1,,,
Ju22,10.1038/s41422-022-00638-6,Pseudovirus (HIV),Figure S1F,Etesevimab,Wild Type (B),=,12,ng/ml,1,Delta,19,T19R + G142D + Δ157-158 + L452R + T478K + P681R + D950N,1,=,149,ng/ml,1,=,12.4,,,
Dejnirattisai22,10.1016/j.cell.2021.12.046,Virus isolate,"Figure 4C, Table S1",Etesevimab,Wild Type (B),=,34,ng/ml,1,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,12,ng/ml,1,=,0.4,,,
Liu21f,10.1016/j.cell.2021.06.020,Virus isolate,Table S1,Etesevimab,Wild Type (B),=,34,ng/ml,1,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,12,ng/ml,1,=,0.4,,,
FDA21,https://www.fda.gov/drugs/drug-safety-and-availability/fda-authorizes-revisions-fact-sheets-address-sars-cov-2-variants-monoclonal-antibody-products-under,Virus isolate,BAM+ETE page 27,Etesevimab,Wild Type (B),,,,,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,,,,,=,1,,,
Cao22d,10.1038/s41586-021-04385-3,Pseudovirus (VSV),Fig 4b,Etesevimab,Wild Type (B.1),=,32,ng/ml,1,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,24,ng/ml,1,=,0.8,,,
Tada22,10.1016/j.ebiom.2022.103944,Pseudovirus (lentivirus),Figure 2e,Etesevimab,Wild Type (B.1),=,5.3,ng/ml,1,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,3,ng/ml,1,=,0.6,,,
Zhou21e,10.1126/science.abn8897,Pseudovirus (lentivirus),Figure 2C,Etesevimab,Wild Type (B.1),=,50.5,ng/ml,1,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,14.8,ng/ml,1,=,0.3,,,
Zhou22,10.3390/v14061334,Pseudovirus (lentivirus),Figure 2B,Etesevimab,Wild Type (B.1),=,37.1,ng/ml,1,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,58,ng/ml,1,=,1.6,,,
Chen22e,10.1016/j.celrep.2022.111528,Pseudovirus (lentivirus),Figure 2B,Etesevimab,Wild Type (A),=,19,ng/ml,1,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,5,ng/ml,1,=,0.3,,,
Wang22c,10.1038/s41586-022-04466-x,Pseudovirus (VSV),Supplmentary Table 2,Etesevimab,Wild Type (B),=,19,ng/ml,1,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,16,ng/ml,1,=,0.8,,,
Yuan22,10.1101/2022.03.13.484037,Pseudovirus (MLV),Figure 2A,Etesevimab,Wild Type (B),=,9,ng/ml,1,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,4,ng/ml,1,=,0.4,,,
FDA21,https://www.fda.gov/drugs/drug-safety-and-availability/fda-authorizes-revisions-fact-sheets-address-sars-cov-2-variants-monoclonal-antibody-products-under,Pseudovirus (VSV),BAM+ETE page 27,Etesevimab,Wild Type (B),,,,,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,,,,,=,1,,,
Planas21b,10.1038/s41586-021-03777-9,Virus isolate,"Fig.1, Extended Data Fig.5, 2021.05.26.445838 Figure 3a",Etesevimab,Wild Type (B.1),=,1.2,ng/ml,1,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,0.9,ng/ml,1,=,0.8,,,
Boschi22,10.1093/cid/ciac143,Virus isolate,Figure 1A,Bamlanivimab + Etesevimab,Wild Type (B.1.1),=,0.5,ng/ml,1,Delta,(Various),(Various),2,=,0.2,ng/ml,1,=,0.4,0.4,0.4,
Takashita22,10.1056/NEJMc2119407,Virus isolate,Table 1,Bamlanivimab + Etesevimab,Wild Type (A),=,25.2,ng/ml,1,Delta,19,T19R + T95I + G142D + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,20.6,ng/ml,1,=,0.8,,,Combination therapies in this study were specified at ng/ml of each component so needs to multiply by 2
Misasi22,10.1101/2022.07.29.502029,Pseudovirus (lentivirus),Figure 1B,Bamlanivimab + Etesevimab,Wild Type (B.1),=,5.6,ng/ml,1,Delta,19,T19R + G142D + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,14,ng/ml,1,=,2.5,,,
FDA21,https://www.fda.gov/drugs/drug-safety-and-availability/fda-authorizes-revisions-fact-sheets-address-sars-cov-2-variants-monoclonal-antibody-products-under,Virus isolate,BAM+ETE Table 4 page 27,Bamlanivimab + Etesevimab,Wild Type (B),,,,,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,,,,,=,1,,,
Tada22,10.1016/j.ebiom.2022.103944,Pseudovirus (lentivirus),Figure 2e,Bamlanivimab + Etesevimab,Wild Type (B.1),=,5.1,ng/ml,1,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,3.6,ng/ml,1,=,0.7,,,
Zhou22,10.3390/v14061334,Pseudovirus (lentivirus),Figure 2B,Bamlanivimab + Etesevimab,Wild Type (B.1),=,11.7,ng/ml,1,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,64.6,ng/ml,1,=,5.5,,,
Yuan22,10.1101/2022.03.13.484037,Pseudovirus (MLV),Figure 2A,Bamlanivimab + Etesevimab,Wild Type (B),=,9,ng/ml,1,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,12,ng/ml,1,=,1.3,,,
FDA21,https://www.fda.gov/drugs/drug-safety-and-availability/fda-authorizes-revisions-fact-sheets-address-sars-cov-2-variants-monoclonal-antibody-products-under,Pseudovirus (VSV),BAM+ETE Table 3 page 27,Bamlanivimab + Etesevimab,Wild Type (B),,,,,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,,,,,=,1,,,
Boschi22,10.1093/cid/ciac143,Virus isolate,Figure 1B,Casirivimab,Wild Type (B.1.1),=,0.7,ng/ml,1,Delta,(Various),(Various),2,=,0,ng/ml,1.5,<,0.1,0,0.1,
Takashita22,10.1056/NEJMc2119407,Virus isolate,Table 1,Casirivimab,Wild Type (A),=,2.8,ng/ml,1,Delta,19,T19R + T95I + G142D + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,2.9,ng/ml,1,=,1,,,
Misasi22,10.1101/2022.07.29.502029,Pseudovirus (lentivirus),Figure 1A,Casirivimab,Wild Type (B.1),=,5.3,ng/ml,1,Delta,19,T19R + G142D + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,5.5,ng/ml,1,=,1,,,
Huang22,10.1016/j.immuni.2022.06.005,Pseudovirus (VSV),Figure 2,Casirivimab,Wild Type (B),=,11,ng/ml,1,Delta,19,T19R + G142D + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,5,ng/ml,1,=,0.5,,,
Wang21e,10.1126/science.abh1766,Pseudovirus (lentivirus),Fig 2C,Casirivimab,Wild Type (A),=,7.7,ng/ml,1,Delta,19,T19R + G142D + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,3.2,ng/ml,1,=,0.4,,,
Du22,10.1126/sciimmunol.abp9312,Pseudovirus,Fig 1E,Casirivimab,Wild Type (B),=,3.2,ng/ml,1,Delta,19,T19R + G142D + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,1.5,ng/ml,1,=,0.5,,,
Ohashi22,10.1101/2022.02.27.482147,Virus isolate,Table 1,Casirivimab,Wild Type (A),=,13.9,ng/ml,1,Delta,19,T19R + G142D + Δ156-157 + R158G + L452R + T478K + P681R + D950N,1,=,21.7,ng/ml,1,=,1.6,,,
Tada21c,10.1016/j.isci.2021.103341,Pseudovirus (HIV),Table 1,Casirivimab,Wild Type (B.1),=,3.2,ng/ml,1,Delta,19,T19R + G142D + Δ156-157 + R158G + L452R + T478K + P681R + D950N,1,=,62.1,ng/ml,1,=,19.4,,,
Tada21e,10.3389/fimmu.2022.797589,Pseudovirus (HIV),Figure 2,Casirivimab,Wild Type (B.1),=,3.3,ng/ml,1,Delta,19,T19R + G142D + Δ156-157 + R158G + L452R + T478K + P681R + D950N,1,=,39.1,ng/ml,1,=,11.8,,,
Arora21,10.1016/j.celrep.2021.109825,Pseudovirus (VSV),Figure 1F,Casirivimab,Wild Type (B),=,0.7,ng/ml,1,Delta,19,T19R + G142D + Δ156-157 + R158G + L452R + T478K + P681R + D950N,1,=,0.5,ng/ml,1,=,0.7,,,
Arora21b,10.1038/s41423-021-00772-y,Pseudovirus (VSV),Figure 1D,Casirivimab,Wild Type (B),=,22.8,ng/ml,1,Delta,19,T19R + G142D + Δ156-157 + R158G + L452R + T478K + P681R + D950N,1,=,11.5,ng/ml,1,=,0.5,,,
Gruell22,10.1038/s41591-021-01676-0,Pseudovirus (HIV),Fig 2,Casirivimab,Wild Type (B),=,1.9,ng/ml,1,Delta,19,T19R + G142D + Δ156-157 + R158G + L452R + T478K + P681R + D950N,1,=,0.9,ng/ml,1,=,0.5,,,
Mlcochova21,10.1038/s41586-021-03944-y,Pseudovirus (VSV),Extended Data Table 2,Casirivimab,Wild Type (B),=,6,ng/ml,1,Delta,19,T19R + G142D + Δ156-157 + R158G + L452R + T478K + P681R + D950N,1,=,7.2,ng/ml,1,=,1.2,,,
Yao21,10.1101/2021.01.27.428353,Pseudovirus (MLV),Figure 5,Casirivimab,Wild Type (B),=,6.8,ng/ml,1,Delta,19,T19R + G142D + Δ156-157 + R158G + L452R + T478K + D950N,1,=,5,ng/ml,1,=,0.7,,,
Ju22,10.1038/s41422-022-00638-6,Pseudovirus (HIV),Figure S1F,Casirivimab,Wild Type (B),=,2,ng/ml,1,Delta,19,T19R + G142D + Δ157-158 + L452R + T478K + P681R + D950N,1,=,2,ng/ml,1,=,1,,,
Kaleta22,10.1038/s41467-022-28766-y,Virus isolate,Table 2,Casirivimab,Wild Type (B.1),=,90,ng/ml,1,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,10,ng/ml,1,=,0.1,,,
Dejnirattisai22,10.1016/j.cell.2021.12.046,Virus isolate,"Figure 4C, Table S1",Casirivimab,Wild Type (B),=,4,ng/ml,1,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,3,ng/ml,1,=,0.8,,,
Liu21f,10.1016/j.cell.2021.06.020,Virus isolate,Table S1,Casirivimab,Wild Type (B),=,4,ng/ml,1,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,3,ng/ml,1,=,0.8,,,
Du22,10.1126/sciimmunol.abp9312,Virus isolate,Fig 1E,Casirivimab,Wild Type (B),=,3.4,ng/ml,1,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,0.4,ng/ml,1,=,0.1,,,
Cao22d,10.1038/s41586-021-04385-3,Pseudovirus (VSV),Fig 4b,Casirivimab,Wild Type (B.1),=,5,ng/ml,1,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,3,ng/ml,1,=,0.6,,,
Miyakawa21b,10.1101/2021.09.23.21264014,Pseudovirus,Figure 1C,Casirivimab,Wild Type (B.1),=,89,ng/ml,1,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,84,ng/ml,1,=,0.9,,,
Tada22,10.1016/j.ebiom.2022.103944,Pseudovirus (lentivirus),Figure 2e,Casirivimab,Wild Type (B.1),=,2.1,ng/ml,1,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,6.1,ng/ml,1,=,2.9,,,
Zhou21e,10.1126/science.abn8897,Pseudovirus (lentivirus),Figure 2C,Casirivimab,Wild Type (B.1),=,6.1,ng/ml,1,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,3,ng/ml,1,=,0.5,,,
Zhou22,10.3390/v14061334,Pseudovirus (lentivirus),Figure 2B,Casirivimab,Wild Type (B.1),=,7.6,ng/ml,1,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,13.8,ng/ml,1,=,1.8,,,
Ragonnet-Cronin22,10.1101/2022.07.14.500063,Pseudovirus (lentivirus),Figure 1C,Casirivimab,Wild Type (B),=,2,ng/ml,1,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,1,ng/ml,1,=,0.5,,,
Chen22e,10.1016/j.celrep.2022.111528,Pseudovirus (lentivirus),Figure 2B,Casirivimab,Wild Type (A),=,2,ng/ml,1,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,1,ng/ml,1,=,0.5,,,
Chen22,10.1101/2022.01.12.22269023,Pseudovirus (lentivirus),Fig 1h,Casirivimab,Wild Type (A),=,2,ng/ml,1,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,1,ng/ml,1,=,0.5,,,
Pelzek22,10.1101/2022.02.06.479332,Pseudovirus (lentivirus),Extended Table 1,Casirivimab,Wild Type (B),=,24,ng/ml,1,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,16,ng/ml,1,=,0.7,,,
Yuan22,10.1101/2022.03.13.484037,Pseudovirus (MLV),Figure 2A,Casirivimab,Wild Type (B),=,6,ng/ml,1,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,7,ng/ml,1,=,1.2,,,
Planas21b,10.1038/s41586-021-03777-9,Virus isolate,"Fig.1, Extended Data Fig.5, 2021.05.26.445838 Figure 3a",Casirivimab,Wild Type (B.1),=,0.1,ng/ml,1,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,0.1,ng/ml,1,=,1,,,
Syed21,10.1101/2021.12.20.21268048,VLP,Table 2,Casirivimab,Wild Type (B.1),=,36,ng/ml,1,Delta,67,A67V + G142D + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,21,ng/ml,1,=,0.6,,,
Boschi22,10.1093/cid/ciac143,Virus isolate,Figure 1B,Imdevimab,Wild Type (B.1.1),=,8.9,ng/ml,1,Delta,(Various),(Various),2,=,8.8,ng/ml,11.4,=,5.6,2.9,8.4,
Takashita22,10.1056/NEJMc2119407,Virus isolate,Table 1,Imdevimab,Wild Type (A),=,3,ng/ml,1,Delta,19,T19R + T95I + G142D + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,4,ng/ml,1,=,1.3,,,
Misasi22,10.1101/2022.07.29.502029,Pseudovirus (lentivirus),Figure 1A,Imdevimab,Wild Type (B.1),=,10.8,ng/ml,1,Delta,19,T19R + G142D + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,65.7,ng/ml,1,=,6.1,,,
Huang22,10.1016/j.immuni.2022.06.005,Pseudovirus (VSV),Figure 2,Imdevimab,Wild Type (B),=,6,ng/ml,1,Delta,19,T19R + G142D + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,6,ng/ml,1,=,1,,,
Wang21e,10.1126/science.abh1766,Pseudovirus (lentivirus),Fig 2C,Imdevimab,Wild Type (A),=,71,ng/ml,1,Delta,19,T19R + G142D + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,312.8,ng/ml,1,=,4.4,,,
Du22,10.1126/sciimmunol.abp9312,Pseudovirus,Fig 1E,Imdevimab,Wild Type (B),=,4.7,ng/ml,1,Delta,19,T19R + G142D + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,10.5,ng/ml,1,=,2.2,,,
Ohashi22,10.1101/2022.02.27.482147,Virus isolate,Table 1,Imdevimab,Wild Type (A),=,12.5,ng/ml,1,Delta,19,T19R + G142D + Δ156-157 + R158G + L452R + T478K + P681R + D950N,1,=,29,ng/ml,1,=,2.3,,,
Tada21c,10.1016/j.isci.2021.103341,Pseudovirus (HIV),Table 1,Imdevimab,Wild Type (B.1),=,50.3,ng/ml,1,Delta,19,T19R + G142D + Δ156-157 + R158G + L452R + T478K + P681R + D950N,1,=,28.2,ng/ml,1,=,0.6,,,
Tada21e,10.3389/fimmu.2022.797589,Pseudovirus (HIV),Figure 2,Imdevimab,Wild Type (B.1),=,9.3,ng/ml,1,Delta,19,T19R + G142D + Δ156-157 + R158G + L452R + T478K + P681R + D950N,1,=,28.8,ng/ml,1,=,3.1,,,
Arora21,10.1016/j.celrep.2021.109825,Pseudovirus (VSV),Figure 1F,Imdevimab,Wild Type (B),=,8.3,ng/ml,1,Delta,19,T19R + G142D + Δ156-157 + R158G + L452R + T478K + P681R + D950N,1,=,4.3,ng/ml,1,=,0.5,,,
Arora21b,10.1038/s41423-021-00772-y,Pseudovirus (VSV),Figure 1D,Imdevimab,Wild Type (B),=,22.7,ng/ml,1,Delta,19,T19R + G142D + Δ156-157 + R158G + L452R + T478K + P681R + D950N,1,=,33.5,ng/ml,1,=,1.5,,,
Gruell22,10.1038/s41591-021-01676-0,Pseudovirus (HIV),Fig 2,Imdevimab,Wild Type (B),=,9.4,ng/ml,1,Delta,19,T19R + G142D + Δ156-157 + R158G + L452R + T478K + P681R + D950N,1,=,45.4,ng/ml,1,=,4.8,,,
Mlcochova21,10.1038/s41586-021-03944-y,Pseudovirus (VSV),Extended Data Table 2,Imdevimab,Wild Type (B),=,31.9,ng/ml,1,Delta,19,T19R + G142D + Δ156-157 + R158G + L452R + T478K + P681R + D950N,1,=,45.4,ng/ml,1,=,1.4,,,
Yao21,10.1101/2021.01.27.428353,Pseudovirus (MLV),Figure 5,Imdevimab,Wild Type (B),=,6.8,ng/ml,1,Delta,19,T19R + G142D + Δ156-157 + R158G + L452R + T478K + D950N,1,=,30.8,ng/ml,1,=,4.5,,,
Ju22,10.1038/s41422-022-00638-6,Pseudovirus (HIV),Figure S1F,Imdevimab,Wild Type (B),=,2,ng/ml,1,Delta,19,T19R + G142D + Δ157-158 + L452R + T478K + P681R + D950N,1,=,3,ng/ml,1,=,1.5,,,
Kaleta22,10.1038/s41467-022-28766-y,Virus isolate,Table 2,Imdevimab,Wild Type (B.1),=,20,ng/ml,1,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,40,ng/ml,1,=,2,,,
Dejnirattisai22,10.1016/j.cell.2021.12.046,Virus isolate,"Figure 4C, Table S1",Imdevimab,Wild Type (B),=,32,ng/ml,1,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,17,ng/ml,1,=,0.5,,,
Liu21f,10.1016/j.cell.2021.06.020,Virus isolate,Table S1,Imdevimab,Wild Type (B),=,32,ng/ml,1,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,17,ng/ml,1,=,0.5,,,
Cao22d,10.1038/s41586-021-04385-3,Pseudovirus (VSV),Fig 4b,Imdevimab,Wild Type (B.1),=,5,ng/ml,1,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,5,ng/ml,1,=,1,,,
Miyakawa21b,10.1101/2021.09.23.21264014,Pseudovirus,Figure 1C,Imdevimab,Wild Type (B.1),=,65,ng/ml,1,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,96,ng/ml,1,=,1.5,,,
Tada22,10.1016/j.ebiom.2022.103944,Pseudovirus (lentivirus),Figure 2e,Imdevimab,Wild Type (B.1),=,2,ng/ml,1,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,6,ng/ml,1,=,3,,,
Zhou21e,10.1126/science.abn8897,Pseudovirus (lentivirus),Figure 2C,Imdevimab,Wild Type (B.1),=,20,ng/ml,1,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,455,ng/ml,1,=,22.8,,,
Zhou22,10.3390/v14061334,Pseudovirus (lentivirus),Figure 2B,Imdevimab,Wild Type (B.1),=,30.9,ng/ml,1,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,24.2,ng/ml,1,=,0.8,,,
Ragonnet-Cronin22,10.1101/2022.07.14.500063,Pseudovirus (lentivirus),Figure 1C,Imdevimab,Wild Type (B),=,12,ng/ml,1,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,4,ng/ml,1,=,0.3,,,
Chen22e,10.1016/j.celrep.2022.111528,Pseudovirus (lentivirus),Figure 2B,Imdevimab,Wild Type (A),=,9,ng/ml,1,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,3,ng/ml,1,=,0.3,,,
Chen22,10.1101/2022.01.12.22269023,Pseudovirus (lentivirus),Fig 1h,Imdevimab,Wild Type (A),=,9,ng/ml,1,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,3,ng/ml,1,=,0.3,,,
Pelzek22,10.1101/2022.02.06.479332,Pseudovirus (lentivirus),Extended Table 1,Imdevimab,Wild Type (B),=,23,ng/ml,1,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,81,ng/ml,1,=,3.5,,,
Wang22c,10.1038/s41586-022-04466-x,Pseudovirus (VSV),Supplmentary Table 2,Imdevimab,Wild Type (B),=,13,ng/ml,1,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,49,ng/ml,1,=,3.8,,,
Yuan22,10.1101/2022.03.13.484037,Pseudovirus (MLV),Figure 2A,Imdevimab,Wild Type (B),=,25,ng/ml,1,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,174,ng/ml,1,=,7,,,
Planas21b,10.1038/s41586-021-03777-9,Virus isolate,"Fig.1, Extended Data Fig.5, 2021.05.26.445838 Figure 3a",Imdevimab,Wild Type (B.1),=,0.1,ng/ml,1,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,0.1,ng/ml,1,=,1,,,
Wang22b,10.1101/2022.01.30.478305,Pseudovirus (HIV),Figure 1B,Imdevimab,Wild Type (B),=,2.3,ng/ml,1,Delta,19,T19R + Δ157-158 + L452R + T478K + P681R + D950N,1,=,32.9,ng/ml,1,=,14.3,,,
Syed21,10.1101/2021.12.20.21268048,VLP,Table 2,Imdevimab,Wild Type (B.1),=,34,ng/ml,1,Delta,67,A67V + G142D + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,125,ng/ml,1,=,3.7,,,
Boschi22,10.1093/cid/ciac143,Virus isolate,Figure 1B,Casirivimab + Imdevimab,Wild Type (B.1.1),=,0.1,ng/ml,1,Delta,(Various),(Various),2,=,0,ng/ml,1,=,0.2,0.2,0.2,
Takashita22,10.1056/NEJMc2119407,Virus isolate,Table 1,Casirivimab + Imdevimab,Wild Type (A),=,7,ng/ml,1,Delta,19,T19R + T95I + G142D + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,3.8,ng/ml,1,=,0.5,,,Combination therapies in this study were specified at ng/ml of each component so needs to multiply by 2
Misasi22,10.1101/2022.07.29.502029,Pseudovirus (lentivirus),Figure 1B,Casirivimab + Imdevimab,Wild Type (B.1),=,3.4,ng/ml,1,Delta,19,T19R + G142D + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,13.9,ng/ml,1,=,4.1,,,
Tada21c,10.1016/j.isci.2021.103341,Pseudovirus (HIV),Table 1,Casirivimab + Imdevimab,Wild Type (B.1),=,8.1,ng/ml,1,Delta,19,T19R + G142D + Δ156-157 + R158G + L452R + T478K + P681R + D950N,1,=,20.1,ng/ml,1,=,2.5,,,
Tada21e,10.3389/fimmu.2022.797589,Pseudovirus (HIV),Figure 2,Casirivimab + Imdevimab,Wild Type (B.1),=,4.4,ng/ml,1,Delta,19,T19R + G142D + Δ156-157 + R158G + L452R + T478K + P681R + D950N,1,=,9.8,ng/ml,1,=,2.2,,,
Hao22,10.1101/2022.08.12.22278720,Virus isolate,Figure 5A,Casirivimab + Imdevimab,Wild Type (A),=,87,ng/ml,1,Delta,19,T19R + G142D + L452R + T478K + P681R + D950N,1,=,129,ng/ml,1,=,1.5,,,
Kaleta22,10.1038/s41467-022-28766-y,Virus isolate,Table 2,Casirivimab + Imdevimab,Wild Type (B.1),=,30,ng/ml,1,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,20,ng/ml,1,=,0.7,,,
FDA21,https://www.fda.gov/drugs/drug-safety-and-availability/fda-authorizes-revisions-fact-sheets-address-sars-cov-2-variants-monoclonal-antibody-products-under,Virus isolate,CAS+IMD Table 10 page 42,Casirivimab + Imdevimab,Wild Type (B),,,,,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,,,,,=,1,,,
Tada22,10.1016/j.ebiom.2022.103944,Pseudovirus (lentivirus),Figure 2e,Casirivimab + Imdevimab,Wild Type (B.1),=,0.8,ng/ml,1,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,2.4,ng/ml,1,=,3,,,
Zhou22,10.3390/v14061334,Pseudovirus (lentivirus),Figure 2B,Casirivimab + Imdevimab,Wild Type (B.1),=,3.3,ng/ml,1,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,9.1,ng/ml,1,=,2.8,,,
Ragonnet-Cronin22,10.1101/2022.07.14.500063,Pseudovirus (lentivirus),Figure 1C,Casirivimab + Imdevimab,Wild Type (B),=,2,ng/ml,1,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,1,ng/ml,1,=,0.5,,,
Yuan22,10.1101/2022.03.13.484037,Pseudovirus (MLV),Figure 2A,Casirivimab + Imdevimab,Wild Type (B),=,6,ng/ml,1,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,12,ng/ml,1,=,2,,,
FDA21,https://www.fda.gov/drugs/drug-safety-and-availability/fda-authorizes-revisions-fact-sheets-address-sars-cov-2-variants-monoclonal-antibody-products-under,Pseudovirus (VSV),CAS+IMD Table 9 page 42,Casirivimab + Imdevimab,Wild Type (B),,,,,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,,,,,=,1,,,
Takashita22,10.1056/NEJMc2119407,Virus isolate,Table 1,Cilgavimab,Wild Type (A),=,7.7,ng/ml,1,Delta,19,T19R + T95I + G142D + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,12.8,ng/ml,1,=,1.7,,,
Aggarwal22b,10.1016/j.ebiom.2022.104270,Virus isolate,Figure 1,Cilgavimab,Wild Type (A.2.2),=,29,ng/ml,1,Delta,19,T19R + T95I + G142D + Δ156-157 + R158G + L452R + T478K + P681R + D950N,1,=,70,ng/ml,1,=,2.4,,,
Touret22b,10.1038/s41598-022-16964-z,Virus isolate,Table 1,Cilgavimab,Wild Type (B.1),=,19.2,ng/ml,1,Delta,19,T19R + G142D + E156G + Δ157-158 + A222V + L452R + T478K + P681R + D950N + S1252F,1,=,40.3,ng/ml,1,=,2.1,,,
Misasi22,10.1101/2022.07.29.502029,Pseudovirus (lentivirus),Figure 1A,Cilgavimab,Wild Type (B.1),=,4.6,ng/ml,1,Delta,19,T19R + G142D + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,31.2,ng/ml,1,=,6.8,,,
Boschi22,10.1093/cid/ciac143,Virus isolate,Figure 1C,Cilgavimab,Wild Type (B.1.1),=,0.3,ng/ml,1,Delta,19,T19R + G142D + Δ156-157 + R158G + A222V + L452R + T478K + N679I + N679N + N679S + N679T + P681H + P681L + P681P + P681R + R682G + R682R + R682W + D950N + S1252F,1,=,5.8,ng/ml,1,=,23.2,,,
Dong21,10.1038/s41564-021-00972-2,SARS-CoV-2 recombinant,Figure 4i,Cilgavimab,Wild Type (B.1),=,28,ng/ml,1,Delta,19,T19R + G142D + Δ156-157 + R158G + L452R + T478K + P681R + D950N,1,=,43,ng/ml,1,=,1.5,,,
Dejnirattisai22,10.1016/j.cell.2021.12.046,Virus isolate,"Figure 4C, Table S1",Cilgavimab,Wild Type (B),=,13,ng/ml,1,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,38,ng/ml,1,=,2.9,,,
Liu21f,10.1016/j.cell.2021.06.020,Virus isolate,Table S1,Cilgavimab,Wild Type (B),=,13,ng/ml,1,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,38,ng/ml,1,=,2.9,,,
Cao22d,10.1038/s41586-021-04385-3,Pseudovirus (VSV),Fig 4b,Cilgavimab,Wild Type (B.1),=,2,ng/ml,1,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,4,ng/ml,1,=,2,,,
Tada22,10.1016/j.ebiom.2022.103944,Pseudovirus (lentivirus),Figure 2e,Cilgavimab,Wild Type (B.1),=,18.2,ng/ml,1,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,16.1,ng/ml,1,=,0.9,,,
Zhou21e,10.1126/science.abn8897,Pseudovirus (lentivirus),Figure 2C,Cilgavimab,Wild Type (B.1),=,3.7,ng/ml,1,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,25,ng/ml,1,=,6.8,,,
Zhou22,10.3390/v14061334,Pseudovirus (lentivirus),Figure 2B,Cilgavimab,Wild Type (B.1),=,6.9,ng/ml,1,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,14.7,ng/ml,1,=,2.1,,,
Chen22e,10.1016/j.celrep.2022.111528,Pseudovirus (lentivirus),Figure 2B,Cilgavimab,Wild Type (A),=,1,ng/ml,1,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,15,ng/ml,1,=,15,,,
Yuan22,10.1101/2022.03.13.484037,Pseudovirus (MLV),Figure 2A,Cilgavimab,Wild Type (B),=,5,ng/ml,1,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,60,ng/ml,1,=,12,,,
Takashita22,10.1056/NEJMc2119407,Virus isolate,Table 1,Tixagevimab,Wild Type (A),=,1.9,ng/ml,1,Delta,19,T19R + T95I + G142D + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,4,ng/ml,1,=,2.1,,,
Aggarwal22b,10.1016/j.ebiom.2022.104270,Virus isolate,Figure 1,Tixagevimab,Wild Type (A.2.2),=,9,ng/ml,1,Delta,19,T19R + T95I + G142D + Δ156-157 + R158G + L452R + T478K + P681R + D950N,1,=,7,ng/ml,1,=,0.8,,,
Touret22b,10.1038/s41598-022-16964-z,Virus isolate,Table 1,Tixagevimab,Wild Type (B.1),=,18.3,ng/ml,1,Delta,19,T19R + G142D + E156G + Δ157-158 + A222V + L452R + T478K + P681R + D950N + S1252F,1,=,17.2,ng/ml,1,=,0.9,,,
Misasi22,10.1101/2022.07.29.502029,Pseudovirus (lentivirus),Figure 1A,Tixagevimab,Wild Type (B.1),=,1.5,ng/ml,1,Delta,19,T19R + G142D + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,1,ng/ml,1,=,0.7,,,
Boschi22,10.1093/cid/ciac143,Virus isolate,Figure 1C,Tixagevimab,Wild Type (B.1.1),=,0.1,ng/ml,1,Delta,19,T19R + G142D + Δ156-157 + R158G + A222V + L452R + T478K + N679I + N679N + N679S + N679T + P681H + P681L + P681P + P681R + R682G + R682R + R682W + D950N + S1252F,1,=,0.1,ng/ml,1,=,1,,,
Dong21,10.1038/s41564-021-00972-2,SARS-CoV-2 recombinant,Figure 4i,Tixagevimab,Wild Type (B.1),=,4,ng/ml,1,Delta,19,T19R + G142D + Δ156-157 + R158G + L452R + T478K + P681R + D950N,1,=,2,ng/ml,1,=,0.5,,,
Dejnirattisai22,10.1016/j.cell.2021.12.046,Virus isolate,"Figure 4C, Table S1",Tixagevimab,Wild Type (B),=,5,ng/ml,1,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,3,ng/ml,1,=,0.6,,,
Liu21f,10.1016/j.cell.2021.06.020,Virus isolate,Table S1,Tixagevimab,Wild Type (B),=,5,ng/ml,1,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,3,ng/ml,1,=,0.6,,,
Cao22d,10.1038/s41586-021-04385-3,Pseudovirus (VSV),Fig 4b,Tixagevimab,Wild Type (B.1),=,1,ng/ml,1,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,2,ng/ml,1,=,2,,,
Tada22,10.1016/j.ebiom.2022.103944,Pseudovirus (lentivirus),Figure 2e,Tixagevimab,Wild Type (B.1),=,41,ng/ml,1,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,206.6,ng/ml,1,=,5,,,
Zhou21e,10.1126/science.abn8897,Pseudovirus (lentivirus),Figure 2C,Tixagevimab,Wild Type (B.1),=,2,ng/ml,1,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,1.4,ng/ml,1,=,0.7,,,
Zhou22,10.3390/v14061334,Pseudovirus (lentivirus),Figure 2B,Tixagevimab,Wild Type (B.1),=,8.7,ng/ml,1,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,15.7,ng/ml,1,=,1.8,,,
Chen22e,10.1016/j.celrep.2022.111528,Pseudovirus (lentivirus),Figure 2B,Tixagevimab,Wild Type (A),=,1,ng/ml,1,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,1,ng/ml,1,=,1,,,
Wang22c,10.1038/s41586-022-04466-x,Pseudovirus (VSV),Supplmentary Table 2,Tixagevimab,Wild Type (B),=,5,ng/ml,1,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,6,ng/ml,1,=,1.2,,,
Yuan22,10.1101/2022.03.13.484037,Pseudovirus (MLV),Figure 2A,Tixagevimab,Wild Type (B),=,1,ng/ml,1,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,1,ng/ml,1,=,1,,,
Takashita22,10.1056/NEJMc2119407,Virus isolate,Table 1,Cilgavimab + Tixagevimab,Wild Type (A),=,6.8,ng/ml,1,Delta,19,T19R + T95I + G142D + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,11,ng/ml,1,=,1.6,,,Combination therapies in this study were specified at ng/ml of each component so needs to multiply by 2
Aggarwal22b,10.1016/j.ebiom.2022.104270,Virus isolate,Figure 1,Cilgavimab + Tixagevimab,Wild Type (A.2.2),=,16,ng/ml,1,Delta,19,T19R + T95I + G142D + Δ156-157 + R158G + L452R + T478K + P681R + D950N,1,=,6,ng/ml,1,=,0.4,,,
Touret22b,10.1038/s41598-022-16964-z,Virus isolate,Table 1,Cilgavimab + Tixagevimab,Wild Type (B.1),=,20.2,ng/ml,1,Delta,19,T19R + G142D + E156G + Δ157-158 + A222V + L452R + T478K + P681R + D950N + S1252F,1,=,24.7,ng/ml,1,=,1.2,,,
Misasi22,10.1101/2022.07.29.502029,Pseudovirus (lentivirus),Figure 1B,Cilgavimab + Tixagevimab,Wild Type (B.1),=,2.2,ng/ml,1,Delta,19,T19R + G142D + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,2.4,ng/ml,1,=,1.1,,,
Boschi22,10.1093/cid/ciac143,Virus isolate,Figure 1C,Cilgavimab + Tixagevimab,Wild Type (B.1.1),=,0.1,ng/ml,1,Delta,19,T19R + G142D + Δ156-157 + R158G + A222V + L452R + T478K + N679I + N679N + N679S + N679T + P681H + P681L + P681P + P681R + R682G + R682R + R682W + D950N + S1252F,1,=,0,ng/ml,1,=,0.3,,,
Dong21,10.1038/s41564-021-00972-2,SARS-CoV-2 recombinant,Figure 4i,Cilgavimab + Tixagevimab,Wild Type (B.1),=,4,ng/ml,1,Delta,19,T19R + G142D + Δ156-157 + R158G + L452R + T478K + P681R + D950N,1,=,3,ng/ml,1,=,0.8,,,
EMA21e,https://www.ema.europa.eu/en/documents/product-information/evusheld-epar-product-information_en.pdf,Pseudovirus,Table 3,Cilgavimab + Tixagevimab,Wild Type (B),=,1.9,ng/ml,1,Delta,(Various),(Various),2,=,1.9,ng/ml,1,=,1,1,1,
FDA21c,https://www.fda.gov/media/154701/download,Pseudovirus,"Feb 2022, Table 6, Page 17, Antiviral resistance paragraph 6",Cilgavimab + Tixagevimab,Wild Type (B),,,,,Delta,(Various),(Various),2,,,,,=,1.1,1.1,1.1,
Dejnirattisai22,10.1016/j.cell.2021.12.046,Virus isolate,"Figure 4C, Table S1",Cilgavimab + Tixagevimab,Wild Type (B),=,9,ng/ml,1,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,5,ng/ml,1,=,0.6,,,
Liu21f,10.1016/j.cell.2021.06.020,Virus isolate,Table S1,Cilgavimab + Tixagevimab,Wild Type (B),=,9,ng/ml,1,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,5,ng/ml,1,=,0.6,,,
EMA21e,https://www.ema.europa.eu/en/documents/product-information/evusheld-epar-product-information_en.pdf,Virus isolate,Table 3,Cilgavimab + Tixagevimab,Wild Type (B),=,8,ng/ml,1,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,3,ng/ml,1,=,0.4,,,
FDA21c,https://www.fda.gov/media/154701/download,Virus isolate,"Feb 2022, Table 6",Cilgavimab + Tixagevimab,Wild Type (B),,,,,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,,,,,=,1,,,
Tada22,10.1016/j.ebiom.2022.103944,Pseudovirus (lentivirus),Figure 2e,Cilgavimab + Tixagevimab,Wild Type (B.1),=,13.6,ng/ml,1,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,28.8,ng/ml,1,=,2.1,,,
Zhou22,10.3390/v14061334,Pseudovirus (lentivirus),Figure 2B,Cilgavimab + Tixagevimab,Wild Type (B.1),=,2.4,ng/ml,1,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,7.5,ng/ml,1,=,3.1,,,
Yuan22,10.1101/2022.03.13.484037,Pseudovirus (MLV),Figure 2A,Cilgavimab + Tixagevimab,Wild Type (B),=,5,ng/ml,1,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,2,ng/ml,1,=,0.4,,,
Cathcart21,10.1101/2021.03.09.434607,Pseudovirus (VSV),Table 2,Sotrovimab,Wild Type (B),,,,,Delta,(Various),(Various),2,,,,,=,1.3,1.1,1.5,
EMA21d,https://www.ema.europa.eu/en/documents/product-information/xevudy-epar-product-information_en.pdf,Pseudovirus,Table 2,Sotrovimab,Wild Type (B),,,,,Delta,(Various),(Various),3,,,,,=,1,1,1,
Takashita22,10.1056/NEJMc2119407,Virus isolate,Table 1,Sotrovimab,Wild Type (A),=,27.3,ng/ml,1,Delta,19,T19R + T95I + G142D + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,111.4,ng/ml,1,=,4.1,,,
Aggarwal22b,10.1016/j.ebiom.2022.104270,Virus isolate,Figure 1,Sotrovimab,Wild Type (A.2.2),=,384,ng/ml,1,Delta,19,T19R + T95I + G142D + Δ156-157 + R158G + L452R + T478K + P681R + D950N,1,=,181,ng/ml,1,=,0.5,,,
Touret22b,10.1038/s41598-022-16964-z,Virus isolate,Table 1,Sotrovimab,Wild Type (B.1),=,46,ng/ml,1,Delta,19,T19R + G142D + E156G + Δ157-158 + A222V + L452R + T478K + P681R + D950N + S1252F,1,=,51.5,ng/ml,1,=,1.1,,,
Misasi22,10.1101/2022.07.29.502029,Pseudovirus (lentivirus),Figure 1A,Sotrovimab,Wild Type (B.1),=,84.6,ng/ml,1,Delta,19,T19R + G142D + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,156.6,ng/ml,1,=,1.9,,,
Huang22,10.1016/j.immuni.2022.06.005,Pseudovirus (VSV),Figure 2,Sotrovimab,Wild Type (B),=,21,ng/ml,1,Delta,19,T19R + G142D + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,16,ng/ml,1,=,0.8,,,
Liu22,10.1126/scitranslmed.abn6859,Virus isolate,Fig2B,Sotrovimab,Wild Type (A),=,39,ng/ml,1,Delta,19,T19R + G142D + Δ156-157 + R158G + L452R + T478K + P681R + A771S + D950N,1,=,21,ng/ml,1,=,0.5,,,
Ohashi22,10.1101/2022.02.27.482147,Virus isolate,Table 1,Sotrovimab,Wild Type (A),=,158.7,ng/ml,1,Delta,19,T19R + G142D + Δ156-157 + R158G + L452R + T478K + P681R + D950N,1,=,87,ng/ml,1,=,0.5,,,
Gruell22,10.1038/s41591-021-01676-0,Pseudovirus (HIV),Fig 2,Sotrovimab,Wild Type (B),=,1964.2,ng/ml,1,Delta,19,T19R + G142D + Δ156-157 + R158G + L452R + T478K + P681R + D950N,1,=,218.8,ng/ml,1,=,0.1,,,
Mlcochova21,10.1038/s41586-021-03944-y,Pseudovirus (VSV),Extended Data Table 2,Sotrovimab,Wild Type (B),=,63.9,ng/ml,1,Delta,19,T19R + G142D + Δ156-157 + R158G + L452R + T478K + P681R + D950N,1,=,46.4,ng/ml,1,=,0.7,,,
Ju22,10.1038/s41422-022-00638-6,Pseudovirus (HIV),Figure S1F,Sotrovimab,Wild Type (B),=,93,ng/ml,1,Delta,19,T19R + G142D + Δ157-158 + L452R + T478K + P681R + D950N,1,=,42,ng/ml,1,=,0.5,,,
Dejnirattisai22,10.1016/j.cell.2021.12.046,Virus isolate,"Figure 4C, Table S1",Sotrovimab,Wild Type (B),=,40,ng/ml,1,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,113,ng/ml,1,=,2.8,,,
Liu21f,10.1016/j.cell.2021.06.020,Virus isolate,Table S1,Sotrovimab,Wild Type (B),=,40,ng/ml,1,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,113,ng/ml,1,=,2.8,,,
Cathcart21,10.1101/2021.03.09.434607,Virus isolate,Table 1,Sotrovimab,Wild Type (A),,,,,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,,,,,=,0.4,,,
EMA21d,https://www.ema.europa.eu/en/documents/product-information/xevudy-epar-product-information_en.pdf,Virus isolate,Table 2,Sotrovimab,Wild Type (B),,,,,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,,,,,=,1,,,
Liu22,10.1126/scitranslmed.abn6859,Pseudovirus (VSV),Fig2A,Sotrovimab,Wild Type (B.1),=,11,ng/ml,1,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,32,ng/ml,1,=,2.9,,,
Cao22d,10.1038/s41586-021-04385-3,Pseudovirus (VSV),Fig 4b,Sotrovimab,Wild Type (B.1),=,58,ng/ml,1,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,73,ng/ml,1,=,1.3,,,
Tada22,10.1016/j.ebiom.2022.103944,Pseudovirus (lentivirus),Figure 2e,Sotrovimab,Wild Type (B.1),=,123.2,ng/ml,1,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,201.1,ng/ml,1,=,1.6,,,
Zhou21e,10.1126/science.abn8897,Pseudovirus (lentivirus),Figure 2C,Sotrovimab,Wild Type (B.1),=,36.1,ng/ml,1,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,45.2,ng/ml,1,=,1.3,,,
Zhou22,10.3390/v14061334,Pseudovirus (lentivirus),Figure 2B,Sotrovimab,Wild Type (B.1),=,140.3,ng/ml,1,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,297.9,ng/ml,1,=,2.1,,,
Chen22e,10.1016/j.celrep.2022.111528,Pseudovirus (lentivirus),Figure 2B,Sotrovimab,Wild Type (A),=,184,ng/ml,1,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,244,ng/ml,1,=,1.3,,,
Pelzek22,10.1101/2022.02.06.479332,Pseudovirus (lentivirus),Extended Table 1,Sotrovimab,Wild Type (B),=,3819,ng/ml,1,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,501,ng/ml,1,=,0.1,,,
Wang22c,10.1038/s41586-022-04466-x,Pseudovirus (VSV),Supplmentary Table 2,Sotrovimab,Wild Type (B),=,68,ng/ml,1,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,212,ng/ml,1,=,3.1,,,
Yuan22,10.1101/2022.03.13.484037,Pseudovirus (MLV),Figure 2A,Sotrovimab,Wild Type (B),=,72,ng/ml,1,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,162,ng/ml,1,=,2.3,,,
Wang22b,10.1101/2022.01.30.478305,Pseudovirus (HIV),Figure 1B,Sotrovimab,Wild Type (B),=,30.8,ng/ml,1,Delta,19,T19R + Δ157-158 + L452R + T478K + P681R + D950N,1,=,63.5,ng/ml,1,=,2.1,,,
Westendorf22,10.1016/j.celrep.2022.110812,Pseudovirus (VSV),Table 3B,Bebtelovimab,Wild Type (A),=,3,ng/ml,1,Delta,(Various),(Various),3,=,1.6,ng/ml,1.4,=,0.7,0.5,0.7,
Misasi22,10.1101/2022.07.29.502029,Pseudovirus (lentivirus),Figure 1A,Bebtelovimab,Wild Type (B.1),=,3.3,ng/ml,1,Delta,19,T19R + G142D + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,10.5,ng/ml,1,=,3.2,,,
FDA22,https://www.fda.gov/media/156152/download,Pseudovirus,"Mar 2022, Page 13, antiviral resistance, Table 2",Bebtelovimab,Wild Type (B),,,,,Delta,(Various),(Various),2,,,,,=,1,1,1,
FDA22,https://www.fda.gov/media/156152/download,VLP,"Mar 2022, Page 12, antiviral resistance, paragraph 2",Bebtelovimab,Wild Type (B),,,,,Delta,19,T19R + E156G + Δ157-158 + G446V + L452R + T478K + P681R + D950N,1,,,,,=,16.4,,,
Westendorf22,10.1016/j.celrep.2022.110812,Virus isolate,Table 3A,Bebtelovimab,Wild Type (A),=,11,ng/ml,1,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,8,ng/ml,1,=,0.7,,,
FDA22,https://www.fda.gov/media/156152/download,Virus isolate,"Mar 2022, Page 14, antiviral resistance, Table 3",Bebtelovimab,Wild Type (B),,,,,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,,,,,=,1,,,
Zhou21e,10.1126/science.abn8897,Pseudovirus (lentivirus),Figure 2C,Bebtelovimab,Wild Type (B.1),=,3,ng/ml,1,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,3.7,ng/ml,1,=,1.2,,,
Zhou22,10.3390/v14061334,Pseudovirus (lentivirus),Figure 2B,Bebtelovimab,Wild Type (B.1),=,9.5,ng/ml,1,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,9.4,ng/ml,1,=,1,,,
Ryu21b,10.1016/j.bbrc.2021.09.023,Virus isolate,"Table 2, preprint 10.1101/2021.07.23.453472",Regdanvimab,Wild Type (B),=,6.8,ng/ml,1,Delta,5,L5F + T19R + G142D + Δ156-157 + R158G + L452R + Q613H + P681R + D950N,1,=,1237,ng/ml,1,=,183,,,
EMA21c,https://www.ema.europa.eu/en/documents/product-information/regkirona-epar-product-information_en.pdf,Pseudovirus,Table 3,Regdanvimab,Wild Type (B),,,,,Delta,(Various),(Various),2,,,,,=,45.7,36.7,54.7,
Misasi22,10.1101/2022.07.29.502029,Pseudovirus (lentivirus),Figure 1A,Regdanvimab,Wild Type (B.1),=,2.8,ng/ml,1,Delta,19,T19R + G142D + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,16.5,ng/ml,1,=,5.9,,,
Mlcochova21,10.1038/s41586-021-03944-y,Pseudovirus (VSV),Extended Data Table 2,Regdanvimab,Wild Type (B),=,2.2,ng/ml,1,Delta,19,T19R + G142D + Δ156-157 + R158G + L452R + T478K + P681R + D950N,1,=,16.3,ng/ml,1,=,7.4,,,
EMA21c,https://www.ema.europa.eu/en/documents/product-information/regkirona-epar-product-information_en.pdf,Virus isolate,Table 3,Regdanvimab,Wild Type (B),,,,,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,,,,,=,183,,,
Zhou21e,10.1126/science.abn8897,Pseudovirus (lentivirus),Figure 2C,Regdanvimab,Wild Type (B.1),=,1.5,ng/ml,1,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,14.7,ng/ml,1,=,9.8,,,
Huang22,10.1016/j.immuni.2022.06.005,Pseudovirus (VSV),Figure 2,Amubarvimab,Wild Type (B),=,39,ng/ml,1,Delta,19,T19R + G142D + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,12,ng/ml,1,=,0.3,,,
Cao22d,10.1038/s41586-021-04385-3,Pseudovirus (VSV),Fig 4b,Amubarvimab,Wild Type (B.1),=,53,ng/ml,1,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,42,ng/ml,1,=,0.8,,,
Margolis21,https://idweek.org/Margolis,Pseudovirus,Table 2,Amubarvimab + Romlusevimab,Wild Type (B.1),,,,,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,,,,,=,2.5,,,
Huang22,10.1016/j.immuni.2022.06.005,Pseudovirus (VSV),Figure 2,DXP-604,Wild Type (B),=,27,ng/ml,1,Delta,19,T19R + G142D + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,23,ng/ml,1,=,0.9,,,
Cao22d,10.1038/s41586-021-04385-3,Pseudovirus (VSV),Fig 4b,DXP-604,Wild Type (B.1),=,10,ng/ml,1,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,16,ng/ml,1,=,1.6,,,
Wang22c,10.1038/s41586-022-04466-x,Pseudovirus (VSV),Supplmentary Table 2,DXP-604,Wild Type (B),=,17,ng/ml,1,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,30,ng/ml,1,=,1.8,,,
Cobb22,10.1016/j.medj.2022.01.004,Virus isolate,Table 1,COV2-2381 + Cilgavimab,Wild Type (A),=,28,ng/ml,1,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,25,ng/ml,1,=,0.9,,,
Wang21d,10.1016/j.chom.2021.04.007,Pseudovirus (VSV),Figure S1A,Bamlanivimab,Wild Type (B.1),=,1.9,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y,1,=,8000,ng/ml,1,>,424.6,,,Corrected Gamma 800 to 8000
Wang21e,10.1126/science.abh1766,Pseudovirus (lentivirus),Fig 2C,Bamlanivimab,Wild Type (A),=,7.1,ng/ml,1,Gamma,(Various),(Various),2,>,10000,ng/ml,1,>,1000,1408.5,1408.5,
Takashita22,10.1056/NEJMc2119407,Virus isolate,Table 1,Bamlanivimab,Wild Type (A),=,4.7,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,1601.7,ng/ml,1,=,341.5,,,
Wang21d,10.1016/j.chom.2021.04.007,Virus isolate,Figure S1A,Bamlanivimab,Wild Type (A),=,3.7,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,>,10000,ng/ml,1,>,1000,,,LOD set to 10000
Kaleta22,10.1038/s41467-022-28766-y,Virus isolate,Table 2,Bamlanivimab,Wild Type (B.1),=,110,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,>,10000,ng/ml,1,>,90.9,,,
Dejnirattisai21,10.1016/j.cell.2021.03.055,Virus isolate,Table S2,Bamlanivimab,Wild Type (B),=,6,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,>,10000,ng/ml,1,>,1000,,,
Dejnirattisai22,10.1016/j.cell.2021.12.046,Virus isolate,"Figure 4C, Table S1",Bamlanivimab,Wild Type (B),=,6,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,>,10000,ng/ml,1,>,1000,,,
Cao22d,10.1038/s41586-021-04385-3,Pseudovirus (VSV),Fig 4b,Bamlanivimab,Wild Type (B.1),=,13,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,>,10000,ng/ml,1,>,769.2,,,
Hoffmann21,10.1016/j.cell.2021.03.036,Pseudovirus (VSV),Figure 6,Bamlanivimab,Wild Type (B.1),=,4.8,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,>,16000,ng/ml,1,>,1000,,,
Zhou21e,10.1126/science.abn8897,Pseudovirus (lentivirus),Figure 2C,Bamlanivimab,Wild Type (B.1),=,3.6,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,>,10000,ng/ml,1,>,1000,,,
Yuan22,10.1101/2022.03.13.484037,Pseudovirus (MLV),Figure 2A,Bamlanivimab,Wild Type (B),=,7,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,>,5000,ng/ml,1,>,714.3,,,
FDA21,https://www.fda.gov/drugs/drug-safety-and-availability/fda-authorizes-revisions-fact-sheets-address-sars-cov-2-variants-monoclonal-antibody-products-under,Pseudovirus (VSV),BAM Table 3,Bamlanivimab,Wild Type (B),,,,,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,,,,,>,1000,,,
Chen21e,10.1038/s41586-021-03720-y,SARS-CoV-2 recombinant,Figure 1c,Bamlanivimab,Wild Type (B.1),=,5,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,>,10000,ng/ml,1,>,1000,,,
Nabel21,10.1126/science.abl6251,Pseudovirus (lentivirus),"Fig 2A, 2B",Bamlanivimab,Wild Type (B.1),=,22,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,>,100000,ng/ml,1,>,1000,,,
Yao21,10.1101/2021.01.27.428353,Pseudovirus (MLV),Figure 5,Bamlanivimab,Wild Type (B),=,6.8,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,>,4000,ng/ml,1,>,588.2,,,
Wang21d,10.1016/j.chom.2021.04.007,Pseudovirus (VSV),Figure S1A,Etesevimab,Wild Type (B.1),=,2.6,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y,1,>,10000,ng/ml,1,>,1000,,,LOD set to 10000
Wang21e,10.1126/science.abh1766,Pseudovirus (lentivirus),Fig 2C,Etesevimab,Wild Type (A),=,26.2,ng/ml,1,Gamma,(Various),(Various),2,>,10000,ng/ml,1,>,381.7,381.7,381.7,
Takashita22,10.1056/NEJMc2119407,Virus isolate,Table 1,Etesevimab,Wild Type (A),=,18.2,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,>,50000,ng/ml,1,>,1000,,,
Wang21d,10.1016/j.chom.2021.04.007,Virus isolate,Figure S1A,Etesevimab,Wild Type (A),=,88.1,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,>,10000,ng/ml,1,>,567.7,,,LOD set to 10000
Dejnirattisai21,10.1016/j.cell.2021.03.055,Virus isolate,Table S2,Etesevimab,Wild Type (B),=,34,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,>,10000,ng/ml,1,>,294.1,,,
Dejnirattisai22,10.1016/j.cell.2021.12.046,Virus isolate,"Figure 4C, Table S1",Etesevimab,Wild Type (B),=,34,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,>,10000,ng/ml,1,>,294.1,,,
Cao22d,10.1038/s41586-021-04385-3,Pseudovirus (VSV),Fig 4b,Etesevimab,Wild Type (B.1),=,32,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,>,10000,ng/ml,1,>,312.5,,,
Zhou21e,10.1126/science.abn8897,Pseudovirus (lentivirus),Figure 2C,Etesevimab,Wild Type (B.1),=,50.5,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,>,10000,ng/ml,1,>,198,,,
Wang22c,10.1038/s41586-022-04466-x,Pseudovirus (VSV),Supplmentary Table 2,Etesevimab,Wild Type (B),=,19,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,8258,ng/ml,1,=,434.6,,,
Yuan22,10.1101/2022.03.13.484037,Pseudovirus (MLV),Figure 2A,Etesevimab,Wild Type (B),=,9,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,>,5000,ng/ml,1,>,555.6,,,
Wang21f,10.1016/j.immuni.2021.06.003,Pseudovirus (HIV),"Figure 1C, Figure S1",Etesevimab,Wild Type (B.1),=,20.4,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,>,1000,ng/ml,1,>,49,,,
Chen21e,10.1038/s41586-021-03720-y,SARS-CoV-2 recombinant,Extended Data Fig 13,Etesevimab,Wild Type (B.1),=,52,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,>,10000,ng/ml,1,>,192.3,,,
Nabel21,10.1126/science.abl6251,Pseudovirus (lentivirus),"Fig 2A, 2B",Etesevimab,Wild Type (B.1),=,27,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,>,100000,ng/ml,1,>,1000,,,
Yao21,10.1101/2021.01.27.428353,Pseudovirus (MLV),Figure 5,Etesevimab,Wild Type (B),=,80.5,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,>,4000,ng/ml,1,>,49.7,,,
Zhang21c,10.1038/s42003-021-02728-4,Pseudovirus (VSV),Supplementary Figure 3,Etesevimab,Wild Type (B.1),,,,,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,,,,,=,17,,,
Takashita22,10.1056/NEJMc2119407,Virus isolate,Table 1,Bamlanivimab + Etesevimab,Wild Type (A),=,25.2,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,5090,ng/ml,1,=,202,,,Combination therapies in this study were specified at ng/ml of each component so needs to multiply by 2
Yuan22,10.1101/2022.03.13.484037,Pseudovirus (MLV),Figure 2A,Bamlanivimab + Etesevimab,Wild Type (B),=,9,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,>,5000,ng/ml,1,>,555.6,,,
FDA21,https://www.fda.gov/drugs/drug-safety-and-availability/fda-authorizes-revisions-fact-sheets-address-sars-cov-2-variants-monoclonal-antibody-products-under,Pseudovirus (VSV),BAM+ETE Table 3 page 27,Bamlanivimab + Etesevimab,Wild Type (B),,,,,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,,,,,=,252,,,
Chen21e,10.1038/s41586-021-03720-y,SARS-CoV-2 recombinant,Extended Data Fig 13,Bamlanivimab + Etesevimab,Wild Type (B.1),=,9,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,>,10000,ng/ml,1,>,1000,,,
Ohashi22,10.1101/2022.02.27.482147,Virus isolate,Table 1,Casirivimab,Wild Type (A),=,13.9,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + G181V + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,14,ng/ml,1,=,1,,,
Wang21d,10.1016/j.chom.2021.04.007,Pseudovirus (VSV),Figure S1A,Casirivimab,Wild Type (B.1),=,1.1,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y,1,=,489.8,ng/ml,1,=,438.5,,,
Wang21e,10.1126/science.abh1766,Pseudovirus (lentivirus),Fig 2C,Casirivimab,Wild Type (A),=,7.7,ng/ml,1,Gamma,(Various),(Various),2,=,1267.8,ng/ml,1.2,=,167.7,151.8,183.6,
Moriyama21,10.1016/j.immuni.2021.06.015,Virus isolate,Figure 3E,Casirivimab,Wild Type (A),=,941,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,>,100000,ng/ml,1,>,106.3,,,
Takashita22,10.1056/NEJMc2119407,Virus isolate,Table 1,Casirivimab,Wild Type (A),=,2.8,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,187.7,ng/ml,1,=,67.3,,,
Wang21d,10.1016/j.chom.2021.04.007,Virus isolate,Figure S1A,Casirivimab,Wild Type (A),=,1.8,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,3527.8,ng/ml,1,>,1000,,,
Kaleta22,10.1038/s41467-022-28766-y,Virus isolate,Table 2,Casirivimab,Wild Type (B.1),=,90,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,>,10000,ng/ml,1,>,111.1,,,
Dejnirattisai21,10.1016/j.cell.2021.03.055,Virus isolate,Table S2,Casirivimab,Wild Type (B),=,4,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,6177,ng/ml,1,>,1000,,,
Dejnirattisai22,10.1016/j.cell.2021.12.046,Virus isolate,"Figure 4C, Table S1",Casirivimab,Wild Type (B),=,4,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,6177,ng/ml,1,>,1000,,,
Du22,10.1126/sciimmunol.abp9312,Virus isolate,Fig 1E,Casirivimab,Wild Type (B),=,3.4,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,54,ng/ml,1,=,15.9,,,
FDA21,https://www.fda.gov/drugs/drug-safety-and-availability/fda-authorizes-revisions-fact-sheets-address-sars-cov-2-variants-monoclonal-antibody-products-under,Virus isolate,CAS+IMD Table 10 page 42,Casirivimab,Wild Type (B),,,,,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,,,,,=,154,,,
Cao22d,10.1038/s41586-021-04385-3,Pseudovirus (VSV),Fig 4b,Casirivimab,Wild Type (B.1),=,5,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,55,ng/ml,1,=,11,,,
Hoffmann21,10.1016/j.cell.2021.03.036,Pseudovirus (VSV),Figure 6,Casirivimab,Wild Type (B.1),=,1,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,15.1,ng/ml,1,>,15.8,,,Mistakenly censored
Miyakawa21b,10.1101/2021.09.23.21264014,Pseudovirus,Figure 1C,Casirivimab,Wild Type (B.1),=,89,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,1479,ng/ml,1,=,16.6,,,
Tada21,10.1128/mBio.00696-21,Pseudovirus (HIV),Table 3,Casirivimab,Wild Type (B.1),=,7.4,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,>,2000,ng/ml,1,>,268.8,,,
Zhou21e,10.1126/science.abn8897,Pseudovirus (lentivirus),Figure 2C,Casirivimab,Wild Type (B.1),=,6.1,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,1536.3,ng/ml,1,=,251.9,,,
Pelzek22,10.1101/2022.02.06.479332,Pseudovirus (lentivirus),Extended Table 1,Casirivimab,Wild Type (B),=,24,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,2189,ng/ml,1,=,91.2,,,
Yuan22,10.1101/2022.03.13.484037,Pseudovirus (MLV),Figure 2A,Casirivimab,Wild Type (B),=,6,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,231,ng/ml,1,=,38.5,,,
Wang21f,10.1016/j.immuni.2021.06.003,Pseudovirus (HIV),"Figure 1C, Figure S1",Casirivimab,Wild Type (B.1),=,3.3,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,27.5,ng/ml,1,=,8.3,,,
Chen21e,10.1038/s41586-021-03720-y,SARS-CoV-2 recombinant,Figure 1c,Casirivimab,Wild Type (B.1),=,7,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,5002,ng/ml,1,=,714.6,,,
Copin21,10.1016/j.cell.2021.06.002,Pseudovirus (VSV),Figure 1A,Casirivimab,Wild Type (B.1),=,8.4,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,2452.1,ng/ml,1,=,291.9,,,
Nabel21,10.1126/science.abl6251,Pseudovirus (lentivirus),"Fig 2A, 2B",Casirivimab,Wild Type (B.1),=,25,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,171,ng/ml,1,=,6.8,,,
Yao21,10.1101/2021.01.27.428353,Pseudovirus (MLV),Figure 5,Casirivimab,Wild Type (B),=,6.8,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,>,4000,ng/ml,1,>,588.2,,,
Ohashi22,10.1101/2022.02.27.482147,Virus isolate,Table 1,Imdevimab,Wild Type (A),=,12.5,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + G181V + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,8.2,ng/ml,1,=,0.7,,,
Wang21d,10.1016/j.chom.2021.04.007,Pseudovirus (VSV),Figure S1A,Imdevimab,Wild Type (B.1),=,0.6,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y,1,=,0.3,ng/ml,1,=,0.5,,,
Wang21e,10.1126/science.abh1766,Pseudovirus (lentivirus),Fig 2C,Imdevimab,Wild Type (A),=,71,ng/ml,1,Gamma,(Various),(Various),2,=,5.1,ng/ml,1.3,=,0.1,0.1,0.1,
Moriyama21,10.1016/j.immuni.2021.06.015,Virus isolate,Figure 3G,Imdevimab,Wild Type (A),=,2581,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,136,ng/ml,1,=,0.1,,,
Takashita22,10.1056/NEJMc2119407,Virus isolate,Table 1,Imdevimab,Wild Type (A),=,3,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,1,ng/ml,1,=,0.3,,,
Wang21d,10.1016/j.chom.2021.04.007,Virus isolate,Figure S1A,Imdevimab,Wild Type (A),=,1.8,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,3.2,ng/ml,1,=,1.8,,,
Kaleta22,10.1038/s41467-022-28766-y,Virus isolate,Table 2,Imdevimab,Wild Type (B.1),=,20,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,10,ng/ml,1,=,0.5,,,
Dejnirattisai21,10.1016/j.cell.2021.03.055,Virus isolate,Table S2,Imdevimab,Wild Type (B),=,32,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,13,ng/ml,1,=,0.4,,,
Dejnirattisai22,10.1016/j.cell.2021.12.046,Virus isolate,"Figure 4C, Table S1",Imdevimab,Wild Type (B),=,32,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,13,ng/ml,1,=,0.4,,,
Cao22d,10.1038/s41586-021-04385-3,Pseudovirus (VSV),Fig 4b,Imdevimab,Wild Type (B.1),=,5,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,3,ng/ml,1,=,0.6,,,
Hoffmann21,10.1016/j.cell.2021.03.036,Pseudovirus (VSV),Figure 6,Imdevimab,Wild Type (B.1),=,0.9,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,0.6,ng/ml,1,=,0.7,,,
Miyakawa21b,10.1101/2021.09.23.21264014,Pseudovirus,Figure 1C,Imdevimab,Wild Type (B.1),=,65,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,20,ng/ml,1,=,0.3,,,
Tada21,10.1128/mBio.00696-21,Pseudovirus (HIV),Table 3,Imdevimab,Wild Type (B.1),=,19.4,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,36.4,ng/ml,1,=,1.9,,,
Zhou21e,10.1126/science.abn8897,Pseudovirus (lentivirus),Figure 2C,Imdevimab,Wild Type (B.1),=,20,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,6.5,ng/ml,1,=,0.3,,,
Pelzek22,10.1101/2022.02.06.479332,Pseudovirus (lentivirus),Extended Table 1,Imdevimab,Wild Type (B),=,23,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,10,ng/ml,1,=,0.4,,,
Wang22c,10.1038/s41586-022-04466-x,Pseudovirus (VSV),Supplmentary Table 2,Imdevimab,Wild Type (B),=,13,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,5,ng/ml,1,=,0.4,,,
Yuan22,10.1101/2022.03.13.484037,Pseudovirus (MLV),Figure 2A,Imdevimab,Wild Type (B),=,25,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,10,ng/ml,1,=,0.4,,,
Wang21f,10.1016/j.immuni.2021.06.003,Pseudovirus (HIV),"Figure 1C, Figure S1",Imdevimab,Wild Type (B.1),=,4.4,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,1.5,ng/ml,1,=,0.3,,,
Chen21e,10.1038/s41586-021-03720-y,SARS-CoV-2 recombinant,Figure 1c,Imdevimab,Wild Type (B.1),=,12,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,7,ng/ml,1,=,0.6,,,
Copin21,10.1016/j.cell.2021.06.002,Pseudovirus (VSV),Figure 1A,Imdevimab,Wild Type (B.1),=,6.9,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,1.1,ng/ml,1,=,0.2,,,
Nabel21,10.1126/science.abl6251,Pseudovirus (lentivirus),"Fig 2A, 2B",Imdevimab,Wild Type (B.1),=,32,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,68,ng/ml,1,=,2.1,,,
Wang22b,10.1101/2022.01.30.478305,Pseudovirus (HIV),Figure 1B,Imdevimab,Wild Type (B),=,2.3,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,38.5,ng/ml,1,=,16.7,,,
Yao21,10.1101/2021.01.27.428353,Pseudovirus (MLV),Figure 5,Imdevimab,Wild Type (B),=,6.8,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,5,ng/ml,1,=,0.7,,,
FDA21,https://www.fda.gov/drugs/drug-safety-and-availability/fda-authorizes-revisions-fact-sheets-address-sars-cov-2-variants-monoclonal-antibody-products-under,Pseudovirus,CAS+IMD Table 9 page 42,Casirivimab + Imdevimab,Wild Type (B),,,,,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I,1,,,,,=,1,,,
Takashita22,10.1056/NEJMc2119407,Virus isolate,Table 1,Casirivimab + Imdevimab,Wild Type (A),=,7,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,4.2,ng/ml,1,=,0.6,,,Combination therapies in this study were specified at ng/ml of each component so needs to multiply by 2
Kaleta22,10.1038/s41467-022-28766-y,Virus isolate,Table 2,Casirivimab + Imdevimab,Wild Type (B.1),=,30,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,20,ng/ml,1,=,0.7,,,
FDA21,https://www.fda.gov/drugs/drug-safety-and-availability/fda-authorizes-revisions-fact-sheets-address-sars-cov-2-variants-monoclonal-antibody-products-under,Virus isolate,CAS+IMD Table 10 page 42,Casirivimab + Imdevimab,Wild Type (B),,,,,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,,,,,=,1,,,
Hoffmann21,10.1016/j.cell.2021.03.036,Pseudovirus (VSV),Figure 6,Casirivimab + Imdevimab,Wild Type (B.1),=,1,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,1,ng/ml,1,=,1,,,
Tada21,10.1128/mBio.00696-21,Pseudovirus (HIV),Table 3,Casirivimab + Imdevimab,Wild Type (B.1),=,1.7,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,26.7,ng/ml,1,=,15.8,,,
Yuan22,10.1101/2022.03.13.484037,Pseudovirus (MLV),Figure 2A,Casirivimab + Imdevimab,Wild Type (B),=,6,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,17,ng/ml,1,=,2.8,,,
Chen21e,10.1038/s41586-021-03720-y,SARS-CoV-2 recombinant,Figure 1c,Casirivimab + Imdevimab,Wild Type (B.1),=,5,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,7,ng/ml,1,=,1.4,,,
Copin21,10.1016/j.cell.2021.06.002,Pseudovirus (VSV),Figure 1A,Casirivimab + Imdevimab,Wild Type (B.1),=,5.7,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,4,ng/ml,1,=,0.7,,,
Wang21d,10.1016/j.chom.2021.04.007,Pseudovirus (VSV),Figure S1A,Cilgavimab,Wild Type (B.1),=,2.6,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y,1,=,1.2,ng/ml,1,=,0.4,,,
Dong21,10.1038/s41564-021-00972-2,SARS-CoV-2 recombinant,Figure 4i,Cilgavimab,Wild Type (B.1),=,28,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I,1,=,10,ng/ml,1,=,0.4,,,
Takashita22,10.1056/NEJMc2119407,Virus isolate,Table 1,Cilgavimab,Wild Type (A),=,7.7,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,4,ng/ml,1,=,0.5,,,
Wang21d,10.1016/j.chom.2021.04.007,Virus isolate,Figure S1A,Cilgavimab,Wild Type (A),=,5.8,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,3.2,ng/ml,1,=,0.5,,,
Chen21d,10.1016/j.celrep.2021.109604,Virus isolate,Figure 2K,Cilgavimab,Wild Type (B.1),=,3,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,24,ng/ml,1,=,8,,,
Dejnirattisai21,10.1016/j.cell.2021.03.055,Virus isolate,Table S2,Cilgavimab,Wild Type (B),=,13,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,7,ng/ml,1,=,0.5,,,
Dejnirattisai22,10.1016/j.cell.2021.12.046,Virus isolate,"Figure 4C, Table S1",Cilgavimab,Wild Type (B),=,13,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,7,ng/ml,1,=,0.5,,,
Cao22d,10.1038/s41586-021-04385-3,Pseudovirus (VSV),Fig 4b,Cilgavimab,Wild Type (B.1),=,2,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,2,ng/ml,1,=,1,,,
Zhou21e,10.1126/science.abn8897,Pseudovirus (lentivirus),Figure 2C,Cilgavimab,Wild Type (B.1),=,3.7,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,14.1,ng/ml,1,=,3.8,,,
Yuan22,10.1101/2022.03.13.484037,Pseudovirus (MLV),Figure 2A,Cilgavimab,Wild Type (B),=,5,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,6,ng/ml,1,=,1.2,,,
House22,10.1371/journal.pone.0267796,Pseudovirus,Fig 1A,Cilgavimab,Wild Type (B.1),,,,,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,,,,,=,1.3,,,
Chen21e,10.1038/s41586-021-03720-y,SARS-CoV-2 recombinant,Figure 1c,Cilgavimab,Wild Type (B.1),=,26,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,7,ng/ml,1,=,0.3,,,
Wang21d,10.1016/j.chom.2021.04.007,Pseudovirus (VSV),Figure S1A,Tixagevimab,Wild Type (B.1),=,0.6,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y,1,=,2.3,ng/ml,1,=,3.7,,,
Dong21,10.1038/s41564-021-00972-2,SARS-CoV-2 recombinant,Figure 4i,Tixagevimab,Wild Type (B.1),=,4,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I,1,=,46,ng/ml,1,=,11.5,,,
Takashita22,10.1056/NEJMc2119407,Virus isolate,Table 1,Tixagevimab,Wild Type (A),=,1.9,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,6.6,ng/ml,1,=,3.4,,,
Wang21d,10.1016/j.chom.2021.04.007,Virus isolate,Figure S1A,Tixagevimab,Wild Type (A),=,3.4,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,3.5,ng/ml,1,=,1,,,
Dejnirattisai21,10.1016/j.cell.2021.03.055,Virus isolate,Table S2,Tixagevimab,Wild Type (B),=,5,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,46,ng/ml,1,=,9.2,,,
Dejnirattisai22,10.1016/j.cell.2021.12.046,Virus isolate,"Figure 4C, Table S1",Tixagevimab,Wild Type (B),=,5,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,46,ng/ml,1,=,9.2,,,
Cao22d,10.1038/s41586-021-04385-3,Pseudovirus (VSV),Fig 4b,Tixagevimab,Wild Type (B.1),=,1,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,12,ng/ml,1,=,12,,,
Zhou21e,10.1126/science.abn8897,Pseudovirus (lentivirus),Figure 2C,Tixagevimab,Wild Type (B.1),=,2,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,1.9,ng/ml,1,=,1,,,
Wang22c,10.1038/s41586-022-04466-x,Pseudovirus (VSV),Supplmentary Table 2,Tixagevimab,Wild Type (B),=,5,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,8,ng/ml,1,=,1.6,,,
Yuan22,10.1101/2022.03.13.484037,Pseudovirus (MLV),Figure 2A,Tixagevimab,Wild Type (B),=,1,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,2,ng/ml,1,=,2,,,
Chen21e,10.1038/s41586-021-03720-y,SARS-CoV-2 recombinant,Figure 1c,Tixagevimab,Wild Type (B.1),=,4,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,32,ng/ml,1,=,8,,,
Dong21,10.1038/s41564-021-00972-2,SARS-CoV-2 recombinant,Figure 4i,Cilgavimab + Tixagevimab,Wild Type (B.1),=,4,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I,1,=,8,ng/ml,1,=,2,,,
Takashita22,10.1056/NEJMc2119407,Virus isolate,Table 1,Cilgavimab + Tixagevimab,Wild Type (A),=,6.8,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,3.6,ng/ml,1,=,0.5,,,Combination therapies in this study were specified at ng/ml of each component so needs to multiply by 2
Dejnirattisai21,10.1016/j.cell.2021.03.055,Virus isolate,Table S2,Cilgavimab + Tixagevimab,Wild Type (B),=,9,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,6,ng/ml,1,=,0.7,,,
Dejnirattisai22,10.1016/j.cell.2021.12.046,Virus isolate,"Figure 4C, Table S1",Cilgavimab + Tixagevimab,Wild Type (B),=,9,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,6,ng/ml,1,=,0.7,,,
EMA21e,https://www.ema.europa.eu/en/documents/product-information/evusheld-epar-product-information_en.pdf,Virus isolate,Table 3,Cilgavimab + Tixagevimab,Wild Type (B),=,8,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,3.2,ng/ml,1,=,0.4,,,
FDA21c,https://www.fda.gov/media/154701/download,Virus isolate,"Feb 2022, Table 6",Cilgavimab + Tixagevimab,Wild Type (B),,,,,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,,,,,=,1,,,
EMA21e,https://www.ema.europa.eu/en/documents/product-information/evusheld-epar-product-information_en.pdf,Pseudovirus,Table 3,Cilgavimab + Tixagevimab,Wild Type (B),=,1.9,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,1.8,ng/ml,1,=,0.9,,,
Yuan22,10.1101/2022.03.13.484037,Pseudovirus (MLV),Figure 2A,Cilgavimab + Tixagevimab,Wild Type (B),=,5,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,4,ng/ml,1,=,0.8,,,
FDA21c,https://www.fda.gov/media/154701/download,Pseudovirus,"Feb 2022, Table 6, Page 17, Antiviral resistance paragraph 6",Cilgavimab + Tixagevimab,Wild Type (B),,,,,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,,,,,=,1.2,,,
Chen21e,10.1038/s41586-021-03720-y,SARS-CoV-2 recombinant,Figure 1c,Cilgavimab + Tixagevimab,Wild Type (B.1),=,4,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,7,ng/ml,1,=,1.8,,,
Ohashi22,10.1101/2022.02.27.482147,Virus isolate,Table 1,Sotrovimab,Wild Type (A),=,158.7,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + G181V + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,38.4,ng/ml,1,=,0.2,,,
Wang21d,10.1016/j.chom.2021.04.007,Pseudovirus (VSV),Figure S1A,Sotrovimab,Wild Type (B.1),=,11.5,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y,1,=,15.4,ng/ml,1,=,1.3,,,
Takashita22,10.1056/NEJMc2119407,Virus isolate,Table 1,Sotrovimab,Wild Type (A),=,27.3,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,28.4,ng/ml,1,=,1,,,
Liu22,10.1126/scitranslmed.abn6859,Virus isolate,Fig2B,Sotrovimab,Wild Type (A),=,39,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,21,ng/ml,1,=,0.5,,,
Wang21d,10.1016/j.chom.2021.04.007,Virus isolate,Figure S1A,Sotrovimab,Wild Type (A),=,16.9,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,8,ng/ml,1,=,0.5,,,
Dejnirattisai21,10.1016/j.cell.2021.03.055,Virus isolate,Table S2,Sotrovimab,Wild Type (B),=,40,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,76,ng/ml,1,=,1.9,,,
Dejnirattisai22,10.1016/j.cell.2021.12.046,Virus isolate,"Figure 4C, Table S1",Sotrovimab,Wild Type (B),=,40,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,76,ng/ml,1,=,1.9,,,
Cathcart21,10.1101/2021.03.09.434607,Virus isolate,Table 1,Sotrovimab,Wild Type (A),,,,,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,,,,,=,1.6,,,
EMA21d,https://www.ema.europa.eu/en/documents/product-information/xevudy-epar-product-information_en.pdf,Virus isolate,Table 2,Sotrovimab,Wild Type (B),,,,,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,,,,,=,1,,,
FDA21e,https://www.fda.gov/media/149534/download,Virus isolate,"SOT Page 22, Table 1",Sotrovimab,Wild Type (B),,,,,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,,,,,=,1.6,,,
Liu22,10.1126/scitranslmed.abn6859,Pseudovirus (VSV),Fig2A,Sotrovimab,Wild Type (B.1),=,11,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,24,ng/ml,1,=,2.2,,,
Cao22d,10.1038/s41586-021-04385-3,Pseudovirus (VSV),Fig 4b,Sotrovimab,Wild Type (B.1),=,58,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,66,ng/ml,1,=,1.1,,,
Zhou21e,10.1126/science.abn8897,Pseudovirus (lentivirus),Figure 2C,Sotrovimab,Wild Type (B.1),=,36.1,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,41.8,ng/ml,1,=,1.2,,,
Pelzek22,10.1101/2022.02.06.479332,Pseudovirus (lentivirus),Extended Table 1,Sotrovimab,Wild Type (B),=,3819,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,73,ng/ml,1,<,0.1,,,
Wang22c,10.1038/s41586-022-04466-x,Pseudovirus (VSV),Supplmentary Table 2,Sotrovimab,Wild Type (B),=,68,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,68,ng/ml,1,=,1,,,
Yuan22,10.1101/2022.03.13.484037,Pseudovirus (MLV),Figure 2A,Sotrovimab,Wild Type (B),=,72,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,37,ng/ml,1,=,0.5,,,
Chen21,10.1038/s41591-021-01294-w,Pseudovirus (VSV),Extended Data Fig. 3b,Sotrovimab,Wild Type (B.1),,,,,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,,,,,=,4,,,
EMA21d,https://www.ema.europa.eu/en/documents/product-information/xevudy-epar-product-information_en.pdf,Pseudovirus,Table 2,Sotrovimab,Wild Type (B),,,,,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,,,,,=,1,,,
Wang21f,10.1016/j.immuni.2021.06.003,Pseudovirus (HIV),"Figure 1C, Figure S1",Sotrovimab,Wild Type (B.1),=,4.1,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,2.9,ng/ml,1,=,0.7,,,
Chen21e,10.1038/s41586-021-03720-y,SARS-CoV-2 recombinant,Figure 1c,Sotrovimab,Wild Type (B.1),=,156,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,18,ng/ml,1,=,0.1,,,
Wang22b,10.1101/2022.01.30.478305,Pseudovirus (HIV),Figure 1B,Sotrovimab,Wild Type (B),=,30.8,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,60,ng/ml,1,=,1.9,,,
Cathcart21,10.1101/2021.03.09.434607,Pseudovirus (VSV),Table 2,Sotrovimab,Wild Type (B),,,,,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,,,,,=,0.4,,,
FDA21e,https://www.fda.gov/media/149534/download,Pseudovirus,"SOT Page 22, Table 1",Sotrovimab,Wild Type (B),,,,,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,,,,,=,0.4,,,
FDA22,https://www.fda.gov/media/156152/download,Virus isolate,"Mar 2022, Page 14, antiviral resistance, Table 3",Bebtelovimab,Wild Type (B),,,,,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,,,,,=,1,,,
Zhou21e,10.1126/science.abn8897,Pseudovirus (lentivirus),Figure 2C,Bebtelovimab,Wild Type (B.1),=,3,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,11.5,ng/ml,1,=,3.8,,,
Westendorf22,10.1016/j.celrep.2022.110812,Pseudovirus (VSV),Table 3B,Bebtelovimab,Wild Type (A),=,3,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,2,ng/ml,1,=,0.7,,,
Westendorf22,10.1016/j.celrep.2022.110812,Pseudovirus (lentivirus),Table 3B,Bebtelovimab,Wild Type (A),=,5,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,2,ng/ml,1,=,0.4,,,
FDA22,https://www.fda.gov/media/156152/download,Pseudovirus,"Mar 2022, Page 13, antiviral resistance, Table 2",Bebtelovimab,Wild Type (B),,,,,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,,,,,=,1,,,
Ryu21b,10.1016/j.bbrc.2021.09.023,Virus isolate,"Table 2, preprint 10.1101/2021.07.08.451696",Regdanvimab,Wild Type (B.1),=,2,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,275.8,ng/ml,1,=,137.9,,,
EMA21c,https://www.ema.europa.eu/en/documents/product-information/regkirona-epar-product-information_en.pdf,Virus isolate,Table 3,Regdanvimab,Wild Type (B),,,,,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,,,,,=,167.9,,,
Zhou21e,10.1126/science.abn8897,Pseudovirus (lentivirus),Figure 2C,Regdanvimab,Wild Type (B.1),=,1.5,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,39.6,ng/ml,1,=,26.4,,,
EMA21c,https://www.ema.europa.eu/en/documents/product-information/regkirona-epar-product-information_en.pdf,Pseudovirus,Table 3,Regdanvimab,Wild Type (B),,,,,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,,,,,=,61.4,,,
Ryu21b,10.1016/j.bbrc.2021.09.023,Pseudovirus (HIV),"Table 2, preprint 10.1101/2021.07.08.451696",Regdanvimab,Wild Type (B.1),=,0.2,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,13.5,ng/ml,1,=,61.4,,,
Cao22d,10.1038/s41586-021-04385-3,Pseudovirus (VSV),Fig 4b,Amubarvimab,Wild Type (B.1),=,53,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,41,ng/ml,1,=,0.8,,,
Wang21f,10.1016/j.immuni.2021.06.003,Pseudovirus (HIV),"Figure 1C, Figure S1",Amubarvimab,Wild Type (B.1),=,14.1,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,4.1,ng/ml,1,=,0.3,,,
Wang21f,10.1016/j.immuni.2021.06.003,Pseudovirus (HIV),"Figure 1C, Figure S1",Romlusevimab,Wild Type (B.1),=,18.6,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,12.4,ng/ml,1,=,0.7,,,
Margolis21,https://idweek.org/Margolis,Pseudovirus,Table 2,Amubarvimab + Romlusevimab,Wild Type (B.1),,,,,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,,,,,=,2.5,,,
Cao22d,10.1038/s41586-021-04385-3,Pseudovirus (VSV),Fig 4b,DXP-604,Wild Type (B.1),=,10,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,5,ng/ml,1,=,0.5,,,
Wang22c,10.1038/s41586-022-04466-x,Pseudovirus (VSV),Supplmentary Table 2,DXP-604,Wild Type (B),=,17,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,11,ng/ml,1,=,0.6,,,
Chen21e,10.1038/s41586-021-03720-y,SARS-CoV-2 recombinant,Figure 1c,S2E12 + Sotrovimab,Wild Type (B.1),=,7,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,3,ng/ml,1,=,0.4,,,
House22,10.1371/journal.pone.0267796,Pseudovirus,Fig 1A,COV2-2381 + Cilgavimab,Wild Type (B.1),,,,,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,,,,,=,0.6,,,
FDA21,https://www.fda.gov/drugs/drug-safety-and-availability/fda-authorizes-revisions-fact-sheets-address-sars-cov-2-variants-monoclonal-antibody-products-under,Pseudovirus (VSV),BAM Table 3,Bamlanivimab,Wild Type (B),,,,,Epsilon,13,S13I + W152C + L452R,1,,,,,>,1000,,,
FDA21,https://www.fda.gov/drugs/drug-safety-and-availability/fda-authorizes-revisions-fact-sheets-address-sars-cov-2-variants-monoclonal-antibody-products-under,SARS-CoV-2 recombinant,BAM+ETE page 29,Bamlanivimab,Wild Type (B),,,,,Epsilon,13,S13I + W152C + L452R,1,,,,,=,833,,,
Boschi22,10.1093/cid/ciac143,Virus isolate,Figure 1A,Bamlanivimab,Wild Type (B.1.1),=,0.2,ng/ml,1,Epsilon,13,S13I + W152C + L452R,1,>,3500,ng/ml,1,>,1000,,,Censored at 3500
Chen21e,10.1038/s41586-021-03720-y,SARS-CoV-2 recombinant,Figure 1c,Bamlanivimab,Wild Type (B.1),=,5,ng/ml,1,Epsilon,13,S13I + W152C + L452R,1,>,10000,ng/ml,1,>,1000,,,
McCallum21b,10.1126/science.abi7994,Pseudovirus (VSV),Figure 3C,Bamlanivimab,Wild Type (B.1),=,7,ng/ml,1,Epsilon,13,S13I + W152C + L452R,1,>,100000,ng/ml,1,>,1000,,,
Nabel21,10.1126/science.abl6251,Pseudovirus (lentivirus),"Fig 2A, 2B",Bamlanivimab,Wild Type (B.1),=,22,ng/ml,1,Epsilon,13,S13I + W152C + L452R,1,>,100000,ng/ml,1,>,1000,,,
Wang21e,10.1126/science.abh1766,Pseudovirus (lentivirus),Fig 2C,Bamlanivimab,Wild Type (A),=,7.1,ng/ml,1,Epsilon,13,S13I + W152C + L452R,1,>,10000,ng/ml,1,>,1000,,,
FDA21,https://www.fda.gov/drugs/drug-safety-and-availability/fda-authorizes-revisions-fact-sheets-address-sars-cov-2-variants-monoclonal-antibody-products-under,SARS-CoV-2 recombinant,BAM+ETE page 29,Etesevimab,Wild Type (B),,,,,Epsilon,13,S13I + W152C + L452R,1,,,,,=,1,,,
Boschi22,10.1093/cid/ciac143,Virus isolate,Figure 1A,Etesevimab,Wild Type (B.1.1),=,6,ng/ml,1,Epsilon,13,S13I + W152C + L452R,1,=,1.1,ng/ml,1,=,0.2,,,
Chen21e,10.1038/s41586-021-03720-y,SARS-CoV-2 recombinant,Extended Data Fig 13,Etesevimab,Wild Type (B.1),=,52,ng/ml,1,Epsilon,13,S13I + W152C + L452R,1,=,38,ng/ml,1,=,0.7,,,
McCallum21b,10.1126/science.abi7994,Pseudovirus (VSV),Figure 3C,Etesevimab,Wild Type (B.1),=,6,ng/ml,1,Epsilon,13,S13I + W152C + L452R,1,=,35,ng/ml,1,=,5.8,,,
Nabel21,10.1126/science.abl6251,Pseudovirus (lentivirus),"Fig 2A, 2B",Etesevimab,Wild Type (B.1),=,27,ng/ml,1,Epsilon,13,S13I + W152C + L452R,1,=,64,ng/ml,1,=,2.4,,,
Wang21e,10.1126/science.abh1766,Pseudovirus (lentivirus),Fig 2C,Etesevimab,Wild Type (A),=,26.2,ng/ml,1,Epsilon,13,S13I + W152C + L452R,1,=,22.9,ng/ml,1,=,0.9,,,
Zhang21c,10.1038/s42003-021-02728-4,Pseudovirus (VSV),Supplementary Figure 3,Etesevimab,Wild Type (B.1),,,,,Epsilon,13,S13I + W152C + L452R,1,,,,,=,1,,,
FDA21,https://www.fda.gov/drugs/drug-safety-and-availability/fda-authorizes-revisions-fact-sheets-address-sars-cov-2-variants-monoclonal-antibody-products-under,Pseudovirus (VSV),BAM+ETE Table 3 page 27,Bamlanivimab + Etesevimab,Wild Type (B),,,,,Epsilon,13,S13I + W152C + L452R,1,,,,,=,9,,,
FDA21,https://www.fda.gov/drugs/drug-safety-and-availability/fda-authorizes-revisions-fact-sheets-address-sars-cov-2-variants-monoclonal-antibody-products-under,SARS-CoV-2 recombinant,BAM+ETE Table 4 page 29,Bamlanivimab + Etesevimab,Wild Type (B),,,,,Epsilon,13,S13I + W152C + L452R,1,,,,,=,11,,,
Boschi22,10.1093/cid/ciac143,Virus isolate,Figure 1A,Bamlanivimab + Etesevimab,Wild Type (B.1.1),=,0.5,ng/ml,1,Epsilon,13,S13I + W152C + L452R,1,=,1.1,ng/ml,1,=,2.1,,,
Chen21e,10.1038/s41586-021-03720-y,SARS-CoV-2 recombinant,Extended Data Fig 13,Bamlanivimab + Etesevimab,Wild Type (B.1),=,9,ng/ml,1,Epsilon,13,S13I + W152C + L452R,1,=,63,ng/ml,1,=,7,,,
Pelzek22,10.1101/2022.02.06.479332,Pseudovirus (lentivirus),Extended Table 1,Casirivimab,Wild Type (B),=,24,ng/ml,1,Epsilon,13,S13I + W152C + L452R,1,=,27,ng/ml,1,=,1.1,,,
Boschi22,10.1093/cid/ciac143,Virus isolate,Figure 1B,Casirivimab,Wild Type (B.1.1),=,0.7,ng/ml,1,Epsilon,13,S13I + W152C + L452R,1,=,0.3,ng/ml,1,=,0.5,,,
Chen21e,10.1038/s41586-021-03720-y,SARS-CoV-2 recombinant,Figure 1c,Casirivimab,Wild Type (B.1),=,7,ng/ml,1,Epsilon,13,S13I + W152C + L452R,1,=,4,ng/ml,1,=,0.6,,,
McCallum21b,10.1126/science.abi7994,Pseudovirus (VSV),Figure 3C,Casirivimab,Wild Type (B.1),=,7,ng/ml,1,Epsilon,13,S13I + W152C + L452R,1,=,9,ng/ml,1,=,1.3,,,
Nabel21,10.1126/science.abl6251,Pseudovirus (lentivirus),"Fig 2A, 2B",Casirivimab,Wild Type (B.1),=,25,ng/ml,1,Epsilon,13,S13I + W152C + L452R,1,=,40,ng/ml,1,=,1.6,,,
Wang21e,10.1126/science.abh1766,Pseudovirus (lentivirus),Fig 2C,Casirivimab,Wild Type (A),=,7.7,ng/ml,1,Epsilon,13,S13I + W152C + L452R,1,=,9,ng/ml,1,=,1.2,,,
Pelzek22,10.1101/2022.02.06.479332,Pseudovirus (lentivirus),Extended Table 1,Imdevimab,Wild Type (B),=,23,ng/ml,1,Epsilon,13,S13I + W152C + L452R,1,=,18,ng/ml,1,=,0.8,,,
Boschi22,10.1093/cid/ciac143,Virus isolate,Figure 1B,Imdevimab,Wild Type (B.1.1),=,8.9,ng/ml,1,Epsilon,13,S13I + W152C + L452R,1,=,10,ng/ml,1,=,1.1,,,
Chen21e,10.1038/s41586-021-03720-y,SARS-CoV-2 recombinant,Figure 1c,Imdevimab,Wild Type (B.1),=,12,ng/ml,1,Epsilon,13,S13I + W152C + L452R,1,=,108,ng/ml,1,=,9,,,
McCallum21b,10.1126/science.abi7994,Pseudovirus (VSV),Figure 3C,Imdevimab,Wild Type (B.1),=,23,ng/ml,1,Epsilon,13,S13I + W152C + L452R,1,=,51,ng/ml,1,=,2.2,,,
Nabel21,10.1126/science.abl6251,Pseudovirus (lentivirus),"Fig 2A, 2B",Imdevimab,Wild Type (B.1),=,32,ng/ml,1,Epsilon,13,S13I + W152C + L452R,1,=,1900,ng/ml,1,=,59.4,,,
Wang21e,10.1126/science.abh1766,Pseudovirus (lentivirus),Fig 2C,Imdevimab,Wild Type (A),=,71,ng/ml,1,Epsilon,13,S13I + W152C + L452R,1,=,74.9,ng/ml,1,=,1.1,,,
FDA21,https://www.fda.gov/drugs/drug-safety-and-availability/fda-authorizes-revisions-fact-sheets-address-sars-cov-2-variants-monoclonal-antibody-products-under,Pseudovirus (VSV),CAS+IMD Table 9 page 42,Casirivimab + Imdevimab,Wild Type (B),,,,,Epsilon,13,S13I + W152C + L452R,1,,,,,=,1,,,
Boschi22,10.1093/cid/ciac143,Virus isolate,Figure 1B,Casirivimab + Imdevimab,Wild Type (B.1.1),=,0.1,ng/ml,1,Epsilon,13,S13I + W152C + L452R,1,=,0,ng/ml,1,=,0.2,,,
Chen21e,10.1038/s41586-021-03720-y,SARS-CoV-2 recombinant,Figure 1c,Casirivimab + Imdevimab,Wild Type (B.1),=,5,ng/ml,1,Epsilon,13,S13I + W152C + L452R,1,=,4,ng/ml,1,=,0.8,,,
House22,10.1371/journal.pone.0267796,Pseudovirus,Fig 1A,Cilgavimab,Wild Type (B.1),,,,,Epsilon,(Various),(Various),2,,,,,=,2.7,1.9,3.5,
Chen21d,10.1016/j.celrep.2021.109604,Virus isolate,Figure 2K,Cilgavimab,Wild Type (B.1),=,3,ng/ml,1,Epsilon,13,S13I + W152C + L452R,1,=,9,ng/ml,1,=,3,,,
Chen21e,10.1038/s41586-021-03720-y,SARS-CoV-2 recombinant,Figure 1c,Cilgavimab,Wild Type (B.1),=,26,ng/ml,1,Epsilon,13,S13I + W152C + L452R,1,=,55,ng/ml,1,=,2.1,,,
Dong21,10.1038/s41564-021-00972-2,SARS-CoV-2 recombinant,Figure 4i,Cilgavimab,Wild Type (B.1),=,28,ng/ml,1,Epsilon,13,S13I + W152C + L452R,1,=,75,ng/ml,1,=,2.7,,,
Chen21e,10.1038/s41586-021-03720-y,SARS-CoV-2 recombinant,Figure 1c,Tixagevimab,Wild Type (B.1),=,4,ng/ml,1,Epsilon,13,S13I + W152C + L452R,1,=,11,ng/ml,1,=,2.8,,,
Dong21,10.1038/s41564-021-00972-2,SARS-CoV-2 recombinant,Figure 4i,Tixagevimab,Wild Type (B.1),=,4,ng/ml,1,Epsilon,13,S13I + W152C + L452R,1,=,5,ng/ml,1,=,1.3,,,
EMA21e,https://www.ema.europa.eu/en/documents/product-information/evusheld-epar-product-information_en.pdf,Virus isolate,Table 3,Cilgavimab + Tixagevimab,Wild Type (B),=,8,ng/ml,1,Epsilon,13,S13I + W152C + L452R,1,=,5,ng/ml,1,=,0.6,,,
FDA21c,https://www.fda.gov/media/154701/download,Virus isolate,"Feb 2022, Table 6",Cilgavimab + Tixagevimab,Wild Type (B),,,,,Epsilon,13,S13I + W152C + L452R,1,,,,,=,1,,,
EMA21e,https://www.ema.europa.eu/en/documents/product-information/evusheld-epar-product-information_en.pdf,Pseudovirus,Table 3,Cilgavimab + Tixagevimab,Wild Type (B),=,1.9,ng/ml,1,Epsilon,13,S13I + W152C + L452R,1,=,1.2,ng/ml,1,=,0.6,,,
FDA21c,https://www.fda.gov/media/154701/download,Pseudovirus,"Feb 2022, Table 6, Page 17, Antiviral resistance paragraph 6",Cilgavimab + Tixagevimab,Wild Type (B),,,,,Epsilon,13,S13I + W152C + L452R,1,,,,,=,2.2,,,
Chen21e,10.1038/s41586-021-03720-y,SARS-CoV-2 recombinant,Figure 1c,Cilgavimab + Tixagevimab,Wild Type (B.1),=,4,ng/ml,1,Epsilon,13,S13I + W152C + L452R,1,=,5,ng/ml,1,=,1.3,,,
Dong21,10.1038/s41564-021-00972-2,SARS-CoV-2 recombinant,Figure 4i,Cilgavimab + Tixagevimab,Wild Type (B.1),=,4,ng/ml,1,Epsilon,13,S13I + W152C + L452R,1,=,14,ng/ml,1,=,3.5,,,
EMA21d,https://www.ema.europa.eu/en/documents/product-information/xevudy-epar-product-information_en.pdf,Pseudovirus,Table 2,Sotrovimab,Wild Type (B),,,,,Epsilon,13,S13I + W152C + L452R,1,,,,,=,1,,,
Liu22,10.1126/scitranslmed.abn6859,Pseudovirus (VSV),Fig2A,Sotrovimab,Wild Type (B.1),=,11,ng/ml,1,Epsilon,13,S13I + W152C + L452R,1,=,32,ng/ml,1,=,2.9,,,
Chen21e,10.1038/s41586-021-03720-y,SARS-CoV-2 recombinant,Figure 1c,Sotrovimab,Wild Type (B.1),=,156,ng/ml,1,Epsilon,13,S13I + W152C + L452R,1,=,20,ng/ml,1,=,0.1,,,
McCallum21b,10.1126/science.abi7994,Pseudovirus (VSV),Figure 3C,Sotrovimab,Wild Type (B.1),=,67,ng/ml,1,Epsilon,13,S13I + W152C + L452R,1,=,58,ng/ml,1,=,0.9,,,
Cathcart21,10.1101/2021.03.09.434607,Pseudovirus (VSV),Table 2,Sotrovimab,Wild Type (B),,,,,Epsilon,13,S13I + W152C + L452R,1,,,,,=,0.7,,,
FDA21e,https://www.fda.gov/media/149534/download,Pseudovirus,"SOT Page 22, Table 1",Sotrovimab,Wild Type (B),,,,,Epsilon,13,S13I + W152C + L452R,1,,,,,=,0.7,,,
FDA22,https://www.fda.gov/media/156152/download,Virus isolate,"Mar 2022, Page 14, antiviral resistance, Table 3",Bebtelovimab,Wild Type (B),,,,,Epsilon,13,S13I + W152C + L452R,1,,,,,=,1,,,
Westendorf22,10.1016/j.celrep.2022.110812,Pseudovirus (VSV),Table 3B,Bebtelovimab,Wild Type (A),=,3,ng/ml,1,Epsilon,13,S13I + W152C + L452R,1,=,2,ng/ml,1,=,0.7,,,
Westendorf22,10.1016/j.celrep.2022.110812,Pseudovirus (lentivirus),Table 3B,Bebtelovimab,Wild Type (A),=,5,ng/ml,1,Epsilon,13,S13I + W152C + L452R,1,=,2,ng/ml,1,=,0.4,,,
FDA22,https://www.fda.gov/media/156152/download,Pseudovirus,"Mar 2022, Page 13, antiviral resistance, Table 2",Bebtelovimab,Wild Type (B),,,,,Epsilon,13,S13I + W152C + L452R,1,,,,,=,1,,,
Ryu21b,10.1016/j.bbrc.2021.09.023,Pseudovirus (MLV),"Table 2, preprint 10.1101/2021.07.23.453472",Regdanvimab,Wild Type (B.1),=,0.2,ng/ml,1,Epsilon,13,S13I + W152C + L452R,1,=,6.8,ng/ml,1,=,31.1,,,
EMA21c,https://www.ema.europa.eu/en/documents/product-information/regkirona-epar-product-information_en.pdf,Virus isolate,Table 3,Regdanvimab,Wild Type (B),,,,,Epsilon,13,S13I + W152C + L452R,2,,,,,=,64,59.1,69,
EMA21c,https://www.ema.europa.eu/en/documents/product-information/regkirona-epar-product-information_en.pdf,Pseudovirus,Table 3,Regdanvimab,Wild Type (B),,,,,Epsilon,13,S13I + W152C + L452R,1,,,,,=,35,,,
Ryu21b,10.1016/j.bbrc.2021.09.023,Virus isolate,"Table 2, preprint 10.1101/2021.07.23.453472",Regdanvimab,Wild Type (B),=,6.8,ng/ml,1,Epsilon,13,S13I + W152C + L452R,2,=,427.3,ng/ml,1.2,=,64,59.1,69,
McCallum21b,10.1126/science.abi7994,Pseudovirus (VSV),Figure 3C,Regdanvimab,Wild Type (B.1),=,4,ng/ml,1,Epsilon,13,S13I + W152C + L452R,1,=,56,ng/ml,1,=,14,,,
Margolis21,https://idweek.org/Margolis,Pseudovirus,Table 2,Amubarvimab + Romlusevimab,Wild Type (B.1),,,,,Epsilon,13,S13I + W152C + L452R,1,,,,,=,2.5,,,
Chen21e,10.1038/s41586-021-03720-y,SARS-CoV-2 recombinant,Figure 1c,S2E12 + Sotrovimab,Wild Type (B.1),=,7,ng/ml,1,Epsilon,13,S13I + W152C + L452R,1,=,5,ng/ml,1,=,0.7,,,
House22,10.1371/journal.pone.0267796,Pseudovirus,Fig 1A,COV2-2381 + Cilgavimab,Wild Type (B.1),,,,,Epsilon,(Various),(Various),2,,,,,=,1.3,1,1.6,
Gruell22c,10.1016/S1473-3099(22)00580-1,Pseudovirus,Figure B,Bamlanivimab,Wild Type (B.1),=,5,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Saito22,10.1016/j.chom.2022.10.003,Pseudovirus (lentivirus),Table 1,Bamlanivimab,Wild Type (B.1),=,6.7,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,4725,ng/ml,1,>,705.2,,,
Cao22c,10.1016/j.chom.2022.09.018,Pseudovirus (VSV),Figure 5b,Bamlanivimab,Wild Type (B.1),=,15,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,666.7,,,
Sheward22b,10.1101/2022.07.19.500716,Pseudovirus (lentivirus),Table S1,Bamlanivimab,Wild Type (B.1),=,7,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,1000,ng/ml,1,>,142.9,,,Some LOD values of 10000 were reported. Corrected to 1000
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Bamlanivimab,Wild Type (B.1),=,6,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Yamasoba22c,10.1101/2022.07.14.500041,Pseudovirus,Table 1,Bamlanivimab,Wild Type (B.1),=,6.7,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,4725,ng/ml,1,>,705.2,,,
Huo22b,10.1016/j.celrep.2022.111903,Pseudovirus (lentivirus),Supplementary Table 1B,Bamlanivimab,Wild Type (B),=,2,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Gruell22c,10.1016/S1473-3099(22)00580-1,Pseudovirus,Figure B,Etesevimab,Wild Type (B.1),=,30,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,333.3,,,
Saito22,10.1016/j.chom.2022.10.003,Pseudovirus (lentivirus),Table 1,Etesevimab,Wild Type (B.1),=,12,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,4600,ng/ml,1,>,383.3,,,
Cao22c,10.1016/j.chom.2022.09.018,Pseudovirus (VSV),Figure 5b,Etesevimab,Wild Type (B.1),=,32,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,312.5,,,
Sheward22b,10.1101/2022.07.19.500716,Pseudovirus (lentivirus),Table S1,Etesevimab,Wild Type (B.1),=,34,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,1000,ng/ml,1,>,29.4,,,Some LOD values of 10000 were reported. Corrected to 1000
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Etesevimab,Wild Type (B.1),=,9,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Yamasoba22c,10.1101/2022.07.14.500041,Pseudovirus,Table 1,Etesevimab,Wild Type (B.1),=,12,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,4600,ng/ml,1,>,383.3,,,
Huo22b,10.1016/j.celrep.2022.111903,Pseudovirus (lentivirus),Supplementary Table 1B,Etesevimab,Wild Type (B),=,14,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,714.3,,,
Saito22,10.1016/j.chom.2022.10.003,Pseudovirus (lentivirus),Table 1,Bamlanivimab + Etesevimab,Wild Type (B.1),=,8.3,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,4600,ng/ml,1,>,554.2,,,
Cao22c,10.1016/j.chom.2022.09.018,Pseudovirus (VSV),Figure 5b,Bamlanivimab + Etesevimab,Wild Type (B.1),=,20,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,500,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Bamlanivimab + Etesevimab,Wild Type (B.1),=,6,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Yamasoba22c,10.1101/2022.07.14.500041,Pseudovirus,Table 1,Bamlanivimab + Etesevimab,Wild Type (B.1),=,8.3,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,4600,ng/ml,1,>,554.2,,,
Park22,10.1126/science.adc9127,Pseudovirus (VSV),Fig 1A,Bamlanivimab + Etesevimab,Wild Type (B),=,17,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,588.2,,,
Gruell22c,10.1016/S1473-3099(22)00580-1,Pseudovirus,Figure B,Casirivimab,Wild Type (B.1),=,5,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1167,ng/ml,1,=,233.4,,,
Saito22,10.1016/j.chom.2022.10.003,Pseudovirus (lentivirus),Table 1,Casirivimab,Wild Type (B.1),=,3.4,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,2303,ng/ml,1,=,677.4,,,
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Casirivimab,Omicron/BA.2,>,10000,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,278,ng/ml,1,=,0.3,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22c,10.1016/j.chom.2022.09.018,Pseudovirus (VSV),Figure 5b,Casirivimab,Wild Type (B.1),=,5.6,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,278,ng/ml,1,=,49.6,,,
Sheward22b,10.1101/2022.07.19.500716,Pseudovirus (lentivirus),Table S1,Casirivimab,Wild Type (B.1),=,11,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,1000,ng/ml,1,>,90.9,,,Some LOD values of 10000 were reported. Corrected to 1000
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Casirivimab,Wild Type (B.1),=,3,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,664,ng/ml,1,=,221.3,,,
Yamasoba22c,10.1101/2022.07.14.500041,Pseudovirus,Table 1,Casirivimab,Wild Type (B.1),=,3.4,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,2303,ng/ml,1,=,677.4,,,
Huo22b,10.1016/j.celrep.2022.111903,Pseudovirus (lentivirus),Supplementary Table 1B,Casirivimab,Wild Type (B),=,1,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Takashita22d,10.1056/NEJMc2209952,Virus isolate,Table 1,Casirivimab,Wild Type (A),=,2.4,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1153.2,ng/ml,1,=,476.5,,,
Gruell22c,10.1016/S1473-3099(22)00580-1,Pseudovirus,Figure B,Imdevimab,Wild Type (B.1),=,5,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Saito22,10.1016/j.chom.2022.10.003,Pseudovirus (lentivirus),Table 1,Imdevimab,Wild Type (B.1),=,8,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,5000,ng/ml,1,>,625,,,
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Imdevimab,Omicron/BA.2,=,590,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1.7,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22c,10.1016/j.chom.2022.09.018,Pseudovirus (VSV),Figure 5b,Imdevimab,Wild Type (B.1),=,5.7,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Sheward22b,10.1101/2022.07.19.500716,Pseudovirus (lentivirus),Table S1,Imdevimab,Wild Type (B.1),=,7,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,1000,ng/ml,1,>,142.9,,,Some LOD values of 10000 were reported. Corrected to 1000
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Imdevimab,Wild Type (B.1),=,3,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Yamasoba22c,10.1101/2022.07.14.500041,Pseudovirus,Table 1,Imdevimab,Wild Type (B.1),=,8,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,5000,ng/ml,1,>,625,,,
Huo22b,10.1016/j.celrep.2022.111903,Pseudovirus (lentivirus),Supplementary Table 1B,Imdevimab,Wild Type (B),=,2,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Takashita22d,10.1056/NEJMc2209952,Virus isolate,Table 1,Imdevimab,Wild Type (A),=,4.4,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,50000,ng/ml,1,>,1000,,,
Saito22,10.1016/j.chom.2022.10.003,Pseudovirus (lentivirus),Table 1,Casirivimab + Imdevimab,Wild Type (B.1),=,3.9,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,5000,ng/ml,1,>,1000,,,
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Casirivimab + Imdevimab,Omicron/BA.2,=,821,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,410,ng/ml,1,=,0.5,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22c,10.1016/j.chom.2022.09.018,Pseudovirus (VSV),Figure 5b,Casirivimab + Imdevimab,Wild Type (B.1),=,5,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,410,ng/ml,1,=,82,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Casirivimab + Imdevimab,Wild Type (B.1),=,3,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,3504,ng/ml,1,>,1000,,,
Yamasoba22c,10.1101/2022.07.14.500041,Pseudovirus,Table 1,Casirivimab + Imdevimab,Wild Type (B.1),=,3.9,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,5000,ng/ml,1,>,1000,,,
Park22,10.1126/science.adc9127,Pseudovirus (VSV),Fig 1A,Casirivimab + Imdevimab,Wild Type (B),=,5,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,8139,ng/ml,1,>,1000,,,
Takashita22d,10.1056/NEJMc2209952,Virus isolate,Table 1,Casirivimab + Imdevimab,Wild Type (A),=,4.4,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,3623.6,ng/ml,1,=,812.5,,,Combination therapies in this study were specified at ng/ml of each component so needs to multiply by 2
Gruell22c,10.1016/S1473-3099(22)00580-1,Pseudovirus,Figure B,Cilgavimab,Wild Type (B.1),=,5,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,95,ng/ml,1,=,19,,,
Saito22,10.1016/j.chom.2022.10.003,Pseudovirus (lentivirus),Table 1,Cilgavimab,Wild Type (B.1),=,14,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,479,ng/ml,1,=,34.2,,,
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Cilgavimab,Omicron/BA.2,=,6.3,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,352,ng/ml,1,=,55.9,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22c,10.1016/j.chom.2022.09.018,Pseudovirus (VSV),Figure 5b,Cilgavimab,Wild Type (B.1),=,2.5,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,564,ng/ml,1,=,225.6,,,
Sheward22b,10.1101/2022.07.19.500716,Pseudovirus (lentivirus),Table S1,Cilgavimab,Wild Type (B.1),=,6,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,83,ng/ml,1,=,13.8,,,Some LOD values of 10000 were reported. Corrected to 1000
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Cilgavimab,Wild Type (B.1),=,10,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,43,ng/ml,1,=,4.3,,,
Yamasoba22c,10.1101/2022.07.14.500041,Pseudovirus,Table 1,Cilgavimab,Wild Type (B.1),=,14,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,479,ng/ml,1,=,34.2,,,
Huo22b,10.1016/j.celrep.2022.111903,Pseudovirus (lentivirus),Supplementary Table 1B,Cilgavimab,Wild Type (B),=,2,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,21,ng/ml,1,=,10.5,,,
Park22,10.1126/science.adc9127,Pseudovirus (VSV),Fig 1A,Cilgavimab,Wild Type (B),=,6,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,62,ng/ml,1,=,10.3,,,
Takashita22d,10.1056/NEJMc2209952,Virus isolate,Table 1,Cilgavimab,Wild Type (A),=,5.4,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,101.7,ng/ml,1,=,19,,,
Gruell22c,10.1016/S1473-3099(22)00580-1,Pseudovirus,Figure B,Tixagevimab,Wild Type (B.1),=,5,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,17,ng/ml,1,=,3.4,,,
Saito22,10.1016/j.chom.2022.10.003,Pseudovirus (lentivirus),Table 1,Tixagevimab,Wild Type (B.1),=,1.5,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,45,ng/ml,1,=,30,,,
Cao22c,10.1016/j.chom.2022.09.018,Pseudovirus (VSV),Figure 5b,Tixagevimab,Wild Type (B.1),=,1.6,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,225,ng/ml,1,=,140.6,,,
Sheward22b,10.1101/2022.07.19.500716,Pseudovirus (lentivirus),Table S1,Tixagevimab,Wild Type (B.1),=,4,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,119,ng/ml,1,=,29.8,,,Some LOD values of 10000 were reported. Corrected to 1000
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Tixagevimab,Wild Type (B.1),=,3,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,53,ng/ml,1,=,17.7,,,
Yamasoba22c,10.1101/2022.07.14.500041,Pseudovirus,Table 1,Tixagevimab,Wild Type (B.1),=,1.5,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,45,ng/ml,1,=,30,,,
Huo22b,10.1016/j.celrep.2022.111903,Pseudovirus (lentivirus),Supplementary Table 1B,Tixagevimab,Wild Type (B),=,1,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,8,ng/ml,1,=,8,,,
Park22,10.1126/science.adc9127,Pseudovirus (VSV),Fig 1A,Tixagevimab,Wild Type (B),=,2,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,58,ng/ml,1,=,29,,,
Takashita22d,10.1056/NEJMc2209952,Virus isolate,Table 1,Tixagevimab,Wild Type (A),=,1.9,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,122.3,ng/ml,1,=,64,,,
Saito22,10.1016/j.chom.2022.10.003,Pseudovirus (lentivirus),Table 1,Cilgavimab + Tixagevimab,Wild Type (B.1),=,4.7,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,113,ng/ml,1,=,24,,,
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Cilgavimab + Tixagevimab,Omicron/BA.2,=,8.2,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,121,ng/ml,1,=,14.8,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22c,10.1016/j.chom.2022.09.018,Pseudovirus (VSV),Figure 5b,Cilgavimab + Tixagevimab,Wild Type (B.1),=,2.1,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,177,ng/ml,1,=,84.3,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Cilgavimab + Tixagevimab,Wild Type (B.1),=,2,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,49,ng/ml,1,=,24.5,,,
Yamasoba22c,10.1101/2022.07.14.500041,Pseudovirus,Table 1,Cilgavimab + Tixagevimab,Wild Type (B.1),=,4.7,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,113,ng/ml,1,=,24,,,
Huo22b,10.1016/j.celrep.2022.111903,Pseudovirus (lentivirus),Supplementary Table 1B,Cilgavimab + Tixagevimab,Wild Type (B),=,1,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,17,ng/ml,1,=,17,,,
Park22,10.1126/science.adc9127,Pseudovirus (VSV),Fig 1A,Cilgavimab + Tixagevimab,Wild Type (B),=,2,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,52,ng/ml,1,=,26,,,
Takashita22d,10.1056/NEJMc2209952,Virus isolate,Table 1,Cilgavimab + Tixagevimab,Wild Type (A),=,13,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,68.4,ng/ml,1,=,5.3,,,Combination therapies in this study were specified at ng/ml of each component so needs to multiply by 2
Gruell22c,10.1016/S1473-3099(22)00580-1,Pseudovirus,Figure B,Sotrovimab,Wild Type (B.1),=,28,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,655,ng/ml,1,=,23.4,,,
Saito22,10.1016/j.chom.2022.10.003,Pseudovirus (lentivirus),Table 1,Sotrovimab,Wild Type (B.1),=,47,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,240,ng/ml,1,=,5.1,,,
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Sotrovimab,Omicron/BA.2,=,852,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,672,ng/ml,1,=,0.8,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22c,10.1016/j.chom.2022.09.018,Pseudovirus (VSV),Figure 5b,Sotrovimab,Wild Type (B.1),=,74,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,749,ng/ml,1,=,10.1,,,
Sheward22b,10.1101/2022.07.19.500716,Pseudovirus (lentivirus),Table S1,Sotrovimab,Wild Type (B.1),=,78,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,1000,ng/ml,1,>,12.8,,,Some LOD values of 10000 were reported. Corrected to 1000
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Sotrovimab,Wild Type (B.1),=,25,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,467,ng/ml,1,=,18.7,,,
Yamasoba22c,10.1101/2022.07.14.500041,Pseudovirus,Table 1,Sotrovimab,Wild Type (B.1),=,47,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,240,ng/ml,1,=,5.1,,,
Huo22b,10.1016/j.celrep.2022.111903,Pseudovirus (lentivirus),Supplementary Table 1B,Sotrovimab,Wild Type (B),=,79,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,202,ng/ml,1,=,2.6,,,
Park22,10.1126/science.adc9127,Pseudovirus (VSV),Fig 1A,Sotrovimab,Wild Type (B),=,69,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,597,ng/ml,1,=,8.7,,,
Takashita22d,10.1056/NEJMc2209952,Virus isolate,Table 1,Sotrovimab,Wild Type (A),=,32.8,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,28536.5,ng/ml,1,=,870,,,
Gruell22c,10.1016/S1473-3099(22)00580-1,Pseudovirus,Figure B,Bebtelovimab,Wild Type (B.1),=,1,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,7,ng/ml,1,=,7,,,
Saito22,10.1016/j.chom.2022.10.003,Pseudovirus (lentivirus),Table 1,Bebtelovimab,Wild Type (B.1),=,2.4,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,34,ng/ml,1,=,14.2,,,
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Bebtelovimab,Omicron/BA.2,=,0.9,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,2.2,ng/ml,1,=,2.4,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22c,10.1016/j.chom.2022.09.018,Pseudovirus (VSV),Figure 5b,Bebtelovimab,Wild Type (B.1),=,0.7,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,2.2,ng/ml,1,=,3.1,,,
Sheward22b,10.1101/2022.07.19.500716,Pseudovirus (lentivirus),Table S1,Bebtelovimab,Wild Type (B.1),=,2,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,12,ng/ml,1,=,6,,,Some LOD values of 10000 were reported. Corrected to 1000
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Bebtelovimab,Wild Type (B.1),=,2,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,6,ng/ml,1,=,3,,,
Yamasoba22c,10.1101/2022.07.14.500041,Pseudovirus,Table 1,Bebtelovimab,Wild Type (B.1),=,2.4,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,34,ng/ml,1,=,14.2,,,
Huo22b,10.1016/j.celrep.2022.111903,Pseudovirus (lentivirus),Supplementary Table 1B,Bebtelovimab,Wild Type (B),=,1,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,2,ng/ml,1,=,2,,,
Park22,10.1126/science.adc9127,Pseudovirus (VSV),Fig 1A,Bebtelovimab,Wild Type (B),=,3,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,7,ng/ml,1,=,2.3,,,
Takashita22d,10.1056/NEJMc2209952,Virus isolate,Table 1,Bebtelovimab,Wild Type (A),=,1.4,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,6.2,ng/ml,1,=,4.4,,,
Gruell22c,10.1016/S1473-3099(22)00580-1,Pseudovirus,Figure B,Regdanvimab,Wild Type (B.1),=,5,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,40,ng/ml,1,=,8,,,
Saito22,10.1016/j.chom.2022.10.003,Pseudovirus (lentivirus),Table 1,Regdanvimab,Wild Type (B.1),=,1,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,42,ng/ml,1,=,42,,,
Yamasoba22c,10.1101/2022.07.14.500041,Pseudovirus,Table 1,Regdanvimab,Wild Type (B.1),=,1,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,42,ng/ml,1,=,42,,,
Park22,10.1126/science.adc9127,Pseudovirus (VSV),Fig 1A,Regdanvimab,Wild Type (B),=,1.5,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,85,ng/ml,1,=,56.7,,,
Gruell22c,10.1016/S1473-3099(22)00580-1,Pseudovirus,Figure B,Amubarvimab,Wild Type (B.1),=,9,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,4323,ng/ml,1,=,480.3,,,
Cao22c,10.1016/j.chom.2022.09.018,Pseudovirus (VSV),Figure 5b,Amubarvimab,Wild Type (B.1),=,53,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1730,ng/ml,1,=,32.6,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Amubarvimab,Wild Type (B.1),=,15,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1214,ng/ml,1,=,80.9,,,
Cao22c,10.1016/j.chom.2022.09.018,Pseudovirus (VSV),Figure 5b,Romlusevimab,Wild Type (B.1),=,1239,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,6622,ng/ml,1,=,5.3,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Romlusevimab,Wild Type (B.1),=,166,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1016,ng/ml,1,=,6.1,,,
Cao22c,10.1016/j.chom.2022.09.018,Pseudovirus (VSV),Figure 5b,Amubarvimab + Romlusevimab,Wild Type (B.1),=,81,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,5339,ng/ml,1,=,65.9,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Amubarvimab + Romlusevimab,Wild Type (B.1),=,32,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,963,ng/ml,1,=,30.1,,,
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,DXP-604,Omicron/BA.2,=,219,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,5920,ng/ml,1,>,27,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22c,10.1016/j.chom.2022.09.018,Pseudovirus (VSV),Figure 5b,DXP-604,Wild Type (B.1),=,11,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,5920,ng/ml,1,=,538.2,,,
Hoffmann21c,10.1016/j.celrep.2021.109415,Pseudovirus (VSV),Figure 4,Bamlanivimab,Wild Type (B.1),=,4.5,ng/ml,1,Kappa,21,R21T + E154K + Q218H + L452R + E484Q + P681R + H1101D,1,>,10000,ng/ml,1,>,1000,,,
Liu21f,10.1016/j.cell.2021.06.020,Pseudovirus (lentivirus),Table S1,Bamlanivimab,Wild Type (B),=,4,ng/ml,1,Kappa,95,T95I + G142D + E154K + L452R + E484Q + P681R + Q1071H,1,>,10000,ng/ml,1,>,1000,,,
Nabel21,10.1126/science.abl6251,Pseudovirus (lentivirus),"Fig 2A, 2B",Bamlanivimab,Wild Type (B.1),=,22,ng/ml,1,Kappa,95,T95I + G142D + E154K + L452R + E484Q + P681R + Q1071H,1,>,100000,ng/ml,1,>,1000,,,
Wang21e,10.1126/science.abh1766,Pseudovirus (lentivirus),Fig 2C,Bamlanivimab,Wild Type (A),=,7.1,ng/ml,1,Kappa,95,T95I + G142D + E154K + L452R + E484Q + P681R + Q1071H,1,>,10000,ng/ml,1,>,1000,,,
Yao21,10.1101/2021.01.27.428353,Pseudovirus (MLV),Figure 5,Bamlanivimab,Wild Type (B),=,6.8,ng/ml,1,Kappa,95,T95I + G142D + E154K + L452R + E484Q + Q1071H,1,>,4000,ng/ml,1,>,588.2,,,
FDA21,https://www.fda.gov/drugs/drug-safety-and-availability/fda-authorizes-revisions-fact-sheets-address-sars-cov-2-variants-monoclonal-antibody-products-under,Pseudovirus (VSV),BAM+ETE page 28,Bamlanivimab,Wild Type (B),,,,,Kappa,142,G142D + E154K + L452R + E484Q + P681R + Q1071H + H1101D,1,,,,,>,1000,,,
Chen21e,10.1038/s41586-021-03720-y,SARS-CoV-2 recombinant,Figure 1c,Bamlanivimab,Wild Type (B.1),=,5,ng/ml,1,Kappa,142,G142D + E154K + L452R + E484Q + P681R + Q1071H + H1101D,1,>,10000,ng/ml,1,>,1000,,,
Hoffmann21c,10.1016/j.celrep.2021.109415,Pseudovirus (VSV),Figure 4,Etesevimab,Wild Type (B.1),=,14.3,ng/ml,1,Kappa,21,R21T + E154K + Q218H + L452R + E484Q + P681R + H1101D,1,=,11.9,ng/ml,1,=,0.8,,,
Liu21f,10.1016/j.cell.2021.06.020,Pseudovirus (lentivirus),Table S1,Etesevimab,Wild Type (B),=,26,ng/ml,1,Kappa,95,T95I + G142D + E154K + L452R + E484Q + P681R + Q1071H,1,=,10,ng/ml,1,=,0.4,,,
Nabel21,10.1126/science.abl6251,Pseudovirus (lentivirus),"Fig 2A, 2B",Etesevimab,Wild Type (B.1),=,27,ng/ml,1,Kappa,95,T95I + G142D + E154K + L452R + E484Q + P681R + Q1071H,1,=,60,ng/ml,1,=,2.2,,,
Wang21e,10.1126/science.abh1766,Pseudovirus (lentivirus),Fig 2C,Etesevimab,Wild Type (A),=,26.2,ng/ml,1,Kappa,95,T95I + G142D + E154K + L452R + E484Q + P681R + Q1071H,1,=,36.5,ng/ml,1,=,1.4,,,
Yao21,10.1101/2021.01.27.428353,Pseudovirus (MLV),Figure 5,Etesevimab,Wild Type (B),=,80.5,ng/ml,1,Kappa,95,T95I + G142D + E154K + L452R + E484Q + Q1071H,1,=,76.9,ng/ml,1,=,1,,,
Chen21e,10.1038/s41586-021-03720-y,SARS-CoV-2 recombinant,Extended Data Fig 13,Etesevimab,Wild Type (B.1),=,52,ng/ml,1,Kappa,142,G142D + E154K + L452R + E484Q + P681R + Q1071H + H1101D,1,=,20,ng/ml,1,=,0.4,,,
Hoffmann21c,10.1016/j.celrep.2021.109415,Pseudovirus (VSV),Figure 4,Bamlanivimab + Etesevimab,Wild Type (B.1),=,6.4,ng/ml,1,Kappa,21,R21T + E154K + Q218H + L452R + E484Q + P681R + H1101D,1,=,32.1,ng/ml,1,=,5,,,
FDA21,https://www.fda.gov/drugs/drug-safety-and-availability/fda-authorizes-revisions-fact-sheets-address-sars-cov-2-variants-monoclonal-antibody-products-under,Pseudovirus (VSV),BAM+ETE Table 3 page 27,Bamlanivimab + Etesevimab,Wild Type (B),,,,,Kappa,142,G142D + E154K + L452R + E484Q + P681R + Q1071H + H1101D,1,,,,,=,6,,,
Chen21e,10.1038/s41586-021-03720-y,SARS-CoV-2 recombinant,Extended Data Fig 13,Bamlanivimab + Etesevimab,Wild Type (B.1),=,9,ng/ml,1,Kappa,142,G142D + E154K + L452R + E484Q + P681R + Q1071H + H1101D,1,=,65,ng/ml,1,=,7.2,,,
Hoffmann21c,10.1016/j.celrep.2021.109415,Pseudovirus (VSV),Figure 4,Casirivimab,Wild Type (B.1),=,2.9,ng/ml,1,Kappa,21,R21T + E154K + Q218H + L452R + E484Q + P681R + H1101D,1,=,11.9,ng/ml,1,=,4.1,,,
Tada21c,10.1016/j.isci.2021.103341,Pseudovirus (HIV),Table 1,Casirivimab,Wild Type (B.1),=,3.2,ng/ml,1,Kappa,95,T95I + G142D + E154K + L452R + E484Q + P681R + Q1071H,1,=,78.8,ng/ml,1,=,24.6,,,
FDA21,https://www.fda.gov/drugs/drug-safety-and-availability/fda-authorizes-revisions-fact-sheets-address-sars-cov-2-variants-monoclonal-antibody-products-under,Virus isolate,CAS+IMD Table 10 page 42,Casirivimab,Wild Type (B),,,,,Kappa,95,T95I + G142D + E154K + L452R + E484Q + P681R + Q1071H,1,,,,,=,6,,,
Liu21f,10.1016/j.cell.2021.06.020,Pseudovirus (lentivirus),Table S1,Casirivimab,Wild Type (B),=,2,ng/ml,1,Kappa,95,T95I + G142D + E154K + L452R + E484Q + P681R + Q1071H,1,=,10,ng/ml,1,=,5,,,
Nabel21,10.1126/science.abl6251,Pseudovirus (lentivirus),"Fig 2A, 2B",Casirivimab,Wild Type (B.1),=,25,ng/ml,1,Kappa,95,T95I + G142D + E154K + L452R + E484Q + P681R + Q1071H,1,=,98,ng/ml,1,=,3.9,,,
Wang21e,10.1126/science.abh1766,Pseudovirus (lentivirus),Fig 2C,Casirivimab,Wild Type (A),=,7.7,ng/ml,1,Kappa,95,T95I + G142D + E154K + L452R + E484Q + P681R + Q1071H,1,=,97.1,ng/ml,1,=,12.6,,,
Yao21,10.1101/2021.01.27.428353,Pseudovirus (MLV),Figure 5,Casirivimab,Wild Type (B),=,6.8,ng/ml,1,Kappa,95,T95I + G142D + E154K + L452R + E484Q + Q1071H,1,=,95.7,ng/ml,1,=,14.1,,,
Chen21e,10.1038/s41586-021-03720-y,SARS-CoV-2 recombinant,Figure 1c,Casirivimab,Wild Type (B.1),=,7,ng/ml,1,Kappa,142,G142D + E154K + L452R + E484Q + P681R + Q1071H + H1101D,1,=,133,ng/ml,1,=,19,,,
Hoffmann21c,10.1016/j.celrep.2021.109415,Pseudovirus (VSV),Figure 4,Imdevimab,Wild Type (B.1),=,0.9,ng/ml,1,Kappa,21,R21T + E154K + Q218H + L452R + E484Q + P681R + H1101D,1,=,0.9,ng/ml,1,=,1,,,
Tada21c,10.1016/j.isci.2021.103341,Pseudovirus (HIV),Table 1,Imdevimab,Wild Type (B.1),=,50.3,ng/ml,1,Kappa,95,T95I + G142D + E154K + L452R + E484Q + P681R + Q1071H,1,=,151.7,ng/ml,1,=,3,,,
Liu21f,10.1016/j.cell.2021.06.020,Pseudovirus (lentivirus),Table S1,Imdevimab,Wild Type (B),=,14,ng/ml,1,Kappa,95,T95I + G142D + E154K + L452R + E484Q + P681R + Q1071H,1,=,21,ng/ml,1,=,1.5,,,
Nabel21,10.1126/science.abl6251,Pseudovirus (lentivirus),"Fig 2A, 2B",Imdevimab,Wild Type (B.1),=,32,ng/ml,1,Kappa,95,T95I + G142D + E154K + L452R + E484Q + P681R + Q1071H,1,=,1000,ng/ml,1,=,31.3,,,
Wang21e,10.1126/science.abh1766,Pseudovirus (lentivirus),Fig 2C,Imdevimab,Wild Type (A),=,71,ng/ml,1,Kappa,95,T95I + G142D + E154K + L452R + E484Q + P681R + Q1071H,1,=,65.7,ng/ml,1,=,0.9,,,
Yao21,10.1101/2021.01.27.428353,Pseudovirus (MLV),Figure 5,Imdevimab,Wild Type (B),=,6.8,ng/ml,1,Kappa,95,T95I + G142D + E154K + L452R + E484Q + Q1071H,1,=,14.2,ng/ml,1,=,2.1,,,
Chen21e,10.1038/s41586-021-03720-y,SARS-CoV-2 recombinant,Figure 1c,Imdevimab,Wild Type (B.1),=,12,ng/ml,1,Kappa,142,G142D + E154K + L452R + E484Q + P681R + Q1071H + H1101D,1,=,93,ng/ml,1,=,7.8,,,
Hoffmann21c,10.1016/j.celrep.2021.109415,Pseudovirus (VSV),Figure 4,Casirivimab + Imdevimab,Wild Type (B.1),=,2.2,ng/ml,1,Kappa,21,R21T + E154K + Q218H + L452R + E484Q + P681R + H1101D,1,=,2.2,ng/ml,1,=,1,,,
Tada21c,10.1016/j.isci.2021.103341,Pseudovirus (HIV),Table 1,Casirivimab + Imdevimab,Wild Type (B.1),=,8.1,ng/ml,1,Kappa,95,T95I + G142D + E154K + L452R + E484Q + P681R + Q1071H,1,=,55.3,ng/ml,1,=,6.8,,,
FDA21,https://www.fda.gov/drugs/drug-safety-and-availability/fda-authorizes-revisions-fact-sheets-address-sars-cov-2-variants-monoclonal-antibody-products-under,Virus isolate,CAS+IMD Table 10 page 42,Casirivimab + Imdevimab,Wild Type (B),,,,,Kappa,95,T95I + G142D + E154K + L452R + E484Q + P681R + Q1071H,1,,,,,=,1,,,
FDA21,https://www.fda.gov/drugs/drug-safety-and-availability/fda-authorizes-revisions-fact-sheets-address-sars-cov-2-variants-monoclonal-antibody-products-under,Pseudovirus (VSV),CAS+IMD Table 9,Casirivimab + Imdevimab,Wild Type (B),,,,,Kappa,142,G142D + E154K + L452R + E484Q + P681R + Q1071H + H1101D,1,,,,,=,1,,,
Chen21e,10.1038/s41586-021-03720-y,SARS-CoV-2 recombinant,Figure 1c,Casirivimab + Imdevimab,Wild Type (B.1),=,5,ng/ml,1,Kappa,142,G142D + E154K + L452R + E484Q + P681R + Q1071H + H1101D,1,=,4,ng/ml,1,=,0.8,,,
Liu21f,10.1016/j.cell.2021.06.020,Pseudovirus (lentivirus),Table S1,Cilgavimab,Wild Type (B),=,7,ng/ml,1,Kappa,95,T95I + G142D + E154K + L452R + E484Q + P681R + Q1071H,1,=,33,ng/ml,1,=,4.7,,,
Dong21,10.1038/s41564-021-00972-2,SARS-CoV-2 recombinant,Figure 4i,Cilgavimab,Wild Type (B.1),=,28,ng/ml,1,Kappa,142,G142D + E154K + V382L + L452R + E484Q + P681R + Q1071H + D1153Y,1,=,14,ng/ml,1,=,0.5,,,
Chen21e,10.1038/s41586-021-03720-y,SARS-CoV-2 recombinant,Figure 1c,Cilgavimab,Wild Type (B.1),=,26,ng/ml,1,Kappa,142,G142D + E154K + L452R + E484Q + P681R + Q1071H + H1101D,1,=,62,ng/ml,1,=,2.4,,,
Liu21f,10.1016/j.cell.2021.06.020,Pseudovirus (lentivirus),Table S1,Tixagevimab,Wild Type (B),=,3,ng/ml,1,Kappa,95,T95I + G142D + E154K + L452R + E484Q + P681R + Q1071H,1,=,2,ng/ml,1,=,0.7,,,
Dong21,10.1038/s41564-021-00972-2,SARS-CoV-2 recombinant,Figure 4i,Tixagevimab,Wild Type (B.1),=,4,ng/ml,1,Kappa,142,G142D + E154K + V382L + L452R + E484Q + P681R + Q1071H + D1153Y,1,=,2,ng/ml,1,=,0.5,,,
Chen21e,10.1038/s41586-021-03720-y,SARS-CoV-2 recombinant,Figure 1c,Tixagevimab,Wild Type (B.1),=,4,ng/ml,1,Kappa,142,G142D + E154K + L452R + E484Q + P681R + Q1071H + H1101D,1,=,5,ng/ml,1,=,1.3,,,
EMA21e,https://www.ema.europa.eu/en/documents/product-information/evusheld-epar-product-information_en.pdf,Virus isolate,Table 3,Cilgavimab + Tixagevimab,Wild Type (B),=,8,ng/ml,1,Kappa,95,T95I + G142D + E154K + L452R + E484Q + P681R + Q1071H,1,=,2,ng/ml,1,=,0.3,,,
FDA21c,https://www.fda.gov/media/154701/download,Virus isolate,"Feb 2022, Table 6",Cilgavimab + Tixagevimab,Wild Type (B),,,,,Kappa,95,T95I + G142D + E154K + L452R + E484Q + P681R + Q1071H,1,,,,,=,1,,,
Liu21f,10.1016/j.cell.2021.06.020,Pseudovirus (lentivirus),Table S1,Cilgavimab + Tixagevimab,Wild Type (B),=,2,ng/ml,1,Kappa,95,T95I + G142D + E154K + L452R + E484Q + P681R + Q1071H,1,=,4,ng/ml,1,=,2,,,
Dong21,10.1038/s41564-021-00972-2,SARS-CoV-2 recombinant,Figure 4i,Cilgavimab + Tixagevimab,Wild Type (B.1),=,4,ng/ml,1,Kappa,142,G142D + E154K + V382L + L452R + E484Q + P681R + Q1071H + D1153Y,1,=,2,ng/ml,1,=,0.5,,,
EMA21e,https://www.ema.europa.eu/en/documents/product-information/evusheld-epar-product-information_en.pdf,Pseudovirus,Table 3,Cilgavimab + Tixagevimab,Wild Type (B),=,1.9,ng/ml,1,Kappa,142,G142D + E154K + L452R + E484Q + P681R + Q1071H + H1101D,1,=,2.5,ng/ml,1,=,1.3,,,
FDA21c,https://www.fda.gov/media/154701/download,Pseudovirus,"Feb 2022, Table 6, Page 17, Antiviral resistance paragraph 6",Cilgavimab + Tixagevimab,Wild Type (B),,,,,Kappa,142,G142D + E154K + L452R + E484Q + P681R + Q1071H + H1101D,1,,,,,=,2,,,
Chen21e,10.1038/s41586-021-03720-y,SARS-CoV-2 recombinant,Figure 1c,Cilgavimab + Tixagevimab,Wild Type (B.1),=,4,ng/ml,1,Kappa,142,G142D + E154K + L452R + E484Q + P681R + Q1071H + H1101D,1,=,5,ng/ml,1,=,1.3,,,
Cathcart21,10.1101/2021.03.09.434607,Virus isolate,Table 1,Sotrovimab,Wild Type (A),,,,,Kappa,95,T95I + G142D + E154K + L452R + E484Q + P681R + Q1071H,1,,,,,=,0.9,,,
Cathcart21,10.1101/2021.03.09.434607,Pseudovirus (VSV),Table 2,Sotrovimab,Wild Type (B),,,,,Kappa,95,T95I + G142D + E154K + L452R + E484Q + P681R + Q1071H,1,,,,,=,0.7,,,
FDA21e,https://www.fda.gov/media/149534/download,Pseudovirus,"SOT Page 22, Table 1",Sotrovimab,Wild Type (B),,,,,Kappa,95,T95I + G142D + E154K + L452R + E484Q + P681R + Q1071H,1,,,,,=,0.7,,,
Liu22,10.1126/scitranslmed.abn6859,Pseudovirus (VSV),Fig2A,Sotrovimab,Wild Type (B.1),=,11,ng/ml,1,Kappa,142,G142D + E154K + L452R + E484Q + P681R + Q1071H + H1101D,1,=,27,ng/ml,1,=,2.5,,,
EMA21d,https://www.ema.europa.eu/en/documents/product-information/xevudy-epar-product-information_en.pdf,Pseudovirus,Table 2,Sotrovimab,Wild Type (B),,,,,Kappa,142,G142D + E154K + L452R + E484Q + P681R + Q1071H + H1101D,1,,,,,=,1,,,
Chen21e,10.1038/s41586-021-03720-y,SARS-CoV-2 recombinant,Figure 1c,Sotrovimab,Wild Type (B.1),=,156,ng/ml,1,Kappa,142,G142D + E154K + L452R + E484Q + P681R + Q1071H + H1101D,1,=,110,ng/ml,1,=,0.7,,,
Westendorf22,10.1016/j.celrep.2022.110812,Pseudovirus (VSV),Table 3B,Bebtelovimab,Wild Type (A),=,3,ng/ml,1,Kappa,142,G142D + E154K + L452R + E484Q + P681R + Q1071H + H1101D,1,=,2,ng/ml,1,=,0.7,,,
FDA22,https://www.fda.gov/media/156152/download,Pseudovirus,"Mar 2022, Page 13, antiviral resistance, Table 2",Bebtelovimab,Wild Type (B),,,,,Kappa,142,G142D + E154K + L452R + E484Q + P681R + Q1071H + H1101D,1,,,,,=,1,,,
EMA21c,https://www.ema.europa.eu/en/documents/product-information/regkirona-epar-product-information_en.pdf,Virus isolate,Table 3,Regdanvimab,Wild Type (B),,,,,Kappa,95,T95I + G142D + E154K + L452R + E484Q + P681R + Q1071H,1,,,,,=,23.9,,,
EMA21c,https://www.ema.europa.eu/en/documents/product-information/regkirona-epar-product-information_en.pdf,Pseudovirus,Table 3,Regdanvimab,Wild Type (B),,,,,Kappa,142,G142D + E154K + L452R + E484Q + P681R + Q1071H + H1101D,1,,,,,=,44.1,,,
Ryu21b,10.1016/j.bbrc.2021.09.023,Virus isolate,"Table 2, preprint 10.1101/2021.07.23.453472",Regdanvimab,Wild Type (B),=,6.8,ng/ml,1,Kappa,142,G142D + E154K + L452R + E484Q + P681R + Q1071H + H1101D,1,=,161.5,ng/ml,1,=,23.9,,,
Margolis21,https://idweek.org/Margolis,Pseudovirus,Table 2,Amubarvimab + Romlusevimab,Wild Type (B.1),,,,,Kappa,142,G142D + E154K + L452R + E484Q + P681R + Q1071H + H1101D,1,,,,,=,2.5,,,
Chen21e,10.1038/s41586-021-03720-y,SARS-CoV-2 recombinant,Figure 1c,S2E12 + Sotrovimab,Wild Type (B.1),=,7,ng/ml,1,Kappa,142,G142D + E154K + L452R + E484Q + P681R + Q1071H + H1101D,1,=,6,ng/ml,1,=,0.9,,,
Chen21e,10.1038/s41586-021-03720-y,SARS-CoV-2 recombinant,Figure 1c,Bamlanivimab,Wild Type (B.1),=,5,ng/ml,1,Iota/E484K,5,L5F + T95I + D253G + E484K + A701V,1,>,10000,ng/ml,1,>,1000,,,
FDA21,https://www.fda.gov/drugs/drug-safety-and-availability/fda-authorizes-revisions-fact-sheets-address-sars-cov-2-variants-monoclonal-antibody-products-under,Pseudovirus (VSV),BAM Table 3,Bamlanivimab,Wild Type (B),,,,,Iota/E484K,5,L5F + T95I + D253G + E484K + A701V,1,,,,,>,1000,,,
Annavajhala21b,10.1038/s41586-021-03908-2,Virus isolate,Figure 3a,Bamlanivimab,Wild Type (A),=,4.1,ng/ml,1,Iota/E484K,5,L5F + T95I + D253G + E484K + A701V,1,>,20383.3,ng/ml,1,>,1000,,,
Annavajhala21b,10.1038/s41586-021-03908-2,Pseudovirus (VSV),Figure 3a,Bamlanivimab,Wild Type (B.1),=,1.4,ng/ml,1,Iota/E484K,5,L5F + T95I + D253G + E484K + A701V,1,>,21374.5,ng/ml,1,>,1000,,,
Nabel21,10.1126/science.abl6251,Pseudovirus (lentivirus),"Fig 2A, 2B",Bamlanivimab,Wild Type (B.1),=,22,ng/ml,1,Iota/E484K,5,L5F + T95I + D253G + E484K + A701V,1,>,100000,ng/ml,1,>,1000,,,
Wang21e,10.1126/science.abh1766,Pseudovirus (lentivirus),Fig 2C,Bamlanivimab,Wild Type (A),=,7.1,ng/ml,1,Iota/E484K,5,L5F + T95I + D253G + E484K + A701V,1,>,10000,ng/ml,1,>,1000,,,
FDA21,https://www.fda.gov/drugs/drug-safety-and-availability/fda-authorizes-revisions-fact-sheets-address-sars-cov-2-variants-monoclonal-antibody-products-under,SARS-CoV-2 recombinant,BAM+ETE page 29,Bamlanivimab,Wild Type (B),,,,,Iota/E484K,5,L5F + T95I + D253G + E484K + A701V,1,,,,,>,1000,,,
Chen21e,10.1038/s41586-021-03720-y,SARS-CoV-2 recombinant,Extended Data Fig 13,Etesevimab,Wild Type (B.1),=,52,ng/ml,1,Iota/E484K,5,L5F + T95I + D253G + E484K + A701V,1,=,99,ng/ml,1,=,1.9,,,
Annavajhala21b,10.1038/s41586-021-03908-2,Virus isolate,Figure 3a,Etesevimab,Wild Type (A),=,80.8,ng/ml,1,Iota/E484K,5,L5F + T95I + D253G + E484K + A701V,1,=,123.8,ng/ml,1,=,1.5,,,
Annavajhala21b,10.1038/s41586-021-03908-2,Pseudovirus (VSV),Figure 3a,Etesevimab,Wild Type (B.1),=,7.7,ng/ml,1,Iota/E484K,5,L5F + T95I + D253G + E484K + A701V,1,=,10.9,ng/ml,1,=,1.4,,,
Nabel21,10.1126/science.abl6251,Pseudovirus (lentivirus),"Fig 2A, 2B",Etesevimab,Wild Type (B.1),=,27,ng/ml,1,Iota/E484K,5,L5F + T95I + D253G + E484K + A701V,1,=,52,ng/ml,1,=,1.9,,,
Wang21e,10.1126/science.abh1766,Pseudovirus (lentivirus),Fig 2C,Etesevimab,Wild Type (A),=,26.2,ng/ml,1,Iota/E484K,5,L5F + T95I + D253G + E484K + A701V,1,=,35.3,ng/ml,1,=,1.3,,,
FDA21,https://www.fda.gov/drugs/drug-safety-and-availability/fda-authorizes-revisions-fact-sheets-address-sars-cov-2-variants-monoclonal-antibody-products-under,SARS-CoV-2 recombinant,BAM+ETE page 29,Etesevimab,Wild Type (B),,,,,Iota/E484K,5,L5F + T95I + D253G + E484K + A701V,1,,,,,=,1,,,
Zhang21c,10.1038/s42003-021-02728-4,Pseudovirus (VSV),Supplementary Figure 3,Etesevimab,Wild Type (B.1),,,,,Iota/E484K,5,L5F + T95I + D253G + E484K + A701V,1,,,,,=,2.9,,,
Chen21e,10.1038/s41586-021-03720-y,SARS-CoV-2 recombinant,Extended Data Fig 13,Bamlanivimab + Etesevimab,Wild Type (B.1),=,9,ng/ml,1,Iota/E484K,5,L5F + T95I + D253G + E484K + A701V,1,=,261,ng/ml,1,=,29,,,
FDA21,https://www.fda.gov/drugs/drug-safety-and-availability/fda-authorizes-revisions-fact-sheets-address-sars-cov-2-variants-monoclonal-antibody-products-under,Pseudovirus (VSV),BAM+ETE Table 3,Bamlanivimab + Etesevimab,Wild Type (B),,,,,Iota/E484K,5,L5F + T95I + D253G + E484K + A701V,1,,,,,=,30,,,
FDA21,https://www.fda.gov/drugs/drug-safety-and-availability/fda-authorizes-revisions-fact-sheets-address-sars-cov-2-variants-monoclonal-antibody-products-under,SARS-CoV-2 recombinant,BAM+ETE Table 4 page 29,Bamlanivimab + Etesevimab,Wild Type (B),,,,,Iota/E484K,5,L5F + T95I + D253G + E484K + A701V,1,,,,,=,11,,,
Chen21e,10.1038/s41586-021-03720-y,SARS-CoV-2 recombinant,Figure 1c,Casirivimab,Wild Type (B.1),=,7,ng/ml,1,Iota/E484K,5,L5F + T95I + D253G + E484K + A701V,1,=,82,ng/ml,1,=,11.7,,,
Pelzek22,10.1101/2022.02.06.479332,Pseudovirus (lentivirus),Extended Table 1,Casirivimab,Wild Type (B),=,24,ng/ml,1,Iota/E484K,5,L5F + T95I + D253G + E484K + A701V,1,=,116,ng/ml,1,=,4.8,,,
Annavajhala21b,10.1038/s41586-021-03908-2,Virus isolate,Figure 3a,Casirivimab,Wild Type (A),=,2.1,ng/ml,1,Iota/E484K,5,L5F + T95I + D253G + E484K + A701V,1,=,71.7,ng/ml,1,=,34.3,,,
Annavajhala21b,10.1038/s41586-021-03908-2,Pseudovirus (VSV),Figure 3a,Casirivimab,Wild Type (B.1),=,1.8,ng/ml,1,Iota/E484K,5,L5F + T95I + D253G + E484K + A701V,1,=,17.3,ng/ml,1,=,9.4,,,
Nabel21,10.1126/science.abl6251,Pseudovirus (lentivirus),"Fig 2A, 2B",Casirivimab,Wild Type (B.1),=,25,ng/ml,1,Iota/E484K,5,L5F + T95I + D253G + E484K + A701V,1,=,63,ng/ml,1,=,2.5,,,
Zhou21c,10.1128/mBio.01386-21,Pseudovirus (HIV),Table 1,Casirivimab,Wild Type (B.1),=,5.7,ng/ml,1,Iota/E484K,5,L5F + T95I + D253G + E484K + A701V,1,=,69.4,ng/ml,1,=,12.2,,,
Wang21e,10.1126/science.abh1766,Pseudovirus (lentivirus),Fig 2C,Casirivimab,Wild Type (A),=,7.7,ng/ml,1,Iota/E484K,5,L5F + T95I + D253G + E484K + A701V,1,=,71.3,ng/ml,1,=,9.3,,,
Chen21e,10.1038/s41586-021-03720-y,SARS-CoV-2 recombinant,Figure 1c,Imdevimab,Wild Type (B.1),=,12,ng/ml,1,Iota/E484K,5,L5F + T95I + D253G + E484K + A701V,1,=,104,ng/ml,1,=,8.7,,,
Pelzek22,10.1101/2022.02.06.479332,Pseudovirus (lentivirus),Extended Table 1,Imdevimab,Wild Type (B),=,23,ng/ml,1,Iota/E484K,5,L5F + T95I + D253G + E484K + A701V,1,=,18,ng/ml,1,=,0.8,,,
Annavajhala21b,10.1038/s41586-021-03908-2,Virus isolate,Figure 3a,Imdevimab,Wild Type (A),=,1.9,ng/ml,1,Iota/E484K,5,L5F + T95I + D253G + E484K + A701V,1,=,4.7,ng/ml,1,=,2.5,,,
Annavajhala21b,10.1038/s41586-021-03908-2,Pseudovirus (VSV),Figure 3a,Imdevimab,Wild Type (B.1),=,2,ng/ml,1,Iota/E484K,5,L5F + T95I + D253G + E484K + A701V,1,=,2.4,ng/ml,1,=,1.2,,,
Nabel21,10.1126/science.abl6251,Pseudovirus (lentivirus),"Fig 2A, 2B",Imdevimab,Wild Type (B.1),=,32,ng/ml,1,Iota/E484K,5,L5F + T95I + D253G + E484K + A701V,1,=,88,ng/ml,1,=,2.8,,,
Zhou21c,10.1128/mBio.01386-21,Pseudovirus (HIV),Table 1,Imdevimab,Wild Type (B.1),=,18.1,ng/ml,1,Iota/E484K,5,L5F + T95I + D253G + E484K + A701V,1,=,20.6,ng/ml,1,=,1.1,,,
Wang21e,10.1126/science.abh1766,Pseudovirus (lentivirus),Fig 2C,Imdevimab,Wild Type (A),=,71,ng/ml,1,Iota/E484K,5,L5F + T95I + D253G + E484K + A701V,1,=,27.5,ng/ml,1,=,0.4,,,
Chen21e,10.1038/s41586-021-03720-y,SARS-CoV-2 recombinant,Figure 1c,Casirivimab + Imdevimab,Wild Type (B.1),=,5,ng/ml,1,Iota/E484K,5,L5F + T95I + D253G + E484K + A701V,1,=,5,ng/ml,1,=,1,,,
FDA21,https://www.fda.gov/drugs/drug-safety-and-availability/fda-authorizes-revisions-fact-sheets-address-sars-cov-2-variants-monoclonal-antibody-products-under,Pseudovirus (VSV),CAS+IMD Table 9,Casirivimab + Imdevimab,Wild Type (B),,,,,Iota/E484K,5,L5F + T95I + D253G + E484K + A701V,1,,,,,=,1,,,
Zhou21c,10.1128/mBio.01386-21,Pseudovirus (HIV),Table 1,Casirivimab + Imdevimab,Wild Type (B.1),=,4.7,ng/ml,1,Iota/E484K,5,L5F + T95I + D253G + E484K + A701V,1,=,6.2,ng/ml,1,=,1.3,,,
Chen21e,10.1038/s41586-021-03720-y,SARS-CoV-2 recombinant,Figure 1c,Cilgavimab,Wild Type (B.1),=,26,ng/ml,1,Iota/E484K,5,L5F + T95I + D253G + E484K + A701V,1,=,13,ng/ml,1,=,0.5,,,
House22,10.1371/journal.pone.0267796,Pseudovirus,Fig 1A,Cilgavimab,Wild Type (B.1),,,,,Iota/E484K,5,L5F + T95I + D253G + E484K + A701V,1,,,,,=,0.9,,,
Annavajhala21b,10.1038/s41586-021-03908-2,Virus isolate,Figure 3a,Cilgavimab,Wild Type (A),=,5.7,ng/ml,1,Iota/E484K,5,L5F + T95I + D253G + E484K + A701V,1,=,5.7,ng/ml,1,=,1,,,
Annavajhala21b,10.1038/s41586-021-03908-2,Pseudovirus (VSV),Figure 3a,Cilgavimab,Wild Type (B.1),=,2.6,ng/ml,1,Iota/E484K,5,L5F + T95I + D253G + E484K + A701V,1,=,2,ng/ml,1,=,0.8,,,
Chen21e,10.1038/s41586-021-03720-y,SARS-CoV-2 recombinant,Figure 1c,Tixagevimab,Wild Type (B.1),=,4,ng/ml,1,Iota/E484K,5,L5F + T95I + D253G + E484K + A701V,1,=,10,ng/ml,1,=,2.5,,,
Annavajhala21b,10.1038/s41586-021-03908-2,Virus isolate,Figure 3a,Tixagevimab,Wild Type (A),=,3,ng/ml,1,Iota/E484K,5,L5F + T95I + D253G + E484K + A701V,1,=,39.6,ng/ml,1,=,13.3,,,
Annavajhala21b,10.1038/s41586-021-03908-2,Pseudovirus (VSV),Figure 3a,Tixagevimab,Wild Type (B.1),=,1.3,ng/ml,1,Iota/E484K,5,L5F + T95I + D253G + E484K + A701V,1,=,4,ng/ml,1,=,3.2,,,
EMA21e,https://www.ema.europa.eu/en/documents/product-information/evusheld-epar-product-information_en.pdf,Virus isolate,Table 3,Cilgavimab + Tixagevimab,Wild Type (B),=,8,ng/ml,1,Iota/E484K,5,L5F + T95I + D253G + E484K + A701V,1,=,1,ng/ml,1,=,0.1,,,
FDA21c,https://www.fda.gov/media/154701/download,Virus isolate,"Feb 2022, Table 6",Cilgavimab + Tixagevimab,Wild Type (B),,,,,Iota/E484K,5,L5F + T95I + D253G + E484K + A701V,1,,,,,=,1,,,
Chen21e,10.1038/s41586-021-03720-y,SARS-CoV-2 recombinant,Figure 1c,Cilgavimab + Tixagevimab,Wild Type (B.1),=,4,ng/ml,1,Iota/E484K,5,L5F + T95I + D253G + E484K + A701V,1,=,7,ng/ml,1,=,1.8,,,
EMA21e,https://www.ema.europa.eu/en/documents/product-information/evusheld-epar-product-information_en.pdf,Pseudovirus,Table 3,Cilgavimab + Tixagevimab,Wild Type (B),=,1.9,ng/ml,1,Iota/E484K,5,L5F + T95I + D253G + E484K + A701V,1,=,1.8,ng/ml,1,=,0.9,,,
FDA21c,https://www.fda.gov/media/154701/download,Pseudovirus,"Feb 2022, Table 6, Page 17, Antiviral resistance paragraph 6",Cilgavimab + Tixagevimab,Wild Type (B),,,,,Iota/E484K,5,L5F + T95I + D253G + E484K + A701V,1,,,,,=,1.9,,,
Chen21e,10.1038/s41586-021-03720-y,SARS-CoV-2 recombinant,Figure 1c,Sotrovimab,Wild Type (B.1),=,156,ng/ml,1,Iota/E484K,5,L5F + T95I + D253G + E484K + A701V,1,=,40,ng/ml,1,=,0.3,,,
Liu22,10.1126/scitranslmed.abn6859,Pseudovirus (VSV),Fig2A,Sotrovimab,Wild Type (B.1),=,11,ng/ml,1,Iota/E484K,5,L5F + T95I + D253G + E484K + A701V,1,=,22,ng/ml,1,=,2,,,
EMA21d,https://www.ema.europa.eu/en/documents/product-information/xevudy-epar-product-information_en.pdf,Pseudovirus,Table 2,Sotrovimab,Wild Type (B),,,,,Iota/E484K,5,L5F + T95I + D253G + E484K + A701V,1,,,,,=,1,,,
Annavajhala21b,10.1038/s41586-021-03908-2,Virus isolate,Figure 3a,Sotrovimab,Wild Type (A),=,14.3,ng/ml,1,Iota/E484K,5,L5F + T95I + D253G + E484K + A701V,1,=,14.3,ng/ml,1,=,1,,,
Annavajhala21b,10.1038/s41586-021-03908-2,Pseudovirus (VSV),Figure 3a,Sotrovimab,Wild Type (B.1),=,18.1,ng/ml,1,Iota/E484K,5,L5F + T95I + D253G + E484K + A701V,1,=,16.1,ng/ml,1,=,0.9,,,
Cathcart21,10.1101/2021.03.09.434607,Pseudovirus (VSV),Table 2,Sotrovimab,Wild Type (B),,,,,Iota/E484K,5,L5F + T95I + D253G + E484K + A701V,1,,,,,=,0.6,,,
FDA21e,https://www.fda.gov/media/149534/download,Pseudovirus,"SOT Page 22, Table 1",Sotrovimab,Wild Type (B),,,,,Iota/E484K,5,L5F + T95I + D253G + E484K + A701V,1,,,,,=,0.6,,,
FDA22,https://www.fda.gov/media/156152/download,Virus isolate,"Mar 2022, Page 14, antiviral resistance, Table 3",Bebtelovimab,Wild Type (B),,,,,Iota/E484K,5,L5F + T95I + D253G + E484K + A701V,1,,,,,=,1,,,
Westendorf22,10.1016/j.celrep.2022.110812,Pseudovirus (VSV),Table 3B,Bebtelovimab,Wild Type (A),=,3,ng/ml,1,Iota/E484K,5,L5F + T95I + D253G + E484K + A701V,1,=,2,ng/ml,1,=,0.7,,,
Westendorf22,10.1016/j.celrep.2022.110812,Pseudovirus (lentivirus),Table 3B,Bebtelovimab,Wild Type (A),=,5,ng/ml,1,Iota/E484K,5,L5F + T95I + D253G + E484K + A701V,1,=,2,ng/ml,1,=,0.4,,,
FDA22,https://www.fda.gov/media/156152/download,Pseudovirus,"Mar 2022, Page 13, antiviral resistance, Table 2",Bebtelovimab,Wild Type (B),,,,,Iota/E484K,5,L5F + T95I + D253G + E484K + A701V,1,,,,,=,1,,,
EMA21c,https://www.ema.europa.eu/en/documents/product-information/regkirona-epar-product-information_en.pdf,Virus isolate,Table 3,Regdanvimab,Wild Type (B),,,,,Iota/E484K,5,L5F + T95I + D253G + E484K + A701V,1,,,,,=,1,,,
EMA21c,https://www.ema.europa.eu/en/documents/product-information/regkirona-epar-product-information_en.pdf,Pseudovirus,Table 3,Regdanvimab,Wild Type (B),,,,,Iota/E484K,5,L5F + T95I + D253G + E484K + A701V,1,,,,,=,6.8,,,
Margolis21,https://idweek.org/Margolis,Pseudovirus,Table 2,Amubarvimab + Romlusevimab,Wild Type (B.1),,,,,Iota/E484K,5,L5F + T95I + D253G + E484K + A701V,1,,,,,=,2.5,,,
Chen21e,10.1038/s41586-021-03720-y,SARS-CoV-2 recombinant,Figure 1c,S2E12 + Sotrovimab,Wild Type (B.1),=,7,ng/ml,1,Iota/E484K,5,L5F + T95I + D253G + E484K + A701V,1,=,7,ng/ml,1,=,1,,,
House22,10.1371/journal.pone.0267796,Pseudovirus,Fig 1A,COV2-2381 + Cilgavimab,Wild Type (B.1),,,,,Iota/E484K,5,L5F + T95I + D253G + E484K + A701V,1,,,,,=,1.6,,,
Boschi22,10.1093/cid/ciac143,Virus isolate,Figure 1A,Bamlanivimab,Wild Type (B.1.1),=,0.2,ng/ml,1,Mu,95,T95I + Y144S + Y145N + R346K + L455F + L455L + E484K + N501Y + P681H + D950N,1,>,3500,ng/ml,1,>,1000,,,Censored at 3500
Yuan22,10.1101/2022.03.13.484037,Pseudovirus (MLV),Figure 2A,Bamlanivimab,Wild Type (B),=,7,ng/ml,1,Mu,95,T95I + Y144S + Y145N + R346K + E484K + N501Y + P681H + D950N,1,>,5000,ng/ml,1,>,714.3,,,
Arora22c,10.1016/j.celrep.2022.110754,Pseudovirus (VSV),Supplementary Figure 1D,Bamlanivimab,Wild Type (B.1),=,11.7,ng/ml,1,Mu,95,T95I + Y144S + Y145N + R346K + E484K + N501Y + P681H + D950N,1,>,2000,ng/ml,1,>,170.9,,,
Boschi22,10.1093/cid/ciac143,Virus isolate,Figure 1A,Etesevimab,Wild Type (B.1.1),=,6,ng/ml,1,Mu,95,T95I + Y144S + Y145N + R346K + L455F + L455L + E484K + N501Y + P681H + D950N,1,=,100,ng/ml,1,=,16.7,,,
Yuan22,10.1101/2022.03.13.484037,Pseudovirus (MLV),Figure 2A,Etesevimab,Wild Type (B),=,9,ng/ml,1,Mu,95,T95I + Y144S + Y145N + R346K + E484K + N501Y + P681H + D950N,1,=,33,ng/ml,1,=,3.7,,,
Arora22c,10.1016/j.celrep.2022.110754,Pseudovirus (VSV),Supplementary Figure 1D,Etesevimab,Wild Type (B.1),=,29.4,ng/ml,1,Mu,95,T95I + Y144S + Y145N + R346K + E484K + N501Y + P681H + D950N,1,=,137,ng/ml,1,=,4.7,,,
Ju22,10.1038/s41422-022-00638-6,Pseudovirus (HIV),Figure S1F,Etesevimab,Wild Type (B),=,12,ng/ml,1,Mu,95,T95I + Y144S + Y145N + R346K + E484K + N501Y + P681H + D950N,1,=,150,ng/ml,1,=,12.5,,,
Boschi22,10.1093/cid/ciac143,Virus isolate,Figure 1A,Bamlanivimab + Etesevimab,Wild Type (B.1.1),=,0.5,ng/ml,1,Mu,95,T95I + Y144S + Y145N + R346K + L455F + L455L + E484K + N501Y + P681H + D950N,1,=,28.8,ng/ml,1,=,54.4,,,
Yuan22,10.1101/2022.03.13.484037,Pseudovirus (MLV),Figure 2A,Bamlanivimab + Etesevimab,Wild Type (B),=,9,ng/ml,1,Mu,95,T95I + Y144S + Y145N + R346K + E484K + N501Y + P681H + D950N,1,=,234,ng/ml,1,=,26,,,
FDA21,https://www.fda.gov/drugs/drug-safety-and-availability/fda-authorizes-revisions-fact-sheets-address-sars-cov-2-variants-monoclonal-antibody-products-under,Pseudovirus (VSV),BAM+ETE page 28,Bamlanivimab + Etesevimab,Wild Type (B),,,,,Mu,95,T95I + Y144S + Y145N + R346K + E484K + N501Y + P681H + D950N,1,,,,,=,133,,,
Arora22c,10.1016/j.celrep.2022.110754,Pseudovirus (VSV),Supplementary Figure 1D,Bamlanivimab + Etesevimab,Wild Type (B.1),=,11.2,ng/ml,1,Mu,95,T95I + Y144S + Y145N + R346K + E484K + N501Y + P681H + D950N,1,=,111.5,ng/ml,1,=,10,,,
Boschi22,10.1093/cid/ciac143,Virus isolate,Figure 1B,Casirivimab,Wild Type (B.1.1),=,0.7,ng/ml,1,Mu,95,T95I + Y144S + Y145N + R346K + L455F + L455L + E484K + N501Y + P681H + D950N,1,>,12000,ng/ml,1,>,1000,,,Censored at 12000
Miyakawa21b,10.1101/2021.09.23.21264014,Pseudovirus,Figure 1C,Casirivimab,Wild Type (B.1),=,89,ng/ml,1,Mu,95,T95I + Y144S + Y145N + R346K + E484K + N501Y + P681H + D950N,1,=,554,ng/ml,1,=,6.2,,,
Yuan22,10.1101/2022.03.13.484037,Pseudovirus (MLV),Figure 2A,Casirivimab,Wild Type (B),=,6,ng/ml,1,Mu,95,T95I + Y144S + Y145N + R346K + E484K + N501Y + P681H + D950N,1,=,19,ng/ml,1,=,3.2,,,
Arora22c,10.1016/j.celrep.2022.110754,Pseudovirus (VSV),Supplementary Figure 1D,Casirivimab,Wild Type (B.1),=,9.7,ng/ml,1,Mu,95,T95I + Y144S + Y145N + R346K + E484K + N501Y + P681H + D950N,1,=,58.6,ng/ml,1,=,6,,,
Ju22,10.1038/s41422-022-00638-6,Pseudovirus (HIV),Figure S1F,Casirivimab,Wild Type (B),=,2,ng/ml,1,Mu,95,T95I + Y144S + Y145N + R346K + E484K + N501Y + P681H + D950N,1,=,81,ng/ml,1,=,40.5,,,
Boschi22,10.1093/cid/ciac143,Virus isolate,Figure 1B,Imdevimab,Wild Type (B.1.1),=,8.9,ng/ml,1,Mu,95,T95I + Y144S + Y145N + R346K + L455F + L455L + E484K + N501Y + P681H + D950N,1,=,98.1,ng/ml,1,=,11,,,
Miyakawa21b,10.1101/2021.09.23.21264014,Pseudovirus,Figure 1C,Imdevimab,Wild Type (B.1),=,65,ng/ml,1,Mu,95,T95I + Y144S + Y145N + R346K + E484K + N501Y + P681H + D950N,1,=,64,ng/ml,1,=,1,,,
Yuan22,10.1101/2022.03.13.484037,Pseudovirus (MLV),Figure 2A,Imdevimab,Wild Type (B),=,25,ng/ml,1,Mu,95,T95I + Y144S + Y145N + R346K + E484K + N501Y + P681H + D950N,1,=,37,ng/ml,1,=,1.5,,,
Arora22c,10.1016/j.celrep.2022.110754,Pseudovirus (VSV),Supplementary Figure 1D,Imdevimab,Wild Type (B.1),=,10.5,ng/ml,1,Mu,95,T95I + Y144S + Y145N + R346K + E484K + N501Y + P681H + D950N,1,=,10.1,ng/ml,1,=,1,,,
Ju22,10.1038/s41422-022-00638-6,Pseudovirus (HIV),Figure S1F,Imdevimab,Wild Type (B),=,2,ng/ml,1,Mu,95,T95I + Y144S + Y145N + R346K + E484K + N501Y + P681H + D950N,1,=,1,ng/ml,1,=,0.5,,,
Boschi22,10.1093/cid/ciac143,Virus isolate,Figure 1B,Casirivimab + Imdevimab,Wild Type (B.1.1),=,0.1,ng/ml,1,Mu,95,T95I + Y144S + Y145N + R346K + L455F + L455L + E484K + N501Y + P681H + D950N,1,=,1.8,ng/ml,1,=,12.2,,,
Yuan22,10.1101/2022.03.13.484037,Pseudovirus (MLV),Figure 2A,Casirivimab + Imdevimab,Wild Type (B),=,6,ng/ml,1,Mu,95,T95I + Y144S + Y145N + R346K + E484K + N501Y + P681H + D950N,1,=,11,ng/ml,1,=,1.8,,,
FDA21,https://www.fda.gov/drugs/drug-safety-and-availability/fda-authorizes-revisions-fact-sheets-address-sars-cov-2-variants-monoclonal-antibody-products-under,Pseudovirus (VSV),CAS+IMD Table 9 page 42,Casirivimab + Imdevimab,Wild Type (B),,,,,Mu,95,T95I + Y144S + Y145N + R346K + E484K + N501Y + P681H + D950N,1,,,,,=,1,,,
Arora22c,10.1016/j.celrep.2022.110754,Pseudovirus (VSV),Supplementary Figure 1D,Casirivimab + Imdevimab,Wild Type (B.1),=,11.1,ng/ml,1,Mu,95,T95I + Y144S + Y145N + R346K + E484K + N501Y + P681H + D950N,1,=,18.7,ng/ml,1,=,1.7,,,
Yuan22,10.1101/2022.03.13.484037,Pseudovirus (MLV),Figure 2A,Cilgavimab,Wild Type (B),=,5,ng/ml,1,Mu,95,T95I + Y144S + Y145N + R346K + E484K + N501Y + P681H + D950N,1,=,167,ng/ml,1,=,33.4,,,
FDA21c,https://www.fda.gov/media/154701/download,Pseudovirus,"Feb 2022, Page 17, Antiviral resistance paragraph 4",Cilgavimab,Wild Type (B),,,,,Mu,95,T95I + Y144S + Y145N + R346K + E484K + N501Y + P681H + D950N,1,,,,,=,21,,,
Yuan22,10.1101/2022.03.13.484037,Pseudovirus (MLV),Figure 2A,Tixagevimab,Wild Type (B),=,1,ng/ml,1,Mu,95,T95I + Y144S + Y145N + R346K + E484K + N501Y + P681H + D950N,1,=,3,ng/ml,1,=,3,,,
EMA21e,https://www.ema.europa.eu/en/documents/product-information/evusheld-epar-product-information_en.pdf,Pseudovirus,Table 3,Cilgavimab + Tixagevimab,Wild Type (B),=,1.9,ng/ml,1,Mu,95,T95I + Y144S + Y145N + R346K + E484K + N501Y + P681H + D950N,1,=,13.5,ng/ml,1,=,7.1,,,
Yuan22,10.1101/2022.03.13.484037,Pseudovirus (MLV),Figure 2A,Cilgavimab + Tixagevimab,Wild Type (B),=,5,ng/ml,1,Mu,95,T95I + Y144S + Y145N + R346K + E484K + N501Y + P681H + D950N,1,=,13,ng/ml,1,=,2.6,,,
FDA21c,https://www.fda.gov/media/154701/download,Pseudovirus,"Feb 2022, Table 6, Page 17, Antiviral resistance paragraph 6",Cilgavimab + Tixagevimab,Wild Type (B),,,,,Mu,95,T95I + Y144S + Y145N + R346K + E484K + N501Y + P681H + D950N,1,,,,,=,7.5,,,
Liu22,10.1126/scitranslmed.abn6859,Virus isolate,Fig2B,Sotrovimab,Wild Type (A),=,39,ng/ml,1,Mu,95,T95I + Y144S + Y145N + R346K + E484K + N501Y + P681H + D950N,1,=,21,ng/ml,1,=,0.5,,,
Liu22,10.1126/scitranslmed.abn6859,Pseudovirus (VSV),Fig2A,Sotrovimab,Wild Type (B.1),=,11,ng/ml,1,Mu,95,T95I + Y144S + Y145N + R346K + E484K + N501Y + P681H + D950N,1,=,26,ng/ml,1,=,2.4,,,
Yuan22,10.1101/2022.03.13.484037,Pseudovirus (MLV),Figure 2A,Sotrovimab,Wild Type (B),=,72,ng/ml,1,Mu,95,T95I + Y144S + Y145N + R346K + E484K + N501Y + P681H + D950N,1,=,88,ng/ml,1,=,1.2,,,
EMA21d,https://www.ema.europa.eu/en/documents/product-information/xevudy-epar-product-information_en.pdf,Pseudovirus,Table 2,Sotrovimab,Wild Type (B),,,,,Mu,95,T95I + Y144S + Y145N + R346K + E484K + N501Y + P681H + D950N,1,,,,,=,1,,,
Ju22,10.1038/s41422-022-00638-6,Pseudovirus (HIV),Figure S1F,Sotrovimab,Wild Type (B),=,93,ng/ml,1,Mu,95,T95I + Y144S + Y145N + R346K + E484K + N501Y + P681H + D950N,1,=,70,ng/ml,1,=,0.8,,,
Cathcart21,10.1101/2021.03.09.434607,Pseudovirus (VSV),Table 2,Sotrovimab,Wild Type (B),,,,,Mu,95,T95I + Y144T + Y145S + H146N + R346K + E484K + N501Y + P681H + D950N,1,,,,,=,1.3,,,
FDA22,https://www.fda.gov/media/156152/download,Pseudovirus,"Mar 2022, Page 13, antiviral resistance, Table 2",Bebtelovimab,Wild Type (B),,,,,Mu,95,T95I + Y144S + Y145N + R346K + E484K + N501Y + P681H + D950N,1,,,,,=,5.3,,,
EMA21c,https://www.ema.europa.eu/en/documents/product-information/regkirona-epar-product-information_en.pdf,Pseudovirus,Table 3,Regdanvimab,Wild Type (B),,,,,Mu,95,T95I + Y144S + Y145N + R346K + E484K + N501Y + P681H + D950N,1,,,,,=,38.7,,,
Margolis21,https://idweek.org/Margolis,Pseudovirus,Table 2,Amubarvimab + Romlusevimab,Wild Type (B.1),,,,,Mu,95,T95I + Y144S + Y145N + R346K + E484K + N501Y + P681H + D950N,1,,,,,=,2.5,,,
Arora22f,10.1016/S1473-3099(22)00733-2,Pseudovirus (VSV),Figure B,Bamlanivimab,Wild Type (B.1),=,16,ng/ml,1,Omicron/BA.4.6,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N658S + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,50000,ng/ml,1,>,1000,,,
Sheward22c,10.1101/2022.09.16.508299,Pseudovirus,Figure 1B,Bamlanivimab,Wild Type (B.1),=,9,ng/ml,1,Omicron/BA.4.6,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N658S + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,1000,ng/ml,1,>,111.1,,,
Arora22f,10.1016/S1473-3099(22)00733-2,Pseudovirus (VSV),Figure B,Etesevimab,Wild Type (B.1),=,53,ng/ml,1,Omicron/BA.4.6,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N658S + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,50000,ng/ml,1,>,943.4,,,
Sheward22c,10.1101/2022.09.16.508299,Pseudovirus,Figure 1B,Etesevimab,Wild Type (B.1),=,29,ng/ml,1,Omicron/BA.4.6,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N658S + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,1000,ng/ml,1,>,34.5,,,
Arora22f,10.1016/S1473-3099(22)00733-2,Pseudovirus (VSV),Figure B,Bamlanivimab + Etesevimab,Wild Type (B.1),=,18,ng/ml,1,Omicron/BA.4.6,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N658S + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,50000,ng/ml,1,>,1000,,,
Arora22f,10.1016/S1473-3099(22)00733-2,Pseudovirus (VSV),Figure B,Casirivimab,Wild Type (B.1),=,21,ng/ml,1,Omicron/BA.4.6,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N658S + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,50000,ng/ml,1,>,1000,,,
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Casirivimab,Omicron/BA.2,>,10000,ng/ml,1,Omicron/BA.4.6,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N658S + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Sheward22c,10.1101/2022.09.16.508299,Pseudovirus,Figure 1B,Casirivimab,Wild Type (B.1),=,14,ng/ml,1,Omicron/BA.4.6,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N658S + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,1000,ng/ml,1,>,71.4,,,
Planas22b,10.1101/2022.11.17.516888,Virus isolate,Figure 3b,Casirivimab,Wild Type (B.1),=,1.7,ng/ml,1,Omicron/BA.4.6,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N658S + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Arora22f,10.1016/S1473-3099(22)00733-2,Pseudovirus (VSV),Figure B,Imdevimab,Wild Type (B.1),=,19,ng/ml,1,Omicron/BA.4.6,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N658S + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,2109,ng/ml,1,=,111,,,
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Imdevimab,Omicron/BA.2,=,590,ng/ml,1,Omicron/BA.4.6,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N658S + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,2195,ng/ml,1,>,3.7,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Sheward22c,10.1101/2022.09.16.508299,Pseudovirus,Figure 1B,Imdevimab,Wild Type (B.1),=,10,ng/ml,1,Omicron/BA.4.6,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N658S + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,1000,ng/ml,1,>,100,,,
Planas22b,10.1101/2022.11.17.516888,Virus isolate,Figure 3b,Imdevimab,Wild Type (B.1),=,2.1,ng/ml,1,Omicron/BA.4.6,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N658S + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,493,ng/ml,1,=,234.8,,,
Arora22f,10.1016/S1473-3099(22)00733-2,Pseudovirus (VSV),Figure B,Casirivimab + Imdevimab,Wild Type (B.1),=,9,ng/ml,1,Omicron/BA.4.6,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N658S + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,5395,ng/ml,1,=,599.4,,,
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Casirivimab + Imdevimab,Omicron/BA.2,=,821,ng/ml,1,Omicron/BA.4.6,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N658S + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,4388,ng/ml,1,>,5.3,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Planas22b,10.1101/2022.11.17.516888,Virus isolate,Figure 3b,Casirivimab + Imdevimab,Wild Type (B.1),=,1.6,ng/ml,1,Omicron/BA.4.6,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N658S + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1181,ng/ml,1,=,738.1,,,
Wang22j,10.1016/S1473-3099(22)00694-6,Virus isolate,Figure S5,Cilgavimab,Wild Type (B.1),=,95,ng/ml,1,Omicron/BA.4.6,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N658S + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,105.3,,,
Arora22f,10.1016/S1473-3099(22)00733-2,Pseudovirus (VSV),Figure B,Cilgavimab,Wild Type (B.1),=,37,ng/ml,1,Omicron/BA.4.6,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N658S + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,24200,ng/ml,1,=,654.1,,,
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Cilgavimab,Omicron/BA.2,=,6.3,ng/ml,1,Omicron/BA.4.6,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N658S + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,158.7,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Sheward22c,10.1101/2022.09.16.508299,Pseudovirus,Figure 1B,Cilgavimab,Wild Type (B.1),=,12,ng/ml,1,Omicron/BA.4.6,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N658S + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,1000,ng/ml,1,>,83.3,,,
Wang22j,10.1016/S1473-3099(22)00694-6,Pseudovirus (VSV),Figure S3,Cilgavimab,Wild Type (B.1),=,8,ng/ml,1,Omicron/BA.4.6,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N658S + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Planas22b,10.1101/2022.11.17.516888,Virus isolate,Figure 3b,Cilgavimab,Wild Type (B.1),=,2.9,ng/ml,1,Omicron/BA.4.6,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N658S + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Wang22j,10.1016/S1473-3099(22)00694-6,Virus isolate,Figure S5,Tixagevimab,Wild Type (B.1),=,81,ng/ml,1,Omicron/BA.4.6,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N658S + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,123.5,,,
Arora22f,10.1016/S1473-3099(22)00733-2,Pseudovirus (VSV),Figure B,Tixagevimab,Wild Type (B.1),=,7,ng/ml,1,Omicron/BA.4.6,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N658S + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,27740,ng/ml,1,>,1000,,,
Sheward22c,10.1101/2022.09.16.508299,Pseudovirus,Figure 1B,Tixagevimab,Wild Type (B.1),=,4,ng/ml,1,Omicron/BA.4.6,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N658S + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,1000,ng/ml,1,>,250,,,
Wang22j,10.1016/S1473-3099(22)00694-6,Pseudovirus (VSV),Figure S3,Tixagevimab,Wild Type (B.1),=,3,ng/ml,1,Omicron/BA.4.6,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N658S + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Planas22b,10.1101/2022.11.17.516888,Virus isolate,Figure 3b,Tixagevimab,Wild Type (B.1),=,1.3,ng/ml,1,Omicron/BA.4.6,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N658S + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Wang22j,10.1016/S1473-3099(22)00694-6,Virus isolate,Figure S5,Cilgavimab + Tixagevimab,Wild Type (B.1),=,66,ng/ml,1,Omicron/BA.4.6,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N658S + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,151.5,,,
Arora22f,10.1016/S1473-3099(22)00733-2,Pseudovirus (VSV),Figure B,Cilgavimab + Tixagevimab,Wild Type (B.1),=,7,ng/ml,1,Omicron/BA.4.6,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N658S + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,7131,ng/ml,1,>,1000,,,
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Cilgavimab + Tixagevimab,Omicron/BA.2,=,8.2,ng/ml,1,Omicron/BA.4.6,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N658S + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,122,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Sheward22c,10.1101/2022.09.16.508299,Pseudovirus,Figure 1B,Cilgavimab + Tixagevimab,Wild Type (B.1),=,6,ng/ml,1,Omicron/BA.4.6,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N658S + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,1000,ng/ml,1,>,166.7,,,
Wang22j,10.1016/S1473-3099(22)00694-6,Pseudovirus (VSV),Figure S3,Cilgavimab + Tixagevimab,Wild Type (B.1),=,3,ng/ml,1,Omicron/BA.4.6,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N658S + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Planas22b,10.1101/2022.11.17.516888,Virus isolate,Figure 3b,Cilgavimab + Tixagevimab,Wild Type (B.1),=,1.3,ng/ml,1,Omicron/BA.4.6,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N658S + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Arora22f,10.1016/S1473-3099(22)00733-2,Pseudovirus (VSV),Figure B,Sotrovimab,Wild Type (B.1),=,157,ng/ml,1,Omicron/BA.4.6,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N658S + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,13000,ng/ml,1,=,82.8,,,
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Sotrovimab,Omicron/BA.2,=,852,ng/ml,1,Omicron/BA.4.6,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N658S + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,3543,ng/ml,1,>,4.2,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Sheward22c,10.1101/2022.09.16.508299,Pseudovirus,Figure 1B,Sotrovimab,Wild Type (B.1),=,119,ng/ml,1,Omicron/BA.4.6,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N658S + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,925,ng/ml,1,=,7.8,,,
Wang22j,10.1016/S1473-3099(22)00694-6,Pseudovirus (VSV),Figure S3,Sotrovimab,Wild Type (B.1),=,66,ng/ml,1,Omicron/BA.4.6,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N658S + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,2679,ng/ml,1,=,40.6,,,
Planas22b,10.1101/2022.11.17.516888,Virus isolate,Figure 3b,Sotrovimab,Wild Type (B.1),=,65,ng/ml,1,Omicron/BA.4.6,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N658S + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,2874,ng/ml,1,=,44.2,,,
Wang22j,10.1016/S1473-3099(22)00694-6,Virus isolate,Figure S5,Bebtelovimab,Wild Type (B.1),=,19,ng/ml,1,Omicron/BA.4.6,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N658S + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,9,ng/ml,1,=,0.5,,,
Arora22f,10.1016/S1473-3099(22)00733-2,Pseudovirus (VSV),Figure B,Bebtelovimab,Wild Type (B.1),=,5,ng/ml,1,Omicron/BA.4.6,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N658S + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,7,ng/ml,1,=,1.4,,,
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Bebtelovimab,Omicron/BA.2,=,0.9,ng/ml,1,Omicron/BA.4.6,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N658S + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1,ng/ml,1,=,1.1,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Sheward22c,10.1101/2022.09.16.508299,Pseudovirus,Figure 1B,Bebtelovimab,Wild Type (B.1),=,4,ng/ml,1,Omicron/BA.4.6,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N658S + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,2,ng/ml,1,=,0.5,,,
Wang22j,10.1016/S1473-3099(22)00694-6,Pseudovirus (VSV),Figure S3,Bebtelovimab,Wild Type (B.1),=,1.5,ng/ml,1,Omicron/BA.4.6,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N658S + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1.2,ng/ml,1,=,0.8,,,
Planas22b,10.1101/2022.11.17.516888,Virus isolate,Figure 3b,Bebtelovimab,Wild Type (B.1),=,1.4,ng/ml,1,Omicron/BA.4.6,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N658S + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,2.7,ng/ml,1,=,1.9,,,
Arora22f,10.1016/S1473-3099(22)00733-2,Pseudovirus (VSV),Figure B,Regdanvimab,Wild Type (B.1),=,7,ng/ml,1,Omicron/BA.4.6,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N658S + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,50000,ng/ml,1,>,1000,,,
Arora22f,10.1016/S1473-3099(22)00733-2,Pseudovirus (VSV),Figure B,Amubarvimab,Wild Type (B.1),=,53,ng/ml,1,Omicron/BA.4.6,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N658S + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1290,ng/ml,1,=,24.3,,,
Wang22j,10.1016/S1473-3099(22)00694-6,Pseudovirus (VSV),Figure S3,Amubarvimab,Wild Type (B.1),=,24,ng/ml,1,Omicron/BA.4.6,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N658S + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,909,ng/ml,1,=,37.9,,,
Arora22f,10.1016/S1473-3099(22)00733-2,Pseudovirus (VSV),Figure B,Romlusevimab,Wild Type (B.1),=,852,ng/ml,1,Omicron/BA.4.6,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N658S + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,50000,ng/ml,1,>,58.7,,,
Wang22j,10.1016/S1473-3099(22)00694-6,Pseudovirus (VSV),Figure S3,Romlusevimab,Wild Type (B.1),=,436,ng/ml,1,Omicron/BA.4.6,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N658S + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,22.9,,,
Arora22f,10.1016/S1473-3099(22)00733-2,Pseudovirus (VSV),Figure B,Amubarvimab + Romlusevimab,Wild Type (B.1),=,64,ng/ml,1,Omicron/BA.4.6,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N658S + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1015,ng/ml,1,=,15.9,,,
Wang22j,10.1016/S1473-3099(22)00694-6,Pseudovirus (VSV),Figure S3,Amubarvimab + Romlusevimab,Wild Type (B.1),=,34,ng/ml,1,Omicron/BA.4.6,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N658S + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,2119,ng/ml,1,=,62.3,,,
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,DXP-604,Omicron/BA.2,=,219,ng/ml,1,Omicron/BA.4.6,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N658S + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,4116,ng/ml,1,>,18.8,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b,Bamlanivimab,Wild Type (B.1),=,4,ng/ml,1,Omicron/BA.2/R493Q,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493Q + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Bamlanivimab,Wild Type (B.1),=,6,ng/ml,1,Omicron/BA.2/R493Q,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493Q + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Yamasoba22b,10.1016/S1473-3099(22)00365-6,Pseudovirus (HIV),Table,Bamlanivimab,Wild Type (B.1),=,12.8,ng/ml,1,Omicron/BA.2/R493Q,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493Q + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,3700,ng/ml,1,>,289.1,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b,Etesevimab,Wild Type (B.1),=,12,ng/ml,1,Omicron/BA.2/R493Q,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493Q + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,833.3,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Etesevimab,Wild Type (B.1),=,9,ng/ml,1,Omicron/BA.2/R493Q,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493Q + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Yamasoba22b,10.1016/S1473-3099(22)00365-6,Pseudovirus (HIV),Table,Etesevimab,Wild Type (B.1),=,12,ng/ml,1,Omicron/BA.2/R493Q,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493Q + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,6050,ng/ml,1,>,504.2,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b,Bamlanivimab + Etesevimab,Wild Type (B.1),=,5,ng/ml,1,Omicron/BA.2/R493Q,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493Q + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Bamlanivimab + Etesevimab,Wild Type (B.1),=,6,ng/ml,1,Omicron/BA.2/R493Q,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493Q + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Yamasoba22b,10.1016/S1473-3099(22)00365-6,Pseudovirus (HIV),Table,Bamlanivimab + Etesevimab,Wild Type (B.1),=,6.7,ng/ml,1,Omicron/BA.2/R493Q,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493Q + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,3700,ng/ml,1,>,552.2,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b,Casirivimab,Wild Type (B.1),=,5,ng/ml,1,Omicron/BA.2/R493Q,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493Q + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,960,ng/ml,1,=,192,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Casirivimab,Wild Type (B.1),=,3,ng/ml,1,Omicron/BA.2/R493Q,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493Q + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,836,ng/ml,1,=,278.7,,,
Yamasoba22b,10.1016/S1473-3099(22)00365-6,Pseudovirus (HIV),Table,Casirivimab,Wild Type (B.1),=,9.9,ng/ml,1,Omicron/BA.2/R493Q,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493Q + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,3697,ng/ml,1,=,373.4,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b,Imdevimab,Wild Type (B.1),=,1,ng/ml,1,Omicron/BA.2/R493Q,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493Q + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,454,ng/ml,1,=,454,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Imdevimab,Wild Type (B.1),=,3,ng/ml,1,Omicron/BA.2/R493Q,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493Q + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,700,ng/ml,1,=,233.3,,,
Yamasoba22b,10.1016/S1473-3099(22)00365-6,Pseudovirus (HIV),Table,Imdevimab,Wild Type (B.1),=,79,ng/ml,1,Omicron/BA.2/R493Q,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493Q + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,50000,ng/ml,1,>,632.9,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b,Casirivimab + Imdevimab,Wild Type (B.1),=,1,ng/ml,1,Omicron/BA.2/R493Q,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493Q + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,641,ng/ml,1,=,641,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Casirivimab + Imdevimab,Wild Type (B.1),=,3,ng/ml,1,Omicron/BA.2/R493Q,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493Q + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,718,ng/ml,1,=,239.3,,,
Yamasoba22b,10.1016/S1473-3099(22)00365-6,Pseudovirus (HIV),Table,Casirivimab + Imdevimab,Wild Type (B.1),=,6.2,ng/ml,1,Omicron/BA.2/R493Q,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493Q + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,431,ng/ml,1,=,69.5,,,
Saito22,10.1016/j.chom.2022.10.003,Pseudovirus (lentivirus),Table S3,Cilgavimab,Wild Type (B.1),=,14,ng/ml,1,Omicron/BA.2/R493Q,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493Q + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,38,ng/ml,1,=,2.7,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b,Cilgavimab,Wild Type (B.1),=,6,ng/ml,1,Omicron/BA.2/R493Q,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493Q + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,9,ng/ml,1,=,1.5,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Cilgavimab,Wild Type (B.1),=,10,ng/ml,1,Omicron/BA.2/R493Q,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493Q + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,8,ng/ml,1,=,0.8,,,
Wang22l,10.1101/2022.11.23.517532,Pseudovirus,Figure S2,Cilgavimab,Wild Type (B.1),=,7,ng/ml,1,Omicron/BA.2/R493Q,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493Q + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,10,ng/ml,1,=,1.4,,,
Yamasoba22b,10.1016/S1473-3099(22)00365-6,Pseudovirus (HIV),Table,Cilgavimab,Wild Type (B.1),=,21,ng/ml,1,Omicron/BA.2/R493Q,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493Q + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,22,ng/ml,1,=,1,,,
Saito22,10.1016/j.chom.2022.10.003,Pseudovirus (lentivirus),Table S3,Tixagevimab,Wild Type (B.1),=,1.5,ng/ml,1,Omicron/BA.2/R493Q,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493Q + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,38.6,ng/ml,1,=,25.7,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b,Tixagevimab,Wild Type (B.1),=,2,ng/ml,1,Omicron/BA.2/R493Q,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493Q + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,49,ng/ml,1,=,24.5,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Tixagevimab,Wild Type (B.1),=,3,ng/ml,1,Omicron/BA.2/R493Q,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493Q + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,24,ng/ml,1,=,8,,,
Wang22l,10.1101/2022.11.23.517532,Pseudovirus,Figure S2,Tixagevimab,Wild Type (B.1),=,2,ng/ml,1,Omicron/BA.2/R493Q,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493Q + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,34,ng/ml,1,=,17,,,
Yamasoba22b,10.1016/S1473-3099(22)00365-6,Pseudovirus (HIV),Table,Tixagevimab,Wild Type (B.1),=,6.7,ng/ml,1,Omicron/BA.2/R493Q,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493Q + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,101,ng/ml,1,=,15.1,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b,Cilgavimab + Tixagevimab,Wild Type (B.1),=,2,ng/ml,1,Omicron/BA.2/R493Q,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493Q + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,9,ng/ml,1,=,4.5,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Cilgavimab + Tixagevimab,Wild Type (B.1),=,2,ng/ml,1,Omicron/BA.2/R493Q,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493Q + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,12,ng/ml,1,=,6,,,
Wang22l,10.1101/2022.11.23.517532,Pseudovirus,Figure S2,Cilgavimab + Tixagevimab,Wild Type (B.1),=,3,ng/ml,1,Omicron/BA.2/R493Q,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493Q + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,8,ng/ml,1,=,2.7,,,
Yamasoba22b,10.1016/S1473-3099(22)00365-6,Pseudovirus (HIV),Table,Cilgavimab + Tixagevimab,Wild Type (B.1),=,4.1,ng/ml,1,Omicron/BA.2/R493Q,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493Q + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,31,ng/ml,1,=,7.6,,,
Saito22,10.1016/j.chom.2022.10.003,Pseudovirus (lentivirus),Table S3,Sotrovimab,Wild Type (B.1),=,47,ng/ml,1,Omicron/BA.2/R493Q,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493Q + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,533.3,ng/ml,1,=,11.3,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b,Sotrovimab,Wild Type (B.1),=,14,ng/ml,1,Omicron/BA.2/R493Q,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493Q + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,485,ng/ml,1,=,34.6,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Sotrovimab,Wild Type (B.1),=,25,ng/ml,1,Omicron/BA.2/R493Q,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493Q + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,416,ng/ml,1,=,16.6,,,
Wang22l,10.1101/2022.11.23.517532,Pseudovirus,Figure S2,Sotrovimab,Wild Type (B.1),=,23,ng/ml,1,Omicron/BA.2/R493Q,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493Q + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1109,ng/ml,1,=,48.2,,,
Yamasoba22b,10.1016/S1473-3099(22)00365-6,Pseudovirus (HIV),Table,Sotrovimab,Wild Type (B.1),=,94,ng/ml,1,Omicron/BA.2/R493Q,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493Q + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1791,ng/ml,1,=,19.1,,,
Saito22,10.1016/j.chom.2022.10.003,Pseudovirus (lentivirus),Table S3,Bebtelovimab,Wild Type (B.1),=,2.4,ng/ml,1,Omicron/BA.2/R493Q,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493Q + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,2.9,ng/ml,1,=,1.2,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b,Bebtelovimab,Wild Type (B.1),=,1,ng/ml,1,Omicron/BA.2/R493Q,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493Q + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,2,ng/ml,1,=,2,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Bebtelovimab,Wild Type (B.1),=,2,ng/ml,1,Omicron/BA.2/R493Q,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493Q + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,2,ng/ml,1,=,1,,,
Wang22l,10.1101/2022.11.23.517532,Pseudovirus,Figure S2,Bebtelovimab,Wild Type (B.1),=,2,ng/ml,1,Omicron/BA.2/R493Q,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493Q + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1,ng/ml,1,=,0.5,,,
Yamasoba22b,10.1016/S1473-3099(22)00365-6,Pseudovirus (HIV),Table,Bebtelovimab,Wild Type (B.1),=,8.1,ng/ml,1,Omicron/BA.2/R493Q,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493Q + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,4.2,ng/ml,1,=,0.5,,,
Saito22,10.1016/j.chom.2022.10.003,Pseudovirus (lentivirus),Table S3,Regdanvimab,Wild Type (B.1),=,1,ng/ml,1,Omicron/BA.2/R493Q,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493Q + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,39.7,ng/ml,1,=,39.7,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b,Amubarvimab,Wild Type (B.1),=,18,ng/ml,1,Omicron/BA.2/R493Q,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493Q + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,33,ng/ml,1,=,1.8,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Amubarvimab,Wild Type (B.1),=,15,ng/ml,1,Omicron/BA.2/R493Q,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493Q + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,17,ng/ml,1,=,1.1,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b,Romlusevimab,Wild Type (B.1),=,110,ng/ml,1,Omicron/BA.2/R493Q,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493Q + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1089,ng/ml,1,=,9.9,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Romlusevimab,Wild Type (B.1),=,166,ng/ml,1,Omicron/BA.2/R493Q,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493Q + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1274,ng/ml,1,=,7.7,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b,Amubarvimab + Romlusevimab,Wild Type (B.1),=,22,ng/ml,1,Omicron/BA.2/R493Q,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493Q + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,21,ng/ml,1,=,1,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Amubarvimab + Romlusevimab,Wild Type (B.1),=,32,ng/ml,1,Omicron/BA.2/R493Q,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493Q + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,50,ng/ml,1,=,1.6,,,
Nabel21,10.1126/science.abl6251,Pseudovirus (lentivirus),"Fig 2A, 2B",Bamlanivimab,Wild Type (B.1),=,22,ng/ml,1,Lambda,75,G75V + T76I + Δ246-252 + D253N + L452Q + F490S + T859N,1,>,100000,ng/ml,1,>,1000,,,
Nabel21,10.1126/science.abl6251,Pseudovirus (lentivirus),"Fig 2A, 2B",Etesevimab,Wild Type (B.1),=,27,ng/ml,1,Lambda,75,G75V + T76I + Δ246-252 + D253N + L452Q + F490S + T859N,1,=,9,ng/ml,1,=,0.3,,,
Wang21l,10.1080/22221751.2021.2008775,Pseudovirus (VSV),Figure 3A,Etesevimab,Wild Type (B.1),,,,,Lambda,75,G75V + T76I + Δ246-252 + D253N + L452Q + F490S + M869N,1,,,,,=,0.5,,,
Wang22c,10.1038/s41586-022-04466-x,Pseudovirus (VSV),Supplmentary Table 2,Etesevimab,Wild Type (B),=,19,ng/ml,1,Lambda,75,G75V + T76I + Δ246-252 + L452Q + F490S + M869N,1,=,8,ng/ml,1,=,0.4,,,
Nabel21,10.1126/science.abl6251,Pseudovirus (lentivirus),"Fig 2A, 2B",Casirivimab,Wild Type (B.1),=,25,ng/ml,1,Lambda,75,G75V + T76I + Δ246-252 + D253N + L452Q + F490S + T859N,1,=,5,ng/ml,1,=,0.2,,,
Miyakawa21b,10.1101/2021.09.23.21264014,Pseudovirus,Figure 1C,Casirivimab,Wild Type (B.1),=,89,ng/ml,1,Lambda,75,G75V + T76I + Δ246-252 + L452Q + F490S + M869N,1,=,83,ng/ml,1,=,0.9,,,
Tada21d,10.1101/2021.07.02.450959,Pseudovirus (HIV),Figure 2A table,Casirivimab,Wild Type (B.1),=,3.3,ng/ml,1,Lambda,75,G75V + T76I + Δ246-252 + L452Q + F490S + M869N,1,=,2.9,ng/ml,1,=,0.9,,,
Tada21e,10.3389/fimmu.2022.797589,Pseudovirus (HIV),Figure 2,Casirivimab,Wild Type (B.1),=,3.3,ng/ml,1,Lambda,75,G75V + T76I + Δ246-252 + L452Q + F490S + M869N,1,=,2.9,ng/ml,1,=,0.9,,,
Nabel21,10.1126/science.abl6251,Pseudovirus (lentivirus),"Fig 2A, 2B",Imdevimab,Wild Type (B.1),=,32,ng/ml,1,Lambda,75,G75V + T76I + Δ246-252 + D253N + L452Q + F490S + T859N,1,=,12,ng/ml,1,=,0.4,,,
Miyakawa21b,10.1101/2021.09.23.21264014,Pseudovirus,Figure 1C,Imdevimab,Wild Type (B.1),=,65,ng/ml,1,Lambda,75,G75V + T76I + Δ246-252 + L452Q + F490S + M869N,1,=,119,ng/ml,1,=,1.8,,,
Tada21d,10.1101/2021.07.02.450959,Pseudovirus (HIV),Figure 2A table,Imdevimab,Wild Type (B.1),=,9.3,ng/ml,1,Lambda,75,G75V + T76I + Δ246-252 + L452Q + F490S + M869N,1,=,33.7,ng/ml,1,=,3.6,,,
Wang22c,10.1038/s41586-022-04466-x,Pseudovirus (VSV),Supplmentary Table 2,Imdevimab,Wild Type (B),=,13,ng/ml,1,Lambda,75,G75V + T76I + Δ246-252 + L452Q + F490S + M869N,1,=,50,ng/ml,1,=,3.8,,,
FDA21,https://www.fda.gov/drugs/drug-safety-and-availability/fda-authorizes-revisions-fact-sheets-address-sars-cov-2-variants-monoclonal-antibody-products-under,Pseudovirus (VSV),CAS+IMD Table 9 page 42,Imdevimab,Wild Type (B),,,,,Lambda,75,G75V + T76I + Δ246-252 + L452Q + F490S + M869N,1,,,,,=,1,,,
Tada21e,10.3389/fimmu.2022.797589,Pseudovirus (HIV),Figure 2,Imdevimab,Wild Type (B.1),=,9.3,ng/ml,1,Lambda,75,G75V + T76I + Δ246-252 + L452Q + F490S + M869N,1,=,33.7,ng/ml,1,=,3.6,,,
Tada21d,10.1101/2021.07.02.450959,Pseudovirus (HIV),Figure 2A table,Casirivimab + Imdevimab,Wild Type (B.1),=,4.4,ng/ml,1,Lambda,75,G75V + T76I + Δ246-252 + L452Q + F490S + M869N,1,=,7,ng/ml,1,=,1.6,,,
Tada21e,10.3389/fimmu.2022.797589,Pseudovirus (HIV),Figure 2,Casirivimab + Imdevimab,Wild Type (B.1),=,4.4,ng/ml,1,Lambda,75,G75V + T76I + Δ246-252 + L452Q + F490S + M869N,1,=,7,ng/ml,1,=,1.6,,,
Wang22c,10.1038/s41586-022-04466-x,Pseudovirus (VSV),Supplmentary Table 2,Tixagevimab,Wild Type (B),=,5,ng/ml,1,Lambda,75,G75V + T76I + Δ246-252 + L452Q + F490S + M869N,1,=,5,ng/ml,1,=,1,,,
EMA21e,https://www.ema.europa.eu/en/documents/product-information/evusheld-epar-product-information_en.pdf,Pseudovirus,Table 3,Cilgavimab + Tixagevimab,Wild Type (B),=,1.9,ng/ml,1,Lambda,75,G75V + T76I + Δ246-252 + L452Q + F490S + M869N,1,=,1.1,ng/ml,1,=,0.6,,,
FDA21c,https://www.fda.gov/media/154701/download,Pseudovirus,"Feb 2022, Table 6, Page 17, Antiviral resistance paragraph 6",Cilgavimab + Tixagevimab,Wild Type (B),,,,,Lambda,75,G75V + T76I + Δ246-252 + L452Q + F490S + M869N,1,,,,,=,0.7,,,
Liu22,10.1126/scitranslmed.abn6859,Virus isolate,Fig2B,Sotrovimab,Wild Type (A),=,39,ng/ml,1,Lambda,75,G75V + T76I + R246N + Δ247-253 + L452Q + F490S + T859N,1,=,30,ng/ml,1,=,0.8,,,
Liu22,10.1126/scitranslmed.abn6859,Pseudovirus (VSV),Fig2A,Sotrovimab,Wild Type (B.1),=,11,ng/ml,1,Lambda,75,G75V + T76I + Δ246-252 + L452Q + F490S + M869N,1,=,57,ng/ml,1,=,5.2,,,
Wang22c,10.1038/s41586-022-04466-x,Pseudovirus (VSV),Supplmentary Table 2,Sotrovimab,Wild Type (B),=,68,ng/ml,1,Lambda,75,G75V + T76I + Δ246-252 + L452Q + F490S + M869N,1,=,305,ng/ml,1,=,4.5,,,
EMA21d,https://www.ema.europa.eu/en/documents/product-information/xevudy-epar-product-information_en.pdf,Pseudovirus,Table 2,Sotrovimab,Wild Type (B),,,,,Lambda,75,G75V + T76I + Δ246-252 + L452Q + F490S + M869N,1,,,,,=,1,,,
Cathcart21,10.1101/2021.03.09.434607,Pseudovirus (VSV),Table 2,Sotrovimab,Wild Type (B),,,,,Lambda,75,G75V + T76I + Δ246-252 + L452Q + F490S + M869N,1,,,,,=,1.5,,,
FDA22,https://www.fda.gov/media/156152/download,Pseudovirus,"Mar 2022, Page 13, antiviral resistance, Table 2",Bebtelovimab,Wild Type (B),,,,,Lambda,75,G75V + T76I + Δ246-252 + L452Q + F490S + M869N,1,,,,,=,1,,,
EMA21c,https://www.ema.europa.eu/en/documents/product-information/regkirona-epar-product-information_en.pdf,Pseudovirus,Table 3,Regdanvimab,Wild Type (B),,,,,Lambda,75,G75V + T76I + Δ246-252 + L452Q + F490S + M869N,1,,,,,=,15.5,,,
Margolis21,https://idweek.org/Margolis,Pseudovirus,Table 2,Amubarvimab + Romlusevimab,Wild Type (B.1),,,,,Lambda,75,G75V + T76I + Δ246-252 + L452Q + F490S + M869N,1,,,,,=,2.5,,,
Wang22c,10.1038/s41586-022-04466-x,Pseudovirus (VSV),Supplmentary Table 2,DXP-604,Wild Type (B),=,17,ng/ml,1,Lambda,75,G75V + T76I + Δ246-252 + L452Q + F490S + M869N,1,=,17,ng/ml,1,=,1,,,
Wang21e,10.1126/science.abh1766,Pseudovirus (lentivirus),Fig 2C,Bamlanivimab,Wild Type (A),=,7.1,ng/ml,1,Alpha/E484K,69,Δ69-70 + Δ144-145 + E484K + N501Y + A570D + P681H + T716I + S982A + D1118H,1,>,10000,ng/ml,1,>,1000,,,
Wang21e,10.1126/science.abh1766,Pseudovirus (lentivirus),Fig 2C,Etesevimab,Wild Type (A),=,26.2,ng/ml,1,Alpha/E484K,69,Δ69-70 + Δ144-145 + E484K + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,575.8,ng/ml,1,=,22,,,
Wang21e,10.1126/science.abh1766,Pseudovirus (lentivirus),Fig 2C,Casirivimab,Wild Type (A),=,7.7,ng/ml,1,Alpha/E484K,69,Δ69-70 + Δ144-145 + E484K + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,87.5,ng/ml,1,=,11.4,,,
Wang21e,10.1126/science.abh1766,Pseudovirus (lentivirus),Fig 2C,Imdevimab,Wild Type (A),=,71,ng/ml,1,Alpha/E484K,69,Δ69-70 + Δ144-145 + E484K + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,10.9,ng/ml,1,=,0.2,,,
House22,10.1371/journal.pone.0267796,Pseudovirus,Fig 1A,Cilgavimab,Wild Type (B.1),,,,,Alpha/E484K,69,Δ69-70 + Δ144-145 + E484K + N501Y + A570D + P681H + T716I + S982A + D1118H,1,,,,,=,1.5,,,
FDA21c,https://www.fda.gov/media/154701/download,Pseudovirus,"Feb 2022, Page 17, Antiviral resistance paragraph 4",Tixagevimab,Wild Type (B),,,,,Alpha/E484K,69,Δ69-70 + Δ144-145 + E484K + N501Y + A570D + P681H + T716I + S982A + D1118H,1,,,,,=,18.5,,,
Cathcart21,10.1101/2021.03.09.434607,Pseudovirus (VSV),Table 2,Sotrovimab,Wild Type (B),,,,,Alpha/E484K,69,Δ69-70 + Δ144-145 + E484K + N501Y + A570D + P681H + T716I + S982A + D1118H,1,,,,,=,1.7,,,
Westendorf22,10.1016/j.celrep.2022.110812,Pseudovirus (VSV),Table 3B,Bebtelovimab,Wild Type (A),=,3,ng/ml,1,Alpha/E484K,69,Δ69-70 + Δ144-145 + E484K + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,3,ng/ml,1,=,1,,,
Westendorf22,10.1016/j.celrep.2022.110812,Pseudovirus (lentivirus),Table 3B,Bebtelovimab,Wild Type (A),=,5,ng/ml,1,Alpha/E484K,69,Δ69-70 + Δ144-145 + E484K + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,8,ng/ml,1,=,1.6,,,
House22,10.1371/journal.pone.0267796,Pseudovirus,Fig 1A,COV2-2381 + Cilgavimab,Wild Type (B.1),,,,,Alpha/E484K,69,Δ69-70 + Δ144-145 + E484K + N501Y + A570D + P681H + T716I + S982A + D1118H,1,,,,,=,1.5,,,
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Casirivimab,Omicron/BA.2,>,10000,ng/ml,1,Omicron/BA.4.7,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346S + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N658S + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Imdevimab,Omicron/BA.2,=,590,ng/ml,1,Omicron/BA.4.7,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346S + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N658S + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1362,ng/ml,1,>,2.3,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Casirivimab + Imdevimab,Omicron/BA.2,=,821,ng/ml,1,Omicron/BA.4.7,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346S + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N658S + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,2420,ng/ml,1,>,2.9,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Cilgavimab,Omicron/BA.2,=,6.3,ng/ml,1,Omicron/BA.4.7,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346S + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N658S + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,158.7,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Wang22j,10.1016/S1473-3099(22)00694-6,Pseudovirus (VSV),Figure S3,Cilgavimab,Wild Type (B.1),=,8,ng/ml,1,Omicron/BA.4.7,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346S + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N658S + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Wang22j,10.1016/S1473-3099(22)00694-6,Pseudovirus (VSV),Figure S3,Tixagevimab,Wild Type (B.1),=,3,ng/ml,1,Omicron/BA.4.7,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346S + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N658S + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Cilgavimab + Tixagevimab,Omicron/BA.2,=,8.2,ng/ml,1,Omicron/BA.4.7,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346S + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N658S + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,122,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Wang22j,10.1016/S1473-3099(22)00694-6,Pseudovirus (VSV),Figure S3,Cilgavimab + Tixagevimab,Wild Type (B.1),=,3,ng/ml,1,Omicron/BA.4.7,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346S + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N658S + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Sotrovimab,Omicron/BA.2,=,852,ng/ml,1,Omicron/BA.4.7,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346S + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N658S + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,2899,ng/ml,1,>,3.4,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Wang22j,10.1016/S1473-3099(22)00694-6,Pseudovirus (VSV),Figure S3,Sotrovimab,Wild Type (B.1),=,66,ng/ml,1,Omicron/BA.4.7,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346S + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N658S + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1440,ng/ml,1,=,21.8,,,
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Bebtelovimab,Omicron/BA.2,=,0.9,ng/ml,1,Omicron/BA.4.7,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346S + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N658S + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1.4,ng/ml,1,=,1.6,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Wang22j,10.1016/S1473-3099(22)00694-6,Pseudovirus (VSV),Figure S3,Bebtelovimab,Wild Type (B.1),=,1.5,ng/ml,1,Omicron/BA.4.7,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346S + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N658S + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1,ng/ml,1,=,0.7,,,
Wang22j,10.1016/S1473-3099(22)00694-6,Pseudovirus (VSV),Figure S3,Amubarvimab,Wild Type (B.1),=,24,ng/ml,1,Omicron/BA.4.7,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346S + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N658S + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,531,ng/ml,1,=,22.1,,,
Wang22j,10.1016/S1473-3099(22)00694-6,Pseudovirus (VSV),Figure S3,Romlusevimab,Wild Type (B.1),=,436,ng/ml,1,Omicron/BA.4.7,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346S + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N658S + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,22.9,,,
Wang22j,10.1016/S1473-3099(22)00694-6,Pseudovirus (VSV),Figure S3,Amubarvimab + Romlusevimab,Wild Type (B.1),=,34,ng/ml,1,Omicron/BA.4.7,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346S + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N658S + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1195,ng/ml,1,=,35.1,,,
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,DXP-604,Omicron/BA.2,=,219,ng/ml,1,Omicron/BA.4.7,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346S + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N658S + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,5189,ng/ml,1,>,23.7,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Casirivimab,Omicron/BA.2,>,10000,ng/ml,1,Omicron/BA.5.9,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346I + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Imdevimab,Omicron/BA.2,=,590,ng/ml,1,Omicron/BA.5.9,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346I + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,2701,ng/ml,1,>,4.6,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Casirivimab + Imdevimab,Omicron/BA.2,=,821,ng/ml,1,Omicron/BA.5.9,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346I + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,3498,ng/ml,1,>,4.3,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Cilgavimab,Omicron/BA.2,=,6.3,ng/ml,1,Omicron/BA.5.9,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346I + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,158.7,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Wang22j,10.1016/S1473-3099(22)00694-6,Pseudovirus (VSV),Figure S3,Cilgavimab,Wild Type (B.1),=,8,ng/ml,1,Omicron/BA.5.9,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346I + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Wang22j,10.1016/S1473-3099(22)00694-6,Pseudovirus (VSV),Figure S3,Tixagevimab,Wild Type (B.1),=,3,ng/ml,1,Omicron/BA.5.9,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346I + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Cilgavimab + Tixagevimab,Omicron/BA.2,=,8.2,ng/ml,1,Omicron/BA.5.9,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346I + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,122,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Wang22j,10.1016/S1473-3099(22)00694-6,Pseudovirus (VSV),Figure S3,Cilgavimab + Tixagevimab,Wild Type (B.1),=,3,ng/ml,1,Omicron/BA.5.9,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346I + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Sotrovimab,Omicron/BA.2,=,852,ng/ml,1,Omicron/BA.5.9,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346I + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,4780,ng/ml,1,>,5.6,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Wang22j,10.1016/S1473-3099(22)00694-6,Pseudovirus (VSV),Figure S3,Sotrovimab,Wild Type (B.1),=,66,ng/ml,1,Omicron/BA.5.9,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346I + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,3188,ng/ml,1,=,48.3,,,
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Bebtelovimab,Omicron/BA.2,=,0.9,ng/ml,1,Omicron/BA.5.9,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346I + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1.3,ng/ml,1,=,1.4,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Wang22j,10.1016/S1473-3099(22)00694-6,Pseudovirus (VSV),Figure S3,Bebtelovimab,Wild Type (B.1),=,1.5,ng/ml,1,Omicron/BA.5.9,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346I + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,0.9,ng/ml,1,=,0.6,,,
Wang22j,10.1016/S1473-3099(22)00694-6,Pseudovirus (VSV),Figure S3,Amubarvimab,Wild Type (B.1),=,24,ng/ml,1,Omicron/BA.5.9,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346I + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,466,ng/ml,1,=,19.4,,,
Wang22j,10.1016/S1473-3099(22)00694-6,Pseudovirus (VSV),Figure S3,Romlusevimab,Wild Type (B.1),=,436,ng/ml,1,Omicron/BA.5.9,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346I + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,22.9,,,
Wang22j,10.1016/S1473-3099(22)00694-6,Pseudovirus (VSV),Figure S3,Amubarvimab + Romlusevimab,Wild Type (B.1),=,34,ng/ml,1,Omicron/BA.5.9,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346I + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1000,ng/ml,1,=,29.4,,,
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,DXP-604,Omicron/BA.2,=,219,ng/ml,1,Omicron/BA.5.9,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346I + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,8360,ng/ml,1,>,38.2,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Arora22f,10.1016/S1473-3099(22)00733-2,Pseudovirus (VSV),Figure B,Bamlanivimab,Wild Type (B.1),=,16,ng/ml,1,Omicron/BA.2.75.2,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + F486S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K + D1199N,1,>,50000,ng/ml,1,>,1000,,,
Sheward22c,10.1101/2022.09.16.508299,Pseudovirus,Figure 1B,Bamlanivimab,Wild Type (B.1),=,9,ng/ml,1,Omicron/BA.2.75.2,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + F486S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K + D1199N,1,>,1000,ng/ml,1,>,111.1,,,
Arora22f,10.1016/S1473-3099(22)00733-2,Pseudovirus (VSV),Figure B,Etesevimab,Wild Type (B.1),=,53,ng/ml,1,Omicron/BA.2.75.2,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + F486S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K + D1199N,1,>,50000,ng/ml,1,>,943.4,,,
Sheward22c,10.1101/2022.09.16.508299,Pseudovirus,Figure 1B,Etesevimab,Wild Type (B.1),=,29,ng/ml,1,Omicron/BA.2.75.2,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + F486S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K + D1199N,1,>,1000,ng/ml,1,>,34.5,,,
Arora22f,10.1016/S1473-3099(22)00733-2,Pseudovirus (VSV),Figure B,Bamlanivimab + Etesevimab,Wild Type (B.1),=,18,ng/ml,1,Omicron/BA.2.75.2,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + F486S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K + D1199N,1,>,50000,ng/ml,1,>,1000,,,
Arora22f,10.1016/S1473-3099(22)00733-2,Pseudovirus (VSV),Figure B,Casirivimab,Wild Type (B.1),=,21,ng/ml,1,Omicron/BA.2.75.2,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + F486S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K + D1199N,1,>,50000,ng/ml,1,>,1000,,,
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Casirivimab,Omicron/BA.2,>,10000,ng/ml,1,Omicron/BA.2.75.2,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + F486S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K + D1199N,1,>,10000,ng/ml,1,>,1,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Sheward22c,10.1101/2022.09.16.508299,Pseudovirus,Figure 1B,Casirivimab,Wild Type (B.1),=,14,ng/ml,1,Omicron/BA.2.75.2,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + F486S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K + D1199N,1,>,1000,ng/ml,1,>,71.4,,,
Planas22b,10.1101/2022.11.17.516888,Virus isolate,Figure 3b,Casirivimab,Wild Type (B.1),=,1.7,ng/ml,1,Omicron/BA.2.75.2,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + F486S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K + D1199N,1,>,10000,ng/ml,1,>,1000,,,
Touret22c,10.1101/2022.12.22.521201,Virus isolate,Table 1,Casirivimab,Delta,=,14.7,ng/ml,1,Omicron/BA.2.75.2,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + F486S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K + D1199N + D1259D + D1259H + D1259N + D1259Y,1,>,5000,ng/ml,1,>,340.1,,,
Arora22f,10.1016/S1473-3099(22)00733-2,Pseudovirus (VSV),Figure B,Imdevimab,Wild Type (B.1),=,19,ng/ml,1,Omicron/BA.2.75.2,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + F486S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K + D1199N,1,>,50000,ng/ml,1,>,1000,,,
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Imdevimab,Omicron/BA.2,=,590,ng/ml,1,Omicron/BA.2.75.2,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + F486S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K + D1199N,1,>,10000,ng/ml,1,>,1.7,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Sheward22c,10.1101/2022.09.16.508299,Pseudovirus,Figure 1B,Imdevimab,Wild Type (B.1),=,10,ng/ml,1,Omicron/BA.2.75.2,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + F486S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K + D1199N,1,>,1000,ng/ml,1,>,100,,,
Planas22b,10.1101/2022.11.17.516888,Virus isolate,Figure 3b,Imdevimab,Wild Type (B.1),=,2.1,ng/ml,1,Omicron/BA.2.75.2,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + F486S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K + D1199N,1,>,10000,ng/ml,1,>,1000,,,
Touret22c,10.1101/2022.12.22.521201,Virus isolate,Table 1,Imdevimab,Delta,=,20.1,ng/ml,1,Omicron/BA.2.75.2,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + F486S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K + D1199N + D1259D + D1259H + D1259N + D1259Y,1,>,5000,ng/ml,1,>,248.8,,,
Arora22f,10.1016/S1473-3099(22)00733-2,Pseudovirus (VSV),Figure B,Casirivimab + Imdevimab,Wild Type (B.1),=,9,ng/ml,1,Omicron/BA.2.75.2,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + F486S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K + D1199N,1,>,50000,ng/ml,1,>,1000,,,
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Casirivimab + Imdevimab,Omicron/BA.2,=,821,ng/ml,1,Omicron/BA.2.75.2,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + F486S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K + D1199N,1,>,10000,ng/ml,1,>,1.2,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Planas22b,10.1101/2022.11.17.516888,Virus isolate,Figure 3b,Casirivimab + Imdevimab,Wild Type (B.1),=,1.6,ng/ml,1,Omicron/BA.2.75.2,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + F486S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K + D1199N,1,>,10000,ng/ml,1,>,1000,,,
Arora22f,10.1016/S1473-3099(22)00733-2,Pseudovirus (VSV),Figure B,Cilgavimab,Wild Type (B.1),=,37,ng/ml,1,Omicron/BA.2.75.2,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + F486S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K + D1199N,1,>,50000,ng/ml,1,>,1000,,,
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Cilgavimab,Omicron/BA.2,=,6.3,ng/ml,1,Omicron/BA.2.75.2,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + F486S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K + D1199N,1,>,10000,ng/ml,1,>,158.7,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Sheward22c,10.1101/2022.09.16.508299,Pseudovirus,Figure 1B,Cilgavimab,Wild Type (B.1),=,12,ng/ml,1,Omicron/BA.2.75.2,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + F486S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K + D1199N,1,>,1000,ng/ml,1,>,83.3,,,
Planas22b,10.1101/2022.11.17.516888,Virus isolate,Figure 3b,Cilgavimab,Wild Type (B.1),=,2.9,ng/ml,1,Omicron/BA.2.75.2,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + F486S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K + D1199N,1,>,10000,ng/ml,1,>,1000,,,
Touret22c,10.1101/2022.12.22.521201,Virus isolate,Table 1,Cilgavimab,Delta,=,21.7,ng/ml,1,Omicron/BA.2.75.2,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + F486S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K + D1199N + D1259D + D1259H + D1259N + D1259Y,1,>,5000,ng/ml,1,>,230.4,,,
Arora22f,10.1016/S1473-3099(22)00733-2,Pseudovirus (VSV),Figure B,Tixagevimab,Wild Type (B.1),=,7,ng/ml,1,Omicron/BA.2.75.2,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + F486S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K + D1199N,1,>,50000,ng/ml,1,>,1000,,,
Sheward22c,10.1101/2022.09.16.508299,Pseudovirus,Figure 1B,Tixagevimab,Wild Type (B.1),=,4,ng/ml,1,Omicron/BA.2.75.2,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + F486S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K + D1199N,1,>,1000,ng/ml,1,>,250,,,
Planas22b,10.1101/2022.11.17.516888,Virus isolate,Figure 3b,Tixagevimab,Wild Type (B.1),=,1.3,ng/ml,1,Omicron/BA.2.75.2,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + F486S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K + D1199N,1,>,10000,ng/ml,1,>,1000,,,
Touret22c,10.1101/2022.12.22.521201,Virus isolate,Table 1,Tixagevimab,Delta,=,12.4,ng/ml,1,Omicron/BA.2.75.2,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + F486S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K + D1199N + D1259D + D1259H + D1259N + D1259Y,1,>,5000,ng/ml,1,>,403.2,,,
Arora22f,10.1016/S1473-3099(22)00733-2,Pseudovirus (VSV),Figure B,Cilgavimab + Tixagevimab,Wild Type (B.1),=,7,ng/ml,1,Omicron/BA.2.75.2,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + F486S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K + D1199N,1,>,50000,ng/ml,1,>,1000,,,
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Cilgavimab + Tixagevimab,Omicron/BA.2,=,8.2,ng/ml,1,Omicron/BA.2.75.2,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + F486S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K + D1199N,1,>,10000,ng/ml,1,>,122,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Sheward22c,10.1101/2022.09.16.508299,Pseudovirus,Figure 1B,Cilgavimab + Tixagevimab,Wild Type (B.1),=,6,ng/ml,1,Omicron/BA.2.75.2,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + F486S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K + D1199N,1,>,1000,ng/ml,1,>,166.7,,,
Planas22b,10.1101/2022.11.17.516888,Virus isolate,Figure 3b,Cilgavimab + Tixagevimab,Wild Type (B.1),=,1.3,ng/ml,1,Omicron/BA.2.75.2,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + F486S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K + D1199N,1,>,10000,ng/ml,1,>,1000,,,
Touret22c,10.1101/2022.12.22.521201,Virus isolate,Table 1,Cilgavimab + Tixagevimab,Delta,=,12.5,ng/ml,1,Omicron/BA.2.75.2,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + F486S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K + D1199N + D1259D + D1259H + D1259N + D1259Y,1,>,5000,ng/ml,1,>,400,,,
Arora22f,10.1016/S1473-3099(22)00733-2,Pseudovirus (VSV),Figure B,Sotrovimab,Wild Type (B.1),=,157,ng/ml,1,Omicron/BA.2.75.2,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + F486S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K + D1199N,1,=,3239,ng/ml,1,=,20.6,,,
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Sotrovimab,Omicron/BA.2,=,852,ng/ml,1,Omicron/BA.2.75.2,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + F486S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K + D1199N,1,=,852,ng/ml,1,=,1,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Sheward22c,10.1101/2022.09.16.508299,Pseudovirus,Figure 1B,Sotrovimab,Wild Type (B.1),=,119,ng/ml,1,Omicron/BA.2.75.2,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + F486S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K + D1199N,1,=,442,ng/ml,1,=,3.7,,,
Planas22b,10.1101/2022.11.17.516888,Virus isolate,Figure 3b,Sotrovimab,Wild Type (B.1),=,65,ng/ml,1,Omicron/BA.2.75.2,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + F486S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K + D1199N,1,>,19391,ng/ml,1,>,298.3,,,
Touret22c,10.1101/2022.12.22.521201,Virus isolate,Table 1,Sotrovimab,Delta,=,98.6,ng/ml,1,Omicron/BA.2.75.2,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + F486S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K + D1199N + D1259D + D1259H + D1259N + D1259Y,1,=,422.3,ng/ml,1,=,4.3,,,
Arora22f,10.1016/S1473-3099(22)00733-2,Pseudovirus (VSV),Figure B,Bebtelovimab,Wild Type (B.1),=,5,ng/ml,1,Omicron/BA.2.75.2,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + F486S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K + D1199N,1,=,14,ng/ml,1,=,2.8,,,
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Bebtelovimab,Omicron/BA.2,=,0.9,ng/ml,1,Omicron/BA.2.75.2,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + F486S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K + D1199N,1,=,3,ng/ml,1,=,3.3,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Sheward22c,10.1101/2022.09.16.508299,Pseudovirus,Figure 1B,Bebtelovimab,Wild Type (B.1),=,4,ng/ml,1,Omicron/BA.2.75.2,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + F486S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K + D1199N,1,=,2,ng/ml,1,=,0.5,,,
Planas22b,10.1101/2022.11.17.516888,Virus isolate,Figure 3b,Bebtelovimab,Wild Type (B.1),=,1.4,ng/ml,1,Omicron/BA.2.75.2,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + F486S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K + D1199N,1,=,4.3,ng/ml,1,=,3.1,,,
Touret22c,10.1101/2022.12.22.521201,Virus isolate,Table 1,Bebtelovimab,Delta,=,0.4,ng/ml,1,Omicron/BA.2.75.2,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + F486S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K + D1199N + D1259D + D1259H + D1259N + D1259Y,1,=,0.6,ng/ml,1,=,1.5,,,
Arora22f,10.1016/S1473-3099(22)00733-2,Pseudovirus (VSV),Figure B,Regdanvimab,Wild Type (B.1),=,7,ng/ml,1,Omicron/BA.2.75.2,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + F486S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K + D1199N,1,=,6336,ng/ml,1,=,905.1,,,
Arora22f,10.1016/S1473-3099(22)00733-2,Pseudovirus (VSV),Figure B,Amubarvimab,Wild Type (B.1),=,53,ng/ml,1,Omicron/BA.2.75.2,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + F486S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K + D1199N,1,>,50000,ng/ml,1,>,943.4,,,
Arora22f,10.1016/S1473-3099(22)00733-2,Pseudovirus (VSV),Figure B,Romlusevimab,Wild Type (B.1),=,852,ng/ml,1,Omicron/BA.2.75.2,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + F486S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K + D1199N,1,>,50000,ng/ml,1,>,58.7,,,
Arora22f,10.1016/S1473-3099(22)00733-2,Pseudovirus (VSV),Figure B,Amubarvimab + Romlusevimab,Wild Type (B.1),=,64,ng/ml,1,Omicron/BA.2.75.2,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + F486S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K + D1199N,1,>,50000,ng/ml,1,>,781.3,,,
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,DXP-604,Omicron/BA.2,=,219,ng/ml,1,Omicron/BA.2.75.2,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + F486S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K + D1199N,1,>,10000,ng/ml,1,>,4.6,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Chen21e,10.1038/s41586-021-03720-y,SARS-CoV-2 recombinant,Figure 1c,Bamlanivimab,Wild Type (B.1),=,5,ng/ml,1,Iota/S477N,5,L5F + T95I + D253G + S477N + A701V,1,=,2,ng/ml,1,=,0.4,,,
Nabel21,10.1126/science.abl6251,Pseudovirus (lentivirus),"Fig 2A, 2B",Bamlanivimab,Wild Type (B.1),=,22,ng/ml,1,Iota/S477N,5,L5F + T95I + D253G + S477N + A701V,1,=,19,ng/ml,1,=,0.9,,,
Chen21e,10.1038/s41586-021-03720-y,SARS-CoV-2 recombinant,Extended Data Fig 13,Etesevimab,Wild Type (B.1),=,52,ng/ml,1,Iota/S477N,5,L5F + T95I + D253G + S477N + A701V,1,=,9,ng/ml,1,=,0.2,,,
Nabel21,10.1126/science.abl6251,Pseudovirus (lentivirus),"Fig 2A, 2B",Etesevimab,Wild Type (B.1),=,27,ng/ml,1,Iota/S477N,5,L5F + T95I + D253G + S477N + A701V,1,=,22,ng/ml,1,=,0.8,,,
Zhang21c,10.1038/s42003-021-02728-4,Pseudovirus (VSV),Supplementary Figure 3,Etesevimab,Wild Type (B.1),,,,,Iota/S477N,5,L5F + T95I + D253G + S477N + Q957R,1,,,,,=,1.4,,,
Chen21e,10.1038/s41586-021-03720-y,SARS-CoV-2 recombinant,Extended Data Fig 13,Bamlanivimab + Etesevimab,Wild Type (B.1),=,9,ng/ml,1,Iota/S477N,5,L5F + T95I + D253G + S477N + A701V,1,=,3,ng/ml,1,=,0.3,,,
Chen21e,10.1038/s41586-021-03720-y,SARS-CoV-2 recombinant,Figure 1c,Casirivimab,Wild Type (B.1),=,7,ng/ml,1,Iota/S477N,5,L5F + T95I + D253G + S477N + A701V,1,=,4,ng/ml,1,=,0.6,,,
Nabel21,10.1126/science.abl6251,Pseudovirus (lentivirus),"Fig 2A, 2B",Casirivimab,Wild Type (B.1),=,25,ng/ml,1,Iota/S477N,5,L5F + T95I + D253G + S477N + A701V,1,=,25,ng/ml,1,=,1,,,
Zhou21c,10.1128/mBio.01386-21,Pseudovirus (HIV),Table 1,Casirivimab,Wild Type (B.1),=,5.7,ng/ml,1,Iota/S477N,5,L5F + T95I + D253G + S477N + A701V,1,=,1.2,ng/ml,1,=,0.2,,,
Chen21e,10.1038/s41586-021-03720-y,SARS-CoV-2 recombinant,Figure 1c,Imdevimab,Wild Type (B.1),=,12,ng/ml,1,Iota/S477N,5,L5F + T95I + D253G + S477N + A701V,1,=,71,ng/ml,1,=,5.9,,,
Nabel21,10.1126/science.abl6251,Pseudovirus (lentivirus),"Fig 2A, 2B",Imdevimab,Wild Type (B.1),=,32,ng/ml,1,Iota/S477N,5,L5F + T95I + D253G + S477N + A701V,1,=,44,ng/ml,1,=,1.4,,,
Zhou21c,10.1128/mBio.01386-21,Pseudovirus (HIV),Table 1,Imdevimab,Wild Type (B.1),=,18.1,ng/ml,1,Iota/S477N,5,L5F + T95I + D253G + S477N + A701V,1,=,17.2,ng/ml,1,=,1,,,
Chen21e,10.1038/s41586-021-03720-y,SARS-CoV-2 recombinant,Figure 1c,Casirivimab + Imdevimab,Wild Type (B.1),=,5,ng/ml,1,Iota/S477N,5,L5F + T95I + D253G + S477N + A701V,1,=,2,ng/ml,1,=,0.4,,,
Zhou21c,10.1128/mBio.01386-21,Pseudovirus (HIV),Table 1,Casirivimab + Imdevimab,Wild Type (B.1),=,4.7,ng/ml,1,Iota/S477N,5,L5F + T95I + D253G + S477N + A701V,1,=,3.9,ng/ml,1,=,0.8,,,
Chen21e,10.1038/s41586-021-03720-y,SARS-CoV-2 recombinant,Figure 1c,Cilgavimab,Wild Type (B.1),=,26,ng/ml,1,Iota/S477N,5,L5F + T95I + D253G + S477N + A701V,1,=,8,ng/ml,1,=,0.3,,,
Chen21e,10.1038/s41586-021-03720-y,SARS-CoV-2 recombinant,Figure 1c,Tixagevimab,Wild Type (B.1),=,4,ng/ml,1,Iota/S477N,5,L5F + T95I + D253G + S477N + A701V,1,=,1,ng/ml,1,=,0.3,,,
Chen21e,10.1038/s41586-021-03720-y,SARS-CoV-2 recombinant,Figure 1c,Cilgavimab + Tixagevimab,Wild Type (B.1),=,4,ng/ml,1,Iota/S477N,5,L5F + T95I + D253G + S477N + A701V,1,=,1,ng/ml,1,=,0.3,,,
Chen21e,10.1038/s41586-021-03720-y,SARS-CoV-2 recombinant,Figure 1c,Sotrovimab,Wild Type (B.1),=,156,ng/ml,1,Iota/S477N,5,L5F + T95I + D253G + S477N + A701V,1,=,44,ng/ml,1,=,0.3,,,
Chen21e,10.1038/s41586-021-03720-y,SARS-CoV-2 recombinant,Figure 1c,S2E12 + Sotrovimab,Wild Type (B.1),=,7,ng/ml,1,Iota/S477N,5,L5F + T95I + D253G + S477N + A701V,1,=,2,ng/ml,1,=,0.3,,,
Yuan22,10.1101/2022.03.13.484037,Pseudovirus (MLV),Figure 2A,Bamlanivimab,Wild Type (B),=,7,ng/ml,1,WIV1,1,M1K + F2L + V3L + F4V + L7F + L8A + P9T + S12ins + S13Y + Q14T + C15I + V16E + N17K + L18C + T19L + T20D + R21F + T22D + Q23D + L24R + P25ins + Y28N + N30ins + F32S + T33H + K41D + V42I + S46N + S50L + T51V + L54H + F59D + W64R + H66I + A67T + I68F + H69G + V70L + S71N + Δ72-78 + V83I + L84I + N87K + V90I + S94A + I100V + I105V + T108S + L110M + D111N + S112N + T114S + L117V + L118I + V120M + A123S + V126L + K129R + V130A + E132N + Q134E + F135L + N137D + D138N + L141F + G142V + Y144L + Y145K + H146S + Δ147 + Δ150-152 + M153T + E154Q + S155I + E156P + F157S + R158Y + V159I + Y160F + S161N + S162N + N164F + Q173K + P174D + L176N + M177L + E180G + G181E + Q183P + N188D + K195R + I197K + Y200F + F201L + K202H + I203V + K206G + H207Y + T208Q + N211S + L212A + V213A + R214S + D215G + Q218T + S221N + E224K + L226I + V227F + D228K + I231L + R237N + Q239R + A243T + L244A + Δ245-246 + S247F + Y248P + L249P + T250R + G252D + D253Y + Δ254-257 + T259G + A260T + G261S + Y266F + Q271K + R273T + L276M + N280D + A292S + L293Q + D294N + S297A + T299L + T302S + L303V + T307E + V308I + E309D + Q321A + T323S + E324K + S325E + I326V + R346T + A348P + N354E + A372T + P384A + T393S + I402V + R403K + E406D + K417V + I434L + S438T + N439R + L441I + S443A + K444T + V445Q + G446T + L452K + L455S + F456L + K458H + S459G + N460K + K462R + T470N + E471V + I472P + Y473F + Q474S + A475P + G476D + S477G + T478K + N481T + G482P + Δ483 + E484P + G485A + F490W + Q493N + S494D + Q498Y + P499I + V503I + H519N + K529L + N532D + V534I + K537Q + E554P + N556S + K558R + L560Q + I569V + A570S + T572F + A575S + Q580K + L582S + T588S + N606S + Q607E + E619D + T632S + Y636H + S640N + R646Q + N657D + N658T + Q675H + Q677V + T678S + N679S + S680L + Δ681-684 + V687T + A688S + S689Q + Q690K + I693V + E702D + N703S + V705I + S711T + T719S + V722I + I726V + L727M + T732A + T739N + S750A + T768S + K776R + Q779R + I788M + P793T + I794L + S810L + S813T + I834M + D839E + A845N + E868D + Q872A + S875A + L878V + A879S + I882A + S884A + L922Q + S929K + G932S + K933Q + D936E + S939T + S940T + A942S + S943T + S1055A + A1070S + K1073R + D1084E + H1088Y + S1097F + H1101S + V1104I + Y1110F + E1111S + N1125S + V1133I + I1216V + M1233L + C1247A,1,>,5000,ng/ml,1,>,714.3,,,
Yuan22,10.1101/2022.03.13.484037,Pseudovirus (MLV),Figure 2A,Etesevimab,Wild Type (B),=,9,ng/ml,1,WIV1,1,M1K + F2L + V3L + F4V + L7F + L8A + P9T + S12ins + S13Y + Q14T + C15I + V16E + N17K + L18C + T19L + T20D + R21F + T22D + Q23D + L24R + P25ins + Y28N + N30ins + F32S + T33H + K41D + V42I + S46N + S50L + T51V + L54H + F59D + W64R + H66I + A67T + I68F + H69G + V70L + S71N + Δ72-78 + V83I + L84I + N87K + V90I + S94A + I100V + I105V + T108S + L110M + D111N + S112N + T114S + L117V + L118I + V120M + A123S + V126L + K129R + V130A + E132N + Q134E + F135L + N137D + D138N + L141F + G142V + Y144L + Y145K + H146S + Δ147 + Δ150-152 + M153T + E154Q + S155I + E156P + F157S + R158Y + V159I + Y160F + S161N + S162N + N164F + Q173K + P174D + L176N + M177L + E180G + G181E + Q183P + N188D + K195R + I197K + Y200F + F201L + K202H + I203V + K206G + H207Y + T208Q + N211S + L212A + V213A + R214S + D215G + Q218T + S221N + E224K + L226I + V227F + D228K + I231L + R237N + Q239R + A243T + L244A + Δ245-246 + S247F + Y248P + L249P + T250R + G252D + D253Y + Δ254-257 + T259G + A260T + G261S + Y266F + Q271K + R273T + L276M + N280D + A292S + L293Q + D294N + S297A + T299L + T302S + L303V + T307E + V308I + E309D + Q321A + T323S + E324K + S325E + I326V + R346T + A348P + N354E + A372T + P384A + T393S + I402V + R403K + E406D + K417V + I434L + S438T + N439R + L441I + S443A + K444T + V445Q + G446T + L452K + L455S + F456L + K458H + S459G + N460K + K462R + T470N + E471V + I472P + Y473F + Q474S + A475P + G476D + S477G + T478K + N481T + G482P + Δ483 + E484P + G485A + F490W + Q493N + S494D + Q498Y + P499I + V503I + H519N + K529L + N532D + V534I + K537Q + E554P + N556S + K558R + L560Q + I569V + A570S + T572F + A575S + Q580K + L582S + T588S + N606S + Q607E + E619D + T632S + Y636H + S640N + R646Q + N657D + N658T + Q675H + Q677V + T678S + N679S + S680L + Δ681-684 + V687T + A688S + S689Q + Q690K + I693V + E702D + N703S + V705I + S711T + T719S + V722I + I726V + L727M + T732A + T739N + S750A + T768S + K776R + Q779R + I788M + P793T + I794L + S810L + S813T + I834M + D839E + A845N + E868D + Q872A + S875A + L878V + A879S + I882A + S884A + L922Q + S929K + G932S + K933Q + D936E + S939T + S940T + A942S + S943T + S1055A + A1070S + K1073R + D1084E + H1088Y + S1097F + H1101S + V1104I + Y1110F + E1111S + N1125S + V1133I + I1216V + M1233L + C1247A,1,>,5000,ng/ml,1,>,555.6,,,
Yuan22,10.1101/2022.03.13.484037,Pseudovirus (MLV),Figure 2A,Bamlanivimab + Etesevimab,Wild Type (B),=,9,ng/ml,1,WIV1,1,M1K + F2L + V3L + F4V + L7F + L8A + P9T + S12ins + S13Y + Q14T + C15I + V16E + N17K + L18C + T19L + T20D + R21F + T22D + Q23D + L24R + P25ins + Y28N + N30ins + F32S + T33H + K41D + V42I + S46N + S50L + T51V + L54H + F59D + W64R + H66I + A67T + I68F + H69G + V70L + S71N + Δ72-78 + V83I + L84I + N87K + V90I + S94A + I100V + I105V + T108S + L110M + D111N + S112N + T114S + L117V + L118I + V120M + A123S + V126L + K129R + V130A + E132N + Q134E + F135L + N137D + D138N + L141F + G142V + Y144L + Y145K + H146S + Δ147 + Δ150-152 + M153T + E154Q + S155I + E156P + F157S + R158Y + V159I + Y160F + S161N + S162N + N164F + Q173K + P174D + L176N + M177L + E180G + G181E + Q183P + N188D + K195R + I197K + Y200F + F201L + K202H + I203V + K206G + H207Y + T208Q + N211S + L212A + V213A + R214S + D215G + Q218T + S221N + E224K + L226I + V227F + D228K + I231L + R237N + Q239R + A243T + L244A + Δ245-246 + S247F + Y248P + L249P + T250R + G252D + D253Y + Δ254-257 + T259G + A260T + G261S + Y266F + Q271K + R273T + L276M + N280D + A292S + L293Q + D294N + S297A + T299L + T302S + L303V + T307E + V308I + E309D + Q321A + T323S + E324K + S325E + I326V + R346T + A348P + N354E + A372T + P384A + T393S + I402V + R403K + E406D + K417V + I434L + S438T + N439R + L441I + S443A + K444T + V445Q + G446T + L452K + L455S + F456L + K458H + S459G + N460K + K462R + T470N + E471V + I472P + Y473F + Q474S + A475P + G476D + S477G + T478K + N481T + G482P + Δ483 + E484P + G485A + F490W + Q493N + S494D + Q498Y + P499I + V503I + H519N + K529L + N532D + V534I + K537Q + E554P + N556S + K558R + L560Q + I569V + A570S + T572F + A575S + Q580K + L582S + T588S + N606S + Q607E + E619D + T632S + Y636H + S640N + R646Q + N657D + N658T + Q675H + Q677V + T678S + N679S + S680L + Δ681-684 + V687T + A688S + S689Q + Q690K + I693V + E702D + N703S + V705I + S711T + T719S + V722I + I726V + L727M + T732A + T739N + S750A + T768S + K776R + Q779R + I788M + P793T + I794L + S810L + S813T + I834M + D839E + A845N + E868D + Q872A + S875A + L878V + A879S + I882A + S884A + L922Q + S929K + G932S + K933Q + D936E + S939T + S940T + A942S + S943T + S1055A + A1070S + K1073R + D1084E + H1088Y + S1097F + H1101S + V1104I + Y1110F + E1111S + N1125S + V1133I + I1216V + M1233L + C1247A,1,>,5000,ng/ml,1,>,555.6,,,
Yuan22,10.1101/2022.03.13.484037,Pseudovirus (MLV),Figure 2A,Casirivimab,Wild Type (B),=,6,ng/ml,1,WIV1,1,M1K + F2L + V3L + F4V + L7F + L8A + P9T + S12ins + S13Y + Q14T + C15I + V16E + N17K + L18C + T19L + T20D + R21F + T22D + Q23D + L24R + P25ins + Y28N + N30ins + F32S + T33H + K41D + V42I + S46N + S50L + T51V + L54H + F59D + W64R + H66I + A67T + I68F + H69G + V70L + S71N + Δ72-78 + V83I + L84I + N87K + V90I + S94A + I100V + I105V + T108S + L110M + D111N + S112N + T114S + L117V + L118I + V120M + A123S + V126L + K129R + V130A + E132N + Q134E + F135L + N137D + D138N + L141F + G142V + Y144L + Y145K + H146S + Δ147 + Δ150-152 + M153T + E154Q + S155I + E156P + F157S + R158Y + V159I + Y160F + S161N + S162N + N164F + Q173K + P174D + L176N + M177L + E180G + G181E + Q183P + N188D + K195R + I197K + Y200F + F201L + K202H + I203V + K206G + H207Y + T208Q + N211S + L212A + V213A + R214S + D215G + Q218T + S221N + E224K + L226I + V227F + D228K + I231L + R237N + Q239R + A243T + L244A + Δ245-246 + S247F + Y248P + L249P + T250R + G252D + D253Y + Δ254-257 + T259G + A260T + G261S + Y266F + Q271K + R273T + L276M + N280D + A292S + L293Q + D294N + S297A + T299L + T302S + L303V + T307E + V308I + E309D + Q321A + T323S + E324K + S325E + I326V + R346T + A348P + N354E + A372T + P384A + T393S + I402V + R403K + E406D + K417V + I434L + S438T + N439R + L441I + S443A + K444T + V445Q + G446T + L452K + L455S + F456L + K458H + S459G + N460K + K462R + T470N + E471V + I472P + Y473F + Q474S + A475P + G476D + S477G + T478K + N481T + G482P + Δ483 + E484P + G485A + F490W + Q493N + S494D + Q498Y + P499I + V503I + H519N + K529L + N532D + V534I + K537Q + E554P + N556S + K558R + L560Q + I569V + A570S + T572F + A575S + Q580K + L582S + T588S + N606S + Q607E + E619D + T632S + Y636H + S640N + R646Q + N657D + N658T + Q675H + Q677V + T678S + N679S + S680L + Δ681-684 + V687T + A688S + S689Q + Q690K + I693V + E702D + N703S + V705I + S711T + T719S + V722I + I726V + L727M + T732A + T739N + S750A + T768S + K776R + Q779R + I788M + P793T + I794L + S810L + S813T + I834M + D839E + A845N + E868D + Q872A + S875A + L878V + A879S + I882A + S884A + L922Q + S929K + G932S + K933Q + D936E + S939T + S940T + A942S + S943T + S1055A + A1070S + K1073R + D1084E + H1088Y + S1097F + H1101S + V1104I + Y1110F + E1111S + N1125S + V1133I + I1216V + M1233L + C1247A,1,>,5000,ng/ml,1,>,833.3,,,
Wang22b,10.1101/2022.01.30.478305,Pseudovirus (HIV),Figure 1B,Imdevimab,Wild Type (B),=,2.3,ng/ml,1,WIV1,1,M1K + F2L + V3L + F4V + L7F + L8A + P9T + S12ins + S13Y + Q14T + C15I + V16E + N17K + L18C + T19L + T20D + R21F + T22D + Q23D + L24R + P25ins + Y28N + N30ins + F32S + T33H + K41D + V42I + S46N + S50L + T51V + L54H + F59D + W64R + H66I + A67T + I68F + H69G + V70L + S71N + Δ72-78 + V83I + L84I + N87K + V90I + S94A + I100V + I105V + T108S + L110M + D111N + S112N + T114S + L117V + L118I + V120M + A123S + V126L + K129R + V130A + E132N + Q134E + F135L + N137D + D138N + L141F + G142V + Y144L + Y145K + H146S + Δ147 + Δ150-152 + M153T + E154Q + S155I + E156P + F157S + R158Y + V159I + Y160F + S161N + S162N + N164F + Q173K + P174D + L176N + M177L + E180G + G181E + Q183P + N188D + K195R + I197K + Y200F + F201L + K202H + I203V + K206G + H207Y + T208Q + N211S + L212A + V213A + R214S + D215G + Q218T + S221N + E224K + L226I + V227F + D228K + I231L + R237N + Q239R + A243T + L244A + Δ245-246 + S247F + Y248P + L249P + T250R + G252D + D253Y + Δ254-257 + T259G + A260T + G261S + Y266F + Q271K + R273T + L276M + N280D + A292S + L293Q + D294N + S297A + T299L + T302S + L303V + T307E + V308I + E309D + Q321A + T323S + E324K + S325E + I326V + R346T + A348P + N354E + A372T + P384A + T393S + I402V + R403K + E406D + K417V + I434L + S438T + N439R + L441I + S443A + K444T + V445Q + G446T + L452K + L455S + F456L + K458H + S459G + N460K + K462R + T470N + E471V + I472P + Y473F + Q474S + A475P + G476D + S477G + T478K + N481T + G482P + Δ483 + E484P + G485A + F490W + Q493N + S494D + Q498Y + P499I + V503I + H519N + K529L + N532D + V534I + K537Q + E554P + N556S + K558R + L560Q + I569V + A570S + T572F + A575S + Q580K + L582S + T588S + N606S + Q607E + E619D + T632S + Y636H + S640N + R646Q + N657D + N658T + Q675H + Q677V + T678S + N679S + S680L + Δ681-684 + V687T + A688S + S689Q + Q690K + I693V + E702D + N703S + V705I + S711T + T719S + V722I + I726V + L727M + T732A + T739N + S750A + T768S + K776R + Q779R + I788M + P793T + I794L + S810L + S813T + I834M + D839E + A845N + E868D + Q872A + S875A + L878V + A879S + I882A + S884A + L922Q + S929K + G932S + K933Q + D936E + S939T + S940T + A942S + S943T + S1055A + A1070S + K1073R + D1084E + H1088Y + S1097F + H1101S + V1104I + Y1110F + E1111S + N1125S + V1133I + I1216V + M1233L + C1247A,1,>,10000,ng/ml,1,>,1000,,,
Yuan22,10.1101/2022.03.13.484037,Pseudovirus (MLV),Figure 2A,Imdevimab,Wild Type (B),=,25,ng/ml,1,WIV1,1,M1K + F2L + V3L + F4V + L7F + L8A + P9T + S12ins + S13Y + Q14T + C15I + V16E + N17K + L18C + T19L + T20D + R21F + T22D + Q23D + L24R + P25ins + Y28N + N30ins + F32S + T33H + K41D + V42I + S46N + S50L + T51V + L54H + F59D + W64R + H66I + A67T + I68F + H69G + V70L + S71N + Δ72-78 + V83I + L84I + N87K + V90I + S94A + I100V + I105V + T108S + L110M + D111N + S112N + T114S + L117V + L118I + V120M + A123S + V126L + K129R + V130A + E132N + Q134E + F135L + N137D + D138N + L141F + G142V + Y144L + Y145K + H146S + Δ147 + Δ150-152 + M153T + E154Q + S155I + E156P + F157S + R158Y + V159I + Y160F + S161N + S162N + N164F + Q173K + P174D + L176N + M177L + E180G + G181E + Q183P + N188D + K195R + I197K + Y200F + F201L + K202H + I203V + K206G + H207Y + T208Q + N211S + L212A + V213A + R214S + D215G + Q218T + S221N + E224K + L226I + V227F + D228K + I231L + R237N + Q239R + A243T + L244A + Δ245-246 + S247F + Y248P + L249P + T250R + G252D + D253Y + Δ254-257 + T259G + A260T + G261S + Y266F + Q271K + R273T + L276M + N280D + A292S + L293Q + D294N + S297A + T299L + T302S + L303V + T307E + V308I + E309D + Q321A + T323S + E324K + S325E + I326V + R346T + A348P + N354E + A372T + P384A + T393S + I402V + R403K + E406D + K417V + I434L + S438T + N439R + L441I + S443A + K444T + V445Q + G446T + L452K + L455S + F456L + K458H + S459G + N460K + K462R + T470N + E471V + I472P + Y473F + Q474S + A475P + G476D + S477G + T478K + N481T + G482P + Δ483 + E484P + G485A + F490W + Q493N + S494D + Q498Y + P499I + V503I + H519N + K529L + N532D + V534I + K537Q + E554P + N556S + K558R + L560Q + I569V + A570S + T572F + A575S + Q580K + L582S + T588S + N606S + Q607E + E619D + T632S + Y636H + S640N + R646Q + N657D + N658T + Q675H + Q677V + T678S + N679S + S680L + Δ681-684 + V687T + A688S + S689Q + Q690K + I693V + E702D + N703S + V705I + S711T + T719S + V722I + I726V + L727M + T732A + T739N + S750A + T768S + K776R + Q779R + I788M + P793T + I794L + S810L + S813T + I834M + D839E + A845N + E868D + Q872A + S875A + L878V + A879S + I882A + S884A + L922Q + S929K + G932S + K933Q + D936E + S939T + S940T + A942S + S943T + S1055A + A1070S + K1073R + D1084E + H1088Y + S1097F + H1101S + V1104I + Y1110F + E1111S + N1125S + V1133I + I1216V + M1233L + C1247A,1,>,5000,ng/ml,1,>,200,,,
Yuan22,10.1101/2022.03.13.484037,Pseudovirus (MLV),Figure 2A,Casirivimab + Imdevimab,Wild Type (B),=,6,ng/ml,1,WIV1,1,M1K + F2L + V3L + F4V + L7F + L8A + P9T + S12ins + S13Y + Q14T + C15I + V16E + N17K + L18C + T19L + T20D + R21F + T22D + Q23D + L24R + P25ins + Y28N + N30ins + F32S + T33H + K41D + V42I + S46N + S50L + T51V + L54H + F59D + W64R + H66I + A67T + I68F + H69G + V70L + S71N + Δ72-78 + V83I + L84I + N87K + V90I + S94A + I100V + I105V + T108S + L110M + D111N + S112N + T114S + L117V + L118I + V120M + A123S + V126L + K129R + V130A + E132N + Q134E + F135L + N137D + D138N + L141F + G142V + Y144L + Y145K + H146S + Δ147 + Δ150-152 + M153T + E154Q + S155I + E156P + F157S + R158Y + V159I + Y160F + S161N + S162N + N164F + Q173K + P174D + L176N + M177L + E180G + G181E + Q183P + N188D + K195R + I197K + Y200F + F201L + K202H + I203V + K206G + H207Y + T208Q + N211S + L212A + V213A + R214S + D215G + Q218T + S221N + E224K + L226I + V227F + D228K + I231L + R237N + Q239R + A243T + L244A + Δ245-246 + S247F + Y248P + L249P + T250R + G252D + D253Y + Δ254-257 + T259G + A260T + G261S + Y266F + Q271K + R273T + L276M + N280D + A292S + L293Q + D294N + S297A + T299L + T302S + L303V + T307E + V308I + E309D + Q321A + T323S + E324K + S325E + I326V + R346T + A348P + N354E + A372T + P384A + T393S + I402V + R403K + E406D + K417V + I434L + S438T + N439R + L441I + S443A + K444T + V445Q + G446T + L452K + L455S + F456L + K458H + S459G + N460K + K462R + T470N + E471V + I472P + Y473F + Q474S + A475P + G476D + S477G + T478K + N481T + G482P + Δ483 + E484P + G485A + F490W + Q493N + S494D + Q498Y + P499I + V503I + H519N + K529L + N532D + V534I + K537Q + E554P + N556S + K558R + L560Q + I569V + A570S + T572F + A575S + Q580K + L582S + T588S + N606S + Q607E + E619D + T632S + Y636H + S640N + R646Q + N657D + N658T + Q675H + Q677V + T678S + N679S + S680L + Δ681-684 + V687T + A688S + S689Q + Q690K + I693V + E702D + N703S + V705I + S711T + T719S + V722I + I726V + L727M + T732A + T739N + S750A + T768S + K776R + Q779R + I788M + P793T + I794L + S810L + S813T + I834M + D839E + A845N + E868D + Q872A + S875A + L878V + A879S + I882A + S884A + L922Q + S929K + G932S + K933Q + D936E + S939T + S940T + A942S + S943T + S1055A + A1070S + K1073R + D1084E + H1088Y + S1097F + H1101S + V1104I + Y1110F + E1111S + N1125S + V1133I + I1216V + M1233L + C1247A,1,>,5000,ng/ml,1,>,833.3,,,
Yuan22,10.1101/2022.03.13.484037,Pseudovirus (MLV),Figure 2A,Cilgavimab,Wild Type (B),=,5,ng/ml,1,WIV1,1,M1K + F2L + V3L + F4V + L7F + L8A + P9T + S12ins + S13Y + Q14T + C15I + V16E + N17K + L18C + T19L + T20D + R21F + T22D + Q23D + L24R + P25ins + Y28N + N30ins + F32S + T33H + K41D + V42I + S46N + S50L + T51V + L54H + F59D + W64R + H66I + A67T + I68F + H69G + V70L + S71N + Δ72-78 + V83I + L84I + N87K + V90I + S94A + I100V + I105V + T108S + L110M + D111N + S112N + T114S + L117V + L118I + V120M + A123S + V126L + K129R + V130A + E132N + Q134E + F135L + N137D + D138N + L141F + G142V + Y144L + Y145K + H146S + Δ147 + Δ150-152 + M153T + E154Q + S155I + E156P + F157S + R158Y + V159I + Y160F + S161N + S162N + N164F + Q173K + P174D + L176N + M177L + E180G + G181E + Q183P + N188D + K195R + I197K + Y200F + F201L + K202H + I203V + K206G + H207Y + T208Q + N211S + L212A + V213A + R214S + D215G + Q218T + S221N + E224K + L226I + V227F + D228K + I231L + R237N + Q239R + A243T + L244A + Δ245-246 + S247F + Y248P + L249P + T250R + G252D + D253Y + Δ254-257 + T259G + A260T + G261S + Y266F + Q271K + R273T + L276M + N280D + A292S + L293Q + D294N + S297A + T299L + T302S + L303V + T307E + V308I + E309D + Q321A + T323S + E324K + S325E + I326V + R346T + A348P + N354E + A372T + P384A + T393S + I402V + R403K + E406D + K417V + I434L + S438T + N439R + L441I + S443A + K444T + V445Q + G446T + L452K + L455S + F456L + K458H + S459G + N460K + K462R + T470N + E471V + I472P + Y473F + Q474S + A475P + G476D + S477G + T478K + N481T + G482P + Δ483 + E484P + G485A + F490W + Q493N + S494D + Q498Y + P499I + V503I + H519N + K529L + N532D + V534I + K537Q + E554P + N556S + K558R + L560Q + I569V + A570S + T572F + A575S + Q580K + L582S + T588S + N606S + Q607E + E619D + T632S + Y636H + S640N + R646Q + N657D + N658T + Q675H + Q677V + T678S + N679S + S680L + Δ681-684 + V687T + A688S + S689Q + Q690K + I693V + E702D + N703S + V705I + S711T + T719S + V722I + I726V + L727M + T732A + T739N + S750A + T768S + K776R + Q779R + I788M + P793T + I794L + S810L + S813T + I834M + D839E + A845N + E868D + Q872A + S875A + L878V + A879S + I882A + S884A + L922Q + S929K + G932S + K933Q + D936E + S939T + S940T + A942S + S943T + S1055A + A1070S + K1073R + D1084E + H1088Y + S1097F + H1101S + V1104I + Y1110F + E1111S + N1125S + V1133I + I1216V + M1233L + C1247A,1,>,5000,ng/ml,1,>,1000,,,
Yuan22,10.1101/2022.03.13.484037,Pseudovirus (MLV),Figure 2A,Tixagevimab,Wild Type (B),=,1,ng/ml,1,WIV1,1,M1K + F2L + V3L + F4V + L7F + L8A + P9T + S12ins + S13Y + Q14T + C15I + V16E + N17K + L18C + T19L + T20D + R21F + T22D + Q23D + L24R + P25ins + Y28N + N30ins + F32S + T33H + K41D + V42I + S46N + S50L + T51V + L54H + F59D + W64R + H66I + A67T + I68F + H69G + V70L + S71N + Δ72-78 + V83I + L84I + N87K + V90I + S94A + I100V + I105V + T108S + L110M + D111N + S112N + T114S + L117V + L118I + V120M + A123S + V126L + K129R + V130A + E132N + Q134E + F135L + N137D + D138N + L141F + G142V + Y144L + Y145K + H146S + Δ147 + Δ150-152 + M153T + E154Q + S155I + E156P + F157S + R158Y + V159I + Y160F + S161N + S162N + N164F + Q173K + P174D + L176N + M177L + E180G + G181E + Q183P + N188D + K195R + I197K + Y200F + F201L + K202H + I203V + K206G + H207Y + T208Q + N211S + L212A + V213A + R214S + D215G + Q218T + S221N + E224K + L226I + V227F + D228K + I231L + R237N + Q239R + A243T + L244A + Δ245-246 + S247F + Y248P + L249P + T250R + G252D + D253Y + Δ254-257 + T259G + A260T + G261S + Y266F + Q271K + R273T + L276M + N280D + A292S + L293Q + D294N + S297A + T299L + T302S + L303V + T307E + V308I + E309D + Q321A + T323S + E324K + S325E + I326V + R346T + A348P + N354E + A372T + P384A + T393S + I402V + R403K + E406D + K417V + I434L + S438T + N439R + L441I + S443A + K444T + V445Q + G446T + L452K + L455S + F456L + K458H + S459G + N460K + K462R + T470N + E471V + I472P + Y473F + Q474S + A475P + G476D + S477G + T478K + N481T + G482P + Δ483 + E484P + G485A + F490W + Q493N + S494D + Q498Y + P499I + V503I + H519N + K529L + N532D + V534I + K537Q + E554P + N556S + K558R + L560Q + I569V + A570S + T572F + A575S + Q580K + L582S + T588S + N606S + Q607E + E619D + T632S + Y636H + S640N + R646Q + N657D + N658T + Q675H + Q677V + T678S + N679S + S680L + Δ681-684 + V687T + A688S + S689Q + Q690K + I693V + E702D + N703S + V705I + S711T + T719S + V722I + I726V + L727M + T732A + T739N + S750A + T768S + K776R + Q779R + I788M + P793T + I794L + S810L + S813T + I834M + D839E + A845N + E868D + Q872A + S875A + L878V + A879S + I882A + S884A + L922Q + S929K + G932S + K933Q + D936E + S939T + S940T + A942S + S943T + S1055A + A1070S + K1073R + D1084E + H1088Y + S1097F + H1101S + V1104I + Y1110F + E1111S + N1125S + V1133I + I1216V + M1233L + C1247A,1,>,5000,ng/ml,1,>,1000,,,
Yuan22,10.1101/2022.03.13.484037,Pseudovirus (MLV),Figure 2A,Cilgavimab + Tixagevimab,Wild Type (B),=,5,ng/ml,1,WIV1,1,M1K + F2L + V3L + F4V + L7F + L8A + P9T + S12ins + S13Y + Q14T + C15I + V16E + N17K + L18C + T19L + T20D + R21F + T22D + Q23D + L24R + P25ins + Y28N + N30ins + F32S + T33H + K41D + V42I + S46N + S50L + T51V + L54H + F59D + W64R + H66I + A67T + I68F + H69G + V70L + S71N + Δ72-78 + V83I + L84I + N87K + V90I + S94A + I100V + I105V + T108S + L110M + D111N + S112N + T114S + L117V + L118I + V120M + A123S + V126L + K129R + V130A + E132N + Q134E + F135L + N137D + D138N + L141F + G142V + Y144L + Y145K + H146S + Δ147 + Δ150-152 + M153T + E154Q + S155I + E156P + F157S + R158Y + V159I + Y160F + S161N + S162N + N164F + Q173K + P174D + L176N + M177L + E180G + G181E + Q183P + N188D + K195R + I197K + Y200F + F201L + K202H + I203V + K206G + H207Y + T208Q + N211S + L212A + V213A + R214S + D215G + Q218T + S221N + E224K + L226I + V227F + D228K + I231L + R237N + Q239R + A243T + L244A + Δ245-246 + S247F + Y248P + L249P + T250R + G252D + D253Y + Δ254-257 + T259G + A260T + G261S + Y266F + Q271K + R273T + L276M + N280D + A292S + L293Q + D294N + S297A + T299L + T302S + L303V + T307E + V308I + E309D + Q321A + T323S + E324K + S325E + I326V + R346T + A348P + N354E + A372T + P384A + T393S + I402V + R403K + E406D + K417V + I434L + S438T + N439R + L441I + S443A + K444T + V445Q + G446T + L452K + L455S + F456L + K458H + S459G + N460K + K462R + T470N + E471V + I472P + Y473F + Q474S + A475P + G476D + S477G + T478K + N481T + G482P + Δ483 + E484P + G485A + F490W + Q493N + S494D + Q498Y + P499I + V503I + H519N + K529L + N532D + V534I + K537Q + E554P + N556S + K558R + L560Q + I569V + A570S + T572F + A575S + Q580K + L582S + T588S + N606S + Q607E + E619D + T632S + Y636H + S640N + R646Q + N657D + N658T + Q675H + Q677V + T678S + N679S + S680L + Δ681-684 + V687T + A688S + S689Q + Q690K + I693V + E702D + N703S + V705I + S711T + T719S + V722I + I726V + L727M + T732A + T739N + S750A + T768S + K776R + Q779R + I788M + P793T + I794L + S810L + S813T + I834M + D839E + A845N + E868D + Q872A + S875A + L878V + A879S + I882A + S884A + L922Q + S929K + G932S + K933Q + D936E + S939T + S940T + A942S + S943T + S1055A + A1070S + K1073R + D1084E + H1088Y + S1097F + H1101S + V1104I + Y1110F + E1111S + N1125S + V1133I + I1216V + M1233L + C1247A,1,>,5000,ng/ml,1,>,1000,,,
Liu22,10.1126/scitranslmed.abn6859,Pseudovirus (VSV),Fig2C,Sotrovimab,Wild Type (B.1),=,11,ng/ml,1,WIV1,1,M1K + F2L + V3L + F4V + L7F + L8A + P9T + S12ins + S13Y + Q14T + C15I + V16E + N17K + L18C + T19L + T20D + R21F + T22D + Q23D + L24R + P25ins + Y28N + N30ins + F32S + T33H + K41D + V42I + S46N + S50L + T51V + L54H + F59D + W64R + H66I + A67T + I68F + H69G + V70L + S71N + Δ72-78 + V83I + L84I + N87K + V90I + S94A + I100V + I105V + T108S + L110M + D111N + S112N + T114S + L117V + L118I + V120M + A123S + V126L + K129R + V130A + E132N + Q134E + F135L + N137D + D138N + L141F + G142V + Y144L + Y145K + H146S + Δ147 + Δ150-152 + M153T + E154Q + S155I + E156P + F157S + R158Y + V159I + Y160F + S161N + S162N + N164F + Q173K + P174D + L176N + M177L + E180G + G181E + Q183P + N188D + K195R + I197K + Y200F + F201L + K202H + I203V + K206G + H207Y + T208Q + N211S + L212A + V213A + R214S + D215G + Q218T + S221N + E224K + L226I + V227F + D228K + I231L + R237N + Q239R + A243T + L244A + Δ245-246 + S247F + Y248P + L249P + T250R + G252D + D253Y + Δ254-257 + T259G + A260T + G261S + Y266F + Q271K + R273T + L276M + N280D + A292S + L293Q + D294N + S297A + T299L + T302S + L303V + T307E + V308I + E309D + Q321A + T323S + E324K + S325E + I326V + R346T + A348P + N354E + A372T + P384A + T393S + I402V + R403K + E406D + K417V + I434L + S438T + N439R + L441I + S443A + K444T + V445Q + G446T + L452K + L455S + F456L + K458H + S459G + N460K + K462R + T470N + E471V + I472P + Y473F + Q474S + A475P + G476D + S477G + T478K + N481T + G482P + Δ483 + E484P + G485A + F490W + Q493N + S494D + Q498Y + P499I + V503I + H519N + K529L + N532D + V534I + K537Q + E554P + N556S + K558R + L560Q + I569V + A570S + T572F + A575S + Q580K + L582S + T588S + N606S + Q607E + E619D + T632S + Y636H + S640N + R646Q + N657D + N658T + Q675H + Q677V + T678S + N679S + S680L + Δ681-684 + V687T + A688S + S689Q + Q690K + I693V + E702D + N703S + V705I + S711T + T719S + V722I + I726V + L727M + T732A + T739N + S750A + T768S + K776R + Q779R + I788M + P793T + I794L + S810L + S813T + I834M + D839E + A845N + E868D + Q872A + S875A + L878V + A879S + I882A + S884A + L922Q + S929K + G932S + K933Q + D936E + S939T + S940T + A942S + S943T + S1055A + A1070S + K1073R + D1084E + H1088Y + S1097F + H1101S + V1104I + Y1110F + E1111S + N1125S + V1133I + I1216V + M1233L + C1247A,1,=,1117,ng/ml,1,=,101.5,,,
Wang22b,10.1101/2022.01.30.478305,Pseudovirus (HIV),Figure 1B,Sotrovimab,Wild Type (B),=,30.8,ng/ml,1,WIV1,1,M1K + F2L + V3L + F4V + L7F + L8A + P9T + S12ins + S13Y + Q14T + C15I + V16E + N17K + L18C + T19L + T20D + R21F + T22D + Q23D + L24R + P25ins + Y28N + N30ins + F32S + T33H + K41D + V42I + S46N + S50L + T51V + L54H + F59D + W64R + H66I + A67T + I68F + H69G + V70L + S71N + Δ72-78 + V83I + L84I + N87K + V90I + S94A + I100V + I105V + T108S + L110M + D111N + S112N + T114S + L117V + L118I + V120M + A123S + V126L + K129R + V130A + E132N + Q134E + F135L + N137D + D138N + L141F + G142V + Y144L + Y145K + H146S + Δ147 + Δ150-152 + M153T + E154Q + S155I + E156P + F157S + R158Y + V159I + Y160F + S161N + S162N + N164F + Q173K + P174D + L176N + M177L + E180G + G181E + Q183P + N188D + K195R + I197K + Y200F + F201L + K202H + I203V + K206G + H207Y + T208Q + N211S + L212A + V213A + R214S + D215G + Q218T + S221N + E224K + L226I + V227F + D228K + I231L + R237N + Q239R + A243T + L244A + Δ245-246 + S247F + Y248P + L249P + T250R + G252D + D253Y + Δ254-257 + T259G + A260T + G261S + Y266F + Q271K + R273T + L276M + N280D + A292S + L293Q + D294N + S297A + T299L + T302S + L303V + T307E + V308I + E309D + Q321A + T323S + E324K + S325E + I326V + R346T + A348P + N354E + A372T + P384A + T393S + I402V + R403K + E406D + K417V + I434L + S438T + N439R + L441I + S443A + K444T + V445Q + G446T + L452K + L455S + F456L + K458H + S459G + N460K + K462R + T470N + E471V + I472P + Y473F + Q474S + A475P + G476D + S477G + T478K + N481T + G482P + Δ483 + E484P + G485A + F490W + Q493N + S494D + Q498Y + P499I + V503I + H519N + K529L + N532D + V534I + K537Q + E554P + N556S + K558R + L560Q + I569V + A570S + T572F + A575S + Q580K + L582S + T588S + N606S + Q607E + E619D + T632S + Y636H + S640N + R646Q + N657D + N658T + Q675H + Q677V + T678S + N679S + S680L + Δ681-684 + V687T + A688S + S689Q + Q690K + I693V + E702D + N703S + V705I + S711T + T719S + V722I + I726V + L727M + T732A + T739N + S750A + T768S + K776R + Q779R + I788M + P793T + I794L + S810L + S813T + I834M + D839E + A845N + E868D + Q872A + S875A + L878V + A879S + I882A + S884A + L922Q + S929K + G932S + K933Q + D936E + S939T + S940T + A942S + S943T + S1055A + A1070S + K1073R + D1084E + H1088Y + S1097F + H1101S + V1104I + Y1110F + E1111S + N1125S + V1133I + I1216V + M1233L + C1247A,1,=,113,ng/ml,1,=,3.7,,,
Yuan22,10.1101/2022.03.13.484037,Pseudovirus (MLV),Figure 2A,Sotrovimab,Wild Type (B),=,72,ng/ml,1,WIV1,1,M1K + F2L + V3L + F4V + L7F + L8A + P9T + S12ins + S13Y + Q14T + C15I + V16E + N17K + L18C + T19L + T20D + R21F + T22D + Q23D + L24R + P25ins + Y28N + N30ins + F32S + T33H + K41D + V42I + S46N + S50L + T51V + L54H + F59D + W64R + H66I + A67T + I68F + H69G + V70L + S71N + Δ72-78 + V83I + L84I + N87K + V90I + S94A + I100V + I105V + T108S + L110M + D111N + S112N + T114S + L117V + L118I + V120M + A123S + V126L + K129R + V130A + E132N + Q134E + F135L + N137D + D138N + L141F + G142V + Y144L + Y145K + H146S + Δ147 + Δ150-152 + M153T + E154Q + S155I + E156P + F157S + R158Y + V159I + Y160F + S161N + S162N + N164F + Q173K + P174D + L176N + M177L + E180G + G181E + Q183P + N188D + K195R + I197K + Y200F + F201L + K202H + I203V + K206G + H207Y + T208Q + N211S + L212A + V213A + R214S + D215G + Q218T + S221N + E224K + L226I + V227F + D228K + I231L + R237N + Q239R + A243T + L244A + Δ245-246 + S247F + Y248P + L249P + T250R + G252D + D253Y + Δ254-257 + T259G + A260T + G261S + Y266F + Q271K + R273T + L276M + N280D + A292S + L293Q + D294N + S297A + T299L + T302S + L303V + T307E + V308I + E309D + Q321A + T323S + E324K + S325E + I326V + R346T + A348P + N354E + A372T + P384A + T393S + I402V + R403K + E406D + K417V + I434L + S438T + N439R + L441I + S443A + K444T + V445Q + G446T + L452K + L455S + F456L + K458H + S459G + N460K + K462R + T470N + E471V + I472P + Y473F + Q474S + A475P + G476D + S477G + T478K + N481T + G482P + Δ483 + E484P + G485A + F490W + Q493N + S494D + Q498Y + P499I + V503I + H519N + K529L + N532D + V534I + K537Q + E554P + N556S + K558R + L560Q + I569V + A570S + T572F + A575S + Q580K + L582S + T588S + N606S + Q607E + E619D + T632S + Y636H + S640N + R646Q + N657D + N658T + Q675H + Q677V + T678S + N679S + S680L + Δ681-684 + V687T + A688S + S689Q + Q690K + I693V + E702D + N703S + V705I + S711T + T719S + V722I + I726V + L727M + T732A + T739N + S750A + T768S + K776R + Q779R + I788M + P793T + I794L + S810L + S813T + I834M + D839E + A845N + E868D + Q872A + S875A + L878V + A879S + I882A + S884A + L922Q + S929K + G932S + K933Q + D936E + S939T + S940T + A942S + S943T + S1055A + A1070S + K1073R + D1084E + H1088Y + S1097F + H1101S + V1104I + Y1110F + E1111S + N1125S + V1133I + I1216V + M1233L + C1247A,1,=,37,ng/ml,1,=,0.5,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b,Bamlanivimab,Wild Type (B.1),=,4,ng/ml,1,Omicron/BA.2/F486V,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + F486V + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Yamasoba22b,10.1016/S1473-3099(22)00365-6,Pseudovirus (HIV),Table,Bamlanivimab,Wild Type (B.1),=,12.8,ng/ml,1,Omicron/BA.2/F486V,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + F486V + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,3700,ng/ml,1,>,289.1,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b,Etesevimab,Wild Type (B.1),=,12,ng/ml,1,Omicron/BA.2/F486V,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + F486V + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,833.3,,,
Yamasoba22b,10.1016/S1473-3099(22)00365-6,Pseudovirus (HIV),Table,Etesevimab,Wild Type (B.1),=,12,ng/ml,1,Omicron/BA.2/F486V,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + F486V + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,6050,ng/ml,1,>,504.2,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b,Bamlanivimab + Etesevimab,Wild Type (B.1),=,5,ng/ml,1,Omicron/BA.2/F486V,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + F486V + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Yamasoba22b,10.1016/S1473-3099(22)00365-6,Pseudovirus (HIV),Table,Bamlanivimab + Etesevimab,Wild Type (B.1),=,6.7,ng/ml,1,Omicron/BA.2/F486V,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + F486V + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,3700,ng/ml,1,>,552.2,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b,Casirivimab,Wild Type (B.1),=,5,ng/ml,1,Omicron/BA.2/F486V,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + F486V + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Yamasoba22b,10.1016/S1473-3099(22)00365-6,Pseudovirus (HIV),Table,Casirivimab,Wild Type (B.1),=,9.9,ng/ml,1,Omicron/BA.2/F486V,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + F486V + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,50417,ng/ml,1,>,1000,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b,Imdevimab,Wild Type (B.1),=,1,ng/ml,1,Omicron/BA.2/F486V,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + F486V + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1681,ng/ml,1,>,1000,,,
Yamasoba22b,10.1016/S1473-3099(22)00365-6,Pseudovirus (HIV),Table,Imdevimab,Wild Type (B.1),=,79,ng/ml,1,Omicron/BA.2/F486V,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + F486V + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,50000,ng/ml,1,>,632.9,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b,Casirivimab + Imdevimab,Wild Type (B.1),=,1,ng/ml,1,Omicron/BA.2/F486V,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + F486V + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,7366,ng/ml,1,>,1000,,,
Yamasoba22b,10.1016/S1473-3099(22)00365-6,Pseudovirus (HIV),Table,Casirivimab + Imdevimab,Wild Type (B.1),=,6.2,ng/ml,1,Omicron/BA.2/F486V,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + F486V + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,2400,ng/ml,1,>,387.1,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b,Cilgavimab,Wild Type (B.1),=,6,ng/ml,1,Omicron/BA.2/F486V,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + F486V + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,5,ng/ml,1,=,0.8,,,
Yamasoba22b,10.1016/S1473-3099(22)00365-6,Pseudovirus (HIV),Table,Cilgavimab,Wild Type (B.1),=,21,ng/ml,1,Omicron/BA.2/F486V,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + F486V + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,18,ng/ml,1,=,0.9,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b,Tixagevimab,Wild Type (B.1),=,2,ng/ml,1,Omicron/BA.2/F486V,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + F486V + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Yamasoba22b,10.1016/S1473-3099(22)00365-6,Pseudovirus (HIV),Table,Tixagevimab,Wild Type (B.1),=,6.7,ng/ml,1,Omicron/BA.2/F486V,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + F486V + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,2750,ng/ml,1,>,410.4,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b,Cilgavimab + Tixagevimab,Wild Type (B.1),=,2,ng/ml,1,Omicron/BA.2/F486V,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + F486V + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,20,ng/ml,1,=,10,,,
Yamasoba22b,10.1016/S1473-3099(22)00365-6,Pseudovirus (HIV),Table,Cilgavimab + Tixagevimab,Wild Type (B.1),=,4.1,ng/ml,1,Omicron/BA.2/F486V,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + F486V + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,23,ng/ml,1,=,5.6,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b,Sotrovimab,Wild Type (B.1),=,14,ng/ml,1,Omicron/BA.2/F486V,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + F486V + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,412,ng/ml,1,=,29.4,,,
Yamasoba22b,10.1016/S1473-3099(22)00365-6,Pseudovirus (HIV),Table,Sotrovimab,Wild Type (B.1),=,94,ng/ml,1,Omicron/BA.2/F486V,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + F486V + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1575,ng/ml,1,=,16.8,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b,Bebtelovimab,Wild Type (B.1),=,1,ng/ml,1,Omicron/BA.2/F486V,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + F486V + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1,ng/ml,1,=,1,,,
Yamasoba22b,10.1016/S1473-3099(22)00365-6,Pseudovirus (HIV),Table,Bebtelovimab,Wild Type (B.1),=,8.1,ng/ml,1,Omicron/BA.2/F486V,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + F486V + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1.1,ng/ml,1,=,0.1,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b,Amubarvimab,Wild Type (B.1),=,18,ng/ml,1,Omicron/BA.2/F486V,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + F486V + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,555.6,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b,Romlusevimab,Wild Type (B.1),=,110,ng/ml,1,Omicron/BA.2/F486V,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + F486V + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,887,ng/ml,1,=,8.1,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b,Amubarvimab + Romlusevimab,Wild Type (B.1),=,22,ng/ml,1,Omicron/BA.2/F486V,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + F486V + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,5377,ng/ml,1,=,244.4,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b,Bamlanivimab,Wild Type (B.1),=,4,ng/ml,1,Omicron/BA.2/L452Q,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Yamasoba22b,10.1016/S1473-3099(22)00365-6,Pseudovirus (HIV),Table,Bamlanivimab,Wild Type (B.1),=,12.8,ng/ml,1,Omicron/BA.2/L452Q,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,3700,ng/ml,1,>,289.1,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b,Etesevimab,Wild Type (B.1),=,12,ng/ml,1,Omicron/BA.2/L452Q,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,833.3,,,
Yamasoba22b,10.1016/S1473-3099(22)00365-6,Pseudovirus (HIV),Table,Etesevimab,Wild Type (B.1),=,12,ng/ml,1,Omicron/BA.2/L452Q,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,6050,ng/ml,1,>,504.2,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b,Bamlanivimab + Etesevimab,Wild Type (B.1),=,5,ng/ml,1,Omicron/BA.2/L452Q,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Yamasoba22b,10.1016/S1473-3099(22)00365-6,Pseudovirus (HIV),Table,Bamlanivimab + Etesevimab,Wild Type (B.1),=,6.7,ng/ml,1,Omicron/BA.2/L452Q,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,3700,ng/ml,1,>,552.2,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b,Casirivimab,Wild Type (B.1),=,5,ng/ml,1,Omicron/BA.2/L452Q,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Yamasoba22b,10.1016/S1473-3099(22)00365-6,Pseudovirus (HIV),Table,Casirivimab,Wild Type (B.1),=,9.9,ng/ml,1,Omicron/BA.2/L452Q,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,50417,ng/ml,1,>,1000,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b,Imdevimab,Wild Type (B.1),=,1,ng/ml,1,Omicron/BA.2/L452Q,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,872,ng/ml,1,=,872,,,
Yamasoba22b,10.1016/S1473-3099(22)00365-6,Pseudovirus (HIV),Table,Imdevimab,Wild Type (B.1),=,79,ng/ml,1,Omicron/BA.2/L452Q,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,50000,ng/ml,1,>,632.9,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b,Casirivimab + Imdevimab,Wild Type (B.1),=,1,ng/ml,1,Omicron/BA.2/L452Q,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,4793,ng/ml,1,>,1000,,,
Yamasoba22b,10.1016/S1473-3099(22)00365-6,Pseudovirus (HIV),Table,Casirivimab + Imdevimab,Wild Type (B.1),=,6.2,ng/ml,1,Omicron/BA.2/L452Q,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,2400,ng/ml,1,>,387.1,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b,Cilgavimab,Wild Type (B.1),=,6,ng/ml,1,Omicron/BA.2/L452Q,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,10,ng/ml,1,=,1.7,,,
Yamasoba22b,10.1016/S1473-3099(22)00365-6,Pseudovirus (HIV),Table,Cilgavimab,Wild Type (B.1),=,21,ng/ml,1,Omicron/BA.2/L452Q,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,26,ng/ml,1,=,1.2,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b,Tixagevimab,Wild Type (B.1),=,2,ng/ml,1,Omicron/BA.2/L452Q,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,655,ng/ml,1,=,327.5,,,
Yamasoba22b,10.1016/S1473-3099(22)00365-6,Pseudovirus (HIV),Table,Tixagevimab,Wild Type (B.1),=,6.7,ng/ml,1,Omicron/BA.2/L452Q,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,2750,ng/ml,1,>,410.4,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b,Cilgavimab + Tixagevimab,Wild Type (B.1),=,2,ng/ml,1,Omicron/BA.2/L452Q,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,24,ng/ml,1,=,12,,,
Yamasoba22b,10.1016/S1473-3099(22)00365-6,Pseudovirus (HIV),Table,Cilgavimab + Tixagevimab,Wild Type (B.1),=,4.1,ng/ml,1,Omicron/BA.2/L452Q,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,82,ng/ml,1,=,20,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b,Sotrovimab,Wild Type (B.1),=,14,ng/ml,1,Omicron/BA.2/L452Q,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,535,ng/ml,1,=,38.2,,,
Yamasoba22b,10.1016/S1473-3099(22)00365-6,Pseudovirus (HIV),Table,Sotrovimab,Wild Type (B.1),=,94,ng/ml,1,Omicron/BA.2/L452Q,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,2443,ng/ml,1,=,26,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b,Bebtelovimab,Wild Type (B.1),=,1,ng/ml,1,Omicron/BA.2/L452Q,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,2,ng/ml,1,=,2,,,
Yamasoba22b,10.1016/S1473-3099(22)00365-6,Pseudovirus (HIV),Table,Bebtelovimab,Wild Type (B.1),=,8.1,ng/ml,1,Omicron/BA.2/L452Q,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,5,ng/ml,1,=,0.6,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b,Amubarvimab,Wild Type (B.1),=,18,ng/ml,1,Omicron/BA.2/L452Q,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1717,ng/ml,1,=,95.4,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b,Romlusevimab,Wild Type (B.1),=,110,ng/ml,1,Omicron/BA.2/L452Q,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,90.9,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b,Amubarvimab + Romlusevimab,Wild Type (B.1),=,22,ng/ml,1,Omicron/BA.2/L452Q,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,5525,ng/ml,1,=,251.1,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b,Bamlanivimab,Wild Type (B.1),=,4,ng/ml,1,Omicron/BA.2/S704L,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Yamasoba22b,10.1016/S1473-3099(22)00365-6,Pseudovirus (HIV),Table,Bamlanivimab,Wild Type (B.1),=,12.8,ng/ml,1,Omicron/BA.2/S704L,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,>,3700,ng/ml,1,>,289.1,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b,Etesevimab,Wild Type (B.1),=,12,ng/ml,1,Omicron/BA.2/S704L,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,833.3,,,
Yamasoba22b,10.1016/S1473-3099(22)00365-6,Pseudovirus (HIV),Table,Etesevimab,Wild Type (B.1),=,12,ng/ml,1,Omicron/BA.2/S704L,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,>,6050,ng/ml,1,>,504.2,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b,Bamlanivimab + Etesevimab,Wild Type (B.1),=,5,ng/ml,1,Omicron/BA.2/S704L,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Yamasoba22b,10.1016/S1473-3099(22)00365-6,Pseudovirus (HIV),Table,Bamlanivimab + Etesevimab,Wild Type (B.1),=,6.7,ng/ml,1,Omicron/BA.2/S704L,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,>,3700,ng/ml,1,>,552.2,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b,Casirivimab,Wild Type (B.1),=,5,ng/ml,1,Omicron/BA.2/S704L,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Yamasoba22b,10.1016/S1473-3099(22)00365-6,Pseudovirus (HIV),Table,Casirivimab,Wild Type (B.1),=,9.9,ng/ml,1,Omicron/BA.2/S704L,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,>,50417,ng/ml,1,>,1000,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b,Imdevimab,Wild Type (B.1),=,1,ng/ml,1,Omicron/BA.2/S704L,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,=,262,ng/ml,1,=,262,,,
Yamasoba22b,10.1016/S1473-3099(22)00365-6,Pseudovirus (HIV),Table,Imdevimab,Wild Type (B.1),=,79,ng/ml,1,Omicron/BA.2/S704L,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,>,50000,ng/ml,1,>,632.9,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b,Casirivimab + Imdevimab,Wild Type (B.1),=,1,ng/ml,1,Omicron/BA.2/S704L,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,=,1262,ng/ml,1,>,1000,,,
Yamasoba22b,10.1016/S1473-3099(22)00365-6,Pseudovirus (HIV),Table,Casirivimab + Imdevimab,Wild Type (B.1),=,6.2,ng/ml,1,Omicron/BA.2/S704L,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,>,2400,ng/ml,1,>,387.1,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b,Cilgavimab,Wild Type (B.1),=,6,ng/ml,1,Omicron/BA.2/S704L,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,=,6,ng/ml,1,=,1,,,
Yamasoba22b,10.1016/S1473-3099(22)00365-6,Pseudovirus (HIV),Table,Cilgavimab,Wild Type (B.1),=,21,ng/ml,1,Omicron/BA.2/S704L,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,=,28,ng/ml,1,=,1.3,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b,Tixagevimab,Wild Type (B.1),=,2,ng/ml,1,Omicron/BA.2/S704L,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,=,686,ng/ml,1,=,343,,,
Yamasoba22b,10.1016/S1473-3099(22)00365-6,Pseudovirus (HIV),Table,Tixagevimab,Wild Type (B.1),=,6.7,ng/ml,1,Omicron/BA.2/S704L,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,>,2750,ng/ml,1,>,410.4,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b,Cilgavimab + Tixagevimab,Wild Type (B.1),=,2,ng/ml,1,Omicron/BA.2/S704L,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,=,10,ng/ml,1,=,5,,,
Yamasoba22b,10.1016/S1473-3099(22)00365-6,Pseudovirus (HIV),Table,Cilgavimab + Tixagevimab,Wild Type (B.1),=,4.1,ng/ml,1,Omicron/BA.2/S704L,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,=,27,ng/ml,1,=,6.6,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b,Sotrovimab,Wild Type (B.1),=,14,ng/ml,1,Omicron/BA.2/S704L,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,=,539,ng/ml,1,=,38.5,,,
Yamasoba22b,10.1016/S1473-3099(22)00365-6,Pseudovirus (HIV),Table,Sotrovimab,Wild Type (B.1),=,94,ng/ml,1,Omicron/BA.2/S704L,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,=,1213,ng/ml,1,=,12.9,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b,Bebtelovimab,Wild Type (B.1),=,1,ng/ml,1,Omicron/BA.2/S704L,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,=,2,ng/ml,1,=,2,,,
Yamasoba22b,10.1016/S1473-3099(22)00365-6,Pseudovirus (HIV),Table,Bebtelovimab,Wild Type (B.1),=,8.1,ng/ml,1,Omicron/BA.2/S704L,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,=,1.1,ng/ml,1,=,0.1,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b,Amubarvimab,Wild Type (B.1),=,18,ng/ml,1,Omicron/BA.2/S704L,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,=,1464,ng/ml,1,=,81.3,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b,Romlusevimab,Wild Type (B.1),=,110,ng/ml,1,Omicron/BA.2/S704L,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,=,735,ng/ml,1,=,6.7,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b,Amubarvimab + Romlusevimab,Wild Type (B.1),=,22,ng/ml,1,Omicron/BA.2/S704L,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,=,800,ng/ml,1,=,36.4,,,
Sheward22c,10.1101/2022.09.16.508299,Pseudovirus,Figure 1B,Bamlanivimab,Wild Type (B.1),=,9,ng/ml,1,Omicron/BA.2.10.4,19,T19I + L24S + Δ25-27 + W64R + Δ141-144 + V213G + Δ243-244 + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + S477N + T478K + E484A + F486P + S494P + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K + P1143L,1,>,1000,ng/ml,1,>,111.1,,,
Sheward22c,10.1101/2022.09.16.508299,Pseudovirus,Figure 1B,Etesevimab,Wild Type (B.1),=,29,ng/ml,1,Omicron/BA.2.10.4,19,T19I + L24S + Δ25-27 + W64R + Δ141-144 + V213G + Δ243-244 + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + S477N + T478K + E484A + F486P + S494P + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K + P1143L,1,>,1000,ng/ml,1,>,34.5,,,
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Casirivimab,Omicron/BA.2,>,10000,ng/ml,1,Omicron/BA.2.10.4,19,T19I + L24S + Δ25-27 + W64R + Δ141-144 + V213G + Δ243-244 + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + S477N + T478K + E484A + F486P + S494P + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K + P1143L,1,>,10000,ng/ml,1,>,1,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Sheward22c,10.1101/2022.09.16.508299,Pseudovirus,Figure 1B,Casirivimab,Wild Type (B.1),=,14,ng/ml,1,Omicron/BA.2.10.4,19,T19I + L24S + Δ25-27 + W64R + Δ141-144 + V213G + Δ243-244 + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + S477N + T478K + E484A + F486P + S494P + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K + P1143L,1,>,1000,ng/ml,1,>,71.4,,,
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Imdevimab,Omicron/BA.2,=,590,ng/ml,1,Omicron/BA.2.10.4,19,T19I + L24S + Δ25-27 + W64R + Δ141-144 + V213G + Δ243-244 + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + S477N + T478K + E484A + F486P + S494P + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K + P1143L,1,>,10000,ng/ml,1,>,1.7,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Sheward22c,10.1101/2022.09.16.508299,Pseudovirus,Figure 1B,Imdevimab,Wild Type (B.1),=,10,ng/ml,1,Omicron/BA.2.10.4,19,T19I + L24S + Δ25-27 + W64R + Δ141-144 + V213G + Δ243-244 + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + S477N + T478K + E484A + F486P + S494P + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K + P1143L,1,>,1000,ng/ml,1,>,100,,,
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Casirivimab + Imdevimab,Omicron/BA.2,=,821,ng/ml,1,Omicron/BA.2.10.4,19,T19I + L24S + Δ25-27 + W64R + Δ141-144 + V213G + Δ243-244 + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + S477N + T478K + E484A + F486P + S494P + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K + P1143L,1,>,10000,ng/ml,1,>,1.2,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Cilgavimab,Omicron/BA.2,=,6.3,ng/ml,1,Omicron/BA.2.10.4,19,T19I + L24S + Δ25-27 + W64R + Δ141-144 + V213G + Δ243-244 + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + S477N + T478K + E484A + F486P + S494P + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K + P1143L,1,=,289,ng/ml,1,=,45.9,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Sheward22c,10.1101/2022.09.16.508299,Pseudovirus,Figure 1B,Cilgavimab,Wild Type (B.1),=,12,ng/ml,1,Omicron/BA.2.10.4,19,T19I + L24S + Δ25-27 + W64R + Δ141-144 + V213G + Δ243-244 + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + S477N + T478K + E484A + F486P + S494P + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K + P1143L,1,=,168,ng/ml,1,=,14,,,
Sheward22c,10.1101/2022.09.16.508299,Pseudovirus,Figure 1B,Tixagevimab,Wild Type (B.1),=,4,ng/ml,1,Omicron/BA.2.10.4,19,T19I + L24S + Δ25-27 + W64R + Δ141-144 + V213G + Δ243-244 + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + S477N + T478K + E484A + F486P + S494P + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K + P1143L,1,>,1000,ng/ml,1,>,250,,,
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Cilgavimab + Tixagevimab,Omicron/BA.2,=,8.2,ng/ml,1,Omicron/BA.2.10.4,19,T19I + L24S + Δ25-27 + W64R + Δ141-144 + V213G + Δ243-244 + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + S477N + T478K + E484A + F486P + S494P + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K + P1143L,1,=,501,ng/ml,1,=,61.1,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Sheward22c,10.1101/2022.09.16.508299,Pseudovirus,Figure 1B,Cilgavimab + Tixagevimab,Wild Type (B.1),=,6,ng/ml,1,Omicron/BA.2.10.4,19,T19I + L24S + Δ25-27 + W64R + Δ141-144 + V213G + Δ243-244 + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + S477N + T478K + E484A + F486P + S494P + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K + P1143L,1,=,816,ng/ml,1,=,136,,,
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Sotrovimab,Omicron/BA.2,=,852,ng/ml,1,Omicron/BA.2.10.4,19,T19I + L24S + Δ25-27 + W64R + Δ141-144 + V213G + Δ243-244 + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + S477N + T478K + E484A + F486P + S494P + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K + P1143L,1,=,706,ng/ml,1,=,0.8,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Sheward22c,10.1101/2022.09.16.508299,Pseudovirus,Figure 1B,Sotrovimab,Wild Type (B.1),=,119,ng/ml,1,Omicron/BA.2.10.4,19,T19I + L24S + Δ25-27 + W64R + Δ141-144 + V213G + Δ243-244 + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + S477N + T478K + E484A + F486P + S494P + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K + P1143L,1,=,560,ng/ml,1,=,4.7,,,
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Bebtelovimab,Omicron/BA.2,=,0.9,ng/ml,1,Omicron/BA.2.10.4,19,T19I + L24S + Δ25-27 + W64R + Δ141-144 + V213G + Δ243-244 + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + S477N + T478K + E484A + F486P + S494P + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K + P1143L,1,=,1.3,ng/ml,1,=,1.4,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Sheward22c,10.1101/2022.09.16.508299,Pseudovirus,Figure 1B,Bebtelovimab,Wild Type (B.1),=,4,ng/ml,1,Omicron/BA.2.10.4,19,T19I + L24S + Δ25-27 + W64R + Δ141-144 + V213G + Δ243-244 + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + S477N + T478K + E484A + F486P + S494P + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K + P1143L,1,=,3,ng/ml,1,=,0.8,,,
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,DXP-604,Omicron/BA.2,=,219,ng/ml,1,Omicron/BA.2.10.4,19,T19I + L24S + Δ25-27 + W64R + Δ141-144 + V213G + Δ243-244 + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + S477N + T478K + E484A + F486P + S494P + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K + P1143L,1,=,6348,ng/ml,1,>,29,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b,Bamlanivimab,Wild Type (B.1),=,4,ng/ml,1,Omicron/BA.2.11,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Yamasoba22b,10.1016/S1473-3099(22)00365-6,Pseudovirus (HIV),Table,Bamlanivimab,Wild Type (B.1),=,12.8,ng/ml,1,Omicron/BA.2.11,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,3700,ng/ml,1,>,289.1,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b,Etesevimab,Wild Type (B.1),=,12,ng/ml,1,Omicron/BA.2.11,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,833.3,,,
Yamasoba22b,10.1016/S1473-3099(22)00365-6,Pseudovirus (HIV),Table,Etesevimab,Wild Type (B.1),=,12,ng/ml,1,Omicron/BA.2.11,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,6050,ng/ml,1,>,504.2,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b,Bamlanivimab + Etesevimab,Wild Type (B.1),=,5,ng/ml,1,Omicron/BA.2.11,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Yamasoba22b,10.1016/S1473-3099(22)00365-6,Pseudovirus (HIV),Table,Bamlanivimab + Etesevimab,Wild Type (B.1),=,6.7,ng/ml,1,Omicron/BA.2.11,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,3700,ng/ml,1,>,552.2,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b,Casirivimab,Wild Type (B.1),=,5,ng/ml,1,Omicron/BA.2.11,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Yamasoba22b,10.1016/S1473-3099(22)00365-6,Pseudovirus (HIV),Table,Casirivimab,Wild Type (B.1),=,9.9,ng/ml,1,Omicron/BA.2.11,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,50417,ng/ml,1,>,1000,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b,Imdevimab,Wild Type (B.1),=,1,ng/ml,1,Omicron/BA.2.11,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,2832,ng/ml,1,>,1000,,,
Yamasoba22b,10.1016/S1473-3099(22)00365-6,Pseudovirus (HIV),Table,Imdevimab,Wild Type (B.1),=,79,ng/ml,1,Omicron/BA.2.11,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,50000,ng/ml,1,>,632.9,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b,Casirivimab + Imdevimab,Wild Type (B.1),=,1,ng/ml,1,Omicron/BA.2.11,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1864,ng/ml,1,>,1000,,,
Yamasoba22b,10.1016/S1473-3099(22)00365-6,Pseudovirus (HIV),Table,Casirivimab + Imdevimab,Wild Type (B.1),=,6.2,ng/ml,1,Omicron/BA.2.11,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,2400,ng/ml,1,>,387.1,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b,Cilgavimab,Wild Type (B.1),=,6,ng/ml,1,Omicron/BA.2.11,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,25,ng/ml,1,=,4.2,,,
Yamasoba22b,10.1016/S1473-3099(22)00365-6,Pseudovirus (HIV),Table,Cilgavimab,Wild Type (B.1),=,21,ng/ml,1,Omicron/BA.2.11,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,71,ng/ml,1,=,3.4,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b,Tixagevimab,Wild Type (B.1),=,2,ng/ml,1,Omicron/BA.2.11,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1228,ng/ml,1,=,614,,,
Yamasoba22b,10.1016/S1473-3099(22)00365-6,Pseudovirus (HIV),Table,Tixagevimab,Wild Type (B.1),=,6.7,ng/ml,1,Omicron/BA.2.11,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,2750,ng/ml,1,>,410.4,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b,Cilgavimab + Tixagevimab,Wild Type (B.1),=,2,ng/ml,1,Omicron/BA.2.11,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,28,ng/ml,1,=,14,,,
Yamasoba22b,10.1016/S1473-3099(22)00365-6,Pseudovirus (HIV),Table,Cilgavimab + Tixagevimab,Wild Type (B.1),=,4.1,ng/ml,1,Omicron/BA.2.11,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,154,ng/ml,1,=,37.6,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b,Sotrovimab,Wild Type (B.1),=,14,ng/ml,1,Omicron/BA.2.11,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1022,ng/ml,1,=,73,,,
Yamasoba22b,10.1016/S1473-3099(22)00365-6,Pseudovirus (HIV),Table,Sotrovimab,Wild Type (B.1),=,94,ng/ml,1,Omicron/BA.2.11,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,540,ng/ml,1,=,5.7,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b,Bebtelovimab,Wild Type (B.1),=,1,ng/ml,1,Omicron/BA.2.11,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1,ng/ml,1,=,1,,,
Yamasoba22b,10.1016/S1473-3099(22)00365-6,Pseudovirus (HIV),Table,Bebtelovimab,Wild Type (B.1),=,8.1,ng/ml,1,Omicron/BA.2.11,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,2.3,ng/ml,1,=,0.3,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b,Amubarvimab,Wild Type (B.1),=,18,ng/ml,1,Omicron/BA.2.11,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,6815,ng/ml,1,=,378.6,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b,Romlusevimab,Wild Type (B.1),=,110,ng/ml,1,Omicron/BA.2.11,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,90.9,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b,Amubarvimab + Romlusevimab,Wild Type (B.1),=,22,ng/ml,1,Omicron/BA.2.11,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,454.5,,,
Wang21e,10.1126/science.abh1766,Pseudovirus (lentivirus),Fig 2C,Bamlanivimab,Wild Type (A),=,7.1,ng/ml,1,Zeta (E484K + V1176F),484,E484K + V1176F,1,>,10000,ng/ml,1,>,1000,,,
Wang21e,10.1126/science.abh1766,Pseudovirus (lentivirus),Fig 2C,Etesevimab,Wild Type (A),=,26.2,ng/ml,1,Zeta (E484K + V1176F),484,E484K + V1176F,1,=,49.4,ng/ml,1,=,1.9,,,
Zhang21c,10.1038/s42003-021-02728-4,Pseudovirus (VSV),Supplementary Figure 3,Etesevimab,Wild Type (B.1),,,,,Zeta (E484K + V1176F),484,E484K + V1176F,1,,,,,=,1.4,,,
Wang21e,10.1126/science.abh1766,Pseudovirus (lentivirus),Fig 2C,Casirivimab,Wild Type (A),=,7.7,ng/ml,1,Zeta (E484K + V1176F),484,E484K + V1176F,1,=,56.2,ng/ml,1,=,7.3,,,
Wang21e,10.1126/science.abh1766,Pseudovirus (lentivirus),Fig 2C,Imdevimab,Wild Type (A),=,71,ng/ml,1,Zeta (E484K + V1176F),484,E484K + V1176F,1,=,33.9,ng/ml,1,=,0.5,,,
FDA21c,https://www.fda.gov/media/154701/download,Pseudovirus,"Feb 2022, Page 17, Antiviral resistance paragraph 4",Tixagevimab,Wild Type (B),,,,,Zeta (E484K + V1176F),484,E484K + V1176F,1,,,,,=,7.3,,,
EMA21e,https://www.ema.europa.eu/en/documents/product-information/evusheld-epar-product-information_en.pdf,Pseudovirus,Table 3,Cilgavimab + Tixagevimab,Wild Type (B),=,1.9,ng/ml,1,Zeta (E484K + V1176F),484,E484K + V1176F,1,=,10.4,ng/ml,1,=,5.5,,,
FDA21c,https://www.fda.gov/media/154701/download,Pseudovirus,"Feb 2022, Table 6",Cilgavimab + Tixagevimab,Wild Type (B),,,,,Zeta (E484K + V1176F),484,E484K + V1176F,1,,,,,=,1,,,
EMA21c,https://www.ema.europa.eu/en/documents/product-information/regkirona-epar-product-information_en.pdf,Virus isolate,Table 3,Regdanvimab,Wild Type (B),,,,,Zeta (E484K + V1176F),484,E484K + V1176F,1,,,,,=,1,,,
EMA21c,https://www.ema.europa.eu/en/documents/product-information/regkirona-epar-product-information_en.pdf,Pseudovirus,Table 3,Regdanvimab,Wild Type (B),,,,,Zeta (E484K + V1176F),484,E484K + V1176F,1,,,,,=,8.7,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Bamlanivimab,Wild Type (B.1),=,6,ng/ml,1,Omicron/BA.2/D339H,19,T19I + L24S + Δ25-27 + G142D + V213G + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Etesevimab,Wild Type (B.1),=,9,ng/ml,1,Omicron/BA.2/D339H,19,T19I + L24S + Δ25-27 + G142D + V213G + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Bamlanivimab + Etesevimab,Wild Type (B.1),=,6,ng/ml,1,Omicron/BA.2/D339H,19,T19I + L24S + Δ25-27 + G142D + V213G + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Casirivimab,Wild Type (B.1),=,3,ng/ml,1,Omicron/BA.2/D339H,19,T19I + L24S + Δ25-27 + G142D + V213G + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Imdevimab,Wild Type (B.1),=,3,ng/ml,1,Omicron/BA.2/D339H,19,T19I + L24S + Δ25-27 + G142D + V213G + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1116,ng/ml,1,=,372,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Casirivimab + Imdevimab,Wild Type (B.1),=,3,ng/ml,1,Omicron/BA.2/D339H,19,T19I + L24S + Δ25-27 + G142D + V213G + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,2569,ng/ml,1,=,856.3,,,
Saito22,10.1016/j.chom.2022.10.003,Pseudovirus (lentivirus),Table S3,Cilgavimab,Wild Type (B.1),=,14,ng/ml,1,Omicron/BA.2/D339H,19,T19I + L24S + Δ25-27 + G142D + V213G + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,22.3,ng/ml,1,=,1.6,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Cilgavimab,Wild Type (B.1),=,10,ng/ml,1,Omicron/BA.2/D339H,19,T19I + L24S + Δ25-27 + G142D + V213G + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,11,ng/ml,1,=,1.1,,,
Wang22l,10.1101/2022.11.23.517532,Pseudovirus,Figure S2,Cilgavimab,Wild Type (B.1),=,7,ng/ml,1,Omicron/BA.2/D339H,19,T19I + L24S + Δ25-27 + G142D + V213G + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,12,ng/ml,1,=,1.7,,,
Saito22,10.1016/j.chom.2022.10.003,Pseudovirus (lentivirus),Table S3,Tixagevimab,Wild Type (B.1),=,1.5,ng/ml,1,Omicron/BA.2/D339H,19,T19I + L24S + Δ25-27 + G142D + V213G + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1487,ng/ml,1,=,991.3,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Tixagevimab,Wild Type (B.1),=,3,ng/ml,1,Omicron/BA.2/D339H,19,T19I + L24S + Δ25-27 + G142D + V213G + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,2170,ng/ml,1,=,723.3,,,
Wang22l,10.1101/2022.11.23.517532,Pseudovirus,Figure S2,Tixagevimab,Wild Type (B.1),=,2,ng/ml,1,Omicron/BA.2/D339H,19,T19I + L24S + Δ25-27 + G142D + V213G + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,3876,ng/ml,1,>,1000,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Cilgavimab + Tixagevimab,Wild Type (B.1),=,2,ng/ml,1,Omicron/BA.2/D339H,19,T19I + L24S + Δ25-27 + G142D + V213G + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,21,ng/ml,1,=,10.5,,,
Wang22l,10.1101/2022.11.23.517532,Pseudovirus,Figure S2,Cilgavimab + Tixagevimab,Wild Type (B.1),=,3,ng/ml,1,Omicron/BA.2/D339H,19,T19I + L24S + Δ25-27 + G142D + V213G + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,23,ng/ml,1,=,7.7,,,
Saito22,10.1016/j.chom.2022.10.003,Pseudovirus (lentivirus),Table S3,Sotrovimab,Wild Type (B.1),=,47,ng/ml,1,Omicron/BA.2/D339H,19,T19I + L24S + Δ25-27 + G142D + V213G + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,236.5,ng/ml,1,=,5,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Sotrovimab,Wild Type (B.1),=,25,ng/ml,1,Omicron/BA.2/D339H,19,T19I + L24S + Δ25-27 + G142D + V213G + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,229,ng/ml,1,=,9.2,,,
Wang22l,10.1101/2022.11.23.517532,Pseudovirus,Figure S2,Sotrovimab,Wild Type (B.1),=,23,ng/ml,1,Omicron/BA.2/D339H,19,T19I + L24S + Δ25-27 + G142D + V213G + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,302,ng/ml,1,=,13.1,,,
Saito22,10.1016/j.chom.2022.10.003,Pseudovirus (lentivirus),Table S3,Bebtelovimab,Wild Type (B.1),=,2.4,ng/ml,1,Omicron/BA.2/D339H,19,T19I + L24S + Δ25-27 + G142D + V213G + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1.4,ng/ml,1,=,0.6,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Bebtelovimab,Wild Type (B.1),=,2,ng/ml,1,Omicron/BA.2/D339H,19,T19I + L24S + Δ25-27 + G142D + V213G + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,2,ng/ml,1,=,1,,,
Wang22l,10.1101/2022.11.23.517532,Pseudovirus,Figure S2,Bebtelovimab,Wild Type (B.1),=,2,ng/ml,1,Omicron/BA.2/D339H,19,T19I + L24S + Δ25-27 + G142D + V213G + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,2,ng/ml,1,=,1,,,
Saito22,10.1016/j.chom.2022.10.003,Pseudovirus (lentivirus),Table S3,Regdanvimab,Wild Type (B.1),=,1,ng/ml,1,Omicron/BA.2/D339H,19,T19I + L24S + Δ25-27 + G142D + V213G + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,6175,ng/ml,1,>,1000,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Amubarvimab,Wild Type (B.1),=,15,ng/ml,1,Omicron/BA.2/D339H,19,T19I + L24S + Δ25-27 + G142D + V213G + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1731,ng/ml,1,=,115.4,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Romlusevimab,Wild Type (B.1),=,166,ng/ml,1,Omicron/BA.2/D339H,19,T19I + L24S + Δ25-27 + G142D + V213G + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1033,ng/ml,1,=,6.2,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Amubarvimab + Romlusevimab,Wild Type (B.1),=,32,ng/ml,1,Omicron/BA.2/D339H,19,T19I + L24S + Δ25-27 + G142D + V213G + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1182,ng/ml,1,=,36.9,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Bamlanivimab,Wild Type (B.1),=,6,ng/ml,1,Omicron/BA.2/F157L,19,T19I + L24S + Δ25-27 + G142D + F157L + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Etesevimab,Wild Type (B.1),=,9,ng/ml,1,Omicron/BA.2/F157L,19,T19I + L24S + Δ25-27 + G142D + F157L + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Bamlanivimab + Etesevimab,Wild Type (B.1),=,6,ng/ml,1,Omicron/BA.2/F157L,19,T19I + L24S + Δ25-27 + G142D + F157L + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Casirivimab,Wild Type (B.1),=,3,ng/ml,1,Omicron/BA.2/F157L,19,T19I + L24S + Δ25-27 + G142D + F157L + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Imdevimab,Wild Type (B.1),=,3,ng/ml,1,Omicron/BA.2/F157L,19,T19I + L24S + Δ25-27 + G142D + F157L + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,582,ng/ml,1,=,194,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Casirivimab + Imdevimab,Wild Type (B.1),=,3,ng/ml,1,Omicron/BA.2/F157L,19,T19I + L24S + Δ25-27 + G142D + F157L + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,2698,ng/ml,1,=,899.3,,,
Saito22,10.1016/j.chom.2022.10.003,Pseudovirus (lentivirus),Table S3,Cilgavimab,Wild Type (B.1),=,14,ng/ml,1,Omicron/BA.2/F157L,19,T19I + L24S + Δ25-27 + G142D + F157L + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,24.4,ng/ml,1,=,1.7,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Cilgavimab,Wild Type (B.1),=,10,ng/ml,1,Omicron/BA.2/F157L,19,T19I + L24S + Δ25-27 + G142D + F157L + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,12,ng/ml,1,=,1.2,,,
Saito22,10.1016/j.chom.2022.10.003,Pseudovirus (lentivirus),Table S3,Tixagevimab,Wild Type (B.1),=,1.5,ng/ml,1,Omicron/BA.2/F157L,19,T19I + L24S + Δ25-27 + G142D + F157L + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,983.9,ng/ml,1,=,655.9,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Tixagevimab,Wild Type (B.1),=,3,ng/ml,1,Omicron/BA.2/F157L,19,T19I + L24S + Δ25-27 + G142D + F157L + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,3181,ng/ml,1,>,1000,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Cilgavimab + Tixagevimab,Wild Type (B.1),=,2,ng/ml,1,Omicron/BA.2/F157L,19,T19I + L24S + Δ25-27 + G142D + F157L + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,28,ng/ml,1,=,14,,,
Saito22,10.1016/j.chom.2022.10.003,Pseudovirus (lentivirus),Table S3,Sotrovimab,Wild Type (B.1),=,47,ng/ml,1,Omicron/BA.2/F157L,19,T19I + L24S + Δ25-27 + G142D + F157L + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,858.8,ng/ml,1,=,18.3,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Sotrovimab,Wild Type (B.1),=,25,ng/ml,1,Omicron/BA.2/F157L,19,T19I + L24S + Δ25-27 + G142D + F157L + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,563,ng/ml,1,=,22.5,,,
Saito22,10.1016/j.chom.2022.10.003,Pseudovirus (lentivirus),Table S3,Bebtelovimab,Wild Type (B.1),=,2.4,ng/ml,1,Omicron/BA.2/F157L,19,T19I + L24S + Δ25-27 + G142D + F157L + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1.5,ng/ml,1,=,0.6,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Bebtelovimab,Wild Type (B.1),=,2,ng/ml,1,Omicron/BA.2/F157L,19,T19I + L24S + Δ25-27 + G142D + F157L + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1,ng/ml,1,=,0.5,,,
Saito22,10.1016/j.chom.2022.10.003,Pseudovirus (lentivirus),Table S3,Regdanvimab,Wild Type (B.1),=,1,ng/ml,1,Omicron/BA.2/F157L,19,T19I + L24S + Δ25-27 + G142D + F157L + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,6175,ng/ml,1,>,1000,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Amubarvimab,Wild Type (B.1),=,15,ng/ml,1,Omicron/BA.2/F157L,19,T19I + L24S + Δ25-27 + G142D + F157L + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1319,ng/ml,1,=,87.9,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Romlusevimab,Wild Type (B.1),=,166,ng/ml,1,Omicron/BA.2/F157L,19,T19I + L24S + Δ25-27 + G142D + F157L + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1389,ng/ml,1,=,8.4,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Amubarvimab + Romlusevimab,Wild Type (B.1),=,32,ng/ml,1,Omicron/BA.2/F157L,19,T19I + L24S + Δ25-27 + G142D + F157L + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1747,ng/ml,1,=,54.6,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Bamlanivimab,Wild Type (B.1),=,6,ng/ml,1,Omicron/BA.2/G257S,19,T19I + L24S + Δ25-27 + G142D + V213G + G257S + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Etesevimab,Wild Type (B.1),=,9,ng/ml,1,Omicron/BA.2/G257S,19,T19I + L24S + Δ25-27 + G142D + V213G + G257S + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Bamlanivimab + Etesevimab,Wild Type (B.1),=,6,ng/ml,1,Omicron/BA.2/G257S,19,T19I + L24S + Δ25-27 + G142D + V213G + G257S + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Casirivimab,Wild Type (B.1),=,3,ng/ml,1,Omicron/BA.2/G257S,19,T19I + L24S + Δ25-27 + G142D + V213G + G257S + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Imdevimab,Wild Type (B.1),=,3,ng/ml,1,Omicron/BA.2/G257S,19,T19I + L24S + Δ25-27 + G142D + V213G + G257S + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1098,ng/ml,1,=,366,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Casirivimab + Imdevimab,Wild Type (B.1),=,3,ng/ml,1,Omicron/BA.2/G257S,19,T19I + L24S + Δ25-27 + G142D + V213G + G257S + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1033,ng/ml,1,=,344.3,,,
Saito22,10.1016/j.chom.2022.10.003,Pseudovirus (lentivirus),Table S3,Cilgavimab,Wild Type (B.1),=,14,ng/ml,1,Omicron/BA.2/G257S,19,T19I + L24S + Δ25-27 + G142D + V213G + G257S + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,22.5,ng/ml,1,=,1.6,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Cilgavimab,Wild Type (B.1),=,10,ng/ml,1,Omicron/BA.2/G257S,19,T19I + L24S + Δ25-27 + G142D + V213G + G257S + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,10,ng/ml,1,=,1,,,
Saito22,10.1016/j.chom.2022.10.003,Pseudovirus (lentivirus),Table S3,Tixagevimab,Wild Type (B.1),=,1.5,ng/ml,1,Omicron/BA.2/G257S,19,T19I + L24S + Δ25-27 + G142D + V213G + G257S + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,4375,ng/ml,1,>,1000,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Tixagevimab,Wild Type (B.1),=,3,ng/ml,1,Omicron/BA.2/G257S,19,T19I + L24S + Δ25-27 + G142D + V213G + G257S + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1419,ng/ml,1,=,473,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Cilgavimab + Tixagevimab,Wild Type (B.1),=,2,ng/ml,1,Omicron/BA.2/G257S,19,T19I + L24S + Δ25-27 + G142D + V213G + G257S + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,14,ng/ml,1,=,7,,,
Saito22,10.1016/j.chom.2022.10.003,Pseudovirus (lentivirus),Table S3,Sotrovimab,Wild Type (B.1),=,47,ng/ml,1,Omicron/BA.2/G257S,19,T19I + L24S + Δ25-27 + G142D + V213G + G257S + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,716.5,ng/ml,1,=,15.2,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Sotrovimab,Wild Type (B.1),=,25,ng/ml,1,Omicron/BA.2/G257S,19,T19I + L24S + Δ25-27 + G142D + V213G + G257S + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,375,ng/ml,1,=,15,,,
Saito22,10.1016/j.chom.2022.10.003,Pseudovirus (lentivirus),Table S3,Bebtelovimab,Wild Type (B.1),=,2.4,ng/ml,1,Omicron/BA.2/G257S,19,T19I + L24S + Δ25-27 + G142D + V213G + G257S + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1.6,ng/ml,1,=,0.7,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Bebtelovimab,Wild Type (B.1),=,2,ng/ml,1,Omicron/BA.2/G257S,19,T19I + L24S + Δ25-27 + G142D + V213G + G257S + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,2,ng/ml,1,=,1,,,
Saito22,10.1016/j.chom.2022.10.003,Pseudovirus (lentivirus),Table S3,Regdanvimab,Wild Type (B.1),=,1,ng/ml,1,Omicron/BA.2/G257S,19,T19I + L24S + Δ25-27 + G142D + V213G + G257S + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,6175,ng/ml,1,>,1000,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Amubarvimab,Wild Type (B.1),=,15,ng/ml,1,Omicron/BA.2/G257S,19,T19I + L24S + Δ25-27 + G142D + V213G + G257S + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,5475,ng/ml,1,=,365,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Romlusevimab,Wild Type (B.1),=,166,ng/ml,1,Omicron/BA.2/G257S,19,T19I + L24S + Δ25-27 + G142D + V213G + G257S + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1531,ng/ml,1,=,9.2,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Amubarvimab + Romlusevimab,Wild Type (B.1),=,32,ng/ml,1,Omicron/BA.2/G257S,19,T19I + L24S + Δ25-27 + G142D + V213G + G257S + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1218,ng/ml,1,=,38.1,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Bamlanivimab,Wild Type (B.1),=,6,ng/ml,1,Omicron/BA.2/I210V,19,T19I + L24S + Δ25-27 + G142D + I210V + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Etesevimab,Wild Type (B.1),=,9,ng/ml,1,Omicron/BA.2/I210V,19,T19I + L24S + Δ25-27 + G142D + I210V + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Bamlanivimab + Etesevimab,Wild Type (B.1),=,6,ng/ml,1,Omicron/BA.2/I210V,19,T19I + L24S + Δ25-27 + G142D + I210V + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Casirivimab,Wild Type (B.1),=,3,ng/ml,1,Omicron/BA.2/I210V,19,T19I + L24S + Δ25-27 + G142D + I210V + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Imdevimab,Wild Type (B.1),=,3,ng/ml,1,Omicron/BA.2/I210V,19,T19I + L24S + Δ25-27 + G142D + I210V + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1381,ng/ml,1,=,460.3,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Casirivimab + Imdevimab,Wild Type (B.1),=,3,ng/ml,1,Omicron/BA.2/I210V,19,T19I + L24S + Δ25-27 + G142D + I210V + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1786,ng/ml,1,=,595.3,,,
Saito22,10.1016/j.chom.2022.10.003,Pseudovirus (lentivirus),Table S3,Cilgavimab,Wild Type (B.1),=,14,ng/ml,1,Omicron/BA.2/I210V,19,T19I + L24S + Δ25-27 + G142D + I210V + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,18.6,ng/ml,1,=,1.3,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Cilgavimab,Wild Type (B.1),=,10,ng/ml,1,Omicron/BA.2/I210V,19,T19I + L24S + Δ25-27 + G142D + I210V + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,12,ng/ml,1,=,1.2,,,
Saito22,10.1016/j.chom.2022.10.003,Pseudovirus (lentivirus),Table S3,Tixagevimab,Wild Type (B.1),=,1.5,ng/ml,1,Omicron/BA.2/I210V,19,T19I + L24S + Δ25-27 + G142D + I210V + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,2575,ng/ml,1,>,1000,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Tixagevimab,Wild Type (B.1),=,3,ng/ml,1,Omicron/BA.2/I210V,19,T19I + L24S + Δ25-27 + G142D + I210V + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,878,ng/ml,1,=,292.7,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Cilgavimab + Tixagevimab,Wild Type (B.1),=,2,ng/ml,1,Omicron/BA.2/I210V,19,T19I + L24S + Δ25-27 + G142D + I210V + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,18,ng/ml,1,=,9,,,
Saito22,10.1016/j.chom.2022.10.003,Pseudovirus (lentivirus),Table S3,Sotrovimab,Wild Type (B.1),=,47,ng/ml,1,Omicron/BA.2/I210V,19,T19I + L24S + Δ25-27 + G142D + I210V + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,990.3,ng/ml,1,=,21.1,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Sotrovimab,Wild Type (B.1),=,25,ng/ml,1,Omicron/BA.2/I210V,19,T19I + L24S + Δ25-27 + G142D + I210V + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,526,ng/ml,1,=,21,,,
Saito22,10.1016/j.chom.2022.10.003,Pseudovirus (lentivirus),Table S3,Bebtelovimab,Wild Type (B.1),=,2.4,ng/ml,1,Omicron/BA.2/I210V,19,T19I + L24S + Δ25-27 + G142D + I210V + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1.8,ng/ml,1,=,0.8,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Bebtelovimab,Wild Type (B.1),=,2,ng/ml,1,Omicron/BA.2/I210V,19,T19I + L24S + Δ25-27 + G142D + I210V + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,2,ng/ml,1,=,1,,,
Saito22,10.1016/j.chom.2022.10.003,Pseudovirus (lentivirus),Table S3,Regdanvimab,Wild Type (B.1),=,1,ng/ml,1,Omicron/BA.2/I210V,19,T19I + L24S + Δ25-27 + G142D + I210V + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,6175,ng/ml,1,>,1000,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Amubarvimab,Wild Type (B.1),=,15,ng/ml,1,Omicron/BA.2/I210V,19,T19I + L24S + Δ25-27 + G142D + I210V + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1674,ng/ml,1,=,111.6,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Romlusevimab,Wild Type (B.1),=,166,ng/ml,1,Omicron/BA.2/I210V,19,T19I + L24S + Δ25-27 + G142D + I210V + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1296,ng/ml,1,=,7.8,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Amubarvimab + Romlusevimab,Wild Type (B.1),=,32,ng/ml,1,Omicron/BA.2/I210V,19,T19I + L24S + Δ25-27 + G142D + I210V + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,918,ng/ml,1,=,28.7,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Bamlanivimab,Wild Type (B.1),=,6,ng/ml,1,Omicron/BA.2/K147E,19,T19I + L24S + Δ25-27 + G142D + K147E + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Etesevimab,Wild Type (B.1),=,9,ng/ml,1,Omicron/BA.2/K147E,19,T19I + L24S + Δ25-27 + G142D + K147E + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Bamlanivimab + Etesevimab,Wild Type (B.1),=,6,ng/ml,1,Omicron/BA.2/K147E,19,T19I + L24S + Δ25-27 + G142D + K147E + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Casirivimab,Wild Type (B.1),=,3,ng/ml,1,Omicron/BA.2/K147E,19,T19I + L24S + Δ25-27 + G142D + K147E + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Imdevimab,Wild Type (B.1),=,3,ng/ml,1,Omicron/BA.2/K147E,19,T19I + L24S + Δ25-27 + G142D + K147E + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1625,ng/ml,1,=,541.7,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Casirivimab + Imdevimab,Wild Type (B.1),=,3,ng/ml,1,Omicron/BA.2/K147E,19,T19I + L24S + Δ25-27 + G142D + K147E + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1993,ng/ml,1,=,664.3,,,
Saito22,10.1016/j.chom.2022.10.003,Pseudovirus (lentivirus),Table S3,Cilgavimab,Wild Type (B.1),=,14,ng/ml,1,Omicron/BA.2/K147E,19,T19I + L24S + Δ25-27 + G142D + K147E + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,19.7,ng/ml,1,=,1.4,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Cilgavimab,Wild Type (B.1),=,10,ng/ml,1,Omicron/BA.2/K147E,19,T19I + L24S + Δ25-27 + G142D + K147E + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,12,ng/ml,1,=,1.2,,,
Saito22,10.1016/j.chom.2022.10.003,Pseudovirus (lentivirus),Table S3,Tixagevimab,Wild Type (B.1),=,1.5,ng/ml,1,Omicron/BA.2/K147E,19,T19I + L24S + Δ25-27 + G142D + K147E + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,4375,ng/ml,1,>,1000,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Tixagevimab,Wild Type (B.1),=,3,ng/ml,1,Omicron/BA.2/K147E,19,T19I + L24S + Δ25-27 + G142D + K147E + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,2174,ng/ml,1,=,724.7,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Cilgavimab + Tixagevimab,Wild Type (B.1),=,2,ng/ml,1,Omicron/BA.2/K147E,19,T19I + L24S + Δ25-27 + G142D + K147E + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,27,ng/ml,1,=,13.5,,,
Saito22,10.1016/j.chom.2022.10.003,Pseudovirus (lentivirus),Table S3,Sotrovimab,Wild Type (B.1),=,47,ng/ml,1,Omicron/BA.2/K147E,19,T19I + L24S + Δ25-27 + G142D + K147E + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,893.6,ng/ml,1,=,19,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Sotrovimab,Wild Type (B.1),=,25,ng/ml,1,Omicron/BA.2/K147E,19,T19I + L24S + Δ25-27 + G142D + K147E + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,532,ng/ml,1,=,21.3,,,
Saito22,10.1016/j.chom.2022.10.003,Pseudovirus (lentivirus),Table S3,Bebtelovimab,Wild Type (B.1),=,2.4,ng/ml,1,Omicron/BA.2/K147E,19,T19I + L24S + Δ25-27 + G142D + K147E + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1.2,ng/ml,1,=,0.5,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Bebtelovimab,Wild Type (B.1),=,2,ng/ml,1,Omicron/BA.2/K147E,19,T19I + L24S + Δ25-27 + G142D + K147E + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,2,ng/ml,1,=,1,,,
Saito22,10.1016/j.chom.2022.10.003,Pseudovirus (lentivirus),Table S3,Regdanvimab,Wild Type (B.1),=,1,ng/ml,1,Omicron/BA.2/K147E,19,T19I + L24S + Δ25-27 + G142D + K147E + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,6175,ng/ml,1,>,1000,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Amubarvimab,Wild Type (B.1),=,15,ng/ml,1,Omicron/BA.2/K147E,19,T19I + L24S + Δ25-27 + G142D + K147E + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1987,ng/ml,1,=,132.5,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Romlusevimab,Wild Type (B.1),=,166,ng/ml,1,Omicron/BA.2/K147E,19,T19I + L24S + Δ25-27 + G142D + K147E + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1973,ng/ml,1,=,11.9,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Amubarvimab + Romlusevimab,Wild Type (B.1),=,32,ng/ml,1,Omicron/BA.2/K147E,19,T19I + L24S + Δ25-27 + G142D + K147E + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1523,ng/ml,1,=,47.6,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Bamlanivimab,Wild Type (B.1),=,6,ng/ml,1,Omicron/BA.2/N460K,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + N460K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Etesevimab,Wild Type (B.1),=,9,ng/ml,1,Omicron/BA.2/N460K,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + N460K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Bamlanivimab + Etesevimab,Wild Type (B.1),=,6,ng/ml,1,Omicron/BA.2/N460K,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + N460K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Casirivimab,Wild Type (B.1),=,3,ng/ml,1,Omicron/BA.2/N460K,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + N460K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Imdevimab,Wild Type (B.1),=,3,ng/ml,1,Omicron/BA.2/N460K,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + N460K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,3029,ng/ml,1,>,1000,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Casirivimab + Imdevimab,Wild Type (B.1),=,3,ng/ml,1,Omicron/BA.2/N460K,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + N460K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,4905,ng/ml,1,>,1000,,,
Saito22,10.1016/j.chom.2022.10.003,Pseudovirus (lentivirus),Table S3,Cilgavimab,Wild Type (B.1),=,14,ng/ml,1,Omicron/BA.2/N460K,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + N460K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,21.1,ng/ml,1,=,1.5,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Cilgavimab,Wild Type (B.1),=,10,ng/ml,1,Omicron/BA.2/N460K,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + N460K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,17,ng/ml,1,=,1.7,,,
Wang22l,10.1101/2022.11.23.517532,Pseudovirus,Figure S2,Cilgavimab,Wild Type (B.1),=,7,ng/ml,1,Omicron/BA.2/N460K,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + N460K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,13,ng/ml,1,=,1.9,,,
Saito22,10.1016/j.chom.2022.10.003,Pseudovirus (lentivirus),Table S3,Tixagevimab,Wild Type (B.1),=,1.5,ng/ml,1,Omicron/BA.2/N460K,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + N460K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1334,ng/ml,1,=,889.3,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Tixagevimab,Wild Type (B.1),=,3,ng/ml,1,Omicron/BA.2/N460K,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + N460K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,2421,ng/ml,1,=,807,,,
Wang22l,10.1101/2022.11.23.517532,Pseudovirus,Figure S2,Tixagevimab,Wild Type (B.1),=,2,ng/ml,1,Omicron/BA.2/N460K,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + N460K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1756,ng/ml,1,=,878,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Cilgavimab + Tixagevimab,Wild Type (B.1),=,2,ng/ml,1,Omicron/BA.2/N460K,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + N460K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,22,ng/ml,1,=,11,,,
Wang22l,10.1101/2022.11.23.517532,Pseudovirus,Figure S2,Cilgavimab + Tixagevimab,Wild Type (B.1),=,3,ng/ml,1,Omicron/BA.2/N460K,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + N460K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,25,ng/ml,1,=,8.3,,,
Saito22,10.1016/j.chom.2022.10.003,Pseudovirus (lentivirus),Table S3,Sotrovimab,Wild Type (B.1),=,47,ng/ml,1,Omicron/BA.2/N460K,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + N460K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,589.4,ng/ml,1,=,12.5,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Sotrovimab,Wild Type (B.1),=,25,ng/ml,1,Omicron/BA.2/N460K,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + N460K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,712,ng/ml,1,=,28.5,,,
Wang22l,10.1101/2022.11.23.517532,Pseudovirus,Figure S2,Sotrovimab,Wild Type (B.1),=,23,ng/ml,1,Omicron/BA.2/N460K,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + N460K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,878,ng/ml,1,=,38.2,,,
Saito22,10.1016/j.chom.2022.10.003,Pseudovirus (lentivirus),Table S3,Bebtelovimab,Wild Type (B.1),=,2.4,ng/ml,1,Omicron/BA.2/N460K,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + N460K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1.3,ng/ml,1,=,0.5,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Bebtelovimab,Wild Type (B.1),=,2,ng/ml,1,Omicron/BA.2/N460K,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + N460K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,2,ng/ml,1,=,1,,,
Wang22l,10.1101/2022.11.23.517532,Pseudovirus,Figure S2,Bebtelovimab,Wild Type (B.1),=,2,ng/ml,1,Omicron/BA.2/N460K,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + N460K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1,ng/ml,1,=,0.5,,,
Saito22,10.1016/j.chom.2022.10.003,Pseudovirus (lentivirus),Table S3,Regdanvimab,Wild Type (B.1),=,1,ng/ml,1,Omicron/BA.2/N460K,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + N460K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,6175,ng/ml,1,>,1000,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Amubarvimab,Wild Type (B.1),=,15,ng/ml,1,Omicron/BA.2/N460K,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + N460K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,666.7,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Romlusevimab,Wild Type (B.1),=,166,ng/ml,1,Omicron/BA.2/N460K,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + N460K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,3521,ng/ml,1,=,21.2,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Amubarvimab + Romlusevimab,Wild Type (B.1),=,32,ng/ml,1,Omicron/BA.2/N460K,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + N460K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,312.5,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Bamlanivimab,Wild Type (B.1),=,6,ng/ml,1,Omicron/BA.2/W152R,19,T19I + L24S + Δ25-27 + G142D + W152R + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Etesevimab,Wild Type (B.1),=,9,ng/ml,1,Omicron/BA.2/W152R,19,T19I + L24S + Δ25-27 + G142D + W152R + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Bamlanivimab + Etesevimab,Wild Type (B.1),=,6,ng/ml,1,Omicron/BA.2/W152R,19,T19I + L24S + Δ25-27 + G142D + W152R + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Casirivimab,Wild Type (B.1),=,3,ng/ml,1,Omicron/BA.2/W152R,19,T19I + L24S + Δ25-27 + G142D + W152R + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Imdevimab,Wild Type (B.1),=,3,ng/ml,1,Omicron/BA.2/W152R,19,T19I + L24S + Δ25-27 + G142D + W152R + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,764,ng/ml,1,=,254.7,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Casirivimab + Imdevimab,Wild Type (B.1),=,3,ng/ml,1,Omicron/BA.2/W152R,19,T19I + L24S + Δ25-27 + G142D + W152R + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1812,ng/ml,1,=,604,,,
Saito22,10.1016/j.chom.2022.10.003,Pseudovirus (lentivirus),Table S3,Cilgavimab,Wild Type (B.1),=,14,ng/ml,1,Omicron/BA.2/W152R,19,T19I + L24S + Δ25-27 + G142D + W152R + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,27.1,ng/ml,1,=,1.9,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Cilgavimab,Wild Type (B.1),=,10,ng/ml,1,Omicron/BA.2/W152R,19,T19I + L24S + Δ25-27 + G142D + W152R + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,12,ng/ml,1,=,1.2,,,
Saito22,10.1016/j.chom.2022.10.003,Pseudovirus (lentivirus),Table S3,Tixagevimab,Wild Type (B.1),=,1.5,ng/ml,1,Omicron/BA.2/W152R,19,T19I + L24S + Δ25-27 + G142D + W152R + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,4375,ng/ml,1,>,1000,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Tixagevimab,Wild Type (B.1),=,3,ng/ml,1,Omicron/BA.2/W152R,19,T19I + L24S + Δ25-27 + G142D + W152R + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1614,ng/ml,1,=,538,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Cilgavimab + Tixagevimab,Wild Type (B.1),=,2,ng/ml,1,Omicron/BA.2/W152R,19,T19I + L24S + Δ25-27 + G142D + W152R + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,21,ng/ml,1,=,10.5,,,
Saito22,10.1016/j.chom.2022.10.003,Pseudovirus (lentivirus),Table S3,Sotrovimab,Wild Type (B.1),=,47,ng/ml,1,Omicron/BA.2/W152R,19,T19I + L24S + Δ25-27 + G142D + W152R + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,783.9,ng/ml,1,=,16.7,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Sotrovimab,Wild Type (B.1),=,25,ng/ml,1,Omicron/BA.2/W152R,19,T19I + L24S + Δ25-27 + G142D + W152R + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,364,ng/ml,1,=,14.6,,,
Saito22,10.1016/j.chom.2022.10.003,Pseudovirus (lentivirus),Table S3,Bebtelovimab,Wild Type (B.1),=,2.4,ng/ml,1,Omicron/BA.2/W152R,19,T19I + L24S + Δ25-27 + G142D + W152R + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1.8,ng/ml,1,=,0.8,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Bebtelovimab,Wild Type (B.1),=,2,ng/ml,1,Omicron/BA.2/W152R,19,T19I + L24S + Δ25-27 + G142D + W152R + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,2,ng/ml,1,=,1,,,
Saito22,10.1016/j.chom.2022.10.003,Pseudovirus (lentivirus),Table S3,Regdanvimab,Wild Type (B.1),=,1,ng/ml,1,Omicron/BA.2/W152R,19,T19I + L24S + Δ25-27 + G142D + W152R + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,6175,ng/ml,1,>,1000,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Amubarvimab,Wild Type (B.1),=,15,ng/ml,1,Omicron/BA.2/W152R,19,T19I + L24S + Δ25-27 + G142D + W152R + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1397,ng/ml,1,=,93.1,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Romlusevimab,Wild Type (B.1),=,166,ng/ml,1,Omicron/BA.2/W152R,19,T19I + L24S + Δ25-27 + G142D + W152R + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1361,ng/ml,1,=,8.2,,,
Wang22h,10.1016/j.chom.2022.09.002,Pseudovirus (VSV),Extended Data Table 2,Amubarvimab + Romlusevimab,Wild Type (B.1),=,32,ng/ml,1,Omicron/BA.2/W152R,19,T19I + L24S + Δ25-27 + G142D + W152R + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1436,ng/ml,1,=,44.9,,,
Jian22,10.1016/S1473-3099(22)00642-9,Pseudovirus (VSV),Supplementary Figure 3,Imdevimab,Omicron/BA.5,=,520,ng/ml,1,Omicron/BA.5/R346S,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346S + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1362,ng/ml,1,=,2.6,,,
Jian22,10.1016/S1473-3099(22)00642-9,Pseudovirus (VSV),Supplementary Figure 3,Casirivimab + Imdevimab,Omicron/BA.5,=,709,ng/ml,1,Omicron/BA.5/R346S,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346S + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,2420,ng/ml,1,=,3.4,,,
Jian22,10.1016/S1473-3099(22)00642-9,Pseudovirus (VSV),Supplementary Figure 3,Cilgavimab,Omicron/BA.5,=,23,ng/ml,1,Omicron/BA.5/R346S,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346S + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,434.8,,,
Wang22j,10.1016/S1473-3099(22)00694-6,Pseudovirus (VSV),Figure S3,Cilgavimab,Wild Type (B.1),=,8,ng/ml,1,Omicron/BA.5/R346S,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346S + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Wang22j,10.1016/S1473-3099(22)00694-6,Pseudovirus (VSV),Figure S3,Tixagevimab,Wild Type (B.1),=,3,ng/ml,1,Omicron/BA.5/R346S,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346S + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Jian22,10.1016/S1473-3099(22)00642-9,Pseudovirus (VSV),Supplementary Figure 3,Cilgavimab + Tixagevimab,Omicron/BA.5,=,40,ng/ml,1,Omicron/BA.5/R346S,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346S + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,250,,,
Wang22j,10.1016/S1473-3099(22)00694-6,Pseudovirus (VSV),Figure S3,Cilgavimab + Tixagevimab,Wild Type (B.1),=,3,ng/ml,1,Omicron/BA.5/R346S,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346S + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Jian22,10.1016/S1473-3099(22)00642-9,Pseudovirus (VSV),Supplementary Figure 3,Sotrovimab,Omicron/BA.5,=,1055,ng/ml,1,Omicron/BA.5/R346S,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346S + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,2899,ng/ml,1,=,2.7,,,
Wang22j,10.1016/S1473-3099(22)00694-6,Pseudovirus (VSV),Figure S3,Sotrovimab,Wild Type (B.1),=,66,ng/ml,1,Omicron/BA.5/R346S,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346S + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,4939,ng/ml,1,=,74.8,,,
Jian22,10.1016/S1473-3099(22)00642-9,Pseudovirus (VSV),Supplementary Figure 3,Bebtelovimab,Omicron/BA.5,=,0.8,ng/ml,1,Omicron/BA.5/R346S,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346S + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1.4,ng/ml,1,=,1.8,,,
Wang22j,10.1016/S1473-3099(22)00694-6,Pseudovirus (VSV),Figure S3,Bebtelovimab,Wild Type (B.1),=,1.5,ng/ml,1,Omicron/BA.5/R346S,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346S + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,0.7,ng/ml,1,=,0.5,,,
Jian22,10.1016/S1473-3099(22)00642-9,Pseudovirus (VSV),Supplementary Figure 3,Amubarvimab,Omicron/BA.5,=,7124,ng/ml,1,Omicron/BA.5/R346S,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346S + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,3395,ng/ml,1,=,0.5,,,
Wang22j,10.1016/S1473-3099(22)00694-6,Pseudovirus (VSV),Figure S3,Amubarvimab,Wild Type (B.1),=,24,ng/ml,1,Omicron/BA.5/R346S,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346S + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,754,ng/ml,1,=,31.4,,,
Wang22j,10.1016/S1473-3099(22)00694-6,Pseudovirus (VSV),Figure S3,Romlusevimab,Wild Type (B.1),=,436,ng/ml,1,Omicron/BA.5/R346S,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346S + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,22.9,,,
Wang22j,10.1016/S1473-3099(22)00694-6,Pseudovirus (VSV),Figure S3,Amubarvimab + Romlusevimab,Wild Type (B.1),=,34,ng/ml,1,Omicron/BA.5/R346S,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346S + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1533,ng/ml,1,=,45.1,,,
Jian22,10.1016/S1473-3099(22)00642-9,Pseudovirus (VSV),Supplementary Figure 3,Imdevimab,Omicron/BA.5,=,520,ng/ml,1,Omicron/BF.7,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,2195,ng/ml,1,=,4.2,,,
Jian22,10.1016/S1473-3099(22)00642-9,Pseudovirus (VSV),Supplementary Figure 3,Casirivimab + Imdevimab,Omicron/BA.5,=,709,ng/ml,1,Omicron/BF.7,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,4388,ng/ml,1,=,6.2,,,
Jian22,10.1016/S1473-3099(22)00642-9,Pseudovirus (VSV),Supplementary Figure 3,Cilgavimab,Omicron/BA.5,=,23,ng/ml,1,Omicron/BF.7,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,434.8,,,
Wang22j,10.1016/S1473-3099(22)00694-6,Pseudovirus (VSV),Figure S3,Cilgavimab,Wild Type (B.1),=,8,ng/ml,1,Omicron/BF.7,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Wang22j,10.1016/S1473-3099(22)00694-6,Pseudovirus (VSV),Figure S3,Tixagevimab,Wild Type (B.1),=,3,ng/ml,1,Omicron/BF.7,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Jian22,10.1016/S1473-3099(22)00642-9,Pseudovirus (VSV),Supplementary Figure 3,Cilgavimab + Tixagevimab,Omicron/BA.5,=,40,ng/ml,1,Omicron/BF.7,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,250,,,
Wang22j,10.1016/S1473-3099(22)00694-6,Pseudovirus (VSV),Figure S3,Cilgavimab + Tixagevimab,Wild Type (B.1),=,3,ng/ml,1,Omicron/BF.7,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Jian22,10.1016/S1473-3099(22)00642-9,Pseudovirus (VSV),Supplementary Figure 3,Sotrovimab,Omicron/BA.5,=,1055,ng/ml,1,Omicron/BF.7,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,3543,ng/ml,1,=,3.4,,,
Wang22j,10.1016/S1473-3099(22)00694-6,Pseudovirus (VSV),Figure S3,Sotrovimab,Wild Type (B.1),=,66,ng/ml,1,Omicron/BF.7,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,3218,ng/ml,1,=,48.8,,,
Jian22,10.1016/S1473-3099(22)00642-9,Pseudovirus (VSV),Supplementary Figure 3,Bebtelovimab,Omicron/BA.5,=,0.8,ng/ml,1,Omicron/BF.7,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1,ng/ml,1,=,1.3,,,
Wang22j,10.1016/S1473-3099(22)00694-6,Pseudovirus (VSV),Figure S3,Bebtelovimab,Wild Type (B.1),=,1.5,ng/ml,1,Omicron/BF.7,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1.5,ng/ml,1,=,1,,,
Jian22,10.1016/S1473-3099(22)00642-9,Pseudovirus (VSV),Supplementary Figure 3,Amubarvimab,Omicron/BA.5,=,7124,ng/ml,1,Omicron/BF.7,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,4356,ng/ml,1,=,0.6,,,
Wang22j,10.1016/S1473-3099(22)00694-6,Pseudovirus (VSV),Figure S3,Amubarvimab,Wild Type (B.1),=,24,ng/ml,1,Omicron/BF.7,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,604,ng/ml,1,=,25.2,,,
Wang22j,10.1016/S1473-3099(22)00694-6,Pseudovirus (VSV),Figure S3,Romlusevimab,Wild Type (B.1),=,436,ng/ml,1,Omicron/BF.7,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,22.9,,,
Wang22j,10.1016/S1473-3099(22)00694-6,Pseudovirus (VSV),Figure S3,Amubarvimab + Romlusevimab,Wild Type (B.1),=,34,ng/ml,1,Omicron/BF.7,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1061,ng/ml,1,=,31.2,,,
Yuan22,10.1101/2022.03.13.484037,Pseudovirus (MLV),Figure 2A,Bamlanivimab,Wild Type (B),=,7,ng/ml,1,pCoV-GX,6,V6F + L7V + Q23G + L24I + A27G + F32S + V47I + S50L + H66N + A67T + H69N + V70Y + S71Q + Δ73-74 + T76F + R78K + S112A + K113R + N137T + K147N + S151T + M153V + S155N + V171I + I197V + N211D + Q218R + S221A + D253K + S254L + S255E + A260T + P272Q + K278S + E281Q + A292S + F306L + E324I + T345S + R346K + A372T + I402V + R403K + K417V + N439V + N440K + L441Q + S443A + K444L + V445T + N450G + N460K + V483Q + E484V + F486L + F490Y + Q493E + S494R + Q498H + N501T + G504N + Y508F + H519N + A520G + K529L + N532T + N536D + E554T + N556K + K558Q + A570S + V622M + D627E + T632A + T638A + S640A + I651V + I666V + Q675H + T676S + Q677M + T678S + N679S + S680F + Δ681-684 + A688N + S689Q + Q690R + T747I + D1084E + V1104I + N1125S + V1228I,1,>,5000,ng/ml,1,>,714.3,,,
Yuan22,10.1101/2022.03.13.484037,Pseudovirus (MLV),Figure 2A,Etesevimab,Wild Type (B),=,9,ng/ml,1,pCoV-GX,6,V6F + L7V + Q23G + L24I + A27G + F32S + V47I + S50L + H66N + A67T + H69N + V70Y + S71Q + Δ73-74 + T76F + R78K + S112A + K113R + N137T + K147N + S151T + M153V + S155N + V171I + I197V + N211D + Q218R + S221A + D253K + S254L + S255E + A260T + P272Q + K278S + E281Q + A292S + F306L + E324I + T345S + R346K + A372T + I402V + R403K + K417V + N439V + N440K + L441Q + S443A + K444L + V445T + N450G + N460K + V483Q + E484V + F486L + F490Y + Q493E + S494R + Q498H + N501T + G504N + Y508F + H519N + A520G + K529L + N532T + N536D + E554T + N556K + K558Q + A570S + V622M + D627E + T632A + T638A + S640A + I651V + I666V + Q675H + T676S + Q677M + T678S + N679S + S680F + Δ681-684 + A688N + S689Q + Q690R + T747I + D1084E + V1104I + N1125S + V1228I,1,>,5000,ng/ml,1,>,555.6,,,
Yuan22,10.1101/2022.03.13.484037,Pseudovirus (MLV),Figure 2A,Bamlanivimab + Etesevimab,Wild Type (B),=,9,ng/ml,1,pCoV-GX,6,V6F + L7V + Q23G + L24I + A27G + F32S + V47I + S50L + H66N + A67T + H69N + V70Y + S71Q + Δ73-74 + T76F + R78K + S112A + K113R + N137T + K147N + S151T + M153V + S155N + V171I + I197V + N211D + Q218R + S221A + D253K + S254L + S255E + A260T + P272Q + K278S + E281Q + A292S + F306L + E324I + T345S + R346K + A372T + I402V + R403K + K417V + N439V + N440K + L441Q + S443A + K444L + V445T + N450G + N460K + V483Q + E484V + F486L + F490Y + Q493E + S494R + Q498H + N501T + G504N + Y508F + H519N + A520G + K529L + N532T + N536D + E554T + N556K + K558Q + A570S + V622M + D627E + T632A + T638A + S640A + I651V + I666V + Q675H + T676S + Q677M + T678S + N679S + S680F + Δ681-684 + A688N + S689Q + Q690R + T747I + D1084E + V1104I + N1125S + V1228I,1,>,5000,ng/ml,1,>,555.6,,,
Yuan22,10.1101/2022.03.13.484037,Pseudovirus (MLV),Figure 2A,Casirivimab,Wild Type (B),=,6,ng/ml,1,pCoV-GX,6,V6F + L7V + Q23G + L24I + A27G + F32S + V47I + S50L + H66N + A67T + H69N + V70Y + S71Q + Δ73-74 + T76F + R78K + S112A + K113R + N137T + K147N + S151T + M153V + S155N + V171I + I197V + N211D + Q218R + S221A + D253K + S254L + S255E + A260T + P272Q + K278S + E281Q + A292S + F306L + E324I + T345S + R346K + A372T + I402V + R403K + K417V + N439V + N440K + L441Q + S443A + K444L + V445T + N450G + N460K + V483Q + E484V + F486L + F490Y + Q493E + S494R + Q498H + N501T + G504N + Y508F + H519N + A520G + K529L + N532T + N536D + E554T + N556K + K558Q + A570S + V622M + D627E + T632A + T638A + S640A + I651V + I666V + Q675H + T676S + Q677M + T678S + N679S + S680F + Δ681-684 + A688N + S689Q + Q690R + T747I + D1084E + V1104I + N1125S + V1228I,1,>,5000,ng/ml,1,>,833.3,,,
Yuan22,10.1101/2022.03.13.484037,Pseudovirus (MLV),Figure 2A,Imdevimab,Wild Type (B),=,25,ng/ml,1,pCoV-GX,6,V6F + L7V + Q23G + L24I + A27G + F32S + V47I + S50L + H66N + A67T + H69N + V70Y + S71Q + Δ73-74 + T76F + R78K + S112A + K113R + N137T + K147N + S151T + M153V + S155N + V171I + I197V + N211D + Q218R + S221A + D253K + S254L + S255E + A260T + P272Q + K278S + E281Q + A292S + F306L + E324I + T345S + R346K + A372T + I402V + R403K + K417V + N439V + N440K + L441Q + S443A + K444L + V445T + N450G + N460K + V483Q + E484V + F486L + F490Y + Q493E + S494R + Q498H + N501T + G504N + Y508F + H519N + A520G + K529L + N532T + N536D + E554T + N556K + K558Q + A570S + V622M + D627E + T632A + T638A + S640A + I651V + I666V + Q675H + T676S + Q677M + T678S + N679S + S680F + Δ681-684 + A688N + S689Q + Q690R + T747I + D1084E + V1104I + N1125S + V1228I,1,>,5000,ng/ml,1,>,200,,,
Yuan22,10.1101/2022.03.13.484037,Pseudovirus (MLV),Figure 2A,Casirivimab + Imdevimab,Wild Type (B),=,6,ng/ml,1,pCoV-GX,6,V6F + L7V + Q23G + L24I + A27G + F32S + V47I + S50L + H66N + A67T + H69N + V70Y + S71Q + Δ73-74 + T76F + R78K + S112A + K113R + N137T + K147N + S151T + M153V + S155N + V171I + I197V + N211D + Q218R + S221A + D253K + S254L + S255E + A260T + P272Q + K278S + E281Q + A292S + F306L + E324I + T345S + R346K + A372T + I402V + R403K + K417V + N439V + N440K + L441Q + S443A + K444L + V445T + N450G + N460K + V483Q + E484V + F486L + F490Y + Q493E + S494R + Q498H + N501T + G504N + Y508F + H519N + A520G + K529L + N532T + N536D + E554T + N556K + K558Q + A570S + V622M + D627E + T632A + T638A + S640A + I651V + I666V + Q675H + T676S + Q677M + T678S + N679S + S680F + Δ681-684 + A688N + S689Q + Q690R + T747I + D1084E + V1104I + N1125S + V1228I,1,>,5000,ng/ml,1,>,833.3,,,
Yuan22,10.1101/2022.03.13.484037,Pseudovirus (MLV),Figure 2A,Cilgavimab,Wild Type (B),=,5,ng/ml,1,pCoV-GX,6,V6F + L7V + Q23G + L24I + A27G + F32S + V47I + S50L + H66N + A67T + H69N + V70Y + S71Q + Δ73-74 + T76F + R78K + S112A + K113R + N137T + K147N + S151T + M153V + S155N + V171I + I197V + N211D + Q218R + S221A + D253K + S254L + S255E + A260T + P272Q + K278S + E281Q + A292S + F306L + E324I + T345S + R346K + A372T + I402V + R403K + K417V + N439V + N440K + L441Q + S443A + K444L + V445T + N450G + N460K + V483Q + E484V + F486L + F490Y + Q493E + S494R + Q498H + N501T + G504N + Y508F + H519N + A520G + K529L + N532T + N536D + E554T + N556K + K558Q + A570S + V622M + D627E + T632A + T638A + S640A + I651V + I666V + Q675H + T676S + Q677M + T678S + N679S + S680F + Δ681-684 + A688N + S689Q + Q690R + T747I + D1084E + V1104I + N1125S + V1228I,1,>,5000,ng/ml,1,>,1000,,,
Yuan22,10.1101/2022.03.13.484037,Pseudovirus (MLV),Figure 2A,Tixagevimab,Wild Type (B),=,1,ng/ml,1,pCoV-GX,6,V6F + L7V + Q23G + L24I + A27G + F32S + V47I + S50L + H66N + A67T + H69N + V70Y + S71Q + Δ73-74 + T76F + R78K + S112A + K113R + N137T + K147N + S151T + M153V + S155N + V171I + I197V + N211D + Q218R + S221A + D253K + S254L + S255E + A260T + P272Q + K278S + E281Q + A292S + F306L + E324I + T345S + R346K + A372T + I402V + R403K + K417V + N439V + N440K + L441Q + S443A + K444L + V445T + N450G + N460K + V483Q + E484V + F486L + F490Y + Q493E + S494R + Q498H + N501T + G504N + Y508F + H519N + A520G + K529L + N532T + N536D + E554T + N556K + K558Q + A570S + V622M + D627E + T632A + T638A + S640A + I651V + I666V + Q675H + T676S + Q677M + T678S + N679S + S680F + Δ681-684 + A688N + S689Q + Q690R + T747I + D1084E + V1104I + N1125S + V1228I,1,=,138,ng/ml,1,=,138,,,
Yuan22,10.1101/2022.03.13.484037,Pseudovirus (MLV),Figure 2A,Cilgavimab + Tixagevimab,Wild Type (B),=,5,ng/ml,1,pCoV-GX,6,V6F + L7V + Q23G + L24I + A27G + F32S + V47I + S50L + H66N + A67T + H69N + V70Y + S71Q + Δ73-74 + T76F + R78K + S112A + K113R + N137T + K147N + S151T + M153V + S155N + V171I + I197V + N211D + Q218R + S221A + D253K + S254L + S255E + A260T + P272Q + K278S + E281Q + A292S + F306L + E324I + T345S + R346K + A372T + I402V + R403K + K417V + N439V + N440K + L441Q + S443A + K444L + V445T + N450G + N460K + V483Q + E484V + F486L + F490Y + Q493E + S494R + Q498H + N501T + G504N + Y508F + H519N + A520G + K529L + N532T + N536D + E554T + N556K + K558Q + A570S + V622M + D627E + T632A + T638A + S640A + I651V + I666V + Q675H + T676S + Q677M + T678S + N679S + S680F + Δ681-684 + A688N + S689Q + Q690R + T747I + D1084E + V1104I + N1125S + V1228I,1,=,184,ng/ml,1,=,36.8,,,
Yuan22,10.1101/2022.03.13.484037,Pseudovirus (MLV),Figure 2A,Sotrovimab,Wild Type (B),=,72,ng/ml,1,pCoV-GX,6,V6F + L7V + Q23G + L24I + A27G + F32S + V47I + S50L + H66N + A67T + H69N + V70Y + S71Q + Δ73-74 + T76F + R78K + S112A + K113R + N137T + K147N + S151T + M153V + S155N + V171I + I197V + N211D + Q218R + S221A + D253K + S254L + S255E + A260T + P272Q + K278S + E281Q + A292S + F306L + E324I + T345S + R346K + A372T + I402V + R403K + K417V + N439V + N440K + L441Q + S443A + K444L + V445T + N450G + N460K + V483Q + E484V + F486L + F490Y + Q493E + S494R + Q498H + N501T + G504N + Y508F + H519N + A520G + K529L + N532T + N536D + E554T + N556K + K558Q + A570S + V622M + D627E + T632A + T638A + S640A + I651V + I666V + Q675H + T676S + Q677M + T678S + N679S + S680F + Δ681-684 + A688N + S689Q + Q690R + T747I + D1084E + V1104I + N1125S + V1228I,1,=,45,ng/ml,1,=,0.6,,,
Liu22,10.1126/scitranslmed.abn6859,Pseudovirus (VSV),Fig2C,Sotrovimab,Wild Type (B.1),=,11,ng/ml,1,pCoV-GX,6,V6F + L7V + Q23G + L24I + A27G + F32S + V47I + S50L + H66N + A67T + H69N + V70Y + S71Q + Δ73-74 + T76F + R78K + S112A + K113R + N137T + K147N + S151T + M153V + S155N + V171I + I197V + N211D + Q218R + S221A + D253N + S254L + S255E + A260T + P272Q + K278S + E281Q + A292S + F306L + E324I + T345S + R346K + A372T + I402V + R403K + K417V + N439V + N440K + L441Q + S443A + K444L + V445T + N450G + N460K + V483Q + E484V + F486L + F490Y + Q493E + S494R + Q498H + N501T + G504N + Y508F + H519N + A520G + K529L + N532T + N536D + E554T + N556K + K558Q + A570S + V622M + D627E + T632A + T638A + S640A + I651V + I666V + Q675H + T676S + Q677M + T678S + N679S + S680L + Δ681-684 + A688N + S689Q + Q690R + T747I + D1084E + V1104I + N1125S + L1197P + V1228I,1,=,3526,ng/ml,1,=,320.5,,,
Arora22f,10.1016/S1473-3099(22)00733-2,Pseudovirus (VSV),Figure B,Bamlanivimab,Wild Type (B.1),=,16,ng/ml,1,Omicron/BQ.1.1,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444T + L452R + N460K + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,50000,ng/ml,1,>,1000,,,
Arora22f,10.1016/S1473-3099(22)00733-2,Pseudovirus (VSV),Figure B,Etesevimab,Wild Type (B.1),=,53,ng/ml,1,Omicron/BQ.1.1,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444T + L452R + N460K + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,50000,ng/ml,1,>,943.4,,,
Arora22f,10.1016/S1473-3099(22)00733-2,Pseudovirus (VSV),Figure B,Bamlanivimab + Etesevimab,Wild Type (B.1),=,18,ng/ml,1,Omicron/BQ.1.1,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444T + L452R + N460K + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,50000,ng/ml,1,>,1000,,,
Arora22f,10.1016/S1473-3099(22)00733-2,Pseudovirus (VSV),Figure B,Casirivimab,Wild Type (B.1),=,21,ng/ml,1,Omicron/BQ.1.1,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444T + L452R + N460K + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,50000,ng/ml,1,>,1000,,,
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Casirivimab,Omicron/BA.2,>,10000,ng/ml,1,Omicron/BQ.1.1,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444T + L452R + N460K + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Planas22b,10.1101/2022.11.17.516888,Virus isolate,Figure 3b,Casirivimab,Wild Type (B.1),=,1.7,ng/ml,1,Omicron/BQ.1.1,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444T + L452R + N460K + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Touret22c,10.1101/2022.12.22.521201,Virus isolate,Table 1,Casirivimab,Delta,=,14.7,ng/ml,1,Omicron/BQ.1.1,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444T + L452R + N460K + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,5000,ng/ml,1,>,340.1,,,
Arora22f,10.1016/S1473-3099(22)00733-2,Pseudovirus (VSV),Figure B,Imdevimab,Wild Type (B.1),=,19,ng/ml,1,Omicron/BQ.1.1,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444T + L452R + N460K + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,50000,ng/ml,1,>,1000,,,
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Imdevimab,Omicron/BA.2,=,590,ng/ml,1,Omicron/BQ.1.1,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444T + L452R + N460K + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1.7,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Planas22b,10.1101/2022.11.17.516888,Virus isolate,Figure 3b,Imdevimab,Wild Type (B.1),=,2.1,ng/ml,1,Omicron/BQ.1.1,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444T + L452R + N460K + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Touret22c,10.1101/2022.12.22.521201,Virus isolate,Table 1,Imdevimab,Delta,=,20.1,ng/ml,1,Omicron/BQ.1.1,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444T + L452R + N460K + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,5000,ng/ml,1,>,248.8,,,
Arora22f,10.1016/S1473-3099(22)00733-2,Pseudovirus (VSV),Figure B,Casirivimab + Imdevimab,Wild Type (B.1),=,9,ng/ml,1,Omicron/BQ.1.1,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444T + L452R + N460K + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,50000,ng/ml,1,>,1000,,,
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Casirivimab + Imdevimab,Omicron/BA.2,=,821,ng/ml,1,Omicron/BQ.1.1,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444T + L452R + N460K + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1.2,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Planas22b,10.1101/2022.11.17.516888,Virus isolate,Figure 3b,Casirivimab + Imdevimab,Wild Type (B.1),=,1.6,ng/ml,1,Omicron/BQ.1.1,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444T + L452R + N460K + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Arora22f,10.1016/S1473-3099(22)00733-2,Pseudovirus (VSV),Figure B,Cilgavimab,Wild Type (B.1),=,37,ng/ml,1,Omicron/BQ.1.1,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444T + L452R + N460K + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,50000,ng/ml,1,>,1000,,,
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Cilgavimab,Omicron/BA.2,=,6.3,ng/ml,1,Omicron/BQ.1.1,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444T + L452R + N460K + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,158.7,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Wang22l,10.1101/2022.11.23.517532,Pseudovirus,Figure S2,Cilgavimab,Wild Type (B.1),=,7,ng/ml,1,Omicron/BQ.1.1,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444T + L452R + N460K + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Planas22b,10.1101/2022.11.17.516888,Virus isolate,Figure 3b,Cilgavimab,Wild Type (B.1),=,2.9,ng/ml,1,Omicron/BQ.1.1,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444T + L452R + N460K + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Touret22c,10.1101/2022.12.22.521201,Virus isolate,Table 1,Cilgavimab,Delta,=,21.7,ng/ml,1,Omicron/BQ.1.1,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444T + L452R + N460K + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,5000,ng/ml,1,>,230.4,,,
Arora22f,10.1016/S1473-3099(22)00733-2,Pseudovirus (VSV),Figure B,Tixagevimab,Wild Type (B.1),=,7,ng/ml,1,Omicron/BQ.1.1,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444T + L452R + N460K + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,50000,ng/ml,1,>,1000,,,
Wang22l,10.1101/2022.11.23.517532,Pseudovirus,Figure S2,Tixagevimab,Wild Type (B.1),=,2,ng/ml,1,Omicron/BQ.1.1,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444T + L452R + N460K + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Planas22b,10.1101/2022.11.17.516888,Virus isolate,Figure 3b,Tixagevimab,Wild Type (B.1),=,1.3,ng/ml,1,Omicron/BQ.1.1,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444T + L452R + N460K + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Touret22c,10.1101/2022.12.22.521201,Virus isolate,Table 1,Tixagevimab,Delta,=,12.4,ng/ml,1,Omicron/BQ.1.1,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444T + L452R + N460K + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,5000,ng/ml,1,>,403.2,,,
Arora22f,10.1016/S1473-3099(22)00733-2,Pseudovirus (VSV),Figure B,Cilgavimab + Tixagevimab,Wild Type (B.1),=,7,ng/ml,1,Omicron/BQ.1.1,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444T + L452R + N460K + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,50000,ng/ml,1,>,1000,,,
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Cilgavimab + Tixagevimab,Omicron/BA.2,=,8.2,ng/ml,1,Omicron/BQ.1.1,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444T + L452R + N460K + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,122,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Wang22l,10.1101/2022.11.23.517532,Pseudovirus,Figure S2,Cilgavimab + Tixagevimab,Wild Type (B.1),=,3,ng/ml,1,Omicron/BQ.1.1,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444T + L452R + N460K + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Planas22b,10.1101/2022.11.17.516888,Virus isolate,Figure 3b,Cilgavimab + Tixagevimab,Wild Type (B.1),=,1.3,ng/ml,1,Omicron/BQ.1.1,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444T + L452R + N460K + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Touret22c,10.1101/2022.12.22.521201,Virus isolate,Table 1,Cilgavimab + Tixagevimab,Delta,=,12.5,ng/ml,1,Omicron/BQ.1.1,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444T + L452R + N460K + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,5000,ng/ml,1,>,400,,,
Arora22f,10.1016/S1473-3099(22)00733-2,Pseudovirus (VSV),Figure B,Sotrovimab,Wild Type (B.1),=,157,ng/ml,1,Omicron/BQ.1.1,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444T + L452R + N460K + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,50000,ng/ml,1,>,318.5,,,
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Sotrovimab,Omicron/BA.2,=,852,ng/ml,1,Omicron/BQ.1.1,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444T + L452R + N460K + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,5581,ng/ml,1,>,6.6,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Wang22l,10.1101/2022.11.23.517532,Pseudovirus,Figure S2,Sotrovimab,Wild Type (B.1),=,23,ng/ml,1,Omicron/BQ.1.1,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444T + L452R + N460K + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,2140,ng/ml,1,=,93,,,
Planas22b,10.1101/2022.11.17.516888,Virus isolate,Figure 3b,Sotrovimab,Wild Type (B.1),=,65,ng/ml,1,Omicron/BQ.1.1,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444T + L452R + N460K + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,7640,ng/ml,1,=,117.5,,,
Touret22c,10.1101/2022.12.22.521201,Virus isolate,Table 1,Sotrovimab,Delta,=,98.6,ng/ml,1,Omicron/BQ.1.1,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444T + L452R + N460K + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1238,ng/ml,1,=,12.6,,,
Arora22f,10.1016/S1473-3099(22)00733-2,Pseudovirus (VSV),Figure B,Bebtelovimab,Wild Type (B.1),=,5,ng/ml,1,Omicron/BQ.1.1,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444T + L452R + N460K + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,50000,ng/ml,1,>,1000,,,
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Bebtelovimab,Omicron/BA.2,=,0.9,ng/ml,1,Omicron/BQ.1.1,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444T + L452R + N460K + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Wang22l,10.1101/2022.11.23.517532,Pseudovirus,Figure S2,Bebtelovimab,Wild Type (B.1),=,2,ng/ml,1,Omicron/BQ.1.1,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444T + L452R + N460K + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Planas22b,10.1101/2022.11.17.516888,Virus isolate,Figure 3b,Bebtelovimab,Wild Type (B.1),=,1.4,ng/ml,1,Omicron/BQ.1.1,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444T + L452R + N460K + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Touret22c,10.1101/2022.12.22.521201,Virus isolate,Table 1,Bebtelovimab,Delta,=,0.4,ng/ml,1,Omicron/BQ.1.1,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444T + L452R + N460K + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,5000,ng/ml,1,>,1000,,,
Arora22f,10.1016/S1473-3099(22)00733-2,Pseudovirus (VSV),Figure B,Regdanvimab,Wild Type (B.1),=,7,ng/ml,1,Omicron/BQ.1.1,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444T + L452R + N460K + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,50000,ng/ml,1,>,1000,,,
Arora22f,10.1016/S1473-3099(22)00733-2,Pseudovirus (VSV),Figure B,Amubarvimab,Wild Type (B.1),=,53,ng/ml,1,Omicron/BQ.1.1,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444T + L452R + N460K + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,50000,ng/ml,1,>,943.4,,,
Arora22f,10.1016/S1473-3099(22)00733-2,Pseudovirus (VSV),Figure B,Romlusevimab,Wild Type (B.1),=,852,ng/ml,1,Omicron/BQ.1.1,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444T + L452R + N460K + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,50000,ng/ml,1,>,58.7,,,
Arora22f,10.1016/S1473-3099(22)00733-2,Pseudovirus (VSV),Figure B,Amubarvimab + Romlusevimab,Wild Type (B.1),=,64,ng/ml,1,Omicron/BQ.1.1,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444T + L452R + N460K + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,50000,ng/ml,1,>,781.3,,,
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,DXP-604,Omicron/BA.2,=,219,ng/ml,1,Omicron/BQ.1.1,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444T + L452R + N460K + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,4.6,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 5b,Casirivimab + Imdevimab,Omicron/BA.2,=,821,ng/ml,1,Omicron/BA.5/G339H+R346T+K356T+K417T+K444T+N460K,(Various),(Various),3,>,10000,ng/ml,1,>,1.2,1.2,1.2,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 5b,Cilgavimab + Tixagevimab,Omicron/BA.2,=,8.2,ng/ml,1,Omicron/BA.5/G339H+R346T+K356T+K417T+K444T+N460K,(Various),(Various),3,>,10000,ng/ml,1,>,122,122,122,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 5b,Sotrovimab,Omicron/BA.2,=,852,ng/ml,1,Omicron/BA.5/G339H+R346T+K356T+K417T+K444T+N460K,(Various),(Various),3,>,10000,ng/ml,1,>,1.2,1.2,1.2,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 5b,Bebtelovimab,Omicron/BA.2,=,0.9,ng/ml,1,Omicron/BA.5/G339H+R346T+K356T+K417T+K444T+N460K,(Various),(Various),3,>,10000,ng/ml,1,>,1000,1111.1,1111.1,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Zhang21c,10.1038/s42003-021-02728-4,Pseudovirus (VSV),Supplementary Figure 3,Etesevimab,Wild Type (B.1),,,,,B.1.1.298,69,Δ69-70 + Y453F + I692V + M1229I,1,,,,,=,2,,,
Fenwick21,10.1016/j.celrep.2021.109814,SARS-CoV-2 recombinant,Figure 3B,Casirivimab,Wild Type (B),=,48,ng/ml,1,B.1.1.298,5,L5F + Δ69-70 + Y453F + N751Y + C1250F,1,=,1064,ng/ml,1,=,22.2,,,
Tada21,10.1128/mBio.00696-21,Pseudovirus (HIV),Table 3,Casirivimab,Wild Type (B.1),=,7.4,ng/ml,1,B.1.1.298,69,Δ69-70 + Y453F + I692V + S1147L + M1229I,1,=,1599,ng/ml,1,=,214.9,,,
Fenwick21,10.1016/j.celrep.2021.109814,SARS-CoV-2 recombinant,Figure 3B,Imdevimab,Wild Type (B),=,28,ng/ml,1,B.1.1.298,5,L5F + Δ69-70 + Y453F + N751Y + C1250F,1,=,6,ng/ml,1,=,0.2,,,
Tada21,10.1128/mBio.00696-21,Pseudovirus (HIV),Table 3,Imdevimab,Wild Type (B.1),=,19.4,ng/ml,1,B.1.1.298,69,Δ69-70 + Y453F + I692V + S1147L + M1229I,1,=,54.3,ng/ml,1,=,2.8,,,
Tada21,10.1128/mBio.00696-21,Pseudovirus (HIV),Table 3,Casirivimab + Imdevimab,Wild Type (B.1),=,1.7,ng/ml,1,B.1.1.298,69,Δ69-70 + Y453F + I692V + S1147L + M1229I,1,=,27.4,ng/ml,1,=,16.2,,,
Chen21d,10.1016/j.celrep.2021.109604,Virus isolate,Figure 2K,Cilgavimab,Wild Type (B.1),=,3,ng/ml,1,B.1.1.298 (Δ69-70 + Y453F),69,Δ69-70 + Y453F,1,=,5,ng/ml,1,=,1.7,,,
Fenwick21,10.1016/j.celrep.2021.109814,SARS-CoV-2 recombinant,Figure 3B,Sotrovimab,Wild Type (B),=,147,ng/ml,1,B.1.1.298,5,L5F + Δ69-70 + Y453F + N751Y + C1250F,1,=,127,ng/ml,1,=,0.9,,,
Zhang21c,10.1038/s42003-021-02728-4,Pseudovirus (VSV),Supplementary Figure 3,Etesevimab,Wild Type (B.1),,,,,Eta,52,Q52R + A67V + Δ69-70 + Δ144-145 + E484K + Q677H + F888L,1,,,,,=,2,,,
Pelzek22,10.1101/2022.02.06.479332,Pseudovirus (lentivirus),Extended Table 1,Casirivimab,Wild Type (B),=,24,ng/ml,1,Eta,52,Q52R + A67V + Δ69-70 + Δ144-145 + E484K + Q677H + F888L,1,=,55,ng/ml,1,=,2.3,,,
Pelzek22,10.1101/2022.02.06.479332,Pseudovirus (lentivirus),Extended Table 1,Imdevimab,Wild Type (B),=,23,ng/ml,1,Eta,52,Q52R + A67V + Δ69-70 + Δ144-145 + E484K + Q677H + F888L,1,=,22,ng/ml,1,=,1,,,
EMA21e,https://www.ema.europa.eu/en/documents/product-information/evusheld-epar-product-information_en.pdf,Pseudovirus,Table 3,Cilgavimab + Tixagevimab,Wild Type (B),=,1.9,ng/ml,1,Eta,52,Q52R + A67V + Δ69-70 + Δ144-145 + E484K + Q677H + F888L,1,=,5,ng/ml,1,=,2.6,,,
FDA21c,https://www.fda.gov/media/154701/download,Pseudovirus,"Feb 2022, Table 6, Page 17, Antiviral resistance paragraph 6",Cilgavimab + Tixagevimab,Wild Type (B),,,,,Eta,52,Q52R + A67V + Δ69-70 + Δ144-145 + E484K + Q677H + F888L,1,,,,,=,3.1,,,
Cathcart21,10.1101/2021.03.09.434607,Pseudovirus (VSV),Table 2,Sotrovimab,Wild Type (B),,,,,Eta,52,Q52R + A67V + Δ69-70 + Δ144-145 + E484K + Q677H + F888L,1,,,,,=,0.9,,,
EMA21c,https://www.ema.europa.eu/en/documents/product-information/regkirona-epar-product-information_en.pdf,Virus isolate,Table 3,Regdanvimab,Wild Type (B),,,,,Eta,52,Q52R + A67V + Δ69-70 + Δ144-145 + E484K + Q677H + F888L,1,,,,,=,1,,,
EMA21c,https://www.ema.europa.eu/en/documents/product-information/regkirona-epar-product-information_en.pdf,Pseudovirus,Table 3,Regdanvimab,Wild Type (B),,,,,Eta,52,Q52R + A67V + Δ69-70 + Δ144-145 + E484K + Q677H + F888L,1,,,,,=,7.2,,,
Margolis21,https://idweek.org/Margolis,Pseudovirus,Table 2,Amubarvimab + Romlusevimab,Wild Type (B.1),,,,,Eta,52,Q52R + A67V + Δ69-70 + Δ144-145 + E484K + Q677H + F888L,1,,,,,=,2.5,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b,Bamlanivimab,Wild Type (B.1),=,4,ng/ml,1,Omicron/BA.2/F486V+R493Q,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + F486V + Q493Q + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b,Etesevimab,Wild Type (B.1),=,12,ng/ml,1,Omicron/BA.2/F486V+R493Q,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + F486V + Q493Q + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,833.3,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b,Bamlanivimab + Etesevimab,Wild Type (B.1),=,5,ng/ml,1,Omicron/BA.2/F486V+R493Q,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + F486V + Q493Q + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b,Casirivimab,Wild Type (B.1),=,5,ng/ml,1,Omicron/BA.2/F486V+R493Q,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + F486V + Q493Q + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b,Imdevimab,Wild Type (B.1),=,1,ng/ml,1,Omicron/BA.2/F486V+R493Q,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + F486V + Q493Q + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,757,ng/ml,1,=,757,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b,Casirivimab + Imdevimab,Wild Type (B.1),=,1,ng/ml,1,Omicron/BA.2/F486V+R493Q,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + F486V + Q493Q + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,2498,ng/ml,1,>,1000,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b,Cilgavimab,Wild Type (B.1),=,6,ng/ml,1,Omicron/BA.2/F486V+R493Q,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + F486V + Q493Q + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,9,ng/ml,1,=,1.5,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b,Tixagevimab,Wild Type (B.1),=,2,ng/ml,1,Omicron/BA.2/F486V+R493Q,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + F486V + Q493Q + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b,Cilgavimab + Tixagevimab,Wild Type (B.1),=,2,ng/ml,1,Omicron/BA.2/F486V+R493Q,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + F486V + Q493Q + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,17,ng/ml,1,=,8.5,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b,Sotrovimab,Wild Type (B.1),=,14,ng/ml,1,Omicron/BA.2/F486V+R493Q,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + F486V + Q493Q + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,754,ng/ml,1,=,53.9,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b,Bebtelovimab,Wild Type (B.1),=,1,ng/ml,1,Omicron/BA.2/F486V+R493Q,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + F486V + Q493Q + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,2,ng/ml,1,=,2,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b,Amubarvimab,Wild Type (B.1),=,18,ng/ml,1,Omicron/BA.2/F486V+R493Q,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + F486V + Q493Q + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,394,ng/ml,1,=,21.9,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b,Romlusevimab,Wild Type (B.1),=,110,ng/ml,1,Omicron/BA.2/F486V+R493Q,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + F486V + Q493Q + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1414,ng/ml,1,=,12.9,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b,Amubarvimab + Romlusevimab,Wild Type (B.1),=,22,ng/ml,1,Omicron/BA.2/F486V+R493Q,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + F486V + Q493Q + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,586,ng/ml,1,=,26.6,,,
Wang22j,10.1016/S1473-3099(22)00694-6,Pseudovirus (VSV),Figure S3,Cilgavimab,Wild Type (B.1),=,8,ng/ml,1,Omicron/BA.5/N658S,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N658S + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,55,ng/ml,1,=,6.9,,,
Wang22j,10.1016/S1473-3099(22)00694-6,Pseudovirus (VSV),Figure S3,Tixagevimab,Wild Type (B.1),=,3,ng/ml,1,Omicron/BA.5/N658S,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N658S + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Wang22j,10.1016/S1473-3099(22)00694-6,Pseudovirus (VSV),Figure S3,Cilgavimab + Tixagevimab,Wild Type (B.1),=,3,ng/ml,1,Omicron/BA.5/N658S,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N658S + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,92,ng/ml,1,=,30.7,,,
Wang22j,10.1016/S1473-3099(22)00694-6,Pseudovirus (VSV),Figure S3,Sotrovimab,Wild Type (B.1),=,66,ng/ml,1,Omicron/BA.5/N658S,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N658S + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1414,ng/ml,1,=,21.4,,,
Wang22j,10.1016/S1473-3099(22)00694-6,Pseudovirus (VSV),Figure S3,Bebtelovimab,Wild Type (B.1),=,1.5,ng/ml,1,Omicron/BA.5/N658S,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N658S + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,0.6,ng/ml,1,=,0.4,,,
Wang22j,10.1016/S1473-3099(22)00694-6,Pseudovirus (VSV),Figure S3,Amubarvimab,Wild Type (B.1),=,24,ng/ml,1,Omicron/BA.5/N658S,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N658S + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,345,ng/ml,1,=,14.4,,,
Wang22j,10.1016/S1473-3099(22)00694-6,Pseudovirus (VSV),Figure S3,Romlusevimab,Wild Type (B.1),=,436,ng/ml,1,Omicron/BA.5/N658S,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N658S + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,22.9,,,
Wang22j,10.1016/S1473-3099(22)00694-6,Pseudovirus (VSV),Figure S3,Amubarvimab + Romlusevimab,Wild Type (B.1),=,34,ng/ml,1,Omicron/BA.5/N658S,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N658S + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1168,ng/ml,1,=,34.4,,,
Arora22c,10.1016/j.celrep.2022.110754,Pseudovirus (VSV),Supplementary Figure 1D,Bamlanivimab,Wild Type (B.1),=,11.7,ng/ml,1,C.1.2,(Various),(Various),2,>,2000,ng/ml,1,>,170.9,170.9,170.9,
Arora22c,10.1016/j.celrep.2022.110754,Pseudovirus (VSV),Supplementary Figure 1D,Etesevimab,Wild Type (B.1),=,29.4,ng/ml,1,C.1.2,(Various),(Various),2,=,181.8,ng/ml,1.9,=,7.5,5.4,9.7,
Ju22,10.1038/s41422-022-00638-6,Pseudovirus (HIV),Figure S1F,Etesevimab,Wild Type (B),=,12,ng/ml,1,C.1.2,9,P9L + C136F + Δ144-145 + R190S + D215G + Y449H + E484K + N501Y + H655Y + N679K + T716I + T859N,1,=,230,ng/ml,1,=,19.2,,,
Arora22c,10.1016/j.celrep.2022.110754,Pseudovirus (VSV),Supplementary Figure 1D,Bamlanivimab + Etesevimab,Wild Type (B.1),=,11.2,ng/ml,1,C.1.2,(Various),(Various),2,=,78.3,ng/ml,1.1,=,7,6.6,7.5,
Arora22c,10.1016/j.celrep.2022.110754,Pseudovirus (VSV),Supplementary Figure 1D,Casirivimab,Wild Type (B.1),=,9.7,ng/ml,1,C.1.2,(Various),(Various),2,=,46,ng/ml,1.6,=,5.2,4.1,6.3,
Ju22,10.1038/s41422-022-00638-6,Pseudovirus (HIV),Figure S1F,Casirivimab,Wild Type (B),=,2,ng/ml,1,C.1.2,9,P9L + C136F + Δ144-145 + R190S + D215G + Y449H + E484K + N501Y + H655Y + N679K + T716I + T859N,1,=,25,ng/ml,1,=,12.5,,,
Arora22c,10.1016/j.celrep.2022.110754,Pseudovirus (VSV),Supplementary Figure 1D,Imdevimab,Wild Type (B.1),=,10.5,ng/ml,1,C.1.2,(Various),(Various),2,=,7.9,ng/ml,1.1,=,0.8,0.7,0.8,
Ju22,10.1038/s41422-022-00638-6,Pseudovirus (HIV),Figure S1F,Imdevimab,Wild Type (B),=,2,ng/ml,1,C.1.2,9,P9L + C136F + Δ144-145 + R190S + D215G + Y449H + E484K + N501Y + H655Y + N679K + T716I + T859N,1,=,2,ng/ml,1,=,1,,,
Arora22c,10.1016/j.celrep.2022.110754,Pseudovirus (VSV),Supplementary Figure 1D,Casirivimab + Imdevimab,Wild Type (B.1),=,11.1,ng/ml,1,C.1.2,(Various),(Various),2,=,7.8,ng/ml,1.2,=,0.7,0.7,0.8,
Ju22,10.1038/s41422-022-00638-6,Pseudovirus (HIV),Figure S1F,Sotrovimab,Wild Type (B),=,93,ng/ml,1,C.1.2,9,P9L + C136F + Δ144-145 + R190S + D215G + Y449H + E484K + N501Y + H655Y + N679K + T716I + T859N,1,=,219,ng/ml,1,=,2.4,,,
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Casirivimab,Omicron/BA.2,>,10000,ng/ml,1,Omicron/BA.2.3.20,19,T19I + L24S + Δ25-27 + G142D + M153T + N164K + V213G + H245N + G257D + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444R + N450D + L452M + N460K + S477N + T478K + E484R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,121,ng/ml,1,=,0.1,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Imdevimab,Omicron/BA.2,=,590,ng/ml,1,Omicron/BA.2.3.20,19,T19I + L24S + Δ25-27 + G142D + M153T + N164K + V213G + H245N + G257D + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444R + N450D + L452M + N460K + S477N + T478K + E484R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1.7,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Casirivimab + Imdevimab,Omicron/BA.2,=,821,ng/ml,1,Omicron/BA.2.3.20,19,T19I + L24S + Δ25-27 + G142D + M153T + N164K + V213G + H245N + G257D + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444R + N450D + L452M + N460K + S477N + T478K + E484R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,199,ng/ml,1,=,0.2,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Cilgavimab,Omicron/BA.2,=,6.3,ng/ml,1,Omicron/BA.2.3.20,19,T19I + L24S + Δ25-27 + G142D + M153T + N164K + V213G + H245N + G257D + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444R + N450D + L452M + N460K + S477N + T478K + E484R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,158.7,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Cilgavimab + Tixagevimab,Omicron/BA.2,=,8.2,ng/ml,1,Omicron/BA.2.3.20,19,T19I + L24S + Δ25-27 + G142D + M153T + N164K + V213G + H245N + G257D + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444R + N450D + L452M + N460K + S477N + T478K + E484R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,26,ng/ml,1,=,3.2,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Sotrovimab,Omicron/BA.2,=,852,ng/ml,1,Omicron/BA.2.3.20,19,T19I + L24S + Δ25-27 + G142D + M153T + N164K + V213G + H245N + G257D + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444R + N450D + L452M + N460K + S477N + T478K + E484R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,897,ng/ml,1,=,1.1,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Bebtelovimab,Omicron/BA.2,=,0.9,ng/ml,1,Omicron/BA.2.3.20,19,T19I + L24S + Δ25-27 + G142D + M153T + N164K + V213G + H245N + G257D + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444R + N450D + L452M + N460K + S477N + T478K + E484R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,9.7,ng/ml,1,=,10.8,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,DXP-604,Omicron/BA.2,=,219,ng/ml,1,Omicron/BA.2.3.20,19,T19I + L24S + Δ25-27 + G142D + M153T + N164K + V213G + H245N + G257D + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444R + N450D + L452M + N460K + S477N + T478K + E484R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,181,ng/ml,1,=,0.8,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Arora22f,10.1016/S1473-3099(22)00733-2,Pseudovirus (VSV),Figure B,Bamlanivimab,Wild Type (B.1),=,16,ng/ml,1,Omicron/BJ.1,19,T19I + L24S + Δ25-27 + V83A + G142D + Δ144 + H146Q + Q183E + V213E + G339H + R346T + L368I + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + V445P + G446S + S477N + T478K + V483A + E484A + F490V + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + G798D + Q954H + N969K + S1003I,1,>,50000,ng/ml,1,>,1000,,,
Arora22f,10.1016/S1473-3099(22)00733-2,Pseudovirus (VSV),Figure B,Etesevimab,Wild Type (B.1),=,53,ng/ml,1,Omicron/BJ.1,19,T19I + L24S + Δ25-27 + V83A + G142D + Δ144 + H146Q + Q183E + V213E + G339H + R346T + L368I + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + V445P + G446S + S477N + T478K + V483A + E484A + F490V + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + G798D + Q954H + N969K + S1003I,1,>,50000,ng/ml,1,>,943.4,,,
Arora22f,10.1016/S1473-3099(22)00733-2,Pseudovirus (VSV),Figure B,Bamlanivimab + Etesevimab,Wild Type (B.1),=,18,ng/ml,1,Omicron/BJ.1,19,T19I + L24S + Δ25-27 + V83A + G142D + Δ144 + H146Q + Q183E + V213E + G339H + R346T + L368I + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + V445P + G446S + S477N + T478K + V483A + E484A + F490V + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + G798D + Q954H + N969K + S1003I,1,>,50000,ng/ml,1,>,1000,,,
Arora22f,10.1016/S1473-3099(22)00733-2,Pseudovirus (VSV),Figure B,Casirivimab,Wild Type (B.1),=,21,ng/ml,1,Omicron/BJ.1,19,T19I + L24S + Δ25-27 + V83A + G142D + Δ144 + H146Q + Q183E + V213E + G339H + R346T + L368I + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + V445P + G446S + S477N + T478K + V483A + E484A + F490V + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + G798D + Q954H + N969K + S1003I,1,=,880,ng/ml,1,=,41.9,,,
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Casirivimab,Omicron/BA.2,>,10000,ng/ml,1,Omicron/BJ.1,19,T19I + L24S + Δ25-27 + V83A + G142D + Δ144 + H146Q + Q183E + V213E + G339H + R346T + L368I + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + V445P + G446S + S477N + T478K + V483A + E484A + F490V + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + G798D + Q954H + N969K + S1003I,1,>,10000,ng/ml,1,>,1,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Arora22f,10.1016/S1473-3099(22)00733-2,Pseudovirus (VSV),Figure B,Imdevimab,Wild Type (B.1),=,19,ng/ml,1,Omicron/BJ.1,19,T19I + L24S + Δ25-27 + V83A + G142D + Δ144 + H146Q + Q183E + V213E + G339H + R346T + L368I + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + V445P + G446S + S477N + T478K + V483A + E484A + F490V + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + G798D + Q954H + N969K + S1003I,1,>,50000,ng/ml,1,>,1000,,,
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Imdevimab,Omicron/BA.2,=,590,ng/ml,1,Omicron/BJ.1,19,T19I + L24S + Δ25-27 + V83A + G142D + Δ144 + H146Q + Q183E + V213E + G339H + R346T + L368I + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + V445P + G446S + S477N + T478K + V483A + E484A + F490V + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + G798D + Q954H + N969K + S1003I,1,>,10000,ng/ml,1,>,1.7,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Arora22f,10.1016/S1473-3099(22)00733-2,Pseudovirus (VSV),Figure B,Casirivimab + Imdevimab,Wild Type (B.1),=,9,ng/ml,1,Omicron/BJ.1,19,T19I + L24S + Δ25-27 + V83A + G142D + Δ144 + H146Q + Q183E + V213E + G339H + R346T + L368I + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + V445P + G446S + S477N + T478K + V483A + E484A + F490V + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + G798D + Q954H + N969K + S1003I,1,=,2456,ng/ml,1,=,272.9,,,
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Casirivimab + Imdevimab,Omicron/BA.2,=,821,ng/ml,1,Omicron/BJ.1,19,T19I + L24S + Δ25-27 + V83A + G142D + Δ144 + H146Q + Q183E + V213E + G339H + R346T + L368I + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + V445P + G446S + S477N + T478K + V483A + E484A + F490V + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + G798D + Q954H + N969K + S1003I,1,>,10000,ng/ml,1,>,1.2,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Arora22f,10.1016/S1473-3099(22)00733-2,Pseudovirus (VSV),Figure B,Cilgavimab,Wild Type (B.1),=,37,ng/ml,1,Omicron/BJ.1,19,T19I + L24S + Δ25-27 + V83A + G142D + Δ144 + H146Q + Q183E + V213E + G339H + R346T + L368I + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + V445P + G446S + S477N + T478K + V483A + E484A + F490V + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + G798D + Q954H + N969K + S1003I,1,>,50000,ng/ml,1,>,1000,,,
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Cilgavimab,Omicron/BA.2,=,6.3,ng/ml,1,Omicron/BJ.1,19,T19I + L24S + Δ25-27 + V83A + G142D + Δ144 + H146Q + Q183E + V213E + G339H + R346T + L368I + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + V445P + G446S + S477N + T478K + V483A + E484A + F490V + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + G798D + Q954H + N969K + S1003I,1,>,10000,ng/ml,1,>,158.7,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Arora22f,10.1016/S1473-3099(22)00733-2,Pseudovirus (VSV),Figure B,Tixagevimab,Wild Type (B.1),=,7,ng/ml,1,Omicron/BJ.1,19,T19I + L24S + Δ25-27 + V83A + G142D + Δ144 + H146Q + Q183E + V213E + G339H + R346T + L368I + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + V445P + G446S + S477N + T478K + V483A + E484A + F490V + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + G798D + Q954H + N969K + S1003I,1,=,304,ng/ml,1,=,43.4,,,
Arora22f,10.1016/S1473-3099(22)00733-2,Pseudovirus (VSV),Figure B,Cilgavimab + Tixagevimab,Wild Type (B.1),=,7,ng/ml,1,Omicron/BJ.1,19,T19I + L24S + Δ25-27 + V83A + G142D + Δ144 + H146Q + Q183E + V213E + G339H + R346T + L368I + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + V445P + G446S + S477N + T478K + V483A + E484A + F490V + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + G798D + Q954H + N969K + S1003I,1,=,482,ng/ml,1,=,68.9,,,
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Cilgavimab + Tixagevimab,Omicron/BA.2,=,8.2,ng/ml,1,Omicron/BJ.1,19,T19I + L24S + Δ25-27 + V83A + G142D + Δ144 + H146Q + Q183E + V213E + G339H + R346T + L368I + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + V445P + G446S + S477N + T478K + V483A + E484A + F490V + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + G798D + Q954H + N969K + S1003I,1,=,5985,ng/ml,1,>,729.9,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Arora22f,10.1016/S1473-3099(22)00733-2,Pseudovirus (VSV),Figure B,Sotrovimab,Wild Type (B.1),=,157,ng/ml,1,Omicron/BJ.1,19,T19I + L24S + Δ25-27 + V83A + G142D + Δ144 + H146Q + Q183E + V213E + G339H + R346T + L368I + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + V445P + G446S + S477N + T478K + V483A + E484A + F490V + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + G798D + Q954H + N969K + S1003I,1,=,825,ng/ml,1,=,5.3,,,
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Sotrovimab,Omicron/BA.2,=,852,ng/ml,1,Omicron/BJ.1,19,T19I + L24S + Δ25-27 + V83A + G142D + Δ144 + H146Q + Q183E + V213E + G339H + R346T + L368I + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + V445P + G446S + S477N + T478K + V483A + E484A + F490V + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + G798D + Q954H + N969K + S1003I,1,=,709,ng/ml,1,=,0.8,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Arora22f,10.1016/S1473-3099(22)00733-2,Pseudovirus (VSV),Figure B,Bebtelovimab,Wild Type (B.1),=,5,ng/ml,1,Omicron/BJ.1,19,T19I + L24S + Δ25-27 + V83A + G142D + Δ144 + H146Q + Q183E + V213E + G339H + R346T + L368I + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + V445P + G446S + S477N + T478K + V483A + E484A + F490V + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + G798D + Q954H + N969K + S1003I,1,>,50000,ng/ml,1,>,1000,,,
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Bebtelovimab,Omicron/BA.2,=,0.9,ng/ml,1,Omicron/BJ.1,19,T19I + L24S + Δ25-27 + V83A + G142D + Δ144 + H146Q + Q183E + V213E + G339H + R346T + L368I + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + V445P + G446S + S477N + T478K + V483A + E484A + F490V + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + G798D + Q954H + N969K + S1003I,1,>,10000,ng/ml,1,>,1000,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Arora22f,10.1016/S1473-3099(22)00733-2,Pseudovirus (VSV),Figure B,Regdanvimab,Wild Type (B.1),=,7,ng/ml,1,Omicron/BJ.1,19,T19I + L24S + Δ25-27 + V83A + G142D + Δ144 + H146Q + Q183E + V213E + G339H + R346T + L368I + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + V445P + G446S + S477N + T478K + V483A + E484A + F490V + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + G798D + Q954H + N969K + S1003I,1,>,50000,ng/ml,1,>,1000,,,
Arora22f,10.1016/S1473-3099(22)00733-2,Pseudovirus (VSV),Figure B,Amubarvimab,Wild Type (B.1),=,53,ng/ml,1,Omicron/BJ.1,19,T19I + L24S + Δ25-27 + V83A + G142D + Δ144 + H146Q + Q183E + V213E + G339H + R346T + L368I + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + V445P + G446S + S477N + T478K + V483A + E484A + F490V + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + G798D + Q954H + N969K + S1003I,1,=,4762,ng/ml,1,=,89.8,,,
Arora22f,10.1016/S1473-3099(22)00733-2,Pseudovirus (VSV),Figure B,Romlusevimab,Wild Type (B.1),=,852,ng/ml,1,Omicron/BJ.1,19,T19I + L24S + Δ25-27 + V83A + G142D + Δ144 + H146Q + Q183E + V213E + G339H + R346T + L368I + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + V445P + G446S + S477N + T478K + V483A + E484A + F490V + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + G798D + Q954H + N969K + S1003I,1,>,50000,ng/ml,1,>,58.7,,,
Arora22f,10.1016/S1473-3099(22)00733-2,Pseudovirus (VSV),Figure B,Amubarvimab + Romlusevimab,Wild Type (B.1),=,64,ng/ml,1,Omicron/BJ.1,19,T19I + L24S + Δ25-27 + V83A + G142D + Δ144 + H146Q + Q183E + V213E + G339H + R346T + L368I + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + V445P + G446S + S477N + T478K + V483A + E484A + F490V + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + G798D + Q954H + N969K + S1003I,1,=,5359,ng/ml,1,=,83.7,,,
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,DXP-604,Omicron/BA.2,=,219,ng/ml,1,Omicron/BJ.1,19,T19I + L24S + Δ25-27 + V83A + G142D + Δ144 + H146Q + Q183E + V213E + G339H + R346T + L368I + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + V445P + G446S + S477N + T478K + V483A + E484A + F490V + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + G798D + Q954H + N969K + S1003I,1,=,166,ng/ml,1,=,0.8,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Touret22c,10.1101/2022.12.22.521201,Virus isolate,Table 1,Casirivimab,Delta,=,14.7,ng/ml,1,Omicron/XBB,19,T19I + L24S + Δ25-27 + V83A + G142D + Δ144 + H146Q + Q183E + V213E + G339H + R346T + L368I + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + V445P + G446S + N460K + S477N + T478K + E484A + F486S + F490S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,5000,ng/ml,1,>,340.1,,,
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Casirivimab,Omicron/BA.2,>,10000,ng/ml,1,Omicron/XBB,19,T19I + L24S + Δ25-27 + V83A + G142D + Δ144 + H146Q + Q183E + V213E + G339H + R346T + L368I + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + V445P + G446S + N460K + S477N + T478K + E484A + F486S + F490S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Touret22c,10.1101/2022.12.22.521201,Virus isolate,Table 1,Imdevimab,Delta,=,20.1,ng/ml,1,Omicron/XBB,19,T19I + L24S + Δ25-27 + V83A + G142D + Δ144 + H146Q + Q183E + V213E + G339H + R346T + L368I + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + V445P + G446S + N460K + S477N + T478K + E484A + F486S + F490S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,5000,ng/ml,1,>,248.8,,,
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Imdevimab,Omicron/BA.2,=,590,ng/ml,1,Omicron/XBB,19,T19I + L24S + Δ25-27 + V83A + G142D + Δ144 + H146Q + Q183E + V213E + G339H + R346T + L368I + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + V445P + G446S + N460K + S477N + T478K + E484A + F486S + F490S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1.7,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Casirivimab + Imdevimab,Omicron/BA.2,=,821,ng/ml,1,Omicron/XBB,19,T19I + L24S + Δ25-27 + V83A + G142D + Δ144 + H146Q + Q183E + V213E + G339H + R346T + L368I + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + V445P + G446S + N460K + S477N + T478K + E484A + F486S + F490S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1.2,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Touret22c,10.1101/2022.12.22.521201,Virus isolate,Table 1,Cilgavimab,Delta,=,21.7,ng/ml,1,Omicron/XBB,19,T19I + L24S + Δ25-27 + V83A + G142D + Δ144 + H146Q + Q183E + V213E + G339H + R346T + L368I + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + V445P + G446S + N460K + S477N + T478K + E484A + F486S + F490S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,5000,ng/ml,1,>,230.4,,,
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Cilgavimab,Omicron/BA.2,=,6.3,ng/ml,1,Omicron/XBB,19,T19I + L24S + Δ25-27 + V83A + G142D + Δ144 + H146Q + Q183E + V213E + G339H + R346T + L368I + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + V445P + G446S + N460K + S477N + T478K + E484A + F486S + F490S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,158.7,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Wang22l,10.1101/2022.11.23.517532,Pseudovirus,Figure S2,Cilgavimab,Wild Type (B.1),=,7,ng/ml,1,Omicron/XBB,19,T19I + L24S + Δ25-27 + V83A + G142D + Δ144 + H146Q + Q183E + V213E + G339H + R346T + L368I + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + V445P + G446S + N460K + S477N + T478K + E484A + F486S + F490S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Touret22c,10.1101/2022.12.22.521201,Virus isolate,Table 1,Tixagevimab,Delta,=,12.4,ng/ml,1,Omicron/XBB,19,T19I + L24S + Δ25-27 + V83A + G142D + Δ144 + H146Q + Q183E + V213E + G339H + R346T + L368I + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + V445P + G446S + N460K + S477N + T478K + E484A + F486S + F490S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,5000,ng/ml,1,>,403.2,,,
Wang22l,10.1101/2022.11.23.517532,Pseudovirus,Figure S2,Tixagevimab,Wild Type (B.1),=,2,ng/ml,1,Omicron/XBB,19,T19I + L24S + Δ25-27 + V83A + G142D + Δ144 + H146Q + Q183E + V213E + G339H + R346T + L368I + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + V445P + G446S + N460K + S477N + T478K + E484A + F486S + F490S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Touret22c,10.1101/2022.12.22.521201,Virus isolate,Table 1,Cilgavimab + Tixagevimab,Delta,=,12.5,ng/ml,1,Omicron/XBB,19,T19I + L24S + Δ25-27 + V83A + G142D + Δ144 + H146Q + Q183E + V213E + G339H + R346T + L368I + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + V445P + G446S + N460K + S477N + T478K + E484A + F486S + F490S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,5000,ng/ml,1,>,400,,,
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Cilgavimab + Tixagevimab,Omicron/BA.2,=,8.2,ng/ml,1,Omicron/XBB,19,T19I + L24S + Δ25-27 + V83A + G142D + Δ144 + H146Q + Q183E + V213E + G339H + R346T + L368I + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + V445P + G446S + N460K + S477N + T478K + E484A + F486S + F490S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,122,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Wang22l,10.1101/2022.11.23.517532,Pseudovirus,Figure S2,Cilgavimab + Tixagevimab,Wild Type (B.1),=,3,ng/ml,1,Omicron/XBB,19,T19I + L24S + Δ25-27 + V83A + G142D + Δ144 + H146Q + Q183E + V213E + G339H + R346T + L368I + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + V445P + G446S + N460K + S477N + T478K + E484A + F486S + F490S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Touret22c,10.1101/2022.12.22.521201,Virus isolate,Table 1,Sotrovimab,Delta,=,98.6,ng/ml,1,Omicron/XBB,19,T19I + L24S + Δ25-27 + V83A + G142D + Δ144 + H146Q + Q183E + V213E + G339H + R346T + L368I + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + V445P + G446S + N460K + S477N + T478K + E484A + F486S + F490S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,806.6,ng/ml,1,=,8.2,,,
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Sotrovimab,Omicron/BA.2,=,852,ng/ml,1,Omicron/XBB,19,T19I + L24S + Δ25-27 + V83A + G142D + Δ144 + H146Q + Q183E + V213E + G339H + R346T + L368I + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + V445P + G446S + N460K + S477N + T478K + E484A + F486S + F490S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,963,ng/ml,1,=,1.1,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Wang22l,10.1101/2022.11.23.517532,Pseudovirus,Figure S2,Sotrovimab,Wild Type (B.1),=,23,ng/ml,1,Omicron/XBB,19,T19I + L24S + Δ25-27 + V83A + G142D + Δ144 + H146Q + Q183E + V213E + G339H + R346T + L368I + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + V445P + G446S + N460K + S477N + T478K + E484A + F486S + F490S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,343,ng/ml,1,=,14.9,,,
Touret22c,10.1101/2022.12.22.521201,Virus isolate,Table 1,Bebtelovimab,Delta,=,0.4,ng/ml,1,Omicron/XBB,19,T19I + L24S + Δ25-27 + V83A + G142D + Δ144 + H146Q + Q183E + V213E + G339H + R346T + L368I + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + V445P + G446S + N460K + S477N + T478K + E484A + F486S + F490S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,5000,ng/ml,1,>,1000,,,
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Bebtelovimab,Omicron/BA.2,=,0.9,ng/ml,1,Omicron/XBB,19,T19I + L24S + Δ25-27 + V83A + G142D + Δ144 + H146Q + Q183E + V213E + G339H + R346T + L368I + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + V445P + G446S + N460K + S477N + T478K + E484A + F486S + F490S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Wang22l,10.1101/2022.11.23.517532,Pseudovirus,Figure S2,Bebtelovimab,Wild Type (B.1),=,2,ng/ml,1,Omicron/XBB,19,T19I + L24S + Δ25-27 + V83A + G142D + Δ144 + H146Q + Q183E + V213E + G339H + R346T + L368I + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + V445P + G446S + N460K + S477N + T478K + E484A + F486S + F490S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,DXP-604,Omicron/BA.2,=,219,ng/ml,1,Omicron/XBB,19,T19I + L24S + Δ25-27 + V83A + G142D + Δ144 + H146Q + Q183E + V213E + G339H + R346T + L368I + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + V445P + G446S + N460K + S477N + T478K + E484A + F486S + F490S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,4.6,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Casirivimab,Omicron/BA.2,>,10000,ng/ml,1,Omicron/BA.2.38.1,19,T19I + L24S + Δ25-27 + G142D + V213G + S247N + Y248S + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417T + N440K + K444N + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Imdevimab,Omicron/BA.2,=,590,ng/ml,1,Omicron/BA.2.38.1,19,T19I + L24S + Δ25-27 + G142D + V213G + S247N + Y248S + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417T + N440K + K444N + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1.7,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Casirivimab + Imdevimab,Omicron/BA.2,=,821,ng/ml,1,Omicron/BA.2.38.1,19,T19I + L24S + Δ25-27 + G142D + V213G + S247N + Y248S + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417T + N440K + K444N + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1.2,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Cilgavimab,Omicron/BA.2,=,6.3,ng/ml,1,Omicron/BA.2.38.1,19,T19I + L24S + Δ25-27 + G142D + V213G + S247N + Y248S + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417T + N440K + K444N + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,158.7,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Cilgavimab + Tixagevimab,Omicron/BA.2,=,8.2,ng/ml,1,Omicron/BA.2.38.1,19,T19I + L24S + Δ25-27 + G142D + V213G + S247N + Y248S + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417T + N440K + K444N + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,4736,ng/ml,1,>,577.6,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Sotrovimab,Omicron/BA.2,=,852,ng/ml,1,Omicron/BA.2.38.1,19,T19I + L24S + Δ25-27 + G142D + V213G + S247N + Y248S + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417T + N440K + K444N + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,876,ng/ml,1,=,1,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Bebtelovimab,Omicron/BA.2,=,0.9,ng/ml,1,Omicron/BA.2.38.1,19,T19I + L24S + Δ25-27 + G142D + V213G + S247N + Y248S + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417T + N440K + K444N + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1504,ng/ml,1,>,1000,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,DXP-604,Omicron/BA.2,=,219,ng/ml,1,Omicron/BA.2.38.1,19,T19I + L24S + Δ25-27 + G142D + V213G + S247N + Y248S + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417T + N440K + K444N + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,33,ng/ml,1,=,0.2,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Casirivimab,Omicron/BA.2,>,10000,ng/ml,1,Omicron/BA.2.74,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452M + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Imdevimab,Omicron/BA.2,=,590,ng/ml,1,Omicron/BA.2.74,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452M + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,2250,ng/ml,1,>,3.8,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Casirivimab + Imdevimab,Omicron/BA.2,=,821,ng/ml,1,Omicron/BA.2.74,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452M + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,3211,ng/ml,1,>,3.9,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Cilgavimab,Omicron/BA.2,=,6.3,ng/ml,1,Omicron/BA.2.74,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452M + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,158.7,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Cilgavimab + Tixagevimab,Omicron/BA.2,=,8.2,ng/ml,1,Omicron/BA.2.74,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452M + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,4300,ng/ml,1,>,524.4,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Sotrovimab,Omicron/BA.2,=,852,ng/ml,1,Omicron/BA.2.74,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452M + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,4943,ng/ml,1,>,5.8,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Bebtelovimab,Omicron/BA.2,=,0.9,ng/ml,1,Omicron/BA.2.74,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452M + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,2.6,ng/ml,1,=,2.9,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,DXP-604,Omicron/BA.2,=,219,ng/ml,1,Omicron/BA.2.74,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452M + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,191,ng/ml,1,=,0.9,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Casirivimab,Omicron/BA.2,>,10000,ng/ml,1,Omicron/BA.2.75.4,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + L452R + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,249,ng/ml,1,=,0.2,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Imdevimab,Omicron/BA.2,=,590,ng/ml,1,Omicron/BA.2.75.4,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + L452R + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1.7,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Casirivimab + Imdevimab,Omicron/BA.2,=,821,ng/ml,1,Omicron/BA.2.75.4,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + L452R + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,461,ng/ml,1,=,0.6,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Cilgavimab,Omicron/BA.2,=,6.3,ng/ml,1,Omicron/BA.2.75.4,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + L452R + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,158.7,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Cilgavimab + Tixagevimab,Omicron/BA.2,=,8.2,ng/ml,1,Omicron/BA.2.75.4,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + L452R + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,194,ng/ml,1,=,23.7,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Sotrovimab,Omicron/BA.2,=,852,ng/ml,1,Omicron/BA.2.75.4,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + L452R + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,424,ng/ml,1,=,0.5,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Bebtelovimab,Omicron/BA.2,=,0.9,ng/ml,1,Omicron/BA.2.75.4,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + L452R + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,4,ng/ml,1,=,4.4,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,DXP-604,Omicron/BA.2,=,219,ng/ml,1,Omicron/BA.2.75.4,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + L452R + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,6553,ng/ml,1,>,29.9,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Casirivimab,Omicron/BA.2,>,10000,ng/ml,1,Omicron/BA.2.75.5,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,245,ng/ml,1,=,0.2,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Imdevimab,Omicron/BA.2,=,590,ng/ml,1,Omicron/BA.2.75.5,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1.7,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Casirivimab + Imdevimab,Omicron/BA.2,=,821,ng/ml,1,Omicron/BA.2.75.5,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,410,ng/ml,1,=,0.5,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Cilgavimab,Omicron/BA.2,=,6.3,ng/ml,1,Omicron/BA.2.75.5,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,550,ng/ml,1,=,87.3,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Cilgavimab + Tixagevimab,Omicron/BA.2,=,8.2,ng/ml,1,Omicron/BA.2.75.5,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,188,ng/ml,1,=,22.9,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Sotrovimab,Omicron/BA.2,=,852,ng/ml,1,Omicron/BA.2.75.5,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,4780,ng/ml,1,>,5.6,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Bebtelovimab,Omicron/BA.2,=,0.9,ng/ml,1,Omicron/BA.2.75.5,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,2.2,ng/ml,1,=,2.4,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,DXP-604,Omicron/BA.2,=,219,ng/ml,1,Omicron/BA.2.75.5,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,6691,ng/ml,1,>,30.6,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Casirivimab,Omicron/BA.2,>,10000,ng/ml,1,Omicron/BA.2.76,19,T19I + L24S + Δ25-27 + G142D + V213G + Y248N + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Imdevimab,Omicron/BA.2,=,590,ng/ml,1,Omicron/BA.2.76,19,T19I + L24S + Δ25-27 + G142D + V213G + Y248N + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,2336,ng/ml,1,>,4,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Casirivimab + Imdevimab,Omicron/BA.2,=,821,ng/ml,1,Omicron/BA.2.76,19,T19I + L24S + Δ25-27 + G142D + V213G + Y248N + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,4241,ng/ml,1,>,5.2,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Cilgavimab,Omicron/BA.2,=,6.3,ng/ml,1,Omicron/BA.2.76,19,T19I + L24S + Δ25-27 + G142D + V213G + Y248N + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,158.7,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Cilgavimab + Tixagevimab,Omicron/BA.2,=,8.2,ng/ml,1,Omicron/BA.2.76,19,T19I + L24S + Δ25-27 + G142D + V213G + Y248N + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,5450,ng/ml,1,>,664.6,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Sotrovimab,Omicron/BA.2,=,852,ng/ml,1,Omicron/BA.2.76,19,T19I + L24S + Δ25-27 + G142D + V213G + Y248N + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,6303,ng/ml,1,>,7.4,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Bebtelovimab,Omicron/BA.2,=,0.9,ng/ml,1,Omicron/BA.2.76,19,T19I + L24S + Δ25-27 + G142D + V213G + Y248N + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1.3,ng/ml,1,=,1.4,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,DXP-604,Omicron/BA.2,=,219,ng/ml,1,Omicron/BA.2.76,19,T19I + L24S + Δ25-27 + G142D + V213G + Y248N + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,181,ng/ml,1,=,0.8,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Casirivimab,Omicron/BA.2,>,10000,ng/ml,1,Omicron/BA.2.77,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + E340K + K356T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + D936H + Q954H + N969K,1,>,10000,ng/ml,1,>,1,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Imdevimab,Omicron/BA.2,=,590,ng/ml,1,Omicron/BA.2.77,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + E340K + K356T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + D936H + Q954H + N969K,1,=,657,ng/ml,1,=,1.1,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Casirivimab + Imdevimab,Omicron/BA.2,=,821,ng/ml,1,Omicron/BA.2.77,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + E340K + K356T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + D936H + Q954H + N969K,1,=,584,ng/ml,1,=,0.7,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Cilgavimab,Omicron/BA.2,=,6.3,ng/ml,1,Omicron/BA.2.77,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + E340K + K356T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + D936H + Q954H + N969K,1,=,24,ng/ml,1,=,3.8,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Cilgavimab + Tixagevimab,Omicron/BA.2,=,8.2,ng/ml,1,Omicron/BA.2.77,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + E340K + K356T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + D936H + Q954H + N969K,1,=,45,ng/ml,1,=,5.5,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Sotrovimab,Omicron/BA.2,=,852,ng/ml,1,Omicron/BA.2.77,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + E340K + K356T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + D936H + Q954H + N969K,1,>,10000,ng/ml,1,>,1.2,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Bebtelovimab,Omicron/BA.2,=,0.9,ng/ml,1,Omicron/BA.2.77,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + E340K + K356T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + D936H + Q954H + N969K,1,=,0.9,ng/ml,1,=,1,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,DXP-604,Omicron/BA.2,=,219,ng/ml,1,Omicron/BA.2.77,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + E340K + K356T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + D936H + Q954H + N969K,1,=,259,ng/ml,1,=,1.2,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Casirivimab,Omicron/BA.2,>,10000,ng/ml,1,Omicron/BA.2.79,19,T19I + L24S + Δ25-27 + G142D + V213G + Y248S + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + N450D + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Imdevimab,Omicron/BA.2,=,590,ng/ml,1,Omicron/BA.2.79,19,T19I + L24S + Δ25-27 + G142D + V213G + Y248S + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + N450D + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,3051,ng/ml,1,>,5.2,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Casirivimab + Imdevimab,Omicron/BA.2,=,821,ng/ml,1,Omicron/BA.2.79,19,T19I + L24S + Δ25-27 + G142D + V213G + Y248S + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + N450D + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,7703,ng/ml,1,>,9.4,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Cilgavimab,Omicron/BA.2,=,6.3,ng/ml,1,Omicron/BA.2.79,19,T19I + L24S + Δ25-27 + G142D + V213G + Y248S + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + N450D + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,3633,ng/ml,1,>,576.7,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Cilgavimab + Tixagevimab,Omicron/BA.2,=,8.2,ng/ml,1,Omicron/BA.2.79,19,T19I + L24S + Δ25-27 + G142D + V213G + Y248S + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + N450D + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,3019,ng/ml,1,>,368.2,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Sotrovimab,Omicron/BA.2,=,852,ng/ml,1,Omicron/BA.2.79,19,T19I + L24S + Δ25-27 + G142D + V213G + Y248S + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + N450D + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1023,ng/ml,1,>,1.2,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Bebtelovimab,Omicron/BA.2,=,0.9,ng/ml,1,Omicron/BA.2.79,19,T19I + L24S + Δ25-27 + G142D + V213G + Y248S + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + N450D + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,14,ng/ml,1,=,15.6,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,DXP-604,Omicron/BA.2,=,219,ng/ml,1,Omicron/BA.2.79,19,T19I + L24S + Δ25-27 + G142D + V213G + Y248S + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + N450D + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,178,ng/ml,1,=,0.8,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Casirivimab,Omicron/BA.2,>,10000,ng/ml,1,Omicron/BA.2.79,19,T19I + L24S + Δ25-27 + G142D + V213G + Y248S + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + N450D + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Imdevimab,Omicron/BA.2,=,590,ng/ml,1,Omicron/BA.2.79,19,T19I + L24S + Δ25-27 + G142D + V213G + Y248S + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + N450D + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,3051,ng/ml,1,>,5.2,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Casirivimab + Imdevimab,Omicron/BA.2,=,821,ng/ml,1,Omicron/BA.2.79,19,T19I + L24S + Δ25-27 + G142D + V213G + Y248S + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + N450D + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,7703,ng/ml,1,>,9.4,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Cilgavimab,Omicron/BA.2,=,6.3,ng/ml,1,Omicron/BA.2.79,19,T19I + L24S + Δ25-27 + G142D + V213G + Y248S + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + N450D + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,3633,ng/ml,1,>,576.7,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Cilgavimab + Tixagevimab,Omicron/BA.2,=,8.2,ng/ml,1,Omicron/BA.2.79,19,T19I + L24S + Δ25-27 + G142D + V213G + Y248S + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + N450D + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,3019,ng/ml,1,>,368.2,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Sotrovimab,Omicron/BA.2,=,852,ng/ml,1,Omicron/BA.2.79,19,T19I + L24S + Δ25-27 + G142D + V213G + Y248S + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + N450D + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1023,ng/ml,1,>,1.2,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Bebtelovimab,Omicron/BA.2,=,0.9,ng/ml,1,Omicron/BA.2.79,19,T19I + L24S + Δ25-27 + G142D + V213G + Y248S + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + N450D + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,14,ng/ml,1,=,15.6,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,DXP-604,Omicron/BA.2,=,219,ng/ml,1,Omicron/BA.2.79,19,T19I + L24S + Δ25-27 + G142D + V213G + Y248S + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + N450D + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,178,ng/ml,1,=,0.8,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Casirivimab,Omicron/BA.2,>,10000,ng/ml,1,Omicron/BL.1,19,T19I + L24S + Δ25-27 + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + D574V + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,260,ng/ml,1,=,0.3,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Imdevimab,Omicron/BA.2,=,590,ng/ml,1,Omicron/BL.1,19,T19I + L24S + Δ25-27 + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + D574V + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1.7,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Casirivimab + Imdevimab,Omicron/BA.2,=,821,ng/ml,1,Omicron/BL.1,19,T19I + L24S + Δ25-27 + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + D574V + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,511,ng/ml,1,=,0.6,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Cilgavimab,Omicron/BA.2,=,6.3,ng/ml,1,Omicron/BL.1,19,T19I + L24S + Δ25-27 + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + D574V + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,158.7,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Cilgavimab + Tixagevimab,Omicron/BA.2,=,8.2,ng/ml,1,Omicron/BL.1,19,T19I + L24S + Δ25-27 + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + D574V + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,174,ng/ml,1,=,21.2,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Sotrovimab,Omicron/BA.2,=,852,ng/ml,1,Omicron/BL.1,19,T19I + L24S + Δ25-27 + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + D574V + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,508,ng/ml,1,=,0.6,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Bebtelovimab,Omicron/BA.2,=,0.9,ng/ml,1,Omicron/BL.1,19,T19I + L24S + Δ25-27 + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + D574V + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,2.8,ng/ml,1,=,3.1,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,DXP-604,Omicron/BA.2,=,219,ng/ml,1,Omicron/BL.1,19,T19I + L24S + Δ25-27 + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + D574V + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,7193,ng/ml,1,>,32.8,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Casirivimab,Omicron/BA.2,>,10000,ng/ml,1,Omicron/BR.1,19,T19I + L24S + Δ25-27 + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444M + G446S + L452R + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,319,ng/ml,1,=,0.3,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Imdevimab,Omicron/BA.2,=,590,ng/ml,1,Omicron/BR.1,19,T19I + L24S + Δ25-27 + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444M + G446S + L452R + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1.7,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Casirivimab + Imdevimab,Omicron/BA.2,=,821,ng/ml,1,Omicron/BR.1,19,T19I + L24S + Δ25-27 + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444M + G446S + L452R + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,679,ng/ml,1,=,0.8,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Cilgavimab,Omicron/BA.2,=,6.3,ng/ml,1,Omicron/BR.1,19,T19I + L24S + Δ25-27 + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444M + G446S + L452R + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,158.7,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Cilgavimab + Tixagevimab,Omicron/BA.2,=,8.2,ng/ml,1,Omicron/BR.1,19,T19I + L24S + Δ25-27 + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444M + G446S + L452R + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,170,ng/ml,1,=,20.7,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Sotrovimab,Omicron/BA.2,=,852,ng/ml,1,Omicron/BR.1,19,T19I + L24S + Δ25-27 + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444M + G446S + L452R + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,564,ng/ml,1,=,0.7,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Bebtelovimab,Omicron/BA.2,=,0.9,ng/ml,1,Omicron/BR.1,19,T19I + L24S + Δ25-27 + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444M + G446S + L452R + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,DXP-604,Omicron/BA.2,=,219,ng/ml,1,Omicron/BR.1,19,T19I + L24S + Δ25-27 + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444M + G446S + L452R + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,6689,ng/ml,1,>,30.5,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Casirivimab,Omicron/BA.2,>,10000,ng/ml,1,Omicron/BN.2.1,19,T19I + L24S + Δ25-27 + H49Y + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + K356T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + F490S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,390,ng/ml,1,=,0.4,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Imdevimab,Omicron/BA.2,=,590,ng/ml,1,Omicron/BN.2.1,19,T19I + L24S + Δ25-27 + H49Y + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + K356T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + F490S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1.7,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Casirivimab + Imdevimab,Omicron/BA.2,=,821,ng/ml,1,Omicron/BN.2.1,19,T19I + L24S + Δ25-27 + H49Y + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + K356T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + F490S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,701,ng/ml,1,=,0.9,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Cilgavimab,Omicron/BA.2,=,6.3,ng/ml,1,Omicron/BN.2.1,19,T19I + L24S + Δ25-27 + H49Y + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + K356T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + F490S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,303,ng/ml,1,=,48.1,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Cilgavimab + Tixagevimab,Omicron/BA.2,=,8.2,ng/ml,1,Omicron/BN.2.1,19,T19I + L24S + Δ25-27 + H49Y + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + K356T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + F490S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,109,ng/ml,1,=,13.3,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Sotrovimab,Omicron/BA.2,=,852,ng/ml,1,Omicron/BN.2.1,19,T19I + L24S + Δ25-27 + H49Y + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + K356T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + F490S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,6979,ng/ml,1,>,8.2,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Bebtelovimab,Omicron/BA.2,=,0.9,ng/ml,1,Omicron/BN.2.1,19,T19I + L24S + Δ25-27 + H49Y + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + K356T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + F490S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1.7,ng/ml,1,=,1.9,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,DXP-604,Omicron/BA.2,=,219,ng/ml,1,Omicron/BN.2.1,19,T19I + L24S + Δ25-27 + H49Y + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + K356T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + F490S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,8901,ng/ml,1,>,40.6,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Casirivimab,Omicron/BA.2,>,10000,ng/ml,1,Omicron/BN.1,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + K356T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + F490S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,344,ng/ml,1,=,0.3,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Imdevimab,Omicron/BA.2,=,590,ng/ml,1,Omicron/BN.1,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + K356T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + F490S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1.7,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Casirivimab + Imdevimab,Omicron/BA.2,=,821,ng/ml,1,Omicron/BN.1,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + K356T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + F490S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,599,ng/ml,1,=,0.7,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Cilgavimab,Omicron/BA.2,=,6.3,ng/ml,1,Omicron/BN.1,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + K356T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + F490S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,158.7,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Cilgavimab + Tixagevimab,Omicron/BA.2,=,8.2,ng/ml,1,Omicron/BN.1,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + K356T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + F490S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,166,ng/ml,1,=,20.2,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Sotrovimab,Omicron/BA.2,=,852,ng/ml,1,Omicron/BN.1,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + K356T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + F490S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1.2,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Bebtelovimab,Omicron/BA.2,=,0.9,ng/ml,1,Omicron/BN.1,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + K356T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + F490S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,3.3,ng/ml,1,=,3.7,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,DXP-604,Omicron/BA.2,=,219,ng/ml,1,Omicron/BN.1,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + K356T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + F490S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,6012,ng/ml,1,>,27.5,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Casirivimab,Omicron/BA.2,>,10000,ng/ml,1,Omicron/BM.1,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + F486S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Imdevimab,Omicron/BA.2,=,590,ng/ml,1,Omicron/BM.1,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + F486S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1.7,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Casirivimab + Imdevimab,Omicron/BA.2,=,821,ng/ml,1,Omicron/BM.1,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + F486S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1.2,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Cilgavimab,Omicron/BA.2,=,6.3,ng/ml,1,Omicron/BM.1,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + F486S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,301,ng/ml,1,=,47.8,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Cilgavimab + Tixagevimab,Omicron/BA.2,=,8.2,ng/ml,1,Omicron/BM.1,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + F486S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,563,ng/ml,1,=,68.7,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Sotrovimab,Omicron/BA.2,=,852,ng/ml,1,Omicron/BM.1,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + F486S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,796,ng/ml,1,=,0.9,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Bebtelovimab,Omicron/BA.2,=,0.9,ng/ml,1,Omicron/BM.1,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + F486S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1.9,ng/ml,1,=,2.1,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,DXP-604,Omicron/BA.2,=,219,ng/ml,1,Omicron/BM.1,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + F486S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,4.6,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Casirivimab,Omicron/BA.2,>,10000,ng/ml,1,Omicron/BM.1.1,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + F486S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Imdevimab,Omicron/BA.2,=,590,ng/ml,1,Omicron/BM.1.1,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + F486S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1.7,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Casirivimab + Imdevimab,Omicron/BA.2,=,821,ng/ml,1,Omicron/BM.1.1,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + F486S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1.2,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Cilgavimab,Omicron/BA.2,=,6.3,ng/ml,1,Omicron/BM.1.1,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + F486S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,158.7,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Cilgavimab + Tixagevimab,Omicron/BA.2,=,8.2,ng/ml,1,Omicron/BM.1.1,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + F486S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,122,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Sotrovimab,Omicron/BA.2,=,852,ng/ml,1,Omicron/BM.1.1,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + F486S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,879,ng/ml,1,=,1,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Bebtelovimab,Omicron/BA.2,=,0.9,ng/ml,1,Omicron/BM.1.1,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + F486S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,2.3,ng/ml,1,=,2.6,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,DXP-604,Omicron/BA.2,=,219,ng/ml,1,Omicron/BM.1.1,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + F486S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,4.6,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Casirivimab,Omicron/BA.2,>,10000,ng/ml,1,Omicron/BM.1.1.1,19,T19I + L24S + Δ25-27 + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + F486S + F490S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Imdevimab,Omicron/BA.2,=,590,ng/ml,1,Omicron/BM.1.1.1,19,T19I + L24S + Δ25-27 + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + F486S + F490S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1.7,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Casirivimab + Imdevimab,Omicron/BA.2,=,821,ng/ml,1,Omicron/BM.1.1.1,19,T19I + L24S + Δ25-27 + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + F486S + F490S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1.2,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Cilgavimab,Omicron/BA.2,=,6.3,ng/ml,1,Omicron/BM.1.1.1,19,T19I + L24S + Δ25-27 + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + F486S + F490S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,158.7,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Cilgavimab + Tixagevimab,Omicron/BA.2,=,8.2,ng/ml,1,Omicron/BM.1.1.1,19,T19I + L24S + Δ25-27 + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + F486S + F490S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,122,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Sotrovimab,Omicron/BA.2,=,852,ng/ml,1,Omicron/BM.1.1.1,19,T19I + L24S + Δ25-27 + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + F486S + F490S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,956,ng/ml,1,=,1.1,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Bebtelovimab,Omicron/BA.2,=,0.9,ng/ml,1,Omicron/BM.1.1.1,19,T19I + L24S + Δ25-27 + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + F486S + F490S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1.9,ng/ml,1,=,2.1,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,DXP-604,Omicron/BA.2,=,219,ng/ml,1,Omicron/BM.1.1.1,19,T19I + L24S + Δ25-27 + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + F486S + F490S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,4.6,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Casirivimab,Omicron/BA.2,>,10000,ng/ml,1,Omicron/BR.2,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + L452R + N460K + S477N + T478K + E484A + F486I + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Imdevimab,Omicron/BA.2,=,590,ng/ml,1,Omicron/BR.2,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + L452R + N460K + S477N + T478K + E484A + F486I + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1.7,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Casirivimab + Imdevimab,Omicron/BA.2,=,821,ng/ml,1,Omicron/BR.2,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + L452R + N460K + S477N + T478K + E484A + F486I + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1.2,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Cilgavimab,Omicron/BA.2,=,6.3,ng/ml,1,Omicron/BR.2,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + L452R + N460K + S477N + T478K + E484A + F486I + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,158.7,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Cilgavimab + Tixagevimab,Omicron/BA.2,=,8.2,ng/ml,1,Omicron/BR.2,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + L452R + N460K + S477N + T478K + E484A + F486I + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,122,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Sotrovimab,Omicron/BA.2,=,852,ng/ml,1,Omicron/BR.2,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + L452R + N460K + S477N + T478K + E484A + F486I + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,921,ng/ml,1,=,1.1,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Bebtelovimab,Omicron/BA.2,=,0.9,ng/ml,1,Omicron/BR.2,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + L452R + N460K + S477N + T478K + E484A + F486I + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,2.6,ng/ml,1,=,2.9,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,DXP-604,Omicron/BA.2,=,219,ng/ml,1,Omicron/BR.2,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + L452R + N460K + S477N + T478K + E484A + F486I + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,4.6,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Casirivimab,Omicron/BA.2,>,10000,ng/ml,1,Omicron/CA.1,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + L452R + N460K + S477N + T478K + E484A + F486S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K + D1199N,1,>,10000,ng/ml,1,>,1,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Imdevimab,Omicron/BA.2,=,590,ng/ml,1,Omicron/CA.1,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + L452R + N460K + S477N + T478K + E484A + F486S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K + D1199N,1,>,10000,ng/ml,1,>,1.7,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Casirivimab + Imdevimab,Omicron/BA.2,=,821,ng/ml,1,Omicron/CA.1,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + L452R + N460K + S477N + T478K + E484A + F486S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K + D1199N,1,>,10000,ng/ml,1,>,1.2,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Cilgavimab,Omicron/BA.2,=,6.3,ng/ml,1,Omicron/CA.1,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + L452R + N460K + S477N + T478K + E484A + F486S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K + D1199N,1,>,10000,ng/ml,1,>,158.7,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Cilgavimab + Tixagevimab,Omicron/BA.2,=,8.2,ng/ml,1,Omicron/CA.1,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + L452R + N460K + S477N + T478K + E484A + F486S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K + D1199N,1,>,10000,ng/ml,1,>,122,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Sotrovimab,Omicron/BA.2,=,852,ng/ml,1,Omicron/CA.1,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + L452R + N460K + S477N + T478K + E484A + F486S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K + D1199N,1,=,897,ng/ml,1,=,1.1,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Bebtelovimab,Omicron/BA.2,=,0.9,ng/ml,1,Omicron/CA.1,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + L452R + N460K + S477N + T478K + E484A + F486S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K + D1199N,1,=,3.2,ng/ml,1,=,3.6,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,DXP-604,Omicron/BA.2,=,219,ng/ml,1,Omicron/CA.1,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + L452R + N460K + S477N + T478K + E484A + F486S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K + D1199N,1,>,10000,ng/ml,1,>,4.6,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Takashita22c,10.1056/NEJMc2207519,Virus isolate,Table 1,Casirivimab,Wild Type (A),=,6.1,ng/ml,1,Omicron/BA.4,3,V3G + T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,50000,ng/ml,1,>,1000,,,
Takashita22c,10.1056/NEJMc2207519,Virus isolate,Table 1,Imdevimab,Wild Type (A),=,7.4,ng/ml,1,Omicron/BA.4,3,V3G + T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,132.6,ng/ml,1,=,17.9,,,
Wang22d,10.1038/s41586-022-05053-w,Virus isolate,Extended Data Table 1b,Imdevimab,Omicron/BA.2,=,305.7,ng/ml,1,Omicron/BA.4,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N658S + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,641.8,ng/ml,1,=,2.1,,,
Takashita22c,10.1056/NEJMc2207519,Virus isolate,Table 1,Casirivimab + Imdevimab,Wild Type (A),=,6.8,ng/ml,1,Omicron/BA.4,3,V3G + T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,918.2,ng/ml,1,=,135,,,Combination therapies in this study were specified at ng/ml of each component so needs to multiply by 2
Takashita22c,10.1056/NEJMc2207519,Virus isolate,Table 1,Cilgavimab,Wild Type (A),=,7,ng/ml,1,Omicron/BA.4,3,V3G + T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,53.6,ng/ml,1,=,7.7,,,
Takashita22c,10.1056/NEJMc2207519,Virus isolate,Table 1,Tixagevimab,Wild Type (A),=,6.1,ng/ml,1,Omicron/BA.4,3,V3G + T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,50000,ng/ml,1,>,1000,,,
Wang22d,10.1038/s41586-022-05053-w,Virus isolate,Extended Data Table 1b,Tixagevimab,Omicron/BA.2,=,828.7,ng/ml,1,Omicron/BA.4,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N658S + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,5000,ng/ml,1,>,6,,,
Takashita22c,10.1056/NEJMc2207519,Virus isolate,Table 1,Cilgavimab + Tixagevimab,Wild Type (A),=,12.6,ng/ml,1,Omicron/BA.4,3,V3G + T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,75.6,ng/ml,1,=,6,,,Combination therapies in this study were specified at ng/ml of each component so needs to multiply by 2
Park22,10.1126/science.adc9127,Pseudovirus (VSV),Fig 1B,Sotrovimab,Wild Type (B),=,69,ng/ml,1,Omicron/BA.4,3,V3G + T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1885,ng/ml,1,=,27.3,,,
Takashita22c,10.1056/NEJMc2207519,Virus isolate,Table 1,Sotrovimab,Wild Type (A),=,95.1,ng/ml,1,Omicron/BA.4,3,V3G + T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,50000,ng/ml,1,>,525.8,,,
Park22,10.1126/science.adc9127,Virus isolate,Fig S12A,Sotrovimab,Wild Type (B),=,49.8,ng/ml,1,Omicron/BA.4,3,V3G + T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,2650.7,ng/ml,1,=,53.2,,,
Takashita22c,10.1056/NEJMc2207519,Virus isolate,Table 1,Bebtelovimab,Wild Type (A),=,2.5,ng/ml,1,Omicron/BA.4,3,V3G + T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,2.9,ng/ml,1,=,1.2,,,
Wang22d,10.1038/s41586-022-05053-w,Virus isolate,Extended Data Table 1b,Bebtelovimab,Omicron/BA.2,=,1,ng/ml,1,Omicron/BA.4,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N658S + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1,ng/ml,1,=,1,,,
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Casirivimab,Omicron/BA.2,>,10000,ng/ml,1,Omicron/BA.4.6.1,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + W152L + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N658S + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Imdevimab,Omicron/BA.2,=,590,ng/ml,1,Omicron/BA.4.6.1,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + W152L + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N658S + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,2338,ng/ml,1,>,4,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Casirivimab + Imdevimab,Omicron/BA.2,=,821,ng/ml,1,Omicron/BA.4.6.1,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + W152L + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N658S + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,5402,ng/ml,1,>,6.6,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Cilgavimab,Omicron/BA.2,=,6.3,ng/ml,1,Omicron/BA.4.6.1,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + W152L + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N658S + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,158.7,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Cilgavimab + Tixagevimab,Omicron/BA.2,=,8.2,ng/ml,1,Omicron/BA.4.6.1,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + W152L + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N658S + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,122,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Sotrovimab,Omicron/BA.2,=,852,ng/ml,1,Omicron/BA.4.6.1,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + W152L + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N658S + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,4456,ng/ml,1,>,5.2,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Bebtelovimab,Omicron/BA.2,=,0.9,ng/ml,1,Omicron/BA.4.6.1,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + W152L + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N658S + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1.2,ng/ml,1,=,1.3,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,DXP-604,Omicron/BA.2,=,219,ng/ml,1,Omicron/BA.4.6.1,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + W152L + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N658S + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,4634,ng/ml,1,>,21.2,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Casirivimab,Omicron/BA.2,>,10000,ng/ml,1,Omicron/BA.5.1.12,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + V445A + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Imdevimab,Omicron/BA.2,=,590,ng/ml,1,Omicron/BA.5.1.12,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + V445A + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1.7,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Casirivimab + Imdevimab,Omicron/BA.2,=,821,ng/ml,1,Omicron/BA.5.1.12,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + V445A + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1.2,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Cilgavimab,Omicron/BA.2,=,6.3,ng/ml,1,Omicron/BA.5.1.12,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + V445A + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1843,ng/ml,1,>,292.5,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Cilgavimab + Tixagevimab,Omicron/BA.2,=,8.2,ng/ml,1,Omicron/BA.5.1.12,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + V445A + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,4818,ng/ml,1,>,587.6,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Sotrovimab,Omicron/BA.2,=,852,ng/ml,1,Omicron/BA.5.1.12,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + V445A + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1752,ng/ml,1,>,2.1,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Bebtelovimab,Omicron/BA.2,=,0.9,ng/ml,1,Omicron/BA.5.1.12,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + V445A + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,98,ng/ml,1,=,108.9,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,DXP-604,Omicron/BA.2,=,219,ng/ml,1,Omicron/BA.5.1.12,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + V445A + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,8268,ng/ml,1,>,37.8,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Casirivimab,Omicron/BA.2,>,10000,ng/ml,1,Omicron/BA.5.2.7,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + N440M + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Imdevimab,Omicron/BA.2,=,590,ng/ml,1,Omicron/BA.5.2.7,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + N440M + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1.7,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Casirivimab + Imdevimab,Omicron/BA.2,=,821,ng/ml,1,Omicron/BA.5.2.7,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + N440M + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1.2,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Cilgavimab,Omicron/BA.2,=,6.3,ng/ml,1,Omicron/BA.5.2.7,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + N440M + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,158.7,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Cilgavimab + Tixagevimab,Omicron/BA.2,=,8.2,ng/ml,1,Omicron/BA.5.2.7,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + N440M + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,122,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Sotrovimab,Omicron/BA.2,=,852,ng/ml,1,Omicron/BA.5.2.7,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + N440M + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1419,ng/ml,1,>,1.7,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Bebtelovimab,Omicron/BA.2,=,0.9,ng/ml,1,Omicron/BA.5.2.7,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + N440M + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,25,ng/ml,1,=,27.8,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,DXP-604,Omicron/BA.2,=,219,ng/ml,1,Omicron/BA.5.2.7,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + N440M + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,6263,ng/ml,1,>,28.6,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Casirivimab,Omicron/BA.2,>,10000,ng/ml,1,Omicron/BA.5.5.1,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + N450D + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Imdevimab,Omicron/BA.2,=,590,ng/ml,1,Omicron/BA.5.5.1,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + N450D + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1936,ng/ml,1,>,3.3,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Casirivimab + Imdevimab,Omicron/BA.2,=,821,ng/ml,1,Omicron/BA.5.5.1,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + N450D + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,2963,ng/ml,1,>,3.6,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Cilgavimab,Omicron/BA.2,=,6.3,ng/ml,1,Omicron/BA.5.5.1,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + N450D + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,158.7,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Cilgavimab + Tixagevimab,Omicron/BA.2,=,8.2,ng/ml,1,Omicron/BA.5.5.1,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + N450D + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,122,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Sotrovimab,Omicron/BA.2,=,852,ng/ml,1,Omicron/BA.5.5.1,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + N450D + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1293,ng/ml,1,>,1.5,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Bebtelovimab,Omicron/BA.2,=,0.9,ng/ml,1,Omicron/BA.5.5.1,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + N450D + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,5.1,ng/ml,1,=,5.7,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,DXP-604,Omicron/BA.2,=,219,ng/ml,1,Omicron/BA.5.5.1,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + N450D + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,6807,ng/ml,1,>,31.1,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Casirivimab,Omicron/BA.2,>,10000,ng/ml,1,Omicron/BA.5.6.2,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444T + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Imdevimab,Omicron/BA.2,=,590,ng/ml,1,Omicron/BA.5.6.2,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444T + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1.7,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Casirivimab + Imdevimab,Omicron/BA.2,=,821,ng/ml,1,Omicron/BA.5.6.2,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444T + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1.2,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Cilgavimab,Omicron/BA.2,=,6.3,ng/ml,1,Omicron/BA.5.6.2,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444T + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,158.7,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Cilgavimab + Tixagevimab,Omicron/BA.2,=,8.2,ng/ml,1,Omicron/BA.5.6.2,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444T + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,122,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Sotrovimab,Omicron/BA.2,=,852,ng/ml,1,Omicron/BA.5.6.2,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444T + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1408,ng/ml,1,>,1.7,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Bebtelovimab,Omicron/BA.2,=,0.9,ng/ml,1,Omicron/BA.5.6.2,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444T + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1662,ng/ml,1,>,1000,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,DXP-604,Omicron/BA.2,=,219,ng/ml,1,Omicron/BA.5.6.2,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444T + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,5892,ng/ml,1,>,26.9,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Casirivimab,Omicron/BA.2,>,10000,ng/ml,1,Omicron/BF.16,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444R + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Imdevimab,Omicron/BA.2,=,590,ng/ml,1,Omicron/BF.16,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444R + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,883,ng/ml,1,=,1.5,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Casirivimab + Imdevimab,Omicron/BA.2,=,821,ng/ml,1,Omicron/BF.16,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444R + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1863,ng/ml,1,>,2.3,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Cilgavimab,Omicron/BA.2,=,6.3,ng/ml,1,Omicron/BF.16,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444R + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,48,ng/ml,1,=,7.6,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Cilgavimab + Tixagevimab,Omicron/BA.2,=,8.2,ng/ml,1,Omicron/BF.16,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444R + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,79,ng/ml,1,=,9.6,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Sotrovimab,Omicron/BA.2,=,852,ng/ml,1,Omicron/BF.16,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444R + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1575,ng/ml,1,>,1.8,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,Bebtelovimab,Omicron/BA.2,=,0.9,ng/ml,1,Omicron/BF.16,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444R + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,2.7,ng/ml,1,=,3,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Extended Data Fig 2a,DXP-604,Omicron/BA.2,=,219,ng/ml,1,Omicron/BF.16,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444R + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,7505,ng/ml,1,>,34.3,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Casirivimab,Omicron/BA.2,>,10000,ng/ml,1,Omicron/BQ.1,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444T + L452R + N460K + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Touret22c,10.1101/2022.12.22.521201,Virus isolate,Table 1,Casirivimab,Delta,=,14.7,ng/ml,1,Omicron/BQ.1,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444T + L452R + N460K + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,5000,ng/ml,1,>,340.1,,,
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Imdevimab,Omicron/BA.2,=,590,ng/ml,1,Omicron/BQ.1,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444T + L452R + N460K + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1.7,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Touret22c,10.1101/2022.12.22.521201,Virus isolate,Table 1,Imdevimab,Delta,=,20.1,ng/ml,1,Omicron/BQ.1,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444T + L452R + N460K + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,5000,ng/ml,1,>,248.8,,,
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Casirivimab + Imdevimab,Omicron/BA.2,=,821,ng/ml,1,Omicron/BQ.1,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444T + L452R + N460K + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1.2,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Cilgavimab,Omicron/BA.2,=,6.3,ng/ml,1,Omicron/BQ.1,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444T + L452R + N460K + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,158.7,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Wang22l,10.1101/2022.11.23.517532,Pseudovirus,Figure S2,Cilgavimab,Wild Type (B.1),=,7,ng/ml,1,Omicron/BQ.1,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444T + L452R + N460K + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Touret22c,10.1101/2022.12.22.521201,Virus isolate,Table 1,Cilgavimab,Delta,=,21.7,ng/ml,1,Omicron/BQ.1,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444T + L452R + N460K + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,5000,ng/ml,1,>,230.4,,,
Wang22l,10.1101/2022.11.23.517532,Pseudovirus,Figure S2,Tixagevimab,Wild Type (B.1),=,2,ng/ml,1,Omicron/BQ.1,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444T + L452R + N460K + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Touret22c,10.1101/2022.12.22.521201,Virus isolate,Table 1,Tixagevimab,Delta,=,12.4,ng/ml,1,Omicron/BQ.1,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444T + L452R + N460K + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,5000,ng/ml,1,>,403.2,,,
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Cilgavimab + Tixagevimab,Omicron/BA.2,=,8.2,ng/ml,1,Omicron/BQ.1,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444T + L452R + N460K + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,122,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Wang22l,10.1101/2022.11.23.517532,Pseudovirus,Figure S2,Cilgavimab + Tixagevimab,Wild Type (B.1),=,3,ng/ml,1,Omicron/BQ.1,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444T + L452R + N460K + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Touret22c,10.1101/2022.12.22.521201,Virus isolate,Table 1,Cilgavimab + Tixagevimab,Delta,=,12.5,ng/ml,1,Omicron/BQ.1,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444T + L452R + N460K + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,5000,ng/ml,1,>,400,,,
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Sotrovimab,Omicron/BA.2,=,852,ng/ml,1,Omicron/BQ.1,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444T + L452R + N460K + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1709,ng/ml,1,>,2,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Wang22l,10.1101/2022.11.23.517532,Pseudovirus,Figure S2,Sotrovimab,Wild Type (B.1),=,23,ng/ml,1,Omicron/BQ.1,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444T + L452R + N460K + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,600,ng/ml,1,=,26.1,,,
Touret22c,10.1101/2022.12.22.521201,Virus isolate,Table 1,Sotrovimab,Delta,=,98.6,ng/ml,1,Omicron/BQ.1,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444T + L452R + N460K + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,688.2,ng/ml,1,=,7,,,
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Bebtelovimab,Omicron/BA.2,=,0.9,ng/ml,1,Omicron/BQ.1,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444T + L452R + N460K + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1905,ng/ml,1,>,1000,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Wang22l,10.1101/2022.11.23.517532,Pseudovirus,Figure S2,Bebtelovimab,Wild Type (B.1),=,2,ng/ml,1,Omicron/BQ.1,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444T + L452R + N460K + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Touret22c,10.1101/2022.12.22.521201,Virus isolate,Table 1,Bebtelovimab,Delta,=,0.4,ng/ml,1,Omicron/BQ.1,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444T + L452R + N460K + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,5000,ng/ml,1,>,1000,,,
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,DXP-604,Omicron/BA.2,=,219,ng/ml,1,Omicron/BQ.1,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444T + L452R + N460K + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,4.6,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Casirivimab,Omicron/BA.2,>,10000,ng/ml,1,Omicron/BU.1,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + Δ144 + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444M + L452R + N460K + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Imdevimab,Omicron/BA.2,=,590,ng/ml,1,Omicron/BU.1,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + Δ144 + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444M + L452R + N460K + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1.7,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Casirivimab + Imdevimab,Omicron/BA.2,=,821,ng/ml,1,Omicron/BU.1,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + Δ144 + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444M + L452R + N460K + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1.2,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Cilgavimab,Omicron/BA.2,=,6.3,ng/ml,1,Omicron/BU.1,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + Δ144 + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444M + L452R + N460K + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,158.7,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Cilgavimab + Tixagevimab,Omicron/BA.2,=,8.2,ng/ml,1,Omicron/BU.1,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + Δ144 + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444M + L452R + N460K + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,122,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Sotrovimab,Omicron/BA.2,=,852,ng/ml,1,Omicron/BU.1,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + Δ144 + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444M + L452R + N460K + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1082,ng/ml,1,>,1.3,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,Bebtelovimab,Omicron/BA.2,=,0.9,ng/ml,1,Omicron/BU.1,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + Δ144 + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444M + L452R + N460K + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,26,ng/ml,1,=,28.9,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 2a,DXP-604,Omicron/BA.2,=,219,ng/ml,1,Omicron/BU.1,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + Δ144 + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444M + L452R + N460K + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,4.6,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Nabel21,10.1126/science.abl6251,Pseudovirus (lentivirus),"Fig 2A, 2B",Bamlanivimab,Wild Type (B.1),=,22,ng/ml,1,Delta/K417N,19,T19R + V70F + E156G + Δ157-158 + A222V + K417N + L452R + T478K + P681R + D950N,1,=,5800,ng/ml,1,=,263.6,,,
Arora21b,10.1038/s41423-021-00772-y,Pseudovirus (VSV),Figure 1D,Bamlanivimab,Wild Type (B),=,14.1,ng/ml,1,Delta/K417N,19,T19R + G142D + Δ156-157 + R158G + K417N + L452R + T478K + P681R + D950N,1,>,10000,ng/ml,1,>,709.2,,,
Nabel21,10.1126/science.abl6251,Pseudovirus (lentivirus),"Fig 2A, 2B",Etesevimab,Wild Type (B.1),=,27,ng/ml,1,Delta/K417N,19,T19R + V70F + E156G + Δ157-158 + A222V + K417N + L452R + T478K + P681R + D950N,1,=,16700,ng/ml,1,=,618.5,,,
Arora21b,10.1038/s41423-021-00772-y,Pseudovirus (VSV),Figure 1D,Etesevimab,Wild Type (B),=,105.9,ng/ml,1,Delta/K417N,19,T19R + G142D + Δ156-157 + R158G + K417N + L452R + T478K + P681R + D950N,1,>,10000,ng/ml,1,>,94.4,,,
FDA21,https://www.fda.gov/drugs/drug-safety-and-availability/fda-authorizes-revisions-fact-sheets-address-sars-cov-2-variants-monoclonal-antibody-products-under,Pseudovirus (VSV),BAM+ETE Table 3 page 27,Bamlanivimab + Etesevimab,Wild Type (B),,,,,Delta/K417N,19,T19R + G142D + Δ156-157 + R158G + K417N + L452R + T478K + P681R + D950N,1,,,,,>,1000,,,
Nabel21,10.1126/science.abl6251,Pseudovirus (lentivirus),"Fig 2A, 2B",Casirivimab,Wild Type (B.1),=,25,ng/ml,1,Delta/K417N,19,T19R + V70F + E156G + Δ157-158 + A222V + K417N + L452R + T478K + P681R + D950N,1,=,2,ng/ml,1,=,0.1,,,
Tada21e,10.3389/fimmu.2022.797589,Pseudovirus (HIV),Figure 2,Casirivimab,Wild Type (B.1),=,3.3,ng/ml,1,Delta/K417N,19,T19R + G142D + Δ156-157 + R158G + K417N + L452R + T478K + P681R + D950N,1,=,306.3,ng/ml,1,=,92.8,,,
Arora21b,10.1038/s41423-021-00772-y,Pseudovirus (VSV),Figure 1D,Casirivimab,Wild Type (B),=,22.8,ng/ml,1,Delta/K417N,19,T19R + G142D + Δ156-157 + R158G + K417N + L452R + T478K + P681R + D950N,1,=,9.2,ng/ml,1,=,0.4,,,
Nabel21,10.1126/science.abl6251,Pseudovirus (lentivirus),"Fig 2A, 2B",Imdevimab,Wild Type (B.1),=,32,ng/ml,1,Delta/K417N,19,T19R + V70F + E156G + Δ157-158 + A222V + K417N + L452R + T478K + P681R + D950N,1,=,48,ng/ml,1,=,1.5,,,
Tada21e,10.3389/fimmu.2022.797589,Pseudovirus (HIV),Figure 2,Imdevimab,Wild Type (B.1),=,9.3,ng/ml,1,Delta/K417N,19,T19R + G142D + Δ156-157 + R158G + K417N + L452R + T478K + P681R + D950N,1,=,29.7,ng/ml,1,=,3.2,,,
Arora21b,10.1038/s41423-021-00772-y,Pseudovirus (VSV),Figure 1D,Imdevimab,Wild Type (B),=,22.7,ng/ml,1,Delta/K417N,19,T19R + G142D + Δ156-157 + R158G + K417N + L452R + T478K + P681R + D950N,1,=,13.7,ng/ml,1,=,0.6,,,
Tada21e,10.3389/fimmu.2022.797589,Pseudovirus (HIV),Figure 2,Casirivimab + Imdevimab,Wild Type (B.1),=,4.4,ng/ml,1,Delta/K417N,19,T19R + G142D + Δ156-157 + R158G + K417N + L452R + T478K + P681R + D950N,1,=,19.5,ng/ml,1,=,4.4,,,
FDA21,https://www.fda.gov/drugs/drug-safety-and-availability/fda-authorizes-revisions-fact-sheets-address-sars-cov-2-variants-monoclonal-antibody-products-under,Pseudovirus (VSV),CAS+IMD Table 9 page 42,Casirivimab + Imdevimab,Wild Type (B),,,,,Delta/K417N,19,T19R + G142D + Δ156-157 + R158G + K417N + L452R + T478K + P681R + D950N,1,,,,,=,1,,,
FDA21c,https://www.fda.gov/media/154701/download,Virus isolate,"Feb 2022, Table 6",Cilgavimab + Tixagevimab,Wild Type (B),,,,,Delta/K417N,(WT),(WT),1,,,,,=,1,,,
Cathcart21,10.1101/2021.03.09.434607,Pseudovirus (VSV),Table 2,Sotrovimab,Wild Type (B),,,,,Delta/K417N,(Various),(Various),2,,,,,=,1.2,1.2,1.3,
Cao22c,10.1016/j.chom.2022.09.018,Pseudovirus (VSV),Figure 5b,Bamlanivimab,Wild Type (B.1),=,15,ng/ml,1,Omicron/BA.2.38,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417T + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,666.7,,,
Cao22c,10.1016/j.chom.2022.09.018,Pseudovirus (VSV),Figure 5b,Etesevimab,Wild Type (B.1),=,32,ng/ml,1,Omicron/BA.2.38,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417T + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,312.5,,,
Cao22c,10.1016/j.chom.2022.09.018,Pseudovirus (VSV),Figure 5b,Bamlanivimab + Etesevimab,Wild Type (B.1),=,20,ng/ml,1,Omicron/BA.2.38,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417T + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,500,,,
Cao22c,10.1016/j.chom.2022.09.018,Pseudovirus (VSV),Figure 5b,Casirivimab,Wild Type (B.1),=,5.6,ng/ml,1,Omicron/BA.2.38,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417T + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Cao22c,10.1016/j.chom.2022.09.018,Pseudovirus (VSV),Figure 5b,Imdevimab,Wild Type (B.1),=,5.7,ng/ml,1,Omicron/BA.2.38,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417T + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,493,ng/ml,1,=,86.5,,,
Cao22c,10.1016/j.chom.2022.09.018,Pseudovirus (VSV),Figure 5b,Casirivimab + Imdevimab,Wild Type (B.1),=,5,ng/ml,1,Omicron/BA.2.38,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417T + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,816,ng/ml,1,=,163.2,,,
Cao22c,10.1016/j.chom.2022.09.018,Pseudovirus (VSV),Figure 5b,Cilgavimab,Wild Type (B.1),=,2.5,ng/ml,1,Omicron/BA.2.38,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417T + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,11,ng/ml,1,=,4.4,,,
Cao22c,10.1016/j.chom.2022.09.018,Pseudovirus (VSV),Figure 5b,Tixagevimab,Wild Type (B.1),=,1.6,ng/ml,1,Omicron/BA.2.38,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417T + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,3221,ng/ml,1,>,1000,,,
Cao22c,10.1016/j.chom.2022.09.018,Pseudovirus (VSV),Figure 5b,Cilgavimab + Tixagevimab,Wild Type (B.1),=,2.1,ng/ml,1,Omicron/BA.2.38,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417T + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,15,ng/ml,1,=,7.1,,,
Cao22c,10.1016/j.chom.2022.09.018,Pseudovirus (VSV),Figure 5b,Sotrovimab,Wild Type (B.1),=,74,ng/ml,1,Omicron/BA.2.38,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417T + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,926,ng/ml,1,=,12.5,,,
Cao22c,10.1016/j.chom.2022.09.018,Pseudovirus (VSV),Figure 5b,Bebtelovimab,Wild Type (B.1),=,0.7,ng/ml,1,Omicron/BA.2.38,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417T + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1.3,ng/ml,1,=,1.9,,,
Cao22c,10.1016/j.chom.2022.09.018,Pseudovirus (VSV),Figure 5b,Amubarvimab,Wild Type (B.1),=,53,ng/ml,1,Omicron/BA.2.38,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417T + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,648,ng/ml,1,=,12.2,,,
Cao22c,10.1016/j.chom.2022.09.018,Pseudovirus (VSV),Figure 5b,Romlusevimab,Wild Type (B.1),=,1239,ng/ml,1,Omicron/BA.2.38,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417T + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,7553,ng/ml,1,=,6.1,,,
Cao22c,10.1016/j.chom.2022.09.018,Pseudovirus (VSV),Figure 5b,Amubarvimab + Romlusevimab,Wild Type (B.1),=,81,ng/ml,1,Omicron/BA.2.38,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417T + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,992,ng/ml,1,=,12.2,,,
Cao22c,10.1016/j.chom.2022.09.018,Pseudovirus (VSV),Figure 5b,DXP-604,Wild Type (B.1),=,11,ng/ml,1,Omicron/BA.2.38,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417T + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,24,ng/ml,1,=,2.2,,,
House22,10.1371/journal.pone.0267796,Pseudovirus,Fig 1A,Cilgavimab,Wild Type (B.1),,,,,R.1,152,W152L + E484K + G769V,1,,,,,=,1.2,,,
EMA21e,https://www.ema.europa.eu/en/documents/product-information/evusheld-epar-product-information_en.pdf,Pseudovirus,Table 3,Cilgavimab + Tixagevimab,Wild Type (B),=,1.9,ng/ml,1,R.1,152,W152L + E484K + G769V,1,=,4.6,ng/ml,1,=,2.4,,,
FDA21c,https://www.fda.gov/media/154701/download,Pseudovirus,"Feb 2022, Table 6, Page 17, Antiviral resistance paragraph 6",Cilgavimab + Tixagevimab,Wild Type (B),,,,,R.1,152,W152L + E484K + G769V,1,,,,,=,3.5,,,
Liu22,10.1126/scitranslmed.abn6859,Pseudovirus (VSV),Fig2A,Sotrovimab,Wild Type (B.1),=,11,ng/ml,1,R.1,152,W152L + E484K + G769V,1,=,30,ng/ml,1,=,2.7,,,
Westendorf22,10.1016/j.celrep.2022.110812,Pseudovirus (VSV),Table 3B,Bebtelovimab,Wild Type (A),=,3,ng/ml,1,R.1,152,W152L + E484K + G769V,1,=,3,ng/ml,1,=,1,,,
House22,10.1371/journal.pone.0267796,Pseudovirus,Fig 1A,COV2-2381 + Cilgavimab,Wild Type (B.1),,,,,R.1,152,W152L + E484K + G769V,1,,,,,=,1.9,,,
Li21c,10.1016/j.cell.2021.02.042,Pseudovirus (VSV),Figure S2,Amubarvimab,Wild Type (B.1),,,,,Beta w/o K417N,80,D80A + D215G + E484K + N501Y + A701V,1,,,,,=,1.5,,,
Liu21f,10.1016/j.cell.2021.06.020,Pseudovirus (lentivirus),Table S1,Bamlanivimab,Wild Type (B),=,4,ng/ml,1,B.1.1.519,478,T478K + P681H + T732A,1,=,5,ng/ml,1,=,1.3,,,
Liu21f,10.1016/j.cell.2021.06.020,Pseudovirus (lentivirus),Table S1,Etesevimab,Wild Type (B),=,26,ng/ml,1,B.1.1.519,478,T478K + P681H + T732A,1,=,6,ng/ml,1,=,0.2,,,
Liu21f,10.1016/j.cell.2021.06.020,Pseudovirus (lentivirus),Table S1,Casirivimab,Wild Type (B),=,2,ng/ml,1,B.1.1.519,478,T478K + P681H + T732A,1,=,1,ng/ml,1,=,0.5,,,
Liu21f,10.1016/j.cell.2021.06.020,Pseudovirus (lentivirus),Table S1,Imdevimab,Wild Type (B),=,14,ng/ml,1,B.1.1.519,478,T478K + P681H + T732A,1,=,8,ng/ml,1,=,0.6,,,
Liu21f,10.1016/j.cell.2021.06.020,Pseudovirus (lentivirus),Table S1,Cilgavimab,Wild Type (B),=,7,ng/ml,1,B.1.1.519,478,T478K + P681H + T732A,1,=,4,ng/ml,1,=,0.6,,,
Liu21f,10.1016/j.cell.2021.06.020,Pseudovirus (lentivirus),Table S1,Tixagevimab,Wild Type (B),=,3,ng/ml,1,B.1.1.519,478,T478K + P681H + T732A,1,=,1,ng/ml,1,=,0.3,,,
Liu21f,10.1016/j.cell.2021.06.020,Pseudovirus (lentivirus),Table S1,Cilgavimab + Tixagevimab,Wild Type (B),=,2,ng/ml,1,B.1.1.519,478,T478K + P681H + T732A,1,=,2,ng/ml,1,=,1,,,
EMA21e,https://www.ema.europa.eu/en/documents/product-information/evusheld-epar-product-information_en.pdf,Pseudovirus,Table 3,Cilgavimab + Tixagevimab,Wild Type (B),=,1.9,ng/ml,1,B.1.1.519,478,T478K + P681H + T732A,1,=,2.3,ng/ml,1,=,1.2,,,
FDA21c,https://www.fda.gov/media/154701/download,Pseudovirus,"Feb 2022, Table 6, Page 17, Antiviral resistance paragraph 6",Cilgavimab + Tixagevimab,Wild Type (B),,,,,B.1.1.519,478,T478K + P681H + T732A,1,,,,,=,1.4,,,
Cathcart21,10.1101/2021.03.09.434607,Pseudovirus (VSV),Table 2,Sotrovimab,Wild Type (B),,,,,B.1.1.519,478,T478K + P681H + T732A,1,,,,,=,0.8,,,
Westendorf22,10.1016/j.celrep.2022.110812,Pseudovirus (VSV),Table 3B,Bebtelovimab,Wild Type (A),=,3,ng/ml,1,B.1.1.519,478,T478K + P681H + T732A,1,=,3,ng/ml,1,=,1,,,
Wang21e,10.1126/science.abh1766,Pseudovirus (lentivirus),Fig 2C,Bamlanivimab,Wild Type (A),=,7.1,ng/ml,1,Epsilon/E484K,13,S13I + W152C + L452R + E484K,1,>,10000,ng/ml,1,>,1000,,,
Wang21e,10.1126/science.abh1766,Pseudovirus (lentivirus),Fig 2C,Etesevimab,Wild Type (A),=,26.2,ng/ml,1,Epsilon/E484K,13,S13I + W152C + L452R + E484K,1,=,118.1,ng/ml,1,=,4.5,,,
Wang21e,10.1126/science.abh1766,Pseudovirus (lentivirus),Fig 2C,Casirivimab,Wild Type (A),=,7.7,ng/ml,1,Epsilon/E484K,13,S13I + W152C + L452R + E484K,1,=,62.5,ng/ml,1,=,8.1,,,
Wang21e,10.1126/science.abh1766,Pseudovirus (lentivirus),Fig 2C,Imdevimab,Wild Type (A),=,71,ng/ml,1,Epsilon/E484K,13,S13I + W152C + L452R + E484K,1,=,113.6,ng/ml,1,=,1.6,,,
Zhang21c,10.1038/s42003-021-02728-4,Pseudovirus (VSV),Supplementary Figure 3,Etesevimab,Wild Type (B.1),,,,,B.1.1.318,95,T95I + Δ144-145 + E484K + P681H + D796H,1,,,,,=,2.9,,,
Liu22,10.1126/scitranslmed.abn6859,Pseudovirus (VSV),Fig2C,Sotrovimab,Wild Type (B.1),=,11,ng/ml,1,Rs4084,2,F2K + V3L + F4L + L5V + V6L + L7V + L8F + P9A + L10T + V11L + S12V + Q14S + C15Y + V16T + N17I + L18ins + T19D + T20D + Q23P + L24P + P25A + P26N + A27T + Y28Q + T29F + N30L + F32S + T33H + K41D + V42I + S46N + S50L + T51V + L54H + F59D + W64R + H66I + A67T + I68F + H69G + V70L + S71N + Δ72-78 + V83I + L84I + N87R + V90I + S94A + I100V + I105V + T108S + L110M + D111N + S112N + T114S + L117V + L118I + V120M + A123S + V126L + K129R + V130A + E132N + Q134E + F135L + N137D + D138N + L141F + G142V + Y144L + Y145K + H146S + K147N + N149T + Δ150-153 + E154Q + S155I + E156P + F157S + R158Y + V159I + Y160F + S161N + S162N + N164F + Q173K + P174D + L176N + M177L + E180G + G181E + Q183P + N188D + K195R + I197K + Y200F + F201L + K202H + I203V + K206G + H207Y + T208Q + V213P + R214P + D215V + L216V + P217C + S221N + E224K + L226I + V227F + D228K + I231L + R237N + Q239R + A243T + L244A + H245F + Δ246-251 + G252P + D253P + S254R + S255P + S256D + G257Y + T259G + A260T + G261S + Y266F + Q271K + R273T + L276M + N280D + A292S + L293Q + D294N + S297A + T299L + T302S + L303V + T307E + V308I + E309D + Q321A + T323S + E324K + S325E + I326V + R346T + A348P + N354E + V367I + A372T + P384A + T393S + I402V + R403K + E406D + K417V + T430L + I434L + S438T + N440S + L441K + K444S + V445T + G446S + L455W + F456V + K458R + N460K + K462N + F464Y + I468L + T470N + E471D + Q474S + A475P + S477G + T478Q + P479S + N481S + G482A + Δ484 + F486P + F490N + Q493R + S494P + Q498F + P499T + N501A + Y505H + H519N + K529L + N532D + V534I + K537Q + E554P + N556S + K558R + L560Q + I569V + A570S + T572F + A575S + Q580K + L582S + T588S + N606S + Q607E + E619D + T632S + S640N + R646Q + N657D + N658T + Q675H + Q677V + T678S + N679S + S680L + Δ681-684 + V687T + A688S + S689Q + Q690K + I693V + E702D + N703S + V705I + S711T + T719S + V722I + I726V + L727M + T732A + T739N + S750A + T768S + K776R + Q779R + I788M + P793T + I794L + S810L + S813T + I834M + D839E + A845N + E868D + Q872A + S875A + L878V + A879S + I882A + S884A + L922Q + S929K + G932S + K933Q + D936E + S939T + S940T + A942S + S943T + S1055A + A1070S + K1073R + D1084E + H1088Y + S1097F + H1101S + V1104I + Y1110F + E1111S + N1125S + V1133I + I1216V + M1233L + C1247A,1,>,10000,ng/ml,1,>,909.1,,,
Liu22,10.1126/scitranslmed.abn6859,Pseudovirus (VSV),Fig2C,Sotrovimab,Wild Type (B.1),=,11,ng/ml,1,Rs4231,3,V3I + V6F + L7F + P9T + V11T + S12ins + S13E + Q14S + V16T + N17T + L18F + T19D + T20D + R21V + T22Q + Q23A + L24P + P25N + P26Y + A27P + Y28Q + T29H + N30S + F32S + T33R + K41E + V42I + S46D + V47T + H49Y + S50L + F59Y + W64G + A67T + H69N + Δ70-76 + K77H + L84I + N87K + S94A + I100V + I101V + I105V + T108S + L110M + D111N + S112N + T114S + L117V + L118I + V120I + A123S + K129R + V130A + E132N + Q134E + F135L + N137D + D138N + L141F + G142A + Y144S + Y145K + H146P + K147T + N148G + N149T + K150Q + S151T + W152H + M153T + E154M + S155I + E156F + F157D + R158N + V159A + Y160F + S161N + S162C + A163T + N164F + Δ165-168 + V171I + Q173D + P174S + L176S + M177L + L179V + E180A + G181E + Q183S + N188H + I197K + Y200F + F201L + K202Y + I203V + S205K + K206G + H207Y + T208Q + N211D + L212V + Q218S + S221N + A222I + E224K + L226I + V227F + D228K + I231L + R237N + Q239R + T240A + L241I + A243T + L244A + H245F + R246L + Δ247-252 + D253P + S254A + S255Q + S256D + G257T + T259G + A260T + G261S + Y266F + Q271K + R273A + L276M + N280D + A292S + L293Q + D294N + S297A + T299L + T302S + L303V + T307E + V308I + E309D + Q321A + T323S + E324K + S325E + I326V + R346T + A348P + N354E + A372T + P384A + T393S + I402V + R403K + E406D + K417V + T430L + I434L + S438T + N440S + L441K + K444S + V445T + G446S + L455W + F456V + K458R + N460K + K462N + F464Y + I468L + T470N + E471D + Q474S + A475P + S477G + T478Q + P479S + N481S + G482A + V483I + Δ484 + F486P + F490N + Q493R + S494P + Q498F + P499T + N501A + Y505H + H519N + K529L + N532D + V534I + K537Q + E554S + N556S + K558R + L560Q + I569V + A570S + T572F + A575S + Q580K + L582S + T588S + N606S + Q607E + E619D + T632A + V635I + S640N + R646Q + N657D + N658T + Q675H + Q677V + T678S + N679S + S680L + Δ681-684 + V687T + A688S + S689Q + Q690K + I693V + E702D + N703S + V705I + S711T + T719S + V722I + I726V + L727M + T732A + T739N + S750A + T768S + K776R + Q779R + I788M + P793A + I794L + S810L + S813T + I834M + D839E + I844V + A845N + E868D + Q872A + S875A + L878V + A879S + I882A + S884A + L922Q + S929K + G932S + K933Q + D936E + S939T + S940T + A942S + S943T + S1055A + Y1067C + A1070S + K1073R + D1084E + H1088Y + S1097F + H1101S + V1104I + Y1110F + E1111S + N1125S + V1133I + I1216V + M1233L + C1247A,1,>,10000,ng/ml,1,>,909.1,,,
Liu22,10.1126/scitranslmed.abn6859,Pseudovirus (VSV),Fig2C,Sotrovimab,Wild Type (B.1),=,11,ng/ml,1,Rs4231,3,V3I + V6F + L7F + P9T + V11T + S12ins + S13E + Q14S + V16T + N17T + L18F + T19D + T20D + R21V + T22Q + Q23A + L24P + P25N + P26Y + A27P + Y28Q + T29H + N30S + F32S + T33R + K41E + V42I + S46D + V47T + H49Y + S50L + F59Y + W64G + A67T + H69N + Δ70-76 + K77H + L84I + N87K + S94A + I100V + I101V + I105V + T108S + L110M + D111N + S112N + T114S + L117V + L118I + V120I + A123S + K129R + V130A + E132N + Q134E + F135L + N137D + D138N + L141F + G142A + Y144S + Y145K + H146P + K147T + N148G + N149T + K150Q + S151T + W152H + M153T + E154M + S155I + E156F + F157D + R158N + V159A + Y160F + S161N + S162C + A163T + N164F + Δ165-168 + V171I + Q173D + P174S + L176S + M177L + L179V + E180A + G181E + Q183S + N188H + I197K + Y200F + F201L + K202Y + I203V + S205K + K206G + H207Y + T208Q + N211D + L212V + Q218S + S221N + A222I + E224K + L226I + V227F + D228K + I231L + R237N + Q239R + T240A + L241I + A243T + L244A + H245F + R246L + Δ247-252 + D253P + S254A + S255Q + S256D + G257T + T259G + A260T + G261S + Y266F + Q271K + R273A + L276M + N280D + A292S + L293Q + D294N + S297A + T299L + T302S + L303V + T307E + V308I + E309D + Q321A + T323S + E324K + S325E + I326V + R346T + A348P + N354E + A372T + P384A + T393S + I402V + R403K + E406D + K417V + T430L + I434L + S438T + N440S + L441K + K444S + V445T + G446S + L455W + F456V + K458R + N460K + K462N + F464Y + I468L + T470N + E471D + Q474S + A475P + S477G + T478Q + P479S + N481S + G482A + V483I + Δ484 + F486P + F490N + Q493R + S494P + Q498F + P499T + N501A + Y505H + H519N + K529L + N532D + V534I + K537Q + E554S + N556S + K558R + L560Q + I569V + A570S + T572F + A575S + Q580K + L582S + T588S + N606S + Q607E + E619D + T632A + V635I + S640N + R646Q + N657D + N658T + Q675H + Q677V + T678S + N679S + S680L + Δ681-684 + V687T + A688S + S689Q + Q690K + I693V + E702D + N703S + V705I + S711T + T719S + V722I + I726V + L727M + T732A + T739N + S750A + T768S + K776R + Q779R + I788M + P793A + I794L + S810L + S813T + I834M + D839E + I844V + A845N + E868D + Q872A + S875A + L878V + A879S + I882A + S884A + L922Q + S929K + G932S + K933Q + D936E + S939T + S940T + A942S + S943T + S1055A + Y1067C + A1070S + K1073R + D1084E + H1088Y + S1097F + H1101S + V1104I + Y1110F + E1111S + N1125S + V1133I + I1216V + M1233L + C1247A,1,>,10000,ng/ml,1,>,909.1,,,
Liu22,10.1126/scitranslmed.abn6859,Pseudovirus (VSV),Fig2C,Sotrovimab,Wild Type (B.1),=,11,ng/ml,1,SHC014,2,F2K + V3L + F4L + L5V + V6L + L7V + L8F + P9A + L10T + V11L + S12V + Q14S + C15Y + V16T + N17I + L18ins + T19D + T20D + Q23P + L24P + P25A + P26N + A27T + Y28Q + T29F + N30L + F32S + T33H + K41D + V42I + S46N + S50L + T51V + L54H + F59D + W64R + H66I + A67T + I68F + H69G + V70L + S71N + Δ72-78 + V83I + L84I + N87R + V90I + S94A + I100V + I105V + T108S + L110M + D111N + S112N + T114S + L117V + L118I + V120M + A123S + V126L + K129R + V130A + E132N + Q134E + F135L + N137D + D138N + L141F + G142V + Y144L + Y145K + H146S + K147N + N149T + Δ150-153 + E154Q + S155I + E156P + F157S + R158Y + V159I + Y160F + S161N + S162N + N164F + Q173K + P174D + L176N + M177L + E180G + G181E + Q183P + N188D + K195R + I197K + Y200F + F201L + K202H + I203V + K206G + H207Y + T208Q + V213L + R214P + D215V + L216V + P217C + S221N + E224K + L226I + V227F + D228K + I231L + R237N + Q239R + A243T + L244A + H245F + Δ246-251 + G252P + D253P + S254R + S255P + S256D + G257Y + T259G + A260T + G261S + Y266F + Q271K + R273T + L276M + N280D + A292S + L293Q + D294N + S297A + T299L + T302S + L303V + T307E + V308I + E309D + Q321A + T323S + E324K + S325E + I326V + R346T + A348P + N354E + A372T + P384A + T393S + I402V + R403K + E406D + K417V + T430L + I434L + S438T + N440S + L441K + K444S + V445T + G446S + L455W + F456V + K458R + N460K + K462N + F464Y + I468L + T470N + E471D + Q474S + A475P + S477G + T478Q + P479S + N481S + G482A + Δ484 + F486P + F490N + Q493R + S494P + Q498F + P499T + N501A + Y505H + H519N + K529L + N532D + V534I + K537Q + E554P + N556S + K558R + L560Q + I569V + A570S + T572F + A575S + Q580K + L582S + T588S + N606S + Q607E + E619D + T632S + S640N + R646Q + N657D + N658T + Q675H + Q677V + T678S + N679S + S680L + Δ681-684 + V687T + A688S + S689Q + Q690K + I693V + E702D + N703S + V705I + S711T + T719S + V722I + I726V + L727M + T732A + T739N + S750A + T768S + K776R + Q779R + I788M + P793T + I794L + S810L + S813T + I834M + D839E + A845N + E868D + Q872A + S875A + L878V + A879S + I882A + S884A + L922Q + S929K + G932S + K933Q + D936E + S939T + S940T + A942S + S943T + S1055A + A1070S + K1073R + D1084E + H1088Y + S1097F + H1101S + V1104I + Y1110F + E1111S + N1125S + V1133I + I1216V + M1233L + C1247A,1,>,10000,ng/ml,1,>,909.1,,,
Liu22,10.1126/scitranslmed.abn6859,Pseudovirus (VSV),Fig2C,Sotrovimab,Wild Type (B.1),=,11,ng/ml,1,LYRa11,3,V3L + F4T + L5C + V6F + L7I + P9S + L10ins + V11S + S12I + S13D + Q14T + V16E + N17T + L18F + T19D + T20D + R21V + T22S + Q23P + L24P + P25Q + P26Q + A27N + Y28L + T29V + N30S + F32S + T33K + K41D + V42I + F43Y + S46D + L48H + S50L + T51V + F59N + Δ63-69 + S71G + G72L + T73M + N74S + G75F + T76N + K77Y + V83I + L84I + N87K + S94A + I100V + I101V + I105V + T108S + L110M + D111N + S112N + T114S + L117V + L118I + V120M + A123S + K129R + V130A + E132N + F135L + N137D + D138N + L141F + G142A + Y144I + Δ145-148 + N149R + K150P + S151T + W152S + M153Q + E154Q + S155I + F157T + R158I + V159L + Y160F + S161E + S162N + N164F + Q173D + P174S + L179V + E180G + G181E + Q183P + N188H + V193I + I197K + Y200F + F201L + K202N + K206G + H207F + T208Q + P209N + N211D + L212V + V213A + R214N + D215G + Q218S + A222L + E224K + V227L + D228K + I231L + I233L + R237N + Q239R + T240V + A243T + L244A + H245F + R246I + S247P + Y248N + L249I + Δ250-253 + S254G + S255T + Δ256-257 + T259G + A260T + G261S + A262P + A263V + Y266F + Q271K + R273T + L276M + N280D + E281Y + T286V + A292S + L293Q + D294H + S297A + T299L + T302S + L303V + T307E + V308I + E309D + Q321S + T323S + E324K + S325E + I326V + R346T + A348P + N354E + A372T + P384A + T385I + T393S + I402V + R403K + E406D + K417V + T430M + I434L + S438T + N439R + L441I + S443A + K444T + V445S + G446S + Y449F + L452K + L455S + F456L + K458H + S459G + N460K + K462R + T470N + E471V + I472P + Y473F + Q474S + A475P + G476D + S477G + T478K + N481T + Δ482 + V483P + E484P + G485A + F490W + Q493N + S494D + Q498Y + P499T + V503I + H519N + K529L + N532D + V534I + K535T + K537Q + E554P + N556L + K558R + L560Q + I569F + A570S + T572F + A575S + Q580K + I584V + T588S + T604I + N606S + Q607E + E619D + V622T + T632A + V635I + T638A + S640V + R646Q + N658A + Q675H + Q677A + T678S + N679L + S680L + Δ681-684 + S686N + V687T + A688D + S689Q + Q690K + I693V + V705I + S708A + T719S + V722I + I726V + L727M + T732A + T747Q + T768S + P793A + S813T + I834M + D839E + A845S + Q872A + S875A + L878V + A879S + I882A + S884A + L922Q + S929K + G932S + K933Q + D936E + S939T + S940T + A942S + S943T + S1055A + A1070S + K1073R + D1084E + H1088Y + H1101S + V1104I + Y1110F + E1111S + I1114L + V1133I + G1171R + I1216V + V1230A + M1233L + C1247A,1,>,10000,ng/ml,1,>,909.1,,,
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 5b,Casirivimab + Imdevimab,Omicron/BA.2,=,821,ng/ml,1,Omicron/BA.2.75/K444M+L452R,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444M + G446S + L452R + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,679,ng/ml,1,=,0.8,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 5b,Cilgavimab + Tixagevimab,Omicron/BA.2,=,8.2,ng/ml,1,Omicron/BA.2.75/K444M+L452R,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444M + G446S + L452R + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,170,ng/ml,1,=,20.7,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 5b,Sotrovimab,Omicron/BA.2,=,852,ng/ml,1,Omicron/BA.2.75/K444M+L452R,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444M + G446S + L452R + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,564,ng/ml,1,=,0.7,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 5b,Bebtelovimab,Omicron/BA.2,=,0.9,ng/ml,1,Omicron/BA.2.75/K444M+L452R,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444M + G446S + L452R + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 5b,Casirivimab + Imdevimab,Omicron/BA.2,=,821,ng/ml,1,Omicron/BA.2.75/L452R,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + L452R + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,461,ng/ml,1,=,0.6,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 5b,Cilgavimab + Tixagevimab,Omicron/BA.2,=,8.2,ng/ml,1,Omicron/BA.2.75/L452R,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + L452R + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,194,ng/ml,1,=,23.7,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 5b,Sotrovimab,Omicron/BA.2,=,852,ng/ml,1,Omicron/BA.2.75/L452R,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + L452R + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,424,ng/ml,1,=,0.5,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 5b,Bebtelovimab,Omicron/BA.2,=,0.9,ng/ml,1,Omicron/BA.2.75/L452R,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + L452R + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,4,ng/ml,1,=,4.4,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 5b,Casirivimab + Imdevimab,Omicron/BA.2,=,821,ng/ml,1,Omicron/BA.2.75/R346T+K356T+K444M+L452R+F486V,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + K356T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444M + G446S + L452R + N460K + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1.2,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 5b,Cilgavimab + Tixagevimab,Omicron/BA.2,=,8.2,ng/ml,1,Omicron/BA.2.75/R346T+K356T+K444M+L452R+F486V,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + K356T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444M + G446S + L452R + N460K + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,122,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 5b,Sotrovimab,Omicron/BA.2,=,852,ng/ml,1,Omicron/BA.2.75/R346T+K356T+K444M+L452R+F486V,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + K356T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444M + G446S + L452R + N460K + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1.2,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 5b,Bebtelovimab,Omicron/BA.2,=,0.9,ng/ml,1,Omicron/BA.2.75/R346T+K356T+K444M+L452R+F486V,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + K356T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444M + G446S + L452R + N460K + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 5b,Casirivimab + Imdevimab,Omicron/BA.2,=,821,ng/ml,1,Omicron/BA.2.75/R346T+K356T+K444T-G446S+L452R+F486V,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + K356T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444T + L452R + N460K + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1.2,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 5b,Cilgavimab + Tixagevimab,Omicron/BA.2,=,8.2,ng/ml,1,Omicron/BA.2.75/R346T+K356T+K444T-G446S+L452R+F486V,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + K356T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444T + L452R + N460K + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,122,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 5b,Sotrovimab,Omicron/BA.2,=,852,ng/ml,1,Omicron/BA.2.75/R346T+K356T+K444T-G446S+L452R+F486V,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + K356T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444T + L452R + N460K + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1.2,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 5b,Bebtelovimab,Omicron/BA.2,=,0.9,ng/ml,1,Omicron/BA.2.75/R346T+K356T+K444T-G446S+L452R+F486V,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + K356T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444T + L452R + N460K + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 5b,Casirivimab + Imdevimab,Omicron/BA.2,=,821,ng/ml,1,Omicron/BA.2.75/R346T+K417T+K444T-G446S+L452R+F486V,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210T + V213G + R237T + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417T + N440K + K444T + L452R + N460K + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1.2,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 5b,Cilgavimab + Tixagevimab,Omicron/BA.2,=,8.2,ng/ml,1,Omicron/BA.2.75/R346T+K417T+K444T-G446S+L452R+F486V,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210T + V213G + R237T + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417T + N440K + K444T + L452R + N460K + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,122,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 5b,Sotrovimab,Omicron/BA.2,=,852,ng/ml,1,Omicron/BA.2.75/R346T+K417T+K444T-G446S+L452R+F486V,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210T + V213G + R237T + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417T + N440K + K444T + L452R + N460K + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1.2,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 5b,Bebtelovimab,Omicron/BA.2,=,0.9,ng/ml,1,Omicron/BA.2.75/R346T+K417T+K444T-G446S+L452R+F486V,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210T + V213G + R237T + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417T + N440K + K444T + L452R + N460K + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 5b,Casirivimab + Imdevimab,Omicron/BA.2,=,821,ng/ml,1,Omicron/BA.2.75/R346T+K444M+L452R,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444M + G446S + L452R + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,428,ng/ml,1,=,0.5,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 5b,Cilgavimab + Tixagevimab,Omicron/BA.2,=,8.2,ng/ml,1,Omicron/BA.2.75/R346T+K444M+L452R,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444M + G446S + L452R + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,148,ng/ml,1,=,18,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 5b,Sotrovimab,Omicron/BA.2,=,852,ng/ml,1,Omicron/BA.2.75/R346T+K444M+L452R,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444M + G446S + L452R + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1552,ng/ml,1,>,1.8,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 5b,Bebtelovimab,Omicron/BA.2,=,0.9,ng/ml,1,Omicron/BA.2.75/R346T+K444M+L452R,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444M + G446S + L452R + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 5b,Casirivimab + Imdevimab,Omicron/BA.2,=,821,ng/ml,1,Omicron/BA.2.75/R346T+K444M+L452R+F486V,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444M + G446S + L452R + N460K + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1.2,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 5b,Cilgavimab + Tixagevimab,Omicron/BA.2,=,8.2,ng/ml,1,Omicron/BA.2.75/R346T+K444M+L452R+F486V,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444M + G446S + L452R + N460K + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,122,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 5b,Sotrovimab,Omicron/BA.2,=,852,ng/ml,1,Omicron/BA.2.75/R346T+K444M+L452R+F486V,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444M + G446S + L452R + N460K + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,2503,ng/ml,1,>,2.9,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 5b,Bebtelovimab,Omicron/BA.2,=,0.9,ng/ml,1,Omicron/BA.2.75/R346T+K444M+L452R+F486V,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444M + G446S + L452R + N460K + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 5b,Casirivimab + Imdevimab,Omicron/BA.2,=,821,ng/ml,1,Omicron/BA.2.75/R346T+K444T-G446S+L452R+F486V,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210T + V213G + R237T + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444T + L452R + N460K + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1.2,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 5b,Cilgavimab + Tixagevimab,Omicron/BA.2,=,8.2,ng/ml,1,Omicron/BA.2.75/R346T+K444T-G446S+L452R+F486V,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210T + V213G + R237T + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444T + L452R + N460K + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,122,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 5b,Sotrovimab,Omicron/BA.2,=,852,ng/ml,1,Omicron/BA.2.75/R346T+K444T-G446S+L452R+F486V,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210T + V213G + R237T + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444T + L452R + N460K + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1.2,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 5b,Bebtelovimab,Omicron/BA.2,=,0.9,ng/ml,1,Omicron/BA.2.75/R346T+K444T-G446S+L452R+F486V,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210T + V213G + R237T + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444T + L452R + N460K + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 5b,Casirivimab + Imdevimab,Omicron/BA.2,=,821,ng/ml,1,Omicron/BA.5/G339H+R346T+K356T+K417T+K444N+N460K,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339H + R346T + K356T + S371F + S373P + S375F + T376A + D405N + R408S + K417T + N440K + K444N + L452R + N460K + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1.2,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 5b,Cilgavimab + Tixagevimab,Omicron/BA.2,=,8.2,ng/ml,1,Omicron/BA.5/G339H+R346T+K356T+K417T+K444N+N460K,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339H + R346T + K356T + S371F + S373P + S375F + T376A + D405N + R408S + K417T + N440K + K444N + L452R + N460K + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,122,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 5b,Sotrovimab,Omicron/BA.2,=,852,ng/ml,1,Omicron/BA.5/G339H+R346T+K356T+K417T+K444N+N460K,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339H + R346T + K356T + S371F + S373P + S375F + T376A + D405N + R408S + K417T + N440K + K444N + L452R + N460K + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1.2,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 5b,Bebtelovimab,Omicron/BA.2,=,0.9,ng/ml,1,Omicron/BA.5/G339H+R346T+K356T+K417T+K444N+N460K,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339H + R346T + K356T + S371F + S373P + S375F + T376A + D405N + R408S + K417T + N440K + K444N + L452R + N460K + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 5b,Casirivimab + Imdevimab,Omicron/BA.2,=,821,ng/ml,1,Omicron/BA.5/K444N,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444N + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1.2,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 5b,Cilgavimab + Tixagevimab,Omicron/BA.2,=,8.2,ng/ml,1,Omicron/BA.5/K444N,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444N + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,122,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 5b,Sotrovimab,Omicron/BA.2,=,852,ng/ml,1,Omicron/BA.5/K444N,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444N + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1395,ng/ml,1,>,1.6,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 5b,Bebtelovimab,Omicron/BA.2,=,0.9,ng/ml,1,Omicron/BA.5/K444N,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444N + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1504,ng/ml,1,>,1000,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 5b,Casirivimab + Imdevimab,Omicron/BA.2,=,821,ng/ml,1,Omicron/BA.5/R346T+K356T+K417T+K444N+N460K,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + K356T + S371F + S373P + S375F + T376A + D405N + R408S + K417T + N440K + K444N + L452R + N460K + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1.2,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 5b,Cilgavimab + Tixagevimab,Omicron/BA.2,=,8.2,ng/ml,1,Omicron/BA.5/R346T+K356T+K417T+K444N+N460K,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + K356T + S371F + S373P + S375F + T376A + D405N + R408S + K417T + N440K + K444N + L452R + N460K + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,122,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 5b,Sotrovimab,Omicron/BA.2,=,852,ng/ml,1,Omicron/BA.5/R346T+K356T+K417T+K444N+N460K,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + K356T + S371F + S373P + S375F + T376A + D405N + R408S + K417T + N440K + K444N + L452R + N460K + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1.2,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 5b,Bebtelovimab,Omicron/BA.2,=,0.9,ng/ml,1,Omicron/BA.5/R346T+K356T+K417T+K444N+N460K,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + K356T + S371F + S373P + S375F + T376A + D405N + R408S + K417T + N440K + K444N + L452R + N460K + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 5b,Casirivimab + Imdevimab,Omicron/BA.2,=,821,ng/ml,1,Omicron/BA.5/R346T+K417T+K444N+N460K,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417T + N440K + K444N + L452R + N460K + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1.2,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 5b,Cilgavimab + Tixagevimab,Omicron/BA.2,=,8.2,ng/ml,1,Omicron/BA.5/R346T+K417T+K444N+N460K,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417T + N440K + K444N + L452R + N460K + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,122,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 5b,Sotrovimab,Omicron/BA.2,=,852,ng/ml,1,Omicron/BA.5/R346T+K417T+K444N+N460K,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417T + N440K + K444N + L452R + N460K + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,3663,ng/ml,1,>,4.3,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 5b,Bebtelovimab,Omicron/BA.2,=,0.9,ng/ml,1,Omicron/BA.5/R346T+K417T+K444N+N460K,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417T + N440K + K444N + L452R + N460K + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 5b,Casirivimab + Imdevimab,Omicron/BA.2,=,821,ng/ml,1,Omicron/BA.5/R346T+K444N,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444N + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1.2,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 5b,Cilgavimab + Tixagevimab,Omicron/BA.2,=,8.2,ng/ml,1,Omicron/BA.5/R346T+K444N,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444N + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,122,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 5b,Sotrovimab,Omicron/BA.2,=,852,ng/ml,1,Omicron/BA.5/R346T+K444N,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444N + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,2957,ng/ml,1,>,3.5,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Cao22e,10.1101/2022.09.15.507787,Pseudovirus,Figure 5b,Bebtelovimab,Omicron/BA.2,=,0.9,ng/ml,1,Omicron/BA.5/R346T+K444N,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + K444N + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,"Deleted all WT rows because there were not from this study and doubled up with another study. Changed all LOD 1000 to 10000. Changed all "">"" to ""="" where value was reported as not 1000. Changed 999 for Casirivimab to BA.2 to 10000."
Nabel21,10.1126/science.abl6251,Pseudovirus (lentivirus),"Fig 2A, 2B",Bamlanivimab,Wild Type (B.1),=,22,ng/ml,1,Alpha/A372S,69,Δ69-70 + Δ144 + A372S + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,17,ng/ml,1,=,0.8,,,
Nabel21,10.1126/science.abl6251,Pseudovirus (lentivirus),"Fig 2A, 2B",Etesevimab,Wild Type (B.1),=,27,ng/ml,1,Alpha/A372S,69,Δ69-70 + Δ144 + A372S + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,12,ng/ml,1,=,0.4,,,
Nabel21,10.1126/science.abl6251,Pseudovirus (lentivirus),"Fig 2A, 2B",Casirivimab,Wild Type (B.1),=,25,ng/ml,1,Alpha/A372S,69,Δ69-70 + Δ144 + A372S + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,4,ng/ml,1,=,0.2,,,
Nabel21,10.1126/science.abl6251,Pseudovirus (lentivirus),"Fig 2A, 2B",Imdevimab,Wild Type (B.1),=,32,ng/ml,1,Alpha/A372S,69,Δ69-70 + Δ144 + A372S + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,31,ng/ml,1,=,1,,,
Nabel21,10.1126/science.abl6251,Pseudovirus (lentivirus),"Fig 2A, 2B",Bamlanivimab,Wild Type (B.1),=,22,ng/ml,1,Beta/N429K/L452R,80,D80A + D215G + Δ242-244 + K417N + N439K + L452R + E484K + N501Y + A701V,1,>,100000,ng/ml,1,>,1000,,,
Nabel21,10.1126/science.abl6251,Pseudovirus (lentivirus),"Fig 2A, 2B",Etesevimab,Wild Type (B.1),=,27,ng/ml,1,Beta/N429K/L452R,80,D80A + D215G + Δ242-244 + K417N + N439K + L452R + E484K + N501Y + A701V,1,>,100000,ng/ml,1,>,1000,,,
Nabel21,10.1126/science.abl6251,Pseudovirus (lentivirus),"Fig 2A, 2B",Casirivimab,Wild Type (B.1),=,25,ng/ml,1,Beta/N429K/L452R,80,D80A + D215G + Δ242-244 + K417N + N439K + L452R + E484K + N501Y + A701V,1,=,47300,ng/ml,1,>,1000,,,
Nabel21,10.1126/science.abl6251,Pseudovirus (lentivirus),"Fig 2A, 2B",Imdevimab,Wild Type (B.1),=,32,ng/ml,1,Beta/N429K/L452R,80,D80A + D215G + Δ242-244 + K417N + N439K + L452R + E484K + N501Y + A701V,1,=,509,ng/ml,1,=,15.9,,,
Nabel21,10.1126/science.abl6251,Pseudovirus (lentivirus),"Fig 2A, 2B",Bamlanivimab,Wild Type (B.1),=,22,ng/ml,1,Delta/N501Y+E484K+F490S,19,T19R + L452R + T478K + F490S + N501Y + T523N + P681R + D950N,1,>,100000,ng/ml,1,>,1000,,,
Nabel21,10.1126/science.abl6251,Pseudovirus (lentivirus),"Fig 2A, 2B",Etesevimab,Wild Type (B.1),=,27,ng/ml,1,Delta/N501Y+E484K+F490S,19,T19R + L452R + T478K + F490S + N501Y + T523N + P681R + D950N,1,=,9,ng/ml,1,=,0.3,,,
Nabel21,10.1126/science.abl6251,Pseudovirus (lentivirus),"Fig 2A, 2B",Casirivimab,Wild Type (B.1),=,25,ng/ml,1,Delta/N501Y+E484K+F490S,19,T19R + L452R + T478K + F490S + N501Y + T523N + P681R + D950N,1,=,9,ng/ml,1,=,0.4,,,
Nabel21,10.1126/science.abl6251,Pseudovirus (lentivirus),"Fig 2A, 2B",Imdevimab,Wild Type (B.1),=,32,ng/ml,1,Delta/N501Y+E484K+F490S,19,T19R + L452R + T478K + F490S + N501Y + T523N + P681R + D950N,1,=,27,ng/ml,1,=,0.8,,,
Jian22,10.1016/S1473-3099(22)00642-9,Pseudovirus (VSV),Supplementary Figure 3,Imdevimab,Omicron/BA.5,=,520,ng/ml,1,Omicron/BA.5/R346I,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346I + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,2701,ng/ml,1,=,5.2,,,
Jian22,10.1016/S1473-3099(22)00642-9,Pseudovirus (VSV),Supplementary Figure 3,Casirivimab + Imdevimab,Omicron/BA.5,=,709,ng/ml,1,Omicron/BA.5/R346I,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346I + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,3498,ng/ml,1,=,4.9,,,
Jian22,10.1016/S1473-3099(22)00642-9,Pseudovirus (VSV),Supplementary Figure 3,Cilgavimab,Omicron/BA.5,=,23,ng/ml,1,Omicron/BA.5/R346I,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346I + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,434.8,,,
Jian22,10.1016/S1473-3099(22)00642-9,Pseudovirus (VSV),Supplementary Figure 3,Cilgavimab + Tixagevimab,Omicron/BA.5,=,40,ng/ml,1,Omicron/BA.5/R346I,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346I + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,250,,,
Jian22,10.1016/S1473-3099(22)00642-9,Pseudovirus (VSV),Supplementary Figure 3,Sotrovimab,Omicron/BA.5,=,1055,ng/ml,1,Omicron/BA.5/R346I,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346I + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,4780,ng/ml,1,=,4.5,,,
Jian22,10.1016/S1473-3099(22)00642-9,Pseudovirus (VSV),Supplementary Figure 3,Bebtelovimab,Omicron/BA.5,=,0.8,ng/ml,1,Omicron/BA.5/R346I,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346I + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,1.3,ng/ml,1,=,1.6,,,
Jian22,10.1016/S1473-3099(22)00642-9,Pseudovirus (VSV),Supplementary Figure 3,Amubarvimab,Omicron/BA.5,=,7124,ng/ml,1,Omicron/BA.5/R346I,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346I + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,4023,ng/ml,1,=,0.6,,,
Boschi22,10.1093/cid/ciac143,Virus isolate,Figure 1A,Bamlanivimab,Wild Type (B.1.1),=,0.2,ng/ml,1,Iota,5,L5F + T95I + D253V + S477N + A892A + A892D + A892G + A892V + Q957R,1,=,12.9,ng/ml,1,=,56.2,,,
Boschi22,10.1093/cid/ciac143,Virus isolate,Figure 1A,Etesevimab,Wild Type (B.1.1),=,6,ng/ml,1,Iota,5,L5F + T95I + D253V + S477N + A892A + A892D + A892G + A892V + Q957R,1,=,68.1,ng/ml,1,=,11.4,,,
Boschi22,10.1093/cid/ciac143,Virus isolate,Figure 1A,Bamlanivimab + Etesevimab,Wild Type (B.1.1),=,0.5,ng/ml,1,Iota,5,L5F + T95I + D253V + S477N + A892A + A892D + A892G + A892V + Q957R,1,=,0.5,ng/ml,1,=,1,,,
Boschi22,10.1093/cid/ciac143,Virus isolate,Figure 1B,Casirivimab,Wild Type (B.1.1),=,0.7,ng/ml,1,Iota,5,L5F + T95I + D253V + S477N + A892A + A892D + A892G + A892V + Q957R,1,=,10,ng/ml,1,=,13.5,,,
Boschi22,10.1093/cid/ciac143,Virus isolate,Figure 1B,Imdevimab,Wild Type (B.1.1),=,8.9,ng/ml,1,Iota,5,L5F + T95I + D253V + S477N + A892A + A892D + A892G + A892V + Q957R,1,=,45.3,ng/ml,1,=,5.1,,,
Boschi22,10.1093/cid/ciac143,Virus isolate,Figure 1B,Casirivimab + Imdevimab,Wild Type (B.1.1),=,0.1,ng/ml,1,Iota,5,L5F + T95I + D253V + S477N + A892A + A892D + A892G + A892V + Q957R,1,=,0.1,ng/ml,1,=,1,,,
House22,10.1371/journal.pone.0267796,Pseudovirus,Fig 1A,Cilgavimab,Wild Type (B.1),,,,,A.23.1,157,F157L + V367F + Q613H + P681R,1,,,,,=,1,,,
EMA21e,https://www.ema.europa.eu/en/documents/product-information/evusheld-epar-product-information_en.pdf,Pseudovirus,Table 3,Cilgavimab + Tixagevimab,Wild Type (B),=,1.9,ng/ml,1,A.23.1,157,F157L + V367F + Q613H + P681R,1,=,0.5,ng/ml,1,=,0.3,,,
FDA21c,https://www.fda.gov/media/154701/download,Pseudovirus,"Feb 2022, Table 6, Page 17, Antiviral resistance paragraph 6",Cilgavimab + Tixagevimab,Wild Type (B),,,,,A.23.1,157,F157L + V367F + Q613H + P681R,1,,,,,=,0.4,,,
Cathcart21,10.1101/2021.03.09.434607,Pseudovirus (VSV),Table 2,Sotrovimab,Wild Type (B),,,,,A.23.1,102,R102I + F157L + V367F + E484K + Q613H + P681R,1,,,,,=,1.1,,,
House22,10.1371/journal.pone.0267796,Pseudovirus,Fig 1A,COV2-2381 + Cilgavimab,Wild Type (B.1),,,,,A.23.1,157,F157L + V367F + Q613H + P681R,1,,,,,=,0.8,,,
Kaleta22,10.1038/s41467-022-28766-y,Virus isolate,Table 2,Bamlanivimab,Wild Type (B.1),=,110,ng/ml,1,A.27,18,L18F + L452R + N501Y + A653V + H655Y + D796Y + G1219V,1,>,10000,ng/ml,1,>,90.9,,,
Kaleta22,10.1038/s41467-022-28766-y,Virus isolate,Table 2,Casirivimab,Wild Type (B.1),=,90,ng/ml,1,A.27,18,L18F + L452R + N501Y + A653V + H655Y + D796Y + G1219V,1,=,120,ng/ml,1,=,1.3,,,
Kaleta22,10.1038/s41467-022-28766-y,Virus isolate,Table 2,Imdevimab,Wild Type (B.1),=,20,ng/ml,1,A.27,18,L18F + L452R + N501Y + A653V + H655Y + D796Y + G1219V,1,=,50,ng/ml,1,=,2.5,,,
Kaleta22,10.1038/s41467-022-28766-y,Virus isolate,Table 2,Casirivimab + Imdevimab,Wild Type (B.1),=,30,ng/ml,1,A.27,18,L18F + L452R + N501Y + A653V + H655Y + D796Y + G1219V,1,=,50,ng/ml,1,=,1.7,,,
EMA21e,https://www.ema.europa.eu/en/documents/product-information/evusheld-epar-product-information_en.pdf,Pseudovirus,Table 3,Cilgavimab + Tixagevimab,Wild Type (B),=,1.9,ng/ml,1,A.27,18,L18F + L452R + N501Y + A653V + H655Y + D796Y + G1219V,1,=,1.8,ng/ml,1,=,0.9,,,
FDA21c,https://www.fda.gov/media/154701/download,Pseudovirus,"Feb 2022, Table 6, Page 17, Antiviral resistance paragraph 6",Cilgavimab + Tixagevimab,Wild Type (B),,,,,A.27,18,L18F + L452R + N501Y + A653V + H655Y + D796Y + G1219V,1,,,,,=,0.8,,,
Saito22,10.1016/j.chom.2022.10.003,Pseudovirus (lentivirus),Table S3,Cilgavimab,Wild Type (B.1),=,14,ng/ml,1,Omicron/BA.2/K147E+W152R+F157L,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,20.1,ng/ml,1,=,1.4,,,
Saito22,10.1016/j.chom.2022.10.003,Pseudovirus (lentivirus),Table S3,Tixagevimab,Wild Type (B.1),=,1.5,ng/ml,1,Omicron/BA.2/K147E+W152R+F157L,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,4375,ng/ml,1,>,1000,,,
Saito22,10.1016/j.chom.2022.10.003,Pseudovirus (lentivirus),Table S3,Sotrovimab,Wild Type (B.1),=,47,ng/ml,1,Omicron/BA.2/K147E+W152R+F157L,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,485.9,ng/ml,1,=,10.3,,,
Saito22,10.1016/j.chom.2022.10.003,Pseudovirus (lentivirus),Table S3,Bebtelovimab,Wild Type (B.1),=,2.4,ng/ml,1,Omicron/BA.2/K147E+W152R+F157L,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,2.1,ng/ml,1,=,0.9,,,
Saito22,10.1016/j.chom.2022.10.003,Pseudovirus (lentivirus),Table S3,Regdanvimab,Wild Type (B.1),=,1,ng/ml,1,Omicron/BA.2/K147E+W152R+F157L,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,6175,ng/ml,1,>,1000,,,
House22,10.1371/journal.pone.0267796,Pseudovirus,Fig 1A,Cilgavimab,Wild Type (B.1),,,,,Alpha/S494P,69,Δ69-70 + Δ144 + S494P + N501Y + A570D + P681H + T716I + S982A + D1118H,1,,,,,=,1.4,,,
Westendorf22,10.1016/j.celrep.2022.110812,Pseudovirus (VSV),Table 3B,Bebtelovimab,Wild Type (A),=,3,ng/ml,1,Alpha/S494P,69,Δ69-70 + Δ144 + S494P + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,2,ng/ml,1,=,0.7,,,
House22,10.1371/journal.pone.0267796,Pseudovirus,Fig 1A,COV2-2381 + Cilgavimab,Wild Type (B.1),,,,,Alpha/S494P,69,Δ69-70 + Δ144 + S494P + N501Y + A570D + P681H + T716I + S982A + D1118H,1,,,,,=,0.9,,,
Ragonnet-Cronin22,10.1101/2022.07.14.500063,Pseudovirus (lentivirus),Figure 1C,Casirivimab,Wild Type (B),=,2,ng/ml,1,Delta/E406D,19,T19R + E156G + Δ157-158 + E406D + L452R + T478K + P681R + D950N,1,=,2,ng/ml,1,=,1,,,
Ragonnet-Cronin22,10.1101/2022.07.14.500063,Pseudovirus (lentivirus),Figure 1C,Imdevimab,Wild Type (B),=,12,ng/ml,1,Delta/E406D,19,T19R + E156G + Δ157-158 + E406D + L452R + T478K + P681R + D950N,1,=,11,ng/ml,1,=,0.9,,,
Ragonnet-Cronin22,10.1101/2022.07.14.500063,Pseudovirus (lentivirus),Figure 1C,Casirivimab + Imdevimab,Wild Type (B),=,2,ng/ml,1,Delta/E406D,19,T19R + E156G + Δ157-158 + E406D + L452R + T478K + P681R + D950N,1,=,2,ng/ml,1,=,1,,,
Ragonnet-Cronin22,10.1101/2022.07.14.500063,Pseudovirus (lentivirus),Figure 1C,Casirivimab,Wild Type (B),=,2,ng/ml,1,Delta/E406Q,19,T19R + E156G + Δ157-158 + E406Q + L452R + T478K + P681R + D950N,1,=,14,ng/ml,1,=,7,,,
Ragonnet-Cronin22,10.1101/2022.07.14.500063,Pseudovirus (lentivirus),Figure 1C,Imdevimab,Wild Type (B),=,12,ng/ml,1,Delta/E406Q,19,T19R + E156G + Δ157-158 + E406Q + L452R + T478K + P681R + D950N,1,=,15,ng/ml,1,=,1.3,,,
Ragonnet-Cronin22,10.1101/2022.07.14.500063,Pseudovirus (lentivirus),Figure 1C,Casirivimab + Imdevimab,Wild Type (B),=,2,ng/ml,1,Delta/E406Q,19,T19R + E156G + Δ157-158 + E406Q + L452R + T478K + P681R + D950N,1,=,6,ng/ml,1,=,3,,,
Ragonnet-Cronin22,10.1101/2022.07.14.500063,Pseudovirus (lentivirus),Figure 1C,Casirivimab,Wild Type (B),=,2,ng/ml,1,Delta/G446S,19,T19R + E156G + Δ157-158 + G446S + L452R + T478K + P681R + D950N,1,=,1,ng/ml,1,=,0.5,,,
Ragonnet-Cronin22,10.1101/2022.07.14.500063,Pseudovirus (lentivirus),Figure 1C,Imdevimab,Wild Type (B),=,12,ng/ml,1,Delta/G446S,19,T19R + E156G + Δ157-158 + G446S + L452R + T478K + P681R + D950N,1,>,10000,ng/ml,1,>,833.3,,,
Ragonnet-Cronin22,10.1101/2022.07.14.500063,Pseudovirus (lentivirus),Figure 1C,Casirivimab + Imdevimab,Wild Type (B),=,2,ng/ml,1,Delta/G446S,19,T19R + E156G + Δ157-158 + G446S + L452R + T478K + P681R + D950N,1,=,2,ng/ml,1,=,1,,,
Ragonnet-Cronin22,10.1101/2022.07.14.500063,Pseudovirus (lentivirus),Figure 1C,Casirivimab,Wild Type (B),=,2,ng/ml,1,Delta/G446V,19,T19R + E156G + Δ157-158 + G446V + L452R + T478K + P681R + D950N,1,=,1,ng/ml,1,=,0.5,,,
Ragonnet-Cronin22,10.1101/2022.07.14.500063,Pseudovirus (lentivirus),Figure 1C,Imdevimab,Wild Type (B),=,12,ng/ml,1,Delta/G446V,19,T19R + E156G + Δ157-158 + G446V + L452R + T478K + P681R + D950N,1,>,10000,ng/ml,1,>,833.3,,,
Ragonnet-Cronin22,10.1101/2022.07.14.500063,Pseudovirus (lentivirus),Figure 1C,Casirivimab + Imdevimab,Wild Type (B),=,2,ng/ml,1,Delta/G446V,19,T19R + E156G + Δ157-158 + G446V + L452R + T478K + P681R + D950N,1,=,2,ng/ml,1,=,1,,,
Ragonnet-Cronin22,10.1101/2022.07.14.500063,Pseudovirus (lentivirus),Figure 1C,Casirivimab,Wild Type (B),=,2,ng/ml,1,Delta/Y453F,19,T19R + E156G + Δ157-158 + L452R + Y453F + T478K + P681R + D950N,1,=,16,ng/ml,1,=,8,,,
Ragonnet-Cronin22,10.1101/2022.07.14.500063,Pseudovirus (lentivirus),Figure 1C,Imdevimab,Wild Type (B),=,12,ng/ml,1,Delta/Y453F,19,T19R + E156G + Δ157-158 + L452R + Y453F + T478K + P681R + D950N,1,=,12,ng/ml,1,=,1,,,
Ragonnet-Cronin22,10.1101/2022.07.14.500063,Pseudovirus (lentivirus),Figure 1C,Casirivimab + Imdevimab,Wild Type (B),=,2,ng/ml,1,Delta/Y453F,19,T19R + E156G + Δ157-158 + L452R + Y453F + T478K + P681R + D950N,1,=,11,ng/ml,1,=,5.5,,,
Ragonnet-Cronin22,10.1101/2022.07.14.500063,Pseudovirus (lentivirus),Figure 1C,Casirivimab,Wild Type (B),=,2,ng/ml,1,Delta/L455F,19,T19R + E156G + Δ157-158 + L452R + L455F + T478K + P681R + D950N,1,=,17,ng/ml,1,=,8.5,,,
Ragonnet-Cronin22,10.1101/2022.07.14.500063,Pseudovirus (lentivirus),Figure 1C,Imdevimab,Wild Type (B),=,12,ng/ml,1,Delta/L455F,19,T19R + E156G + Δ157-158 + L452R + L455F + T478K + P681R + D950N,1,=,5,ng/ml,1,=,0.4,,,
Ragonnet-Cronin22,10.1101/2022.07.14.500063,Pseudovirus (lentivirus),Figure 1C,Casirivimab + Imdevimab,Wild Type (B),=,2,ng/ml,1,Delta/L455F,19,T19R + E156G + Δ157-158 + L452R + L455F + T478K + P681R + D950N,1,=,5,ng/ml,1,=,2.5,,,
Ragonnet-Cronin22,10.1101/2022.07.14.500063,Pseudovirus (lentivirus),Figure 1C,Casirivimab,Wild Type (B),=,2,ng/ml,1,Delta/L455S,19,T19R + E156G + Δ157-158 + L452R + L455S + T478K + P681R + D950N,1,=,155,ng/ml,1,=,77.5,,,
Ragonnet-Cronin22,10.1101/2022.07.14.500063,Pseudovirus (lentivirus),Figure 1C,Imdevimab,Wild Type (B),=,12,ng/ml,1,Delta/L455S,19,T19R + E156G + Δ157-158 + L452R + L455S + T478K + P681R + D950N,1,=,4,ng/ml,1,=,0.3,,,
Ragonnet-Cronin22,10.1101/2022.07.14.500063,Pseudovirus (lentivirus),Figure 1C,Casirivimab + Imdevimab,Wild Type (B),=,2,ng/ml,1,Delta/L455S,19,T19R + E156G + Δ157-158 + L452R + L455S + T478K + P681R + D950N,1,=,3,ng/ml,1,=,1.5,,,
Ragonnet-Cronin22,10.1101/2022.07.14.500063,Pseudovirus (lentivirus),Figure 1C,Casirivimab,Wild Type (B),=,2,ng/ml,1,Delta/G446V+Y453F,19,T19R + E156G + Δ157-158 + G446V + L452R + Y453F + T478K + P681R + D950N,1,=,626,ng/ml,1,=,313,,,
Ragonnet-Cronin22,10.1101/2022.07.14.500063,Pseudovirus (lentivirus),Figure 1C,Imdevimab,Wild Type (B),=,12,ng/ml,1,Delta/G446V+Y453F,19,T19R + E156G + Δ157-158 + G446V + L452R + Y453F + T478K + P681R + D950N,1,>,10000,ng/ml,1,>,833.3,,,
Ragonnet-Cronin22,10.1101/2022.07.14.500063,Pseudovirus (lentivirus),Figure 1C,Casirivimab + Imdevimab,Wild Type (B),=,2,ng/ml,1,Delta/G446V+Y453F,19,T19R + E156G + Δ157-158 + G446V + L452R + Y453F + T478K + P681R + D950N,1,=,1097,ng/ml,1,=,548.5,,,
Ragonnet-Cronin22,10.1101/2022.07.14.500063,Pseudovirus (lentivirus),Figure 1C,Casirivimab,Wild Type (B),=,2,ng/ml,1,Delta/G446V+Y453F,19,T19R + E156G + Δ157-158 + G446V + L452R + Y453F + T478K + P681R + D950N,1,=,626,ng/ml,1,=,313,,,
Ragonnet-Cronin22,10.1101/2022.07.14.500063,Pseudovirus (lentivirus),Figure 1C,Imdevimab,Wild Type (B),=,12,ng/ml,1,Delta/G446V+Y453F,19,T19R + E156G + Δ157-158 + G446V + L452R + Y453F + T478K + P681R + D950N,1,>,10000,ng/ml,1,>,833.3,,,
Ragonnet-Cronin22,10.1101/2022.07.14.500063,Pseudovirus (lentivirus),Figure 1C,Casirivimab + Imdevimab,Wild Type (B),=,2,ng/ml,1,Delta/G446V+Y453F,19,T19R + E156G + Δ157-158 + G446V + L452R + Y453F + T478K + P681R + D950N,1,=,1097,ng/ml,1,=,548.5,,,
Gliga22,10.1093/cid/ciac802,Pseudovirus,Figure 3B,Sotrovimab,Wild Type (B.1),=,6,ng/ml,1,Omicron/BA.1/P337S,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + P337S + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,100000,ng/ml,1,>,1000,,,
Ragonnet-Cronin22,10.1101/2022.07.14.500063,Pseudovirus (lentivirus),Figure 1D,Sotrovimab,Wild Type (B),=,79,ng/ml,1,Omicron/BA.1/P337S,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + P337S + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,126.6,,,
Gliga22,10.1093/cid/ciac802,Pseudovirus,Figure 3B,Sotrovimab,Wild Type (B.1),=,6,ng/ml,1,Omicron/BA.1/E340D,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + E340D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,100000,ng/ml,1,>,1000,,,
Ragonnet-Cronin22,10.1101/2022.07.14.500063,Pseudovirus (lentivirus),Figure 1D,Sotrovimab,Wild Type (B),=,79,ng/ml,1,Omicron/BA.1/E340D,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + E340D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,126.6,,,
Gliga22,10.1093/cid/ciac802,Pseudovirus,Figure 3B,Sotrovimab,Wild Type (B.1),=,6,ng/ml,1,Omicron/BA.1/E340K,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + E340K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,100000,ng/ml,1,>,1000,,,
Ragonnet-Cronin22,10.1101/2022.07.14.500063,Pseudovirus (lentivirus),Figure 1D,Sotrovimab,Wild Type (B),=,79,ng/ml,1,Omicron/BA.1/E340K,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + E340K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,126.6,,,
Gliga22,10.1093/cid/ciac802,Pseudovirus,Figure 3B,Sotrovimab,Wild Type (B.1),=,6,ng/ml,1,Omicron/BA.1/E340V,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + E340V + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,100000,ng/ml,1,>,1000,,,
Ragonnet-Cronin22,10.1101/2022.07.14.500063,Pseudovirus (lentivirus),Figure 1D,Sotrovimab,Wild Type (B),=,79,ng/ml,1,Omicron/BA.1/E340V,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + E340V + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,126.6,,,
EMA21e,https://www.ema.europa.eu/en/documents/product-information/evusheld-epar-product-information_en.pdf,Pseudovirus,Table 3,Cilgavimab + Tixagevimab,Wild Type (B),=,1.9,ng/ml,1,B.1.619.1,210,I210T + N440K + E484K + D936N + S939F + T1027I,1,=,7.6,ng/ml,1,=,4,,,
FDA21c,https://www.fda.gov/media/154701/download,Pseudovirus,"Feb 2022, Table 6, Page 17, Antiviral resistance paragraph 6",Cilgavimab + Tixagevimab,Wild Type (B),,,,,B.1.619.1,210,I210T + N440K + E484K + D936N + S939F + T1027I,1,,,,,=,3.3,,,
Cathcart21,10.1101/2021.03.09.434607,Pseudovirus (VSV),Table 2,Sotrovimab,Wild Type (B),,,,,B.1.619.1,210,I210T + N440K + E484K + D936N + S939F + T1027I,1,,,,,=,1.3,,,
Ragonnet-Cronin22,10.1101/2022.07.14.500063,Pseudovirus (lentivirus),Figure 1D,Sotrovimab,Wild Type (B),=,79,ng/ml,1,Omicron/BA.1/P337R,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + P337R + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,126.6,,,
Ragonnet-Cronin22,10.1101/2022.07.14.500063,Pseudovirus (lentivirus),Figure 1D,Sotrovimab,Wild Type (B),=,79,ng/ml,1,Omicron/BA.1/E340A,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + E340A + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,126.6,,,
Ragonnet-Cronin22,10.1101/2022.07.14.500063,Pseudovirus (lentivirus),Figure 1D,Sotrovimab,Wild Type (B),=,79,ng/ml,1,Omicron/BA.1/K356T,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + K356T + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,>,10000,ng/ml,1,>,126.6,,,
Ragonnet-Cronin22,10.1101/2022.07.14.500063,Pseudovirus (lentivirus),Figure 1D,Sotrovimab,Wild Type (B),=,79,ng/ml,1,Omicron/BA.1/R493Q,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493Q + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,185,ng/ml,1,=,2.3,,,
Westendorf22,10.1016/j.celrep.2022.110812,Pseudovirus (VSV),Table 3B,Bebtelovimab,Wild Type (A),=,3,ng/ml,1,Alpha/F490S,69,Δ69-70 + Δ144 + F490S + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,3,ng/ml,1,=,1,,,
Westendorf22,10.1016/j.celrep.2022.110812,Pseudovirus (VSV),Table 3B,Bebtelovimab,Wild Type (A),=,3,ng/ml,1,Alpha/L452R,69,Δ69-70 + Δ145 + L452R + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,2,ng/ml,1,=,0.7,,,
EMA21e,https://www.ema.europa.eu/en/documents/product-information/evusheld-epar-product-information_en.pdf,Pseudovirus,Table 3,Cilgavimab + Tixagevimab,Wild Type (B),=,1.9,ng/ml,1,AV.1,80,D80G + T95I + G142D + Δ144 + N439K + E484K + P681H + I1130V + D1139H,1,=,13,ng/ml,1,=,6.8,,,
FDA21c,https://www.fda.gov/media/154701/download,Pseudovirus,"Feb 2022, Table 6, Page 17, Antiviral resistance paragraph 6",Cilgavimab + Tixagevimab,Wild Type (B),,,,,AV.1,80,D80G + T95I + G142D + Δ144 + N439K + E484K + P681H + I1130V + D1139H,1,,,,,=,5.9,,,
EMA21e,https://www.ema.europa.eu/en/documents/product-information/evusheld-epar-product-information_en.pdf,Pseudovirus,Table 3,Cilgavimab + Tixagevimab,Wild Type (B),=,1.9,ng/ml,1,B.1.214.2,214,R214ins + Q414K + N450K + T716I,1,=,1.6,ng/ml,1,=,0.8,,,
FDA21c,https://www.fda.gov/media/154701/download,Pseudovirus,"Feb 2022, Table 6, Page 17, Antiviral resistance paragraph 6",Cilgavimab + Tixagevimab,Wild Type (B),,,,,B.1.214.2,214,R214ins + Q414K + N450K + T716I,1,,,,,=,0.8,,,
EMA21e,https://www.ema.europa.eu/en/documents/product-information/evusheld-epar-product-information_en.pdf,Pseudovirus,Table 3,Cilgavimab + Tixagevimab,Wild Type (B),=,1.9,ng/ml,1,B.1.616,66,H66D + G142V + Δ144 + D215G + V483A + H655Y + G669S + Q949R + N1187D,1,=,1.1,ng/ml,1,=,0.6,,,
FDA21c,https://www.fda.gov/media/154701/download,Pseudovirus,"Feb 2022, Table 6, Page 17, Antiviral resistance paragraph 6",Cilgavimab + Tixagevimab,Wild Type (B),,,,,B.1.616,66,H66D + G142V + Δ144 + D215G + V483A + H655Y + G669S + Q949R + N1187D,1,,,,,=,0.5,,,
EMA21e,https://www.ema.europa.eu/en/documents/product-information/evusheld-epar-product-information_en.pdf,Pseudovirus,Table 3,Cilgavimab + Tixagevimab,Wild Type (B),=,1.9,ng/ml,1,C.36.3,12,S12F + Δ69-70 + W152R + R346S + L452R + Q677H + A899S,1,=,3.9,ng/ml,1,=,2.1,,,
FDA21c,https://www.fda.gov/media/154701/download,Pseudovirus,"Feb 2022, Table 6, Page 17, Antiviral resistance paragraph 6",Cilgavimab + Tixagevimab,Wild Type (B),,,,,C.36.3,12,S12F + Δ69-70 + W152R + R346S + L452R + Q677H + A899S,1,,,,,=,2.3,,,
Gliga22,10.1093/cid/ciac802,Pseudovirus,Figure 3B,Sotrovimab,Wild Type (B.1),=,6,ng/ml,1,Omicron/BA.2/P337S,19,T19I + L24S + Δ25-27 + G142D + V213G + P337S + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,100000,ng/ml,1,>,1000,,,
Gliga22,10.1093/cid/ciac802,Pseudovirus,Figure 3B,Sotrovimab,Wild Type (B.1),=,6,ng/ml,1,Omicron/BA.2/E340D,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + E340D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,100000,ng/ml,1,>,1000,,,
Gliga22,10.1093/cid/ciac802,Pseudovirus,Figure 3B,Sotrovimab,Wild Type (B.1),=,6,ng/ml,1,Omicron/BA.2/E340K,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + E340K + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,100000,ng/ml,1,>,1000,,,
Gliga22,10.1093/cid/ciac802,Pseudovirus,Figure 3B,Sotrovimab,Wild Type (B.1),=,6,ng/ml,1,Omicron/BA.2/E340V,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + E340V + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,100000,ng/ml,1,>,1000,,,
Cathcart21,10.1101/2021.03.09.434607,Pseudovirus (VSV),Table 2,Sotrovimab,Wild Type (B),,,,,R.2,484,E484K + Q677H + T732S + E1202Q,1,,,,,=,0.8,,,
Westendorf22,10.1016/j.celrep.2022.110812,Pseudovirus (VSV),Table 3D,Adintrevimab,Wild Type (B.1),=,5.4,ng/ml,1.1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,2,=,2060.2,ng/ml,1,=,379.9,365.6,394.2,
Zhou21e,10.1126/science.abn8897,Pseudovirus (lentivirus),Figure 2C,Adintrevimab,Wild Type (B.1),=,5.1,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,2037,ng/ml,1,=,399.4,,,
Cao22,10.1101/2022.02.07.479349,Pseudovirus (VSV),Table S2,Adintrevimab,Wild Type (B.1),=,13.4,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,1470,ng/ml,1,=,109.7,,,
Liu22,10.1126/scitranslmed.abn6859,Pseudovirus (VSV),Fig3C,Adintrevimab,Wild Type (B.1),=,1,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,212,ng/ml,1,=,212,,,
Lusvarghi22,10.1126/scitranslmed.abn8543,Pseudovirus (lentivirus),Fig 4,Adintrevimab,Wild Type (B.1),=,0.6,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,211.8,ng/ml,1,=,353,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Table 1a,Adintrevimab,Wild Type (B.1),=,7,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,181,ng/ml,1,=,25.9,,,
Iketani22,10.1038/s41586-022-04594-4,Pseudovirus (VSV),Figure 2b,Adintrevimab,Wild Type (B.1),,,,,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,,,,,=,11,,,
Tuekprakhon22,10.1016/j.cell.2022.06.005,Pseudovirus (lentivirus),Figure 3,Adintrevimab,Wild Type (B),=,3,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,348,ng/ml,1,=,116,,,
Arora22f,10.1016/S1473-3099(22)00733-2,Pseudovirus (VSV),Figure B,Adintrevimab,Wild Type (B.1),=,14,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,23,ng/ml,1,=,1.6,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Adintrevimab,Wild Type (B.1),=,10.7,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,979,ng/ml,1,=,91.5,,,
Huo22b,10.1016/j.celrep.2022.111903,Pseudovirus (lentivirus),Supplementary Table 1B,Adintrevimab,Wild Type (B),=,3,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,348,ng/ml,1,=,116,,,
Ai22,10.1016/j.chom.2022.05.001,Pseudovirus (VSV),Figure 3A,Adintrevimab,Wild Type (B),=,2.6,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,266,ng/ml,1,=,102.3,,,
Gruell22b,10.1016/j.chom.2022.07.002,Pseudovirus (HIV),Figure 4B,Adintrevimab,Wild Type (B),=,5,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,212,ng/ml,1,=,42.4,,,
Yuan22,10.1101/2022.03.13.484037,Pseudovirus (MLV),Figure 2A,Adintrevimab,Wild Type (B),=,12,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,1203,ng/ml,1,=,100.3,,,
Bruel22,10.1038/s41591-022-01792-5,Virus isolate,Table 1,Adintrevimab,Delta,=,4.5,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,198,ng/ml,1,=,44,,,
Planas21c,10.1038/s41586-021-04389-z,Virus isolate,Extended Data Fig 4,Adintrevimab,Delta,=,19.6,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,403,ng/ml,1,=,20.6,,,
Fenwick22,10.1101/2022.03.18.484873,Virus isolate,Figure 2f,Adintrevimab,Delta,=,21,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,1400,ng/ml,1,=,66.7,,,
Dejnirattisai22,10.1016/j.cell.2021.12.046,Virus isolate,"Figure 4C, Table S1",Adintrevimab,Wild Type (B),=,4,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,1104,ng/ml,1,=,276,,,
Liu21l,10.1038/s41586-021-04388-0,Pseudovirus (VSV),Figure 2c,Adintrevimab,Wild Type (B.1),=,2.5,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,95.2,ng/ml,1,=,38.1,,,
Wang22,10.1080/22221751.2022.2030200,Pseudovirus (VSV),Figure 2,Adintrevimab,Wild Type (B.1),=,2.5,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,265.7,ng/ml,1,=,106.3,,,
Hao22,10.1101/2022.08.12.22278720,Virus isolate,Figure 5A,Adintrevimab,Wild Type (A),=,1,ng/ml,1,Omicron/BA.1,67,A67V + Δ69-70 + T95I + Δ142-144 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,284,ng/ml,1,=,284,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b; Extended Data Table 1a,Adintrevimab,Wild Type (B.1),=,7,ng/ml,1,Omicron/BA.2,(Various),(Various),2,>,10000,ng/ml,1,>,1000,1428.6,1428.6,
Cao22,10.1101/2022.02.07.479349,Pseudovirus (VSV),Table S2,Adintrevimab,Wild Type (B.1),=,13.4,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,746.3,,,
Cao22c,10.1016/j.chom.2022.09.018,Pseudovirus (VSV),Figure 5b,Adintrevimab,Wild Type (B.1),=,11,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,909.1,,,
Iketani22,10.1038/s41586-022-04594-4,Pseudovirus (VSV),Figure 2a,Adintrevimab,Wild Type (B.1),=,18.9,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,529.1,,,
Sheward22b,10.1101/2022.07.19.500716,Pseudovirus (lentivirus),Table S1,Adintrevimab,Wild Type (B.1),=,13,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,1000,ng/ml,1,>,76.9,,,Some LOD values of 10000 were reported. Corrected to 1000
Yamasoba22c,10.1101/2022.07.14.500041,Pseudovirus,Table 1,Adintrevimab,Wild Type (B.1),=,6.3,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,2750,ng/ml,1,>,436.5,,,
Tuekprakhon22,10.1016/j.cell.2022.06.005,Pseudovirus (lentivirus),Figure 3,Adintrevimab,Wild Type (B),=,3,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Gruell22c,10.1016/S1473-3099(22)00580-1,Pseudovirus,Figure B,Adintrevimab,Wild Type (B.1),=,5,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Saito22,10.1016/j.chom.2022.10.003,Pseudovirus (lentivirus),Table 1,Adintrevimab,Wild Type (B.1),=,6.3,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,2750,ng/ml,1,>,436.5,,,
Huo22b,10.1016/j.celrep.2022.111903,Pseudovirus (lentivirus),Supplementary Table 1B,Adintrevimab,Wild Type (B),=,3,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Ai22,10.1016/j.chom.2022.05.001,Pseudovirus (VSV),Figure 3A,Adintrevimab,Wild Type (B),=,2.6,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Gruell22b,10.1016/j.chom.2022.07.002,Pseudovirus (HIV),Figure 4B,Adintrevimab,Wild Type (B),=,5,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Fenwick22,10.1101/2022.03.18.484873,Virus isolate,Figure 2f,Adintrevimab,Delta,=,21,ng/ml,1,Omicron/BA.2,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,3500,ng/ml,1,=,166.7,,,
Bruel22,10.1038/s41591-022-01792-5,Virus isolate,Table 1,Adintrevimab,Delta,=,4.5,ng/ml,1,Omicron/BA.2,19,T19I + Δ24-26 + A27S + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + R682W + N764K + D796Y + Q954H + N969K,1,>,9000,ng/ml,1,>,1000,,,
Hao22,10.1101/2022.08.12.22278720,Virus isolate,Figure 5A,Adintrevimab,Wild Type (A),=,1,ng/ml,1,Omicron/BA.2,67,A67V + T95I + Y144L + Y145D + L212I + G339D + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,4048,ng/ml,1,>,1000,,,
Huo22b,10.1016/j.celrep.2022.111903,Pseudovirus (lentivirus),Supplementary Table 1B,Adintrevimab,Wild Type (B),=,3,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Gruell22b,10.1016/j.chom.2022.07.002,Pseudovirus (HIV),Figure 4B,Adintrevimab,Wild Type (B),=,5,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Tuekprakhon22,10.1016/j.cell.2022.06.005,Pseudovirus (lentivirus),Figure 3,Adintrevimab,Wild Type (B),=,3,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Cao22c,10.1016/j.chom.2022.09.018,Pseudovirus (VSV),Figure 5b,Adintrevimab,Wild Type (B.1),=,11,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,909.1,,,
Sheward22b,10.1101/2022.07.19.500716,Pseudovirus (lentivirus),Table S1,Adintrevimab,Wild Type (B.1),=,13,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,1000,ng/ml,1,>,76.9,,,Some LOD values of 10000 were reported. Corrected to 1000
Sheward22c,10.1101/2022.09.16.508299,Pseudovirus,Figure 1B,Adintrevimab,Wild Type (B.1),=,56,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,1000,ng/ml,1,>,17.9,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Table 1a,Adintrevimab,Wild Type (B.1),=,7,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Yamasoba22c,10.1101/2022.07.14.500041,Pseudovirus,Table 1,Adintrevimab,Wild Type (B.1),=,6.3,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,2750,ng/ml,1,>,436.5,,,
Arora22f,10.1016/S1473-3099(22)00733-2,Pseudovirus (VSV),Figure B,Adintrevimab,Wild Type (B.1),=,14,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,50000,ng/ml,1,>,1000,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Adintrevimab,Wild Type (B.1),=,10.7,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,934.6,,,
Gruell22c,10.1016/S1473-3099(22)00580-1,Pseudovirus,Figure B,Adintrevimab,Wild Type (B.1),=,5,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Saito22,10.1016/j.chom.2022.10.003,Pseudovirus (lentivirus),Table 1,Adintrevimab,Wild Type (B.1),=,6.3,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,2750,ng/ml,1,>,436.5,,,
Turelli22b,10.1101/2022.07.28.501852,Virus isolate,Table 2,Adintrevimab,Omicron/BA.4,=,4100,ng/ml,1,Omicron/BA.5,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,4100,ng/ml,1,=,1,,,
Ai22,10.1016/j.chom.2022.05.001,Pseudovirus (VSV),Figure 3A,Adintrevimab,Wild Type (B),=,2.6,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,430,ng/ml,1,=,165.4,,,
Gruell22b,10.1016/j.chom.2022.07.002,Pseudovirus (HIV),Figure 4B,Adintrevimab,Wild Type (B),=,5,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,194,ng/ml,1,=,38.8,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Adintrevimab,Wild Type (B.1),=,10.7,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,991,ng/ml,1,=,92.6,,,
Huo22b,10.1016/j.celrep.2022.111903,Pseudovirus (lentivirus),Supplementary Table 1B,Adintrevimab,Wild Type (B),=,3,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,253,ng/ml,1,=,84.3,,,
Cao22,10.1101/2022.02.07.479349,Pseudovirus (VSV),Table S2,Adintrevimab,Wild Type (B.1),=,13.4,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,991,ng/ml,1,=,74,,,
Liu21l,10.1038/s41586-021-04388-0,Pseudovirus (VSV),Figure 2d,Adintrevimab,Wild Type (B.1),=,2.5,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,450.1,ng/ml,1,=,180,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Table 1a,Adintrevimab,Wild Type (B.1),=,7,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,295,ng/ml,1,=,42.1,,,
Iketani22,10.1038/s41586-022-04594-4,Pseudovirus (VSV),Figure 2b,Adintrevimab,Wild Type (B.1),,,,,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,,,,,=,16,,,
Tuekprakhon22,10.1016/j.cell.2022.06.005,Pseudovirus (lentivirus),Figure 3,Adintrevimab,Wild Type (B),=,3,ng/ml,1,Omicron/BA.1.1,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + R214ins + G339D + R346K + S371L + S373P + S375F + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + G496S + Q498R + N501Y + Y505H + T547K + H655Y + N679K + P681H + N764K + D796Y + N856K + Q954H + N969K + L981F,1,=,253,ng/ml,1,=,84.3,,,
Liu22,10.1126/scitranslmed.abn6859,Virus isolate,Fig2B,Adintrevimab,Wild Type (A),=,1,ng/ml,1,Delta,19,T19R + G142D + Δ156-157 + R158G + L452R + T478K + P681R + A771S + D950N,1,=,9,ng/ml,1,=,9,,,
Hao22,10.1101/2022.08.12.22278720,Virus isolate,Figure 5A,Adintrevimab,Wild Type (A),=,1,ng/ml,1,Delta,19,T19R + G142D + L452R + T478K + P681R + D950N,1,=,1,ng/ml,1,=,1,,,
Dejnirattisai22,10.1016/j.cell.2021.12.046,Virus isolate,"Figure 4C, Table S1",Adintrevimab,Wild Type (B),=,4,ng/ml,1,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,6,ng/ml,1,=,1.5,,,
Liu21f,10.1016/j.cell.2021.06.020,Virus isolate,Table S1,Adintrevimab,Wild Type (B),=,4,ng/ml,1,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,6,ng/ml,1,=,1.5,,,
Yuan22,10.1101/2022.03.13.484037,Pseudovirus (MLV),Figure 2A,Adintrevimab,Wild Type (B),=,12,ng/ml,1,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,14,ng/ml,1,=,1.2,,,
Liu22,10.1126/scitranslmed.abn6859,Pseudovirus (VSV),Fig2A,Adintrevimab,Wild Type (B.1),=,2,ng/ml,1,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,5,ng/ml,1,=,2.5,,,
Zhou21e,10.1126/science.abn8897,Pseudovirus (lentivirus),Figure 2C,Adintrevimab,Wild Type (B.1),=,5.1,ng/ml,1,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,7.6,ng/ml,1,=,1.5,,,
Dejnirattisai22,10.1016/j.cell.2021.12.046,Virus isolate,"Figure 4C, Table S1",Adintrevimab,Wild Type (B),=,4,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,6,ng/ml,1,=,1.5,,,
Supasa21,10.1016/j.cell.2021.02.033,Virus isolate,Dejnirattisai21 Table S2,Adintrevimab,Wild Type (B),=,4,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,6,ng/ml,1,=,1.5,,,
Yuan22,10.1101/2022.03.13.484037,Pseudovirus (MLV),Figure 2A,Adintrevimab,Wild Type (B),=,12,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,9,ng/ml,1,=,0.8,,,
Liu22,10.1126/scitranslmed.abn6859,Pseudovirus (VSV),Fig2A,Adintrevimab,Wild Type (B.1),=,2,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,6,ng/ml,1,=,3,,,
Zhou21e,10.1126/science.abn8897,Pseudovirus (lentivirus),Figure 2C,Adintrevimab,Wild Type (B.1),=,5.1,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,4.7,ng/ml,1,=,0.9,,,
Liu22,10.1126/scitranslmed.abn6859,Virus isolate,Fig2B,Adintrevimab,Wild Type (A),=,1,ng/ml,1,Alpha,69,Δ69-70 + Δ141 + Δ144-145 + N501Y + A570D + P681H + T716I + S982A + D1118H,1,=,1,ng/ml,1,=,1,,,
Dejnirattisai22,10.1016/j.cell.2021.12.046,Virus isolate,"Figure 4C, Table S1",Adintrevimab,Wild Type (B),=,4,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,=,10,ng/ml,1,=,2.5,,,
Zhou21b,10.1016/j.cell.2021.02.037,Virus isolate,Dejnirattisai21 Table S2,Adintrevimab,Wild Type (B),=,4,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,=,10,ng/ml,1,=,2.5,,,
Liu22,10.1126/scitranslmed.abn6859,Pseudovirus (VSV),Fig2A,Adintrevimab,Wild Type (B.1),=,2,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,=,7,ng/ml,1,=,3.5,,,
Zhou21e,10.1126/science.abn8897,Pseudovirus (lentivirus),Figure 2C,Adintrevimab,Wild Type (B.1),=,5.1,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,=,15.5,ng/ml,1,=,3,,,
Yuan22,10.1101/2022.03.13.484037,Pseudovirus (MLV),Figure 2A,Adintrevimab,Wild Type (B),=,12,ng/ml,1,Beta,18,L18F + D80A + D215G + Δ242-244 + R246I + K417N + E484K + N501Y + A701V,1,=,15,ng/ml,1,=,1.3,,,
Liu22,10.1126/scitranslmed.abn6859,Virus isolate,Fig2B,Adintrevimab,Wild Type (A),=,1,ng/ml,1,Beta,80,D80A + D215G + Δ241-244 + K417N + E484K + N501Y + A701V,1,=,3,ng/ml,1,=,3,,,
Liu22,10.1126/scitranslmed.abn6859,Virus isolate,Fig2B,Adintrevimab,Wild Type (A),=,1,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,2,ng/ml,1,=,2,,,
Dejnirattisai21,10.1016/j.cell.2021.03.055,Virus isolate,Table S2,Adintrevimab,Wild Type (B),=,4,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,9,ng/ml,1,=,2.3,,,
Dejnirattisai22,10.1016/j.cell.2021.12.046,Virus isolate,"Figure 4C, Table S1",Adintrevimab,Wild Type (B),=,4,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,9,ng/ml,1,=,2.3,,,
Yuan22,10.1101/2022.03.13.484037,Pseudovirus (MLV),Figure 2A,Adintrevimab,Wild Type (B),=,12,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,13,ng/ml,1,=,1.1,,,
Liu22,10.1126/scitranslmed.abn6859,Pseudovirus (VSV),Fig2A,Adintrevimab,Wild Type (B.1),=,2,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,7,ng/ml,1,=,3.5,,,
Zhou21e,10.1126/science.abn8897,Pseudovirus (lentivirus),Figure 2C,Adintrevimab,Wild Type (B.1),=,5.1,ng/ml,1,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,6.4,ng/ml,1,=,1.3,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Adintrevimab,Wild Type (B.1),=,10.7,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,934.6,,,
Gruell22c,10.1016/S1473-3099(22)00580-1,Pseudovirus,Figure B,Adintrevimab,Wild Type (B.1),=,5,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Cao22c,10.1016/j.chom.2022.09.018,Pseudovirus (VSV),Figure 5b,Adintrevimab,Wild Type (B.1),=,11,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,909.1,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Table 1a,Adintrevimab,Wild Type (B.1),=,7,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Gruell22b,10.1016/j.chom.2022.07.002,Pseudovirus (HIV),Figure 4B,Adintrevimab,Wild Type (B),=,5,ng/ml,1,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Gruell22c,10.1016/S1473-3099(22)00580-1,Pseudovirus,Figure B,Adintrevimab,Wild Type (B.1),=,5,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Saito22,10.1016/j.chom.2022.10.003,Pseudovirus (lentivirus),Table 1,Adintrevimab,Wild Type (B.1),=,6.3,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,2750,ng/ml,1,>,436.5,,,
Cao22c,10.1016/j.chom.2022.09.018,Pseudovirus (VSV),Figure 5b,Adintrevimab,Wild Type (B.1),=,11,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,909.1,,,
Sheward22b,10.1101/2022.07.19.500716,Pseudovirus (lentivirus),Table S1,Adintrevimab,Wild Type (B.1),=,13,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,1000,ng/ml,1,>,76.9,,,Some LOD values of 10000 were reported. Corrected to 1000
Yamasoba22c,10.1101/2022.07.14.500041,Pseudovirus,Table 1,Adintrevimab,Wild Type (B.1),=,6.3,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,2750,ng/ml,1,>,436.5,,,
Huo22b,10.1016/j.celrep.2022.111903,Pseudovirus (lentivirus),Supplementary Table 1B,Adintrevimab,Wild Type (B),=,3,ng/ml,1,Omicron/BA.2.75,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Yuan22,10.1101/2022.03.13.484037,Pseudovirus (MLV),Figure 2A,Adintrevimab,Wild Type (B),=,12,ng/ml,1,SARS-CoV-1,3,V3I + V6L + L7F + P9T + V11T + S12ins + Q14D + C15L + V16D + N17R + L18C + R21F + T22D + Q23D + L24V + P25ins + A27N + N30ins + F32S + T33M + K41E + V42I + S46D + V47T + H49Y + S50L + F59Y + W64G + A67T + H69N + V70H + S71T + Δ72-78 + D80G + L84I + N87K + V90I + S94A + I100V + I101V + I105V + T108S + L110M + D111N + S112N + T114S + L117V + L118I + V120I + A123S + K129R + V130A + E132N + Q134E + F135L + N137D + D138N + L141F + G142A + Y144S + Y145K + H146P + Δ147 + N148M + N149G + Δ150-152 + M153T + E154Q + S155T + E156H + F157T + R158M + V159I + Y160F + S161D + S162N + N164F + V171I + Q173D + P174A + L176S + M177L + L179V + E180S + G181E + Q183S + N188H + I197K + Y200F + F201L + K202Y + I203V + S205K + K206G + H207Y + T208Q + N211D + L212V + Q218S + S221N + A222T + E224K + L226I + V227F + D228K + I231L + R237N + Q239R + T240A + L241I + A243T + L244A + Δ245-246 + S247F + Y248S + L249P + T250A + P251Q + G252D + D253I + Δ254-257 + T259G + A260T + G261S + Y266F + Q271K + R273T + L276M + N280D + A292S + L293Q + D294N + S297A + T299L + T302S + L303V + T307E + V308I + E309D + Q321V + T323S + E324G + S325D + I326V + R346K + A348P + N354E + R357K + A372T + S373F + P384A + T393S + I402V + R403K + E406D + K417V + T430M + I434L + S438T + N439R + L441I + S443A + K444T + V445S + G446T + L452K + L455Y + F456L + K458H + S459G + N460K + K462R + T470N + E471V + I472P + Y473F + Q474S + A475P + G476D + S477G + T478K + N481T + G482P + Δ483 + E484P + G485A + F486L + F490W + Q493N + S494D + Q498Y + P499T + N501T + V503I + H519N + K529L + N532D + V534I + K537Q + E554P + N556S + K558R + L560Q + I569V + A570S + T572F + A575S + Q580K + L582S + T588S + S591A + T604A + N606S + Q607E + E619D + P621S + V622T + T632A + V635I + S640N + R646Q + N657D + N658T + Q675H + Q677V + T678S + N679L + S680L + Δ681-684 + V687T + A688S + S689Q + Q690K + I693V + E702D + N703S + V705I + S711T + T719S + V722I + I726V + L727M + T732A + T739N + S750A + T768S + V772A + K776R + Q779R + I788M + P793T + I794L + D796Y + S810L + S813T + I834M + D839E + A845N + E868D + Q872A + S875A + L878V + A879S + I882A + S884A + L922Q + S929K + G932S + K933Q + D936E + S939T + S940T + A942S + S943T + S1055A + A1070S + K1073R + D1084E + H1088Y + S1097F + H1101S + V1104I + Y1110F + E1111S + V1133I + I1216V + M1233L + C1247A,1,=,2,ng/ml,1,=,0.2,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Adintrevimab,Wild Type (B.1),=,10.7,ng/ml,1,SARS-CoV-1,3,V3I + V6L + L7F + P9T + V11T + S12ins + Q14D + C15L + V16D + N17R + L18C + R21F + T22D + Q23D + L24V + P25ins + A27N + N30ins + F32S + T33M + K41E + V42I + S46D + V47T + H49Y + S50L + F59Y + W64G + A67T + H69N + V70H + S71T + Δ72-78 + D80G + L84I + N87K + V90I + S94A + I100V + I101V + I105V + T108S + L110M + D111N + S112N + T114S + L117V + L118I + V120I + A123S + K129R + V130A + E132N + Q134E + F135L + N137D + D138N + L141F + G142A + Y144S + Y145K + H146P + Δ147 + N148M + N149G + Δ150-152 + M153T + E154Q + S155T + E156H + F157T + R158M + V159I + Y160F + S161D + S162N + N164F + V171I + Q173D + P174A + L176S + M177L + L179V + E180S + G181E + Q183S + N188H + I197K + Y200F + F201L + K202Y + I203V + S205K + K206G + H207Y + T208Q + N211D + L212V + Q218S + S221N + A222T + E224K + L226I + V227F + D228K + I231L + R237N + Q239R + T240A + L241I + A243T + L244A + Δ245-246 + S247F + Y248S + L249P + T250A + P251Q + G252D + D253I + Δ254-257 + T259G + A260T + G261S + Y266F + Q271K + R273T + L276M + N280D + A292S + L293Q + D294N + S297A + T299L + T302S + L303V + T307E + V308I + E309D + Q321V + T323S + E324G + S325D + I326V + R346K + A348P + N354E + R357K + A372T + S373F + P384A + T393S + I402V + R403K + E406D + K417V + T430M + I434L + S438T + N439R + L441I + S443A + K444T + V445S + G446T + L452K + L455Y + F456L + K458H + S459G + N460K + K462R + T470N + E471V + I472P + Y473F + Q474S + A475P + G476D + S477G + T478K + N481T + G482P + Δ483 + E484P + G485A + F486L + F490W + Q493N + S494D + Q498Y + P499T + N501T + V503I + H519N + K529L + N532D + V534I + K537Q + E554P + N556S + K558R + L560Q + I569V + A570S + T572F + A575S + Q580K + L582S + T588S + S591A + T604A + N606S + Q607E + E619D + P621S + V622T + T632A + V635I + S640N + R646Q + N657D + N658T + Q675H + Q677V + T678S + N679L + S680L + Δ681-684 + V687T + A688S + S689Q + Q690K + I693V + E702D + N703S + V705I + S711T + T719S + V722I + I726V + L727M + T732A + T739N + S750A + T768S + V772A + K776R + Q779R + I788M + P793T + I794L + D796Y + S810L + S813T + I834M + D839E + A845N + E868D + Q872A + S875A + L878V + A879S + I882A + S884A + L922Q + S929K + G932S + K933Q + D936E + S939T + S940T + A942S + S943T + S1055A + A1070S + K1073R + D1084E + H1088Y + S1097F + H1101S + V1104I + Y1110F + E1111S + V1133I + I1216V + M1233L + C1247A,1,=,1.7,ng/ml,1,=,0.2,,,
Liu22,10.1126/scitranslmed.abn6859,Pseudovirus (VSV),Fig2C,Adintrevimab,Wild Type (B.1),=,2,ng/ml,1,SARS-CoV-1,3,V3I + V6L + L7F + P9T + V11T + S12ins + Q14D + C15L + V16D + N17R + L18C + R21F + T22D + Q23D + L24V + P25ins + A27N + N30ins + F32S + T33M + K41E + V42I + S46D + V47T + H49Y + S50L + F59Y + W64G + A67T + H69N + V70H + S71T + Δ72-78 + D80G + L84I + N87K + V90I + S94A + I100V + I101V + I105V + T108S + L110M + D111N + S112N + T114S + L117V + L118I + V120I + A123S + K129R + V130A + E132N + Q134E + F135L + N137D + D138N + L141F + G142A + Y144S + Y145K + H146P + Δ147 + N148M + N149G + Δ150-152 + M153T + E154Q + S155T + E156H + F157T + R158M + V159I + Y160F + S161D + S162N + N164F + V171I + Q173D + P174A + L176S + M177L + L179V + E180S + G181E + Q183S + N188H + I197K + Y200F + F201L + K202Y + I203V + S205K + K206G + H207Y + T208Q + N211D + L212V + Q218S + S221N + A222T + E224K + L226I + V227F + D228K + I231L + R237N + Q239R + T240A + L241I + A243T + L244A + Δ245-246 + S247F + Y248S + L249P + T250A + P251Q + G252D + D253I + Δ254-257 + T259G + A260T + G261S + Y266F + Q271K + R273T + L276M + N280D + A292S + L293Q + D294N + S297A + T299L + T302S + L303V + T307E + V308I + E309D + Q321V + T323S + E324G + S325D + I326V + R346K + A348P + N354E + R357K + A372T + S373F + P384A + T393S + I402V + R403K + E406D + K417V + T430M + I434L + S438T + N439R + L441I + S443A + K444T + V445S + G446T + L452K + L455Y + F456L + K458H + S459G + N460K + K462R + T470N + E471V + I472P + Y473F + Q474S + A475P + G476D + S477G + T478K + N481T + G482P + Δ483 + E484P + G485A + F486L + F490W + Q493N + S494D + Q498Y + P499T + N501T + V503I + H519N + K529L + N532D + V534I + K537Q + E554P + N556S + K558R + L560Q + I569V + A570S + T572F + A575S + Q580K + L582S + T588S + S591A + T604A + N606S + Q607E + E619D + P621S + V622T + T632A + V635I + S640N + R646Q + N657D + N658T + Q675H + Q677V + T678S + N679L + S680L + Δ681-684 + V687T + A688S + S689Q + Q690K + I693V + E702D + N703S + V705I + S711T + T719S + V722I + I726V + L727M + T732A + T739N + S750A + T768S + V772A + K776R + Q779R + I788M + P793T + I794L + D796Y + S810L + S813T + I834M + D839E + A845N + E868D + Q872A + S875A + L878V + A879S + I882A + S884A + L922Q + S929K + G932S + K933Q + D936E + S939T + S940T + A942S + S943T + S1055A + A1070S + K1073R + D1084E + H1088Y + S1097F + H1101S + V1104I + Y1110F + E1111S + V1133I + I1216V + M1233L + C1247A,1,=,3,ng/ml,1,=,1.5,,,
Cao22,10.1101/2022.02.07.479349,Pseudovirus (VSV),Table S2,Adintrevimab,Wild Type (B.1),=,13.4,ng/ml,1,SARS-CoV-1,3,V3I + V6L + L7F + P9T + V11T + S12ins + Q14D + C15L + V16D + N17R + L18C + R21F + T22D + Q23D + L24V + P25ins + A27N + N30ins + F32S + T33M + K41E + V42I + S46D + V47T + H49Y + S50L + F59Y + W64G + A67T + H69N + V70H + S71T + Δ72-78 + D80G + L84I + N87K + V90I + S94A + I100V + I101V + I105V + T108S + L110M + D111N + S112N + T114S + L117V + L118I + V120I + A123S + K129R + V130A + E132N + Q134E + F135L + N137D + D138N + L141F + G142A + Y144S + Y145K + H146P + Δ147 + N148M + N149G + Δ150-152 + M153T + E154Q + S155T + E156H + F157T + R158M + V159I + Y160F + S161D + S162N + N164F + V171I + Q173D + P174A + L176S + M177L + L179V + E180S + G181E + Q183S + N188H + I197K + Y200F + F201L + K202Y + I203V + S205K + K206G + H207Y + T208Q + N211D + L212V + Q218S + S221N + A222T + E224K + L226I + V227F + D228K + I231L + R237N + Q239R + T240A + L241I + A243T + L244A + Δ245-246 + S247F + Y248S + L249P + T250A + P251Q + G252D + D253I + Δ254-257 + T259G + A260T + G261S + Y266F + Q271K + R273T + L276M + N280D + A292S + L293Q + D294N + S297A + T299L + T302S + L303V + T307E + V308I + E309D + Q321V + T323S + E324G + S325D + I326V + R346K + A348P + N354E + R357K + A372T + S373F + P384A + T393S + I402V + R403K + E406D + K417V + T430M + I434L + S438T + N439R + L441I + S443A + K444T + V445S + G446T + L452K + L455Y + F456L + K458H + S459G + N460K + K462R + T470N + E471V + I472P + Y473F + Q474S + A475P + G476D + S477G + T478K + N481T + G482P + Δ483 + E484P + G485A + F486L + F490W + Q493N + S494D + Q498Y + P499T + N501T + V503I + H519N + K529L + N532D + V534I + K537Q + E554P + N556S + K558R + L560Q + I569V + A570S + T572F + A575S + Q580K + L582S + T588S + S591A + T604A + N606S + Q607E + E619D + P621S + V622T + T632A + V635I + S640N + R646Q + N657D + N658T + Q675H + Q677V + T678S + N679L + S680L + Δ681-684 + V687T + A688S + S689Q + Q690K + I693V + E702D + N703S + V705I + S711T + T719S + V722I + I726V + L727M + T732A + T739N + S750A + T768S + V772A + K776R + Q779R + I788M + P793T + I794L + D796Y + S810L + S813T + I834M + D839E + A845N + E868D + Q872A + S875A + L878V + A879S + I882A + S884A + L922Q + S929K + G932S + K933Q + D936E + S939T + S940T + A942S + S943T + S1055A + A1070S + K1073R + D1084E + H1088Y + S1097F + H1101S + V1104I + Y1110F + E1111S + V1133I + I1216V + M1233L + C1247A,1,=,1.7,ng/ml,1,=,0.1,,,
Cao22c,10.1016/j.chom.2022.09.018,Pseudovirus (VSV),Figure 5b,Adintrevimab,Wild Type (B.1),=,11,ng/ml,1,SARS-CoV-1,3,V3I + V6L + L7F + P9T + V11T + S12ins + Q14D + C15L + V16D + N17R + L18C + R21F + T22D + Q23D + L24V + P25ins + A27N + N30ins + F32S + T33M + K41E + V42I + S46D + V47T + H49Y + S50L + F59Y + W64G + A67T + H69N + V70H + S71T + Δ72-78 + D80G + L84I + N87K + V90I + S94A + I100V + I101V + I105V + T108S + L110M + D111N + S112N + T114S + L117V + L118I + V120I + A123S + K129R + V130A + E132N + Q134E + F135L + N137D + D138N + L141F + G142A + Y144S + Y145K + H146P + Δ147 + N148M + N149G + Δ150-152 + M153T + E154Q + S155T + E156H + F157T + R158M + V159I + Y160F + S161D + S162N + N164F + V171I + Q173D + P174A + L176S + M177L + L179V + E180S + G181E + Q183S + N188H + I197K + Y200F + F201L + K202Y + I203V + S205K + K206G + H207Y + T208Q + N211D + L212V + Q218S + S221N + A222T + E224K + L226I + V227F + D228K + I231L + R237N + Q239R + T240A + L241I + A243T + L244A + Δ245-246 + S247F + Y248S + L249P + T250A + P251Q + G252D + D253I + Δ254-257 + T259G + A260T + G261S + Y266F + Q271K + R273T + L276M + N280D + A292S + L293Q + D294N + S297A + T299L + T302S + L303V + T307E + V308I + E309D + Q321V + T323S + E324G + S325D + I326V + R346K + A348P + N354E + R357K + A372T + S373F + P384A + T393S + I402V + R403K + E406D + K417V + T430M + I434L + S438T + N439R + L441I + S443A + K444T + V445S + G446T + L452K + L455Y + F456L + K458H + S459G + N460K + K462R + T470N + E471V + I472P + Y473F + Q474S + A475P + G476D + S477G + T478K + N481T + G482P + Δ483 + E484P + G485A + F486L + F490W + Q493N + S494D + Q498Y + P499T + N501T + V503I + H519N + K529L + N532D + V534I + K537Q + E554P + N556S + K558R + L560Q + I569V + A570S + T572F + A575S + Q580K + L582S + T588S + S591A + T604A + N606S + Q607E + E619D + P621S + V622T + T632A + V635I + S640N + R646Q + N657D + N658T + Q675H + Q677V + T678S + N679L + S680L + Δ681-684 + V687T + A688S + S689Q + Q690K + I693V + E702D + N703S + V705I + S711T + T719S + V722I + I726V + L727M + T732A + T739N + S750A + T768S + V772A + K776R + Q779R + I788M + P793T + I794L + D796Y + S810L + S813T + I834M + D839E + A845N + E868D + Q872A + S875A + L878V + A879S + I882A + S884A + L922Q + S929K + G932S + K933Q + D936E + S939T + S940T + A942S + S943T + S1055A + A1070S + K1073R + D1084E + H1088Y + S1097F + H1101S + V1104I + Y1110F + E1111S + V1133I + I1216V + M1233L + C1247A,1,=,1.7,ng/ml,1,=,0.2,,,
Tuekprakhon22,10.1016/j.cell.2022.06.005,Pseudovirus (lentivirus),Figure 3,Adintrevimab,Wild Type (B),=,3,ng/ml,1,Omicron/BA.3,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + G339D + S371F + S373P + S375F + D405N + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Ai22,10.1016/j.chom.2022.05.001,Pseudovirus (VSV),Figure 3A,Adintrevimab,Wild Type (B),=,2.6,ng/ml,1,Omicron/BA.3,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + G339D + S371F + S373P + S375F + D405N + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Adintrevimab,Wild Type (B.1),=,10.7,ng/ml,1,Omicron/BA.3,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + G339D + S371F + S373P + S375F + D405N + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,=,6230,ng/ml,1,=,582.2,,,
Huo22b,10.1016/j.celrep.2022.111903,Pseudovirus (lentivirus),Supplementary Table 1B,Adintrevimab,Wild Type (B),=,3,ng/ml,1,Omicron/BA.3,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + G339D + S371F + S373P + S375F + D405N + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Liu22,10.1126/scitranslmed.abn6859,Virus isolate,Fig2B,Adintrevimab,Wild Type (A),=,1,ng/ml,1,Mu,95,T95I + Y144S + Y145N + R346K + E484K + N501Y + P681H + D950N,1,=,40,ng/ml,1,=,40,,,
Liu22,10.1126/scitranslmed.abn6859,Pseudovirus (VSV),Fig2A,Adintrevimab,Wild Type (B.1),=,2,ng/ml,1,Mu,95,T95I + Y144S + Y145N + R346K + E484K + N501Y + P681H + D950N,1,=,10,ng/ml,1,=,5,,,
Yuan22,10.1101/2022.03.13.484037,Pseudovirus (MLV),Figure 2A,Adintrevimab,Wild Type (B),=,12,ng/ml,1,Mu,95,T95I + Y144S + Y145N + R346K + E484K + N501Y + P681H + D950N,1,=,15,ng/ml,1,=,1.3,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b,Adintrevimab,Wild Type (B.1),=,7,ng/ml,1,Omicron/BA.2.13,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452M + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Adintrevimab,Wild Type (B.1),=,10.7,ng/ml,1,Omicron/BA.2.13,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452M + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,934.6,,,
Liu21f,10.1016/j.cell.2021.06.020,Pseudovirus (lentivirus),Table S1,Adintrevimab,Wild Type (B),=,2,ng/ml,1,Kappa,95,T95I + G142D + E154K + L452R + E484Q + P681R + Q1071H,1,=,5,ng/ml,1,=,2.5,,,
Liu22,10.1126/scitranslmed.abn6859,Pseudovirus (VSV),Fig2A,Adintrevimab,Wild Type (B.1),=,2,ng/ml,1,Kappa,142,G142D + E154K + L452R + E484Q + P681R + Q1071H + H1101D,1,=,4,ng/ml,1,=,2,,,
Liu22,10.1126/scitranslmed.abn6859,Virus isolate,Fig2B,Adintrevimab,Wild Type (A),=,1,ng/ml,1,Lambda,75,G75V + T76I + R246N + Δ247-253 + L452Q + F490S + T859N,1,=,1,ng/ml,1,=,1,,,
Liu22,10.1126/scitranslmed.abn6859,Pseudovirus (VSV),Fig2A,Adintrevimab,Wild Type (B.1),=,2,ng/ml,1,Lambda,75,G75V + T76I + Δ246-252 + L452Q + F490S + M869N,1,=,3,ng/ml,1,=,1.5,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Adintrevimab,Wild Type (B.1),=,10.7,ng/ml,1,pCoV-GD,6,V6ins + L7H + L8F + P9A + S12N + T20G + T22A + Q23A + L24I + P25Q + A27S + Y28F + F32S + T33Q + K41T + V42I + S46N + V47T + S50L + T51S + D53G + L54Y + F59Y + T63S + F65Y + H66Y + I68L + Δ69-70 + S71T + G72K + N74ins + G75A + T76E + F79V + P85D + N87K + V90I + S94A + I101V + S112N + K113T + T114S + V127I + E132N + N137Y + F140Y + G142S + V143G + Δ147 + S151T + M153S + E154T + S155R + R158A + A163Y + N164A + Q173K + P174S + L176M + M177L + L179I + E180A + Q183V + G184A + F186I + N188H + L189I + R190K + K195R + I197V + H207Y + I210V + L212V + V213N + R214S + D215N + Q218I + D228E + L229I + I231A + R237K + Q239R + A243T + L244I + S247G + Y248D + L249P + T250M + Δ252-254 + A260V + G261F + A262S + Q271A + L276M + K278N + T299A + F306L + R346T + A372T + I402V + K417R + Q498H + H519N + K529Q + N556S + R634S + Δ681-684 + A688S + S691A + S708A + T747I + A1070S + A1078T + D1084E + N1125S + V1228I,1,=,5,ng/ml,1,=,0.5,,,
Liu22,10.1126/scitranslmed.abn6859,Pseudovirus (VSV),Fig2C,Adintrevimab,Wild Type (B.1),=,2,ng/ml,1,pCoV-GD,79,F79V + P85D + N87K + V90I + S94A + I101V + S112N + K113T + T114S + V127I + E132N + N137Y + F140Y + G142S + V143G + Δ147 + S151T + M153S + E154T + S155R + R158A + A163Y + N164A + Q173K + P174S + L176M + M177L + L179I + E180A + Q183S + N185L + K187D + N188T + K195R + I197V + H207Y + I210V + L212V + V213N + R214S + D215N + Q218I + D228E + L229I + I231A + R237K + Q239R + A243T + L244I + S247G + Y248D + L249P + T250M + Δ252-254 + S255N + S256N + A260V + G261F + A262S + Q271A + L276M + K278N + T299A + F306L + R346T + A372T + I402V + K417R + Q498H + H519N + K529Q + N556S + R634S + Δ681-684 + A688S + S691A + S708A + T747I + A1070S + A1078T + D1084E + N1125S + V1228I,1,=,4,ng/ml,1,=,2,,,
Yuan22,10.1101/2022.03.13.484037,Pseudovirus (MLV),Figure 2A,Adintrevimab,Wild Type (B),=,12,ng/ml,1,pCoV-GX,6,V6F + L7V + Q23G + L24I + A27G + F32S + V47I + S50L + H66N + A67T + H69N + V70Y + S71Q + Δ73-74 + T76F + R78K + S112A + K113R + N137T + K147N + S151T + M153V + S155N + V171I + I197V + N211D + Q218R + S221A + D253K + S254L + S255E + A260T + P272Q + K278S + E281Q + A292S + F306L + E324I + T345S + R346K + A372T + I402V + R403K + K417V + N439V + N440K + L441Q + S443A + K444L + V445T + N450G + N460K + V483Q + E484V + F486L + F490Y + Q493E + S494R + Q498H + N501T + G504N + Y508F + H519N + A520G + K529L + N532T + N536D + E554T + N556K + K558Q + A570S + V622M + D627E + T632A + T638A + S640A + I651V + I666V + Q675H + T676S + Q677M + T678S + N679S + S680F + Δ681-684 + A688N + S689Q + Q690R + T747I + D1084E + V1104I + N1125S + V1228I,1,=,19,ng/ml,1,=,1.6,,,
Liu22,10.1126/scitranslmed.abn6859,Pseudovirus (VSV),Fig2C,Adintrevimab,Wild Type (B.1),=,2,ng/ml,1,pCoV-GX,6,V6F + L7V + Q23G + L24I + A27G + F32S + V47I + S50L + H66N + A67T + H69N + V70Y + S71Q + Δ73-74 + T76F + R78K + S112A + K113R + N137T + K147N + S151T + M153V + S155N + V171I + I197V + N211D + Q218R + S221A + D253N + S254L + S255E + A260T + P272Q + K278S + E281Q + A292S + F306L + E324I + T345S + R346K + A372T + I402V + R403K + K417V + N439V + N440K + L441Q + S443A + K444L + V445T + N450G + N460K + V483Q + E484V + F486L + F490Y + Q493E + S494R + Q498H + N501T + G504N + Y508F + H519N + A520G + K529L + N532T + N536D + E554T + N556K + K558Q + A570S + V622M + D627E + T632A + T638A + S640A + I651V + I666V + Q675H + T676S + Q677M + T678S + N679S + S680L + Δ681-684 + A688N + S689Q + Q690R + T747I + D1084E + V1104I + N1125S + L1197P + V1228I,1,=,29,ng/ml,1,=,14.5,,,
Yuan22,10.1101/2022.03.13.484037,Pseudovirus (MLV),Figure 2A,Adintrevimab,Wild Type (B),=,12,ng/ml,1,WIV1,1,M1K + F2L + V3L + F4V + L7F + L8A + P9T + S12ins + S13Y + Q14T + C15I + V16E + N17K + L18C + T19L + T20D + R21F + T22D + Q23D + L24R + P25ins + Y28N + N30ins + F32S + T33H + K41D + V42I + S46N + S50L + T51V + L54H + F59D + W64R + H66I + A67T + I68F + H69G + V70L + S71N + Δ72-78 + V83I + L84I + N87K + V90I + S94A + I100V + I105V + T108S + L110M + D111N + S112N + T114S + L117V + L118I + V120M + A123S + V126L + K129R + V130A + E132N + Q134E + F135L + N137D + D138N + L141F + G142V + Y144L + Y145K + H146S + Δ147 + Δ150-152 + M153T + E154Q + S155I + E156P + F157S + R158Y + V159I + Y160F + S161N + S162N + N164F + Q173K + P174D + L176N + M177L + E180G + G181E + Q183P + N188D + K195R + I197K + Y200F + F201L + K202H + I203V + K206G + H207Y + T208Q + N211S + L212A + V213A + R214S + D215G + Q218T + S221N + E224K + L226I + V227F + D228K + I231L + R237N + Q239R + A243T + L244A + Δ245-246 + S247F + Y248P + L249P + T250R + G252D + D253Y + Δ254-257 + T259G + A260T + G261S + Y266F + Q271K + R273T + L276M + N280D + A292S + L293Q + D294N + S297A + T299L + T302S + L303V + T307E + V308I + E309D + Q321A + T323S + E324K + S325E + I326V + R346T + A348P + N354E + A372T + P384A + T393S + I402V + R403K + E406D + K417V + I434L + S438T + N439R + L441I + S443A + K444T + V445Q + G446T + L452K + L455S + F456L + K458H + S459G + N460K + K462R + T470N + E471V + I472P + Y473F + Q474S + A475P + G476D + S477G + T478K + N481T + G482P + Δ483 + E484P + G485A + F490W + Q493N + S494D + Q498Y + P499I + V503I + H519N + K529L + N532D + V534I + K537Q + E554P + N556S + K558R + L560Q + I569V + A570S + T572F + A575S + Q580K + L582S + T588S + N606S + Q607E + E619D + T632S + Y636H + S640N + R646Q + N657D + N658T + Q675H + Q677V + T678S + N679S + S680L + Δ681-684 + V687T + A688S + S689Q + Q690K + I693V + E702D + N703S + V705I + S711T + T719S + V722I + I726V + L727M + T732A + T739N + S750A + T768S + K776R + Q779R + I788M + P793T + I794L + S810L + S813T + I834M + D839E + A845N + E868D + Q872A + S875A + L878V + A879S + I882A + S884A + L922Q + S929K + G932S + K933Q + D936E + S939T + S940T + A942S + S943T + S1055A + A1070S + K1073R + D1084E + H1088Y + S1097F + H1101S + V1104I + Y1110F + E1111S + N1125S + V1133I + I1216V + M1233L + C1247A,1,=,6,ng/ml,1,=,0.5,,,
Liu22,10.1126/scitranslmed.abn6859,Pseudovirus (VSV),Fig2C,Adintrevimab,Wild Type (B.1),=,2,ng/ml,1,WIV1,1,M1K + F2L + V3L + F4V + L7F + L8A + P9T + S12ins + S13Y + Q14T + C15I + V16E + N17K + L18C + T19L + T20D + R21F + T22D + Q23D + L24R + P25ins + Y28N + N30ins + F32S + T33H + K41D + V42I + S46N + S50L + T51V + L54H + F59D + W64R + H66I + A67T + I68F + H69G + V70L + S71N + Δ72-78 + V83I + L84I + N87K + V90I + S94A + I100V + I105V + T108S + L110M + D111N + S112N + T114S + L117V + L118I + V120M + A123S + V126L + K129R + V130A + E132N + Q134E + F135L + N137D + D138N + L141F + G142V + Y144L + Y145K + H146S + Δ147 + Δ150-152 + M153T + E154Q + S155I + E156P + F157S + R158Y + V159I + Y160F + S161N + S162N + N164F + Q173K + P174D + L176N + M177L + E180G + G181E + Q183P + N188D + K195R + I197K + Y200F + F201L + K202H + I203V + K206G + H207Y + T208Q + N211S + L212A + V213A + R214S + D215G + Q218T + S221N + E224K + L226I + V227F + D228K + I231L + R237N + Q239R + A243T + L244A + Δ245-246 + S247F + Y248P + L249P + T250R + G252D + D253Y + Δ254-257 + T259G + A260T + G261S + Y266F + Q271K + R273T + L276M + N280D + A292S + L293Q + D294N + S297A + T299L + T302S + L303V + T307E + V308I + E309D + Q321A + T323S + E324K + S325E + I326V + R346T + A348P + N354E + A372T + P384A + T393S + I402V + R403K + E406D + K417V + I434L + S438T + N439R + L441I + S443A + K444T + V445Q + G446T + L452K + L455S + F456L + K458H + S459G + N460K + K462R + T470N + E471V + I472P + Y473F + Q474S + A475P + G476D + S477G + T478K + N481T + G482P + Δ483 + E484P + G485A + F490W + Q493N + S494D + Q498Y + P499I + V503I + H519N + K529L + N532D + V534I + K537Q + E554P + N556S + K558R + L560Q + I569V + A570S + T572F + A575S + Q580K + L582S + T588S + N606S + Q607E + E619D + T632S + Y636H + S640N + R646Q + N657D + N658T + Q675H + Q677V + T678S + N679S + S680L + Δ681-684 + V687T + A688S + S689Q + Q690K + I693V + E702D + N703S + V705I + S711T + T719S + V722I + I726V + L727M + T732A + T739N + S750A + T768S + K776R + Q779R + I788M + P793T + I794L + S810L + S813T + I834M + D839E + A845N + E868D + Q872A + S875A + L878V + A879S + I882A + S884A + L922Q + S929K + G932S + K933Q + D936E + S939T + S940T + A942S + S943T + S1055A + A1070S + K1073R + D1084E + H1088Y + S1097F + H1101S + V1104I + Y1110F + E1111S + N1125S + V1133I + I1216V + M1233L + C1247A,1,=,5,ng/ml,1,=,2.5,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Adintrevimab,Wild Type (B.1),=,10.7,ng/ml,1,bCoV-RaTG13,32,F32S + S50L + T76I + Q218P + E324D + R346T + A372T + R403T + N439K + N440H + L441I + S443A + V445E + Y449F + S459A + T478K + V483Q + E484T + F486L + F490Y + Q493Y + S494R + Q498Y + N501D + Y505H + H519N + T604A + Δ681-684 + N1125S + V1228I,1,>,10000,ng/ml,1,>,934.6,,,
Liu22,10.1126/scitranslmed.abn6859,Pseudovirus (VSV),Fig2C,Adintrevimab,Wild Type (B.1),=,2,ng/ml,1,bCoV-RaTG13,32,F32S + S50L + T76I + Q218P + E324D + R346T + A372T + R403T + N439K + N440H + L441I + S443A + V445E + Y449F + S459A + T478K + V483Q + E484T + F486L + F490Y + Q493Y + S494R + Q498Y + N501D + Y505H + H519N + T604A + Δ681-684 + N1125S + V1228I,1,>,10000,ng/ml,1,>,1000,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b,Adintrevimab,Wild Type (B.1),=,7,ng/ml,1,Omicron/BA.2/F486V,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + F486V + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b,Adintrevimab,Wild Type (B.1),=,7,ng/ml,1,Omicron/BA.2/F486V+R493Q,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + F486V + Q493Q + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Cao22b,10.1038/s41586-022-04980-y,Pseudovirus (VSV),Suppmentary Table 2,Adintrevimab,Wild Type (B.1),=,10.7,ng/ml,1,Omicron/BA.2/G446S,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,934.6,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b,Adintrevimab,Wild Type (B.1),=,7,ng/ml,1,Omicron/BA.2/L452Q,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b,Adintrevimab,Wild Type (B.1),=,7,ng/ml,1,Omicron/BA.2/R493Q,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493Q + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b,Adintrevimab,Wild Type (B.1),=,7,ng/ml,1,Omicron/BA.2/S704L,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Sheward22c,10.1101/2022.09.16.508299,Pseudovirus,Figure 1B,Adintrevimab,Wild Type (B.1),=,56,ng/ml,1,Omicron/BA.2.10.4,19,T19I + L24S + Δ25-27 + W64R + Δ141-144 + V213G + Δ243-244 + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + S477N + T478K + E484A + F486P + S494P + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K + P1143L,1,>,1000,ng/ml,1,>,17.9,,,
Wang22d,10.1038/s41586-022-05053-w,Pseudovirus (VSV),Extended Data Fig 2b,Adintrevimab,Wild Type (B.1),=,7,ng/ml,1,Omicron/BA.2.11,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,1000,,,
Cao22c,10.1016/j.chom.2022.09.018,Pseudovirus (VSV),Figure 5b,Adintrevimab,Wild Type (B.1),=,11,ng/ml,1,Omicron/BA.2.38,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417T + N440K + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,10000,ng/ml,1,>,909.1,,,
Arora22f,10.1016/S1473-3099(22)00733-2,Pseudovirus (VSV),Figure B,Adintrevimab,Wild Type (B.1),=,14,ng/ml,1,Omicron/BA.2.75.2,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + F486S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K + D1199N,1,>,50000,ng/ml,1,>,1000,,,
Sheward22c,10.1101/2022.09.16.508299,Pseudovirus,Figure 1B,Adintrevimab,Wild Type (B.1),=,56,ng/ml,1,Omicron/BA.2.75.2,19,T19I + L24S + Δ25-27 + G142D + K147E + W152R + F157L + I210V + V213G + G257S + G339H + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + G446S + N460K + S477N + T478K + E484A + F486S + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K + D1199N,1,>,1000,ng/ml,1,>,17.9,,,
Arora22f,10.1016/S1473-3099(22)00733-2,Pseudovirus (VSV),Figure B,Adintrevimab,Wild Type (B.1),=,14,ng/ml,1,Omicron/BA.4.6,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N658S + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,50000,ng/ml,1,>,1000,,,
Sheward22c,10.1101/2022.09.16.508299,Pseudovirus,Figure 1B,Adintrevimab,Wild Type (B.1),=,56,ng/ml,1,Omicron/BA.4.6,19,T19I + L24S + Δ25-27 + Δ69-70 + G142D + V213G + G339D + R346T + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452R + S477N + T478K + E484A + F486V + Q498R + N501Y + Y505H + H655Y + N658S + N679K + P681H + N764K + D796Y + Q954H + N969K,1,>,1000,ng/ml,1,>,17.9,,,
Liu22,10.1126/scitranslmed.abn6859,Pseudovirus (VSV),Fig2A,Adintrevimab,Wild Type (B.1),=,2,ng/ml,1,Epsilon,13,S13I + W152C + L452R,1,=,3,ng/ml,1,=,1.5,,,
Liu22,10.1126/scitranslmed.abn6859,Pseudovirus (VSV),Fig2A,Adintrevimab,Wild Type (B.1),=,2,ng/ml,1,Iota/E484K,5,L5F + T95I + D253G + E484K + A701V,1,=,7,ng/ml,1,=,3.5,,,
Liu21f,10.1016/j.cell.2021.06.020,Pseudovirus (lentivirus),Table S1,Adintrevimab,Wild Type (B),=,2,ng/ml,1,B.1.1.519,478,T478K + P681H + T732A,1,=,3,ng/ml,1,=,1.5,,,
Liu22,10.1126/scitranslmed.abn6859,Pseudovirus (VSV),Fig2A,Adintrevimab,Wild Type (B.1),=,2,ng/ml,1,R.1,152,W152L + E484K + G769V,1,=,5,ng/ml,1,=,2.5,,,
Liu22,10.1126/scitranslmed.abn6859,Pseudovirus (VSV),Fig2C,Adintrevimab,Wild Type (B.1),=,2,ng/ml,1,Rs4084,2,F2K + V3L + F4L + L5V + V6L + L7V + L8F + P9A + L10T + V11L + S12V + Q14S + C15Y + V16T + N17I + L18ins + T19D + T20D + Q23P + L24P + P25A + P26N + A27T + Y28Q + T29F + N30L + F32S + T33H + K41D + V42I + S46N + S50L + T51V + L54H + F59D + W64R + H66I + A67T + I68F + H69G + V70L + S71N + Δ72-78 + V83I + L84I + N87R + V90I + S94A + I100V + I105V + T108S + L110M + D111N + S112N + T114S + L117V + L118I + V120M + A123S + V126L + K129R + V130A + E132N + Q134E + F135L + N137D + D138N + L141F + G142V + Y144L + Y145K + H146S + K147N + N149T + Δ150-153 + E154Q + S155I + E156P + F157S + R158Y + V159I + Y160F + S161N + S162N + N164F + Q173K + P174D + L176N + M177L + E180G + G181E + Q183P + N188D + K195R + I197K + Y200F + F201L + K202H + I203V + K206G + H207Y + T208Q + V213P + R214P + D215V + L216V + P217C + S221N + E224K + L226I + V227F + D228K + I231L + R237N + Q239R + A243T + L244A + H245F + Δ246-251 + G252P + D253P + S254R + S255P + S256D + G257Y + T259G + A260T + G261S + Y266F + Q271K + R273T + L276M + N280D + A292S + L293Q + D294N + S297A + T299L + T302S + L303V + T307E + V308I + E309D + Q321A + T323S + E324K + S325E + I326V + R346T + A348P + N354E + V367I + A372T + P384A + T393S + I402V + R403K + E406D + K417V + T430L + I434L + S438T + N440S + L441K + K444S + V445T + G446S + L455W + F456V + K458R + N460K + K462N + F464Y + I468L + T470N + E471D + Q474S + A475P + S477G + T478Q + P479S + N481S + G482A + Δ484 + F486P + F490N + Q493R + S494P + Q498F + P499T + N501A + Y505H + H519N + K529L + N532D + V534I + K537Q + E554P + N556S + K558R + L560Q + I569V + A570S + T572F + A575S + Q580K + L582S + T588S + N606S + Q607E + E619D + T632S + S640N + R646Q + N657D + N658T + Q675H + Q677V + T678S + N679S + S680L + Δ681-684 + V687T + A688S + S689Q + Q690K + I693V + E702D + N703S + V705I + S711T + T719S + V722I + I726V + L727M + T732A + T739N + S750A + T768S + K776R + Q779R + I788M + P793T + I794L + S810L + S813T + I834M + D839E + A845N + E868D + Q872A + S875A + L878V + A879S + I882A + S884A + L922Q + S929K + G932S + K933Q + D936E + S939T + S940T + A942S + S943T + S1055A + A1070S + K1073R + D1084E + H1088Y + S1097F + H1101S + V1104I + Y1110F + E1111S + N1125S + V1133I + I1216V + M1233L + C1247A,1,=,5,ng/ml,1,=,2.5,,,
Liu22,10.1126/scitranslmed.abn6859,Pseudovirus (VSV),Fig2C,Adintrevimab,Wild Type (B.1),=,2,ng/ml,1,Rs4231,3,V3I + V6F + L7F + P9T + V11T + S12ins + S13E + Q14S + V16T + N17T + L18F + T19D + T20D + R21V + T22Q + Q23A + L24P + P25N + P26Y + A27P + Y28Q + T29H + N30S + F32S + T33R + K41E + V42I + S46D + V47T + H49Y + S50L + F59Y + W64G + A67T + H69N + Δ70-76 + K77H + L84I + N87K + S94A + I100V + I101V + I105V + T108S + L110M + D111N + S112N + T114S + L117V + L118I + V120I + A123S + K129R + V130A + E132N + Q134E + F135L + N137D + D138N + L141F + G142A + Y144S + Y145K + H146P + K147T + N148G + N149T + K150Q + S151T + W152H + M153T + E154M + S155I + E156F + F157D + R158N + V159A + Y160F + S161N + S162C + A163T + N164F + Δ165-168 + V171I + Q173D + P174S + L176S + M177L + L179V + E180A + G181E + Q183S + N188H + I197K + Y200F + F201L + K202Y + I203V + S205K + K206G + H207Y + T208Q + N211D + L212V + Q218S + S221N + A222I + E224K + L226I + V227F + D228K + I231L + R237N + Q239R + T240A + L241I + A243T + L244A + H245F + R246L + Δ247-252 + D253P + S254A + S255Q + S256D + G257T + T259G + A260T + G261S + Y266F + Q271K + R273A + L276M + N280D + A292S + L293Q + D294N + S297A + T299L + T302S + L303V + T307E + V308I + E309D + Q321A + T323S + E324K + S325E + I326V + R346T + A348P + N354E + A372T + P384A + T393S + I402V + R403K + E406D + K417V + T430L + I434L + S438T + N440S + L441K + K444S + V445T + G446S + L455W + F456V + K458R + N460K + K462N + F464Y + I468L + T470N + E471D + Q474S + A475P + S477G + T478Q + P479S + N481S + G482A + V483I + Δ484 + F486P + F490N + Q493R + S494P + Q498F + P499T + N501A + Y505H + H519N + K529L + N532D + V534I + K537Q + E554S + N556S + K558R + L560Q + I569V + A570S + T572F + A575S + Q580K + L582S + T588S + N606S + Q607E + E619D + T632A + V635I + S640N + R646Q + N657D + N658T + Q675H + Q677V + T678S + N679S + S680L + Δ681-684 + V687T + A688S + S689Q + Q690K + I693V + E702D + N703S + V705I + S711T + T719S + V722I + I726V + L727M + T732A + T739N + S750A + T768S + K776R + Q779R + I788M + P793A + I794L + S810L + S813T + I834M + D839E + I844V + A845N + E868D + Q872A + S875A + L878V + A879S + I882A + S884A + L922Q + S929K + G932S + K933Q + D936E + S939T + S940T + A942S + S943T + S1055A + Y1067C + A1070S + K1073R + D1084E + H1088Y + S1097F + H1101S + V1104I + Y1110F + E1111S + N1125S + V1133I + I1216V + M1233L + C1247A,1,=,9,ng/ml,1,=,4.5,,,
Liu22,10.1126/scitranslmed.abn6859,Pseudovirus (VSV),Fig2C,Adintrevimab,Wild Type (B.1),=,2,ng/ml,1,Rs7327,2,F2K + V3L + F4L + L5V + V6L + L7V + L8F + P9A + L10T + V11L + S12V + Q14ins + V16L + N17D + L18F + T19D + T20D + Q23P + L24P + P25A + P26N + A27T + Y28Q + T29F + N30L + F32S + T33H + K41D + V42I + S46N + S50L + T51V + L54H + F59D + W64R + H66I + A67T + I68F + H69G + V70L + S71N + Δ72-78 + V83I + L84I + N87R + V90I + S94A + I100V + I105V + T108S + L110M + D111N + S112N + T114S + L117V + L118I + V120M + A123S + V126L + K129R + V130A + E132N + Q134E + F135L + N137D + D138N + L141F + G142V + Y144L + Y145K + H146S + K147N + N149T + Δ150-153 + E154Q + S155I + E156P + F157S + R158Y + V159I + Y160F + S161N + S162N + N164F + Q173K + P174D + L176N + M177L + E180G + G181E + Q183P + N188D + K195R + I197K + Y200F + F201L + K202H + I203V + K206G + H207Y + T208Q + V213L + R214P + D215V + L216V + P217C + G219L + F220V + S221L + A222M + L223H + E224L + P225N + V227F + D228L + L229S + P230Y + I231L + G232W + I233V + N234L + T236L + R237L + F238I + Q239S + T240E + L241H + L242F + A243stop + H245L + Δ246 + S247F + Y248R + Δ250-252 + Δ254 + S255X + S256D + G257Y + T259G + A260T + G261S + Y266F + Q271K + R273T + L276M + N280D + A292S + L293Q + D294N + S297A + T299L + T302S + L303V + T307E + V308I + E309D + Q321A + T323S + E324K + S325E + I326V + R346T + A348P + N354E + A372T + P384A + T393S + I402V + R403K + E406D + K417V + T430M + I434L + S438T + N439R + L441I + S443A + K444T + V445S + G446T + L452K + L455S + F456L + K458H + S459G + N460K + K462R + T470N + E471V + I472P + Y473F + Q474S + A475P + G476D + S477G + T478K + N481T + Δ482 + V483P + E484P + G485A + F490W + Q493N + S494D + Q498F + P499T + V503I + H519N + K529L + N532D + V534I + K537Q + E554S + N556S + K558R + L560Q + I569V + A570S + T572F + A575S + Q580K + L582S + T588S + N606S + Q607E + E619D + T632A + V635I + S640N + R646Q + N657D + N658T + Q675H + Q677V + T678S + N679S + S680L + Δ681-684 + V687T + A688S + S689Q + Q690K + I693V + E702D + N703S + V705I + A706V + S711T + T719S + V722I + I726V + L727M + T732A + T739N + S750A + T768S + K776R + Q779R + I788M + P793T + I794L + S810L + S813T + I834M + D839E + A845N + E868D + Q872A + S875A + L878V + A879S + I882A + S884A + L922Q + S929K + G932S + K933Q + D936E + S939T + S940T + A942S + S943T + S1055A + A1070S + K1073R + D1084E + H1088Y + S1097F + H1101S + V1104I + Y1110F + E1111S + V1133I + I1216V + M1233L + C1247A,1,=,2,ng/ml,1,=,1,,,
Liu22,10.1126/scitranslmed.abn6859,Pseudovirus (VSV),Fig2C,Adintrevimab,Wild Type (B.1),=,2,ng/ml,1,SHC014,2,F2K + V3L + F4L + L5V + V6L + L7V + L8F + P9A + L10T + V11L + S12V + Q14S + C15Y + V16T + N17I + L18ins + T19D + T20D + Q23P + L24P + P25A + P26N + A27T + Y28Q + T29F + N30L + F32S + T33H + K41D + V42I + S46N + S50L + T51V + L54H + F59D + W64R + H66I + A67T + I68F + H69G + V70L + S71N + Δ72-78 + V83I + L84I + N87R + V90I + S94A + I100V + I105V + T108S + L110M + D111N + S112N + T114S + L117V + L118I + V120M + A123S + V126L + K129R + V130A + E132N + Q134E + F135L + N137D + D138N + L141F + G142V + Y144L + Y145K + H146S + K147N + N149T + Δ150-153 + E154Q + S155I + E156P + F157S + R158Y + V159I + Y160F + S161N + S162N + N164F + Q173K + P174D + L176N + M177L + E180G + G181E + Q183P + N188D + K195R + I197K + Y200F + F201L + K202H + I203V + K206G + H207Y + T208Q + V213L + R214P + D215V + L216V + P217C + S221N + E224K + L226I + V227F + D228K + I231L + R237N + Q239R + A243T + L244A + H245F + Δ246-251 + G252P + D253P + S254R + S255P + S256D + G257Y + T259G + A260T + G261S + Y266F + Q271K + R273T + L276M + N280D + A292S + L293Q + D294N + S297A + T299L + T302S + L303V + T307E + V308I + E309D + Q321A + T323S + E324K + S325E + I326V + R346T + A348P + N354E + A372T + P384A + T393S + I402V + R403K + E406D + K417V + T430L + I434L + S438T + N440S + L441K + K444S + V445T + G446S + L455W + F456V + K458R + N460K + K462N + F464Y + I468L + T470N + E471D + Q474S + A475P + S477G + T478Q + P479S + N481S + G482A + Δ484 + F486P + F490N + Q493R + S494P + Q498F + P499T + N501A + Y505H + H519N + K529L + N532D + V534I + K537Q + E554P + N556S + K558R + L560Q + I569V + A570S + T572F + A575S + Q580K + L582S + T588S + N606S + Q607E + E619D + T632S + S640N + R646Q + N657D + N658T + Q675H + Q677V + T678S + N679S + S680L + Δ681-684 + V687T + A688S + S689Q + Q690K + I693V + E702D + N703S + V705I + S711T + T719S + V722I + I726V + L727M + T732A + T739N + S750A + T768S + K776R + Q779R + I788M + P793T + I794L + S810L + S813T + I834M + D839E + A845N + E868D + Q872A + S875A + L878V + A879S + I882A + S884A + L922Q + S929K + G932S + K933Q + D936E + S939T + S940T + A942S + S943T + S1055A + A1070S + K1073R + D1084E + H1088Y + S1097F + H1101S + V1104I + Y1110F + E1111S + N1125S + V1133I + I1216V + M1233L + C1247A,1,=,6,ng/ml,1,=,3,,,
Liu22,10.1126/scitranslmed.abn6859,Pseudovirus (VSV),Fig2C,Adintrevimab,Wild Type (B.1),=,2,ng/ml,1,LYRa11,3,V3L + F4T + L5C + V6F + L7I + P9S + L10ins + V11S + S12I + S13D + Q14T + V16E + N17T + L18F + T19D + T20D + R21V + T22S + Q23P + L24P + P25Q + P26Q + A27N + Y28L + T29V + N30S + F32S + T33K + K41D + V42I + F43Y + S46D + L48H + S50L + T51V + F59N + Δ63-69 + S71G + G72L + T73M + N74S + G75F + T76N + K77Y + V83I + L84I + N87K + S94A + I100V + I101V + I105V + T108S + L110M + D111N + S112N + T114S + L117V + L118I + V120M + A123S + K129R + V130A + E132N + F135L + N137D + D138N + L141F + G142A + Y144I + Δ145-148 + N149R + K150P + S151T + W152S + M153Q + E154Q + S155I + F157T + R158I + V159L + Y160F + S161E + S162N + N164F + Q173D + P174S + L179V + E180G + G181E + Q183P + N188H + V193I + I197K + Y200F + F201L + K202N + K206G + H207F + T208Q + P209N + N211D + L212V + V213A + R214N + D215G + Q218S + A222L + E224K + V227L + D228K + I231L + I233L + R237N + Q239R + T240V + A243T + L244A + H245F + R246I + S247P + Y248N + L249I + Δ250-253 + S254G + S255T + Δ256-257 + T259G + A260T + G261S + A262P + A263V + Y266F + Q271K + R273T + L276M + N280D + E281Y + T286V + A292S + L293Q + D294H + S297A + T299L + T302S + L303V + T307E + V308I + E309D + Q321S + T323S + E324K + S325E + I326V + R346T + A348P + N354E + A372T + P384A + T385I + T393S + I402V + R403K + E406D + K417V + T430M + I434L + S438T + N439R + L441I + S443A + K444T + V445S + G446S + Y449F + L452K + L455S + F456L + K458H + S459G + N460K + K462R + T470N + E471V + I472P + Y473F + Q474S + A475P + G476D + S477G + T478K + N481T + Δ482 + V483P + E484P + G485A + F490W + Q493N + S494D + Q498Y + P499T + V503I + H519N + K529L + N532D + V534I + K535T + K537Q + E554P + N556L + K558R + L560Q + I569F + A570S + T572F + A575S + Q580K + I584V + T588S + T604I + N606S + Q607E + E619D + V622T + T632A + V635I + T638A + S640V + R646Q + N658A + Q675H + Q677A + T678S + N679L + S680L + Δ681-684 + S686N + V687T + A688D + S689Q + Q690K + I693V + V705I + S708A + T719S + V722I + I726V + L727M + T732A + T747Q + T768S + P793A + S813T + I834M + D839E + A845S + Q872A + S875A + L878V + A879S + I882A + S884A + L922Q + S929K + G932S + K933Q + D936E + S939T + S940T + A942S + S943T + S1055A + A1070S + K1073R + D1084E + H1088Y + H1101S + V1104I + Y1110F + E1111S + I1114L + V1133I + G1171R + I1216V + V1230A + M1233L + C1247A,1,=,2,ng/ml,1,=,1,,,